data_6v5l_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6v5l _Structure_validation_residue.Date_analyzed 2019-12-13 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.773 0.321 . . . . 1.8899999999999999 110.462 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.03 145.17 27.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.259 -0.428 . . . . 1.24 110.73 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -105.58 131.69 52.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.177 -0.465 . . . . 1.27 110.584 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -116.12 116.54 28.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.16 -0.473 . . . . 1.45 110.045 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -97.11 110.68 23.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.137 -0.483 . . . . 1.1799999999999999 110.411 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -127.11 142.79 51.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.872 -0.603 . . . . 2.1099999999999999 111.003 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.8 t -121.91 134.52 64.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.972 0.415 . . . . 1.28 111.027 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.7 t -93.74 103.97 15.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.235 -1.024 . . . . 0.77000000000000002 108.235 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.73 146.49 15.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.278 -0.419 . . . . 0.94999999999999996 111.351 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.94 -175.09 42.87 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.771 -0.728 . . . . 0.56000000000000005 111.299 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.78 158.17 36.08 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.01 0.433 . . . . 0.66000000000000003 111.321 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.29 134.41 15.62 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.55 -0.833 . . . . 0.80000000000000004 111.884 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.69 2.06 60.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.794 -0.717 . . . . 0.45000000000000001 113.568 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -79.25 -24.11 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 117.285 0.542 . . . . 0.98999999999999999 110.91 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.99 25.77 4.35 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.688 -0.768 . . . . 0.48999999999999999 113.467 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -53.44 -55.53 24.42 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 111.891 0.33 . . . . 1.3799999999999999 111.891 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.41 ' O ' HG13 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -59.59 -53.47 57.65 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.888 -0.596 . . . . 0.85999999999999999 112.048 -178.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.83 -43.55 77.09 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.778 0.659 . . . . 0.95999999999999996 112.778 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.1 mt -59.81 -41.27 90.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.823 0.344 . . . . 1.21 111.632 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 m -76.83 -46.2 25.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.411 -0.359 . . . . 1.2 111.657 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 17' ' ' SER . 79.4 mt -60.14 -27.61 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.937 0.399 . . . . 1.3799999999999999 111.631 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.2 -35.07 79.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.915 0.388 . . . . 0.52000000000000002 111.143 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -91.56 -6.39 52.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.992 0.425 . . . . 1.8799999999999999 111.347 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.1 mm -102.81 -43.41 9.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.329 -0.396 . . . . 0.57999999999999996 111.129 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -105.31 -4.78 21.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.513 -0.312 . . . . 1.74 111.676 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.3 t30 64.15 35.27 10.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.024 0.75 . . . . 1.9199999999999999 113.024 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -162.81 154.58 18.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.034 0.445 . . . . 0.85999999999999999 110.817 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -87.81 128.96 35.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.659 -0.701 . . . . 0.77000000000000002 111.205 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.8 120.82 47.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.252 -0.886 . . . . 1.04 109.032 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -77.01 -40.73 45.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 1.1200000000000001 111.176 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -127.5 117.94 23.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.276 -0.42 . . . . 1.1799999999999999 110.537 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -143.29 143.96 31.92 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.297 -0.631 . . . . 0.80000000000000004 109.297 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.76 124.04 66.48 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.847 0.356 . . . . 0.80000000000000004 111.158 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.26 -13.69 9.87 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.883 2.389 . . . . 0.56000000000000005 113.79 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.7 p -98.19 1.15 47.08 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.805 -0.358 . . . . 1.21 111.777 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 mt -83.56 132.13 32.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.073 0.463 . . . . 1.1499999999999999 110.353 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 10.0 tt0 -121.87 82.24 1.93 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.37 -0.832 . . . . 0.81000000000000005 109.069 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -103.45 155.67 18.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.535 -0.757 . . . . 1.29 111.422 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.34 121.45 45.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.173 -0.467 . . . . 1.1699999999999999 110.397 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -108.14 144.84 34.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.744 0.306 . . . . 0.97999999999999998 110.349 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -119.51 141.18 49.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.838 0.351 . . . . 0.69999999999999996 110.531 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -143.48 134.63 25.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.11 -0.495 . . . . 1.78 110.072 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -106.49 122.63 46.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.865 0.364 . . . . 2.3900000000000001 110.409 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -137.39 133.01 46.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 1.3799999999999999 111.232 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 t -85.48 71.58 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.477 0.656 . . . . 0.65000000000000002 109.5 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 pt -88.26 130.88 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.781 -0.645 . . . . 1.47 111.529 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 63.48 31.59 14.81 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.55 -0.75 . . . . 0.96999999999999997 111.077 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.7 11.12 83.3 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.852 -0.613 . . . . 0.59999999999999998 113.097 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -117.28 119.73 36.04 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 122.586 -0.361 . . . . 1.4099999999999999 110.783 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.8 m -79.83 96.73 6.4 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.6 -0.518 . . . . 0.89000000000000001 109.6 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 58.6 m -114.05 158.49 21.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.225 -0.443 . . . . 1.3100000000000001 112.056 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.0 tp -112.64 119.88 39.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.27 -0.877 . . . . 0.85999999999999999 108.885 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 12.3 mt -90.65 131.32 36.42 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.056 0.455 . . . . 1.1299999999999999 111.919 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -114.39 103.29 10.91 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.088 -1.079 . . . . 1.03 108.088 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 3.4 mt -110.9 151.33 13.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.305 -0.407 . . . . 1.1799999999999999 111.706 -177.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.1 tp -131.22 119.37 21.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.332 -0.394 . . . . 0.75 110.327 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 4.6 t0 -84.68 98.3 10.14 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.57 -0.53 . . . . 0.44 109.57 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 36.0 p -64.85 141.18 58.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.778 -0.646 . . . . 0.84999999999999998 112.347 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.88 -58.39 2.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.364 -0.835 . . . . 1.04 109.537 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.23 -47.11 0.53 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.752 -0.658 . . . . 0.71999999999999997 112.262 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -135.93 129.09 31.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.741 0.305 . . . . 1.5 110.59 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -102.44 175.7 5.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.394 -0.595 . . . . 1.5700000000000001 109.394 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -65.57 -43.45 89.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.927 0.394 . . . . 1.3799999999999999 110.2 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -128.72 145.35 51.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.038 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -38.33 89.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.309 -0.405 . . . . 0.90000000000000002 110.893 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.57 -28.28 68.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.186 -0.461 . . . . 0.35999999999999999 111.402 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 82.9 mtp -73.79 -38.32 64.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.93 0.395 . . . . 1.04 110.264 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -71.09 -43.77 67.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.893 -0.594 . . . . 1.0700000000000001 109.821 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.83 -19.5 65.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.362 -0.835 . . . . 1.4099999999999999 111.39 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -59.95 -57.36 13.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.466 -0.334 . . . . 1.77 111.373 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -75.05 -5.02 41.83 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.779 -0.368 . . . . 1.27 111.425 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.5 mtt -76.37 -25.24 54.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.361 -0.607 . . . . 1.28 109.361 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -87.7 -42.32 12.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.605 -0.725 . . . . 1.8600000000000001 110.451 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.17 -20.71 63.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.863 -0.608 . . . . 1.01 112.24 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.78 124.57 18.04 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.798 -0.715 . . . . 0.20000000000000001 112.491 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -88.91 -39.83 13.51 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.794 -0.447 . . . . 0.54000000000000004 109.794 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -128.78 137.58 9.73 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.815 -0.914 . . . . 0.31 110.815 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.417 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 93.9 m-85 -120.75 129.67 53.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.139 0.495 . . . . 0.60999999999999999 111.38 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.6 tp -97.02 110.74 23.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.473 -0.785 . . . . 1.04 108.982 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 3.8 m -96.91 92.36 6.07 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.102 -0.499 . . . . 1.1799999999999999 110.981 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.1 t -98.92 136.26 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.909 -0.587 . . . . 1.03 111.369 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -130.71 172.17 12.28 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.898 -0.779 . . . . 0.41999999999999998 108.898 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.17 122.86 46.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.596 0.236 . . . . 0.76000000000000001 110.514 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.2 pt -66.54 -17.73 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.069 0.462 . . . . 1.1499999999999999 111.562 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -98.14 4.12 49.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.957 0.408 . . . . 0.93999999999999995 110.236 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -135.34 90.38 2.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.737 -0.665 . . . . 1.3799999999999999 110.073 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.61 -28.29 67.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.024 -0.535 . . . . 0.75 112.071 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -59.08 -38.72 80.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 1.4199999999999999 110.559 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.5 p -75.27 -25.87 58.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.71999999999999997 111.326 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -74.99 -34.67 62.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.056 0.455 . . . . 0.51000000000000001 110.721 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -74.6 -24.43 58.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.007 0.432 . . . . 1.4399999999999999 110.438 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -71.5 -14.48 62.13 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.868 -0.606 . . . . 1.02 111.257 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 30.3 mm -58.14 -35.72 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.021 -0.536 . . . . 1.04 110.406 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -61.34 -45.02 96.14 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.073 -0.512 . . . . 1.0900000000000001 110.565 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -63.77 -48.26 77.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.907 -0.588 . . . . 0.98999999999999999 111.75 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -60.53 -52.06 66.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.162 0.43 . . . . 1.73 112.162 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -55.43 -47.55 75.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.208 0.318 . . . . 0.66000000000000003 110.754 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.05 -43.9 86.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.047 -0.524 . . . . 1.3500000000000001 111.763 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.49 ' O ' HG21 ' A' ' 103' ' ' VAL . 56.1 tt0 -63.44 -54.51 35.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 1.3999999999999999 112.165 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.31 -34.41 60.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.642 0.258 . . . . 0.78000000000000003 110.955 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -62.14 -35.35 78.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.066 0.46 . . . . 1.6000000000000001 110.217 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -73.88 -41.15 62.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.617 -0.719 . . . . 1.0900000000000001 110.905 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 99' ' ' GLN . 46.8 t -60.72 -41.92 90.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.89000000000000001 111.382 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -89.21 -14.86 35.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.504 -0.316 . . . . 1.3500000000000001 111.352 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.4 t70 58.82 54.84 4.94 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.748 0.785 . . . . 0.46999999999999997 109.836 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.7 m -154.83 140.26 17.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.6 -0.727 . . . . 1.4399999999999999 110.895 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -88.22 -23.31 23.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.25 0.548 . . . . 1.74 110.003 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -101.06 85.3 2.81 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.487 -0.779 . . . . 0.78000000000000003 109.939 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.5 t -117.71 119.24 34.25 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.625 -0.716 . . . . 0.63 110.098 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.06 115.96 2.89 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.115 2.543 . . . . 0.29999999999999999 112.286 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.417 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 36.5 mtt -146.11 153.05 40.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.777 -0.647 . . . . 1.1899999999999999 110.457 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.9 t -132.88 125.79 52.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.895 -0.78 . . . . 0.63 108.895 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.8 tp -82.72 125.82 31.68 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.545 -0.539 . . . . 0.66000000000000003 109.545 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.2 t -122.83 127.03 74.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.173 -0.467 . . . . 1.3700000000000001 112.223 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.88 96.69 1.26 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.671 -0.971 . . . . 0.27000000000000002 110.671 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -81.71 166.47 20.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.067 0.433 . . . . 0.23999999999999999 111.671 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.6 mttt 72.58 31.79 1.65 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.042 -0.981 . . . . 1.1499999999999999 111.645 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 15.8 p -70.91 -10.13 59.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.887 0.375 . . . . 1.29 111.008 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -94.71 -2.05 51.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.69999999999999996 110.621 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 33.1 mt -104.82 155.34 37.67 Favored Pre-proline 0 C--O 1.236 0.372 0 CA-C-N 116.085 -0.507 . . . . 1.3100000000000001 111.07 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -87.31 -169.83 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.598 2.199 . . . . 0.79000000000000004 112.03 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 m 60.09 45.6 11.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.79 -0.641 . . . . 1.29 111.167 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -76.75 111.81 12.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.587 -0.733 . . . . 0.68000000000000005 110.73 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.6 p -92.77 -31.04 15.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.094 0.473 . . . . 1.28 110.406 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.22 108.19 19.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.988 -0.551 . . . . 0.96999999999999997 109.958 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -71.87 150.11 44.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.86 0.362 . . . . 1.6899999999999999 110.511 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.1 m -57.3 -39.43 75.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.724 -0.671 . . . . 1.6499999999999999 111.631 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -59.46 -41.62 90.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.263 -0.426 . . . . 0.71999999999999997 111.642 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -60.57 -47.02 88.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 1.1100000000000001 110.762 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.07 82.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.962 -0.563 . . . . 0.35999999999999999 111.296 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.04 -40.79 98.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.919 -0.582 . . . . 0.5 109.976 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.38 -42.52 96.01 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.737 -0.665 . . . . 1.1799999999999999 110.95 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 29.1 tp -66.96 -46.09 75.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.882 -0.599 . . . . 0.81000000000000005 110.605 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.21 94.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.882 -0.599 . . . . 0.66000000000000003 111.43 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.1 mtm105 -64.11 -30.33 71.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 2.0699999999999998 110.934 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.5 m -75.15 -34.23 61.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.25 -0.432 . . . . 1.28 110.91 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -78.16 -24.64 47.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.231 -0.44 . . . . 1.0900000000000001 110.715 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.33 37.1 8.38 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.828 -0.909 . . . . 0.33000000000000002 110.828 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.6 pp -135.73 162.62 55.94 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.419 -0.39 . . . . 1.04 110.377 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.61 152.93 11.78 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.09 2.526 . . . . 0.69999999999999996 112.73 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -134.49 130.59 36.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.513 -0.767 . . . . 0.45000000000000001 110.4 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.62 137.2 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.47 -0.332 . . . . 0.85999999999999999 110.169 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -77.31 141.89 39.69 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.843 -0.799 . . . . 0.88 108.843 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 64.8 p -138.47 171.69 13.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.792 0.806 . . . . 0.76000000000000001 112.768 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.1 t -153.58 118.31 5.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.702 -1.136 . . . . 0.35999999999999999 108.827 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.62 -23.54 62.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.042 0.448 . . . . 0.55000000000000004 110.85 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -75.51 -39.93 57.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.177 -0.465 . . . . 1.8300000000000001 111.621 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 61.9 p -102.32 -8.0 21.59 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.94 0.348 . . . . 0.73999999999999999 111.94 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 65.1 23.13 12.38 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.419 0.628 . . . . 2.0800000000000001 110.517 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 144' ' ' THR . 44.3 tt0 -81.45 127.46 32.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.11 -0.496 . . . . 1.04 111.237 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.14 -25.73 2.24 Favored Glycine 0 CA--C 1.518 0.268 0 CA-C-N 116.014 -0.539 . . . . 0.66000000000000003 113.899 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.406 HG21 ' HB ' ' A' ' 144' ' ' THR . 6.6 t -57.09 -41.97 78.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 1.0700000000000001 111.426 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -61.9 -46.49 89.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.364 0.602 . . . . 1.6200000000000001 110.12 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.39 -45.87 82.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.291 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -54.72 -50.99 67.0 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.233 -0.439 . . . . 0.46000000000000002 111.71 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -62.43 -39.34 92.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 2.1000000000000001 111.292 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -68.11 -40.95 82.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.977 0.418 . . . . 1.55 110.498 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 46.5 m -62.16 -40.15 95.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.903 -0.589 . . . . 0.39000000000000001 110.443 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.498 ' O ' HG13 ' A' ' 163' ' ' ILE . 43.5 tp -59.12 -43.35 91.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.763 0.316 . . . . 0.90000000000000002 110.793 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.2 t -62.12 -43.25 97.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.031 0.443 . . . . 0.97999999999999998 110.468 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -67.24 -34.53 77.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 1.0700000000000001 110.668 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -65.73 -36.41 83.52 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.242 -0.651 . . . . 0.72999999999999998 109.242 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 159' ' ' LEU . 96.2 mt -64.12 -48.63 84.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 109.112 -0.699 . . . . 0.84999999999999998 109.112 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -60.77 -43.52 97.93 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.566 -0.743 . . . . 0.98999999999999999 109.929 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.571 ' O ' ' HG3' ' A' ' 169' ' ' LYS . 33.8 ttmt -55.66 -42.51 75.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.778 -0.646 . . . . 1.55 110.466 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.457 ' HA ' ' HD2' ' A' ' 169' ' ' LYS . 42.4 t60 -70.9 -31.26 67.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.84999999999999998 111.435 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -87.39 -4.7 59.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.479 -0.328 . . . . 1.73 111.543 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -117.47 14.1 14.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.051 0.453 . . . . 1.1200000000000001 111.142 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 165' ' ' LYS . 7.8 mtpp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.414 -0.803 . . . . 1.8799999999999999 109.781 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.552 ' HA ' ' O ' ' A' ' 50' ' ' THR . 42.9 ttm . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.886 -0.413 . . . . 1.8899999999999999 109.886 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.6 145.52 34.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.513 -0.312 . . . . 1.24 111.466 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -100.16 138.89 36.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.213 -0.662 . . . . 1.27 109.213 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -123.1 125.36 45.03 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.886 0.374 . . . . 1.45 110.356 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -88.44 102.73 15.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.296 0.57 . . . . 1.1799999999999999 110.533 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 8.0 mp -107.89 131.87 54.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.585 -0.734 . . . . 2.1099999999999999 110.382 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.45 124.62 64.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.277 -0.419 . . . . 1.28 110.913 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.6 t -95.17 119.75 43.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.22 -0.445 . . . . 0.77000000000000002 109.958 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.4 ' HB ' ' CD1' ' A' ' 96' ' ' TYR . 12.0 m -112.54 155.04 13.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.953 0.406 . . . . 0.94999999999999996 110.779 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.79 -176.12 37.43 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.281 -0.962 . . . . 0.56000000000000005 112.537 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.595 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -80.24 161.54 25.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.127 0.489 . . . . 0.66000000000000003 111.132 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.74 109.13 2.75 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.748 -0.739 . . . . 0.80000000000000004 112.055 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.62 -2.7 17.87 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.582 -0.818 . . . . 0.45000000000000001 113.391 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 11' ' ' ALA . 12.8 m -72.44 -28.19 27.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 117.32 0.56 . . . . 0.98999999999999999 110.554 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.79 25.38 4.26 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.124 -1.036 . . . . 0.48999999999999999 114.135 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -55.22 -55.6 29.47 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.066 0.46 . . . . 1.3799999999999999 110.912 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -59.84 -36.42 76.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.245 -0.888 . . . . 0.85999999999999999 111.719 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.66 -42.97 95.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.95999999999999996 110.96 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.6 mt -66.66 -41.24 88.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.23 -0.441 . . . . 1.21 110.825 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.4 m -68.68 -46.04 70.1 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.886 -0.597 . . . . 1.2 111.767 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 82.1 mt -66.2 -24.83 34.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.712 0.291 . . . . 1.3799999999999999 110.997 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 3.9 mm-40 -61.31 -35.42 77.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.797 0.332 . . . . 0.52000000000000002 111.039 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 mp -84.86 -15.44 44.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.921 0.391 . . . . 1.8799999999999999 111.17 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.4 mm -95.42 -56.45 5.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 112.207 0.447 . . . . 0.57999999999999996 112.207 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -96.09 -10.28 28.74 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.815 0.302 . . . . 1.74 111.815 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 32.7 m-20 59.95 36.51 21.67 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.736 0.643 . . . . 1.9199999999999999 112.736 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.88 136.35 15.05 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.655 -0.498 . . . . 0.85999999999999999 109.655 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -70.54 125.3 26.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.077 -0.511 . . . . 0.77000000000000002 111.033 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.3 t -90.43 113.03 25.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.068 -0.715 . . . . 1.04 109.068 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -75.27 -36.91 61.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.421 -0.354 . . . . 1.1200000000000001 111.503 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -124.54 114.44 19.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.768 0.318 . . . . 1.1799999999999999 110.432 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -143.83 130.17 19.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.328 -0.396 . . . . 0.80000000000000004 110.371 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.511 ' HB3' HG13 ' A' ' 36' ' ' ILE . 39.2 t0 -65.05 125.75 89.84 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-N 115.523 -0.762 . . . . 0.80000000000000004 110.62 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.39 -18.46 26.26 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.923 2.415 . . . . 0.56000000000000005 113.507 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.1 p -84.36 0.12 50.51 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.77 0.319 . . . . 1.21 111.595 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.511 HG13 ' HB3' ' A' ' 33' ' ' ASP . 83.5 mt -83.07 122.88 38.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 110.084 -0.339 . . . . 1.1499999999999999 110.084 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -122.76 112.72 18.25 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.469 -0.787 . . . . 0.81000000000000005 109.61 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -144.4 167.21 23.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.836 0.351 . . . . 1.29 110.993 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 1.4 m -117.89 122.62 43.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.3 -0.63 . . . . 1.1699999999999999 109.3 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -103.22 132.74 49.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.325 -0.398 . . . . 0.97999999999999998 110.314 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.28 134.48 51.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.024 -0.535 . . . . 0.69999999999999996 110.662 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -148.47 129.63 14.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.935 -0.575 . . . . 1.78 110.002 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.403 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -92.44 134.53 34.86 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.725 -0.472 . . . . 2.3900000000000001 109.725 179.052 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.59 151.8 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.799 0.333 . . . . 1.3799999999999999 110.864 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.5 t -111.41 91.7 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.928 -0.578 . . . . 0.65000000000000002 109.874 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.24 121.77 54.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.102 -0.499 . . . . 1.47 109.946 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 64.75 23.51 12.74 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.723 -0.671 . . . . 0.96999999999999997 111.316 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.93 -17.18 59.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.844 -0.693 . . . . 0.59999999999999998 112.491 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -82.58 126.19 32.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.942 0.401 . . . . 1.4099999999999999 110.862 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' A' ' 1' ' ' MET . 5.0 m -93.59 103.34 15.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.115 -0.493 . . . . 0.89000000000000001 109.891 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.0 m -121.71 156.65 32.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.194 0.521 . . . . 1.3100000000000001 112.188 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.1 tp -108.43 118.66 37.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.181 -0.918 . . . . 0.85999999999999999 108.712 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.23 121.66 33.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.001 0.429 . . . . 1.1299999999999999 111.418 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -106.88 105.4 15.42 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.125 -1.065 . . . . 1.03 108.125 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 55.4 mt -112.81 130.46 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.978 0.418 . . . . 1.1799999999999999 111.819 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 23.7 tp -106.24 118.14 35.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.925 -0.579 . . . . 0.75 110.505 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.31 93.33 9.36 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.918 -0.771 . . . . 0.44 108.918 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.29 146.31 52.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.896 -0.593 . . . . 0.84999999999999998 111.674 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.21 -46.8 9.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.819 -0.628 . . . . 1.04 110.624 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.79 -70.1 0.34 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.696 -0.764 . . . . 0.71999999999999997 112.161 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -97.99 111.04 23.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.908 0.385 . . . . 1.5 110.849 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.67 166.07 19.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.042 -0.526 . . . . 1.5700000000000001 110.56 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.401 ' HB3' ' SD ' ' A' ' 67' ' ' MET . 25.0 tt0 -62.8 -45.89 90.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.641 -0.503 . . . . 1.3799999999999999 109.641 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -127.85 142.8 51.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.063 -0.718 . . . . 1.0 109.063 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 m -61.56 -26.31 67.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.065 0.459 . . . . 0.90000000000000002 111.102 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.79 -29.89 69.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.914 -0.584 . . . . 0.35999999999999999 110.965 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' A' ' 63' ' ' GLU . 74.3 mtp -69.96 -41.38 74.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.895 -0.593 . . . . 1.04 110.006 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.641 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 36.3 ttp180 -64.43 -39.42 93.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.538 0.685 . . . . 1.0700000000000001 109.571 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.22 -19.01 64.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.775 -1.102 . . . . 1.4099999999999999 111.235 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -77.02 -55.8 5.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.329 -0.396 . . . . 1.77 111.752 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 7.0 p90 -68.51 -16.97 64.06 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.479 -0.488 . . . . 1.27 111.449 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.7 mtt -81.86 -12.95 58.23 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.868 -0.419 . . . . 1.28 109.868 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -95.01 -52.18 4.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.017 -0.538 . . . . 1.8600000000000001 110.997 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -20.27 63.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 1.01 112.083 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.09 129.2 43.28 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.592 -0.813 . . . . 0.20000000000000001 112.555 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -90.78 -48.5 7.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.998 0.427 . . . . 0.54000000000000004 109.999 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.07 128.94 7.73 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.868 -0.682 . . . . 0.31 111.796 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.405 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 59.1 m-85 -111.05 127.84 55.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.115 0.483 . . . . 0.60999999999999999 110.611 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.3 tp -94.44 108.78 20.7 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.453 -0.573 . . . . 1.04 109.453 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -89.01 93.89 9.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.886 -0.597 . . . . 1.1799999999999999 109.822 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 2.3 t -109.59 139.48 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.388 0.613 . . . . 1.03 112.349 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -134.87 179.11 6.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.236 -0.893 . . . . 0.41999999999999998 108.798 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.48 ' HB2' ' OD1' ' A' ' 85' ' ' ASN . . . -111.91 129.52 56.14 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.756 -0.461 . . . . 0.76000000000000001 109.756 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 pt -67.06 -14.55 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.915 0.388 . . . . 1.1499999999999999 111.419 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.48 ' OD1' ' HB2' ' A' ' 83' ' ' ALA . 22.5 p-10 -99.99 -4.52 29.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.01 0.433 . . . . 0.93999999999999995 110.743 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -122.72 101.58 7.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.193 0.521 . . . . 1.3799999999999999 110.229 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -26.82 67.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.926 -0.579 . . . . 0.75 111.98 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -65.25 -42.62 93.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.225 -0.443 . . . . 1.4199999999999999 110.782 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 99.0 p -66.16 -28.64 68.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.679 0.276 . . . . 0.71999999999999997 111.078 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -72.59 -39.44 67.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.243 0.544 . . . . 0.51000000000000001 110.504 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -74.67 -29.86 61.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.196 -0.456 . . . . 1.4399999999999999 110.54 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.63 -16.81 64.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.942 -0.572 . . . . 1.02 110.793 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 32.9 mm -57.55 -34.83 48.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.886 -0.597 . . . . 1.04 110.354 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -62.41 -46.49 88.34 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.075 -0.511 . . . . 1.0900000000000001 110.646 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -57.51 -50.18 73.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.524 -0.762 . . . . 0.98999999999999999 111.389 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.4 ' CD1' ' HB ' ' A' ' 9' ' ' VAL . 17.8 m-85 -63.69 -38.8 92.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.45 -0.341 . . . . 1.73 111.437 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -58.64 -50.72 72.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.66000000000000003 110.187 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -67.08 -42.55 84.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.782 -0.644 . . . . 1.3500000000000001 111.138 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -58.82 -57.56 12.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.002 -0.544 . . . . 1.3999999999999999 112.078 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.8 mt -61.39 -39.2 81.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.671 -0.24 . . . . 0.78000000000000003 111.304 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -60.96 -38.9 87.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 1.6000000000000001 110.803 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -72.62 -40.07 66.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 1.0900000000000001 110.921 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 75.4 t -64.61 -48.01 86.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.42 -0.354 . . . . 0.89000000000000001 111.414 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -81.3 -10.08 59.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 1.3500000000000001 111.177 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.9 t70 51.43 58.56 5.37 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.59 0.709 . . . . 0.46999999999999997 110.812 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.2 m -150.03 138.78 20.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.725 -0.67 . . . . 1.4399999999999999 110.569 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -74.02 -30.26 62.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 1.74 110.631 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -116.93 124.36 49.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.234 -0.439 . . . . 0.78000000000000003 110.705 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.9 t -137.43 129.46 16.62 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.543 -0.539 . . . . 0.63 109.543 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.75 106.39 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.746 2.297 . . . . 0.29999999999999999 111.935 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.405 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 63.7 mtt -138.03 157.49 46.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.886 -0.597 . . . . 1.1899999999999999 110.596 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -140.07 124.52 19.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.159 -0.682 . . . . 0.63 109.159 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 21.7 tp -83.18 119.33 24.4 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.438 -0.579 . . . . 0.66000000000000003 109.438 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 47.7 t -124.23 133.33 69.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.045 -0.525 . . . . 1.3700000000000001 111.328 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -108.58 112.51 3.55 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.258 -1.137 . . . . 0.27000000000000002 110.258 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -92.74 163.91 13.57 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.107 0.453 . . . . 0.23999999999999999 111.399 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' A' ' 14' ' ' VAL . 89.7 mttt 68.21 34.0 4.11 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.346 -0.843 . . . . 1.1499999999999999 111.781 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 24.2 p -69.43 -11.51 60.89 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.032 0.444 . . . . 1.29 110.975 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.05 -13.29 41.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.032 -0.531 . . . . 0.69999999999999996 110.457 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 22.1 mt -88.1 143.48 33.03 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.942 0.401 . . . . 1.3100000000000001 111.029 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.32 -178.45 4.63 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.763 2.308 . . . . 0.79000000000000004 112.096 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.1 m 66.45 42.33 2.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.807 -0.633 . . . . 1.29 110.32 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.5 ttm-85 -68.16 119.94 13.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.658 -0.701 . . . . 0.68000000000000005 110.48 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.4 p -99.68 -27.71 13.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.424 -0.353 . . . . 1.28 110.902 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.7 t -97.96 114.22 34.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.441 -0.345 . . . . 0.96999999999999997 110.421 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -77.02 150.29 35.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.427 -0.351 . . . . 1.6899999999999999 110.674 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.43 -40.47 68.34 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.399 0.518 . . . . 1.6499999999999999 112.399 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -62.2 -37.63 86.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.558 -0.292 . . . . 0.71999999999999997 111.362 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -59.1 -46.63 87.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.119 0.485 . . . . 1.1100000000000001 110.988 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.61 -39.15 58.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.961 -0.563 . . . . 0.35999999999999999 111.339 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -61.4 -42.36 98.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.5 110.739 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.78 -38.82 80.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.276 -0.42 . . . . 1.1799999999999999 110.558 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 43.5 tp -63.29 -46.42 86.87 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.956 -0.565 . . . . 0.81000000000000005 111.146 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.5 -37.26 77.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.943 -0.572 . . . . 0.66000000000000003 110.867 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -66.13 -29.29 69.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.45 -0.795 . . . . 2.0699999999999998 110.928 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.7 m -74.17 -29.98 62.03 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.303 0.573 . . . . 1.28 110.28 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -85.47 -30.14 23.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.97 -0.559 . . . . 1.0900000000000001 110.423 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.31 26.65 10.83 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.957 -0.857 . . . . 0.33000000000000002 110.957 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 23.7 pt -124.56 166.25 20.81 Favored Pre-proline 0 N--CA 1.452 -0.345 0 N-CA-C 110.007 -0.368 . . . . 1.04 110.007 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -90.79 160.29 4.13 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.521 2.148 . . . . 0.69999999999999996 112.736 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 16.9 t80 -127.16 131.09 50.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.376 -0.375 . . . . 0.45000000000000001 110.309 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 53.4 mt -133.14 131.54 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.603 -0.272 . . . . 0.85999999999999999 111.112 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -83.85 130.39 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.836 -0.801 . . . . 0.88 108.836 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 71.3 p -137.6 176.38 8.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.625 0.726 . . . . 0.76000000000000001 112.162 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.8 t -161.41 114.69 1.91 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.747 -1.115 . . . . 0.35999999999999999 108.71 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.45 -15.93 63.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.203 0.525 . . . . 0.55000000000000004 110.605 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -80.58 -29.69 36.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.573 -0.739 . . . . 1.8300000000000001 111.504 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 149' ' ' ARG . 21.1 p -116.18 -8.55 11.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.462 0.541 . . . . 0.73999999999999999 112.462 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 148' ' ' THR . 21.4 mtp85 70.69 13.69 7.21 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.065 -0.516 . . . . 2.0800000000000001 111.099 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 144' ' ' THR . 53.1 tt0 -66.94 112.37 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.453 -0.34 . . . . 1.04 111.78 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 67.18 3.51 24.45 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 114.602 0.601 . . . . 0.66000000000000003 114.602 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 82.3 t -59.53 -49.25 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 117.83 0.815 . . . . 1.0700000000000001 110.743 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.38 -46.61 87.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.25 0.547 . . . . 1.6200000000000001 109.939 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -54.07 -46.85 72.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.056 -0.975 . . . . 1.0 111.851 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.61 -47.61 81.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.127 -0.488 . . . . 0.46000000000000002 111.755 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.444 ' O ' HG22 ' A' ' 160' ' ' VAL . 41.6 m-85 -64.97 -43.66 91.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.307 -0.406 . . . . 2.1000000000000001 111.427 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -63.89 -37.46 87.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.859 0.361 . . . . 1.55 110.739 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 93.0 m -62.37 -43.96 97.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.918 -0.583 . . . . 0.39000000000000001 110.808 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.591 ' O ' HG13 ' A' ' 163' ' ' ILE . 30.7 tp -58.22 -45.53 87.51 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.642 -0.254 . . . . 0.90000000000000002 110.911 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 156' ' ' PHE . 6.1 t -60.9 -39.92 83.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.941 0.4 . . . . 0.97999999999999998 110.512 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -68.76 -33.76 74.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 1.0700000000000001 110.985 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -65.91 -40.58 91.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.321 -0.622 . . . . 0.72999999999999998 109.321 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 159' ' ' LEU . 31.3 mt -62.42 -41.9 93.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.955 -0.757 . . . . 0.84999999999999998 108.955 178.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.555 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 4.4 mtt180 -53.36 -58.34 7.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.013 -0.994 . . . . 0.98999999999999999 110.921 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -62.13 -20.12 63.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.432 -0.803 . . . . 1.55 111.955 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -83.38 -33.99 25.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.767 0.318 . . . . 0.84999999999999998 110.603 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 163' ' ' ILE . 46.8 mtpt -87.06 -8.33 57.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.094 0.405 . . . . 1.73 112.094 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 8.8 pt-20 -108.92 25.11 12.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.961 0.41 . . . . 1.1200000000000001 110.771 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 36.4 mttm . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.447 -0.787 . . . . 1.8799999999999999 109.851 179.291 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 ttm . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 120.64 0.257 . . . . 1.8899999999999999 110.574 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.0 m -111.53 149.06 31.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.523 -0.308 . . . . 1.24 110.356 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -98.41 131.75 44.43 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.046 -0.353 . . . . 1.27 110.046 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -109.91 133.35 53.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.855 -0.424 . . . . 1.45 109.855 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -94.98 104.61 16.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.267 -0.424 . . . . 1.1799999999999999 110.72 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 10.2 mp -112.82 119.63 38.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.872 -0.604 . . . . 2.1099999999999999 111.031 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.73 120.23 61.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.181 0.515 . . . . 1.28 110.153 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.7 t -92.25 112.9 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.827 -0.624 . . . . 0.77000000000000002 109.796 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 m -114.96 -175.45 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.187 -0.46 . . . . 0.94999999999999996 110.638 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.79 -176.08 22.66 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.716 -0.754 . . . . 0.56000000000000005 111.789 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.91 -175.34 2.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.783 0.325 . . . . 0.66000000000000003 111.188 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.23 131.41 10.39 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.586 -0.816 . . . . 0.80000000000000004 113.188 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.47 17.37 79.82 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.287 -0.482 . . . . 0.45000000000000001 113.835 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -77.09 -34.52 21.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 117.492 0.646 . . . . 0.98999999999999999 111.004 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.463 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 132.89 24.49 0.72 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.616 -0.802 . . . . 0.48999999999999999 113.137 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -56.69 -41.27 77.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.061 0.458 . . . . 1.3799999999999999 111.046 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.81 2.01 50.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.85999999999999999 112.093 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.47 -44.76 5.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.712 0.291 . . . . 0.95999999999999996 110.801 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 44.7 mt -58.71 -42.78 89.47 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.558 0.694 . . . . 1.21 110.483 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.474 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -60.89 -52.44 65.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.948 -1.023 . . . . 1.2 111.701 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.8 mt -65.37 -31.09 52.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.388 -0.369 . . . . 1.3799999999999999 111.379 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.601 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 2.8 mm-40 -69.27 -22.38 63.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.999 0.428 . . . . 0.52000000000000002 110.335 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.8 tp -94.16 -26.83 16.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.118 -0.492 . . . . 1.8799999999999999 110.649 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 20' ' ' THR . 35.3 mm -89.73 -60.25 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.57999999999999996 111.558 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -92.51 -13.95 29.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.499 -0.319 . . . . 1.74 111.437 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.601 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 7.9 m-20 66.57 24.71 10.16 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 123.513 0.508 . . . . 1.9199999999999999 111.758 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -129.92 146.51 51.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.711 -0.477 . . . . 0.85999999999999999 109.711 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -85.12 129.97 34.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.377 -0.374 . . . . 0.77000000000000002 111.135 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.8 t -96.95 125.05 50.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 1.04 109.955 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -75.7 -46.38 31.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.763 -0.653 . . . . 1.1200000000000001 111.815 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -130.07 123.73 31.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.969 0.414 . . . . 1.1799999999999999 111.118 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -145.42 146.92 31.72 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.156 -0.683 . . . . 0.80000000000000004 109.156 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -71.66 119.42 74.0 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 0.80000000000000004 110.367 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.94 -17.33 32.31 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.49 2.127 . . . . 0.56000000000000005 113.615 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.24 -7.49 59.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.096 0.474 . . . . 1.21 111.434 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.2 mt -80.77 119.69 30.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.197 0.522 . . . . 1.1499999999999999 110.771 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 22.3 tt0 -118.01 79.49 1.38 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.097 -0.956 . . . . 0.81000000000000005 108.641 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -106.39 159.39 16.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.136 -0.483 . . . . 1.29 111.054 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.66 124.52 52.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.231 -0.44 . . . . 1.1699999999999999 110.325 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -101.97 136.81 41.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.121 -0.491 . . . . 0.97999999999999998 110.347 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.06 128.53 55.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.88 0.371 . . . . 0.69999999999999996 111.234 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -144.51 137.59 26.98 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.387 -0.598 . . . . 1.78 109.387 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -116.26 119.34 35.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.704 0.288 . . . . 2.3900000000000001 110.343 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.9 t -138.58 153.02 25.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.446 . . . . 1.3799999999999999 109.877 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.2 t -76.73 103.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.64 -0.504 . . . . 0.65000000000000002 109.64 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.3 mt -105.37 111.94 36.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.343 -0.389 . . . . 1.47 111.008 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.468 ' HB2' HH12 ' A' ' 164' ' ' ARG . 31.3 m-20 65.4 27.09 11.92 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.757 -0.656 . . . . 0.96999999999999997 111.518 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.49 5.29 65.25 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.873 -0.679 . . . . 0.59999999999999998 112.469 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -126.54 119.75 27.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.791 0.329 . . . . 1.4099999999999999 111.172 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.6 m -77.11 106.75 9.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.641 -0.503 . . . . 0.89000000000000001 109.641 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.1 m -117.71 147.48 42.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.224 0.535 . . . . 1.3100000000000001 111.212 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.0 tp -90.74 122.22 33.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.547 -0.751 . . . . 0.85999999999999999 109.113 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 mt -93.61 113.44 25.54 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.955 0.407 . . . . 1.1299999999999999 111.591 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -100.43 87.71 3.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.256 -1.387 . . . . 1.03 107.256 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 6.6 mt -99.54 127.64 52.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.724 -0.671 . . . . 1.1799999999999999 111.881 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.9 tp -107.88 121.24 44.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.557 -0.747 . . . . 0.75 111.112 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 1.7 t70 -87.47 94.97 9.86 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.44 -0.948 . . . . 0.44 108.44 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.468 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 81.2 p -65.98 146.42 54.72 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.466 0.651 . . . . 0.84999999999999998 111.838 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.01 -58.17 2.56 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.155 -0.929 . . . . 1.04 109.287 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.16 -96.96 0.15 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.799 -0.715 . . . . 0.71999999999999997 111.999 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -83.77 158.44 21.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.679 0.276 . . . . 1.5 110.533 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -130.32 165.86 21.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.238 -0.437 . . . . 1.5700000000000001 110.32 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -78.89 -35.36 43.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.331 -0.618 . . . . 1.3799999999999999 109.331 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -119.86 124.03 45.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.592 -0.731 . . . . 1.0 109.517 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -58.46 -34.9 71.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.419 -0.355 . . . . 0.90000000000000002 111.382 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.26 -27.48 69.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.35999999999999999 111.4 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 78.0 mtp -72.64 -32.65 66.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 1.04 110.467 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -71.17 -46.07 62.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.896 -0.593 . . . . 1.0700000000000001 110.071 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -73.63 -9.06 58.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.654 -0.703 . . . . 1.4099999999999999 111.449 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -67.19 -60.28 2.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.817 -0.174 . . . . 1.77 111.046 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -72.51 -15.88 61.79 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.695 -0.402 . . . . 1.27 111.091 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.406 ' SD ' HG23 ' A' ' 103' ' ' VAL . 35.7 mtt -70.35 -25.74 63.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.24 0.543 . . . . 1.28 109.937 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 73' ' ' ARG . 48.5 mtm180 -84.17 -48.54 9.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.83 -0.623 . . . . 1.8600000000000001 110.673 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -22.67 63.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.938 -0.574 . . . . 1.01 111.953 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.01 123.45 26.3 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.018 -0.61 . . . . 0.20000000000000001 112.087 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -88.9 -40.85 12.8 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.943 -0.391 . . . . 0.54000000000000004 109.943 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -128.88 130.12 6.37 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.414 -0.674 . . . . 0.31 111.414 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -113.98 133.83 55.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.015 0.436 . . . . 0.60999999999999999 111.128 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.8 tp -100.1 106.23 17.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.864 -0.607 . . . . 1.04 110.221 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.5 m -92.36 97.44 10.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.004 0.43 . . . . 1.1799999999999999 110.343 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 4.9 t -110.31 134.1 53.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.002 -0.545 . . . . 1.03 111.37 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -129.6 172.66 11.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.729 -0.668 . . . . 0.41999999999999998 109.441 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.78 133.3 52.37 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.727 -0.471 . . . . 0.76000000000000001 109.727 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.0 pt -76.92 -4.17 6.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 112.782 0.66 . . . . 1.1499999999999999 112.782 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -85.6 -12.18 52.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.738 -0.21 . . . . 0.93999999999999995 111.105 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.465 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 30.8 t-20 -139.79 123.94 17.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.367 . . . . 1.3799999999999999 110.725 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.8 m -69.83 -28.2 65.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.057 -0.52 . . . . 0.75 111.652 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -60.97 -39.29 89.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.618 0.247 . . . . 1.4199999999999999 110.721 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.465 ' OG ' ' HB3' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -64.75 -32.43 74.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.137 0.494 . . . . 0.71999999999999997 110.313 179.147 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -76.95 -35.66 57.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.76 -0.655 . . . . 0.51000000000000001 110.115 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -72.01 -29.8 64.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.707 -0.678 . . . . 1.4399999999999999 110.582 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.38 -24.02 67.14 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.042 -0.527 . . . . 1.02 110.592 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.9 mm -61.45 -30.63 48.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.518 -0.764 . . . . 1.04 110.684 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -60.76 -41.38 95.34 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.205 0.526 . . . . 1.0900000000000001 109.695 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -71.86 -38.43 70.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.562 -0.744 . . . . 0.98999999999999999 110.639 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -63.75 -47.42 81.1 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.252 0.464 . . . . 1.73 112.252 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 25.7 tpt180 -63.73 -33.37 75.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.671 0.272 . . . . 0.66000000000000003 110.856 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -79.19 -43.86 23.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.283 -0.417 . . . . 1.3500000000000001 111.541 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -58.6 -56.99 14.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.086 0.402 . . . . 1.3999999999999999 112.086 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.5 mt -63.38 -31.07 51.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.359 -0.382 . . . . 0.78000000000000003 110.772 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 39.0 ttpt -62.97 -35.38 79.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.343 0.592 . . . . 1.6000000000000001 110.198 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -78.02 -40.61 38.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.713 -0.676 . . . . 1.0900000000000001 110.592 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.406 HG23 ' SD ' ' A' ' 72' ' ' MET . 87.3 t -58.78 -50.75 78.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.907 -0.588 . . . . 0.89000000000000001 110.863 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -82.08 -11.61 58.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.084 -0.507 . . . . 1.3500000000000001 111.036 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.8 t70 54.81 48.82 19.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.583 0.706 . . . . 0.46999999999999997 110.753 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.5 t -158.45 144.42 16.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.51 -0.768 . . . . 1.4399999999999999 110.317 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -90.97 -17.72 25.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.079 0.466 . . . . 1.74 110.76 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -91.08 68.99 6.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.595 0.712 . . . . 0.78000000000000003 110.604 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 85.2 t -108.57 112.34 60.78 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.289 -0.869 . . . . 0.63 109.659 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.82 113.42 1.31 Allowed 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.915 2.41 . . . . 0.29999999999999999 111.656 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 28.6 mtt -141.99 153.35 44.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.09 -0.505 . . . . 1.1899999999999999 111.223 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.3 t -131.91 123.9 52.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.482 -0.781 . . . . 0.63 109.035 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 41.0 tp -85.37 121.85 28.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.042 -0.725 . . . . 0.66000000000000003 109.042 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 11.2 t -127.19 138.05 55.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.004 0.431 . . . . 1.3700000000000001 111.532 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.87 106.85 2.12 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 110.164 -1.174 . . . . 0.27000000000000002 110.164 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -89.2 165.5 14.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.735 0.267 . . . . 0.23999999999999999 111.024 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 67.52 34.85 4.43 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 115.466 -0.788 . . . . 1.1499999999999999 111.008 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 27.5 p -68.75 -13.0 62.11 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.869 0.366 . . . . 1.29 111.344 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.67 -13.72 47.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.69999999999999996 110.612 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 44.1 mt -82.51 142.06 45.96 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.399 -0.364 . . . . 1.3100000000000001 110.175 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.3 -177.52 3.9 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.603 2.202 . . . . 0.79000000000000004 111.925 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.5 m 62.83 48.75 3.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.295 0.569 . . . . 1.29 111.181 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.3 ttm-85 -72.38 110.99 7.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.749 -0.66 . . . . 0.68000000000000005 109.95 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 p -95.14 -21.01 18.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.07 0.462 . . . . 1.28 110.728 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -98.69 110.33 25.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.115 -0.493 . . . . 0.96999999999999997 110.051 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.99 143.12 56.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.985 -0.552 . . . . 1.6899999999999999 111.176 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 m -59.54 -39.92 85.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.006 -0.543 . . . . 1.6499999999999999 110.787 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -61.53 -38.52 87.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.71999999999999997 110.954 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -58.4 -51.94 67.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.139 0.495 . . . . 1.1100000000000001 110.744 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.43 -40.52 85.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.714 -0.675 . . . . 0.35999999999999999 110.875 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -61.38 -40.49 94.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.811 -0.631 . . . . 0.5 110.356 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 -46.46 79.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.384 -0.371 . . . . 1.1799999999999999 110.15 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.85 -44.91 93.87 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.804 -0.634 . . . . 0.81000000000000005 111.0 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.73 -43.55 98.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.965 -0.561 . . . . 0.66000000000000003 110.865 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -63.66 -36.16 82.91 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.837 -0.62 . . . . 2.0699999999999998 111.95 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.4 p -74.77 -23.28 58.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.428 . . . . 1.28 111.133 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -89.45 -16.92 29.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 1.0900000000000001 111.011 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.83 30.1 33.09 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.97 -0.559 . . . . 0.33000000000000002 111.806 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 40.0 pt -127.08 152.97 76.55 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.7 -0.25 . . . . 1.04 110.543 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.7 148.51 22.82 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.669 2.246 . . . . 0.69999999999999996 112.189 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 17.6 t80 -125.35 124.32 41.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.381 -0.372 . . . . 0.45000000000000001 110.61 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.7 mt -132.61 133.73 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.34 -0.391 . . . . 0.85999999999999999 110.343 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -88.52 135.01 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.812 -0.811 . . . . 0.88 108.812 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 70.6 p -138.96 175.53 9.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.52 0.676 . . . . 0.76000000000000001 112.447 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.1 t -152.06 109.44 3.58 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.008 -0.996 . . . . 0.35999999999999999 108.749 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -68.42 -24.48 64.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.273 0.558 . . . . 0.55000000000000004 110.286 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -67.57 -47.83 68.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.004 -0.998 . . . . 1.8300000000000001 111.296 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.9 p -97.04 3.91 51.66 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.711 -0.395 . . . . 0.73999999999999999 110.925 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 55.83 45.73 23.63 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.55 -0.75 . . . . 2.0800000000000001 110.414 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -107.72 120.74 43.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.447 -0.797 . . . . 1.04 111.056 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.31 -1.24 57.31 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.807 -0.633 . . . . 0.66000000000000003 113.747 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 32.6 t -60.1 -42.29 89.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.981 0.391 . . . . 1.0700000000000001 110.744 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.28 -50.77 62.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.795 -0.639 . . . . 1.6200000000000001 110.203 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.12 -45.84 72.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.575 -0.739 . . . . 1.0 111.857 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.94 81.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.664 0.268 . . . . 0.46000000000000002 111.247 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -66.64 -44.1 82.87 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.385 -0.371 . . . . 2.1000000000000001 111.231 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -63.73 -42.35 97.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.446 -0.343 . . . . 1.55 111.564 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 36.6 m -61.82 -38.02 86.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.693 -0.23 . . . . 0.39000000000000001 110.576 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.425 ' O ' HG13 ' A' ' 163' ' ' ILE . 48.3 tp -62.77 -40.6 97.79 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.901 -0.407 . . . . 0.90000000000000002 109.901 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.83 -41.51 85.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.494 . . . . 0.97999999999999998 110.078 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -67.77 -38.26 83.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 1.0700000000000001 110.411 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 158' ' ' THR . 63.5 mm-40 -60.11 -43.51 95.56 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.93 -0.577 . . . . 0.72999999999999998 110.814 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 159' ' ' LEU . 27.1 mt -67.53 -46.07 83.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.94 -0.573 . . . . 0.84999999999999998 110.758 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.468 HH12 ' HB2' ' A' ' 47' ' ' ASP . 85.9 mtt180 -57.2 -42.22 80.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.152 -0.477 . . . . 0.98999999999999999 111.447 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -59.56 -34.99 73.37 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.812 0.339 . . . . 1.55 110.951 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -79.67 -30.91 41.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.879 0.371 . . . . 0.84999999999999998 110.209 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -67.93 -33.64 75.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.106 -0.497 . . . . 1.73 111.799 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 11.9 pt-20 -102.9 17.58 23.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.198 0.523 . . . . 1.1200000000000001 110.602 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 17.8 tttp . . . . . 0 C--O 1.25 1.13 0 CA-C-N 115.518 -0.764 . . . . 1.8799999999999999 110.195 -179.739 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.575 ' HA ' ' O ' ' A' ' 50' ' ' THR . 24.8 ttt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.982 -0.377 . . . . 1.8899999999999999 109.982 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.1 m -106.09 144.15 33.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.116 -0.493 . . . . 1.24 110.752 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -93.26 135.41 34.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.224 -0.444 . . . . 1.27 110.795 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.42 ' CD2' ' HB3' ' A' ' 51' ' ' CYS . 35.0 m-85 -121.84 117.99 27.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.325 -0.62 . . . . 1.45 109.325 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -95.17 107.77 19.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.959 0.409 . . . . 1.1799999999999999 110.516 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 1.2 mp -119.46 141.74 48.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.853 -0.612 . . . . 2.1099999999999999 110.965 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.04 135.67 62.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.227 -0.442 . . . . 1.28 110.552 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.44 115.82 47.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.614 -0.513 . . . . 0.77000000000000002 109.614 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.6 m -114.06 169.32 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.123 -0.489 . . . . 0.94999999999999996 110.251 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.27 170.22 17.9 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.792 -0.718 . . . . 0.56000000000000005 112.033 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.581 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -67.81 159.14 30.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.075 0.464 . . . . 0.66000000000000003 111.714 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.12 99.63 0.72 Allowed Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.827 -0.624 . . . . 0.80000000000000004 112.872 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.26 7.69 5.77 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.673 -0.775 . . . . 0.45000000000000001 113.142 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 11' ' ' ALA . 12.4 m -79.59 -39.06 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.558 -0.457 . . . . 0.98999999999999999 110.625 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.51 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 126.58 24.97 1.32 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.557 -0.83 . . . . 0.48999999999999999 113.573 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -50.98 -52.38 43.25 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.907 0.354 . . . . 1.3799999999999999 111.76 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.64 -40.2 92.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.419 -0.355 . . . . 0.85999999999999999 111.679 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.76 -42.55 97.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 0.95999999999999996 111.548 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 72.0 mt -59.59 -44.88 93.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.368 . . . . 1.21 111.341 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.443 ' O ' HG12 ' A' ' 24' ' ' ILE . 7.7 m -67.16 -51.42 53.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.214 -0.448 . . . . 1.2 111.788 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.96 -31.45 47.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.67 0.272 . . . . 1.3799999999999999 111.697 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 4.8 mm-40 -61.12 -30.0 70.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.913 0.387 . . . . 0.52000000000000002 111.046 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tp -95.34 -35.76 11.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.302 -0.408 . . . . 1.8799999999999999 111.318 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 20' ' ' THR . 40.3 mm -74.14 -55.79 11.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.409 0.522 . . . . 0.57999999999999996 112.409 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -99.82 1.48 43.08 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.045 0.387 . . . . 1.74 112.045 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 73.0 m-20 57.81 32.61 22.15 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.63 0.974 . . . . 1.9199999999999999 113.63 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -153.92 146.73 24.33 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.686 -0.405 . . . . 0.85999999999999999 110.805 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -82.02 129.53 34.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.952 -0.567 . . . . 0.77000000000000002 110.693 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.0 t -98.86 121.41 49.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.05 -0.523 . . . . 1.04 109.891 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.51 -55.95 8.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.615 -0.72 . . . . 1.1200000000000001 111.445 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -113.77 115.12 27.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.324 0.583 . . . . 1.1799999999999999 111.665 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -141.77 136.04 30.3 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.906 -0.776 . . . . 0.80000000000000004 108.906 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -62.71 117.47 32.14 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 120.854 0.359 . . . . 0.80000000000000004 110.561 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.92 -25.87 38.33 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.69 2.26 . . . . 0.56000000000000005 112.898 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -8.47 57.05 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.382 0.512 . . . . 1.21 112.382 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.3 mt -79.24 119.51 28.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.068 0.461 . . . . 1.1499999999999999 111.105 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 8.6 tt0 -111.13 97.9 7.13 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.411 -0.959 . . . . 0.81000000000000005 108.411 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -126.43 163.1 24.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.764 0.316 . . . . 1.29 110.706 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.13 145.39 44.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.036 -0.529 . . . . 1.1699999999999999 109.841 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -131.64 138.35 48.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.748 0.309 . . . . 0.97999999999999998 110.286 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -112.68 127.79 56.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.194 -0.457 . . . . 0.69999999999999996 110.358 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -141.6 120.88 13.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.19 -0.459 . . . . 1.78 110.144 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 10.4 pt20 -93.15 122.0 35.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.947 0.403 . . . . 2.3900000000000001 110.524 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.3 t -125.83 143.75 38.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.076 -0.511 . . . . 1.3799999999999999 110.169 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 t -86.24 102.22 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.299 -0.63 . . . . 0.65000000000000002 109.299 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.9 mt -114.17 123.36 69.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.849 -0.614 . . . . 1.47 110.743 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 64.77 22.59 12.58 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.605 0.566 . . . . 0.96999999999999997 111.495 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.32 0.95 72.66 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.767 -0.73 . . . . 0.59999999999999998 112.679 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -116.68 132.61 56.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.657 0.265 . . . . 1.4099999999999999 110.83 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 1' ' ' MET . 1.3 m -82.9 111.67 19.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.87 -0.418 . . . . 0.89000000000000001 109.87 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.42 ' HB3' ' CD2' ' A' ' 4' ' ' TYR . 2.5 m -112.45 134.73 53.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.391 -0.368 . . . . 1.3100000000000001 111.233 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.9 tp -92.49 107.5 19.26 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.853 -0.795 . . . . 0.85999999999999999 108.853 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 35.7 mt -82.66 115.64 21.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.22 -0.445 . . . . 1.1299999999999999 111.547 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.406 ' OD1' ' HD2' ' A' ' 41' ' ' ARG . 12.5 t70 -103.4 95.65 6.22 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.941 -1.133 . . . . 1.03 107.941 178.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 31.1 mt -109.47 135.01 49.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.236 0.541 . . . . 1.1799999999999999 111.646 -177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.7 tp -112.13 119.48 38.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.353 -0.84 . . . . 0.75 110.631 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 2.5 t70 -87.36 99.81 12.26 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.695 -0.854 . . . . 0.44 108.695 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.7 p -72.15 153.1 41.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.806 -0.634 . . . . 0.84999999999999998 111.41 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.54 -63.92 1.08 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.176 -0.675 . . . . 1.04 109.176 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.75 -91.49 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.683 -0.689 . . . . 0.71999999999999997 111.549 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -121.98 130.66 53.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.071 -0.344 . . . . 1.5 110.071 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.81 179.22 6.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.44 . . . . 1.5700000000000001 110.764 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.18 -43.65 94.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.728 -0.669 . . . . 1.3799999999999999 110.017 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -120.59 145.04 47.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.602 -0.726 . . . . 1.0 109.577 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -63.09 -34.6 77.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.318 -0.401 . . . . 0.90000000000000002 111.26 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.91 -30.94 71.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.325 -0.398 . . . . 0.35999999999999999 111.861 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 95.0 mtp -66.56 -33.46 75.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.094 0.474 . . . . 1.04 109.983 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -76.96 -39.93 48.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.729 -0.669 . . . . 1.0700000000000001 109.856 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.32 -11.02 60.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.686 -0.688 . . . . 1.4099999999999999 110.875 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -66.03 -69.28 0.31 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.017 -0.538 . . . . 1.77 110.347 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.44 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 8.3 p90 -70.41 -11.92 61.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.439 -0.346 . . . . 1.27 111.688 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.9 mtt -73.16 -13.98 61.27 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.903 -0.406 . . . . 1.28 109.903 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 -109.22 -33.61 6.81 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.062 -0.517 . . . . 1.8600000000000001 110.808 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -79.9 -15.55 57.1 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.482 -0.326 . . . . 1.01 111.661 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.8 134.12 34.94 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.705 -0.759 . . . . 0.20000000000000001 112.439 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.8 -36.64 11.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.836 0.351 . . . . 0.54000000000000004 110.359 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.83 128.2 6.8 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.99 -0.624 . . . . 0.31 111.676 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.46 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 94.1 m-85 -112.09 121.36 44.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.121 0.486 . . . . 0.60999999999999999 110.682 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.6 tp -100.18 109.27 21.52 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.86 -0.609 . . . . 1.04 110.765 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 2.7 m -94.18 102.19 14.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.137 -0.483 . . . . 1.1799999999999999 110.012 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.1 t -109.3 140.61 27.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.104 0.478 . . . . 1.03 111.374 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.39 170.53 15.92 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.746 -0.835 . . . . 0.41999999999999998 108.746 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' A' ' 86' ' ' ASN . . . -105.32 133.27 50.37 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.977 -0.379 . . . . 0.76000000000000001 109.977 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 pt -66.49 -16.93 21.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.891 0.376 . . . . 1.1499999999999999 111.496 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -107.78 10.12 28.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.005 0.431 . . . . 0.93999999999999995 110.935 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 13.0 t-20 -132.7 92.69 3.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.087 0.47 . . . . 1.3799999999999999 110.539 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -33.62 71.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.657 -0.701 . . . . 0.75 111.811 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -58.24 -45.46 87.72 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.945 0.402 . . . . 1.4199999999999999 110.999 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.8 p -68.0 -28.13 67.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.71999999999999997 110.974 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -76.06 -43.57 43.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.005 0.431 . . . . 0.51000000000000001 110.686 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -67.28 -33.37 75.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 1.4399999999999999 110.98 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -66.98 -19.76 65.77 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.42 -0.355 . . . . 1.02 111.1 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.48 -29.7 42.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 121.16 0.505 . . . . 1.04 109.994 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -62.25 -36.1 80.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.752 -0.658 . . . . 1.0900000000000001 110.339 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -80.73 -24.75 38.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.194 -0.912 . . . . 0.98999999999999999 110.762 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -62.45 -59.37 5.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.51 . . . . 1.73 110.183 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -55.41 -46.43 76.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.928 -0.578 . . . . 0.66000000000000003 109.91 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -56.15 -48.83 75.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.298 -0.865 . . . . 1.3500000000000001 111.903 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.614 ' O ' HG21 ' A' ' 103' ' ' VAL . 22.7 tt0 -61.79 -57.31 12.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.264 -0.426 . . . . 1.3999999999999999 111.266 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.6 mt -60.07 -35.31 60.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 111.911 0.338 . . . . 0.78000000000000003 111.911 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -59.53 -39.32 83.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.863 0.363 . . . . 1.6000000000000001 110.569 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -75.05 -45.98 37.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.81 -0.632 . . . . 1.0900000000000001 110.954 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.614 HG21 ' O ' ' A' ' 99' ' ' GLN . 21.8 t -59.9 -49.42 83.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.89000000000000001 112.118 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -81.7 -13.32 58.0 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.218 -0.193 . . . . 1.3500000000000001 111.416 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.5 t70 54.61 50.64 15.52 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.882 -0.599 . . . . 0.46999999999999997 111.224 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.9 m -141.54 144.51 34.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.333 -0.394 . . . . 1.4399999999999999 110.176 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -44.12 28.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.364 . . . . 1.74 111.372 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -99.88 119.28 37.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.846 0.355 . . . . 0.78000000000000003 110.46 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.82 123.8 21.27 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 115.977 -0.556 . . . . 0.63 110.142 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.84 108.09 0.45 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.435 2.09 . . . . 0.29999999999999999 111.811 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.46 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 46.5 mtt -139.27 155.19 47.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.078 0.466 . . . . 1.1899999999999999 111.174 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.3 t -135.06 124.71 43.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.524 -0.762 . . . . 0.63 108.953 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.0 tp -84.42 120.54 26.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.567 -0.531 . . . . 0.66000000000000003 109.567 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.96 131.21 73.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.147 -0.479 . . . . 1.3700000000000001 112.132 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -108.35 95.7 0.96 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.348 -1.101 . . . . 0.27000000000000002 110.348 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -78.54 161.44 27.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.925 0.393 . . . . 0.23999999999999999 111.879 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 81.2 mttt 63.7 35.98 11.03 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 115.31 -0.859 . . . . 1.1499999999999999 110.895 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 28.2 p -69.74 -13.16 62.15 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.978 -0.556 . . . . 1.29 111.475 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -82.36 -10.11 59.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.029 -0.532 . . . . 0.69999999999999996 110.951 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 58.6 mt -83.24 141.41 42.88 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.962 0.411 . . . . 1.3100000000000001 110.671 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.28 -178.69 4.61 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.186 1.924 . . . . 0.79000000000000004 111.588 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.8 m 63.5 45.71 4.63 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.183 -0.462 . . . . 1.29 111.059 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -59.27 123.03 15.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.965 -0.562 . . . . 0.68000000000000005 110.401 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.81 -24.77 14.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.913 0.387 . . . . 1.28 111.1 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.3 t -104.82 111.68 35.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.166 -0.47 . . . . 0.96999999999999997 110.758 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.1 141.58 58.67 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.756 -0.461 . . . . 1.6899999999999999 109.756 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.83 -30.16 56.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.189 0.518 . . . . 1.6499999999999999 112.131 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -68.05 -34.32 76.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.887 -0.597 . . . . 0.71999999999999997 111.723 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -59.53 -57.12 14.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.952 0.353 . . . . 1.1100000000000001 111.952 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.94 89.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.509 -0.314 . . . . 0.35999999999999999 111.432 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -63.01 -44.13 96.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.016 0.436 . . . . 0.5 110.069 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.48 -38.72 90.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.656 -0.702 . . . . 1.1799999999999999 110.304 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 65.5 tp -68.51 -41.05 80.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.717 -0.674 . . . . 0.81000000000000005 110.898 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.7 91.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.66000000000000003 110.408 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 135' ' ' ARG . 37.8 ttm105 -62.89 -36.81 84.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.91 -0.586 . . . . 2.0699999999999998 110.774 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.0 m -69.19 -26.28 64.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.045 0.45 . . . . 1.28 111.138 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -91.09 -19.61 22.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.491 . . . . 1.0900000000000001 111.187 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.43 27.53 47.6 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.629 -0.796 . . . . 0.33000000000000002 111.564 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 26.6 pt -125.54 159.11 62.14 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.887 -0.412 . . . . 1.04 109.887 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.45 160.62 17.15 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.678 2.252 . . . . 0.69999999999999996 112.901 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -135.74 131.53 35.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.541 -0.754 . . . . 0.45000000000000001 110.316 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 37.3 mt -142.74 134.97 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.364 -0.38 . . . . 0.85999999999999999 110.386 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -84.21 137.85 33.28 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.067 -0.716 . . . . 0.88 109.067 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 46.9 p -138.31 173.17 11.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.633 0.73 . . . . 0.76000000000000001 111.716 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.4 t -149.01 123.08 9.45 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.066 -1.087 . . . . 0.35999999999999999 108.066 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.44 -11.74 61.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.746 0.308 . . . . 0.55000000000000004 111.291 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -85.13 -57.77 2.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.065 -0.516 . . . . 1.8300000000000001 111.498 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.9 p -86.74 -10.33 53.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.333 . . . . 0.73999999999999999 111.463 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 59.69 40.27 20.08 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.683 -0.69 . . . . 2.0800000000000001 110.744 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 144' ' ' THR . 47.4 tt0 -85.29 114.99 22.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.132 -0.486 . . . . 1.04 110.78 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.1 8.4 61.58 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.941 -0.572 . . . . 0.66000000000000003 112.985 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 22.2 t -65.5 -50.88 69.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.766 0.317 . . . . 1.0700000000000001 110.814 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.93 -37.63 84.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.103 0.477 . . . . 1.6200000000000001 109.815 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.7 -42.72 93.62 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.134 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.68 79.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.915 -0.584 . . . . 0.46000000000000002 111.733 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.94 -39.72 72.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.29 -0.414 . . . . 2.1000000000000001 111.494 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -61.48 -35.74 78.5 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.952 -0.388 . . . . 1.55 109.952 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 22.3 m -70.59 -35.22 72.9 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.541 -0.54 . . . . 0.39000000000000001 109.541 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.27 -40.53 97.65 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.494 -0.558 . . . . 0.90000000000000002 109.494 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 94.0 t -61.78 -42.15 93.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.344 0.592 . . . . 0.97999999999999998 109.712 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -65.3 -36.03 82.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.463 -0.79 . . . . 1.0700000000000001 110.146 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -66.78 -38.84 87.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.967 -0.383 . . . . 0.72999999999999998 109.967 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.514 ' O ' ' HG3' ' A' ' 167' ' ' LYS . 88.4 mt -61.81 -52.21 63.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.307 -0.627 . . . . 0.84999999999999998 109.307 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.6 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 99.1 mtt180 -55.91 -44.81 78.6 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 115.529 -0.759 . . . . 0.98999999999999999 110.077 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -56.49 -42.81 78.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.42 -0.809 . . . . 1.55 111.842 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -71.24 -36.03 71.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.245 -0.434 . . . . 0.84999999999999998 111.519 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 163' ' ' ILE . 30.7 mtpt -74.67 -29.7 61.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.407 0.521 . . . . 1.73 112.407 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.6 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 6.6 pt-20 -86.77 -12.36 48.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.717 0.294 . . . . 1.1200000000000001 111.14 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 31.7 tttp . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.431 -0.795 . . . . 1.8799999999999999 110.395 -179.6 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tmm? . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.196 -0.298 . . . . 1.8899999999999999 110.196 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.439 ' HB ' ' CE2' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -113.87 138.7 49.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.372 -0.376 . . . . 1.24 110.893 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -96.32 131.37 42.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.529 -0.545 . . . . 1.27 109.529 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.439 ' CE2' ' HB ' ' A' ' 2' ' ' THR . 85.5 m-85 -120.91 124.55 45.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.567 -0.288 . . . . 1.45 110.251 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -95.63 107.49 19.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.144 0.497 . . . . 1.1799999999999999 110.545 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 8.5 mp -111.84 133.26 54.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.649 -0.705 . . . . 2.1099999999999999 111.187 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 78' ' ' PHE . 16.5 t -118.47 122.1 68.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.165 -0.47 . . . . 1.28 110.491 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.2 t -94.49 119.42 42.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.281 -0.637 . . . . 0.77000000000000002 109.281 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 m -116.42 157.22 17.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.05 0.453 . . . . 0.94999999999999996 110.987 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.31 170.92 29.9 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.62 -0.8 . . . . 0.56000000000000005 111.772 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.45 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -70.34 173.21 7.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.971 0.415 . . . . 0.66000000000000003 111.597 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.04 112.91 3.54 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.472 -0.87 . . . . 0.80000000000000004 112.49 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.26 4.1 27.35 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.523 -0.846 . . . . 0.45000000000000001 113.562 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 11' ' ' ALA . 18.9 m -76.02 -17.61 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 117.391 0.595 . . . . 0.98999999999999999 111.481 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.62 25.34 8.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.522 -0.847 . . . . 0.48999999999999999 113.597 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -53.55 -55.98 20.97 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.785 0.326 . . . . 1.3799999999999999 111.736 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -52.86 63.75 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.591 0.589 . . . . 0.85999999999999999 112.591 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.82 -38.86 67.9 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.369 0.507 . . . . 0.95999999999999996 112.369 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.0 mt -62.0 -44.47 96.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.543 -0.299 . . . . 1.21 111.354 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.4 ' O ' HG12 ' A' ' 24' ' ' ILE . 1.4 m -73.97 -39.71 63.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.631 0.253 . . . . 1.2 111.026 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.79 -32.61 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.985 0.422 . . . . 1.3799999999999999 110.473 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.706 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 3.6 mm-40 -67.6 -21.96 65.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.883 -0.599 . . . . 0.52000000000000002 111.222 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.14 -30.58 12.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.885 0.374 . . . . 1.8799999999999999 110.625 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 20' ' ' THR . 51.5 mm -81.08 -61.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.927 0.394 . . . . 0.57999999999999996 110.789 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -85.77 -6.69 59.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.293 0.568 . . . . 1.74 110.383 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.706 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 1.3 m-80 55.39 40.44 31.38 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 114.944 -1.025 . . . . 1.9199999999999999 112.966 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -160.7 156.02 24.79 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.873 -0.418 . . . . 0.85999999999999999 109.873 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -80.82 142.29 33.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.141 -0.481 . . . . 0.77000000000000002 111.963 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.59 121.44 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.958 -1.127 . . . . 1.04 107.958 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.23 -41.53 40.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.799 0.666 . . . . 1.1200000000000001 112.799 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -123.17 122.47 38.51 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.073 0.463 . . . . 1.1799999999999999 111.305 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -149.31 139.15 21.91 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.578 -0.897 . . . . 0.80000000000000004 108.578 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.477 ' HB3' HG13 ' A' ' 36' ' ' ILE . 5.8 t70 -62.78 123.74 80.71 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 123.516 0.51 . . . . 0.80000000000000004 110.95 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.2 -13.25 23.38 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.775 2.316 . . . . 0.56000000000000005 113.099 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.2 3.11 56.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.839 0.352 . . . . 1.21 111.352 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.477 HG13 ' HB3' ' A' ' 33' ' ' ASP . 58.3 mt -83.01 130.84 35.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 110.038 -0.356 . . . . 1.1499999999999999 110.038 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 16.9 tt0 -128.57 82.88 2.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.748 -0.66 . . . . 0.81000000000000005 109.435 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -111.47 171.7 7.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.095 -0.502 . . . . 1.29 111.272 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.0 141.66 48.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.989 -0.55 . . . . 1.1699999999999999 109.871 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -126.34 133.43 51.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.106 -0.331 . . . . 0.97999999999999998 110.106 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -107.62 119.7 40.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.951 0.405 . . . . 0.69999999999999996 110.741 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -130.31 132.19 45.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.976 -0.556 . . . . 1.78 109.988 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.504 ' NE2' ' H ' ' A' ' 43' ' ' GLN . 1.4 pm0 -101.93 123.75 46.37 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.195 0.521 . . . . 2.3900000000000001 110.443 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.3 t -130.31 143.37 41.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.013 -0.54 . . . . 1.3799999999999999 109.622 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.51 66.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.178 0.513 . . . . 0.65000000000000002 110.448 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.8 mt -74.2 124.64 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.55 -0.75 . . . . 1.47 110.774 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.41 ' HB2' HH12 ' A' ' 164' ' ' ARG . 0.8 OUTLIER 67.96 17.67 9.58 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.697 -0.683 . . . . 0.96999999999999997 110.975 -179.623 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.02 7.18 81.04 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.472 -0.871 . . . . 0.59999999999999998 112.394 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -116.6 131.45 56.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.764 0.316 . . . . 1.4099999999999999 110.42 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 m -68.15 109.84 3.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.961 0.41 . . . . 0.89000000000000001 110.934 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.2 m -112.65 130.02 56.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.27 -0.423 . . . . 1.3100000000000001 111.004 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.0 tp -97.84 107.3 19.76 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.497 -0.927 . . . . 0.85999999999999999 108.497 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -91.13 120.48 32.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.453 0.538 . . . . 1.1299999999999999 112.453 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -105.85 98.24 7.95 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.873 -1.158 . . . . 1.03 107.873 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 49.8 mt -106.02 134.33 47.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.932 0.396 . . . . 1.1799999999999999 111.932 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.5 tp -109.0 123.9 49.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.671 -0.695 . . . . 0.75 110.431 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 4.0 t70 -88.27 93.04 9.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.948 -0.76 . . . . 0.44 108.948 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.1 p -61.05 146.48 47.06 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.265 0.555 . . . . 0.84999999999999998 111.78 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.76 -73.2 0.47 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.771 -0.65 . . . . 1.04 109.953 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.29 -42.67 0.11 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.255 -0.738 . . . . 0.71999999999999997 111.255 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 61' ' ' GLN . 12.7 mm-40 -133.95 155.03 50.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.711 0.291 . . . . 1.5 110.311 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.467 ' OE1' ' HE2' ' A' ' 67' ' ' MET . 1.6 tm-20 -119.99 154.05 35.09 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.019 -0.537 . . . . 1.5700000000000001 109.783 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.22 -34.27 75.93 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.152 -0.684 . . . . 1.3799999999999999 109.152 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -130.38 127.19 38.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.554 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 m -57.57 -29.03 64.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.172 -0.467 . . . . 0.90000000000000002 111.09 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.66 -37.53 76.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.976 0.417 . . . . 0.35999999999999999 110.812 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.467 ' HE2' ' OE1' ' A' ' 62' ' ' GLU . 6.9 mtp -71.07 -30.91 67.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.936 -0.574 . . . . 1.04 110.143 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -69.77 -51.18 36.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.312 0.577 . . . . 1.0700000000000001 109.671 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -65.87 -20.77 66.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.546 -0.752 . . . . 1.4099999999999999 110.779 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -57.76 -57.77 11.28 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.077 -0.51 . . . . 1.77 111.144 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.422 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 10.9 p90 -70.77 -20.28 62.63 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.552 -0.459 . . . . 1.27 110.77 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 90.9 mtp -75.24 -27.17 59.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.058 0.456 . . . . 1.28 110.071 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.5 mtm105 -82.25 -41.09 20.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.014 0.435 . . . . 1.8600000000000001 109.928 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.422 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 9.7 p -75.78 -12.65 60.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.956 -0.565 . . . . 1.01 111.384 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.34 129.0 11.0 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.926 -0.654 . . . . 0.20000000000000001 112.312 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -87.46 -46.45 9.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.021 0.438 . . . . 0.54000000000000004 110.094 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.69 143.9 14.73 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.135 -0.786 . . . . 0.31 111.135 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.488 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 75.3 m-85 -121.56 135.74 54.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.085 0.469 . . . . 0.60999999999999999 111.557 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.3 tp -97.25 106.78 19.16 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.101 -0.703 . . . . 1.04 109.101 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 111' ' ' MET . 0.1 OUTLIER -78.71 85.68 4.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.065 0.459 . . . . 1.1799999999999999 110.312 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.63 132.88 34.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.135 0.493 . . . . 1.03 111.824 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.459 ' HB3' HD11 ' A' ' 93' ' ' ILE . 29.2 p90 -144.63 169.15 18.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.459 -0.792 . . . . 0.41999999999999998 108.908 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.74 124.05 49.96 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.897 -0.321 . . . . 0.76000000000000001 110.628 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 118' ' ' CYS . 3.4 pt -71.9 -4.9 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.197 0.522 . . . . 1.1499999999999999 111.054 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.518 ' OD1' ' HD2' ' A' ' 117' ' ' LYS . 8.7 p-10 -106.4 14.63 27.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.071 -0.513 . . . . 0.93999999999999995 109.847 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -152.54 100.47 2.57 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.815 -0.63 . . . . 1.3799999999999999 110.479 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.48 -29.2 68.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.636 . . . . 0.75 112.558 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -58.23 -35.97 72.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.757 0.313 . . . . 1.4199999999999999 111.385 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.3 p -80.19 -33.78 37.95 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.762 0.315 . . . . 0.71999999999999997 110.778 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -68.96 -41.73 77.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.51000000000000001 110.844 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.63 -18.58 62.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.186 -0.461 . . . . 1.4399999999999999 111.167 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -81.78 -18.66 43.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.904 0.383 . . . . 1.02 110.402 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.459 HD11 ' HB3' ' A' ' 82' ' ' PHE . 27.8 mm -57.79 -30.69 38.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.563 -0.744 . . . . 1.04 110.834 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -63.05 -47.38 83.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.978 -0.556 . . . . 1.0900000000000001 110.465 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -66.51 -39.37 88.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.89 -0.595 . . . . 0.98999999999999999 111.547 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -59.99 -45.71 91.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.642 0.258 . . . . 1.73 110.681 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.429 ' HG2' ' CE1' ' A' ' 137' ' ' TYR . 18.8 tpt180 -58.63 -49.62 76.82 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.084 -0.507 . . . . 0.66000000000000003 110.282 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -60.73 -39.33 88.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.842 -0.617 . . . . 1.3500000000000001 110.903 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.412 ' O ' HG21 ' A' ' 103' ' ' VAL . 35.4 tp60 -62.24 -53.13 59.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.56 -0.291 . . . . 1.3999999999999999 110.896 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.7 mt -59.22 -42.07 85.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.465 -0.334 . . . . 0.78000000000000003 111.015 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -66.08 -26.03 67.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.471 -0.331 . . . . 1.6000000000000001 111.621 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -87.01 -35.84 18.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.004 0.431 . . . . 1.0900000000000001 110.554 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.412 HG21 ' O ' ' A' ' 99' ' ' GLN . 62.2 t -70.35 -46.92 69.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.817 -0.629 . . . . 0.89000000000000001 111.328 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -87.09 -18.52 30.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.329 . . . . 1.3500000000000001 110.733 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t70 54.6 54.53 9.13 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.306 -0.861 . . . . 0.46999999999999997 111.055 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.3 m -137.31 146.63 44.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.961 -0.563 . . . . 1.4399999999999999 109.877 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.24 -42.9 20.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.001 0.429 . . . . 1.74 110.039 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -93.68 106.74 18.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.857 -0.61 . . . . 0.78000000000000003 110.349 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.48 119.24 29.43 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.938 -0.393 . . . . 0.63 109.938 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.92 103.7 0.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.329 2.019 . . . . 0.29999999999999999 111.275 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.522 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 85.9 mtp -138.07 151.34 47.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.204 -0.453 . . . . 1.1899999999999999 110.399 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.7 t -129.55 121.76 53.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.503 -0.554 . . . . 0.63 109.503 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.6 tp -76.82 117.65 18.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.346 -0.613 . . . . 0.66000000000000003 109.346 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.2 t -117.82 114.99 47.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.0 -0.546 . . . . 1.3700000000000001 112.069 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.55 96.43 1.89 Allowed Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.049 -1.221 . . . . 0.27000000000000002 110.049 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -80.67 162.77 24.02 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.775 0.287 . . . . 0.23999999999999999 111.775 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.518 ' HD2' ' OD1' ' A' ' 85' ' ' ASN . 41.7 mttt 71.39 41.27 0.76 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.382 -0.826 . . . . 1.1499999999999999 111.516 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.429 ' HA ' ' CD1' ' A' ' 84' ' ' ILE . 29.6 p -75.17 -19.36 59.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.944 0.402 . . . . 1.29 111.449 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -89.24 -7.55 55.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.966 0.412 . . . . 0.69999999999999996 111.045 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 51.4 mt -91.56 145.68 31.74 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.256 -0.429 . . . . 1.3100000000000001 110.859 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.63 -170.65 0.86 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.567 2.178 . . . . 0.79000000000000004 112.047 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.2 m 58.78 44.85 16.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.134 -0.485 . . . . 1.29 111.544 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -72.24 118.22 14.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.68000000000000005 110.197 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.49 -17.64 15.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.964 0.411 . . . . 1.28 111.603 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.72 115.52 49.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.07 -0.514 . . . . 0.96999999999999997 110.779 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.74 148.23 42.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 1.6899999999999999 110.59 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.6 m -59.55 -33.71 71.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.823 -0.626 . . . . 1.6499999999999999 111.281 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -64.72 -44.33 90.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.695 -0.23 . . . . 0.71999999999999997 110.673 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -41.44 93.88 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.074 0.464 . . . . 1.1100000000000001 110.655 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.41 -48.33 67.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.594 -0.73 . . . . 0.35999999999999999 110.561 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -62.03 -35.39 78.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.173 0.511 . . . . 0.5 110.382 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -48.92 79.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.812 -0.631 . . . . 1.1799999999999999 110.578 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.32 -41.24 85.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.101 -0.499 . . . . 0.81000000000000005 111.041 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.09 -44.91 83.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.951 0.405 . . . . 0.66000000000000003 111.204 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -69.03 -25.17 64.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 2.0699999999999998 110.899 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.0 m -71.5 -26.74 62.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.151 0.5 . . . . 1.28 110.241 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.429 ' CE1' ' HG2' ' A' ' 97' ' ' ARG . 19.1 m-85 -93.11 -33.3 14.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.245 0.545 . . . . 1.0900000000000001 110.41 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.4 30.11 7.11 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.752 -0.939 . . . . 0.33000000000000002 110.752 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.1 pt -123.55 156.89 63.72 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.283 -0.459 . . . . 1.04 110.486 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.4 157.37 29.19 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.192 1.928 . . . . 0.69999999999999996 112.578 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -132.05 132.11 43.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.928 -0.578 . . . . 0.45000000000000001 110.334 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 63.5 mt -137.81 130.76 41.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.85999999999999999 111.174 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -81.8 128.15 33.71 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.389 -0.967 . . . . 0.88 108.389 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 64.2 p -131.86 174.73 9.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.272 0.558 . . . . 0.76000000000000001 112.236 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.7 t -150.6 134.09 16.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.275 -0.875 . . . . 0.35999999999999999 109.109 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.7 -6.88 59.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.127 0.489 . . . . 0.55000000000000004 110.407 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -91.39 -48.24 7.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.008 -0.542 . . . . 1.8300000000000001 110.912 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.0 p -94.22 -17.62 22.51 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.591 -0.277 . . . . 0.73999999999999999 111.122 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 67.04 23.12 9.8 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.773 0.671 . . . . 2.0800000000000001 110.86 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 144' ' ' THR . 35.2 tt0 -71.42 119.75 16.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.9 -0.591 . . . . 1.04 111.113 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.05 -8.87 42.17 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.923 -0.58 . . . . 0.66000000000000003 114.028 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.38 -49.02 85.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 117.143 0.471 . . . . 1.0700000000000001 111.14 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.37 -48.35 79.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.098 0.475 . . . . 1.6200000000000001 110.148 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.0 -47.47 84.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.431 -0.804 . . . . 1.0 111.583 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -54.73 -50.41 68.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.679 0.276 . . . . 0.46000000000000002 111.7 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.442 ' O ' HG22 ' A' ' 160' ' ' VAL . 26.6 m-85 -62.71 -42.68 99.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.346 -0.388 . . . . 2.1000000000000001 111.578 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -70.22 -35.54 73.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.702 -0.226 . . . . 1.55 111.202 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 39.2 m -64.1 -39.45 94.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.803 0.335 . . . . 0.39000000000000001 110.304 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 25.2 tp -61.64 -37.18 83.06 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.163 -0.471 . . . . 0.90000000000000002 110.394 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 156' ' ' PHE . 21.2 t -64.08 -38.37 82.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.278 0.561 . . . . 0.97999999999999998 109.778 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.6 mtt85 -70.49 -34.3 72.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.8 -0.636 . . . . 1.0700000000000001 110.134 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -59.95 -40.43 88.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.802 -0.636 . . . . 0.72999999999999998 109.96 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 65.4 mt -68.11 -45.2 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.501 -0.772 . . . . 0.84999999999999998 110.268 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.465 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 93.4 mtt180 -54.23 -42.18 69.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.678 -0.692 . . . . 0.98999999999999999 111.043 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -63.26 -36.95 85.36 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 115.796 -0.638 . . . . 1.55 111.135 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -69.69 -26.35 64.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.181 0.515 . . . . 0.84999999999999998 110.411 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -82.82 -34.98 26.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.944 -0.571 . . . . 1.73 110.893 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 8.7 pt-20 -95.96 16.62 17.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.376 -0.375 . . . . 1.1200000000000001 110.566 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.3 tttp . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.22 -0.895 . . . . 1.8799999999999999 110.32 -179.855 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 50' ' ' THR . 31.8 ttm . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.967 0.413 . . . . 1.8899999999999999 110.254 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.2 m -92.73 137.62 32.21 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.431 -0.349 . . . . 1.24 110.965 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -91.13 132.16 36.24 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.619 -0.511 . . . . 1.27 109.619 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -115.26 121.51 43.12 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.138 -0.319 . . . . 1.45 110.138 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -96.53 108.22 20.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.241 0.543 . . . . 1.1799999999999999 110.988 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.8 mp -112.29 142.35 44.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.71 -0.677 . . . . 2.1099999999999999 111.2 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.2 t -128.74 130.01 68.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.866 -0.607 . . . . 1.28 110.677 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.6 t -95.89 114.04 31.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.92 -0.582 . . . . 0.77000000000000002 109.519 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -115.82 136.62 52.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.428 0.633 . . . . 0.94999999999999996 111.425 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.2 176.08 45.0 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.43 -0.805 . . . . 0.56000000000000005 111.589 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.566 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -71.83 167.73 19.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.864 0.364 . . . . 0.66000000000000003 110.114 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.3 128.31 11.48 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.496 -0.859 . . . . 0.80000000000000004 112.765 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.99 10.95 59.34 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.71 -0.757 . . . . 0.45000000000000001 113.744 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 11' ' ' ALA . 27.2 m -85.94 -1.86 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 117.696 0.748 . . . . 0.98999999999999999 111.357 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.502 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 92.46 29.59 10.89 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.954 -0.641 . . . . 0.48999999999999999 113.371 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -60.59 -45.61 93.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.802 0.301 . . . . 1.3799999999999999 111.518 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -75.63 -20.3 58.6 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.874 0.324 . . . . 0.85999999999999999 111.874 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.15 -40.6 64.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.868 0.366 . . . . 0.95999999999999996 110.733 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 37.8 mt -64.57 -27.58 69.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.864 -0.607 . . . . 1.21 110.616 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -74.24 -54.06 8.49 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.033 -0.53 . . . . 1.2 111.351 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.6 mt -61.13 -38.67 80.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.778 0.323 . . . . 1.3799999999999999 111.433 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.618 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 2.5 mm-40 -66.85 -23.82 66.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.009 0.433 . . . . 0.52000000000000002 111.194 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.2 tp -95.08 -40.73 9.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.74 0.305 . . . . 1.8799999999999999 111.54 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 20' ' ' THR . 46.9 mm -74.61 -55.35 12.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.164 -0.471 . . . . 0.57999999999999996 112.232 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 50.9 mt-30 -100.86 -11.64 19.65 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.945 0.35 . . . . 1.74 111.945 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.618 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 70.2 m-20 71.23 17.64 5.92 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.362 0.875 . . . . 1.9199999999999999 113.362 178.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -128.73 128.65 44.45 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.474 -0.49 . . . . 0.85999999999999999 110.548 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -75.48 127.28 32.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.064 -0.971 . . . . 0.77000000000000002 110.959 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.6 t -99.04 136.58 29.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.918 -0.583 . . . . 1.04 109.482 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -83.47 -30.5 27.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.502 -0.317 . . . . 1.1200000000000001 111.778 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -134.84 116.3 14.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.902 0.382 . . . . 1.1799999999999999 111.248 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -141.76 146.31 35.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.848 -0.614 . . . . 0.80000000000000004 109.516 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.33 121.3 73.96 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.052 0.453 . . . . 0.80000000000000004 111.357 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.43 -18.35 15.83 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.55 2.167 . . . . 0.56000000000000005 112.865 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.07 3.32 52.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.261 -0.427 . . . . 1.21 111.208 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 mt -83.92 125.35 40.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.234 0.54 . . . . 1.1499999999999999 111.321 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 18.4 tt0 -125.3 83.41 2.16 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.905 -1.146 . . . . 0.81000000000000005 107.905 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -113.62 162.17 16.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.789 -0.641 . . . . 1.29 111.956 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.74 142.94 26.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.289 -0.869 . . . . 1.1699999999999999 111.652 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -134.97 135.75 41.68 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.053 -0.351 . . . . 0.97999999999999998 110.053 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 1.1 mpp_? -119.2 139.57 51.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.912 0.387 . . . . 0.69999999999999996 110.565 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -143.04 131.33 22.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.1 -0.5 . . . . 1.78 110.302 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -101.7 112.27 24.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.985 0.421 . . . . 2.3900000000000001 110.313 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.95 149.87 30.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.136 -0.484 . . . . 1.3799999999999999 110.968 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.3 t -92.49 93.17 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.947 -0.761 . . . . 0.65000000000000002 108.947 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.3 mt -91.51 114.05 28.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.049 -0.523 . . . . 1.47 111.805 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.497 ' HB2' HH12 ' A' ' 164' ' ' ARG . 56.5 m-20 58.26 37.78 26.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.662 -0.699 . . . . 0.96999999999999997 111.099 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.5 -5.01 84.83 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.086 -0.578 . . . . 0.59999999999999998 113.347 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -108.93 115.61 30.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.878 0.37 . . . . 1.4099999999999999 111.759 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -70.22 116.92 11.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 0.89000000000000001 109.768 178.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.3 m -129.89 151.64 50.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.084 0.469 . . . . 1.3100000000000001 111.72 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.9 tp -104.25 113.45 27.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.001 -0.74 . . . . 0.85999999999999999 109.001 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 53.7 mt -82.39 125.62 31.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.896 -0.593 . . . . 1.1299999999999999 112.027 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -110.41 88.73 2.84 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.106 -1.072 . . . . 1.03 108.106 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.0 mt -99.81 130.58 48.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.96 -0.564 . . . . 1.1799999999999999 111.871 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.7 tp -116.36 107.02 14.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.996 -0.547 . . . . 0.75 109.782 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -75.32 116.16 15.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.876 -0.602 . . . . 0.44 110.267 -179.633 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.7 p -73.45 156.32 38.38 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.515 0.674 . . . . 0.84999999999999998 112.168 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.4 -55.78 2.38 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.79 -1.095 . . . . 1.04 109.949 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.28 -87.46 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.843 -0.617 . . . . 0.71999999999999997 111.957 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -122.91 127.88 49.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.974 -0.38 . . . . 1.5 109.974 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -87.72 -173.73 4.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.271 -0.422 . . . . 1.5700000000000001 111.094 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.13 -47.7 81.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 1.3799999999999999 111.07 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -123.2 148.67 45.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.72 0.295 . . . . 1.0 110.521 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -60.91 -34.35 74.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.088 -0.506 . . . . 0.90000000000000002 110.652 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.76 -28.87 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.891 -0.595 . . . . 0.35999999999999999 111.362 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 86.0 mtp -70.05 -44.61 68.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.228 0.537 . . . . 1.04 109.847 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 71' ' ' TYR . 17.0 ttp180 -65.92 -39.0 90.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.538 -0.755 . . . . 1.0700000000000001 109.91 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -77.79 -5.22 50.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.584 -0.735 . . . . 1.4099999999999999 110.842 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -73.7 -62.86 1.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.661 -0.245 . . . . 1.77 111.642 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 68' ' ' ARG . 1.3 p90 -67.22 -17.83 64.98 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 120.606 0.241 . . . . 1.27 111.047 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.3 mtt -73.51 -17.43 61.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.225 0.536 . . . . 1.28 109.665 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -90.48 -49.77 6.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.557 -0.747 . . . . 1.8600000000000001 110.187 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.15 -12.0 60.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 1.01 112.145 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.47 132.49 38.4 Favored Glycine 0 C--O 1.237 0.344 0 C-N-CA 121.123 -0.56 . . . . 0.20000000000000001 113.18 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -97.96 -36.32 10.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 0.54000000000000004 110.81 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -133.17 128.89 5.23 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.022 -0.831 . . . . 0.31 111.022 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.437 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 91.6 m-85 -114.99 116.85 29.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.244 0.545 . . . . 0.60999999999999999 110.88 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.8 tp -88.8 109.19 19.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.54 -0.755 . . . . 1.04 109.908 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.5 m -82.53 103.54 12.14 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.356 0.41 . . . . 1.1799999999999999 109.959 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.07 129.61 60.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.981 0.419 . . . . 1.03 112.084 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -136.6 162.3 33.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.652 -0.704 . . . . 0.41999999999999998 109.674 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.427 ' HB2' ' OD1' ' A' ' 85' ' ' ASN . . . -100.95 126.76 47.62 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.365 -0.235 . . . . 0.76000000000000001 110.365 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.1 pt -71.13 -12.16 15.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.948 0.404 . . . . 1.1499999999999999 111.375 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.427 ' OD1' ' HB2' ' A' ' 83' ' ' ALA . 10.1 p-10 -95.23 5.79 50.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.826 -0.625 . . . . 0.93999999999999995 110.75 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -148.43 111.73 4.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.072 0.463 . . . . 1.3799999999999999 110.542 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.27 -26.96 66.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.1 -0.5 . . . . 0.75 111.938 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -58.35 -37.85 76.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 1.4199999999999999 110.646 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.42 ' O ' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -67.55 -38.15 83.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.378 -0.373 . . . . 0.71999999999999997 110.796 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -66.67 -39.86 88.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.176 0.512 . . . . 0.51000000000000001 110.068 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.53 -35.08 79.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.87 -0.604 . . . . 1.4399999999999999 110.635 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -63.45 -32.8 74.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.901 -0.591 . . . . 1.02 110.932 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 89' ' ' SER . 45.7 mm -57.87 -31.55 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.586 . . . . 1.04 111.031 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -62.71 -35.92 81.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.126 0.489 . . . . 1.0900000000000001 110.348 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -82.19 -38.5 24.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.98999999999999999 110.104 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -58.69 -48.68 80.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.283 -0.417 . . . . 1.73 111.204 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -56.37 -51.78 67.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.958 -0.565 . . . . 0.66000000000000003 110.919 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -39.89 95.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.032 -0.531 . . . . 1.3500000000000001 111.061 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -59.36 -55.24 37.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.947 -0.57 . . . . 1.3999999999999999 111.117 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.97 -37.76 79.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.435 -0.348 . . . . 0.78000000000000003 110.755 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -61.09 -32.6 72.26 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.974 0.416 . . . . 1.6000000000000001 110.026 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -77.46 -45.32 26.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.893 -0.594 . . . . 1.0900000000000001 110.643 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 66.4 t -59.93 -47.64 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.191 -0.459 . . . . 0.89000000000000001 111.71 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -83.68 -13.32 54.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.451 -0.34 . . . . 1.3500000000000001 110.541 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 t70 54.91 48.56 19.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.622 -0.717 . . . . 0.46999999999999997 109.854 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.8 m -132.61 143.65 49.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.363 -0.835 . . . . 1.4399999999999999 110.314 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.18 -31.06 30.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.1 0.476 . . . . 1.74 110.368 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -119.41 112.35 19.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.96 -0.564 . . . . 0.78000000000000003 110.135 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.21 122.54 24.13 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.695 -0.483 . . . . 0.63 109.695 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -49.69 107.52 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.171 2.581 . . . . 0.29999999999999999 111.982 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.437 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 56.5 mtt -140.04 150.2 44.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.952 -0.567 . . . . 1.1899999999999999 110.719 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.4 t -132.46 121.81 46.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.665 -0.865 . . . . 0.63 108.665 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.626 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 56.3 tp -89.31 125.13 34.98 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.641 -0.503 . . . . 0.66000000000000003 109.641 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.7 129.13 54.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.354 0.597 . . . . 1.3700000000000001 111.861 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -94.5 103.86 3.07 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.224 -1.15 . . . . 0.27000000000000002 110.224 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -81.51 164.52 21.92 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.576 -0.157 . . . . 0.23999999999999999 110.576 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 69.7 mttt 66.97 36.93 4.06 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.733 0.646 . . . . 1.1499999999999999 110.459 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 31.9 p -67.68 -13.63 62.26 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.24 -0.436 . . . . 1.29 111.957 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -89.53 -8.77 52.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.428 -0.351 . . . . 0.69999999999999996 110.936 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 16.3 mt -77.63 130.25 74.35 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.561 0.22 . . . . 1.3100000000000001 110.976 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 11.2 Cg_exo -69.5 171.88 13.39 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.885 2.39 . . . . 0.79000000000000004 112.081 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.8 m 61.57 54.55 3.01 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.393 0.616 . . . . 1.29 110.573 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -64.64 127.41 31.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.381 -0.827 . . . . 0.68000000000000005 111.206 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.14 -41.22 7.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.074 -0.512 . . . . 1.28 110.512 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.3 t -88.96 113.32 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.222 -0.445 . . . . 0.96999999999999997 110.295 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.06 147.61 49.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 1.6899999999999999 110.878 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -46.85 87.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 1.6499999999999999 111.848 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.6 tttm -65.22 -35.69 81.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.61 -0.268 . . . . 0.71999999999999997 110.621 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -59.27 -44.34 92.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 1.1100000000000001 110.881 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.56 -40.04 66.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 0.35999999999999999 110.929 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.8 -34.42 78.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.761 -0.654 . . . . 0.5 110.953 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -40.82 98.46 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.789 -0.641 . . . . 1.1799999999999999 110.226 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 27.8 tp -69.84 -42.07 74.07 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.872 -0.604 . . . . 0.81000000000000005 109.547 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 139' ' ' ILE . . . -58.69 -45.47 89.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.302 -0.863 . . . . 0.66000000000000003 110.423 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -59.07 -45.69 90.17 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.858 -0.61 . . . . 2.0699999999999998 110.683 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.2 m -65.42 -35.08 79.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.945 -0.571 . . . . 1.28 111.301 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -79.02 -22.42 45.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.235 -0.439 . . . . 1.0900000000000001 110.944 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.62 26.61 38.1 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.911 -0.661 . . . . 0.33000000000000002 111.45 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 34.7 pt -124.16 156.17 66.84 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 110.094 -0.335 . . . . 1.04 110.094 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -84.59 155.12 12.04 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.153 1.902 . . . . 0.69999999999999996 112.859 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.626 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 19.0 t80 -130.93 127.03 37.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.918 -0.583 . . . . 0.45000000000000001 110.549 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.9 mt -130.53 139.36 51.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.132 -0.485 . . . . 0.85999999999999999 110.034 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -78.32 137.96 38.32 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.288 -1.005 . . . . 0.88 108.288 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.7 p -139.03 162.02 35.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.519 0.933 . . . . 0.76000000000000001 113.519 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.6 t -155.09 117.25 4.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.687 -1.142 . . . . 0.35999999999999999 108.559 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.87 -11.3 60.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.55000000000000004 111.478 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -84.5 -42.84 15.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.278 -0.419 . . . . 1.8300000000000001 111.439 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.5 p -96.55 -5.56 39.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.696 -0.229 . . . . 0.73999999999999999 111.525 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 38.4 ttt85 59.75 47.66 10.1 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.611 0.719 . . . . 2.0800000000000001 109.829 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -113.31 125.57 54.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.544 -0.753 . . . . 1.04 111.158 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.78 -21.83 3.7 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.802 -0.636 . . . . 0.66000000000000003 113.303 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.17 -46.49 88.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.802 0.334 . . . . 1.0700000000000001 111.654 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.454 ' O ' ' HD2' ' A' ' 157' ' ' TYR . 21.4 t70 -62.0 -49.24 76.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.495 . . . . 1.6200000000000001 110.096 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -39.02 86.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.223 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -58.97 -52.05 67.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.222 -0.445 . . . . 0.46000000000000002 111.94 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -62.58 -41.58 99.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.633 -0.258 . . . . 2.1000000000000001 111.562 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.454 ' HD2' ' O ' ' A' ' 153' ' ' ASP . 29.0 m-85 -66.96 -34.63 78.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 1.55 110.807 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 99.5 m -68.42 -45.61 72.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.319 -0.4 . . . . 0.39000000000000001 110.92 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.46 ' O ' HG13 ' A' ' 163' ' ' ILE . 31.0 tp -55.96 -41.79 75.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.361 -0.381 . . . . 0.90000000000000002 111.052 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.88 -43.47 98.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.322 -0.399 . . . . 0.97999999999999998 110.901 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -65.22 -34.22 77.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.444 -0.344 . . . . 1.0700000000000001 111.011 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -64.05 -44.82 91.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.72999999999999998 110.232 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 159' ' ' LEU . 17.2 mt -62.54 -43.9 98.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.086 0.469 . . . . 0.84999999999999998 110.072 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.497 HH12 ' HB2' ' A' ' 47' ' ' ASP . 93.9 mtt180 -59.15 -42.78 91.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.42 -0.809 . . . . 0.98999999999999999 111.371 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -66.08 -30.57 71.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.218 -0.446 . . . . 1.55 111.191 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -79.73 -26.06 40.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.256 -0.429 . . . . 0.84999999999999998 110.213 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -77.08 -33.66 57.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.594 -0.275 . . . . 1.73 110.408 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -87.04 4.0 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 1.1200000000000001 110.871 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.2 tptt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.367 -0.825 . . . . 1.8799999999999999 110.848 -179.616 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttm . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 121.17 0.51 . . . . 1.8899999999999999 110.371 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.0 m -76.38 126.84 31.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.133 -0.485 . . . . 1.24 110.712 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -94.14 134.67 36.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.133 -0.485 . . . . 1.27 110.253 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -122.49 128.08 50.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.375 -0.375 . . . . 1.45 110.279 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -99.58 108.82 21.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.269 -0.423 . . . . 1.1799999999999999 109.921 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.59 148.94 47.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.394 0.616 . . . . 2.1099999999999999 110.981 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.13 132.03 70.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.924 -0.58 . . . . 1.28 110.862 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.4 t -91.24 119.19 38.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.035 -0.728 . . . . 0.77000000000000002 109.035 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.7 m -116.65 157.83 17.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.829 0.347 . . . . 0.94999999999999996 111.297 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.83 176.27 32.76 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.714 -0.954 . . . . 0.56000000000000005 110.714 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.68 172.63 11.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.974 0.416 . . . . 0.66000000000000003 111.415 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.91 121.19 5.67 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.697 -0.763 . . . . 0.80000000000000004 112.189 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.71 3.03 55.26 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.821 -0.704 . . . . 0.45000000000000001 113.245 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.81 -29.09 28.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 117.391 0.596 . . . . 0.98999999999999999 111.098 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.647 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 115.85 19.97 5.47 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.144 -1.027 . . . . 0.48999999999999999 114.406 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -53.05 -53.58 48.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.468 0.634 . . . . 1.3799999999999999 111.86 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -34.99 75.64 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.322 -0.399 . . . . 0.85999999999999999 111.959 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.63 -40.62 88.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.5 -0.318 . . . . 0.95999999999999996 111.278 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 23.5 mt -63.31 -39.05 93.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.375 -0.375 . . . . 1.21 110.88 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 m -66.14 -47.4 74.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.256 -0.429 . . . . 1.2 111.005 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.416 HG23 HD11 ' A' ' 21' ' ' ILE . 76.5 mt -65.59 -34.8 72.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 1.3799999999999999 111.26 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 2.3 mm-40 -69.97 -12.67 61.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.991 0.424 . . . . 0.52000000000000002 111.323 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.7 tp -102.29 -37.46 8.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.211 0.529 . . . . 1.8799999999999999 110.861 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.9 mm -80.53 -59.08 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.908 -0.587 . . . . 0.57999999999999996 111.425 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -89.92 -17.06 28.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.451 -0.34 . . . . 1.74 110.96 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 45.4 m-80 63.38 46.83 4.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.794 -0.639 . . . . 1.9199999999999999 112.282 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -153.71 143.79 22.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.576 -0.528 . . . . 0.85999999999999999 109.576 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -82.71 129.99 35.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.242 -0.435 . . . . 0.77000000000000002 111.972 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.33 120.02 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.657 -0.701 . . . . 1.04 109.512 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.6 -41.17 32.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.236 -0.438 . . . . 1.1200000000000001 111.888 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -115.6 108.97 17.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.181 0.515 . . . . 1.1799999999999999 111.698 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -142.3 144.07 33.09 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.93 -0.767 . . . . 0.80000000000000004 108.93 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -64.63 123.73 84.06 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.917 0.389 . . . . 0.80000000000000004 110.9 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.18 -15.29 14.54 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.549 2.166 . . . . 0.56000000000000005 113.386 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.44 3.16 56.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.674 0.273 . . . . 1.21 111.733 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.8 mt -86.0 127.46 40.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 120.849 0.357 . . . . 1.1499999999999999 110.462 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 11.3 tt0 -114.86 94.94 4.98 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.215 -1.032 . . . . 0.81000000000000005 108.215 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -115.47 164.18 14.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.01 -0.541 . . . . 1.29 110.918 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 1.2 p -130.06 129.84 44.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.776 -0.647 . . . . 1.1699999999999999 109.961 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -125.35 143.81 50.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.642 -0.254 . . . . 0.97999999999999998 110.947 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.682 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -113.2 143.06 45.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.69999999999999996 110.575 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -147.02 134.85 21.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.703 -0.681 . . . . 1.78 109.459 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -103.18 114.49 28.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.943 0.401 . . . . 2.3900000000000001 110.976 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 31.5 t -127.01 147.81 31.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.767 -0.652 . . . . 1.3799999999999999 110.432 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.61 101.24 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.728 -0.471 . . . . 0.65000000000000002 109.728 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 76.9 mt -105.96 118.1 52.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.963 0.411 . . . . 1.47 111.249 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.51 ' HB2' HH12 ' A' ' 164' ' ' ARG . 86.6 m-20 61.77 30.85 18.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.007 -0.997 . . . . 0.96999999999999997 111.744 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.61 -0.21 73.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.855 -0.688 . . . . 0.59999999999999998 114.163 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -121.68 126.67 49.53 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.46 0.63 . . . . 1.4099999999999999 111.175 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.95 115.36 11.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.976 0.417 . . . . 0.89000000000000001 110.111 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.1 m -116.89 147.72 41.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.108 -0.496 . . . . 1.3100000000000001 111.576 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.9 tp -100.46 120.25 39.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.881 -0.599 . . . . 0.85999999999999999 109.394 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 16.7 mt -89.73 115.99 27.5 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.047 -0.524 . . . . 1.1299999999999999 112.128 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -104.31 95.18 5.77 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.53 -1.285 . . . . 1.03 107.53 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 39' ' ' SER . 6.1 mt -101.85 127.88 54.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.075 -0.511 . . . . 1.1799999999999999 112.367 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.0 tp -114.23 119.45 37.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.057 -0.52 . . . . 0.75 109.859 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 4.5 t70 -89.84 100.88 13.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.115 -0.493 . . . . 0.44 110.074 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.4 p -62.51 138.54 58.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.779 -0.646 . . . . 0.84999999999999998 112.597 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.54 -36.24 24.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.414 -0.812 . . . . 1.04 110.066 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.33 -74.9 0.42 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.964 -0.636 . . . . 0.71999999999999997 111.83 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -108.93 117.89 35.36 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.818 -0.438 . . . . 1.5 109.818 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.94 162.7 15.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.172 -0.467 . . . . 1.5700000000000001 110.432 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -55.56 -51.92 65.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.857 -0.61 . . . . 1.3799999999999999 111.188 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -127.07 148.27 50.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.635 -0.506 . . . . 1.0 109.635 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -35.04 76.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.693 0.282 . . . . 0.90000000000000002 111.361 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.94 -31.91 73.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 0.35999999999999999 111.222 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 85.0 mtp -74.17 -31.67 62.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.268 0.556 . . . . 1.04 109.823 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.498 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 34.9 ttp180 -74.33 -46.45 40.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.453 -0.794 . . . . 1.0700000000000001 109.906 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 39.2 m-20 -65.68 -24.45 67.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.409 -0.814 . . . . 1.4099999999999999 110.228 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -57.9 -56.7 18.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.349 -0.841 . . . . 1.77 111.559 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.498 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 31.1 p90 -72.4 -14.26 61.66 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.861 -0.336 . . . . 1.27 111.407 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.4 mtt -76.16 -28.78 57.5 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.451 -0.574 . . . . 1.28 109.451 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 30.2 mtm180 -83.64 -34.18 25.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.831 -0.622 . . . . 1.8600000000000001 111.163 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.422 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -78.91 -26.77 43.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.27 -0.423 . . . . 1.01 111.603 -179.399 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.82 125.76 28.47 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.038 -0.601 . . . . 0.20000000000000001 112.712 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -92.0 -26.05 18.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.681 -0.488 . . . . 0.54000000000000004 109.681 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -141.78 143.82 13.5 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 110.886 -0.886 . . . . 0.31 110.886 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.419 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 89.8 m-85 -126.8 132.43 51.03 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.229 0.538 . . . . 0.60999999999999999 111.255 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 tp -100.87 112.28 24.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.724 -0.671 . . . . 1.04 109.368 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.7 m -90.01 104.72 17.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.102 0.477 . . . . 1.1799999999999999 110.454 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.1 t -102.73 126.5 56.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.069 -0.514 . . . . 1.03 111.571 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -133.02 160.19 37.87 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.065 -0.717 . . . . 0.41999999999999998 109.065 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.85 128.2 48.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.811 0.338 . . . . 0.76000000000000001 110.492 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 pt -67.29 -14.2 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.367 . . . . 1.1499999999999999 111.828 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -100.85 6.48 43.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.926 0.393 . . . . 0.93999999999999995 110.397 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -135.67 103.32 5.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 1.3799999999999999 110.246 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -27.22 66.97 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.447 0.536 . . . . 0.75 112.447 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -66.88 -37.74 84.98 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.161 -0.216 . . . . 1.4199999999999999 111.123 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.423 ' O ' HG12 ' A' ' 93' ' ' ILE . 91.4 p -64.89 -36.87 85.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.425 . . . . 0.71999999999999997 110.024 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -69.67 -35.71 75.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.924 -0.58 . . . . 0.51000000000000001 109.955 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -65.62 -40.88 93.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.801 -0.636 . . . . 1.4399999999999999 110.471 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.53 -26.35 68.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.737 -0.665 . . . . 1.02 111.769 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 89' ' ' SER . 48.3 mm -57.93 -28.64 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.099 0.476 . . . . 1.04 110.73 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -66.66 -41.12 88.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.973 -0.558 . . . . 1.0900000000000001 110.68 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -77.71 -34.54 52.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.98999999999999999 110.832 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -59.13 -48.02 83.16 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.524 -0.307 . . . . 1.73 110.741 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -60.57 -46.41 90.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.96 -0.564 . . . . 0.66000000000000003 110.016 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -47.92 79.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.742 -0.663 . . . . 1.3500000000000001 111.528 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.538 ' O ' HG21 ' A' ' 103' ' ' VAL . 26.0 tt0 -59.3 -58.19 9.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 1.3999999999999999 112.111 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.33 -39.0 79.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 120.591 0.234 . . . . 0.78000000000000003 111.026 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -61.38 -35.86 78.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.951 0.405 . . . . 1.6000000000000001 110.457 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -73.64 -37.87 65.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.044 -0.525 . . . . 1.0900000000000001 110.972 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 99' ' ' GLN . 47.8 t -68.96 -40.83 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.89000000000000001 110.982 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -82.75 -20.15 36.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.485 -0.325 . . . . 1.3500000000000001 111.222 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 54.92 57.31 5.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.507 0.67 . . . . 0.46999999999999997 110.333 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -141.6 142.01 33.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.656 -0.702 . . . . 1.4399999999999999 109.761 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -75.54 -31.82 60.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.906 0.384 . . . . 1.74 110.004 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.4 123.96 49.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.968 -0.56 . . . . 0.78000000000000003 110.816 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.2 t -135.28 113.38 11.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.187 -0.671 . . . . 0.63 109.187 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.98 109.18 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.854 2.369 . . . . 0.29999999999999999 112.783 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.446 ' O ' ' HB ' ' A' ' 139' ' ' ILE . 30.9 mtt -139.33 152.98 47.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.964 -0.562 . . . . 1.1899999999999999 110.722 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 73.3 t -131.45 127.25 59.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.171 -0.677 . . . . 0.63 109.171 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.4 tp -84.84 118.87 24.75 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.606 -0.516 . . . . 0.66000000000000003 109.606 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 65.0 t -114.68 117.9 57.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.037 -0.529 . . . . 1.3700000000000001 112.008 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.29 93.25 1.49 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.549 -1.02 . . . . 0.27000000000000002 110.549 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -80.73 163.2 23.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.648 0.261 . . . . 0.23999999999999999 111.623 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.6 mttt 68.39 33.84 3.98 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.42 -0.809 . . . . 1.1499999999999999 111.233 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 20.9 p -68.05 -20.35 64.97 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 111.991 0.367 . . . . 1.29 111.991 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -86.54 -12.0 50.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.765 0.317 . . . . 0.69999999999999996 111.383 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.21 142.17 54.71 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.358 -0.383 . . . . 1.3100000000000001 110.737 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.05 174.14 12.48 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.382 2.055 . . . . 0.79000000000000004 111.431 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.6 m 66.15 60.28 0.65 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.352 0.596 . . . . 1.29 111.054 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.5 ttm-85 -75.54 104.89 6.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.736 -0.666 . . . . 0.68000000000000005 110.388 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 m -82.53 -36.84 25.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.093 -0.503 . . . . 1.28 111.045 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.0 t -97.39 111.0 26.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.22 -0.445 . . . . 0.96999999999999997 110.628 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -68.6 148.21 50.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.802 -0.636 . . . . 1.6899999999999999 110.135 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.2 m -57.62 -37.19 72.87 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.339 -0.391 . . . . 1.6499999999999999 111.607 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -63.95 -37.57 87.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.665 0.269 . . . . 0.71999999999999997 111.081 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -58.69 -45.89 88.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 1.1100000000000001 111.236 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.76 -41.33 62.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.85 -0.614 . . . . 0.35999999999999999 111.225 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -61.86 -39.48 92.04 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.031 0.443 . . . . 0.5 109.994 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.86 -46.66 89.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.776 -0.647 . . . . 1.1799999999999999 110.56 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.89 -39.54 90.74 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.785 -0.643 . . . . 0.81000000000000005 110.418 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.81 88.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.574 . . . . 0.66000000000000003 110.945 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -64.4 -38.89 92.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.573 -0.285 . . . . 2.0699999999999998 111.104 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.75 -23.71 62.48 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.094 0.473 . . . . 1.28 111.766 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -91.11 -19.12 23.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.145 -0.479 . . . . 1.0900000000000001 110.283 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.8 32.85 48.5 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.407 -0.677 . . . . 0.33000000000000002 111.407 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 111' ' ' MET . 36.6 pt -127.44 158.16 70.56 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.94 -0.393 . . . . 1.04 109.94 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.19 151.12 17.92 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.448 2.098 . . . . 0.69999999999999996 112.718 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -124.53 129.05 49.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.76 -0.655 . . . . 0.45000000000000001 109.757 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 67.0 mt -137.1 129.41 43.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.394 -0.366 . . . . 0.85999999999999999 111.316 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -85.26 133.74 34.15 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.973 -0.751 . . . . 0.88 108.973 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.4 p -138.84 179.94 6.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.541 0.686 . . . . 0.76000000000000001 111.953 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.5 t -155.46 135.92 13.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.017 -0.992 . . . . 0.35999999999999999 108.843 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.16 -7.4 58.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.064 0.459 . . . . 0.55000000000000004 111.291 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -94.78 -48.75 5.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.068 -0.514 . . . . 1.8300000000000001 111.117 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.9 p -92.71 -12.85 30.38 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 111.928 0.344 . . . . 0.73999999999999999 111.928 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 57.81 38.41 27.26 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.333 0.587 . . . . 2.0800000000000001 110.653 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -69.83 94.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.146 -0.934 . . . . 1.04 112.251 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 68.72 22.25 75.28 Favored Glycine 0 CA--C 1.516 0.153 0 CA-C-N 115.788 -0.642 . . . . 0.66000000000000003 114.561 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.43 -52.1 50.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 117.69 0.745 . . . . 1.0700000000000001 110.618 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.8 -40.59 80.28 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.027 -0.533 . . . . 1.6200000000000001 110.364 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -59.63 -49.57 77.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.251 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.28 84.96 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.099 0.476 . . . . 0.46000000000000002 110.998 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -63.5 -48.87 75.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.681 -0.69 . . . . 2.1000000000000001 111.058 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -67.57 -30.82 70.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.446 -0.343 . . . . 1.55 110.518 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 90.2 m -62.2 -40.84 97.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.39000000000000001 110.257 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 163' ' ' ILE . 51.2 tp -59.14 -42.01 89.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.397 -0.365 . . . . 0.90000000000000002 110.47 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 79.8 t -61.67 -39.74 84.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.97999999999999998 110.365 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -68.4 -33.85 74.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 1.0700000000000001 110.576 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -64.53 -40.89 96.44 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.299 -0.63 . . . . 0.72999999999999998 109.299 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 159' ' ' LEU . 70.2 mt -62.52 -43.9 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.62 -0.718 . . . . 0.84999999999999998 109.947 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.51 HH12 ' HB2' ' A' ' 47' ' ' ASP . 84.8 mtt180 -59.39 -43.94 92.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.905 -0.589 . . . . 0.98999999999999999 111.021 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.413 ' HA ' ' HG2' ' A' ' 168' ' ' GLU . 52.3 mtmt -62.04 -27.93 69.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.319 -0.4 . . . . 1.55 111.304 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -79.96 -35.36 37.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.013 0.435 . . . . 0.84999999999999998 110.616 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 163' ' ' ILE . 29.5 mtpt -77.6 -30.99 52.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.191 -0.459 . . . . 1.73 111.483 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 6.0 pt-20 -86.09 1.17 51.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.709 0.29 . . . . 1.1200000000000001 111.215 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 8.9 tttp . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.614 -0.708 . . . . 1.8799999999999999 110.576 -179.57 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttt . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.95 -0.389 . . . . 1.8899999999999999 109.95 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.7 127.07 32.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.908 -0.587 . . . . 1.24 111.796 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.82 122.43 46.75 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.853 -0.425 . . . . 1.27 109.853 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -122.65 130.79 53.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.479 -0.328 . . . . 1.45 111.023 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HZ3' ' CG ' ' A' ' 54' ' ' ASP . 15.2 mttp -92.19 123.0 35.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.006 -0.543 . . . . 1.1799999999999999 110.915 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 2.8 mp -119.48 133.57 55.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.451 -0.795 . . . . 2.1099999999999999 110.293 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.04 109.49 22.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.021 0.438 . . . . 1.28 110.301 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -76.42 125.68 36.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.287 -0.635 . . . . 0.77000000000000002 109.287 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.1 m -116.84 148.04 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.145 0.498 . . . . 0.94999999999999996 110.837 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.51 176.82 39.11 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.022 -0.831 . . . . 0.56000000000000005 111.022 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -81.08 156.85 25.61 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.017 0.437 . . . . 0.66000000000000003 111.392 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.31 102.7 0.76 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.796 -0.716 . . . . 0.80000000000000004 112.032 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.15 0.73 6.9 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.822 -0.704 . . . . 0.45000000000000001 112.792 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 11' ' ' ALA . 23.4 m -76.1 -19.4 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.828 0.347 . . . . 0.98999999999999999 110.781 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.582 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 104.76 25.47 6.85 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.483 -0.865 . . . . 0.48999999999999999 112.142 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -52.97 -50.96 63.07 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.255 0.465 . . . . 1.3799999999999999 112.255 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.4 m -64.36 -34.06 77.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.922 0.342 . . . . 0.85999999999999999 111.922 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.37 -34.31 75.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.712 -0.222 . . . . 0.95999999999999996 111.472 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 30.4 mt -59.42 -53.98 51.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.355 -0.384 . . . . 1.21 110.756 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.34 -39.61 85.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.779 -0.646 . . . . 1.2 110.991 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.2 mt -58.37 -38.47 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.953 -0.567 . . . . 1.3799999999999999 111.73 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -66.1 -37.56 86.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.928 0.394 . . . . 0.52000000000000002 111.501 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.0 tp -78.78 -32.31 46.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.208 -0.451 . . . . 1.8799999999999999 111.316 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 24' ' ' ILE . 48.9 mm -89.32 -52.96 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 113.068 0.766 . . . . 0.57999999999999996 113.068 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -87.1 -9.48 55.28 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.175 0.435 . . . . 1.74 112.175 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 65.25 21.41 12.05 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.202 0.445 . . . . 1.9199999999999999 112.202 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -159.98 146.97 16.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.804 0.335 . . . . 0.85999999999999999 110.302 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -77.18 145.62 37.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.706 -0.679 . . . . 0.77000000000000002 111.499 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.7 t -119.86 122.31 68.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.183 -0.673 . . . . 1.04 109.183 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -73.71 -50.65 19.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.036 -0.529 . . . . 1.1200000000000001 112.076 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -107.93 109.88 21.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.146 0.498 . . . . 1.1799999999999999 111.951 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -145.46 134.32 22.44 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.875 -0.787 . . . . 0.80000000000000004 108.875 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.01 126.62 90.49 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.009 -0.542 . . . . 0.80000000000000004 111.707 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.27 -19.74 19.45 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.545 2.164 . . . . 0.56000000000000005 112.111 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -16.02 56.25 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.008 -0.542 . . . . 1.21 111.739 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.43 116.96 24.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.382 0.611 . . . . 1.1499999999999999 111.12 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -112.02 117.52 32.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.076 -0.965 . . . . 0.81000000000000005 109.309 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -138.07 158.63 43.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.812 0.339 . . . . 1.29 111.326 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -106.6 127.14 53.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.855 -0.611 . . . . 1.1699999999999999 109.644 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -111.02 139.36 46.44 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.55 -0.295 . . . . 0.97999999999999998 110.791 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.593 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 0.2 OUTLIER -122.28 123.53 41.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.133 0.492 . . . . 0.69999999999999996 110.921 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -134.69 140.44 45.99 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.6 -0.518 . . . . 1.78 109.6 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -110.01 123.18 49.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.883 0.373 . . . . 2.3900000000000001 110.45 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.24 132.18 55.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.751 -0.463 . . . . 1.3799999999999999 109.751 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.1 t -84.04 91.97 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.875 -0.417 . . . . 0.65000000000000002 109.875 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.4 mt -103.23 133.09 48.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.8 -0.636 . . . . 1.47 110.263 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 60.32 27.35 16.9 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.925 -0.58 . . . . 0.96999999999999997 111.368 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.43 -0.15 88.26 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.184 -0.531 . . . . 0.59999999999999998 113.165 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -109.85 130.99 55.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.865 0.364 . . . . 1.4099999999999999 111.36 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.89 95.17 2.41 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.333 -0.617 . . . . 0.89000000000000001 109.333 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 59.7 m -101.19 133.76 45.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.48 0.657 . . . . 1.3100000000000001 111.467 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.6 tp -100.86 124.63 46.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.253 -0.885 . . . . 0.85999999999999999 109.325 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 1.3 mp -93.04 113.13 25.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.116 -0.493 . . . . 1.1299999999999999 111.706 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.593 ' OD1' ' HD2' ' A' ' 41' ' ' ARG . 14.8 t70 -105.3 93.41 4.67 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.154 -1.054 . . . . 1.03 108.154 177.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 13.6 mt -110.88 142.47 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.169 0.433 . . . . 1.1799999999999999 112.169 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.3 tp -119.93 122.14 40.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.541 . . . . 0.75 110.999 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -88.64 89.83 8.15 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.231 -0.655 . . . . 0.44 109.231 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.1 p -65.87 134.95 54.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.004 -0.544 . . . . 0.84999999999999998 111.725 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.93 -55.06 6.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.79 -0.641 . . . . 1.04 110.588 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.33 -76.52 0.17 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.442 -0.663 . . . . 0.71999999999999997 111.442 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -99.95 125.57 45.99 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.955 -0.387 . . . . 1.5 109.955 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -94.46 166.62 11.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.067 -0.515 . . . . 1.5700000000000001 110.659 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -58.28 -56.71 18.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.98 -0.554 . . . . 1.3799999999999999 110.012 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -116.02 144.79 43.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.909 -0.587 . . . . 1.0 109.609 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -31.44 72.64 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.534 -0.303 . . . . 0.90000000000000002 111.13 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.79 -27.89 69.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.35999999999999999 111.458 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 81.7 mtp -68.89 -30.68 69.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.19 -0.459 . . . . 1.04 109.937 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.634 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 24.6 ttp180 -65.6 -45.09 84.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.025 -0.534 . . . . 1.0700000000000001 109.672 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.513 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 67.3 m-20 -65.53 -30.55 71.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.469 -0.787 . . . . 1.4099999999999999 110.255 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -58.24 -58.94 6.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.732 -0.667 . . . . 1.77 111.636 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.634 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 10.4 p90 -67.47 -21.42 65.53 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.373 -0.531 . . . . 1.27 112.104 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.5 mtt -77.19 -31.14 55.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.116 0.484 . . . . 1.28 110.637 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 39.8 mtm180 -77.62 -48.08 17.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.958 0.409 . . . . 1.8600000000000001 110.532 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 m -73.69 -14.13 61.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.703 -0.681 . . . . 1.01 111.614 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.75 120.39 9.84 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.7 -0.762 . . . . 0.20000000000000001 111.633 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -89.71 -32.68 16.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.964 0.411 . . . . 0.54000000000000004 110.161 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -137.37 130.29 5.06 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.421 -0.672 . . . . 0.31 111.421 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.437 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 88.3 m-85 -116.34 126.11 53.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.085 0.443 . . . . 0.60999999999999999 110.999 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.3 tp -96.51 106.5 18.76 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.066 -0.716 . . . . 1.04 109.066 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 56.9 m -83.79 107.46 16.21 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.737 -0.468 . . . . 1.1799999999999999 109.737 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.414 HG23 ' CD1' ' A' ' 19' ' ' LEU . 17.2 t -112.36 142.05 25.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.073 0.463 . . . . 1.03 111.952 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -142.79 167.08 22.92 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.499 -0.926 . . . . 0.41999999999999998 108.499 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.86 132.48 50.08 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.056 -0.35 . . . . 0.76000000000000001 110.056 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 118' ' ' CYS . 3.3 pt -67.6 -13.23 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.514 -0.312 . . . . 1.1499999999999999 111.362 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -107.93 23.1 14.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.286 0.565 . . . . 0.93999999999999995 110.554 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -150.31 98.08 2.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 1.3799999999999999 110.477 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -31.28 71.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.083 -0.508 . . . . 0.75 111.94 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -62.84 -38.89 92.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.525 -0.307 . . . . 1.4199999999999999 110.554 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 82.8 p -69.83 -23.79 63.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.993 0.425 . . . . 0.71999999999999997 110.567 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -77.61 -39.38 45.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.83 -0.623 . . . . 0.51000000000000001 109.652 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -74.0 -30.5 62.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 1.4399999999999999 110.201 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -29.86 68.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.095 -0.502 . . . . 1.02 110.558 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.6 mm -57.58 -34.37 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.549 -0.75 . . . . 1.04 111.779 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -60.54 -45.44 93.88 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.579 -0.526 . . . . 1.0900000000000001 109.579 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -69.29 -34.71 75.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.536 -0.756 . . . . 0.98999999999999999 110.965 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -65.59 -51.26 61.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.728 -0.214 . . . . 1.73 110.92 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -59.37 -36.97 76.73 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.235 0.54 . . . . 0.66000000000000003 110.275 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -70.58 -50.74 34.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.528 -0.76 . . . . 1.3500000000000001 111.701 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -59.49 -49.46 77.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.967 0.358 . . . . 1.3999999999999999 111.967 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 81.2 mt -61.67 -39.6 83.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.294 . . . . 0.78000000000000003 111.243 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -66.85 -30.06 70.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.923 0.392 . . . . 1.6000000000000001 110.744 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -76.66 -43.24 38.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.821 -0.627 . . . . 1.0900000000000001 110.757 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.0 t -65.38 -45.48 93.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.035 -0.53 . . . . 0.89000000000000001 110.801 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -79.32 -15.89 57.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.872 0.368 . . . . 1.3500000000000001 110.528 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.4 t70 55.73 70.81 0.6 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.191 -0.913 . . . . 0.46999999999999997 110.811 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.7 t -164.12 -172.01 2.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.657 -0.701 . . . . 1.4399999999999999 109.818 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -125.41 -55.21 1.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.085 0.469 . . . . 1.74 109.865 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -77.51 91.79 3.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.801 -0.636 . . . . 0.78000000000000003 110.239 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.4 t -118.45 113.13 36.92 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.828 -0.623 . . . . 0.63 109.939 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.74 111.13 0.48 Allowed 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 123.232 2.621 . . . . 0.29999999999999999 113.131 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.437 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 46.3 mtt -144.25 157.44 44.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.89 -0.595 . . . . 1.1899999999999999 110.491 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.1 t -135.38 124.45 40.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.053 -0.721 . . . . 0.63 109.053 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 20.5 tp -80.24 116.52 20.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.443 -0.577 . . . . 0.66000000000000003 109.443 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 47.4 t -119.03 123.06 70.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.105 0.479 . . . . 1.3700000000000001 111.608 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -99.11 114.76 5.12 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.192 -1.163 . . . . 0.27000000000000002 110.192 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -97.32 166.06 11.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.83 0.348 . . . . 0.23999999999999999 110.962 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.6 mttt 68.45 26.06 6.69 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.512 -0.767 . . . . 1.1499999999999999 111.632 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.444 ' HA ' ' CD1' ' A' ' 84' ' ' ILE . 24.8 p -67.32 -19.35 65.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.935 0.398 . . . . 1.29 110.802 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -79.74 -14.25 58.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.872 -0.603 . . . . 0.69999999999999996 110.398 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 54.8 mt -85.72 151.58 55.61 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.128 -0.487 . . . . 1.3100000000000001 109.715 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 1.4 Cg_endo -81.46 -176.63 3.18 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.968 2.445 . . . . 0.79000000000000004 112.366 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 m 61.2 54.09 3.37 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.987 -0.551 . . . . 1.29 110.939 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 14.1 ttm-85 -63.79 112.03 2.7 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.673 -0.694 . . . . 0.68000000000000005 110.3 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.03 -40.19 13.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.835 -0.621 . . . . 1.28 110.55 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.9 t -95.28 119.3 43.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.417 -0.356 . . . . 0.96999999999999997 110.219 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -74.96 155.64 37.18 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.146 0.498 . . . . 1.6899999999999999 111.482 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -38.45 83.76 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.48 -0.782 . . . . 1.6499999999999999 110.958 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -69.4 -36.6 76.9 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.039 -0.528 . . . . 0.71999999999999997 111.011 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -59.04 -43.02 91.6 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.087 0.47 . . . . 1.1100000000000001 110.554 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.1 -40.37 60.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.887 -0.597 . . . . 0.35999999999999999 110.461 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.403 ' O ' ' HG3' ' A' ' 135' ' ' ARG . 6.2 tp-100 -61.95 -39.29 91.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.013 -0.54 . . . . 0.5 109.938 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -63.7 -40.56 97.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.559 -0.746 . . . . 1.1799999999999999 110.578 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.8 tp -68.57 -41.39 79.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.755 -0.657 . . . . 0.81000000000000005 110.937 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.54 -33.44 75.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.66000000000000003 110.512 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 135' ' ' ARG . 63.8 mtt-85 -58.69 -55.52 34.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.709 -0.678 . . . . 2.0699999999999998 111.623 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -42.79 96.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.081 0.467 . . . . 1.28 111.899 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -68.63 -22.34 64.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 1.0900000000000001 111.051 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.36 43.2 46.89 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.968 -0.56 . . . . 0.33000000000000002 112.409 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 31.3 pt -136.95 161.71 59.97 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.996 -0.372 . . . . 1.04 109.996 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.01 156.13 42.92 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.707 2.271 . . . . 0.69999999999999996 112.505 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 5.7 t80 -135.37 125.15 25.45 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.572 -0.529 . . . . 0.45000000000000001 109.572 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.7 mt -135.71 130.46 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.921 -0.312 . . . . 0.85999999999999999 111.217 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -84.18 123.77 30.45 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.063 -1.088 . . . . 0.88 108.063 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.411 ' C ' ' HG ' ' A' ' 118' ' ' CYS . 43.0 p -133.79 177.23 7.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.151 0.501 . . . . 0.76000000000000001 111.252 -177.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.1 t -156.58 124.39 5.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.821 -0.627 . . . . 0.35999999999999999 110.094 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.36 -12.95 60.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.29 0.566 . . . . 0.55000000000000004 110.088 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.9 tttm -79.76 -53.16 7.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.574 -0.739 . . . . 1.8300000000000001 110.743 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.8 p -83.27 -17.34 42.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.295 -0.411 . . . . 0.73999999999999999 110.844 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.1 ttt180 70.3 21.27 5.86 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.932 0.77 . . . . 2.0800000000000001 109.951 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -91.34 122.63 34.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.011 -0.54 . . . . 1.04 110.584 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.7 -4.34 79.05 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.66000000000000003 112.796 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 71.8 t -58.37 -59.99 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.666 0.247 . . . . 1.0700000000000001 111.666 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.68 -47.61 84.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 1.6200000000000001 110.834 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -56.16 -46.32 79.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.59 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -58.96 -53.66 55.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.869 0.322 . . . . 0.46000000000000002 111.869 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -61.07 -49.57 76.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.421 -0.354 . . . . 2.1000000000000001 111.458 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -59.42 -39.51 83.72 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.338 -0.392 . . . . 1.55 111.748 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.543 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 95.9 m -61.06 -44.45 97.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.527 -0.306 . . . . 0.39000000000000001 110.86 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 35.2 tp -65.14 -36.44 84.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.713 -0.221 . . . . 0.90000000000000002 111.174 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.417 ' O ' ' HG3' ' A' ' 164' ' ' ARG . 49.0 t -59.69 -41.02 83.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.194 0.521 . . . . 0.97999999999999998 110.235 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -77.15 -23.62 51.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.812 -0.631 . . . . 1.0700000000000001 110.916 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 158' ' ' THR . 52.6 mm-40 -64.76 -43.77 92.22 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.792 0.33 . . . . 0.72999999999999998 110.379 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 12.1 mt -65.15 -38.95 83.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.047 -0.524 . . . . 0.84999999999999998 111.015 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 75.8 mtt180 -59.27 -38.8 81.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.769 -0.65 . . . . 0.98999999999999999 110.991 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -62.62 -39.12 92.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.063 -0.517 . . . . 1.55 111.061 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -75.28 -34.6 61.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.299 -0.41 . . . . 0.84999999999999998 110.562 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -73.06 -30.79 63.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.586 -0.279 . . . . 1.73 111.408 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -101.86 11.58 38.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.853 0.359 . . . . 1.1200000000000001 110.736 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.7 tttp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.626 -0.702 . . . . 1.8799999999999999 110.951 -179.204 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.5 ttm . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 110.36 -0.237 . . . . 1.8899999999999999 110.36 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.2 m -92.91 134.89 34.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.496 -0.32 . . . . 1.24 110.674 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -87.71 127.14 35.3 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.808 -0.441 . . . . 1.27 109.808 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -112.46 128.02 56.21 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.849 -0.426 . . . . 1.45 109.849 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -97.04 122.83 40.47 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.129 -0.487 . . . . 1.1799999999999999 111.332 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mp -129.75 137.79 50.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.923 -0.581 . . . . 2.1099999999999999 110.7 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.6 t -124.15 128.1 73.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.261 -0.427 . . . . 1.28 110.276 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.2 t -89.18 124.12 41.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.194 -0.669 . . . . 0.77000000000000002 109.194 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.488 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 9.8 m -115.77 148.95 18.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.606 -0.27 . . . . 0.94999999999999996 110.587 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.38 178.24 38.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.985 -0.626 . . . . 0.56000000000000005 112.101 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.502 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -78.24 168.68 19.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.996 0.427 . . . . 0.66000000000000003 111.306 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.7 104.67 1.91 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.943 -0.646 . . . . 0.80000000000000004 112.448 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.49 4.0 10.05 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.494 -0.86 . . . . 0.45000000000000001 112.77 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 11' ' ' ALA . 15.9 m -74.3 -29.32 24.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.913 0.387 . . . . 0.98999999999999999 111.25 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.85 22.06 5.14 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.678 -0.772 . . . . 0.48999999999999999 113.788 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -52.78 -50.19 64.07 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.983 0.392 . . . . 1.3799999999999999 110.933 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.407 ' O ' HG13 ' A' ' 21' ' ' ILE . 3.2 m -63.85 -43.42 96.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.722 0.296 . . . . 0.85999999999999999 111.507 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.71 -48.41 79.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.857 0.317 . . . . 0.95999999999999996 111.857 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.434 ' HG ' ' HB3' ' A' ' 146' ' ' ALA . 2.6 mt -65.29 -36.25 83.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.731 0.3 . . . . 1.21 111.237 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.4 m -70.16 -42.04 73.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.662 0.267 . . . . 1.2 111.024 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 17' ' ' SER . 82.4 mt -68.87 -31.86 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.407 . . . . 1.3799999999999999 109.946 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 4.4 mm-40 -63.67 -21.43 66.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.98 -0.555 . . . . 0.52000000000000002 111.599 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.7 tp -92.2 -14.98 28.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.139 0.495 . . . . 1.8799999999999999 110.864 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.6 mm -104.3 -64.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.075 -0.511 . . . . 0.57999999999999996 111.119 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -84.62 -7.61 59.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 1.74 110.823 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.552 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.6 OUTLIER 56.38 30.03 16.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.577 0.955 . . . . 1.9199999999999999 113.577 177.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -142.2 146.4 35.19 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.932 -0.307 . . . . 0.85999999999999999 110.36 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -68.01 143.07 55.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.12 -0.491 . . . . 0.77000000000000002 111.427 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 t -130.88 99.2 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.153 -0.684 . . . . 1.04 109.153 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.58 -41.46 54.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.15 -0.477 . . . . 1.1200000000000001 111.122 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -94.31 97.46 10.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.216 0.531 . . . . 1.1799999999999999 111.412 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -151.51 136.53 17.38 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.877 -0.786 . . . . 0.80000000000000004 108.877 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -72.1 126.48 91.19 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.963 0.411 . . . . 0.80000000000000004 111.494 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -65.82 -28.0 51.38 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.914 2.409 . . . . 0.56000000000000005 112.83 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.24 -12.57 60.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.876 -0.602 . . . . 1.21 111.645 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -77.29 121.87 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.279 0.562 . . . . 1.1499999999999999 110.34 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 15.3 tt0 -114.26 127.03 55.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.824 -1.08 . . . . 0.81000000000000005 108.777 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -146.33 154.15 41.34 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.302 0.572 . . . . 1.29 111.403 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.4 129.17 53.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.483 -0.78 . . . . 1.1699999999999999 109.953 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -117.83 147.49 43.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.747 0.308 . . . . 0.97999999999999998 110.885 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HD2' ' OD2' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -119.83 138.52 53.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.69999999999999996 110.415 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -146.42 122.09 10.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.271 -0.422 . . . . 1.78 110.775 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.69 116.65 29.17 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.52 -0.548 . . . . 2.3900000000000001 109.52 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.52 136.87 59.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.09 -0.504 . . . . 1.3799999999999999 111.204 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 t -91.58 74.53 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.847 -0.797 . . . . 0.65000000000000002 108.847 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.1 mt -82.9 113.54 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.604 -0.725 . . . . 1.47 111.332 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 65.95 28.84 10.48 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.319 -0.855 . . . . 0.96999999999999997 111.012 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.59 -12.4 67.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.131 -0.556 . . . . 0.59999999999999998 112.515 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -93.97 111.03 22.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.746 0.308 . . . . 1.4099999999999999 111.053 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -73.32 104.59 4.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.137 0.494 . . . . 0.89000000000000001 109.853 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.8 m -114.74 143.85 44.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.094 0.473 . . . . 1.3100000000000001 111.081 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 tp -102.47 109.65 21.36 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.653 -0.869 . . . . 0.85999999999999999 108.653 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 48.7 mt -82.63 117.77 22.83 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.289 -0.414 . . . . 1.1299999999999999 111.654 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.516 ' OD2' ' HD2' ' A' ' 41' ' ' ARG . 15.1 t70 -101.03 86.07 2.97 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.529 -1.285 . . . . 1.03 107.529 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.1 mt -97.94 150.4 4.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.651 -0.704 . . . . 1.1799999999999999 112.238 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 tp -137.84 130.4 29.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 0.75 111.02 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 3.9 t70 -91.91 107.48 19.24 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.574 -0.528 . . . . 0.44 109.574 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.8 p -72.53 137.36 46.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.146 0.498 . . . . 0.84999999999999998 111.981 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.33 -37.8 66.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.542 -0.754 . . . . 1.04 110.209 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.88 -58.9 0.7 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.981 -0.628 . . . . 0.71999999999999997 111.896 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -108.98 140.67 42.16 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.358 -0.608 . . . . 1.5 109.358 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -106.14 165.86 10.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 1.5700000000000001 111.256 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -79.13 -42.06 27.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.113 -1.069 . . . . 1.3799999999999999 108.113 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -126.42 129.67 49.19 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.854 -1.066 . . . . 1.0 109.155 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.41 -33.34 65.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.211 -0.449 . . . . 0.90000000000000002 111.461 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.12 -35.15 77.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.196 -0.456 . . . . 0.35999999999999999 111.205 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 87.9 mtp -69.66 -35.89 75.57 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.887 0.375 . . . . 1.04 110.849 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -66.37 -44.56 82.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.829 -0.623 . . . . 1.0700000000000001 110.24 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 81.0 m-20 -80.69 -10.13 59.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.896 -0.593 . . . . 1.4099999999999999 110.677 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -66.8 -58.45 5.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 1.77 110.639 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -67.16 -17.75 64.98 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.01 0.434 . . . . 1.27 111.336 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 46.0 mtt -69.07 -26.97 65.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.062 -0.517 . . . . 1.28 110.187 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 72.4 mtm180 -84.86 -42.94 14.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.055 -0.52 . . . . 1.8600000000000001 110.345 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -27.39 61.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.771 -0.649 . . . . 1.01 111.812 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.91 139.79 43.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.962 -0.637 . . . . 0.20000000000000001 112.692 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -93.57 -53.6 3.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.787 0.327 . . . . 0.54000000000000004 110.945 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -122.76 138.43 11.8 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.716 -0.754 . . . . 0.31 111.763 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 111' ' ' MET . 79.6 m-85 -117.96 135.27 54.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.172 0.51 . . . . 0.60999999999999999 111.059 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.3 tp -101.86 113.86 27.43 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.717 -0.674 . . . . 1.04 109.866 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 3.6 m -89.44 89.45 7.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.039 -0.528 . . . . 1.1799999999999999 110.579 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 11.8 t -96.86 129.63 46.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.017 -0.538 . . . . 1.03 111.189 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -129.78 179.21 5.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.175 -0.676 . . . . 0.41999999999999998 109.175 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . . . -112.58 130.67 55.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.782 0.325 . . . . 0.76000000000000001 110.457 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 pt -66.83 -19.3 25.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.099 -0.5 . . . . 1.1499999999999999 111.505 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -104.99 15.64 27.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.145 0.498 . . . . 0.93999999999999995 110.818 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.448 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 43.1 t-20 -140.44 92.75 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 1.3799999999999999 110.218 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -25.46 68.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.33 -0.395 . . . . 0.75 111.349 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -67.81 -32.43 72.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.586 -0.279 . . . . 1.4199999999999999 110.473 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.5 p -72.19 -30.44 64.95 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.979 -0.748 . . . . 0.71999999999999997 108.979 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -69.62 -29.91 67.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.433 -0.803 . . . . 0.51000000000000001 109.619 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.79 -38.52 73.37 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.728 -0.669 . . . . 1.4399999999999999 110.101 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.19 -29.04 70.17 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.551 -0.749 . . . . 1.02 110.278 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.5 mm -56.21 -36.2 45.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.636 -0.711 . . . . 1.04 110.38 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -64.91 -36.32 84.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.639 . . . . 1.0900000000000001 111.357 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -80.96 -32.2 34.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.347 -0.388 . . . . 0.98999999999999999 111.032 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.488 ' CE1' ' HB ' ' A' ' 9' ' ' VAL . 3.6 m-85 -61.21 -51.04 70.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.496 0.188 . . . . 1.73 111.228 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.582 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 22.6 tpt180 -62.04 -30.03 70.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.313 0.577 . . . . 0.66000000000000003 110.42 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -76.36 -53.06 8.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.247 -0.888 . . . . 1.3500000000000001 111.98 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -62.37 -58.08 8.98 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.114 0.412 . . . . 1.3999999999999999 112.114 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.5 mt -54.07 -39.74 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.914 0.338 . . . . 0.78000000000000003 111.914 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 6.1 ttpt -66.36 -35.95 81.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.789 0.328 . . . . 1.6000000000000001 110.802 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -76.8 -26.47 54.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.066 0.46 . . . . 1.0900000000000001 110.534 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.5 t -77.16 -40.63 30.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.89000000000000001 110.02 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -80.24 -26.46 39.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.382 -0.372 . . . . 1.3500000000000001 110.757 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 t70 66.73 51.01 1.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.641 -0.709 . . . . 0.46999999999999997 110.34 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.94 163.14 31.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.552 -0.749 . . . . 1.4399999999999999 109.893 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -96.72 -42.21 8.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.839 0.352 . . . . 1.74 110.152 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -102.1 116.35 32.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.013 -0.54 . . . . 0.78000000000000003 110.039 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.4 t -127.96 122.08 22.14 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.097 -0.501 . . . . 0.63 109.794 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.57 104.23 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.787 2.325 . . . . 0.29999999999999999 111.667 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.447 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 31.7 mtt -139.18 151.8 46.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.7 -0.682 . . . . 1.1899999999999999 110.159 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.8 t -136.96 126.3 37.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.451 -0.574 . . . . 0.63 109.451 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 41.0 tp -81.81 122.33 27.56 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.641 -0.503 . . . . 0.66000000000000003 109.641 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 142' ' ' ILE . 95.3 t -124.07 127.95 73.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.091 -0.504 . . . . 1.3700000000000001 111.673 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.41 102.17 2.25 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.659 -0.976 . . . . 0.27000000000000002 110.659 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 144' ' ' THR . 65.6 t30 -86.41 165.82 16.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.703 0.251 . . . . 0.23999999999999999 110.356 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 69.76 29.8 4.01 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.861 0.726 . . . . 1.1499999999999999 110.552 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 30.8 p -67.72 -11.91 59.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.879 -0.6 . . . . 1.29 111.38 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -87.17 -8.36 57.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.692 0.282 . . . . 0.69999999999999996 110.731 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 43.0 mt -85.36 148.64 50.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 1.3100000000000001 110.936 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.31 -177.77 3.66 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.611 2.207 . . . . 0.79000000000000004 111.619 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.2 m 58.09 55.19 5.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.118 0.485 . . . . 1.29 111.055 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -66.97 109.71 3.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.878 -0.601 . . . . 0.68000000000000005 109.9 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.01 -42.45 16.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.002 0.429 . . . . 1.28 110.619 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.31 112.53 22.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.262 -0.426 . . . . 0.96999999999999997 109.875 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.89 148.13 52.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.893 0.378 . . . . 1.6899999999999999 110.679 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.22 -39.51 79.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.896 -0.593 . . . . 1.6499999999999999 112.34 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -68.81 -37.58 79.33 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 120.88 -0.328 . . . . 0.71999999999999997 110.902 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -56.13 -43.91 78.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.763 0.316 . . . . 1.1100000000000001 111.43 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.32 -46.47 55.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.911 -0.586 . . . . 0.35999999999999999 110.894 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -59.96 -44.83 94.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.5 110.418 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -61.81 -42.9 99.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.462 -0.79 . . . . 1.1799999999999999 110.498 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.22 -41.2 90.43 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.992 -0.549 . . . . 0.81000000000000005 110.722 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 139' ' ' ILE . . . -65.89 -35.26 80.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.365 -0.38 . . . . 0.66000000000000003 110.346 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -63.87 -43.58 95.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 2.0699999999999998 111.519 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.19 -17.96 65.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.637 0.256 . . . . 1.28 111.566 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -100.59 -8.12 23.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.236 -0.438 . . . . 1.0900000000000001 110.214 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.8 31.25 70.16 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.762 -0.654 . . . . 0.33000000000000002 112.583 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 44.1 pt -121.58 153.37 59.42 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 122.798 -0.236 . . . . 1.04 110.454 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 139' ' ' ILE . 12.7 Cg_exo -72.01 156.13 56.44 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.883 2.388 . . . . 0.69999999999999996 112.856 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -128.6 120.85 27.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 0.45000000000000001 109.56 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 73.8 mt -132.88 138.25 52.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.757 0.313 . . . . 0.85999999999999999 111.038 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -93.57 126.72 38.88 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.288 -0.634 . . . . 0.88 109.288 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 116' ' ' ASN . 32.1 p -131.67 166.07 22.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.255 0.55 . . . . 0.76000000000000001 111.257 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.2 t -146.33 122.38 10.75 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.496 -0.928 . . . . 0.35999999999999999 108.496 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.434 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . . . -70.0 -10.79 59.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.103 0.478 . . . . 0.55000000000000004 110.863 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -89.0 -48.02 7.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.758 -0.656 . . . . 1.8300000000000001 111.476 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.0 p -93.56 -17.27 23.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.582 0.586 . . . . 0.73999999999999999 112.582 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 69.77 21.75 6.33 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.946 -0.57 . . . . 2.0800000000000001 110.765 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 144' ' ' THR . 6.5 tt0 -73.9 120.27 19.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.639 -0.709 . . . . 1.04 110.809 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 66.44 6.66 35.64 Favored Glycine 0 CA--C 1.516 0.111 0 CA-C-N 116.072 -0.513 . . . . 0.66000000000000003 113.633 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 18.3 t -61.01 -61.04 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.521 0.2 . . . . 1.0700000000000001 111.455 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.93 -37.9 83.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 1.6200000000000001 110.51 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -56.93 -45.22 82.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.769 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -58.33 -47.79 82.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.46000000000000002 111.266 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.482 ' O ' HG22 ' A' ' 160' ' ' VAL . 72.6 m-85 -64.55 -44.35 91.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.185 -0.461 . . . . 2.1000000000000001 110.944 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -60.0 -37.02 78.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 1.55 111.296 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 19.3 m -65.42 -53.69 39.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.138 -0.483 . . . . 0.39000000000000001 111.355 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.536 ' O ' HG13 ' A' ' 163' ' ' ILE . 14.0 tp -57.59 -35.8 70.89 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.702 0.287 . . . . 0.90000000000000002 111.111 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 156' ' ' PHE . 38.3 t -58.36 -40.75 79.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.029 0.443 . . . . 0.97999999999999998 110.733 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -78.96 -30.2 44.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.962 -0.563 . . . . 1.0700000000000001 111.327 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 158' ' ' THR . 7.6 mm-40 -62.16 -40.89 97.5 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.854 -0.424 . . . . 0.72999999999999998 109.854 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 159' ' ' LEU . 52.8 mt -63.36 -43.99 98.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.717 -0.674 . . . . 0.84999999999999998 110.13 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.476 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 96.4 mtt180 -56.85 -49.43 75.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.785 -0.643 . . . . 0.98999999999999999 111.068 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 169' ' ' LYS . 41.3 mtmt -57.36 -34.33 68.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.317 -0.401 . . . . 1.55 111.606 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -74.58 -37.26 62.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.486 -0.325 . . . . 0.84999999999999998 110.692 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -75.82 -33.0 60.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.4 -0.364 . . . . 1.73 111.903 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 10.3 pt-20 -92.49 7.4 43.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.952 0.406 . . . . 1.1200000000000001 110.745 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 165' ' ' LYS . 30.7 tttp . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.245 -0.883 . . . . 1.8799999999999999 110.128 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.6 ttm . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 109.926 -0.398 . . . . 1.8899999999999999 109.926 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.7 m -94.48 134.7 36.73 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.048 -0.352 . . . . 1.24 110.048 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -85.71 129.98 34.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.914 -0.585 . . . . 1.27 110.496 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.418 ' CD2' ' HB3' ' A' ' 51' ' ' CYS . 61.5 m-85 -125.57 115.65 20.51 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.816 -0.438 . . . . 1.45 109.816 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -100.48 113.85 26.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.158 0.504 . . . . 1.1799999999999999 110.272 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.14 138.46 52.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.717 -0.674 . . . . 2.1099999999999999 110.895 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.01 132.41 67.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.327 -0.397 . . . . 1.28 110.637 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 t -94.86 113.56 29.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.871 -0.789 . . . . 0.77000000000000002 108.871 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 m -114.8 166.56 8.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.921 0.391 . . . . 0.94999999999999996 111.291 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.19 -170.31 30.86 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.013 -0.835 . . . . 0.56000000000000005 111.013 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.53 172.16 14.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.241 0.543 . . . . 0.66000000000000003 110.85 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.74 128.09 8.96 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.701 -0.761 . . . . 0.80000000000000004 112.595 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.99 13.32 72.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.899 -0.667 . . . . 0.45000000000000001 114.02 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.4 m -73.41 -29.71 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 117.644 0.722 . . . . 0.98999999999999999 111.031 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.48 20.41 2.65 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.351 -0.928 . . . . 0.48999999999999999 113.84 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -54.68 -58.85 5.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.956 0.408 . . . . 1.3799999999999999 110.97 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -54.28 -47.76 71.99 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.603 -0.726 . . . . 0.85999999999999999 111.829 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.17 84.31 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.677 0.251 . . . . 0.95999999999999996 111.677 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.3 mt -63.83 -40.63 97.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 1.21 110.524 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.9 m -72.04 -43.78 64.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.158 -0.474 . . . . 1.2 110.66 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.74 -42.11 87.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.046 -0.525 . . . . 1.3799999999999999 110.915 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.539 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 4.3 mm-40 -64.02 -20.79 66.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.52000000000000002 111.338 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.2 tp -91.44 -39.78 11.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.918 0.389 . . . . 1.8799999999999999 111.147 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.7 mm -81.51 -50.66 16.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.263 -0.426 . . . . 0.57999999999999996 112.104 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -92.29 -16.49 26.03 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.931 0.345 . . . . 1.74 111.931 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 3.7 m-80 66.42 27.51 9.87 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.735 0.643 . . . . 1.9199999999999999 112.735 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -153.04 144.1 23.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.135 -0.32 . . . . 0.85999999999999999 110.135 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -68.83 142.67 54.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.182 -0.463 . . . . 0.77000000000000002 111.945 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 70.5 t -130.6 114.84 29.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 109.168 -0.679 . . . . 1.04 109.168 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -78.56 -42.72 28.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.926 -0.579 . . . . 1.1200000000000001 111.26 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -100.49 102.16 13.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.297 -0.41 . . . . 1.1799999999999999 111.948 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -155.19 117.59 4.23 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.65 -0.87 . . . . 0.80000000000000004 108.65 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -52.32 122.43 24.77 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.52 0.676 . . . . 0.80000000000000004 111.618 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.61 -18.14 15.62 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.685 2.257 . . . . 0.56000000000000005 113.37 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.09 12.5 11.33 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.282 0.475 . . . . 1.21 112.282 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.5 mt -99.71 105.64 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.244 0.545 . . . . 1.1499999999999999 110.204 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 3.7 tt0 -86.48 87.0 7.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.878 -0.601 . . . . 0.81000000000000005 109.535 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.81 161.69 14.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.626 -0.716 . . . . 1.29 110.583 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.423 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 10.4 p -131.18 144.71 51.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.194 -0.457 . . . . 1.1699999999999999 110.351 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -126.39 149.17 49.4 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.218 -0.446 . . . . 0.97999999999999998 111.083 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 1.7 mpp_? -123.75 123.8 41.3 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.35 -0.386 . . . . 0.69999999999999996 110.458 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -144.62 124.97 13.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.846 0.355 . . . . 1.78 110.281 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -86.53 119.93 27.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.002 0.429 . . . . 2.3900000000000001 110.548 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.3 t -129.53 141.08 47.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.925 -0.58 . . . . 1.3799999999999999 110.166 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.7 t -87.64 106.35 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.78 -0.452 . . . . 0.65000000000000002 109.78 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 32.6 mt -110.6 115.24 49.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.198 -0.455 . . . . 1.47 110.403 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 61.32 43.95 10.17 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.632 0.582 . . . . 0.96999999999999997 111.334 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.1 27.77 71.43 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.59999999999999998 113.317 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -137.74 120.94 16.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.93 0.365 . . . . 1.4099999999999999 111.254 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -75.25 103.32 5.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.862 0.363 . . . . 0.89000000000000001 110.238 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.418 ' HB3' ' CD2' ' A' ' 4' ' ' TYR . 11.5 m -110.44 137.33 48.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.471 -0.331 . . . . 1.3100000000000001 111.751 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.2 tp -92.03 111.55 23.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.149 -1.056 . . . . 0.85999999999999999 108.149 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 60.2 mt -89.97 114.02 25.78 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.052 0.76 . . . . 1.1299999999999999 113.052 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -106.0 101.5 10.99 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.765 -1.198 . . . . 1.03 107.765 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.5 mt -107.0 141.66 21.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.255 -0.429 . . . . 1.1799999999999999 111.727 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.7 tp -122.37 125.91 46.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.792 -0.64 . . . . 0.75 111.108 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 7.0 t70 -92.48 101.89 14.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.25 -0.648 . . . . 0.44 109.25 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.4 p -67.35 134.76 52.12 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.482 0.658 . . . . 0.84999999999999998 112.184 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.45 -37.94 14.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.218 -0.901 . . . . 1.04 110.067 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 142.84 -94.9 0.18 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.84 -0.695 . . . . 0.71999999999999997 112.531 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -101.78 118.23 36.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.159 0.504 . . . . 1.5 111.212 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.2 167.37 14.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.508 -0.769 . . . . 1.5700000000000001 109.275 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -54.19 -52.84 59.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 1.3799999999999999 110.913 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -117.41 141.0 48.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.239 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -63.19 -29.04 70.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.879 0.371 . . . . 0.90000000000000002 111.03 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.84 -26.34 68.29 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.011 -0.54 . . . . 0.35999999999999999 110.347 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 71.8 mtp -72.8 -37.7 67.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.675 -0.693 . . . . 1.04 109.595 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.592 ' HA ' ' CZ ' ' A' ' 71' ' ' TYR . 30.7 ttp180 -70.49 -43.92 68.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.866 -0.606 . . . . 1.0700000000000001 109.967 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -28.3 67.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.427 -0.806 . . . . 1.4099999999999999 110.636 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -56.22 -65.08 0.67 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.424 -0.807 . . . . 1.77 112.088 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.592 ' CZ ' ' HA ' ' A' ' 68' ' ' ARG . 3.5 p90 -69.1 -18.71 64.01 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.337 0.495 . . . . 1.27 112.337 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 32.8 mtt -71.45 -26.76 62.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.304 0.573 . . . . 1.28 109.927 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -90.03 -28.7 18.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.205 -0.452 . . . . 1.8600000000000001 110.925 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.493 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -86.53 -26.24 24.65 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.084 0.402 . . . . 1.01 112.084 -179.169 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.26 125.82 24.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.798 -0.715 . . . . 0.20000000000000001 111.96 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -83.34 -41.49 18.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.78 0.324 . . . . 0.54000000000000004 110.234 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -129.65 133.26 7.4 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.535 -0.626 . . . . 0.31 111.535 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.5 122.39 46.43 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.053 0.454 . . . . 0.60999999999999999 110.934 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.7 tp -88.05 112.0 22.15 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.102 -0.703 . . . . 1.04 109.102 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.2 m -90.54 101.16 13.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.858 0.361 . . . . 1.1799999999999999 110.428 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.3 t -103.01 131.92 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.259 -0.428 . . . . 1.03 111.54 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -134.19 171.06 14.76 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.978 -0.749 . . . . 0.41999999999999998 108.978 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.77 126.64 51.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.856 0.36 . . . . 0.76000000000000001 110.824 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.6 pt -68.64 -16.61 21.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.144 0.497 . . . . 1.1499999999999999 111.074 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -106.97 24.1 13.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.274 -0.421 . . . . 0.93999999999999995 110.932 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.444 ' OD1' ' HB3' ' A' ' 88' ' ' LYS . 28.5 t-20 -156.46 102.17 2.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.07 -0.514 . . . . 1.3799999999999999 110.116 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.18 -23.34 66.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.978 -0.555 . . . . 0.75 111.833 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HB3' ' OD1' ' A' ' 86' ' ' ASN . 51.2 tptt -56.01 -50.87 69.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.313 -0.403 . . . . 1.4199999999999999 110.862 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.3 p -63.43 -41.4 98.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.71999999999999997 111.156 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -61.52 -40.89 96.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.265 -0.425 . . . . 0.51000000000000001 111.142 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -74.85 -11.7 60.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.237 -0.438 . . . . 1.4399999999999999 111.587 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.52 -20.05 23.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.094 0.473 . . . . 1.02 110.271 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.8 mm -58.91 -29.88 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.526 -0.761 . . . . 1.04 110.794 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -59.19 -52.0 67.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.03 -0.532 . . . . 1.0900000000000001 109.821 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -65.16 -32.4 74.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.474 -0.784 . . . . 0.98999999999999999 111.101 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -65.95 -50.23 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.458 0.17 . . . . 1.73 110.856 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -60.05 -46.2 90.32 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.523 -0.547 . . . . 0.66000000000000003 109.523 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.42 -47.92 84.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.767 -0.651 . . . . 1.3500000000000001 111.075 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.526 ' O ' HG21 ' A' ' 103' ' ' VAL . 16.5 tt0 -58.88 -58.84 6.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.834 -0.621 . . . . 1.3999999999999999 111.76 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.3 mt -55.83 -37.61 48.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.522 -0.308 . . . . 0.78000000000000003 111.659 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -65.75 -37.51 86.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.532 0.206 . . . . 1.6000000000000001 110.921 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.0 -33.38 51.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 1.0900000000000001 111.07 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 99' ' ' GLN . 93.5 t -66.82 -45.13 88.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.064 0.459 . . . . 0.89000000000000001 110.285 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -81.46 -26.29 35.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.14 -0.482 . . . . 1.3500000000000001 110.354 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.6 t0 64.66 60.25 0.89 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.336 -0.847 . . . . 0.46999999999999997 110.142 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.7 t -153.69 151.55 29.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.328 -0.851 . . . . 1.4399999999999999 110.016 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -81.37 -42.99 19.65 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.061 -0.518 . . . . 1.74 111.081 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -97.24 117.7 32.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.055 0.455 . . . . 0.78000000000000003 111.838 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 46.9 t -135.66 113.39 10.94 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.046 -0.724 . . . . 0.63 109.046 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.59 112.13 0.96 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.02 2.48 . . . . 0.29999999999999999 112.369 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 50.5 mtt -141.58 156.93 45.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.949 -0.569 . . . . 1.1899999999999999 110.3 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 94.6 t -135.32 129.21 49.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 109.166 -0.679 . . . . 0.63 109.166 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.8 tp -85.0 115.37 22.79 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.549 -0.537 . . . . 0.66000000000000003 109.549 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.1 t -114.99 117.45 55.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.815 -0.63 . . . . 1.3700000000000001 111.756 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -95.92 94.6 1.7 Allowed Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.232 -1.147 . . . . 0.27000000000000002 110.232 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -80.3 166.91 20.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.652 0.263 . . . . 0.23999999999999999 111.415 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 69.69 33.12 3.07 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.465 -0.788 . . . . 1.1499999999999999 111.064 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 18.7 p -69.61 -4.76 20.64 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.417 -0.356 . . . . 1.29 111.853 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -93.36 -11.22 32.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.463 -0.335 . . . . 0.69999999999999996 110.831 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.5 mt -91.43 142.48 27.02 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.396 -0.365 . . . . 1.3100000000000001 111.182 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -79.75 -169.81 0.87 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.828 2.352 . . . . 0.79000000000000004 111.572 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.4 m 57.87 43.89 20.87 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.301 0.572 . . . . 1.29 110.387 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -63.33 119.03 8.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.184 -0.916 . . . . 0.68000000000000005 110.126 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.86 -32.37 12.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.179 -0.464 . . . . 1.28 111.333 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 t -97.23 110.79 25.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.95 0.405 . . . . 0.96999999999999997 110.396 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.16 148.46 48.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.976 -0.556 . . . . 1.6899999999999999 111.044 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.04 -39.93 69.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.581 -0.736 . . . . 1.6499999999999999 112.349 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -65.79 -38.83 90.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.574 0.226 . . . . 0.71999999999999997 111.445 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -61.11 -42.45 98.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.906 0.384 . . . . 1.1100000000000001 110.971 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.27 63.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.269 -0.423 . . . . 0.35999999999999999 110.61 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 135' ' ' ARG . 6.6 tp-100 -62.38 -42.53 99.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.5 110.006 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.76 -35.46 78.18 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.077 0.465 . . . . 1.1799999999999999 110.403 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.9 tp -68.83 -46.83 67.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.727 -0.669 . . . . 0.81000000000000005 109.973 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.56 95.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.716 -0.674 . . . . 0.66000000000000003 110.966 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 131' ' ' GLN . 24.9 mtm180 -65.31 -32.45 74.11 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.321 -0.4 . . . . 2.0699999999999998 111.093 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.6 m -73.44 -29.98 62.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.91 0.385 . . . . 1.28 110.461 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -82.67 -40.08 21.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.183 0.516 . . . . 1.0900000000000001 110.46 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.36 32.1 5.32 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 109.97 -1.252 . . . . 0.33000000000000002 109.97 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 4.6 pt -128.34 168.35 15.91 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.338 -0.431 . . . . 1.04 110.592 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -86.55 160.12 9.4 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.532 2.155 . . . . 0.69999999999999996 112.586 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -134.26 130.36 37.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.45000000000000001 110.151 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.7 mt -139.28 132.41 37.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.139 -0.482 . . . . 0.85999999999999999 110.985 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -82.92 129.71 35.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.728 -1.212 . . . . 0.88 107.728 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 30.9 p -137.71 173.87 11.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.512 0.672 . . . . 0.76000000000000001 111.756 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.7 t -156.24 130.53 8.74 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.82 -1.082 . . . . 0.35999999999999999 108.784 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.62 -8.71 57.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.224 0.535 . . . . 0.55000000000000004 110.317 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -85.48 -51.9 6.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.707 -0.679 . . . . 1.8300000000000001 110.914 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.7 p -91.12 -13.64 32.67 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.173 0.434 . . . . 0.73999999999999999 112.173 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.403 HH12 ' HD3' ' A' ' 149' ' ' ARG . 14.1 mtp-105 66.56 20.47 10.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.129 0.571 . . . . 2.0800000000000001 110.706 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -74.24 121.16 20.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.922 -0.581 . . . . 1.04 111.814 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.26 -4.24 12.71 Favored Glycine 0 C--N 1.33 0.219 0 N-CA-C 114.99 0.756 . . . . 0.66000000000000003 114.99 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.72 -51.26 74.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 117.403 0.601 . . . . 1.0700000000000001 110.645 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.34 -39.06 89.19 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.283 0.563 . . . . 1.6200000000000001 110.565 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.66 -42.04 98.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.557 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.45 81.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.46000000000000002 110.741 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -60.08 -43.03 95.78 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.059 -0.519 . . . . 2.1000000000000001 110.654 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -63.22 -45.58 90.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.849 -0.614 . . . . 1.55 111.04 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 26.5 m -62.65 -40.26 96.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.892 -0.595 . . . . 0.39000000000000001 111.514 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.45 ' O ' HG13 ' A' ' 163' ' ' ILE . 37.3 tp -59.03 -40.79 86.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.932 0.396 . . . . 0.90000000000000002 110.593 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.11 -38.62 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.97999999999999998 110.3 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -68.86 -30.39 68.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.908 -0.587 . . . . 1.0700000000000001 110.667 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -67.26 -44.06 80.3 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.736 -0.839 . . . . 0.72999999999999998 108.736 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 159' ' ' LEU . 74.2 mt -60.74 -44.03 96.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 115.378 -0.828 . . . . 0.84999999999999998 109.837 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 91.3 mtt180 -55.9 -48.66 75.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.738 -0.665 . . . . 0.98999999999999999 110.805 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -61.6 -34.44 75.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 1.55 111.308 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -71.97 -35.99 69.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.84999999999999998 110.282 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -69.62 -36.95 76.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.078 -0.51 . . . . 1.73 111.099 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 9.2 pt-20 -100.38 20.16 15.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.154 -0.476 . . . . 1.1200000000000001 111.065 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.1 mttp . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.598 -0.715 . . . . 1.8799999999999999 109.622 179.403 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.773 0.321 . . . . 1.8899999999999999 110.462 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.03 145.17 27.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.259 -0.428 . . . . 1.24 110.73 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -105.58 131.69 52.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.177 -0.465 . . . . 1.27 110.584 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -116.12 116.54 28.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.16 -0.473 . . . . 1.45 110.045 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -97.11 110.68 23.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.137 -0.483 . . . . 1.1799999999999999 110.411 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -127.11 142.79 51.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.872 -0.603 . . . . 2.1099999999999999 111.003 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.8 t -121.91 134.52 64.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.972 0.415 . . . . 1.28 111.027 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.7 t -93.74 103.97 15.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.235 -1.024 . . . . 0.77000000000000002 108.235 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.73 146.49 15.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.278 -0.419 . . . . 0.94999999999999996 111.351 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.94 -175.09 42.87 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.771 -0.728 . . . . 0.56000000000000005 111.299 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.78 158.17 36.08 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.01 0.433 . . . . 0.66000000000000003 111.321 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.29 134.41 15.62 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.55 -0.833 . . . . 0.80000000000000004 111.884 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.69 2.06 60.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.794 -0.717 . . . . 0.45000000000000001 113.568 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -79.25 -24.11 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 117.285 0.542 . . . . 0.98999999999999999 110.91 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.99 25.77 4.35 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.688 -0.768 . . . . 0.48999999999999999 113.467 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -53.44 -55.53 24.42 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 111.891 0.33 . . . . 1.3799999999999999 111.891 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.486 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 1.0 OUTLIER -59.59 -53.47 57.65 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.888 -0.596 . . . . 0.85999999999999999 112.048 -178.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.83 -43.55 77.09 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.778 0.659 . . . . 0.95999999999999996 112.778 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.1 mt -59.81 -41.27 90.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.823 0.344 . . . . 1.21 111.632 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 m -76.83 -46.2 25.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.411 -0.359 . . . . 1.2 111.657 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 17' ' ' SER . 79.4 mt -60.14 -27.61 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.937 0.399 . . . . 1.3799999999999999 111.631 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.2 -35.07 79.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.915 0.388 . . . . 0.52000000000000002 111.143 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -91.56 -6.39 52.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.992 0.425 . . . . 1.8799999999999999 111.347 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.1 mm -102.81 -43.41 9.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.329 -0.396 . . . . 0.57999999999999996 111.129 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -105.31 -4.78 21.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.513 -0.312 . . . . 1.74 111.676 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.3 t30 64.15 35.27 10.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.024 0.75 . . . . 1.9199999999999999 113.024 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -162.81 154.58 18.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.034 0.445 . . . . 0.85999999999999999 110.817 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -87.81 128.96 35.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.659 -0.701 . . . . 0.77000000000000002 111.205 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.8 120.82 47.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.252 -0.886 . . . . 1.04 109.032 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -77.01 -40.73 45.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 1.1200000000000001 111.176 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -127.5 117.94 23.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.276 -0.42 . . . . 1.1799999999999999 110.537 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -143.29 143.96 31.92 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.297 -0.631 . . . . 0.80000000000000004 109.297 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.76 124.04 66.48 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.847 0.356 . . . . 0.80000000000000004 111.158 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.26 -13.69 9.87 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.883 2.389 . . . . 0.56000000000000005 113.79 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.7 p -98.19 1.15 47.08 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.805 -0.358 . . . . 1.21 111.777 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 mt -83.56 132.13 32.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.073 0.463 . . . . 1.1499999999999999 110.353 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 10.0 tt0 -121.87 82.24 1.93 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.37 -0.832 . . . . 0.81000000000000005 109.069 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -103.45 155.67 18.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.535 -0.757 . . . . 1.29 111.422 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.34 121.45 45.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.173 -0.467 . . . . 1.1699999999999999 110.397 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -108.14 144.84 34.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.744 0.306 . . . . 0.97999999999999998 110.349 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -119.51 141.18 49.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.838 0.351 . . . . 0.69999999999999996 110.531 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -143.48 134.63 25.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.11 -0.495 . . . . 1.78 110.072 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -106.49 122.63 46.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.865 0.364 . . . . 2.3900000000000001 110.409 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -137.39 133.01 46.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 1.3799999999999999 111.232 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 t -85.48 71.58 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.477 0.656 . . . . 0.65000000000000002 109.5 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 pt -88.26 130.88 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.781 -0.645 . . . . 1.47 111.529 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 63.48 31.59 14.81 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.55 -0.75 . . . . 0.96999999999999997 111.077 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.7 11.12 83.3 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.852 -0.613 . . . . 0.59999999999999998 113.097 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -117.28 119.73 36.04 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 122.586 -0.361 . . . . 1.4099999999999999 110.783 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.8 m -79.83 96.73 6.4 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.6 -0.518 . . . . 0.89000000000000001 109.6 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 58.6 m -114.05 158.49 21.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.225 -0.443 . . . . 1.3100000000000001 112.056 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.0 tp -112.64 119.88 39.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.27 -0.877 . . . . 0.85999999999999999 108.885 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 12.3 mt -90.65 131.32 36.42 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.056 0.455 . . . . 1.1299999999999999 111.919 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -114.39 103.29 10.91 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.088 -1.079 . . . . 1.03 108.088 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 3.4 mt -110.9 151.33 13.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.305 -0.407 . . . . 1.1799999999999999 111.706 -177.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.412 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 37.1 tp -131.22 119.37 21.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.332 -0.394 . . . . 0.75 110.327 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 4.6 t0 -84.68 98.3 10.14 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.57 -0.53 . . . . 0.44 109.57 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 36.0 p -64.85 141.18 58.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.778 -0.646 . . . . 0.84999999999999998 112.347 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.88 -58.39 2.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.364 -0.835 . . . . 1.04 109.537 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.23 -47.11 0.53 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.752 -0.658 . . . . 0.71999999999999997 112.262 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -135.93 129.09 31.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.741 0.305 . . . . 1.5 110.59 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -102.44 175.7 5.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.394 -0.595 . . . . 1.5700000000000001 109.394 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -65.57 -43.45 89.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.927 0.394 . . . . 1.3799999999999999 110.2 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -128.72 145.35 51.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.038 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -38.33 89.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.309 -0.405 . . . . 0.90000000000000002 110.893 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.57 -28.28 68.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.186 -0.461 . . . . 0.35999999999999999 111.402 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 82.9 mtp -73.79 -38.32 64.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.93 0.395 . . . . 1.04 110.264 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -71.09 -43.77 67.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.893 -0.594 . . . . 1.0700000000000001 109.821 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.83 -19.5 65.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.362 -0.835 . . . . 1.4099999999999999 111.39 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -59.95 -57.36 13.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.466 -0.334 . . . . 1.77 111.373 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -75.05 -5.02 41.83 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.779 -0.368 . . . . 1.27 111.425 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.5 mtt -76.37 -25.24 54.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.361 -0.607 . . . . 1.28 109.361 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -87.7 -42.32 12.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.605 -0.725 . . . . 1.8600000000000001 110.451 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.17 -20.71 63.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.863 -0.608 . . . . 1.01 112.24 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.78 124.57 18.04 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.798 -0.715 . . . . 0.20000000000000001 112.491 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -88.91 -39.83 13.51 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.794 -0.447 . . . . 0.54000000000000004 109.794 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -128.78 137.58 9.73 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.815 -0.914 . . . . 0.31 110.815 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.417 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 93.9 m-85 -120.75 129.67 53.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.139 0.495 . . . . 0.60999999999999999 111.38 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.6 tp -97.02 110.74 23.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.473 -0.785 . . . . 1.04 108.982 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 3.8 m -96.91 92.36 6.07 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.102 -0.499 . . . . 1.1799999999999999 110.981 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.1 t -98.92 136.26 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.909 -0.587 . . . . 1.03 111.369 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -130.71 172.17 12.28 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.898 -0.779 . . . . 0.41999999999999998 108.898 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.17 122.86 46.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.596 0.236 . . . . 0.76000000000000001 110.514 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.2 pt -66.54 -17.73 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.069 0.462 . . . . 1.1499999999999999 111.562 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -98.14 4.12 49.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.957 0.408 . . . . 0.93999999999999995 110.236 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -135.34 90.38 2.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.737 -0.665 . . . . 1.3799999999999999 110.073 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.61 -28.29 67.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.024 -0.535 . . . . 0.75 112.071 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -59.08 -38.72 80.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 1.4199999999999999 110.559 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.5 p -75.27 -25.87 58.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.71999999999999997 111.326 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -74.99 -34.67 62.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.056 0.455 . . . . 0.51000000000000001 110.721 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -74.6 -24.43 58.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.007 0.432 . . . . 1.4399999999999999 110.438 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -71.5 -14.48 62.13 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.868 -0.606 . . . . 1.02 111.257 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 30.3 mm -58.14 -35.72 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.021 -0.536 . . . . 1.04 110.406 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -61.34 -45.02 96.14 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.073 -0.512 . . . . 1.0900000000000001 110.565 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -63.77 -48.26 77.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.907 -0.588 . . . . 0.98999999999999999 111.75 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -60.53 -52.06 66.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.162 0.43 . . . . 1.73 112.162 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -55.43 -47.55 75.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.208 0.318 . . . . 0.66000000000000003 110.754 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.05 -43.9 86.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.047 -0.524 . . . . 1.3500000000000001 111.763 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.49 ' O ' HG21 ' A' ' 103' ' ' VAL . 56.1 tt0 -63.44 -54.51 35.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 1.3999999999999999 112.165 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.31 -34.41 60.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.642 0.258 . . . . 0.78000000000000003 110.955 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -62.14 -35.35 78.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.066 0.46 . . . . 1.6000000000000001 110.217 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -73.88 -41.15 62.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.617 -0.719 . . . . 1.0900000000000001 110.905 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 99' ' ' GLN . 46.8 t -60.72 -41.92 90.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.89000000000000001 111.382 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -89.21 -14.86 35.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.504 -0.316 . . . . 1.3500000000000001 111.352 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.4 t70 58.82 54.84 4.94 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.748 0.785 . . . . 0.46999999999999997 109.836 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.7 m -154.83 140.26 17.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.6 -0.727 . . . . 1.4399999999999999 110.895 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -88.22 -23.31 23.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.25 0.548 . . . . 1.74 110.003 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -101.06 85.3 2.81 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.487 -0.779 . . . . 0.78000000000000003 109.939 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.5 t -117.71 119.24 34.25 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.625 -0.716 . . . . 0.63 110.098 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.06 115.96 2.89 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.115 2.543 . . . . 0.29999999999999999 112.286 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.417 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 36.5 mtt -146.11 153.05 40.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.777 -0.647 . . . . 1.1899999999999999 110.457 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.9 t -132.88 125.79 52.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.895 -0.78 . . . . 0.63 108.895 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.8 tp -82.72 125.82 31.68 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.545 -0.539 . . . . 0.66000000000000003 109.545 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.2 t -122.83 127.03 74.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.173 -0.467 . . . . 1.3700000000000001 112.223 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.88 96.69 1.26 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.671 -0.971 . . . . 0.27000000000000002 110.671 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -81.71 166.47 20.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.067 0.433 . . . . 0.23999999999999999 111.671 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.6 mttt 72.58 31.79 1.65 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.042 -0.981 . . . . 1.1499999999999999 111.645 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 15.8 p -70.91 -10.13 59.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.887 0.375 . . . . 1.29 111.008 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -94.71 -2.05 51.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.69999999999999996 110.621 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 33.1 mt -104.82 155.34 37.67 Favored Pre-proline 0 C--O 1.236 0.372 0 CA-C-N 116.085 -0.507 . . . . 1.3100000000000001 111.07 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -87.31 -169.83 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.598 2.199 . . . . 0.79000000000000004 112.03 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 m 60.09 45.6 11.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.79 -0.641 . . . . 1.29 111.167 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -76.75 111.81 12.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.587 -0.733 . . . . 0.68000000000000005 110.73 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.6 p -92.77 -31.04 15.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.094 0.473 . . . . 1.28 110.406 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.22 108.19 19.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.988 -0.551 . . . . 0.96999999999999997 109.958 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -71.87 150.11 44.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.86 0.362 . . . . 1.6899999999999999 110.511 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.1 m -57.3 -39.43 75.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.724 -0.671 . . . . 1.6499999999999999 111.631 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -59.46 -41.62 90.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.263 -0.426 . . . . 0.71999999999999997 111.642 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -60.57 -47.02 88.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 1.1100000000000001 110.762 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.07 82.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.962 -0.563 . . . . 0.35999999999999999 111.296 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.04 -40.79 98.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.919 -0.582 . . . . 0.5 109.976 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.38 -42.52 96.01 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.737 -0.665 . . . . 1.1799999999999999 110.95 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 29.1 tp -66.96 -46.09 75.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.882 -0.599 . . . . 0.81000000000000005 110.605 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.21 94.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.882 -0.599 . . . . 0.66000000000000003 111.43 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.1 mtm105 -64.11 -30.33 71.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 2.0699999999999998 110.934 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.5 m -75.15 -34.23 61.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.25 -0.432 . . . . 1.28 110.91 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -78.16 -24.64 47.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.231 -0.44 . . . . 1.0900000000000001 110.715 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.33 37.1 8.38 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.828 -0.909 . . . . 0.33000000000000002 110.828 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.6 pp -135.73 162.62 55.94 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.419 -0.39 . . . . 1.04 110.377 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.61 152.93 11.78 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.09 2.526 . . . . 0.69999999999999996 112.73 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -134.49 130.59 36.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.513 -0.767 . . . . 0.45000000000000001 110.4 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.62 137.2 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.47 -0.332 . . . . 0.85999999999999999 110.169 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -77.31 141.89 39.69 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.843 -0.799 . . . . 0.88 108.843 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 64.8 p -138.47 171.69 13.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.792 0.806 . . . . 0.76000000000000001 112.768 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.1 t -153.58 118.31 5.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.702 -1.136 . . . . 0.35999999999999999 108.827 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.62 -23.54 62.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.042 0.448 . . . . 0.55000000000000004 110.85 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -75.51 -39.93 57.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.177 -0.465 . . . . 1.8300000000000001 111.621 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 61.9 p -102.32 -8.0 21.59 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.94 0.348 . . . . 0.73999999999999999 111.94 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 65.1 23.13 12.38 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.419 0.628 . . . . 2.0800000000000001 110.517 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 144' ' ' THR . 44.3 tt0 -81.45 127.46 32.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.11 -0.496 . . . . 1.04 111.237 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.14 -25.73 2.24 Favored Glycine 0 CA--C 1.518 0.268 0 CA-C-N 116.014 -0.539 . . . . 0.66000000000000003 113.899 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.406 HG21 ' HB ' ' A' ' 144' ' ' THR . 6.6 t -57.09 -41.97 78.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 1.0700000000000001 111.426 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -61.9 -46.49 89.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.364 0.602 . . . . 1.6200000000000001 110.12 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.39 -45.87 82.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.291 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -54.72 -50.99 67.0 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.233 -0.439 . . . . 0.46000000000000002 111.71 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -62.43 -39.34 92.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 2.1000000000000001 111.292 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -68.11 -40.95 82.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.977 0.418 . . . . 1.55 110.498 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 46.5 m -62.16 -40.15 95.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.903 -0.589 . . . . 0.39000000000000001 110.443 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.498 ' O ' HG13 ' A' ' 163' ' ' ILE . 43.5 tp -59.12 -43.35 91.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.763 0.316 . . . . 0.90000000000000002 110.793 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.2 t -62.12 -43.25 97.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.031 0.443 . . . . 0.97999999999999998 110.468 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -67.24 -34.53 77.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 1.0700000000000001 110.668 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -65.73 -36.41 83.52 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.242 -0.651 . . . . 0.72999999999999998 109.242 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 159' ' ' LEU . 96.2 mt -64.12 -48.63 84.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 109.112 -0.699 . . . . 0.84999999999999998 109.112 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -60.77 -43.52 97.93 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.566 -0.743 . . . . 0.98999999999999999 109.929 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.571 ' O ' ' HG3' ' A' ' 169' ' ' LYS . 33.8 ttmt -55.66 -42.51 75.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.778 -0.646 . . . . 1.55 110.466 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.457 ' HA ' ' HD2' ' A' ' 169' ' ' LYS . 42.4 t60 -70.9 -31.26 67.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.84999999999999998 111.435 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -87.39 -4.7 59.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.479 -0.328 . . . . 1.73 111.543 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -117.47 14.1 14.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.051 0.453 . . . . 1.1200000000000001 111.142 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 165' ' ' LYS . 7.8 mtpp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.414 -0.803 . . . . 1.8799999999999999 109.781 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.486 ' O2A' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' QPD . . . . . 0.412 ' N1 ' ' HB2' ' A' ' 56' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.552 ' HA ' ' O ' ' A' ' 50' ' ' THR . 42.9 ttm . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.886 -0.413 . . . . 1.8899999999999999 109.886 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.6 145.52 34.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.513 -0.312 . . . . 1.24 111.466 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -100.16 138.89 36.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.213 -0.662 . . . . 1.27 109.213 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -123.1 125.36 45.03 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.886 0.374 . . . . 1.45 110.356 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -88.44 102.73 15.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.296 0.57 . . . . 1.1799999999999999 110.533 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 8.0 mp -107.89 131.87 54.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.585 -0.734 . . . . 2.1099999999999999 110.382 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.45 124.62 64.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.277 -0.419 . . . . 1.28 110.913 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.6 t -95.17 119.75 43.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.22 -0.445 . . . . 0.77000000000000002 109.958 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.4 ' HB ' ' CD1' ' A' ' 96' ' ' TYR . 12.0 m -112.54 155.04 13.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.953 0.406 . . . . 0.94999999999999996 110.779 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.79 -176.12 37.43 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.281 -0.962 . . . . 0.56000000000000005 112.537 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.595 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -80.24 161.54 25.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.127 0.489 . . . . 0.66000000000000003 111.132 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.74 109.13 2.75 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.748 -0.739 . . . . 0.80000000000000004 112.055 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.62 -2.7 17.87 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.582 -0.818 . . . . 0.45000000000000001 113.391 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 11' ' ' ALA . 12.8 m -72.44 -28.19 27.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 117.32 0.56 . . . . 0.98999999999999999 110.554 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.79 25.38 4.26 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.124 -1.036 . . . . 0.48999999999999999 114.135 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -55.22 -55.6 29.47 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.066 0.46 . . . . 1.3799999999999999 110.912 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.518 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 1.1 m -59.84 -36.42 76.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.245 -0.888 . . . . 0.85999999999999999 111.719 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.66 -42.97 95.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.95999999999999996 110.96 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.6 mt -66.66 -41.24 88.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.23 -0.441 . . . . 1.21 110.825 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.4 m -68.68 -46.04 70.1 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.886 -0.597 . . . . 1.2 111.767 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 82.1 mt -66.2 -24.83 34.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.712 0.291 . . . . 1.3799999999999999 110.997 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 3.9 mm-40 -61.31 -35.42 77.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.797 0.332 . . . . 0.52000000000000002 111.039 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 mp -84.86 -15.44 44.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.921 0.391 . . . . 1.8799999999999999 111.17 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.4 mm -95.42 -56.45 5.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 112.207 0.447 . . . . 0.57999999999999996 112.207 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -96.09 -10.28 28.74 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.815 0.302 . . . . 1.74 111.815 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 32.7 m-20 59.95 36.51 21.67 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.736 0.643 . . . . 1.9199999999999999 112.736 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.88 136.35 15.05 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.655 -0.498 . . . . 0.85999999999999999 109.655 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -70.54 125.3 26.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.077 -0.511 . . . . 0.77000000000000002 111.033 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.3 t -90.43 113.03 25.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.068 -0.715 . . . . 1.04 109.068 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -75.27 -36.91 61.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.421 -0.354 . . . . 1.1200000000000001 111.503 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -124.54 114.44 19.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.768 0.318 . . . . 1.1799999999999999 110.432 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -143.83 130.17 19.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.328 -0.396 . . . . 0.80000000000000004 110.371 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.511 ' HB3' HG13 ' A' ' 36' ' ' ILE . 39.2 t0 -65.05 125.75 89.84 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-N 115.523 -0.762 . . . . 0.80000000000000004 110.62 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.39 -18.46 26.26 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.923 2.415 . . . . 0.56000000000000005 113.507 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.1 p -84.36 0.12 50.51 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.77 0.319 . . . . 1.21 111.595 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.511 HG13 ' HB3' ' A' ' 33' ' ' ASP . 83.5 mt -83.07 122.88 38.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 110.084 -0.339 . . . . 1.1499999999999999 110.084 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -122.76 112.72 18.25 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.469 -0.787 . . . . 0.81000000000000005 109.61 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -144.4 167.21 23.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.836 0.351 . . . . 1.29 110.993 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 1.4 m -117.89 122.62 43.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.3 -0.63 . . . . 1.1699999999999999 109.3 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -103.22 132.74 49.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.325 -0.398 . . . . 0.97999999999999998 110.314 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.28 134.48 51.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.024 -0.535 . . . . 0.69999999999999996 110.662 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -148.47 129.63 14.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.935 -0.575 . . . . 1.78 110.002 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.403 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -92.44 134.53 34.86 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.725 -0.472 . . . . 2.3900000000000001 109.725 179.052 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.59 151.8 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.799 0.333 . . . . 1.3799999999999999 110.864 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.5 t -111.41 91.7 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.928 -0.578 . . . . 0.65000000000000002 109.874 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.24 121.77 54.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.102 -0.499 . . . . 1.47 109.946 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 64.75 23.51 12.74 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.723 -0.671 . . . . 0.96999999999999997 111.316 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.93 -17.18 59.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.844 -0.693 . . . . 0.59999999999999998 112.491 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -82.58 126.19 32.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.942 0.401 . . . . 1.4099999999999999 110.862 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' A' ' 1' ' ' MET . 5.0 m -93.59 103.34 15.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.115 -0.493 . . . . 0.89000000000000001 109.891 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.0 m -121.71 156.65 32.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.194 0.521 . . . . 1.3100000000000001 112.188 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.1 tp -108.43 118.66 37.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.181 -0.918 . . . . 0.85999999999999999 108.712 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.23 121.66 33.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.001 0.429 . . . . 1.1299999999999999 111.418 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -106.88 105.4 15.42 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.125 -1.065 . . . . 1.03 108.125 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 55.4 mt -112.81 130.46 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.978 0.418 . . . . 1.1799999999999999 111.819 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 23.7 tp -106.24 118.14 35.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.925 -0.579 . . . . 0.75 110.505 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.31 93.33 9.36 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.918 -0.771 . . . . 0.44 108.918 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.29 146.31 52.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.896 -0.593 . . . . 0.84999999999999998 111.674 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.21 -46.8 9.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.819 -0.628 . . . . 1.04 110.624 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.79 -70.1 0.34 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.696 -0.764 . . . . 0.71999999999999997 112.161 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -97.99 111.04 23.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.908 0.385 . . . . 1.5 110.849 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.67 166.07 19.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.042 -0.526 . . . . 1.5700000000000001 110.56 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.401 ' HB3' ' SD ' ' A' ' 67' ' ' MET . 25.0 tt0 -62.8 -45.89 90.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.641 -0.503 . . . . 1.3799999999999999 109.641 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -127.85 142.8 51.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.063 -0.718 . . . . 1.0 109.063 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 m -61.56 -26.31 67.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.065 0.459 . . . . 0.90000000000000002 111.102 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.79 -29.89 69.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.914 -0.584 . . . . 0.35999999999999999 110.965 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' A' ' 63' ' ' GLU . 74.3 mtp -69.96 -41.38 74.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.895 -0.593 . . . . 1.04 110.006 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.641 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 36.3 ttp180 -64.43 -39.42 93.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.538 0.685 . . . . 1.0700000000000001 109.571 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.22 -19.01 64.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.775 -1.102 . . . . 1.4099999999999999 111.235 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -77.02 -55.8 5.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.329 -0.396 . . . . 1.77 111.752 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 7.0 p90 -68.51 -16.97 64.06 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.479 -0.488 . . . . 1.27 111.449 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.7 mtt -81.86 -12.95 58.23 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.868 -0.419 . . . . 1.28 109.868 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -95.01 -52.18 4.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.017 -0.538 . . . . 1.8600000000000001 110.997 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -20.27 63.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 1.01 112.083 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.09 129.2 43.28 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.592 -0.813 . . . . 0.20000000000000001 112.555 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -90.78 -48.5 7.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.998 0.427 . . . . 0.54000000000000004 109.999 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.07 128.94 7.73 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.868 -0.682 . . . . 0.31 111.796 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.405 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 59.1 m-85 -111.05 127.84 55.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.115 0.483 . . . . 0.60999999999999999 110.611 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.3 tp -94.44 108.78 20.7 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.453 -0.573 . . . . 1.04 109.453 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -89.01 93.89 9.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.886 -0.597 . . . . 1.1799999999999999 109.822 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 2.3 t -109.59 139.48 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.388 0.613 . . . . 1.03 112.349 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -134.87 179.11 6.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.236 -0.893 . . . . 0.41999999999999998 108.798 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.48 ' HB2' ' OD1' ' A' ' 85' ' ' ASN . . . -111.91 129.52 56.14 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.756 -0.461 . . . . 0.76000000000000001 109.756 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 pt -67.06 -14.55 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.915 0.388 . . . . 1.1499999999999999 111.419 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.48 ' OD1' ' HB2' ' A' ' 83' ' ' ALA . 22.5 p-10 -99.99 -4.52 29.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.01 0.433 . . . . 0.93999999999999995 110.743 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -122.72 101.58 7.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.193 0.521 . . . . 1.3799999999999999 110.229 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -26.82 67.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.926 -0.579 . . . . 0.75 111.98 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -65.25 -42.62 93.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.225 -0.443 . . . . 1.4199999999999999 110.782 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 99.0 p -66.16 -28.64 68.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.679 0.276 . . . . 0.71999999999999997 111.078 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -72.59 -39.44 67.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.243 0.544 . . . . 0.51000000000000001 110.504 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -74.67 -29.86 61.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.196 -0.456 . . . . 1.4399999999999999 110.54 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.63 -16.81 64.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.942 -0.572 . . . . 1.02 110.793 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 32.9 mm -57.55 -34.83 48.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.886 -0.597 . . . . 1.04 110.354 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -62.41 -46.49 88.34 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.075 -0.511 . . . . 1.0900000000000001 110.646 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -57.51 -50.18 73.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.524 -0.762 . . . . 0.98999999999999999 111.389 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.4 ' CD1' ' HB ' ' A' ' 9' ' ' VAL . 17.8 m-85 -63.69 -38.8 92.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.45 -0.341 . . . . 1.73 111.437 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -58.64 -50.72 72.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.66000000000000003 110.187 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -67.08 -42.55 84.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.782 -0.644 . . . . 1.3500000000000001 111.138 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -58.82 -57.56 12.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.002 -0.544 . . . . 1.3999999999999999 112.078 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.8 mt -61.39 -39.2 81.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.671 -0.24 . . . . 0.78000000000000003 111.304 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -60.96 -38.9 87.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 1.6000000000000001 110.803 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -72.62 -40.07 66.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 1.0900000000000001 110.921 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 75.4 t -64.61 -48.01 86.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.42 -0.354 . . . . 0.89000000000000001 111.414 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -81.3 -10.08 59.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 1.3500000000000001 111.177 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.9 t70 51.43 58.56 5.37 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.59 0.709 . . . . 0.46999999999999997 110.812 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.2 m -150.03 138.78 20.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.725 -0.67 . . . . 1.4399999999999999 110.569 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -74.02 -30.26 62.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 1.74 110.631 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -116.93 124.36 49.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.234 -0.439 . . . . 0.78000000000000003 110.705 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.9 t -137.43 129.46 16.62 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.543 -0.539 . . . . 0.63 109.543 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.75 106.39 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.746 2.297 . . . . 0.29999999999999999 111.935 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.405 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 63.7 mtt -138.03 157.49 46.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.886 -0.597 . . . . 1.1899999999999999 110.596 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -140.07 124.52 19.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.159 -0.682 . . . . 0.63 109.159 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 21.7 tp -83.18 119.33 24.4 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.438 -0.579 . . . . 0.66000000000000003 109.438 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 47.7 t -124.23 133.33 69.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.045 -0.525 . . . . 1.3700000000000001 111.328 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -108.58 112.51 3.55 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.258 -1.137 . . . . 0.27000000000000002 110.258 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -92.74 163.91 13.57 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.107 0.453 . . . . 0.23999999999999999 111.399 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' A' ' 14' ' ' VAL . 89.7 mttt 68.21 34.0 4.11 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.346 -0.843 . . . . 1.1499999999999999 111.781 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 24.2 p -69.43 -11.51 60.89 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.032 0.444 . . . . 1.29 110.975 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.05 -13.29 41.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.032 -0.531 . . . . 0.69999999999999996 110.457 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 22.1 mt -88.1 143.48 33.03 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.942 0.401 . . . . 1.3100000000000001 111.029 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.32 -178.45 4.63 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.763 2.308 . . . . 0.79000000000000004 112.096 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.1 m 66.45 42.33 2.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.807 -0.633 . . . . 1.29 110.32 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.5 ttm-85 -68.16 119.94 13.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.658 -0.701 . . . . 0.68000000000000005 110.48 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.4 p -99.68 -27.71 13.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.424 -0.353 . . . . 1.28 110.902 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.7 t -97.96 114.22 34.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.441 -0.345 . . . . 0.96999999999999997 110.421 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -77.02 150.29 35.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.427 -0.351 . . . . 1.6899999999999999 110.674 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.43 -40.47 68.34 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.399 0.518 . . . . 1.6499999999999999 112.399 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -62.2 -37.63 86.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.558 -0.292 . . . . 0.71999999999999997 111.362 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -59.1 -46.63 87.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.119 0.485 . . . . 1.1100000000000001 110.988 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.61 -39.15 58.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.961 -0.563 . . . . 0.35999999999999999 111.339 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -61.4 -42.36 98.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.5 110.739 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.78 -38.82 80.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.276 -0.42 . . . . 1.1799999999999999 110.558 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 43.5 tp -63.29 -46.42 86.87 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.956 -0.565 . . . . 0.81000000000000005 111.146 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.5 -37.26 77.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.943 -0.572 . . . . 0.66000000000000003 110.867 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -66.13 -29.29 69.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.45 -0.795 . . . . 2.0699999999999998 110.928 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.7 m -74.17 -29.98 62.03 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.303 0.573 . . . . 1.28 110.28 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -85.47 -30.14 23.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.97 -0.559 . . . . 1.0900000000000001 110.423 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.31 26.65 10.83 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.957 -0.857 . . . . 0.33000000000000002 110.957 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 23.7 pt -124.56 166.25 20.81 Favored Pre-proline 0 N--CA 1.452 -0.345 0 N-CA-C 110.007 -0.368 . . . . 1.04 110.007 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -90.79 160.29 4.13 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.521 2.148 . . . . 0.69999999999999996 112.736 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 16.9 t80 -127.16 131.09 50.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.376 -0.375 . . . . 0.45000000000000001 110.309 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 53.4 mt -133.14 131.54 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.603 -0.272 . . . . 0.85999999999999999 111.112 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -83.85 130.39 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.836 -0.801 . . . . 0.88 108.836 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 71.3 p -137.6 176.38 8.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.625 0.726 . . . . 0.76000000000000001 112.162 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.8 t -161.41 114.69 1.91 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.747 -1.115 . . . . 0.35999999999999999 108.71 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.45 -15.93 63.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.203 0.525 . . . . 0.55000000000000004 110.605 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -80.58 -29.69 36.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.573 -0.739 . . . . 1.8300000000000001 111.504 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 149' ' ' ARG . 21.1 p -116.18 -8.55 11.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.462 0.541 . . . . 0.73999999999999999 112.462 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 148' ' ' THR . 21.4 mtp85 70.69 13.69 7.21 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.065 -0.516 . . . . 2.0800000000000001 111.099 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 144' ' ' THR . 53.1 tt0 -66.94 112.37 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.453 -0.34 . . . . 1.04 111.78 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 67.18 3.51 24.45 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 114.602 0.601 . . . . 0.66000000000000003 114.602 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 82.3 t -59.53 -49.25 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 117.83 0.815 . . . . 1.0700000000000001 110.743 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.38 -46.61 87.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.25 0.547 . . . . 1.6200000000000001 109.939 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -54.07 -46.85 72.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.056 -0.975 . . . . 1.0 111.851 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.61 -47.61 81.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.127 -0.488 . . . . 0.46000000000000002 111.755 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.444 ' O ' HG22 ' A' ' 160' ' ' VAL . 41.6 m-85 -64.97 -43.66 91.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.307 -0.406 . . . . 2.1000000000000001 111.427 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -63.89 -37.46 87.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.859 0.361 . . . . 1.55 110.739 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 93.0 m -62.37 -43.96 97.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.918 -0.583 . . . . 0.39000000000000001 110.808 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.591 ' O ' HG13 ' A' ' 163' ' ' ILE . 30.7 tp -58.22 -45.53 87.51 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.642 -0.254 . . . . 0.90000000000000002 110.911 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 156' ' ' PHE . 6.1 t -60.9 -39.92 83.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.941 0.4 . . . . 0.97999999999999998 110.512 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -68.76 -33.76 74.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 1.0700000000000001 110.985 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -65.91 -40.58 91.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.321 -0.622 . . . . 0.72999999999999998 109.321 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 159' ' ' LEU . 31.3 mt -62.42 -41.9 93.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.955 -0.757 . . . . 0.84999999999999998 108.955 178.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.555 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 4.4 mtt180 -53.36 -58.34 7.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.013 -0.994 . . . . 0.98999999999999999 110.921 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -62.13 -20.12 63.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.432 -0.803 . . . . 1.55 111.955 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -83.38 -33.99 25.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.767 0.318 . . . . 0.84999999999999998 110.603 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 163' ' ' ILE . 46.8 mtpt -87.06 -8.33 57.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.094 0.405 . . . . 1.73 112.094 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 8.8 pt-20 -108.92 25.11 12.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.961 0.41 . . . . 1.1200000000000001 110.771 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 36.4 mttm . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.447 -0.787 . . . . 1.8799999999999999 109.851 179.291 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.518 ' O2A' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' QPD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 ttm . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 120.64 0.257 . . . . 1.8899999999999999 110.574 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.0 m -111.53 149.06 31.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.523 -0.308 . . . . 1.24 110.356 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -98.41 131.75 44.43 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.046 -0.353 . . . . 1.27 110.046 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -109.91 133.35 53.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.855 -0.424 . . . . 1.45 109.855 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -94.98 104.61 16.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.267 -0.424 . . . . 1.1799999999999999 110.72 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 10.2 mp -112.82 119.63 38.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.872 -0.604 . . . . 2.1099999999999999 111.031 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.73 120.23 61.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.181 0.515 . . . . 1.28 110.153 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.7 t -92.25 112.9 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.827 -0.624 . . . . 0.77000000000000002 109.796 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 m -114.96 -175.45 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.187 -0.46 . . . . 0.94999999999999996 110.638 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.79 -176.08 22.66 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.716 -0.754 . . . . 0.56000000000000005 111.789 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.91 -175.34 2.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.783 0.325 . . . . 0.66000000000000003 111.188 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.23 131.41 10.39 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.586 -0.816 . . . . 0.80000000000000004 113.188 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.47 17.37 79.82 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.287 -0.482 . . . . 0.45000000000000001 113.835 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -77.09 -34.52 21.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 117.492 0.646 . . . . 0.98999999999999999 111.004 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.463 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 132.89 24.49 0.72 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.616 -0.802 . . . . 0.48999999999999999 113.137 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.437 ' HB2' ' O3B' ' A' ' 201' ' ' GDP . 6.4 mtpt -56.69 -41.27 77.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.061 0.458 . . . . 1.3799999999999999 111.046 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.81 2.01 50.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.85999999999999999 112.093 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.47 -44.76 5.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.712 0.291 . . . . 0.95999999999999996 110.801 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 44.7 mt -58.71 -42.78 89.47 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.558 0.694 . . . . 1.21 110.483 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.474 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -60.89 -52.44 65.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.948 -1.023 . . . . 1.2 111.701 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.8 mt -65.37 -31.09 52.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.388 -0.369 . . . . 1.3799999999999999 111.379 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.601 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 2.8 mm-40 -69.27 -22.38 63.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.999 0.428 . . . . 0.52000000000000002 110.335 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.8 tp -94.16 -26.83 16.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.118 -0.492 . . . . 1.8799999999999999 110.649 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 20' ' ' THR . 35.3 mm -89.73 -60.25 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.57999999999999996 111.558 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -92.51 -13.95 29.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.499 -0.319 . . . . 1.74 111.437 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.601 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 7.9 m-20 66.57 24.71 10.16 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 123.513 0.508 . . . . 1.9199999999999999 111.758 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -129.92 146.51 51.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.711 -0.477 . . . . 0.85999999999999999 109.711 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -85.12 129.97 34.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.377 -0.374 . . . . 0.77000000000000002 111.135 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.8 t -96.95 125.05 50.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 1.04 109.955 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -75.7 -46.38 31.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.763 -0.653 . . . . 1.1200000000000001 111.815 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -130.07 123.73 31.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.969 0.414 . . . . 1.1799999999999999 111.118 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -145.42 146.92 31.72 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.156 -0.683 . . . . 0.80000000000000004 109.156 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -71.66 119.42 74.0 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 0.80000000000000004 110.367 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.94 -17.33 32.31 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.49 2.127 . . . . 0.56000000000000005 113.615 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.24 -7.49 59.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.096 0.474 . . . . 1.21 111.434 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.2 mt -80.77 119.69 30.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.197 0.522 . . . . 1.1499999999999999 110.771 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 22.3 tt0 -118.01 79.49 1.38 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.097 -0.956 . . . . 0.81000000000000005 108.641 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -106.39 159.39 16.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.136 -0.483 . . . . 1.29 111.054 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.66 124.52 52.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.231 -0.44 . . . . 1.1699999999999999 110.325 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -101.97 136.81 41.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.121 -0.491 . . . . 0.97999999999999998 110.347 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.06 128.53 55.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.88 0.371 . . . . 0.69999999999999996 111.234 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -144.51 137.59 26.98 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.387 -0.598 . . . . 1.78 109.387 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -116.26 119.34 35.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.704 0.288 . . . . 2.3900000000000001 110.343 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.9 t -138.58 153.02 25.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.446 . . . . 1.3799999999999999 109.877 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.2 t -76.73 103.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.64 -0.504 . . . . 0.65000000000000002 109.64 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.3 mt -105.37 111.94 36.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.343 -0.389 . . . . 1.47 111.008 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.468 ' HB2' HH12 ' A' ' 164' ' ' ARG . 31.3 m-20 65.4 27.09 11.92 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.757 -0.656 . . . . 0.96999999999999997 111.518 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.49 5.29 65.25 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.873 -0.679 . . . . 0.59999999999999998 112.469 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -126.54 119.75 27.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.791 0.329 . . . . 1.4099999999999999 111.172 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.6 m -77.11 106.75 9.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.641 -0.503 . . . . 0.89000000000000001 109.641 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.1 m -117.71 147.48 42.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.224 0.535 . . . . 1.3100000000000001 111.212 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.0 tp -90.74 122.22 33.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.547 -0.751 . . . . 0.85999999999999999 109.113 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 mt -93.61 113.44 25.54 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.955 0.407 . . . . 1.1299999999999999 111.591 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -100.43 87.71 3.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.256 -1.387 . . . . 1.03 107.256 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 6.6 mt -99.54 127.64 52.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.724 -0.671 . . . . 1.1799999999999999 111.881 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.9 tp -107.88 121.24 44.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.557 -0.747 . . . . 0.75 111.112 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 1.7 t70 -87.47 94.97 9.86 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.44 -0.948 . . . . 0.44 108.44 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.468 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 81.2 p -65.98 146.42 54.72 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.466 0.651 . . . . 0.84999999999999998 111.838 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.01 -58.17 2.56 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.155 -0.929 . . . . 1.04 109.287 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.16 -96.96 0.15 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.799 -0.715 . . . . 0.71999999999999997 111.999 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -83.77 158.44 21.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.679 0.276 . . . . 1.5 110.533 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -130.32 165.86 21.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.238 -0.437 . . . . 1.5700000000000001 110.32 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -78.89 -35.36 43.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.331 -0.618 . . . . 1.3799999999999999 109.331 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -119.86 124.03 45.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.592 -0.731 . . . . 1.0 109.517 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -58.46 -34.9 71.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.419 -0.355 . . . . 0.90000000000000002 111.382 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.26 -27.48 69.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.35999999999999999 111.4 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 78.0 mtp -72.64 -32.65 66.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 1.04 110.467 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -71.17 -46.07 62.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.896 -0.593 . . . . 1.0700000000000001 110.071 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -73.63 -9.06 58.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.654 -0.703 . . . . 1.4099999999999999 111.449 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -67.19 -60.28 2.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.817 -0.174 . . . . 1.77 111.046 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -72.51 -15.88 61.79 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.695 -0.402 . . . . 1.27 111.091 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.406 ' SD ' HG23 ' A' ' 103' ' ' VAL . 35.7 mtt -70.35 -25.74 63.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.24 0.543 . . . . 1.28 109.937 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 73' ' ' ARG . 48.5 mtm180 -84.17 -48.54 9.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.83 -0.623 . . . . 1.8600000000000001 110.673 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -22.67 63.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.938 -0.574 . . . . 1.01 111.953 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.01 123.45 26.3 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.018 -0.61 . . . . 0.20000000000000001 112.087 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -88.9 -40.85 12.8 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.943 -0.391 . . . . 0.54000000000000004 109.943 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -128.88 130.12 6.37 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.414 -0.674 . . . . 0.31 111.414 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -113.98 133.83 55.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.015 0.436 . . . . 0.60999999999999999 111.128 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.8 tp -100.1 106.23 17.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.864 -0.607 . . . . 1.04 110.221 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.5 m -92.36 97.44 10.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.004 0.43 . . . . 1.1799999999999999 110.343 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 4.9 t -110.31 134.1 53.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.002 -0.545 . . . . 1.03 111.37 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -129.6 172.66 11.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.729 -0.668 . . . . 0.41999999999999998 109.441 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.78 133.3 52.37 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.727 -0.471 . . . . 0.76000000000000001 109.727 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.0 pt -76.92 -4.17 6.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 112.782 0.66 . . . . 1.1499999999999999 112.782 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -85.6 -12.18 52.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.738 -0.21 . . . . 0.93999999999999995 111.105 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.465 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 30.8 t-20 -139.79 123.94 17.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.367 . . . . 1.3799999999999999 110.725 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.8 m -69.83 -28.2 65.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.057 -0.52 . . . . 0.75 111.652 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -60.97 -39.29 89.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.618 0.247 . . . . 1.4199999999999999 110.721 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.465 ' OG ' ' HB3' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -64.75 -32.43 74.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.137 0.494 . . . . 0.71999999999999997 110.313 179.147 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -76.95 -35.66 57.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.76 -0.655 . . . . 0.51000000000000001 110.115 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -72.01 -29.8 64.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.707 -0.678 . . . . 1.4399999999999999 110.582 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.38 -24.02 67.14 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.042 -0.527 . . . . 1.02 110.592 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.9 mm -61.45 -30.63 48.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.518 -0.764 . . . . 1.04 110.684 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -60.76 -41.38 95.34 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.205 0.526 . . . . 1.0900000000000001 109.695 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -71.86 -38.43 70.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.562 -0.744 . . . . 0.98999999999999999 110.639 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -63.75 -47.42 81.1 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.252 0.464 . . . . 1.73 112.252 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 25.7 tpt180 -63.73 -33.37 75.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.671 0.272 . . . . 0.66000000000000003 110.856 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -79.19 -43.86 23.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.283 -0.417 . . . . 1.3500000000000001 111.541 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -58.6 -56.99 14.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.086 0.402 . . . . 1.3999999999999999 112.086 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.5 mt -63.38 -31.07 51.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.359 -0.382 . . . . 0.78000000000000003 110.772 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 39.0 ttpt -62.97 -35.38 79.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.343 0.592 . . . . 1.6000000000000001 110.198 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -78.02 -40.61 38.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.713 -0.676 . . . . 1.0900000000000001 110.592 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.406 HG23 ' SD ' ' A' ' 72' ' ' MET . 87.3 t -58.78 -50.75 78.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.907 -0.588 . . . . 0.89000000000000001 110.863 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -82.08 -11.61 58.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.084 -0.507 . . . . 1.3500000000000001 111.036 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.8 t70 54.81 48.82 19.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.583 0.706 . . . . 0.46999999999999997 110.753 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.5 t -158.45 144.42 16.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.51 -0.768 . . . . 1.4399999999999999 110.317 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -90.97 -17.72 25.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.079 0.466 . . . . 1.74 110.76 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -91.08 68.99 6.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.595 0.712 . . . . 0.78000000000000003 110.604 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 85.2 t -108.57 112.34 60.78 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.289 -0.869 . . . . 0.63 109.659 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.82 113.42 1.31 Allowed 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.915 2.41 . . . . 0.29999999999999999 111.656 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 28.6 mtt -141.99 153.35 44.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.09 -0.505 . . . . 1.1899999999999999 111.223 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.3 t -131.91 123.9 52.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.482 -0.781 . . . . 0.63 109.035 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 41.0 tp -85.37 121.85 28.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.042 -0.725 . . . . 0.66000000000000003 109.042 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 11.2 t -127.19 138.05 55.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.004 0.431 . . . . 1.3700000000000001 111.532 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.87 106.85 2.12 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 110.164 -1.174 . . . . 0.27000000000000002 110.164 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -89.2 165.5 14.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.735 0.267 . . . . 0.23999999999999999 111.024 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 67.52 34.85 4.43 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 115.466 -0.788 . . . . 1.1499999999999999 111.008 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 27.5 p -68.75 -13.0 62.11 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.869 0.366 . . . . 1.29 111.344 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.67 -13.72 47.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.69999999999999996 110.612 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 44.1 mt -82.51 142.06 45.96 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.399 -0.364 . . . . 1.3100000000000001 110.175 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.3 -177.52 3.9 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.603 2.202 . . . . 0.79000000000000004 111.925 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.5 m 62.83 48.75 3.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.295 0.569 . . . . 1.29 111.181 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.3 ttm-85 -72.38 110.99 7.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.749 -0.66 . . . . 0.68000000000000005 109.95 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 p -95.14 -21.01 18.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.07 0.462 . . . . 1.28 110.728 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -98.69 110.33 25.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.115 -0.493 . . . . 0.96999999999999997 110.051 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.99 143.12 56.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.985 -0.552 . . . . 1.6899999999999999 111.176 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 m -59.54 -39.92 85.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.006 -0.543 . . . . 1.6499999999999999 110.787 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -61.53 -38.52 87.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.71999999999999997 110.954 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -58.4 -51.94 67.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.139 0.495 . . . . 1.1100000000000001 110.744 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.43 -40.52 85.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.714 -0.675 . . . . 0.35999999999999999 110.875 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -61.38 -40.49 94.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.811 -0.631 . . . . 0.5 110.356 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 -46.46 79.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.384 -0.371 . . . . 1.1799999999999999 110.15 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.85 -44.91 93.87 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.804 -0.634 . . . . 0.81000000000000005 111.0 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.73 -43.55 98.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.965 -0.561 . . . . 0.66000000000000003 110.865 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -63.66 -36.16 82.91 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.837 -0.62 . . . . 2.0699999999999998 111.95 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.4 p -74.77 -23.28 58.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.428 . . . . 1.28 111.133 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -89.45 -16.92 29.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 1.0900000000000001 111.011 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.83 30.1 33.09 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.97 -0.559 . . . . 0.33000000000000002 111.806 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 40.0 pt -127.08 152.97 76.55 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.7 -0.25 . . . . 1.04 110.543 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.7 148.51 22.82 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.669 2.246 . . . . 0.69999999999999996 112.189 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 17.6 t80 -125.35 124.32 41.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.381 -0.372 . . . . 0.45000000000000001 110.61 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.7 mt -132.61 133.73 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.34 -0.391 . . . . 0.85999999999999999 110.343 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -88.52 135.01 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.812 -0.811 . . . . 0.88 108.812 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 70.6 p -138.96 175.53 9.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.52 0.676 . . . . 0.76000000000000001 112.447 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.1 t -152.06 109.44 3.58 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.008 -0.996 . . . . 0.35999999999999999 108.749 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -68.42 -24.48 64.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.273 0.558 . . . . 0.55000000000000004 110.286 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -67.57 -47.83 68.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.004 -0.998 . . . . 1.8300000000000001 111.296 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.9 p -97.04 3.91 51.66 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.711 -0.395 . . . . 0.73999999999999999 110.925 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 55.83 45.73 23.63 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.55 -0.75 . . . . 2.0800000000000001 110.414 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -107.72 120.74 43.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.447 -0.797 . . . . 1.04 111.056 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.31 -1.24 57.31 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.807 -0.633 . . . . 0.66000000000000003 113.747 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 32.6 t -60.1 -42.29 89.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.981 0.391 . . . . 1.0700000000000001 110.744 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.28 -50.77 62.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.795 -0.639 . . . . 1.6200000000000001 110.203 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.12 -45.84 72.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.575 -0.739 . . . . 1.0 111.857 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.94 81.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.664 0.268 . . . . 0.46000000000000002 111.247 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -66.64 -44.1 82.87 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.385 -0.371 . . . . 2.1000000000000001 111.231 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -63.73 -42.35 97.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.446 -0.343 . . . . 1.55 111.564 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 36.6 m -61.82 -38.02 86.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.693 -0.23 . . . . 0.39000000000000001 110.576 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.425 ' O ' HG13 ' A' ' 163' ' ' ILE . 48.3 tp -62.77 -40.6 97.79 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.901 -0.407 . . . . 0.90000000000000002 109.901 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.83 -41.51 85.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.494 . . . . 0.97999999999999998 110.078 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -67.77 -38.26 83.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 1.0700000000000001 110.411 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 158' ' ' THR . 63.5 mm-40 -60.11 -43.51 95.56 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.93 -0.577 . . . . 0.72999999999999998 110.814 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 159' ' ' LEU . 27.1 mt -67.53 -46.07 83.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.94 -0.573 . . . . 0.84999999999999998 110.758 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.468 HH12 ' HB2' ' A' ' 47' ' ' ASP . 85.9 mtt180 -57.2 -42.22 80.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.152 -0.477 . . . . 0.98999999999999999 111.447 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -59.56 -34.99 73.37 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.812 0.339 . . . . 1.55 110.951 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -79.67 -30.91 41.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.879 0.371 . . . . 0.84999999999999998 110.209 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -67.93 -33.64 75.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.106 -0.497 . . . . 1.73 111.799 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 11.9 pt-20 -102.9 17.58 23.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.198 0.523 . . . . 1.1200000000000001 110.602 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 17.8 tttp . . . . . 0 C--O 1.25 1.13 0 CA-C-N 115.518 -0.764 . . . . 1.8799999999999999 110.195 -179.739 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.437 ' O3B' ' HB2' ' A' ' 16' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' QPD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.575 ' HA ' ' O ' ' A' ' 50' ' ' THR . 24.8 ttt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.982 -0.377 . . . . 1.8899999999999999 109.982 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.1 m -106.09 144.15 33.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.116 -0.493 . . . . 1.24 110.752 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -93.26 135.41 34.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.224 -0.444 . . . . 1.27 110.795 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.42 ' CD2' ' HB3' ' A' ' 51' ' ' CYS . 35.0 m-85 -121.84 117.99 27.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.325 -0.62 . . . . 1.45 109.325 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -95.17 107.77 19.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.959 0.409 . . . . 1.1799999999999999 110.516 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 1.2 mp -119.46 141.74 48.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.853 -0.612 . . . . 2.1099999999999999 110.965 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.04 135.67 62.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.227 -0.442 . . . . 1.28 110.552 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.44 115.82 47.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.614 -0.513 . . . . 0.77000000000000002 109.614 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.6 m -114.06 169.32 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.123 -0.489 . . . . 0.94999999999999996 110.251 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.27 170.22 17.9 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.792 -0.718 . . . . 0.56000000000000005 112.033 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.581 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -67.81 159.14 30.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.075 0.464 . . . . 0.66000000000000003 111.714 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.12 99.63 0.72 Allowed Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.827 -0.624 . . . . 0.80000000000000004 112.872 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.26 7.69 5.77 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.673 -0.775 . . . . 0.45000000000000001 113.142 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 11' ' ' ALA . 12.4 m -79.59 -39.06 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.558 -0.457 . . . . 0.98999999999999999 110.625 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.51 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 126.58 24.97 1.32 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.557 -0.83 . . . . 0.48999999999999999 113.573 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -50.98 -52.38 43.25 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.907 0.354 . . . . 1.3799999999999999 111.76 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.478 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 1.0 OUTLIER -65.64 -40.2 92.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.419 -0.355 . . . . 0.85999999999999999 111.679 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.76 -42.55 97.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 0.95999999999999996 111.548 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 72.0 mt -59.59 -44.88 93.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.368 . . . . 1.21 111.341 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.443 ' O ' HG12 ' A' ' 24' ' ' ILE . 7.7 m -67.16 -51.42 53.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.214 -0.448 . . . . 1.2 111.788 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.96 -31.45 47.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.67 0.272 . . . . 1.3799999999999999 111.697 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 4.8 mm-40 -61.12 -30.0 70.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.913 0.387 . . . . 0.52000000000000002 111.046 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tp -95.34 -35.76 11.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.302 -0.408 . . . . 1.8799999999999999 111.318 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 20' ' ' THR . 40.3 mm -74.14 -55.79 11.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.409 0.522 . . . . 0.57999999999999996 112.409 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -99.82 1.48 43.08 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.045 0.387 . . . . 1.74 112.045 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 73.0 m-20 57.81 32.61 22.15 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.63 0.974 . . . . 1.9199999999999999 113.63 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -153.92 146.73 24.33 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.686 -0.405 . . . . 0.85999999999999999 110.805 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -82.02 129.53 34.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.952 -0.567 . . . . 0.77000000000000002 110.693 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.0 t -98.86 121.41 49.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.05 -0.523 . . . . 1.04 109.891 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.51 -55.95 8.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.615 -0.72 . . . . 1.1200000000000001 111.445 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -113.77 115.12 27.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.324 0.583 . . . . 1.1799999999999999 111.665 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -141.77 136.04 30.3 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.906 -0.776 . . . . 0.80000000000000004 108.906 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -62.71 117.47 32.14 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 120.854 0.359 . . . . 0.80000000000000004 110.561 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.92 -25.87 38.33 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.69 2.26 . . . . 0.56000000000000005 112.898 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -8.47 57.05 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.382 0.512 . . . . 1.21 112.382 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.3 mt -79.24 119.51 28.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.068 0.461 . . . . 1.1499999999999999 111.105 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 8.6 tt0 -111.13 97.9 7.13 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.411 -0.959 . . . . 0.81000000000000005 108.411 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -126.43 163.1 24.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.764 0.316 . . . . 1.29 110.706 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.13 145.39 44.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.036 -0.529 . . . . 1.1699999999999999 109.841 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -131.64 138.35 48.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.748 0.309 . . . . 0.97999999999999998 110.286 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -112.68 127.79 56.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.194 -0.457 . . . . 0.69999999999999996 110.358 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -141.6 120.88 13.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.19 -0.459 . . . . 1.78 110.144 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 10.4 pt20 -93.15 122.0 35.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.947 0.403 . . . . 2.3900000000000001 110.524 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.3 t -125.83 143.75 38.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.076 -0.511 . . . . 1.3799999999999999 110.169 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 t -86.24 102.22 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.299 -0.63 . . . . 0.65000000000000002 109.299 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.9 mt -114.17 123.36 69.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.849 -0.614 . . . . 1.47 110.743 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 64.77 22.59 12.58 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.605 0.566 . . . . 0.96999999999999997 111.495 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.32 0.95 72.66 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.767 -0.73 . . . . 0.59999999999999998 112.679 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -116.68 132.61 56.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.657 0.265 . . . . 1.4099999999999999 110.83 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 1' ' ' MET . 1.3 m -82.9 111.67 19.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.87 -0.418 . . . . 0.89000000000000001 109.87 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.42 ' HB3' ' CD2' ' A' ' 4' ' ' TYR . 2.5 m -112.45 134.73 53.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.391 -0.368 . . . . 1.3100000000000001 111.233 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.9 tp -92.49 107.5 19.26 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.853 -0.795 . . . . 0.85999999999999999 108.853 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 35.7 mt -82.66 115.64 21.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.22 -0.445 . . . . 1.1299999999999999 111.547 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.406 ' OD1' ' HD2' ' A' ' 41' ' ' ARG . 12.5 t70 -103.4 95.65 6.22 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.941 -1.133 . . . . 1.03 107.941 178.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 31.1 mt -109.47 135.01 49.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.236 0.541 . . . . 1.1799999999999999 111.646 -177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.445 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 26.7 tp -112.13 119.48 38.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.353 -0.84 . . . . 0.75 110.631 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 2.5 t70 -87.36 99.81 12.26 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.695 -0.854 . . . . 0.44 108.695 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.7 p -72.15 153.1 41.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.806 -0.634 . . . . 0.84999999999999998 111.41 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.54 -63.92 1.08 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.176 -0.675 . . . . 1.04 109.176 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.75 -91.49 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.683 -0.689 . . . . 0.71999999999999997 111.549 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -121.98 130.66 53.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.071 -0.344 . . . . 1.5 110.071 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.81 179.22 6.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.44 . . . . 1.5700000000000001 110.764 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.18 -43.65 94.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.728 -0.669 . . . . 1.3799999999999999 110.017 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -120.59 145.04 47.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.602 -0.726 . . . . 1.0 109.577 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -63.09 -34.6 77.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.318 -0.401 . . . . 0.90000000000000002 111.26 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.91 -30.94 71.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.325 -0.398 . . . . 0.35999999999999999 111.861 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 95.0 mtp -66.56 -33.46 75.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.094 0.474 . . . . 1.04 109.983 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -76.96 -39.93 48.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.729 -0.669 . . . . 1.0700000000000001 109.856 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.32 -11.02 60.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.686 -0.688 . . . . 1.4099999999999999 110.875 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -66.03 -69.28 0.31 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.017 -0.538 . . . . 1.77 110.347 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.44 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 8.3 p90 -70.41 -11.92 61.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.439 -0.346 . . . . 1.27 111.688 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.9 mtt -73.16 -13.98 61.27 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.903 -0.406 . . . . 1.28 109.903 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 -109.22 -33.61 6.81 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.062 -0.517 . . . . 1.8600000000000001 110.808 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -79.9 -15.55 57.1 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.482 -0.326 . . . . 1.01 111.661 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.8 134.12 34.94 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.705 -0.759 . . . . 0.20000000000000001 112.439 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.8 -36.64 11.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.836 0.351 . . . . 0.54000000000000004 110.359 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.83 128.2 6.8 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.99 -0.624 . . . . 0.31 111.676 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.46 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 94.1 m-85 -112.09 121.36 44.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.121 0.486 . . . . 0.60999999999999999 110.682 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.6 tp -100.18 109.27 21.52 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.86 -0.609 . . . . 1.04 110.765 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 2.7 m -94.18 102.19 14.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.137 -0.483 . . . . 1.1799999999999999 110.012 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.1 t -109.3 140.61 27.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.104 0.478 . . . . 1.03 111.374 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.39 170.53 15.92 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.746 -0.835 . . . . 0.41999999999999998 108.746 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' A' ' 86' ' ' ASN . . . -105.32 133.27 50.37 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.977 -0.379 . . . . 0.76000000000000001 109.977 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 pt -66.49 -16.93 21.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.891 0.376 . . . . 1.1499999999999999 111.496 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -107.78 10.12 28.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.005 0.431 . . . . 0.93999999999999995 110.935 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 13.0 t-20 -132.7 92.69 3.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.087 0.47 . . . . 1.3799999999999999 110.539 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -33.62 71.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.657 -0.701 . . . . 0.75 111.811 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -58.24 -45.46 87.72 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.945 0.402 . . . . 1.4199999999999999 110.999 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.8 p -68.0 -28.13 67.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.71999999999999997 110.974 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -76.06 -43.57 43.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.005 0.431 . . . . 0.51000000000000001 110.686 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -67.28 -33.37 75.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 1.4399999999999999 110.98 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -66.98 -19.76 65.77 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.42 -0.355 . . . . 1.02 111.1 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.48 -29.7 42.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 121.16 0.505 . . . . 1.04 109.994 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -62.25 -36.1 80.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.752 -0.658 . . . . 1.0900000000000001 110.339 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -80.73 -24.75 38.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.194 -0.912 . . . . 0.98999999999999999 110.762 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -62.45 -59.37 5.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.51 . . . . 1.73 110.183 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -55.41 -46.43 76.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.928 -0.578 . . . . 0.66000000000000003 109.91 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -56.15 -48.83 75.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.298 -0.865 . . . . 1.3500000000000001 111.903 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.614 ' O ' HG21 ' A' ' 103' ' ' VAL . 22.7 tt0 -61.79 -57.31 12.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.264 -0.426 . . . . 1.3999999999999999 111.266 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.6 mt -60.07 -35.31 60.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 111.911 0.338 . . . . 0.78000000000000003 111.911 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -59.53 -39.32 83.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.863 0.363 . . . . 1.6000000000000001 110.569 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -75.05 -45.98 37.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.81 -0.632 . . . . 1.0900000000000001 110.954 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.614 HG21 ' O ' ' A' ' 99' ' ' GLN . 21.8 t -59.9 -49.42 83.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.89000000000000001 112.118 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -81.7 -13.32 58.0 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.218 -0.193 . . . . 1.3500000000000001 111.416 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.5 t70 54.61 50.64 15.52 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.882 -0.599 . . . . 0.46999999999999997 111.224 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.9 m -141.54 144.51 34.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.333 -0.394 . . . . 1.4399999999999999 110.176 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -44.12 28.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.364 . . . . 1.74 111.372 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -99.88 119.28 37.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.846 0.355 . . . . 0.78000000000000003 110.46 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.82 123.8 21.27 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 115.977 -0.556 . . . . 0.63 110.142 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.84 108.09 0.45 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.435 2.09 . . . . 0.29999999999999999 111.811 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.46 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 46.5 mtt -139.27 155.19 47.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.078 0.466 . . . . 1.1899999999999999 111.174 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.3 t -135.06 124.71 43.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.524 -0.762 . . . . 0.63 108.953 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.0 tp -84.42 120.54 26.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.567 -0.531 . . . . 0.66000000000000003 109.567 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.96 131.21 73.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.147 -0.479 . . . . 1.3700000000000001 112.132 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -108.35 95.7 0.96 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.348 -1.101 . . . . 0.27000000000000002 110.348 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -78.54 161.44 27.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.925 0.393 . . . . 0.23999999999999999 111.879 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 81.2 mttt 63.7 35.98 11.03 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 115.31 -0.859 . . . . 1.1499999999999999 110.895 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 28.2 p -69.74 -13.16 62.15 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.978 -0.556 . . . . 1.29 111.475 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -82.36 -10.11 59.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.029 -0.532 . . . . 0.69999999999999996 110.951 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 58.6 mt -83.24 141.41 42.88 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.962 0.411 . . . . 1.3100000000000001 110.671 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.28 -178.69 4.61 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.186 1.924 . . . . 0.79000000000000004 111.588 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.8 m 63.5 45.71 4.63 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.183 -0.462 . . . . 1.29 111.059 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -59.27 123.03 15.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.965 -0.562 . . . . 0.68000000000000005 110.401 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.81 -24.77 14.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.913 0.387 . . . . 1.28 111.1 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.3 t -104.82 111.68 35.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.166 -0.47 . . . . 0.96999999999999997 110.758 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.1 141.58 58.67 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.756 -0.461 . . . . 1.6899999999999999 109.756 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.83 -30.16 56.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.189 0.518 . . . . 1.6499999999999999 112.131 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -68.05 -34.32 76.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.887 -0.597 . . . . 0.71999999999999997 111.723 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -59.53 -57.12 14.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.952 0.353 . . . . 1.1100000000000001 111.952 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.94 89.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.509 -0.314 . . . . 0.35999999999999999 111.432 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -63.01 -44.13 96.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.016 0.436 . . . . 0.5 110.069 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.48 -38.72 90.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.656 -0.702 . . . . 1.1799999999999999 110.304 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 65.5 tp -68.51 -41.05 80.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.717 -0.674 . . . . 0.81000000000000005 110.898 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.7 91.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.66000000000000003 110.408 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 135' ' ' ARG . 37.8 ttm105 -62.89 -36.81 84.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.91 -0.586 . . . . 2.0699999999999998 110.774 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.0 m -69.19 -26.28 64.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.045 0.45 . . . . 1.28 111.138 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -91.09 -19.61 22.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.491 . . . . 1.0900000000000001 111.187 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.43 27.53 47.6 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.629 -0.796 . . . . 0.33000000000000002 111.564 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 26.6 pt -125.54 159.11 62.14 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.887 -0.412 . . . . 1.04 109.887 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.45 160.62 17.15 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.678 2.252 . . . . 0.69999999999999996 112.901 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -135.74 131.53 35.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.541 -0.754 . . . . 0.45000000000000001 110.316 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 37.3 mt -142.74 134.97 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.364 -0.38 . . . . 0.85999999999999999 110.386 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -84.21 137.85 33.28 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.067 -0.716 . . . . 0.88 109.067 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 46.9 p -138.31 173.17 11.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.633 0.73 . . . . 0.76000000000000001 111.716 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.4 t -149.01 123.08 9.45 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.066 -1.087 . . . . 0.35999999999999999 108.066 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.44 -11.74 61.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.746 0.308 . . . . 0.55000000000000004 111.291 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -85.13 -57.77 2.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.065 -0.516 . . . . 1.8300000000000001 111.498 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.9 p -86.74 -10.33 53.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.333 . . . . 0.73999999999999999 111.463 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 59.69 40.27 20.08 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.683 -0.69 . . . . 2.0800000000000001 110.744 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 144' ' ' THR . 47.4 tt0 -85.29 114.99 22.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.132 -0.486 . . . . 1.04 110.78 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.1 8.4 61.58 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.941 -0.572 . . . . 0.66000000000000003 112.985 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 22.2 t -65.5 -50.88 69.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.766 0.317 . . . . 1.0700000000000001 110.814 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.93 -37.63 84.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.103 0.477 . . . . 1.6200000000000001 109.815 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.7 -42.72 93.62 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.134 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.68 79.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.915 -0.584 . . . . 0.46000000000000002 111.733 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.94 -39.72 72.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.29 -0.414 . . . . 2.1000000000000001 111.494 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -61.48 -35.74 78.5 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.952 -0.388 . . . . 1.55 109.952 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 22.3 m -70.59 -35.22 72.9 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.541 -0.54 . . . . 0.39000000000000001 109.541 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.27 -40.53 97.65 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.494 -0.558 . . . . 0.90000000000000002 109.494 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 94.0 t -61.78 -42.15 93.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.344 0.592 . . . . 0.97999999999999998 109.712 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -65.3 -36.03 82.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.463 -0.79 . . . . 1.0700000000000001 110.146 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -66.78 -38.84 87.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.967 -0.383 . . . . 0.72999999999999998 109.967 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.514 ' O ' ' HG3' ' A' ' 167' ' ' LYS . 88.4 mt -61.81 -52.21 63.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.307 -0.627 . . . . 0.84999999999999998 109.307 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.6 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 99.1 mtt180 -55.91 -44.81 78.6 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 115.529 -0.759 . . . . 0.98999999999999999 110.077 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -56.49 -42.81 78.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.42 -0.809 . . . . 1.55 111.842 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -71.24 -36.03 71.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.245 -0.434 . . . . 0.84999999999999998 111.519 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 163' ' ' ILE . 30.7 mtpt -74.67 -29.7 61.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.407 0.521 . . . . 1.73 112.407 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.6 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 6.6 pt-20 -86.77 -12.36 48.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.717 0.294 . . . . 1.1200000000000001 111.14 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 31.7 tttp . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.431 -0.795 . . . . 1.8799999999999999 110.395 -179.6 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.478 ' O2A' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' QPD . . . . . 0.445 ' N1 ' ' HB2' ' A' ' 56' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tmm? . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.196 -0.298 . . . . 1.8899999999999999 110.196 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.439 ' HB ' ' CE2' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -113.87 138.7 49.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.372 -0.376 . . . . 1.24 110.893 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -96.32 131.37 42.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.529 -0.545 . . . . 1.27 109.529 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.439 ' CE2' ' HB ' ' A' ' 2' ' ' THR . 85.5 m-85 -120.91 124.55 45.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.567 -0.288 . . . . 1.45 110.251 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -95.63 107.49 19.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.144 0.497 . . . . 1.1799999999999999 110.545 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 8.5 mp -111.84 133.26 54.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.649 -0.705 . . . . 2.1099999999999999 111.187 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 78' ' ' PHE . 16.5 t -118.47 122.1 68.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.165 -0.47 . . . . 1.28 110.491 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.2 t -94.49 119.42 42.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.281 -0.637 . . . . 0.77000000000000002 109.281 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 m -116.42 157.22 17.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.05 0.453 . . . . 0.94999999999999996 110.987 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.31 170.92 29.9 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.62 -0.8 . . . . 0.56000000000000005 111.772 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.45 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -70.34 173.21 7.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.971 0.415 . . . . 0.66000000000000003 111.597 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.04 112.91 3.54 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.472 -0.87 . . . . 0.80000000000000004 112.49 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.26 4.1 27.35 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.523 -0.846 . . . . 0.45000000000000001 113.562 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 11' ' ' ALA . 18.9 m -76.02 -17.61 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 117.391 0.595 . . . . 0.98999999999999999 111.481 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.62 25.34 8.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.522 -0.847 . . . . 0.48999999999999999 113.597 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -53.55 -55.98 20.97 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.785 0.326 . . . . 1.3799999999999999 111.736 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.495 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 1.0 OUTLIER -57.85 -52.86 63.75 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.591 0.589 . . . . 0.85999999999999999 112.591 -178.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.82 -38.86 67.9 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.369 0.507 . . . . 0.95999999999999996 112.369 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.0 mt -62.0 -44.47 96.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.543 -0.299 . . . . 1.21 111.354 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.4 ' O ' HG12 ' A' ' 24' ' ' ILE . 1.4 m -73.97 -39.71 63.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.631 0.253 . . . . 1.2 111.026 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.79 -32.61 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.985 0.422 . . . . 1.3799999999999999 110.473 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.706 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 3.6 mm-40 -67.6 -21.96 65.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.883 -0.599 . . . . 0.52000000000000002 111.222 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.14 -30.58 12.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.885 0.374 . . . . 1.8799999999999999 110.625 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 20' ' ' THR . 51.5 mm -81.08 -61.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.927 0.394 . . . . 0.57999999999999996 110.789 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -85.77 -6.69 59.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.293 0.568 . . . . 1.74 110.383 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.706 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 1.3 m-80 55.39 40.44 31.38 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 114.944 -1.025 . . . . 1.9199999999999999 112.966 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -160.7 156.02 24.79 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.873 -0.418 . . . . 0.85999999999999999 109.873 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -80.82 142.29 33.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.141 -0.481 . . . . 0.77000000000000002 111.963 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.59 121.44 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.958 -1.127 . . . . 1.04 107.958 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.23 -41.53 40.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.799 0.666 . . . . 1.1200000000000001 112.799 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -123.17 122.47 38.51 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.073 0.463 . . . . 1.1799999999999999 111.305 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -149.31 139.15 21.91 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.578 -0.897 . . . . 0.80000000000000004 108.578 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.477 ' HB3' HG13 ' A' ' 36' ' ' ILE . 5.8 t70 -62.78 123.74 80.71 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 123.516 0.51 . . . . 0.80000000000000004 110.95 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.2 -13.25 23.38 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.775 2.316 . . . . 0.56000000000000005 113.099 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.2 3.11 56.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.839 0.352 . . . . 1.21 111.352 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.477 HG13 ' HB3' ' A' ' 33' ' ' ASP . 58.3 mt -83.01 130.84 35.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 110.038 -0.356 . . . . 1.1499999999999999 110.038 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 16.9 tt0 -128.57 82.88 2.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.748 -0.66 . . . . 0.81000000000000005 109.435 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -111.47 171.7 7.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.095 -0.502 . . . . 1.29 111.272 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.0 141.66 48.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.989 -0.55 . . . . 1.1699999999999999 109.871 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -126.34 133.43 51.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.106 -0.331 . . . . 0.97999999999999998 110.106 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -107.62 119.7 40.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.951 0.405 . . . . 0.69999999999999996 110.741 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -130.31 132.19 45.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.976 -0.556 . . . . 1.78 109.988 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.504 ' NE2' ' H ' ' A' ' 43' ' ' GLN . 1.4 pm0 -101.93 123.75 46.37 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.195 0.521 . . . . 2.3900000000000001 110.443 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.3 t -130.31 143.37 41.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.013 -0.54 . . . . 1.3799999999999999 109.622 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.51 66.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.178 0.513 . . . . 0.65000000000000002 110.448 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.8 mt -74.2 124.64 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.55 -0.75 . . . . 1.47 110.774 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.41 ' HB2' HH12 ' A' ' 164' ' ' ARG . 0.8 OUTLIER 67.96 17.67 9.58 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.697 -0.683 . . . . 0.96999999999999997 110.975 -179.623 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.02 7.18 81.04 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.472 -0.871 . . . . 0.59999999999999998 112.394 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -116.6 131.45 56.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.764 0.316 . . . . 1.4099999999999999 110.42 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 m -68.15 109.84 3.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.961 0.41 . . . . 0.89000000000000001 110.934 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.2 m -112.65 130.02 56.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.27 -0.423 . . . . 1.3100000000000001 111.004 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.0 tp -97.84 107.3 19.76 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.497 -0.927 . . . . 0.85999999999999999 108.497 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -91.13 120.48 32.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.453 0.538 . . . . 1.1299999999999999 112.453 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -105.85 98.24 7.95 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.873 -1.158 . . . . 1.03 107.873 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 49.8 mt -106.02 134.33 47.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.932 0.396 . . . . 1.1799999999999999 111.932 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.505 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 37.5 tp -109.0 123.9 49.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.671 -0.695 . . . . 0.75 110.431 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 4.0 t70 -88.27 93.04 9.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.948 -0.76 . . . . 0.44 108.948 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.1 p -61.05 146.48 47.06 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.265 0.555 . . . . 0.84999999999999998 111.78 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.76 -73.2 0.47 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.771 -0.65 . . . . 1.04 109.953 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.29 -42.67 0.11 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.255 -0.738 . . . . 0.71999999999999997 111.255 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 61' ' ' GLN . 12.7 mm-40 -133.95 155.03 50.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.711 0.291 . . . . 1.5 110.311 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.467 ' OE1' ' HE2' ' A' ' 67' ' ' MET . 1.6 tm-20 -119.99 154.05 35.09 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.019 -0.537 . . . . 1.5700000000000001 109.783 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.22 -34.27 75.93 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.152 -0.684 . . . . 1.3799999999999999 109.152 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -130.38 127.19 38.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.554 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 m -57.57 -29.03 64.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.172 -0.467 . . . . 0.90000000000000002 111.09 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.66 -37.53 76.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.976 0.417 . . . . 0.35999999999999999 110.812 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.467 ' HE2' ' OE1' ' A' ' 62' ' ' GLU . 6.9 mtp -71.07 -30.91 67.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.936 -0.574 . . . . 1.04 110.143 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -69.77 -51.18 36.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.312 0.577 . . . . 1.0700000000000001 109.671 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -65.87 -20.77 66.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.546 -0.752 . . . . 1.4099999999999999 110.779 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -57.76 -57.77 11.28 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.077 -0.51 . . . . 1.77 111.144 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.422 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 10.9 p90 -70.77 -20.28 62.63 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.552 -0.459 . . . . 1.27 110.77 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 90.9 mtp -75.24 -27.17 59.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.058 0.456 . . . . 1.28 110.071 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.5 mtm105 -82.25 -41.09 20.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.014 0.435 . . . . 1.8600000000000001 109.928 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.422 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 9.7 p -75.78 -12.65 60.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.956 -0.565 . . . . 1.01 111.384 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.34 129.0 11.0 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.926 -0.654 . . . . 0.20000000000000001 112.312 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -87.46 -46.45 9.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.021 0.438 . . . . 0.54000000000000004 110.094 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.69 143.9 14.73 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.135 -0.786 . . . . 0.31 111.135 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.488 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 75.3 m-85 -121.56 135.74 54.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.085 0.469 . . . . 0.60999999999999999 111.557 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.3 tp -97.25 106.78 19.16 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.101 -0.703 . . . . 1.04 109.101 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 111' ' ' MET . 0.1 OUTLIER -78.71 85.68 4.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.065 0.459 . . . . 1.1799999999999999 110.312 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.63 132.88 34.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.135 0.493 . . . . 1.03 111.824 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.459 ' HB3' HD11 ' A' ' 93' ' ' ILE . 29.2 p90 -144.63 169.15 18.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.459 -0.792 . . . . 0.41999999999999998 108.908 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.74 124.05 49.96 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.897 -0.321 . . . . 0.76000000000000001 110.628 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 118' ' ' CYS . 3.4 pt -71.9 -4.9 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.197 0.522 . . . . 1.1499999999999999 111.054 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.518 ' OD1' ' HD2' ' A' ' 117' ' ' LYS . 8.7 p-10 -106.4 14.63 27.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.071 -0.513 . . . . 0.93999999999999995 109.847 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -152.54 100.47 2.57 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.815 -0.63 . . . . 1.3799999999999999 110.479 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.48 -29.2 68.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.636 . . . . 0.75 112.558 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -58.23 -35.97 72.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.757 0.313 . . . . 1.4199999999999999 111.385 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.3 p -80.19 -33.78 37.95 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.762 0.315 . . . . 0.71999999999999997 110.778 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -68.96 -41.73 77.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.51000000000000001 110.844 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.63 -18.58 62.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.186 -0.461 . . . . 1.4399999999999999 111.167 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -81.78 -18.66 43.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.904 0.383 . . . . 1.02 110.402 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.459 HD11 ' HB3' ' A' ' 82' ' ' PHE . 27.8 mm -57.79 -30.69 38.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.563 -0.744 . . . . 1.04 110.834 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -63.05 -47.38 83.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.978 -0.556 . . . . 1.0900000000000001 110.465 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -66.51 -39.37 88.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.89 -0.595 . . . . 0.98999999999999999 111.547 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -59.99 -45.71 91.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.642 0.258 . . . . 1.73 110.681 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.429 ' HG2' ' CE1' ' A' ' 137' ' ' TYR . 18.8 tpt180 -58.63 -49.62 76.82 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.084 -0.507 . . . . 0.66000000000000003 110.282 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -60.73 -39.33 88.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.842 -0.617 . . . . 1.3500000000000001 110.903 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.412 ' O ' HG21 ' A' ' 103' ' ' VAL . 35.4 tp60 -62.24 -53.13 59.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.56 -0.291 . . . . 1.3999999999999999 110.896 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.7 mt -59.22 -42.07 85.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.465 -0.334 . . . . 0.78000000000000003 111.015 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -66.08 -26.03 67.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.471 -0.331 . . . . 1.6000000000000001 111.621 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -87.01 -35.84 18.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.004 0.431 . . . . 1.0900000000000001 110.554 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.412 HG21 ' O ' ' A' ' 99' ' ' GLN . 62.2 t -70.35 -46.92 69.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.817 -0.629 . . . . 0.89000000000000001 111.328 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -87.09 -18.52 30.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.329 . . . . 1.3500000000000001 110.733 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t70 54.6 54.53 9.13 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.306 -0.861 . . . . 0.46999999999999997 111.055 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.3 m -137.31 146.63 44.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.961 -0.563 . . . . 1.4399999999999999 109.877 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.24 -42.9 20.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.001 0.429 . . . . 1.74 110.039 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -93.68 106.74 18.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.857 -0.61 . . . . 0.78000000000000003 110.349 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.48 119.24 29.43 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.938 -0.393 . . . . 0.63 109.938 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.92 103.7 0.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.329 2.019 . . . . 0.29999999999999999 111.275 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.522 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 85.9 mtp -138.07 151.34 47.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.204 -0.453 . . . . 1.1899999999999999 110.399 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.7 t -129.55 121.76 53.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.503 -0.554 . . . . 0.63 109.503 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.6 tp -76.82 117.65 18.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.346 -0.613 . . . . 0.66000000000000003 109.346 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.2 t -117.82 114.99 47.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.0 -0.546 . . . . 1.3700000000000001 112.069 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.55 96.43 1.89 Allowed Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.049 -1.221 . . . . 0.27000000000000002 110.049 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -80.67 162.77 24.02 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.775 0.287 . . . . 0.23999999999999999 111.775 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.518 ' HD2' ' OD1' ' A' ' 85' ' ' ASN . 41.7 mttt 71.39 41.27 0.76 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.382 -0.826 . . . . 1.1499999999999999 111.516 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.429 ' HA ' ' CD1' ' A' ' 84' ' ' ILE . 29.6 p -75.17 -19.36 59.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.944 0.402 . . . . 1.29 111.449 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -89.24 -7.55 55.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.966 0.412 . . . . 0.69999999999999996 111.045 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 51.4 mt -91.56 145.68 31.74 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.256 -0.429 . . . . 1.3100000000000001 110.859 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.63 -170.65 0.86 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.567 2.178 . . . . 0.79000000000000004 112.047 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.2 m 58.78 44.85 16.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.134 -0.485 . . . . 1.29 111.544 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -72.24 118.22 14.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.68000000000000005 110.197 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.49 -17.64 15.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.964 0.411 . . . . 1.28 111.603 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.72 115.52 49.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.07 -0.514 . . . . 0.96999999999999997 110.779 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.74 148.23 42.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 1.6899999999999999 110.59 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.6 m -59.55 -33.71 71.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.823 -0.626 . . . . 1.6499999999999999 111.281 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -64.72 -44.33 90.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.695 -0.23 . . . . 0.71999999999999997 110.673 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -41.44 93.88 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.074 0.464 . . . . 1.1100000000000001 110.655 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.41 -48.33 67.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.594 -0.73 . . . . 0.35999999999999999 110.561 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -62.03 -35.39 78.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.173 0.511 . . . . 0.5 110.382 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -48.92 79.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.812 -0.631 . . . . 1.1799999999999999 110.578 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.32 -41.24 85.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.101 -0.499 . . . . 0.81000000000000005 111.041 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.09 -44.91 83.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.951 0.405 . . . . 0.66000000000000003 111.204 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -69.03 -25.17 64.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 2.0699999999999998 110.899 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.0 m -71.5 -26.74 62.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.151 0.5 . . . . 1.28 110.241 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.429 ' CE1' ' HG2' ' A' ' 97' ' ' ARG . 19.1 m-85 -93.11 -33.3 14.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.245 0.545 . . . . 1.0900000000000001 110.41 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.4 30.11 7.11 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.752 -0.939 . . . . 0.33000000000000002 110.752 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.1 pt -123.55 156.89 63.72 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.283 -0.459 . . . . 1.04 110.486 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.4 157.37 29.19 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.192 1.928 . . . . 0.69999999999999996 112.578 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -132.05 132.11 43.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.928 -0.578 . . . . 0.45000000000000001 110.334 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 63.5 mt -137.81 130.76 41.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.85999999999999999 111.174 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -81.8 128.15 33.71 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.389 -0.967 . . . . 0.88 108.389 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 64.2 p -131.86 174.73 9.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.272 0.558 . . . . 0.76000000000000001 112.236 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.7 t -150.6 134.09 16.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.275 -0.875 . . . . 0.35999999999999999 109.109 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.7 -6.88 59.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.127 0.489 . . . . 0.55000000000000004 110.407 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -91.39 -48.24 7.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.008 -0.542 . . . . 1.8300000000000001 110.912 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.0 p -94.22 -17.62 22.51 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.591 -0.277 . . . . 0.73999999999999999 111.122 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 67.04 23.12 9.8 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.773 0.671 . . . . 2.0800000000000001 110.86 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 144' ' ' THR . 35.2 tt0 -71.42 119.75 16.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.9 -0.591 . . . . 1.04 111.113 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.05 -8.87 42.17 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.923 -0.58 . . . . 0.66000000000000003 114.028 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.38 -49.02 85.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 117.143 0.471 . . . . 1.0700000000000001 111.14 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.37 -48.35 79.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.098 0.475 . . . . 1.6200000000000001 110.148 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.0 -47.47 84.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.431 -0.804 . . . . 1.0 111.583 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -54.73 -50.41 68.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.679 0.276 . . . . 0.46000000000000002 111.7 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.442 ' O ' HG22 ' A' ' 160' ' ' VAL . 26.6 m-85 -62.71 -42.68 99.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.346 -0.388 . . . . 2.1000000000000001 111.578 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -70.22 -35.54 73.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.702 -0.226 . . . . 1.55 111.202 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 39.2 m -64.1 -39.45 94.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.803 0.335 . . . . 0.39000000000000001 110.304 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 25.2 tp -61.64 -37.18 83.06 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.163 -0.471 . . . . 0.90000000000000002 110.394 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 156' ' ' PHE . 21.2 t -64.08 -38.37 82.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.278 0.561 . . . . 0.97999999999999998 109.778 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.6 mtt85 -70.49 -34.3 72.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.8 -0.636 . . . . 1.0700000000000001 110.134 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -59.95 -40.43 88.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.802 -0.636 . . . . 0.72999999999999998 109.96 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 65.4 mt -68.11 -45.2 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.501 -0.772 . . . . 0.84999999999999998 110.268 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.465 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 93.4 mtt180 -54.23 -42.18 69.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.678 -0.692 . . . . 0.98999999999999999 111.043 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -63.26 -36.95 85.36 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 115.796 -0.638 . . . . 1.55 111.135 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -69.69 -26.35 64.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.181 0.515 . . . . 0.84999999999999998 110.411 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -82.82 -34.98 26.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.944 -0.571 . . . . 1.73 110.893 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 8.7 pt-20 -95.96 16.62 17.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.376 -0.375 . . . . 1.1200000000000001 110.566 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.3 tttp . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.22 -0.895 . . . . 1.8799999999999999 110.32 -179.855 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.526 " O5'" " H2'" ' A' ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' QPD . . . . . 0.505 ' N1 ' ' HB2' ' A' ' 56' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 50' ' ' THR . 31.8 ttm . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.967 0.413 . . . . 1.8899999999999999 110.254 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.2 m -92.73 137.62 32.21 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.431 -0.349 . . . . 1.24 110.965 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -91.13 132.16 36.24 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.619 -0.511 . . . . 1.27 109.619 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -115.26 121.51 43.12 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.138 -0.319 . . . . 1.45 110.138 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -96.53 108.22 20.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.241 0.543 . . . . 1.1799999999999999 110.988 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.8 mp -112.29 142.35 44.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.71 -0.677 . . . . 2.1099999999999999 111.2 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.2 t -128.74 130.01 68.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.866 -0.607 . . . . 1.28 110.677 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.6 t -95.89 114.04 31.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.92 -0.582 . . . . 0.77000000000000002 109.519 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -115.82 136.62 52.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.428 0.633 . . . . 0.94999999999999996 111.425 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.2 176.08 45.0 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.43 -0.805 . . . . 0.56000000000000005 111.589 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.566 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -71.83 167.73 19.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.864 0.364 . . . . 0.66000000000000003 110.114 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.3 128.31 11.48 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.496 -0.859 . . . . 0.80000000000000004 112.765 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.99 10.95 59.34 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.71 -0.757 . . . . 0.45000000000000001 113.744 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 11' ' ' ALA . 27.2 m -85.94 -1.86 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 117.696 0.748 . . . . 0.98999999999999999 111.357 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.502 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 92.46 29.59 10.89 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.954 -0.641 . . . . 0.48999999999999999 113.371 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -60.59 -45.61 93.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.802 0.301 . . . . 1.3799999999999999 111.518 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.599 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 1.3 m -75.63 -20.3 58.6 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.874 0.324 . . . . 0.85999999999999999 111.874 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.15 -40.6 64.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.868 0.366 . . . . 0.95999999999999996 110.733 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 37.8 mt -64.57 -27.58 69.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.864 -0.607 . . . . 1.21 110.616 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -74.24 -54.06 8.49 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.033 -0.53 . . . . 1.2 111.351 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.6 mt -61.13 -38.67 80.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.778 0.323 . . . . 1.3799999999999999 111.433 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.618 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 2.5 mm-40 -66.85 -23.82 66.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.009 0.433 . . . . 0.52000000000000002 111.194 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.2 tp -95.08 -40.73 9.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.74 0.305 . . . . 1.8799999999999999 111.54 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 20' ' ' THR . 46.9 mm -74.61 -55.35 12.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.164 -0.471 . . . . 0.57999999999999996 112.232 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 50.9 mt-30 -100.86 -11.64 19.65 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.945 0.35 . . . . 1.74 111.945 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.618 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 70.2 m-20 71.23 17.64 5.92 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.362 0.875 . . . . 1.9199999999999999 113.362 178.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -128.73 128.65 44.45 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.474 -0.49 . . . . 0.85999999999999999 110.548 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -75.48 127.28 32.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.064 -0.971 . . . . 0.77000000000000002 110.959 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.6 t -99.04 136.58 29.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.918 -0.583 . . . . 1.04 109.482 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -83.47 -30.5 27.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.502 -0.317 . . . . 1.1200000000000001 111.778 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -134.84 116.3 14.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.902 0.382 . . . . 1.1799999999999999 111.248 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -141.76 146.31 35.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.848 -0.614 . . . . 0.80000000000000004 109.516 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.33 121.3 73.96 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.052 0.453 . . . . 0.80000000000000004 111.357 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.43 -18.35 15.83 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.55 2.167 . . . . 0.56000000000000005 112.865 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.07 3.32 52.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.261 -0.427 . . . . 1.21 111.208 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 mt -83.92 125.35 40.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.234 0.54 . . . . 1.1499999999999999 111.321 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 18.4 tt0 -125.3 83.41 2.16 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.905 -1.146 . . . . 0.81000000000000005 107.905 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -113.62 162.17 16.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.789 -0.641 . . . . 1.29 111.956 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.74 142.94 26.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.289 -0.869 . . . . 1.1699999999999999 111.652 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -134.97 135.75 41.68 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.053 -0.351 . . . . 0.97999999999999998 110.053 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 1.1 mpp_? -119.2 139.57 51.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.912 0.387 . . . . 0.69999999999999996 110.565 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -143.04 131.33 22.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.1 -0.5 . . . . 1.78 110.302 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -101.7 112.27 24.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.985 0.421 . . . . 2.3900000000000001 110.313 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.95 149.87 30.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.136 -0.484 . . . . 1.3799999999999999 110.968 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.3 t -92.49 93.17 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.947 -0.761 . . . . 0.65000000000000002 108.947 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.3 mt -91.51 114.05 28.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.049 -0.523 . . . . 1.47 111.805 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.497 ' HB2' HH12 ' A' ' 164' ' ' ARG . 56.5 m-20 58.26 37.78 26.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.662 -0.699 . . . . 0.96999999999999997 111.099 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.5 -5.01 84.83 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.086 -0.578 . . . . 0.59999999999999998 113.347 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -108.93 115.61 30.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.878 0.37 . . . . 1.4099999999999999 111.759 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -70.22 116.92 11.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 0.89000000000000001 109.768 178.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.3 m -129.89 151.64 50.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.084 0.469 . . . . 1.3100000000000001 111.72 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.9 tp -104.25 113.45 27.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.001 -0.74 . . . . 0.85999999999999999 109.001 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 53.7 mt -82.39 125.62 31.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.896 -0.593 . . . . 1.1299999999999999 112.027 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -110.41 88.73 2.84 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.106 -1.072 . . . . 1.03 108.106 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.0 mt -99.81 130.58 48.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.96 -0.564 . . . . 1.1799999999999999 111.871 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.456 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 22.7 tp -116.36 107.02 14.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.996 -0.547 . . . . 0.75 109.782 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -75.32 116.16 15.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.876 -0.602 . . . . 0.44 110.267 -179.633 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.7 p -73.45 156.32 38.38 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.515 0.674 . . . . 0.84999999999999998 112.168 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.4 -55.78 2.38 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.79 -1.095 . . . . 1.04 109.949 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.28 -87.46 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.843 -0.617 . . . . 0.71999999999999997 111.957 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -122.91 127.88 49.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.974 -0.38 . . . . 1.5 109.974 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -87.72 -173.73 4.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.271 -0.422 . . . . 1.5700000000000001 111.094 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.13 -47.7 81.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 1.3799999999999999 111.07 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -123.2 148.67 45.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.72 0.295 . . . . 1.0 110.521 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -60.91 -34.35 74.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.088 -0.506 . . . . 0.90000000000000002 110.652 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.76 -28.87 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.891 -0.595 . . . . 0.35999999999999999 111.362 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 86.0 mtp -70.05 -44.61 68.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.228 0.537 . . . . 1.04 109.847 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 71' ' ' TYR . 17.0 ttp180 -65.92 -39.0 90.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.538 -0.755 . . . . 1.0700000000000001 109.91 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -77.79 -5.22 50.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.584 -0.735 . . . . 1.4099999999999999 110.842 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -73.7 -62.86 1.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.661 -0.245 . . . . 1.77 111.642 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 68' ' ' ARG . 1.3 p90 -67.22 -17.83 64.98 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 120.606 0.241 . . . . 1.27 111.047 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.3 mtt -73.51 -17.43 61.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.225 0.536 . . . . 1.28 109.665 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -90.48 -49.77 6.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.557 -0.747 . . . . 1.8600000000000001 110.187 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.15 -12.0 60.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 1.01 112.145 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.47 132.49 38.4 Favored Glycine 0 C--O 1.237 0.344 0 C-N-CA 121.123 -0.56 . . . . 0.20000000000000001 113.18 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -97.96 -36.32 10.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 0.54000000000000004 110.81 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -133.17 128.89 5.23 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.022 -0.831 . . . . 0.31 111.022 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.437 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 91.6 m-85 -114.99 116.85 29.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.244 0.545 . . . . 0.60999999999999999 110.88 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.8 tp -88.8 109.19 19.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.54 -0.755 . . . . 1.04 109.908 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.5 m -82.53 103.54 12.14 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.356 0.41 . . . . 1.1799999999999999 109.959 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.07 129.61 60.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.981 0.419 . . . . 1.03 112.084 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -136.6 162.3 33.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.652 -0.704 . . . . 0.41999999999999998 109.674 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.427 ' HB2' ' OD1' ' A' ' 85' ' ' ASN . . . -100.95 126.76 47.62 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.365 -0.235 . . . . 0.76000000000000001 110.365 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.1 pt -71.13 -12.16 15.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.948 0.404 . . . . 1.1499999999999999 111.375 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.427 ' OD1' ' HB2' ' A' ' 83' ' ' ALA . 10.1 p-10 -95.23 5.79 50.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.826 -0.625 . . . . 0.93999999999999995 110.75 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -148.43 111.73 4.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.072 0.463 . . . . 1.3799999999999999 110.542 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.27 -26.96 66.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.1 -0.5 . . . . 0.75 111.938 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -58.35 -37.85 76.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 1.4199999999999999 110.646 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.42 ' O ' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -67.55 -38.15 83.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.378 -0.373 . . . . 0.71999999999999997 110.796 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -66.67 -39.86 88.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.176 0.512 . . . . 0.51000000000000001 110.068 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.53 -35.08 79.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.87 -0.604 . . . . 1.4399999999999999 110.635 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -63.45 -32.8 74.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.901 -0.591 . . . . 1.02 110.932 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 89' ' ' SER . 45.7 mm -57.87 -31.55 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.586 . . . . 1.04 111.031 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -62.71 -35.92 81.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.126 0.489 . . . . 1.0900000000000001 110.348 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -82.19 -38.5 24.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.98999999999999999 110.104 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -58.69 -48.68 80.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.283 -0.417 . . . . 1.73 111.204 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -56.37 -51.78 67.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.958 -0.565 . . . . 0.66000000000000003 110.919 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -39.89 95.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.032 -0.531 . . . . 1.3500000000000001 111.061 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -59.36 -55.24 37.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.947 -0.57 . . . . 1.3999999999999999 111.117 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.97 -37.76 79.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.435 -0.348 . . . . 0.78000000000000003 110.755 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -61.09 -32.6 72.26 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.974 0.416 . . . . 1.6000000000000001 110.026 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -77.46 -45.32 26.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.893 -0.594 . . . . 1.0900000000000001 110.643 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 66.4 t -59.93 -47.64 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.191 -0.459 . . . . 0.89000000000000001 111.71 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -83.68 -13.32 54.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.451 -0.34 . . . . 1.3500000000000001 110.541 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 t70 54.91 48.56 19.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.622 -0.717 . . . . 0.46999999999999997 109.854 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.8 m -132.61 143.65 49.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.363 -0.835 . . . . 1.4399999999999999 110.314 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.18 -31.06 30.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.1 0.476 . . . . 1.74 110.368 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -119.41 112.35 19.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.96 -0.564 . . . . 0.78000000000000003 110.135 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.21 122.54 24.13 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.695 -0.483 . . . . 0.63 109.695 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -49.69 107.52 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.171 2.581 . . . . 0.29999999999999999 111.982 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.437 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 56.5 mtt -140.04 150.2 44.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.952 -0.567 . . . . 1.1899999999999999 110.719 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.4 t -132.46 121.81 46.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.665 -0.865 . . . . 0.63 108.665 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.626 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 56.3 tp -89.31 125.13 34.98 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.641 -0.503 . . . . 0.66000000000000003 109.641 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.7 129.13 54.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.354 0.597 . . . . 1.3700000000000001 111.861 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -94.5 103.86 3.07 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.224 -1.15 . . . . 0.27000000000000002 110.224 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -81.51 164.52 21.92 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.576 -0.157 . . . . 0.23999999999999999 110.576 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 69.7 mttt 66.97 36.93 4.06 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.733 0.646 . . . . 1.1499999999999999 110.459 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 31.9 p -67.68 -13.63 62.26 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.24 -0.436 . . . . 1.29 111.957 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -89.53 -8.77 52.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.428 -0.351 . . . . 0.69999999999999996 110.936 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 16.3 mt -77.63 130.25 74.35 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.561 0.22 . . . . 1.3100000000000001 110.976 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 11.2 Cg_exo -69.5 171.88 13.39 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.885 2.39 . . . . 0.79000000000000004 112.081 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.8 m 61.57 54.55 3.01 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.393 0.616 . . . . 1.29 110.573 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -64.64 127.41 31.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.381 -0.827 . . . . 0.68000000000000005 111.206 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.14 -41.22 7.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.074 -0.512 . . . . 1.28 110.512 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.3 t -88.96 113.32 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.222 -0.445 . . . . 0.96999999999999997 110.295 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.06 147.61 49.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 1.6899999999999999 110.878 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -46.85 87.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 1.6499999999999999 111.848 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.6 tttm -65.22 -35.69 81.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.61 -0.268 . . . . 0.71999999999999997 110.621 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -59.27 -44.34 92.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 1.1100000000000001 110.881 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.56 -40.04 66.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 0.35999999999999999 110.929 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.8 -34.42 78.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.761 -0.654 . . . . 0.5 110.953 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -40.82 98.46 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.789 -0.641 . . . . 1.1799999999999999 110.226 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 27.8 tp -69.84 -42.07 74.07 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.872 -0.604 . . . . 0.81000000000000005 109.547 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 139' ' ' ILE . . . -58.69 -45.47 89.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.302 -0.863 . . . . 0.66000000000000003 110.423 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -59.07 -45.69 90.17 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.858 -0.61 . . . . 2.0699999999999998 110.683 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.2 m -65.42 -35.08 79.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.945 -0.571 . . . . 1.28 111.301 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -79.02 -22.42 45.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.235 -0.439 . . . . 1.0900000000000001 110.944 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.62 26.61 38.1 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.911 -0.661 . . . . 0.33000000000000002 111.45 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 34.7 pt -124.16 156.17 66.84 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 110.094 -0.335 . . . . 1.04 110.094 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -84.59 155.12 12.04 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.153 1.902 . . . . 0.69999999999999996 112.859 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.626 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 19.0 t80 -130.93 127.03 37.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.918 -0.583 . . . . 0.45000000000000001 110.549 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.9 mt -130.53 139.36 51.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.132 -0.485 . . . . 0.85999999999999999 110.034 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -78.32 137.96 38.32 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.288 -1.005 . . . . 0.88 108.288 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.7 p -139.03 162.02 35.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.519 0.933 . . . . 0.76000000000000001 113.519 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.6 t -155.09 117.25 4.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.687 -1.142 . . . . 0.35999999999999999 108.559 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.87 -11.3 60.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.55000000000000004 111.478 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -84.5 -42.84 15.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.278 -0.419 . . . . 1.8300000000000001 111.439 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.5 p -96.55 -5.56 39.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.696 -0.229 . . . . 0.73999999999999999 111.525 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 38.4 ttt85 59.75 47.66 10.1 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.611 0.719 . . . . 2.0800000000000001 109.829 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -113.31 125.57 54.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.544 -0.753 . . . . 1.04 111.158 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.78 -21.83 3.7 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.802 -0.636 . . . . 0.66000000000000003 113.303 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.17 -46.49 88.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.802 0.334 . . . . 1.0700000000000001 111.654 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.454 ' O ' ' HD2' ' A' ' 157' ' ' TYR . 21.4 t70 -62.0 -49.24 76.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.495 . . . . 1.6200000000000001 110.096 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -39.02 86.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.223 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -58.97 -52.05 67.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.222 -0.445 . . . . 0.46000000000000002 111.94 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -62.58 -41.58 99.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.633 -0.258 . . . . 2.1000000000000001 111.562 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.454 ' HD2' ' O ' ' A' ' 153' ' ' ASP . 29.0 m-85 -66.96 -34.63 78.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 1.55 110.807 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 99.5 m -68.42 -45.61 72.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.319 -0.4 . . . . 0.39000000000000001 110.92 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.46 ' O ' HG13 ' A' ' 163' ' ' ILE . 31.0 tp -55.96 -41.79 75.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.361 -0.381 . . . . 0.90000000000000002 111.052 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.88 -43.47 98.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.322 -0.399 . . . . 0.97999999999999998 110.901 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -65.22 -34.22 77.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.444 -0.344 . . . . 1.0700000000000001 111.011 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -64.05 -44.82 91.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.72999999999999998 110.232 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 159' ' ' LEU . 17.2 mt -62.54 -43.9 98.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.086 0.469 . . . . 0.84999999999999998 110.072 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.497 HH12 ' HB2' ' A' ' 47' ' ' ASP . 93.9 mtt180 -59.15 -42.78 91.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.42 -0.809 . . . . 0.98999999999999999 111.371 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -66.08 -30.57 71.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.218 -0.446 . . . . 1.55 111.191 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -79.73 -26.06 40.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.256 -0.429 . . . . 0.84999999999999998 110.213 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -77.08 -33.66 57.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.594 -0.275 . . . . 1.73 110.408 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -87.04 4.0 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 1.1200000000000001 110.871 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.2 tptt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.367 -0.825 . . . . 1.8799999999999999 110.848 -179.616 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.599 ' O2A' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' QPD . . . . . 0.456 ' N1 ' ' HB2' ' A' ' 56' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttm . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 121.17 0.51 . . . . 1.8899999999999999 110.371 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.0 m -76.38 126.84 31.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.133 -0.485 . . . . 1.24 110.712 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -94.14 134.67 36.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.133 -0.485 . . . . 1.27 110.253 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -122.49 128.08 50.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.375 -0.375 . . . . 1.45 110.279 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -99.58 108.82 21.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.269 -0.423 . . . . 1.1799999999999999 109.921 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.59 148.94 47.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.394 0.616 . . . . 2.1099999999999999 110.981 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.13 132.03 70.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.924 -0.58 . . . . 1.28 110.862 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.4 t -91.24 119.19 38.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.035 -0.728 . . . . 0.77000000000000002 109.035 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.7 m -116.65 157.83 17.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.829 0.347 . . . . 0.94999999999999996 111.297 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.83 176.27 32.76 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.714 -0.954 . . . . 0.56000000000000005 110.714 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.68 172.63 11.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.974 0.416 . . . . 0.66000000000000003 111.415 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.91 121.19 5.67 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.697 -0.763 . . . . 0.80000000000000004 112.189 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.71 3.03 55.26 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.821 -0.704 . . . . 0.45000000000000001 113.245 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.81 -29.09 28.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 117.391 0.596 . . . . 0.98999999999999999 111.098 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.647 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 115.85 19.97 5.47 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.144 -1.027 . . . . 0.48999999999999999 114.406 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -53.05 -53.58 48.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.468 0.634 . . . . 1.3799999999999999 111.86 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -34.99 75.64 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.322 -0.399 . . . . 0.85999999999999999 111.959 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.63 -40.62 88.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.5 -0.318 . . . . 0.95999999999999996 111.278 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 23.5 mt -63.31 -39.05 93.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.375 -0.375 . . . . 1.21 110.88 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 m -66.14 -47.4 74.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.256 -0.429 . . . . 1.2 111.005 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.416 HG23 HD11 ' A' ' 21' ' ' ILE . 76.5 mt -65.59 -34.8 72.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 1.3799999999999999 111.26 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 2.3 mm-40 -69.97 -12.67 61.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.991 0.424 . . . . 0.52000000000000002 111.323 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.7 tp -102.29 -37.46 8.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.211 0.529 . . . . 1.8799999999999999 110.861 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.9 mm -80.53 -59.08 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.908 -0.587 . . . . 0.57999999999999996 111.425 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -89.92 -17.06 28.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.451 -0.34 . . . . 1.74 110.96 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 45.4 m-80 63.38 46.83 4.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.794 -0.639 . . . . 1.9199999999999999 112.282 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -153.71 143.79 22.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.576 -0.528 . . . . 0.85999999999999999 109.576 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -82.71 129.99 35.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.242 -0.435 . . . . 0.77000000000000002 111.972 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.33 120.02 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.657 -0.701 . . . . 1.04 109.512 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.6 -41.17 32.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.236 -0.438 . . . . 1.1200000000000001 111.888 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -115.6 108.97 17.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.181 0.515 . . . . 1.1799999999999999 111.698 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -142.3 144.07 33.09 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.93 -0.767 . . . . 0.80000000000000004 108.93 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -64.63 123.73 84.06 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.917 0.389 . . . . 0.80000000000000004 110.9 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.18 -15.29 14.54 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.549 2.166 . . . . 0.56000000000000005 113.386 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.44 3.16 56.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.674 0.273 . . . . 1.21 111.733 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.8 mt -86.0 127.46 40.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 120.849 0.357 . . . . 1.1499999999999999 110.462 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 11.3 tt0 -114.86 94.94 4.98 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.215 -1.032 . . . . 0.81000000000000005 108.215 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -115.47 164.18 14.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.01 -0.541 . . . . 1.29 110.918 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 1.2 p -130.06 129.84 44.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.776 -0.647 . . . . 1.1699999999999999 109.961 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -125.35 143.81 50.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.642 -0.254 . . . . 0.97999999999999998 110.947 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.682 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -113.2 143.06 45.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.69999999999999996 110.575 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -147.02 134.85 21.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.703 -0.681 . . . . 1.78 109.459 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -103.18 114.49 28.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.943 0.401 . . . . 2.3900000000000001 110.976 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 31.5 t -127.01 147.81 31.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.767 -0.652 . . . . 1.3799999999999999 110.432 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.61 101.24 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.728 -0.471 . . . . 0.65000000000000002 109.728 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 76.9 mt -105.96 118.1 52.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.963 0.411 . . . . 1.47 111.249 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.51 ' HB2' HH12 ' A' ' 164' ' ' ARG . 86.6 m-20 61.77 30.85 18.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.007 -0.997 . . . . 0.96999999999999997 111.744 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.61 -0.21 73.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.855 -0.688 . . . . 0.59999999999999998 114.163 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -121.68 126.67 49.53 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.46 0.63 . . . . 1.4099999999999999 111.175 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.95 115.36 11.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.976 0.417 . . . . 0.89000000000000001 110.111 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.1 m -116.89 147.72 41.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.108 -0.496 . . . . 1.3100000000000001 111.576 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.9 tp -100.46 120.25 39.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.881 -0.599 . . . . 0.85999999999999999 109.394 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 16.7 mt -89.73 115.99 27.5 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.047 -0.524 . . . . 1.1299999999999999 112.128 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -104.31 95.18 5.77 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.53 -1.285 . . . . 1.03 107.53 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 39' ' ' SER . 6.1 mt -101.85 127.88 54.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.075 -0.511 . . . . 1.1799999999999999 112.367 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.406 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 42.0 tp -114.23 119.45 37.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.057 -0.52 . . . . 0.75 109.859 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 4.5 t70 -89.84 100.88 13.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.115 -0.493 . . . . 0.44 110.074 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.4 p -62.51 138.54 58.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.779 -0.646 . . . . 0.84999999999999998 112.597 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.54 -36.24 24.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.414 -0.812 . . . . 1.04 110.066 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.33 -74.9 0.42 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.964 -0.636 . . . . 0.71999999999999997 111.83 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -108.93 117.89 35.36 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.818 -0.438 . . . . 1.5 109.818 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.94 162.7 15.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.172 -0.467 . . . . 1.5700000000000001 110.432 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -55.56 -51.92 65.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.857 -0.61 . . . . 1.3799999999999999 111.188 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -127.07 148.27 50.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.635 -0.506 . . . . 1.0 109.635 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -35.04 76.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.693 0.282 . . . . 0.90000000000000002 111.361 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.94 -31.91 73.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 0.35999999999999999 111.222 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 85.0 mtp -74.17 -31.67 62.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.268 0.556 . . . . 1.04 109.823 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.498 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 34.9 ttp180 -74.33 -46.45 40.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.453 -0.794 . . . . 1.0700000000000001 109.906 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 39.2 m-20 -65.68 -24.45 67.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.409 -0.814 . . . . 1.4099999999999999 110.228 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -57.9 -56.7 18.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.349 -0.841 . . . . 1.77 111.559 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.498 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 31.1 p90 -72.4 -14.26 61.66 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.861 -0.336 . . . . 1.27 111.407 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.4 mtt -76.16 -28.78 57.5 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.451 -0.574 . . . . 1.28 109.451 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 30.2 mtm180 -83.64 -34.18 25.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.831 -0.622 . . . . 1.8600000000000001 111.163 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.422 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -78.91 -26.77 43.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.27 -0.423 . . . . 1.01 111.603 -179.399 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.82 125.76 28.47 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.038 -0.601 . . . . 0.20000000000000001 112.712 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -92.0 -26.05 18.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.681 -0.488 . . . . 0.54000000000000004 109.681 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -141.78 143.82 13.5 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 110.886 -0.886 . . . . 0.31 110.886 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.419 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 89.8 m-85 -126.8 132.43 51.03 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.229 0.538 . . . . 0.60999999999999999 111.255 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 tp -100.87 112.28 24.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.724 -0.671 . . . . 1.04 109.368 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.7 m -90.01 104.72 17.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.102 0.477 . . . . 1.1799999999999999 110.454 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.1 t -102.73 126.5 56.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.069 -0.514 . . . . 1.03 111.571 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -133.02 160.19 37.87 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.065 -0.717 . . . . 0.41999999999999998 109.065 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.85 128.2 48.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.811 0.338 . . . . 0.76000000000000001 110.492 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 pt -67.29 -14.2 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.367 . . . . 1.1499999999999999 111.828 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -100.85 6.48 43.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.926 0.393 . . . . 0.93999999999999995 110.397 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -135.67 103.32 5.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 1.3799999999999999 110.246 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -27.22 66.97 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.447 0.536 . . . . 0.75 112.447 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -66.88 -37.74 84.98 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.161 -0.216 . . . . 1.4199999999999999 111.123 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.423 ' O ' HG12 ' A' ' 93' ' ' ILE . 91.4 p -64.89 -36.87 85.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.425 . . . . 0.71999999999999997 110.024 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -69.67 -35.71 75.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.924 -0.58 . . . . 0.51000000000000001 109.955 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -65.62 -40.88 93.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.801 -0.636 . . . . 1.4399999999999999 110.471 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.53 -26.35 68.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.737 -0.665 . . . . 1.02 111.769 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 89' ' ' SER . 48.3 mm -57.93 -28.64 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.099 0.476 . . . . 1.04 110.73 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -66.66 -41.12 88.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.973 -0.558 . . . . 1.0900000000000001 110.68 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -77.71 -34.54 52.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.98999999999999999 110.832 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -59.13 -48.02 83.16 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.524 -0.307 . . . . 1.73 110.741 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -60.57 -46.41 90.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.96 -0.564 . . . . 0.66000000000000003 110.016 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -47.92 79.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.742 -0.663 . . . . 1.3500000000000001 111.528 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.538 ' O ' HG21 ' A' ' 103' ' ' VAL . 26.0 tt0 -59.3 -58.19 9.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 1.3999999999999999 112.111 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.33 -39.0 79.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 120.591 0.234 . . . . 0.78000000000000003 111.026 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -61.38 -35.86 78.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.951 0.405 . . . . 1.6000000000000001 110.457 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -73.64 -37.87 65.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.044 -0.525 . . . . 1.0900000000000001 110.972 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 99' ' ' GLN . 47.8 t -68.96 -40.83 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.89000000000000001 110.982 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -82.75 -20.15 36.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.485 -0.325 . . . . 1.3500000000000001 111.222 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 54.92 57.31 5.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.507 0.67 . . . . 0.46999999999999997 110.333 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -141.6 142.01 33.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.656 -0.702 . . . . 1.4399999999999999 109.761 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -75.54 -31.82 60.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.906 0.384 . . . . 1.74 110.004 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.4 123.96 49.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.968 -0.56 . . . . 0.78000000000000003 110.816 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.2 t -135.28 113.38 11.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.187 -0.671 . . . . 0.63 109.187 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.98 109.18 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.854 2.369 . . . . 0.29999999999999999 112.783 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.446 ' O ' ' HB ' ' A' ' 139' ' ' ILE . 30.9 mtt -139.33 152.98 47.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.964 -0.562 . . . . 1.1899999999999999 110.722 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 73.3 t -131.45 127.25 59.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.171 -0.677 . . . . 0.63 109.171 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.4 tp -84.84 118.87 24.75 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.606 -0.516 . . . . 0.66000000000000003 109.606 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 65.0 t -114.68 117.9 57.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.037 -0.529 . . . . 1.3700000000000001 112.008 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.29 93.25 1.49 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.549 -1.02 . . . . 0.27000000000000002 110.549 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -80.73 163.2 23.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.648 0.261 . . . . 0.23999999999999999 111.623 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.6 mttt 68.39 33.84 3.98 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.42 -0.809 . . . . 1.1499999999999999 111.233 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 20.9 p -68.05 -20.35 64.97 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 111.991 0.367 . . . . 1.29 111.991 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -86.54 -12.0 50.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.765 0.317 . . . . 0.69999999999999996 111.383 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.418 HD12 ' N2 ' ' A' ' 201' ' ' GDP . 17.5 mt -80.21 142.17 54.71 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.358 -0.383 . . . . 1.3100000000000001 110.737 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.05 174.14 12.48 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.382 2.055 . . . . 0.79000000000000004 111.431 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.6 m 66.15 60.28 0.65 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.352 0.596 . . . . 1.29 111.054 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.5 ttm-85 -75.54 104.89 6.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.736 -0.666 . . . . 0.68000000000000005 110.388 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 m -82.53 -36.84 25.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.093 -0.503 . . . . 1.28 111.045 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.0 t -97.39 111.0 26.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.22 -0.445 . . . . 0.96999999999999997 110.628 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -68.6 148.21 50.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.802 -0.636 . . . . 1.6899999999999999 110.135 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.2 m -57.62 -37.19 72.87 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.339 -0.391 . . . . 1.6499999999999999 111.607 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -63.95 -37.57 87.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.665 0.269 . . . . 0.71999999999999997 111.081 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -58.69 -45.89 88.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 1.1100000000000001 111.236 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.76 -41.33 62.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.85 -0.614 . . . . 0.35999999999999999 111.225 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -61.86 -39.48 92.04 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.031 0.443 . . . . 0.5 109.994 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.86 -46.66 89.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.776 -0.647 . . . . 1.1799999999999999 110.56 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.89 -39.54 90.74 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.785 -0.643 . . . . 0.81000000000000005 110.418 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.81 88.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.574 . . . . 0.66000000000000003 110.945 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -64.4 -38.89 92.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.573 -0.285 . . . . 2.0699999999999998 111.104 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.75 -23.71 62.48 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.094 0.473 . . . . 1.28 111.766 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -91.11 -19.12 23.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.145 -0.479 . . . . 1.0900000000000001 110.283 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.8 32.85 48.5 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.407 -0.677 . . . . 0.33000000000000002 111.407 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 111' ' ' MET . 36.6 pt -127.44 158.16 70.56 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.94 -0.393 . . . . 1.04 109.94 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.19 151.12 17.92 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.448 2.098 . . . . 0.69999999999999996 112.718 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -124.53 129.05 49.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.76 -0.655 . . . . 0.45000000000000001 109.757 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 67.0 mt -137.1 129.41 43.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.394 -0.366 . . . . 0.85999999999999999 111.316 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -85.26 133.74 34.15 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.973 -0.751 . . . . 0.88 108.973 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.4 p -138.84 179.94 6.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.541 0.686 . . . . 0.76000000000000001 111.953 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.5 t -155.46 135.92 13.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.017 -0.992 . . . . 0.35999999999999999 108.843 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.16 -7.4 58.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.064 0.459 . . . . 0.55000000000000004 111.291 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -94.78 -48.75 5.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.068 -0.514 . . . . 1.8300000000000001 111.117 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.9 p -92.71 -12.85 30.38 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 111.928 0.344 . . . . 0.73999999999999999 111.928 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 57.81 38.41 27.26 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.333 0.587 . . . . 2.0800000000000001 110.653 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -69.83 94.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.146 -0.934 . . . . 1.04 112.251 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 68.72 22.25 75.28 Favored Glycine 0 CA--C 1.516 0.153 0 CA-C-N 115.788 -0.642 . . . . 0.66000000000000003 114.561 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.43 -52.1 50.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 117.69 0.745 . . . . 1.0700000000000001 110.618 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.8 -40.59 80.28 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.027 -0.533 . . . . 1.6200000000000001 110.364 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -59.63 -49.57 77.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.251 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.28 84.96 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.099 0.476 . . . . 0.46000000000000002 110.998 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -63.5 -48.87 75.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.681 -0.69 . . . . 2.1000000000000001 111.058 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -67.57 -30.82 70.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.446 -0.343 . . . . 1.55 110.518 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 90.2 m -62.2 -40.84 97.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.39000000000000001 110.257 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 163' ' ' ILE . 51.2 tp -59.14 -42.01 89.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.397 -0.365 . . . . 0.90000000000000002 110.47 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 79.8 t -61.67 -39.74 84.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.97999999999999998 110.365 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -68.4 -33.85 74.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 1.0700000000000001 110.576 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -64.53 -40.89 96.44 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.299 -0.63 . . . . 0.72999999999999998 109.299 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 159' ' ' LEU . 70.2 mt -62.52 -43.9 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.62 -0.718 . . . . 0.84999999999999998 109.947 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.51 HH12 ' HB2' ' A' ' 47' ' ' ASP . 84.8 mtt180 -59.39 -43.94 92.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.905 -0.589 . . . . 0.98999999999999999 111.021 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.413 ' HA ' ' HG2' ' A' ' 168' ' ' GLU . 52.3 mtmt -62.04 -27.93 69.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.319 -0.4 . . . . 1.55 111.304 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -79.96 -35.36 37.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.013 0.435 . . . . 0.84999999999999998 110.616 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 163' ' ' ILE . 29.5 mtpt -77.6 -30.99 52.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.191 -0.459 . . . . 1.73 111.483 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 6.0 pt-20 -86.09 1.17 51.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.709 0.29 . . . . 1.1200000000000001 111.215 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 8.9 tttp . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.614 -0.708 . . . . 1.8799999999999999 110.576 -179.57 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.45 ' O1A' ' O1B' ' A' ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' QPD . . . . . 0.411 ' H19' ' N13' ' A' ' 203' ' ' QPD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttt . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.95 -0.389 . . . . 1.8899999999999999 109.95 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.7 127.07 32.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.908 -0.587 . . . . 1.24 111.796 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.82 122.43 46.75 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.853 -0.425 . . . . 1.27 109.853 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -122.65 130.79 53.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.479 -0.328 . . . . 1.45 111.023 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HZ3' ' CG ' ' A' ' 54' ' ' ASP . 15.2 mttp -92.19 123.0 35.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.006 -0.543 . . . . 1.1799999999999999 110.915 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 2.8 mp -119.48 133.57 55.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.451 -0.795 . . . . 2.1099999999999999 110.293 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.04 109.49 22.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.021 0.438 . . . . 1.28 110.301 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -76.42 125.68 36.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.287 -0.635 . . . . 0.77000000000000002 109.287 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.1 m -116.84 148.04 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.145 0.498 . . . . 0.94999999999999996 110.837 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.51 176.82 39.11 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.022 -0.831 . . . . 0.56000000000000005 111.022 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -81.08 156.85 25.61 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.017 0.437 . . . . 0.66000000000000003 111.392 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.31 102.7 0.76 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.796 -0.716 . . . . 0.80000000000000004 112.032 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.15 0.73 6.9 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.822 -0.704 . . . . 0.45000000000000001 112.792 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 11' ' ' ALA . 23.4 m -76.1 -19.4 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.828 0.347 . . . . 0.98999999999999999 110.781 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.582 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 104.76 25.47 6.85 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.483 -0.865 . . . . 0.48999999999999999 112.142 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -52.97 -50.96 63.07 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.255 0.465 . . . . 1.3799999999999999 112.255 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.531 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 2.4 m -64.36 -34.06 77.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.922 0.342 . . . . 0.85999999999999999 111.922 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.37 -34.31 75.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.712 -0.222 . . . . 0.95999999999999996 111.472 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 30.4 mt -59.42 -53.98 51.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.355 -0.384 . . . . 1.21 110.756 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.34 -39.61 85.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.779 -0.646 . . . . 1.2 110.991 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.2 mt -58.37 -38.47 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.953 -0.567 . . . . 1.3799999999999999 111.73 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -66.1 -37.56 86.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.928 0.394 . . . . 0.52000000000000002 111.501 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.0 tp -78.78 -32.31 46.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.208 -0.451 . . . . 1.8799999999999999 111.316 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 24' ' ' ILE . 48.9 mm -89.32 -52.96 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 113.068 0.766 . . . . 0.57999999999999996 113.068 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -87.1 -9.48 55.28 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.175 0.435 . . . . 1.74 112.175 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 65.25 21.41 12.05 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.202 0.445 . . . . 1.9199999999999999 112.202 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -159.98 146.97 16.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.804 0.335 . . . . 0.85999999999999999 110.302 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -77.18 145.62 37.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.706 -0.679 . . . . 0.77000000000000002 111.499 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.7 t -119.86 122.31 68.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.183 -0.673 . . . . 1.04 109.183 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -73.71 -50.65 19.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.036 -0.529 . . . . 1.1200000000000001 112.076 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -107.93 109.88 21.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.146 0.498 . . . . 1.1799999999999999 111.951 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -145.46 134.32 22.44 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.875 -0.787 . . . . 0.80000000000000004 108.875 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.01 126.62 90.49 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.009 -0.542 . . . . 0.80000000000000004 111.707 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.27 -19.74 19.45 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.545 2.164 . . . . 0.56000000000000005 112.111 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -16.02 56.25 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.008 -0.542 . . . . 1.21 111.739 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.43 116.96 24.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.382 0.611 . . . . 1.1499999999999999 111.12 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -112.02 117.52 32.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.076 -0.965 . . . . 0.81000000000000005 109.309 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -138.07 158.63 43.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.812 0.339 . . . . 1.29 111.326 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -106.6 127.14 53.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.855 -0.611 . . . . 1.1699999999999999 109.644 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -111.02 139.36 46.44 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.55 -0.295 . . . . 0.97999999999999998 110.791 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.593 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 0.2 OUTLIER -122.28 123.53 41.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.133 0.492 . . . . 0.69999999999999996 110.921 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -134.69 140.44 45.99 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.6 -0.518 . . . . 1.78 109.6 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -110.01 123.18 49.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.883 0.373 . . . . 2.3900000000000001 110.45 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.24 132.18 55.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.751 -0.463 . . . . 1.3799999999999999 109.751 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.1 t -84.04 91.97 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.875 -0.417 . . . . 0.65000000000000002 109.875 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.4 mt -103.23 133.09 48.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.8 -0.636 . . . . 1.47 110.263 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 60.32 27.35 16.9 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.925 -0.58 . . . . 0.96999999999999997 111.368 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.43 -0.15 88.26 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.184 -0.531 . . . . 0.59999999999999998 113.165 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -109.85 130.99 55.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.865 0.364 . . . . 1.4099999999999999 111.36 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.89 95.17 2.41 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.333 -0.617 . . . . 0.89000000000000001 109.333 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 59.7 m -101.19 133.76 45.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.48 0.657 . . . . 1.3100000000000001 111.467 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.6 tp -100.86 124.63 46.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.253 -0.885 . . . . 0.85999999999999999 109.325 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 1.3 mp -93.04 113.13 25.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.116 -0.493 . . . . 1.1299999999999999 111.706 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.593 ' OD1' ' HD2' ' A' ' 41' ' ' ARG . 14.8 t70 -105.3 93.41 4.67 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.154 -1.054 . . . . 1.03 108.154 177.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 13.6 mt -110.88 142.47 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.169 0.433 . . . . 1.1799999999999999 112.169 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.3 tp -119.93 122.14 40.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.541 . . . . 0.75 110.999 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -88.64 89.83 8.15 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.231 -0.655 . . . . 0.44 109.231 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.1 p -65.87 134.95 54.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.004 -0.544 . . . . 0.84999999999999998 111.725 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.93 -55.06 6.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.79 -0.641 . . . . 1.04 110.588 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.33 -76.52 0.17 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.442 -0.663 . . . . 0.71999999999999997 111.442 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -99.95 125.57 45.99 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.955 -0.387 . . . . 1.5 109.955 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -94.46 166.62 11.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.067 -0.515 . . . . 1.5700000000000001 110.659 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -58.28 -56.71 18.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.98 -0.554 . . . . 1.3799999999999999 110.012 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -116.02 144.79 43.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.909 -0.587 . . . . 1.0 109.609 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -31.44 72.64 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.534 -0.303 . . . . 0.90000000000000002 111.13 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.79 -27.89 69.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.35999999999999999 111.458 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 81.7 mtp -68.89 -30.68 69.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.19 -0.459 . . . . 1.04 109.937 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.634 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 24.6 ttp180 -65.6 -45.09 84.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.025 -0.534 . . . . 1.0700000000000001 109.672 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.513 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 67.3 m-20 -65.53 -30.55 71.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.469 -0.787 . . . . 1.4099999999999999 110.255 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -58.24 -58.94 6.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.732 -0.667 . . . . 1.77 111.636 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.634 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 10.4 p90 -67.47 -21.42 65.53 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.373 -0.531 . . . . 1.27 112.104 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.5 mtt -77.19 -31.14 55.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.116 0.484 . . . . 1.28 110.637 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 39.8 mtm180 -77.62 -48.08 17.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.958 0.409 . . . . 1.8600000000000001 110.532 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 m -73.69 -14.13 61.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.703 -0.681 . . . . 1.01 111.614 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.75 120.39 9.84 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.7 -0.762 . . . . 0.20000000000000001 111.633 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -89.71 -32.68 16.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.964 0.411 . . . . 0.54000000000000004 110.161 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -137.37 130.29 5.06 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.421 -0.672 . . . . 0.31 111.421 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.437 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 88.3 m-85 -116.34 126.11 53.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.085 0.443 . . . . 0.60999999999999999 110.999 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.3 tp -96.51 106.5 18.76 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.066 -0.716 . . . . 1.04 109.066 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 56.9 m -83.79 107.46 16.21 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.737 -0.468 . . . . 1.1799999999999999 109.737 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.414 HG23 ' CD1' ' A' ' 19' ' ' LEU . 17.2 t -112.36 142.05 25.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.073 0.463 . . . . 1.03 111.952 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -142.79 167.08 22.92 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.499 -0.926 . . . . 0.41999999999999998 108.499 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.86 132.48 50.08 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.056 -0.35 . . . . 0.76000000000000001 110.056 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 118' ' ' CYS . 3.3 pt -67.6 -13.23 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.514 -0.312 . . . . 1.1499999999999999 111.362 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -107.93 23.1 14.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.286 0.565 . . . . 0.93999999999999995 110.554 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -150.31 98.08 2.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 1.3799999999999999 110.477 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -31.28 71.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.083 -0.508 . . . . 0.75 111.94 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -62.84 -38.89 92.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.525 -0.307 . . . . 1.4199999999999999 110.554 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 82.8 p -69.83 -23.79 63.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.993 0.425 . . . . 0.71999999999999997 110.567 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -77.61 -39.38 45.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.83 -0.623 . . . . 0.51000000000000001 109.652 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -74.0 -30.5 62.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 1.4399999999999999 110.201 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -29.86 68.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.095 -0.502 . . . . 1.02 110.558 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.6 mm -57.58 -34.37 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.549 -0.75 . . . . 1.04 111.779 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -60.54 -45.44 93.88 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.579 -0.526 . . . . 1.0900000000000001 109.579 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -69.29 -34.71 75.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.536 -0.756 . . . . 0.98999999999999999 110.965 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -65.59 -51.26 61.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.728 -0.214 . . . . 1.73 110.92 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -59.37 -36.97 76.73 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.235 0.54 . . . . 0.66000000000000003 110.275 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -70.58 -50.74 34.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.528 -0.76 . . . . 1.3500000000000001 111.701 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -59.49 -49.46 77.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.967 0.358 . . . . 1.3999999999999999 111.967 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 81.2 mt -61.67 -39.6 83.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.294 . . . . 0.78000000000000003 111.243 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -66.85 -30.06 70.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.923 0.392 . . . . 1.6000000000000001 110.744 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -76.66 -43.24 38.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.821 -0.627 . . . . 1.0900000000000001 110.757 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.0 t -65.38 -45.48 93.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.035 -0.53 . . . . 0.89000000000000001 110.801 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -79.32 -15.89 57.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.872 0.368 . . . . 1.3500000000000001 110.528 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.4 t70 55.73 70.81 0.6 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.191 -0.913 . . . . 0.46999999999999997 110.811 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.7 t -164.12 -172.01 2.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.657 -0.701 . . . . 1.4399999999999999 109.818 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -125.41 -55.21 1.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.085 0.469 . . . . 1.74 109.865 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -77.51 91.79 3.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.801 -0.636 . . . . 0.78000000000000003 110.239 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.4 t -118.45 113.13 36.92 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.828 -0.623 . . . . 0.63 109.939 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.74 111.13 0.48 Allowed 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 123.232 2.621 . . . . 0.29999999999999999 113.131 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.437 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 46.3 mtt -144.25 157.44 44.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.89 -0.595 . . . . 1.1899999999999999 110.491 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.1 t -135.38 124.45 40.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.053 -0.721 . . . . 0.63 109.053 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 20.5 tp -80.24 116.52 20.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.443 -0.577 . . . . 0.66000000000000003 109.443 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 47.4 t -119.03 123.06 70.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.105 0.479 . . . . 1.3700000000000001 111.608 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -99.11 114.76 5.12 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.192 -1.163 . . . . 0.27000000000000002 110.192 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -97.32 166.06 11.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.83 0.348 . . . . 0.23999999999999999 110.962 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.6 mttt 68.45 26.06 6.69 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.512 -0.767 . . . . 1.1499999999999999 111.632 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.444 ' HA ' ' CD1' ' A' ' 84' ' ' ILE . 24.8 p -67.32 -19.35 65.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.935 0.398 . . . . 1.29 110.802 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -79.74 -14.25 58.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.872 -0.603 . . . . 0.69999999999999996 110.398 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 54.8 mt -85.72 151.58 55.61 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.128 -0.487 . . . . 1.3100000000000001 109.715 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 1.4 Cg_endo -81.46 -176.63 3.18 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.968 2.445 . . . . 0.79000000000000004 112.366 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 m 61.2 54.09 3.37 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.987 -0.551 . . . . 1.29 110.939 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 14.1 ttm-85 -63.79 112.03 2.7 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.673 -0.694 . . . . 0.68000000000000005 110.3 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.03 -40.19 13.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.835 -0.621 . . . . 1.28 110.55 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.9 t -95.28 119.3 43.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.417 -0.356 . . . . 0.96999999999999997 110.219 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -74.96 155.64 37.18 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.146 0.498 . . . . 1.6899999999999999 111.482 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -38.45 83.76 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.48 -0.782 . . . . 1.6499999999999999 110.958 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -69.4 -36.6 76.9 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.039 -0.528 . . . . 0.71999999999999997 111.011 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -59.04 -43.02 91.6 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.087 0.47 . . . . 1.1100000000000001 110.554 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.1 -40.37 60.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.887 -0.597 . . . . 0.35999999999999999 110.461 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.403 ' O ' ' HG3' ' A' ' 135' ' ' ARG . 6.2 tp-100 -61.95 -39.29 91.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.013 -0.54 . . . . 0.5 109.938 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -63.7 -40.56 97.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.559 -0.746 . . . . 1.1799999999999999 110.578 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.8 tp -68.57 -41.39 79.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.755 -0.657 . . . . 0.81000000000000005 110.937 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.54 -33.44 75.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.66000000000000003 110.512 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 135' ' ' ARG . 63.8 mtt-85 -58.69 -55.52 34.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.709 -0.678 . . . . 2.0699999999999998 111.623 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -42.79 96.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.081 0.467 . . . . 1.28 111.899 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -68.63 -22.34 64.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 1.0900000000000001 111.051 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.36 43.2 46.89 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.968 -0.56 . . . . 0.33000000000000002 112.409 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 31.3 pt -136.95 161.71 59.97 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.996 -0.372 . . . . 1.04 109.996 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.01 156.13 42.92 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.707 2.271 . . . . 0.69999999999999996 112.505 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 5.7 t80 -135.37 125.15 25.45 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.572 -0.529 . . . . 0.45000000000000001 109.572 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.7 mt -135.71 130.46 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.921 -0.312 . . . . 0.85999999999999999 111.217 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -84.18 123.77 30.45 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.063 -1.088 . . . . 0.88 108.063 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.411 ' C ' ' HG ' ' A' ' 118' ' ' CYS . 43.0 p -133.79 177.23 7.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.151 0.501 . . . . 0.76000000000000001 111.252 -177.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.1 t -156.58 124.39 5.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.821 -0.627 . . . . 0.35999999999999999 110.094 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.36 -12.95 60.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.29 0.566 . . . . 0.55000000000000004 110.088 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.9 tttm -79.76 -53.16 7.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.574 -0.739 . . . . 1.8300000000000001 110.743 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.8 p -83.27 -17.34 42.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.295 -0.411 . . . . 0.73999999999999999 110.844 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.1 ttt180 70.3 21.27 5.86 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.932 0.77 . . . . 2.0800000000000001 109.951 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -91.34 122.63 34.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.011 -0.54 . . . . 1.04 110.584 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.7 -4.34 79.05 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.66000000000000003 112.796 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 71.8 t -58.37 -59.99 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.666 0.247 . . . . 1.0700000000000001 111.666 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.68 -47.61 84.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 1.6200000000000001 110.834 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -56.16 -46.32 79.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.59 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -58.96 -53.66 55.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.869 0.322 . . . . 0.46000000000000002 111.869 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -61.07 -49.57 76.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.421 -0.354 . . . . 2.1000000000000001 111.458 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -59.42 -39.51 83.72 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.338 -0.392 . . . . 1.55 111.748 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.543 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 95.9 m -61.06 -44.45 97.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.527 -0.306 . . . . 0.39000000000000001 110.86 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 35.2 tp -65.14 -36.44 84.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.713 -0.221 . . . . 0.90000000000000002 111.174 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.417 ' O ' ' HG3' ' A' ' 164' ' ' ARG . 49.0 t -59.69 -41.02 83.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.194 0.521 . . . . 0.97999999999999998 110.235 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -77.15 -23.62 51.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.812 -0.631 . . . . 1.0700000000000001 110.916 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 158' ' ' THR . 52.6 mm-40 -64.76 -43.77 92.22 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.792 0.33 . . . . 0.72999999999999998 110.379 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 12.1 mt -65.15 -38.95 83.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.047 -0.524 . . . . 0.84999999999999998 111.015 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 75.8 mtt180 -59.27 -38.8 81.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.769 -0.65 . . . . 0.98999999999999999 110.991 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -62.62 -39.12 92.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.063 -0.517 . . . . 1.55 111.061 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -75.28 -34.6 61.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.299 -0.41 . . . . 0.84999999999999998 110.562 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -73.06 -30.79 63.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.586 -0.279 . . . . 1.73 111.408 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -101.86 11.58 38.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.853 0.359 . . . . 1.1200000000000001 110.736 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.7 tttp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.626 -0.702 . . . . 1.8799999999999999 110.951 -179.204 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.531 ' O2A' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' QPD . . . . . 0.475 ' C8 ' ' C14' ' A' ' 203' ' ' QPD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.5 ttm . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 110.36 -0.237 . . . . 1.8899999999999999 110.36 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.2 m -92.91 134.89 34.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.496 -0.32 . . . . 1.24 110.674 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -87.71 127.14 35.3 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.808 -0.441 . . . . 1.27 109.808 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -112.46 128.02 56.21 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.849 -0.426 . . . . 1.45 109.849 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -97.04 122.83 40.47 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.129 -0.487 . . . . 1.1799999999999999 111.332 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mp -129.75 137.79 50.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.923 -0.581 . . . . 2.1099999999999999 110.7 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.6 t -124.15 128.1 73.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.261 -0.427 . . . . 1.28 110.276 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.2 t -89.18 124.12 41.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.194 -0.669 . . . . 0.77000000000000002 109.194 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.488 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 9.8 m -115.77 148.95 18.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.606 -0.27 . . . . 0.94999999999999996 110.587 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.38 178.24 38.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.985 -0.626 . . . . 0.56000000000000005 112.101 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.502 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -78.24 168.68 19.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.996 0.427 . . . . 0.66000000000000003 111.306 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.7 104.67 1.91 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.943 -0.646 . . . . 0.80000000000000004 112.448 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.49 4.0 10.05 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.494 -0.86 . . . . 0.45000000000000001 112.77 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 11' ' ' ALA . 15.9 m -74.3 -29.32 24.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.913 0.387 . . . . 0.98999999999999999 111.25 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.85 22.06 5.14 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.678 -0.772 . . . . 0.48999999999999999 113.788 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HB2' ' O3B' ' A' ' 201' ' ' GDP . 54.4 mtmt -52.78 -50.19 64.07 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.983 0.392 . . . . 1.3799999999999999 110.933 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.407 ' O ' HG13 ' A' ' 21' ' ' ILE . 3.2 m -63.85 -43.42 96.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.722 0.296 . . . . 0.85999999999999999 111.507 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.71 -48.41 79.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.857 0.317 . . . . 0.95999999999999996 111.857 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.434 ' HG ' ' HB3' ' A' ' 146' ' ' ALA . 2.6 mt -65.29 -36.25 83.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.731 0.3 . . . . 1.21 111.237 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.4 m -70.16 -42.04 73.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.662 0.267 . . . . 1.2 111.024 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 17' ' ' SER . 82.4 mt -68.87 -31.86 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.407 . . . . 1.3799999999999999 109.946 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 4.4 mm-40 -63.67 -21.43 66.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.98 -0.555 . . . . 0.52000000000000002 111.599 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.7 tp -92.2 -14.98 28.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.139 0.495 . . . . 1.8799999999999999 110.864 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.6 mm -104.3 -64.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.075 -0.511 . . . . 0.57999999999999996 111.119 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -84.62 -7.61 59.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 1.74 110.823 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.552 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.6 OUTLIER 56.38 30.03 16.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.577 0.955 . . . . 1.9199999999999999 113.577 177.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -142.2 146.4 35.19 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.932 -0.307 . . . . 0.85999999999999999 110.36 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -68.01 143.07 55.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.12 -0.491 . . . . 0.77000000000000002 111.427 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 t -130.88 99.2 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.153 -0.684 . . . . 1.04 109.153 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.46 ' HA ' " O2'" ' A' ' 201' ' ' GDP . 7.3 t70 -75.58 -41.46 54.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.15 -0.477 . . . . 1.1200000000000001 111.122 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -94.31 97.46 10.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.216 0.531 . . . . 1.1799999999999999 111.412 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -151.51 136.53 17.38 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.877 -0.786 . . . . 0.80000000000000004 108.877 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -72.1 126.48 91.19 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.963 0.411 . . . . 0.80000000000000004 111.494 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -65.82 -28.0 51.38 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.914 2.409 . . . . 0.56000000000000005 112.83 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.24 -12.57 60.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.876 -0.602 . . . . 1.21 111.645 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -77.29 121.87 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.279 0.562 . . . . 1.1499999999999999 110.34 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 15.3 tt0 -114.26 127.03 55.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.824 -1.08 . . . . 0.81000000000000005 108.777 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -146.33 154.15 41.34 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.302 0.572 . . . . 1.29 111.403 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.4 129.17 53.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.483 -0.78 . . . . 1.1699999999999999 109.953 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -117.83 147.49 43.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.747 0.308 . . . . 0.97999999999999998 110.885 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HD2' ' OD2' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -119.83 138.52 53.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.69999999999999996 110.415 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -146.42 122.09 10.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.271 -0.422 . . . . 1.78 110.775 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.69 116.65 29.17 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.52 -0.548 . . . . 2.3900000000000001 109.52 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.52 136.87 59.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.09 -0.504 . . . . 1.3799999999999999 111.204 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 t -91.58 74.53 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.847 -0.797 . . . . 0.65000000000000002 108.847 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.1 mt -82.9 113.54 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.604 -0.725 . . . . 1.47 111.332 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 65.95 28.84 10.48 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.319 -0.855 . . . . 0.96999999999999997 111.012 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.59 -12.4 67.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.131 -0.556 . . . . 0.59999999999999998 112.515 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -93.97 111.03 22.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.746 0.308 . . . . 1.4099999999999999 111.053 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -73.32 104.59 4.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.137 0.494 . . . . 0.89000000000000001 109.853 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.8 m -114.74 143.85 44.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.094 0.473 . . . . 1.3100000000000001 111.081 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 tp -102.47 109.65 21.36 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.653 -0.869 . . . . 0.85999999999999999 108.653 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 48.7 mt -82.63 117.77 22.83 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.289 -0.414 . . . . 1.1299999999999999 111.654 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.516 ' OD2' ' HD2' ' A' ' 41' ' ' ARG . 15.1 t70 -101.03 86.07 2.97 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.529 -1.285 . . . . 1.03 107.529 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.1 mt -97.94 150.4 4.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.651 -0.704 . . . . 1.1799999999999999 112.238 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 tp -137.84 130.4 29.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 0.75 111.02 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 3.9 t70 -91.91 107.48 19.24 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.574 -0.528 . . . . 0.44 109.574 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.8 p -72.53 137.36 46.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.146 0.498 . . . . 0.84999999999999998 111.981 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.33 -37.8 66.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.542 -0.754 . . . . 1.04 110.209 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.88 -58.9 0.7 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.981 -0.628 . . . . 0.71999999999999997 111.896 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -108.98 140.67 42.16 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.358 -0.608 . . . . 1.5 109.358 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -106.14 165.86 10.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 1.5700000000000001 111.256 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -79.13 -42.06 27.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.113 -1.069 . . . . 1.3799999999999999 108.113 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -126.42 129.67 49.19 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.854 -1.066 . . . . 1.0 109.155 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.41 -33.34 65.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.211 -0.449 . . . . 0.90000000000000002 111.461 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.12 -35.15 77.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.196 -0.456 . . . . 0.35999999999999999 111.205 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 87.9 mtp -69.66 -35.89 75.57 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.887 0.375 . . . . 1.04 110.849 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -66.37 -44.56 82.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.829 -0.623 . . . . 1.0700000000000001 110.24 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 81.0 m-20 -80.69 -10.13 59.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.896 -0.593 . . . . 1.4099999999999999 110.677 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -66.8 -58.45 5.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 1.77 110.639 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -67.16 -17.75 64.98 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.01 0.434 . . . . 1.27 111.336 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 46.0 mtt -69.07 -26.97 65.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.062 -0.517 . . . . 1.28 110.187 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 72.4 mtm180 -84.86 -42.94 14.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.055 -0.52 . . . . 1.8600000000000001 110.345 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -27.39 61.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.771 -0.649 . . . . 1.01 111.812 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.91 139.79 43.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.962 -0.637 . . . . 0.20000000000000001 112.692 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -93.57 -53.6 3.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.787 0.327 . . . . 0.54000000000000004 110.945 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -122.76 138.43 11.8 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.716 -0.754 . . . . 0.31 111.763 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 111' ' ' MET . 79.6 m-85 -117.96 135.27 54.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.172 0.51 . . . . 0.60999999999999999 111.059 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.3 tp -101.86 113.86 27.43 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.717 -0.674 . . . . 1.04 109.866 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 3.6 m -89.44 89.45 7.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.039 -0.528 . . . . 1.1799999999999999 110.579 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 11.8 t -96.86 129.63 46.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.017 -0.538 . . . . 1.03 111.189 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -129.78 179.21 5.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.175 -0.676 . . . . 0.41999999999999998 109.175 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . . . -112.58 130.67 55.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.782 0.325 . . . . 0.76000000000000001 110.457 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 pt -66.83 -19.3 25.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.099 -0.5 . . . . 1.1499999999999999 111.505 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -104.99 15.64 27.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.145 0.498 . . . . 0.93999999999999995 110.818 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.448 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 43.1 t-20 -140.44 92.75 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 1.3799999999999999 110.218 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -25.46 68.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.33 -0.395 . . . . 0.75 111.349 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -67.81 -32.43 72.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.586 -0.279 . . . . 1.4199999999999999 110.473 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.5 p -72.19 -30.44 64.95 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.979 -0.748 . . . . 0.71999999999999997 108.979 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -69.62 -29.91 67.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.433 -0.803 . . . . 0.51000000000000001 109.619 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.79 -38.52 73.37 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.728 -0.669 . . . . 1.4399999999999999 110.101 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.19 -29.04 70.17 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.551 -0.749 . . . . 1.02 110.278 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.5 mm -56.21 -36.2 45.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.636 -0.711 . . . . 1.04 110.38 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -64.91 -36.32 84.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.639 . . . . 1.0900000000000001 111.357 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -80.96 -32.2 34.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.347 -0.388 . . . . 0.98999999999999999 111.032 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.488 ' CE1' ' HB ' ' A' ' 9' ' ' VAL . 3.6 m-85 -61.21 -51.04 70.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.496 0.188 . . . . 1.73 111.228 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.582 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 22.6 tpt180 -62.04 -30.03 70.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.313 0.577 . . . . 0.66000000000000003 110.42 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -76.36 -53.06 8.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.247 -0.888 . . . . 1.3500000000000001 111.98 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -62.37 -58.08 8.98 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.114 0.412 . . . . 1.3999999999999999 112.114 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.5 mt -54.07 -39.74 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.914 0.338 . . . . 0.78000000000000003 111.914 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 6.1 ttpt -66.36 -35.95 81.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.789 0.328 . . . . 1.6000000000000001 110.802 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -76.8 -26.47 54.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.066 0.46 . . . . 1.0900000000000001 110.534 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 67.5 t -77.16 -40.63 30.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.89000000000000001 110.02 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -80.24 -26.46 39.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.382 -0.372 . . . . 1.3500000000000001 110.757 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 t70 66.73 51.01 1.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.641 -0.709 . . . . 0.46999999999999997 110.34 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.94 163.14 31.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.552 -0.749 . . . . 1.4399999999999999 109.893 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -96.72 -42.21 8.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.839 0.352 . . . . 1.74 110.152 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -102.1 116.35 32.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.013 -0.54 . . . . 0.78000000000000003 110.039 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.4 t -127.96 122.08 22.14 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.097 -0.501 . . . . 0.63 109.794 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.57 104.23 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.787 2.325 . . . . 0.29999999999999999 111.667 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.447 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 31.7 mtt -139.18 151.8 46.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.7 -0.682 . . . . 1.1899999999999999 110.159 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.8 t -136.96 126.3 37.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.451 -0.574 . . . . 0.63 109.451 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 41.0 tp -81.81 122.33 27.56 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.641 -0.503 . . . . 0.66000000000000003 109.641 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 142' ' ' ILE . 95.3 t -124.07 127.95 73.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.091 -0.504 . . . . 1.3700000000000001 111.673 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.41 102.17 2.25 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.659 -0.976 . . . . 0.27000000000000002 110.659 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 144' ' ' THR . 65.6 t30 -86.41 165.82 16.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.703 0.251 . . . . 0.23999999999999999 110.356 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 69.76 29.8 4.01 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.861 0.726 . . . . 1.1499999999999999 110.552 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 30.8 p -67.72 -11.91 59.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.879 -0.6 . . . . 1.29 111.38 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -87.17 -8.36 57.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.692 0.282 . . . . 0.69999999999999996 110.731 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 43.0 mt -85.36 148.64 50.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 1.3100000000000001 110.936 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.31 -177.77 3.66 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.611 2.207 . . . . 0.79000000000000004 111.619 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.2 m 58.09 55.19 5.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.118 0.485 . . . . 1.29 111.055 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -66.97 109.71 3.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.878 -0.601 . . . . 0.68000000000000005 109.9 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.01 -42.45 16.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.002 0.429 . . . . 1.28 110.619 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.31 112.53 22.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.262 -0.426 . . . . 0.96999999999999997 109.875 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.89 148.13 52.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.893 0.378 . . . . 1.6899999999999999 110.679 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.22 -39.51 79.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.896 -0.593 . . . . 1.6499999999999999 112.34 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -68.81 -37.58 79.33 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 120.88 -0.328 . . . . 0.71999999999999997 110.902 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -56.13 -43.91 78.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.763 0.316 . . . . 1.1100000000000001 111.43 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.32 -46.47 55.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.911 -0.586 . . . . 0.35999999999999999 110.894 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -59.96 -44.83 94.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.5 110.418 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -61.81 -42.9 99.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.462 -0.79 . . . . 1.1799999999999999 110.498 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.22 -41.2 90.43 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.992 -0.549 . . . . 0.81000000000000005 110.722 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 139' ' ' ILE . . . -65.89 -35.26 80.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.365 -0.38 . . . . 0.66000000000000003 110.346 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -63.87 -43.58 95.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 2.0699999999999998 111.519 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.19 -17.96 65.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.637 0.256 . . . . 1.28 111.566 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -100.59 -8.12 23.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.236 -0.438 . . . . 1.0900000000000001 110.214 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.8 31.25 70.16 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.762 -0.654 . . . . 0.33000000000000002 112.583 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 44.1 pt -121.58 153.37 59.42 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 122.798 -0.236 . . . . 1.04 110.454 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 139' ' ' ILE . 12.7 Cg_exo -72.01 156.13 56.44 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.883 2.388 . . . . 0.69999999999999996 112.856 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -128.6 120.85 27.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 0.45000000000000001 109.56 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 73.8 mt -132.88 138.25 52.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.757 0.313 . . . . 0.85999999999999999 111.038 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -93.57 126.72 38.88 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.288 -0.634 . . . . 0.88 109.288 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 116' ' ' ASN . 32.1 p -131.67 166.07 22.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.255 0.55 . . . . 0.76000000000000001 111.257 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.2 t -146.33 122.38 10.75 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.496 -0.928 . . . . 0.35999999999999999 108.496 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.434 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . . . -70.0 -10.79 59.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.103 0.478 . . . . 0.55000000000000004 110.863 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -89.0 -48.02 7.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.758 -0.656 . . . . 1.8300000000000001 111.476 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.0 p -93.56 -17.27 23.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.582 0.586 . . . . 0.73999999999999999 112.582 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 69.77 21.75 6.33 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.946 -0.57 . . . . 2.0800000000000001 110.765 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 144' ' ' THR . 6.5 tt0 -73.9 120.27 19.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.639 -0.709 . . . . 1.04 110.809 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 66.44 6.66 35.64 Favored Glycine 0 CA--C 1.516 0.111 0 CA-C-N 116.072 -0.513 . . . . 0.66000000000000003 113.633 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 18.3 t -61.01 -61.04 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.521 0.2 . . . . 1.0700000000000001 111.455 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.93 -37.9 83.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 1.6200000000000001 110.51 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -56.93 -45.22 82.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.769 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -58.33 -47.79 82.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.46000000000000002 111.266 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.482 ' O ' HG22 ' A' ' 160' ' ' VAL . 72.6 m-85 -64.55 -44.35 91.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.185 -0.461 . . . . 2.1000000000000001 110.944 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -60.0 -37.02 78.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 1.55 111.296 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 19.3 m -65.42 -53.69 39.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.138 -0.483 . . . . 0.39000000000000001 111.355 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.536 ' O ' HG13 ' A' ' 163' ' ' ILE . 14.0 tp -57.59 -35.8 70.89 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.702 0.287 . . . . 0.90000000000000002 111.111 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 156' ' ' PHE . 38.3 t -58.36 -40.75 79.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.029 0.443 . . . . 0.97999999999999998 110.733 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -78.96 -30.2 44.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.962 -0.563 . . . . 1.0700000000000001 111.327 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 158' ' ' THR . 7.6 mm-40 -62.16 -40.89 97.5 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.854 -0.424 . . . . 0.72999999999999998 109.854 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 159' ' ' LEU . 52.8 mt -63.36 -43.99 98.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.717 -0.674 . . . . 0.84999999999999998 110.13 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.476 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 96.4 mtt180 -56.85 -49.43 75.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.785 -0.643 . . . . 0.98999999999999999 111.068 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 169' ' ' LYS . 41.3 mtmt -57.36 -34.33 68.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.317 -0.401 . . . . 1.55 111.606 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -74.58 -37.26 62.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.486 -0.325 . . . . 0.84999999999999998 110.692 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -75.82 -33.0 60.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.4 -0.364 . . . . 1.73 111.903 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 10.3 pt-20 -92.49 7.4 43.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.952 0.406 . . . . 1.1200000000000001 110.745 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 165' ' ' LYS . 30.7 tttp . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.245 -0.883 . . . . 1.8799999999999999 110.128 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.46 " O2'" ' HA ' ' A' ' 30' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' QPD . . . . . 0.492 ' O1 ' ' C14' ' A' ' 203' ' ' QPD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.6 ttm . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 109.926 -0.398 . . . . 1.8899999999999999 109.926 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.7 m -94.48 134.7 36.73 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.048 -0.352 . . . . 1.24 110.048 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -85.71 129.98 34.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.914 -0.585 . . . . 1.27 110.496 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.418 ' CD2' ' HB3' ' A' ' 51' ' ' CYS . 61.5 m-85 -125.57 115.65 20.51 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.816 -0.438 . . . . 1.45 109.816 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -100.48 113.85 26.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.158 0.504 . . . . 1.1799999999999999 110.272 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.14 138.46 52.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.717 -0.674 . . . . 2.1099999999999999 110.895 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.01 132.41 67.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.327 -0.397 . . . . 1.28 110.637 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 t -94.86 113.56 29.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.871 -0.789 . . . . 0.77000000000000002 108.871 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 m -114.8 166.56 8.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.921 0.391 . . . . 0.94999999999999996 111.291 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.19 -170.31 30.86 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.013 -0.835 . . . . 0.56000000000000005 111.013 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.53 172.16 14.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.241 0.543 . . . . 0.66000000000000003 110.85 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.74 128.09 8.96 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.701 -0.761 . . . . 0.80000000000000004 112.595 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.99 13.32 72.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.899 -0.667 . . . . 0.45000000000000001 114.02 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.4 m -73.41 -29.71 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 117.644 0.722 . . . . 0.98999999999999999 111.031 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.48 20.41 2.65 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.351 -0.928 . . . . 0.48999999999999999 113.84 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -54.68 -58.85 5.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.956 0.408 . . . . 1.3799999999999999 110.97 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.457 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 1.2 m -54.28 -47.76 71.99 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.603 -0.726 . . . . 0.85999999999999999 111.829 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.17 84.31 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.677 0.251 . . . . 0.95999999999999996 111.677 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.3 mt -63.83 -40.63 97.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 1.21 110.524 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.9 m -72.04 -43.78 64.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.158 -0.474 . . . . 1.2 110.66 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.74 -42.11 87.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.046 -0.525 . . . . 1.3799999999999999 110.915 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.539 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 4.3 mm-40 -64.02 -20.79 66.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.52000000000000002 111.338 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.2 tp -91.44 -39.78 11.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.918 0.389 . . . . 1.8799999999999999 111.147 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.7 mm -81.51 -50.66 16.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.263 -0.426 . . . . 0.57999999999999996 112.104 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -92.29 -16.49 26.03 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.931 0.345 . . . . 1.74 111.931 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 3.7 m-80 66.42 27.51 9.87 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.735 0.643 . . . . 1.9199999999999999 112.735 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -153.04 144.1 23.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.135 -0.32 . . . . 0.85999999999999999 110.135 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -68.83 142.67 54.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.182 -0.463 . . . . 0.77000000000000002 111.945 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 70.5 t -130.6 114.84 29.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 109.168 -0.679 . . . . 1.04 109.168 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -78.56 -42.72 28.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.926 -0.579 . . . . 1.1200000000000001 111.26 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -100.49 102.16 13.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.297 -0.41 . . . . 1.1799999999999999 111.948 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -155.19 117.59 4.23 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.65 -0.87 . . . . 0.80000000000000004 108.65 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -52.32 122.43 24.77 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.52 0.676 . . . . 0.80000000000000004 111.618 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.61 -18.14 15.62 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.685 2.257 . . . . 0.56000000000000005 113.37 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.09 12.5 11.33 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.282 0.475 . . . . 1.21 112.282 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.5 mt -99.71 105.64 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.244 0.545 . . . . 1.1499999999999999 110.204 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 3.7 tt0 -86.48 87.0 7.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.878 -0.601 . . . . 0.81000000000000005 109.535 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.81 161.69 14.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.626 -0.716 . . . . 1.29 110.583 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.423 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 10.4 p -131.18 144.71 51.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.194 -0.457 . . . . 1.1699999999999999 110.351 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -126.39 149.17 49.4 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.218 -0.446 . . . . 0.97999999999999998 111.083 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 1.7 mpp_? -123.75 123.8 41.3 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.35 -0.386 . . . . 0.69999999999999996 110.458 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -144.62 124.97 13.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.846 0.355 . . . . 1.78 110.281 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -86.53 119.93 27.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.002 0.429 . . . . 2.3900000000000001 110.548 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.3 t -129.53 141.08 47.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.925 -0.58 . . . . 1.3799999999999999 110.166 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.7 t -87.64 106.35 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.78 -0.452 . . . . 0.65000000000000002 109.78 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 32.6 mt -110.6 115.24 49.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.198 -0.455 . . . . 1.47 110.403 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 61.32 43.95 10.17 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.632 0.582 . . . . 0.96999999999999997 111.334 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.1 27.77 71.43 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.59999999999999998 113.317 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -137.74 120.94 16.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.93 0.365 . . . . 1.4099999999999999 111.254 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -75.25 103.32 5.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.862 0.363 . . . . 0.89000000000000001 110.238 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.418 ' HB3' ' CD2' ' A' ' 4' ' ' TYR . 11.5 m -110.44 137.33 48.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.471 -0.331 . . . . 1.3100000000000001 111.751 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.2 tp -92.03 111.55 23.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.149 -1.056 . . . . 0.85999999999999999 108.149 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 60.2 mt -89.97 114.02 25.78 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.052 0.76 . . . . 1.1299999999999999 113.052 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -106.0 101.5 10.99 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.765 -1.198 . . . . 1.03 107.765 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.5 mt -107.0 141.66 21.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.255 -0.429 . . . . 1.1799999999999999 111.727 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.438 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 58.7 tp -122.37 125.91 46.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.792 -0.64 . . . . 0.75 111.108 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 7.0 t70 -92.48 101.89 14.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.25 -0.648 . . . . 0.44 109.25 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.4 p -67.35 134.76 52.12 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.482 0.658 . . . . 0.84999999999999998 112.184 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.45 -37.94 14.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.218 -0.901 . . . . 1.04 110.067 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 142.84 -94.9 0.18 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.84 -0.695 . . . . 0.71999999999999997 112.531 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -101.78 118.23 36.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.159 0.504 . . . . 1.5 111.212 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.2 167.37 14.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.508 -0.769 . . . . 1.5700000000000001 109.275 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -54.19 -52.84 59.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 1.3799999999999999 110.913 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -117.41 141.0 48.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.239 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -63.19 -29.04 70.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.879 0.371 . . . . 0.90000000000000002 111.03 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.84 -26.34 68.29 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.011 -0.54 . . . . 0.35999999999999999 110.347 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 71.8 mtp -72.8 -37.7 67.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.675 -0.693 . . . . 1.04 109.595 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.592 ' HA ' ' CZ ' ' A' ' 71' ' ' TYR . 30.7 ttp180 -70.49 -43.92 68.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.866 -0.606 . . . . 1.0700000000000001 109.967 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -28.3 67.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.427 -0.806 . . . . 1.4099999999999999 110.636 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -56.22 -65.08 0.67 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.424 -0.807 . . . . 1.77 112.088 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.592 ' CZ ' ' HA ' ' A' ' 68' ' ' ARG . 3.5 p90 -69.1 -18.71 64.01 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.337 0.495 . . . . 1.27 112.337 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 32.8 mtt -71.45 -26.76 62.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.304 0.573 . . . . 1.28 109.927 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -90.03 -28.7 18.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.205 -0.452 . . . . 1.8600000000000001 110.925 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.493 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -86.53 -26.24 24.65 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.084 0.402 . . . . 1.01 112.084 -179.169 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.26 125.82 24.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.798 -0.715 . . . . 0.20000000000000001 111.96 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -83.34 -41.49 18.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.78 0.324 . . . . 0.54000000000000004 110.234 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -129.65 133.26 7.4 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.535 -0.626 . . . . 0.31 111.535 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.5 122.39 46.43 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.053 0.454 . . . . 0.60999999999999999 110.934 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.7 tp -88.05 112.0 22.15 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.102 -0.703 . . . . 1.04 109.102 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.2 m -90.54 101.16 13.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.858 0.361 . . . . 1.1799999999999999 110.428 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.3 t -103.01 131.92 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.259 -0.428 . . . . 1.03 111.54 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -134.19 171.06 14.76 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.978 -0.749 . . . . 0.41999999999999998 108.978 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.77 126.64 51.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.856 0.36 . . . . 0.76000000000000001 110.824 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.6 pt -68.64 -16.61 21.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.144 0.497 . . . . 1.1499999999999999 111.074 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -106.97 24.1 13.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.274 -0.421 . . . . 0.93999999999999995 110.932 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.444 ' OD1' ' HB3' ' A' ' 88' ' ' LYS . 28.5 t-20 -156.46 102.17 2.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.07 -0.514 . . . . 1.3799999999999999 110.116 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.18 -23.34 66.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.978 -0.555 . . . . 0.75 111.833 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HB3' ' OD1' ' A' ' 86' ' ' ASN . 51.2 tptt -56.01 -50.87 69.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.313 -0.403 . . . . 1.4199999999999999 110.862 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.3 p -63.43 -41.4 98.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.71999999999999997 111.156 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -61.52 -40.89 96.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.265 -0.425 . . . . 0.51000000000000001 111.142 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -74.85 -11.7 60.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.237 -0.438 . . . . 1.4399999999999999 111.587 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.52 -20.05 23.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.094 0.473 . . . . 1.02 110.271 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.8 mm -58.91 -29.88 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.526 -0.761 . . . . 1.04 110.794 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -59.19 -52.0 67.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.03 -0.532 . . . . 1.0900000000000001 109.821 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -65.16 -32.4 74.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.474 -0.784 . . . . 0.98999999999999999 111.101 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -65.95 -50.23 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.458 0.17 . . . . 1.73 110.856 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -60.05 -46.2 90.32 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.523 -0.547 . . . . 0.66000000000000003 109.523 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.42 -47.92 84.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.767 -0.651 . . . . 1.3500000000000001 111.075 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.526 ' O ' HG21 ' A' ' 103' ' ' VAL . 16.5 tt0 -58.88 -58.84 6.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.834 -0.621 . . . . 1.3999999999999999 111.76 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.3 mt -55.83 -37.61 48.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.522 -0.308 . . . . 0.78000000000000003 111.659 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -65.75 -37.51 86.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.532 0.206 . . . . 1.6000000000000001 110.921 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.0 -33.38 51.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 1.0900000000000001 111.07 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 99' ' ' GLN . 93.5 t -66.82 -45.13 88.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.064 0.459 . . . . 0.89000000000000001 110.285 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -81.46 -26.29 35.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.14 -0.482 . . . . 1.3500000000000001 110.354 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.6 t0 64.66 60.25 0.89 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.336 -0.847 . . . . 0.46999999999999997 110.142 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.7 t -153.69 151.55 29.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.328 -0.851 . . . . 1.4399999999999999 110.016 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -81.37 -42.99 19.65 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.061 -0.518 . . . . 1.74 111.081 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -97.24 117.7 32.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.055 0.455 . . . . 0.78000000000000003 111.838 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 46.9 t -135.66 113.39 10.94 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.046 -0.724 . . . . 0.63 109.046 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.59 112.13 0.96 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.02 2.48 . . . . 0.29999999999999999 112.369 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 50.5 mtt -141.58 156.93 45.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.949 -0.569 . . . . 1.1899999999999999 110.3 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 94.6 t -135.32 129.21 49.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 109.166 -0.679 . . . . 0.63 109.166 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.8 tp -85.0 115.37 22.79 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.549 -0.537 . . . . 0.66000000000000003 109.549 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.1 t -114.99 117.45 55.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.815 -0.63 . . . . 1.3700000000000001 111.756 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -95.92 94.6 1.7 Allowed Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.232 -1.147 . . . . 0.27000000000000002 110.232 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -80.3 166.91 20.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.652 0.263 . . . . 0.23999999999999999 111.415 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 69.69 33.12 3.07 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.465 -0.788 . . . . 1.1499999999999999 111.064 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 18.7 p -69.61 -4.76 20.64 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.417 -0.356 . . . . 1.29 111.853 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -93.36 -11.22 32.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.463 -0.335 . . . . 0.69999999999999996 110.831 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.5 mt -91.43 142.48 27.02 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.396 -0.365 . . . . 1.3100000000000001 111.182 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -79.75 -169.81 0.87 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.828 2.352 . . . . 0.79000000000000004 111.572 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.4 m 57.87 43.89 20.87 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.301 0.572 . . . . 1.29 110.387 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -63.33 119.03 8.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.184 -0.916 . . . . 0.68000000000000005 110.126 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.86 -32.37 12.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.179 -0.464 . . . . 1.28 111.333 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 t -97.23 110.79 25.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.95 0.405 . . . . 0.96999999999999997 110.396 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.16 148.46 48.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.976 -0.556 . . . . 1.6899999999999999 111.044 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.04 -39.93 69.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.581 -0.736 . . . . 1.6499999999999999 112.349 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -65.79 -38.83 90.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.574 0.226 . . . . 0.71999999999999997 111.445 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -61.11 -42.45 98.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.906 0.384 . . . . 1.1100000000000001 110.971 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.27 63.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.269 -0.423 . . . . 0.35999999999999999 110.61 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 135' ' ' ARG . 6.6 tp-100 -62.38 -42.53 99.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.5 110.006 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.76 -35.46 78.18 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.077 0.465 . . . . 1.1799999999999999 110.403 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.9 tp -68.83 -46.83 67.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.727 -0.669 . . . . 0.81000000000000005 109.973 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.56 95.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.716 -0.674 . . . . 0.66000000000000003 110.966 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 131' ' ' GLN . 24.9 mtm180 -65.31 -32.45 74.11 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.321 -0.4 . . . . 2.0699999999999998 111.093 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.6 m -73.44 -29.98 62.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.91 0.385 . . . . 1.28 110.461 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -82.67 -40.08 21.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.183 0.516 . . . . 1.0900000000000001 110.46 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.36 32.1 5.32 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 109.97 -1.252 . . . . 0.33000000000000002 109.97 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 4.6 pt -128.34 168.35 15.91 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.338 -0.431 . . . . 1.04 110.592 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -86.55 160.12 9.4 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.532 2.155 . . . . 0.69999999999999996 112.586 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -134.26 130.36 37.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.45000000000000001 110.151 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.7 mt -139.28 132.41 37.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.139 -0.482 . . . . 0.85999999999999999 110.985 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -82.92 129.71 35.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.728 -1.212 . . . . 0.88 107.728 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 30.9 p -137.71 173.87 11.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.512 0.672 . . . . 0.76000000000000001 111.756 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.7 t -156.24 130.53 8.74 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.82 -1.082 . . . . 0.35999999999999999 108.784 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.62 -8.71 57.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.224 0.535 . . . . 0.55000000000000004 110.317 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -85.48 -51.9 6.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.707 -0.679 . . . . 1.8300000000000001 110.914 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.7 p -91.12 -13.64 32.67 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.173 0.434 . . . . 0.73999999999999999 112.173 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.403 HH12 ' HD3' ' A' ' 149' ' ' ARG . 14.1 mtp-105 66.56 20.47 10.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.129 0.571 . . . . 2.0800000000000001 110.706 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -74.24 121.16 20.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.922 -0.581 . . . . 1.04 111.814 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.26 -4.24 12.71 Favored Glycine 0 C--N 1.33 0.219 0 N-CA-C 114.99 0.756 . . . . 0.66000000000000003 114.99 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.72 -51.26 74.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 117.403 0.601 . . . . 1.0700000000000001 110.645 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.34 -39.06 89.19 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.283 0.563 . . . . 1.6200000000000001 110.565 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.66 -42.04 98.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.557 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.45 81.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.46000000000000002 110.741 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -60.08 -43.03 95.78 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.059 -0.519 . . . . 2.1000000000000001 110.654 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -63.22 -45.58 90.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.849 -0.614 . . . . 1.55 111.04 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 26.5 m -62.65 -40.26 96.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.892 -0.595 . . . . 0.39000000000000001 111.514 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.45 ' O ' HG13 ' A' ' 163' ' ' ILE . 37.3 tp -59.03 -40.79 86.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.932 0.396 . . . . 0.90000000000000002 110.593 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.11 -38.62 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.97999999999999998 110.3 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -68.86 -30.39 68.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.908 -0.587 . . . . 1.0700000000000001 110.667 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -67.26 -44.06 80.3 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.736 -0.839 . . . . 0.72999999999999998 108.736 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 159' ' ' LEU . 74.2 mt -60.74 -44.03 96.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 115.378 -0.828 . . . . 0.84999999999999998 109.837 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 91.3 mtt180 -55.9 -48.66 75.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.738 -0.665 . . . . 0.98999999999999999 110.805 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -61.6 -34.44 75.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 1.55 111.308 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -71.97 -35.99 69.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.84999999999999998 110.282 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -69.62 -36.95 76.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.078 -0.51 . . . . 1.73 111.099 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 9.2 pt-20 -100.38 20.16 15.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.154 -0.476 . . . . 1.1200000000000001 111.065 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.1 mttp . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.598 -0.715 . . . . 1.8799999999999999 109.622 179.403 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.491 " O5'" " H2'" ' A' ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' QPD . . . . . 0.438 ' N1 ' ' HB2' ' A' ' 56' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.773 0.321 . . . . 1.48 110.462 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.03 145.17 27.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.259 -0.428 . . . . 1.04 110.73 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -105.58 131.69 52.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.177 -0.465 . . . . 1.27 110.584 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.607 ' HE2' ' HG ' ' A' ' 51' ' ' CYS . 52.1 m-85 -116.12 116.54 28.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.16 -0.473 . . . . 1.11 110.045 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -97.11 110.68 23.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.137 -0.483 . . . . 0.81 110.411 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -127.11 142.79 51.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.872 -0.603 . . . . 1.39 111.003 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.8 t -121.91 134.52 64.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.972 0.415 . . . . 0.81 111.027 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.7 t -93.74 103.97 15.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.235 -1.024 . . . . 0.44 108.235 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.73 146.49 15.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.278 -0.419 . . . . 0.7 111.351 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.94 -175.09 42.87 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.771 -0.728 . . . . 0.53 111.299 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.78 158.17 36.08 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.01 0.433 . . . . 0.58 111.321 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.29 134.41 15.62 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.55 -0.833 . . . . 0.8 111.884 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.69 2.06 60.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.794 -0.717 . . . . 0.42 113.568 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -79.25 -24.11 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 117.285 0.542 . . . . 0.57 110.91 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.99 25.77 4.35 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.688 -0.768 . . . . 0.49 113.467 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -53.44 -55.53 24.42 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 111.891 0.33 . . . . 0.81 111.891 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.409 ' O ' HG13 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -59.59 -53.47 57.65 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.888 -0.596 . . . . 0.58 112.048 -178.841 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.83 -43.55 77.09 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.778 0.659 . . . . 0.43 112.778 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.499 ' CD1' HG11 ' A' ' 81' ' ' VAL . 39.1 mt -59.81 -41.27 90.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.823 0.344 . . . . 0.92 111.632 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 m -76.83 -46.2 25.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.411 -0.359 . . . . 0.89 111.657 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 17' ' ' SER . 79.4 mt -60.14 -27.61 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.937 0.399 . . . . 0.79 111.631 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.2 -35.07 79.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.915 0.388 . . . . 0.46 111.143 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -91.56 -6.39 52.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.992 0.425 . . . . 1.37 111.347 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.1 mm -102.81 -43.41 9.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.329 -0.396 . . . . 0.58 111.129 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -105.31 -4.78 21.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.513 -0.312 . . . . 1.68 111.676 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.3 t30 64.15 35.27 10.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.024 0.75 . . . . 1.6 113.024 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -162.81 154.58 18.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.034 0.445 . . . . 0.74 110.817 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -87.81 128.96 35.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.659 -0.701 . . . . 0.6 111.205 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.8 120.82 47.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.252 -0.886 . . . . 0.64 109.032 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -77.01 -40.73 45.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 1.12 111.176 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -127.5 117.94 23.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.276 -0.42 . . . . 1.18 110.537 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -143.29 143.96 31.92 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.297 -0.631 . . . . 0.6 109.297 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.76 124.04 66.48 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.847 0.356 . . . . 0.8 111.158 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.26 -13.69 9.87 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.883 2.389 . . . . 0.52 113.79 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.7 p -98.19 1.15 47.08 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.805 -0.358 . . . . 0.89 111.777 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 mt -83.56 132.13 32.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.073 0.463 . . . . 0.73 110.353 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 10.0 tt0 -121.87 82.24 1.93 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.37 -0.832 . . . . 0.81 109.069 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -103.45 155.67 18.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.535 -0.757 . . . . 1.29 111.422 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.34 121.45 45.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.173 -0.467 . . . . 0.78 110.397 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -108.14 144.84 34.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.744 0.306 . . . . 0.94 110.349 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -119.51 141.18 49.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.838 0.351 . . . . 0.56 110.531 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -143.48 134.63 25.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.11 -0.495 . . . . 1.46 110.072 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -106.49 122.63 46.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.865 0.364 . . . . 1.89 110.409 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -137.39 133.01 46.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 1.09 111.232 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 t -85.48 71.58 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.477 0.656 . . . . 0.65 109.5 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 pt -88.26 130.88 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.781 -0.645 . . . . 1.06 111.529 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 63.48 31.59 14.81 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.55 -0.75 . . . . 0.97 111.077 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.7 11.12 83.3 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.852 -0.613 . . . . 0.6 113.097 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -117.28 119.73 36.04 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 122.586 -0.361 . . . . 1.41 110.783 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.8 m -79.83 96.73 6.4 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.6 -0.518 . . . . 0.63 109.6 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.607 ' HG ' ' HE2' ' A' ' 4' ' ' TYR . 58.6 m -114.05 158.49 21.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.225 -0.443 . . . . 0.71 112.056 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.0 tp -112.64 119.88 39.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.27 -0.877 . . . . 0.48 108.885 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 12.3 mt -90.65 131.32 36.42 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.056 0.455 . . . . 0.87 111.919 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -114.39 103.29 10.91 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.088 -1.079 . . . . 1.03 108.088 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 3.4 mt -110.9 151.33 13.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.305 -0.407 . . . . 0.68 111.706 -177.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.1 tp -131.22 119.37 21.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.332 -0.394 . . . . 0.46 110.327 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.562 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 4.6 t0 -84.68 98.3 10.14 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.57 -0.53 . . . . 0.44 109.57 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 36.0 p -64.85 141.18 58.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.778 -0.646 . . . . 0.73 112.347 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.88 -58.39 2.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.364 -0.835 . . . . 0.56 109.537 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.23 -47.11 0.53 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.752 -0.658 . . . . 0.72 112.262 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -135.93 129.09 31.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.741 0.305 . . . . 1.26 110.59 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -102.44 175.7 5.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.394 -0.595 . . . . 1.57 109.394 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -65.57 -43.45 89.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.927 0.394 . . . . 1.38 110.2 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -128.72 145.35 51.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.081 -0.509 . . . . 0.81 110.038 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -38.33 89.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.309 -0.405 . . . . 0.63 110.893 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.57 -28.28 68.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.186 -0.461 . . . . 0.32 111.402 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 82.9 mtp -73.79 -38.32 64.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.93 0.395 . . . . 0.69 110.264 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.402 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 35.7 ttp180 -71.09 -43.77 67.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.893 -0.594 . . . . 0.9 109.821 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.83 -19.5 65.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.362 -0.835 . . . . 1.41 111.39 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -59.95 -57.36 13.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.466 -0.334 . . . . 1.51 111.373 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.402 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 14.7 p90 -75.05 -5.02 41.83 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.779 -0.368 . . . . 1.17 111.425 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.5 mtt -76.37 -25.24 54.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.361 -0.607 . . . . 0.7 109.361 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -87.7 -42.32 12.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.605 -0.725 . . . . 1.29 110.451 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.17 -20.71 63.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.863 -0.608 . . . . 0.72 112.24 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.78 124.57 18.04 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.491 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -88.91 -39.83 13.51 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.794 -0.447 . . . . 0.54 109.794 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -128.78 137.58 9.73 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.815 -0.914 . . . . 0.26 110.815 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.461 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 93.9 m-85 -120.75 129.67 53.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.139 0.495 . . . . 0.48 111.38 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.6 tp -97.02 110.74 23.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.473 -0.785 . . . . 0.37 108.982 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 3.8 m -96.91 92.36 6.07 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.102 -0.499 . . . . 0.61 110.981 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.499 HG11 ' CD1' ' A' ' 19' ' ' LEU . 4.1 t -98.92 136.26 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.909 -0.587 . . . . 0.59 111.369 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -130.71 172.17 12.28 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.898 -0.779 . . . . 0.34 108.898 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.528 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . . . -105.17 122.86 46.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.596 0.236 . . . . 0.32 110.514 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.43 ' HB ' ' HG3' ' A' ' 123' ' ' ARG . 31.2 pt -66.54 -17.73 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.069 0.462 . . . . 0.78 111.562 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -98.14 4.12 49.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.957 0.408 . . . . 0.82 110.236 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 14.6 t-20 -135.34 90.38 2.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.737 -0.665 . . . . 1.07 110.073 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.43 HG23 HG22 ' A' ' 125' ' ' VAL . 0.4 OUTLIER -59.61 -28.29 67.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.024 -0.535 . . . . 0.65 112.071 -178.847 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -59.08 -38.72 80.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 0.89 110.559 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.5 p -75.27 -25.87 58.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.64 111.326 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -74.99 -34.67 62.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.056 0.455 . . . . 0.42 110.721 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.406 ' HA ' ' OE2' ' A' ' 91' ' ' GLU . 10.7 mm-40 -74.6 -24.43 58.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.007 0.432 . . . . 1.44 110.438 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -71.5 -14.48 62.13 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.868 -0.606 . . . . 1.02 111.257 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 30.3 mm -58.14 -35.72 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.021 -0.536 . . . . 0.42 110.406 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -61.34 -45.02 96.14 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.073 -0.512 . . . . 0.83 110.565 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -63.77 -48.26 77.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.907 -0.588 . . . . 0.79 111.75 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -60.53 -52.06 66.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.162 0.43 . . . . 1.17 112.162 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -55.43 -47.55 75.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.208 0.318 . . . . 0.6 110.754 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.05 -43.9 86.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.047 -0.524 . . . . 1.35 111.763 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 103' ' ' VAL . 56.1 tt0 -63.44 -54.51 35.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 1.15 112.165 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.31 -34.41 60.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.642 0.258 . . . . 0.51 110.955 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' A' ' 107' ' ' GLU . 30.0 mtpt -62.14 -35.35 78.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.066 0.46 . . . . 1.05 110.217 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -73.88 -41.15 62.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.617 -0.719 . . . . 0.91 110.905 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 99' ' ' GLN . 46.8 t -60.72 -41.92 90.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.35 111.382 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -89.21 -14.86 35.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.504 -0.316 . . . . 0.63 111.352 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.4 t70 58.82 54.84 4.94 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.748 0.785 . . . . 0.47 109.836 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.7 m -154.83 140.26 17.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.6 -0.727 . . . . 1.14 110.895 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.416 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 21.9 mt-10 -88.22 -23.31 23.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.25 0.548 . . . . 1.74 110.003 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -101.06 85.3 2.81 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.487 -0.779 . . . . 0.78 109.939 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.5 t -117.71 119.24 34.25 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.625 -0.716 . . . . 0.47 110.098 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.403 ' HG3' ' CB ' ' A' ' 166' ' ' HIS . 35.1 Cg_exo -58.06 115.96 2.89 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.115 2.543 . . . . 0.25 112.286 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.461 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 36.5 mtt -146.11 153.05 40.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.777 -0.647 . . . . 0.79 110.457 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.9 t -132.88 125.79 52.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.895 -0.78 . . . . 0.22 108.895 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.8 tp -82.72 125.82 31.68 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.545 -0.539 . . . . 0.29 109.545 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 81' ' ' VAL . 3.2 t -122.83 127.03 74.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.173 -0.467 . . . . 0.82 112.223 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.88 96.69 1.26 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.671 -0.971 . . . . 0.27 110.671 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -81.71 166.47 20.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.067 0.433 . . . . 0.21 111.671 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.6 mttt 72.58 31.79 1.65 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.042 -0.981 . . . . 0.54 111.645 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 15.8 p -70.91 -10.13 59.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.887 0.375 . . . . 0.46 111.008 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -94.71 -2.05 51.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.7 110.621 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 33.1 mt -104.82 155.34 37.67 Favored Pre-proline 0 C--O 1.236 0.372 0 CA-C-N 116.085 -0.507 . . . . 0.67 111.07 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -87.31 -169.83 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.598 2.199 . . . . 0.54 112.03 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 m 60.09 45.6 11.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.79 -0.641 . . . . 0.84 111.167 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.43 ' HG3' ' HB ' ' A' ' 84' ' ' ILE . 12.5 ttm-85 -76.75 111.81 12.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.587 -0.733 . . . . 0.58 110.73 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.6 p -92.77 -31.04 15.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.094 0.473 . . . . 0.81 110.406 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.43 HG22 HG23 ' A' ' 87' ' ' THR . 58.3 t -91.22 108.19 19.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.988 -0.551 . . . . 0.37 109.958 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -71.87 150.11 44.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.86 0.362 . . . . 1.69 110.511 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.1 m -57.3 -39.43 75.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.724 -0.671 . . . . 0.82 111.631 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -59.46 -41.62 90.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.263 -0.426 . . . . 0.62 111.642 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -60.57 -47.02 88.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.93 110.762 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.07 82.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.962 -0.563 . . . . 0.3 111.296 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.04 -40.79 98.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.919 -0.582 . . . . 0.47 109.976 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.38 -42.52 96.01 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.737 -0.665 . . . . 1.18 110.95 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 29.1 tp -66.96 -46.09 75.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.882 -0.599 . . . . 0.44 110.605 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.21 94.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.882 -0.599 . . . . 0.25 111.43 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.1 mtm105 -64.11 -30.33 71.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 1.54 110.934 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.5 m -75.15 -34.23 61.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.25 -0.432 . . . . 0.68 110.91 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -78.16 -24.64 47.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.231 -0.44 . . . . 0.77 110.715 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.33 37.1 8.38 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.828 -0.909 . . . . 0.25 110.828 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.6 pp -135.73 162.62 55.94 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.419 -0.39 . . . . 0.51 110.377 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.61 152.93 11.78 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.09 2.526 . . . . 0.36 112.73 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -134.49 130.59 36.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.513 -0.767 . . . . 0.38 110.4 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.62 137.2 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.47 -0.332 . . . . 0.54 110.169 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -77.31 141.89 39.69 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.843 -0.799 . . . . 0.88 108.843 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 64.8 p -138.47 171.69 13.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.792 0.806 . . . . 0.43 112.768 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.1 t -153.58 118.31 5.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.702 -1.136 . . . . 0.33 108.827 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.62 -23.54 62.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.042 0.448 . . . . 0.45 110.85 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -75.51 -39.93 57.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.177 -0.465 . . . . 1.32 111.621 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 61.9 p -102.32 -8.0 21.59 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.94 0.348 . . . . 0.52 111.94 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 65.1 23.13 12.38 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.419 0.628 . . . . 1.53 110.517 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 144' ' ' THR . 44.3 tt0 -81.45 127.46 32.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.11 -0.496 . . . . 0.87 111.237 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.408 ' C ' HG22 ' A' ' 144' ' ' THR . . . 78.14 -25.73 2.24 Favored Glycine 0 CA--C 1.518 0.268 0 CA-C-N 116.014 -0.539 . . . . 0.51 113.899 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.412 ' H ' HG23 ' A' ' 152' ' ' VAL . 6.6 t -57.09 -41.97 78.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 0.74 111.426 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -61.9 -46.49 89.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.364 0.602 . . . . 1.62 110.12 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.39 -45.87 82.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.291 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -54.72 -50.99 67.0 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.233 -0.439 . . . . 0.37 111.71 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -62.43 -39.34 92.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 1.46 111.292 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -68.11 -40.95 82.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.977 0.418 . . . . 0.99 110.498 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 46.5 m -62.16 -40.15 95.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.903 -0.589 . . . . 0.34 110.443 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 163' ' ' ILE . 43.5 tp -59.12 -43.35 91.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.763 0.316 . . . . 0.42 110.793 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.2 t -62.12 -43.25 97.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.031 0.443 . . . . 0.55 110.468 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -67.24 -34.53 77.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.9 110.668 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -65.73 -36.41 83.52 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.242 -0.651 . . . . 0.73 109.242 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 159' ' ' LEU . 96.2 mt -64.12 -48.63 84.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 109.112 -0.699 . . . . 0.42 109.112 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -60.77 -43.52 97.93 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.566 -0.743 . . . . 0.87 109.929 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.589 ' O ' ' HG3' ' A' ' 169' ' ' LYS . 33.8 ttmt -55.66 -42.51 75.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.778 -0.646 . . . . 0.97 110.466 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 169' ' ' LYS . 42.4 t60 -70.9 -31.26 67.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.71 111.435 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -87.39 -4.7 59.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.479 -0.328 . . . . 1.11 111.543 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -117.47 14.1 14.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.051 0.453 . . . . 1.12 111.142 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 165' ' ' LYS . 7.8 mtpp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.414 -0.803 . . . . 1.47 109.781 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.563 ' HA ' ' O ' ' A' ' 50' ' ' THR . 42.9 ttm . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.886 -0.413 . . . . 1.48 109.886 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.6 145.52 34.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.513 -0.312 . . . . 1.04 111.466 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -100.16 138.89 36.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.213 -0.662 . . . . 1.27 109.213 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -123.1 125.36 45.03 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.886 0.374 . . . . 1.11 110.356 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -88.44 102.73 15.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.296 0.57 . . . . 0.81 110.533 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 8.0 mp -107.89 131.87 54.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.585 -0.734 . . . . 1.39 110.382 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.45 124.62 64.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.277 -0.419 . . . . 0.81 110.913 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.6 t -95.17 119.75 43.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.22 -0.445 . . . . 0.44 109.958 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.412 ' HB ' ' CD1' ' A' ' 96' ' ' TYR . 12.0 m -112.54 155.04 13.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.953 0.406 . . . . 0.7 110.779 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.79 -176.12 37.43 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.281 -0.962 . . . . 0.53 112.537 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.56 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -80.24 161.54 25.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.127 0.489 . . . . 0.58 111.132 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.74 109.13 2.75 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.748 -0.739 . . . . 0.8 112.055 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.62 -2.7 17.87 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.582 -0.818 . . . . 0.42 113.391 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 11' ' ' ALA . 12.8 m -72.44 -28.19 27.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 117.32 0.56 . . . . 0.57 110.554 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.79 25.38 4.26 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.124 -1.036 . . . . 0.49 114.135 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -55.22 -55.6 29.47 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.066 0.46 . . . . 0.81 110.912 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -59.84 -36.42 76.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.245 -0.888 . . . . 0.58 111.719 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.66 -42.97 95.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.43 110.96 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.6 mt -66.66 -41.24 88.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.23 -0.441 . . . . 0.92 110.825 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.4 m -68.68 -46.04 70.1 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.886 -0.597 . . . . 0.89 111.767 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 82.1 mt -66.2 -24.83 34.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.712 0.291 . . . . 0.79 110.997 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 3.9 mm-40 -61.31 -35.42 77.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.797 0.332 . . . . 0.46 111.039 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 mp -84.86 -15.44 44.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.921 0.391 . . . . 1.37 111.17 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.4 mm -95.42 -56.45 5.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 112.207 0.447 . . . . 0.58 112.207 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -96.09 -10.28 28.74 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.815 0.302 . . . . 1.68 111.815 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 32.7 m-20 59.95 36.51 21.67 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.736 0.643 . . . . 1.6 112.736 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.88 136.35 15.05 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.655 -0.498 . . . . 0.74 109.655 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -70.54 125.3 26.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.077 -0.511 . . . . 0.6 111.033 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.3 t -90.43 113.03 25.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.068 -0.715 . . . . 0.64 109.068 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -75.27 -36.91 61.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.421 -0.354 . . . . 1.12 111.503 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -124.54 114.44 19.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.768 0.318 . . . . 1.18 110.432 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -143.83 130.17 19.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.328 -0.396 . . . . 0.6 110.371 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.5 ' HB3' HG13 ' A' ' 36' ' ' ILE . 39.2 t0 -65.05 125.75 89.84 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-N 115.523 -0.762 . . . . 0.8 110.62 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.39 -18.46 26.26 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.923 2.415 . . . . 0.52 113.507 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.1 p -84.36 0.12 50.51 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.77 0.319 . . . . 0.89 111.595 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.5 HG13 ' HB3' ' A' ' 33' ' ' ASP . 83.5 mt -83.07 122.88 38.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 110.084 -0.339 . . . . 0.73 110.084 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -122.76 112.72 18.25 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.469 -0.787 . . . . 0.81 109.61 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -144.4 167.21 23.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.836 0.351 . . . . 1.29 110.993 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 1.4 m -117.89 122.62 43.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.3 -0.63 . . . . 0.78 109.3 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -103.22 132.74 49.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.325 -0.398 . . . . 0.94 110.314 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.28 134.48 51.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.024 -0.535 . . . . 0.56 110.662 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -148.47 129.63 14.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.935 -0.575 . . . . 1.46 110.002 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.44 134.53 34.86 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.725 -0.472 . . . . 1.89 109.725 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.59 151.8 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.799 0.333 . . . . 1.09 110.864 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.5 t -111.41 91.7 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.928 -0.578 . . . . 0.65 109.874 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.24 121.77 54.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.102 -0.499 . . . . 1.06 109.946 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 64.75 23.51 12.74 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.723 -0.671 . . . . 0.97 111.316 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.93 -17.18 59.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.844 -0.693 . . . . 0.6 112.491 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -82.58 126.19 32.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.942 0.401 . . . . 1.41 110.862 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 1' ' ' MET . 5.0 m -93.59 103.34 15.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.115 -0.493 . . . . 0.63 109.891 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.0 m -121.71 156.65 32.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.194 0.521 . . . . 0.71 112.188 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.1 tp -108.43 118.66 37.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.181 -0.918 . . . . 0.48 108.712 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.23 121.66 33.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.001 0.429 . . . . 0.87 111.418 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -106.88 105.4 15.42 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.125 -1.065 . . . . 1.03 108.125 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 55.4 mt -112.81 130.46 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.978 0.418 . . . . 0.68 111.819 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 23.7 tp -106.24 118.14 35.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.925 -0.579 . . . . 0.46 110.505 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.31 93.33 9.36 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.918 -0.771 . . . . 0.44 108.918 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.29 146.31 52.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.896 -0.593 . . . . 0.73 111.674 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.21 -46.8 9.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.819 -0.628 . . . . 0.56 110.624 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.79 -70.1 0.34 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.696 -0.764 . . . . 0.72 112.161 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -97.99 111.04 23.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.908 0.385 . . . . 1.26 110.849 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.67 166.07 19.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.042 -0.526 . . . . 1.57 110.56 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.413 ' HB3' ' SD ' ' A' ' 67' ' ' MET . 25.0 tt0 -62.8 -45.89 90.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.641 -0.503 . . . . 1.38 109.641 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -127.85 142.8 51.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.063 -0.718 . . . . 0.81 109.063 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 m -61.56 -26.31 67.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.065 0.459 . . . . 0.63 111.102 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.79 -29.89 69.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.914 -0.584 . . . . 0.32 110.965 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.413 ' SD ' ' HB3' ' A' ' 63' ' ' GLU . 74.3 mtp -69.96 -41.38 74.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.895 -0.593 . . . . 0.69 110.006 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.648 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 36.3 ttp180 -64.43 -39.42 93.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.538 0.685 . . . . 0.9 109.571 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.22 -19.01 64.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.775 -1.102 . . . . 1.41 111.235 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -77.02 -55.8 5.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.329 -0.396 . . . . 1.51 111.752 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.648 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 7.0 p90 -68.51 -16.97 64.06 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.479 -0.488 . . . . 1.17 111.449 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.7 mtt -81.86 -12.95 58.23 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.868 -0.419 . . . . 0.7 109.868 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -95.01 -52.18 4.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.017 -0.538 . . . . 1.29 110.997 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -20.27 63.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.72 112.083 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.09 129.2 43.28 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.592 -0.813 . . . . 0.19 112.555 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -90.78 -48.5 7.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.998 0.427 . . . . 0.54 109.999 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.07 128.94 7.73 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.868 -0.682 . . . . 0.26 111.796 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.451 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 59.1 m-85 -111.05 127.84 55.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.115 0.483 . . . . 0.48 110.611 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.3 tp -94.44 108.78 20.7 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.453 -0.573 . . . . 0.37 109.453 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -89.01 93.89 9.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.886 -0.597 . . . . 0.61 109.822 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 2.3 t -109.59 139.48 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.388 0.613 . . . . 0.59 112.349 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -134.87 179.11 6.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.236 -0.893 . . . . 0.34 108.798 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.493 ' HB1' ' OD1' ' A' ' 85' ' ' ASN . . . -111.91 129.52 56.14 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.756 -0.461 . . . . 0.32 109.756 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 pt -67.06 -14.55 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.915 0.388 . . . . 0.78 111.419 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.493 ' OD1' ' HB1' ' A' ' 83' ' ' ALA . 22.5 p-10 -99.99 -4.52 29.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.01 0.433 . . . . 0.82 110.743 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -122.72 101.58 7.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.193 0.521 . . . . 1.07 110.229 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -26.82 67.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.926 -0.579 . . . . 0.65 111.98 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -65.25 -42.62 93.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.225 -0.443 . . . . 0.89 110.782 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 99.0 p -66.16 -28.64 68.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.679 0.276 . . . . 0.64 111.078 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -72.59 -39.44 67.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.243 0.544 . . . . 0.42 110.504 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -74.67 -29.86 61.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.196 -0.456 . . . . 1.44 110.54 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.63 -16.81 64.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.942 -0.572 . . . . 1.02 110.793 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 32.9 mm -57.55 -34.83 48.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.886 -0.597 . . . . 0.42 110.354 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -62.41 -46.49 88.34 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.075 -0.511 . . . . 0.83 110.646 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -57.51 -50.18 73.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.524 -0.762 . . . . 0.79 111.389 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.412 ' CD1' ' HB ' ' A' ' 9' ' ' VAL . 17.8 m-85 -63.69 -38.8 92.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.45 -0.341 . . . . 1.17 111.437 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -58.64 -50.72 72.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.6 110.187 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -67.08 -42.55 84.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.782 -0.644 . . . . 1.35 111.138 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -58.82 -57.56 12.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.002 -0.544 . . . . 1.15 112.078 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.8 mt -61.39 -39.2 81.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.671 -0.24 . . . . 0.51 111.304 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -60.96 -38.9 87.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 1.05 110.803 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -72.62 -40.07 66.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.91 110.921 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 75.4 t -64.61 -48.01 86.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.42 -0.354 . . . . 0.35 111.414 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -81.3 -10.08 59.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 0.63 111.177 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.9 t70 51.43 58.56 5.37 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.59 0.709 . . . . 0.47 110.812 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.2 m -150.03 138.78 20.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.725 -0.67 . . . . 1.14 110.569 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -74.02 -30.26 62.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 1.74 110.631 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -116.93 124.36 49.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.234 -0.439 . . . . 0.78 110.705 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.9 t -137.43 129.46 16.62 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.543 -0.539 . . . . 0.47 109.543 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.75 106.39 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.746 2.297 . . . . 0.25 111.935 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.451 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 63.7 mtt -138.03 157.49 46.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.886 -0.597 . . . . 0.79 110.596 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -140.07 124.52 19.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.159 -0.682 . . . . 0.22 109.159 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 21.7 tp -83.18 119.33 24.4 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.438 -0.579 . . . . 0.29 109.438 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 47.7 t -124.23 133.33 69.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.045 -0.525 . . . . 0.82 111.328 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -108.58 112.51 3.55 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.258 -1.137 . . . . 0.27 110.258 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -92.74 163.91 13.57 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.107 0.453 . . . . 0.21 111.399 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.526 ' HE3' ' O ' ' A' ' 14' ' ' VAL . 89.7 mttt 68.21 34.0 4.11 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.346 -0.843 . . . . 0.54 111.781 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 24.2 p -69.43 -11.51 60.89 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.032 0.444 . . . . 0.46 110.975 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.05 -13.29 41.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.032 -0.531 . . . . 0.7 110.457 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 22.1 mt -88.1 143.48 33.03 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.942 0.401 . . . . 0.67 111.029 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.32 -178.45 4.63 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.763 2.308 . . . . 0.54 112.096 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.1 m 66.45 42.33 2.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.807 -0.633 . . . . 0.84 110.32 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.5 ttm-85 -68.16 119.94 13.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.658 -0.701 . . . . 0.58 110.48 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.4 p -99.68 -27.71 13.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.424 -0.353 . . . . 0.81 110.902 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.7 t -97.96 114.22 34.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.441 -0.345 . . . . 0.37 110.421 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -77.02 150.29 35.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.427 -0.351 . . . . 1.69 110.674 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.43 -40.47 68.34 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.399 0.518 . . . . 0.82 112.399 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -62.2 -37.63 86.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.558 -0.292 . . . . 0.62 111.362 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -59.1 -46.63 87.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.119 0.485 . . . . 0.93 110.988 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.61 -39.15 58.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.961 -0.563 . . . . 0.3 111.339 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -61.4 -42.36 98.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.47 110.739 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.78 -38.82 80.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.276 -0.42 . . . . 1.18 110.558 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 43.5 tp -63.29 -46.42 86.87 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.956 -0.565 . . . . 0.44 111.146 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.5 -37.26 77.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.943 -0.572 . . . . 0.25 110.867 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 135' ' ' ARG . 31.9 ttm180 -66.13 -29.29 69.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.45 -0.795 . . . . 1.54 110.928 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.7 m -74.17 -29.98 62.03 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.303 0.573 . . . . 0.68 110.28 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -85.47 -30.14 23.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.97 -0.559 . . . . 0.77 110.423 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.31 26.65 10.83 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.957 -0.857 . . . . 0.25 110.957 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 23.7 pt -124.56 166.25 20.81 Favored Pre-proline 0 N--CA 1.452 -0.345 0 N-CA-C 110.007 -0.368 . . . . 0.51 110.007 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -90.79 160.29 4.13 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.521 2.148 . . . . 0.36 112.736 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 16.9 t80 -127.16 131.09 50.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.376 -0.375 . . . . 0.38 110.309 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 53.4 mt -133.14 131.54 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.603 -0.272 . . . . 0.54 111.112 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -83.85 130.39 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.836 -0.801 . . . . 0.88 108.836 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 71.3 p -137.6 176.38 8.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.625 0.726 . . . . 0.43 112.162 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.8 t -161.41 114.69 1.91 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.747 -1.115 . . . . 0.33 108.71 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.45 -15.93 63.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.203 0.525 . . . . 0.45 110.605 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -80.58 -29.69 36.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.573 -0.739 . . . . 1.32 111.504 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 149' ' ' ARG . 21.1 p -116.18 -8.55 11.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.462 0.541 . . . . 0.52 112.462 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 148' ' ' THR . 21.4 mtp85 70.69 13.69 7.21 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.065 -0.516 . . . . 1.53 111.099 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 144' ' ' THR . 53.1 tt0 -66.94 112.37 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.453 -0.34 . . . . 0.87 111.78 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 67.18 3.51 24.45 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 114.602 0.601 . . . . 0.51 114.602 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 82.3 t -59.53 -49.25 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 117.83 0.815 . . . . 0.74 110.743 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.38 -46.61 87.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.25 0.547 . . . . 1.62 109.939 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -54.07 -46.85 72.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.056 -0.975 . . . . 1.0 111.851 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.61 -47.61 81.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.127 -0.488 . . . . 0.37 111.755 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.463 ' O ' HG23 ' A' ' 160' ' ' VAL . 41.6 m-85 -64.97 -43.66 91.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.307 -0.406 . . . . 1.46 111.427 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -63.89 -37.46 87.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.859 0.361 . . . . 0.99 110.739 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 93.0 m -62.37 -43.96 97.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.918 -0.583 . . . . 0.34 110.808 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.592 ' O ' HG13 ' A' ' 163' ' ' ILE . 30.7 tp -58.22 -45.53 87.51 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.642 -0.254 . . . . 0.42 110.911 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 156' ' ' PHE . 6.1 t -60.9 -39.92 83.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.941 0.4 . . . . 0.55 110.512 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -68.76 -33.76 74.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 0.9 110.985 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -65.91 -40.58 91.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.321 -0.622 . . . . 0.73 109.321 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 159' ' ' LEU . 31.3 mt -62.42 -41.9 93.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.955 -0.757 . . . . 0.42 108.955 178.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.559 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 4.4 mtt180 -53.36 -58.34 7.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.013 -0.994 . . . . 0.87 110.921 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.407 ' HA ' ' HG2' ' A' ' 168' ' ' GLU . 51.3 mtmt -62.13 -20.12 63.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.432 -0.803 . . . . 0.97 111.955 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -83.38 -33.99 25.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.767 0.318 . . . . 0.71 110.603 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 163' ' ' ILE . 46.8 mtpt -87.06 -8.33 57.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.094 0.405 . . . . 1.11 112.094 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 8.8 pt-20 -108.92 25.11 12.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.961 0.41 . . . . 1.12 110.771 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 36.4 mttm . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.447 -0.787 . . . . 1.47 109.851 179.291 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 ttm . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 120.64 0.257 . . . . 1.48 110.574 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.0 m -111.53 149.06 31.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.523 -0.308 . . . . 1.04 110.356 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -98.41 131.75 44.43 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.046 -0.353 . . . . 1.27 110.046 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -109.91 133.35 53.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.855 -0.424 . . . . 1.11 109.855 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -94.98 104.61 16.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.267 -0.424 . . . . 0.81 110.72 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 10.2 mp -112.82 119.63 38.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.872 -0.604 . . . . 1.39 111.031 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.73 120.23 61.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.181 0.515 . . . . 0.81 110.153 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.7 t -92.25 112.9 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.827 -0.624 . . . . 0.44 109.796 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 m -114.96 -175.45 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.187 -0.46 . . . . 0.7 110.638 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.79 -176.08 22.66 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.716 -0.754 . . . . 0.53 111.789 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.91 -175.34 2.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.783 0.325 . . . . 0.58 111.188 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.23 131.41 10.39 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.586 -0.816 . . . . 0.8 113.188 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.47 17.37 79.82 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.287 -0.482 . . . . 0.42 113.835 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -77.09 -34.52 21.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 117.492 0.646 . . . . 0.57 111.004 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.47 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 132.89 24.49 0.72 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.616 -0.802 . . . . 0.49 113.137 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -56.69 -41.27 77.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.061 0.458 . . . . 0.81 111.046 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.81 2.01 50.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.58 112.093 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.47 -44.76 5.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.712 0.291 . . . . 0.43 110.801 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.544 HD23 ' HB2' ' A' ' 146' ' ' ALA . 44.7 mt -58.71 -42.78 89.47 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.558 0.694 . . . . 0.92 110.483 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.493 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -60.89 -52.44 65.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.948 -1.023 . . . . 0.89 111.701 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 29' ' ' VAL . 39.8 mt -65.37 -31.09 52.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.388 -0.369 . . . . 0.79 111.379 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.612 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 2.8 mm-40 -69.27 -22.38 63.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.999 0.428 . . . . 0.46 110.335 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.8 tp -94.16 -26.83 16.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.118 -0.492 . . . . 1.37 110.649 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 20' ' ' THR . 35.3 mm -89.73 -60.25 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.58 111.558 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -92.51 -13.95 29.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.499 -0.319 . . . . 1.68 111.437 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 7.9 m-20 66.57 24.71 10.16 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 123.513 0.508 . . . . 1.6 111.758 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -129.92 146.51 51.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.711 -0.477 . . . . 0.74 109.711 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -85.12 129.97 34.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.377 -0.374 . . . . 0.6 111.135 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.406 HG21 HD12 ' A' ' 21' ' ' ILE . 60.8 t -96.95 125.05 50.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.64 109.955 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -75.7 -46.38 31.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.763 -0.653 . . . . 1.12 111.815 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -130.07 123.73 31.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.969 0.414 . . . . 1.18 111.118 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -145.42 146.92 31.72 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.156 -0.683 . . . . 0.6 109.156 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -71.66 119.42 74.0 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 0.8 110.367 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.94 -17.33 32.31 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.49 2.127 . . . . 0.52 113.615 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.24 -7.49 59.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.096 0.474 . . . . 0.89 111.434 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.2 mt -80.77 119.69 30.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.197 0.522 . . . . 0.73 110.771 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 22.3 tt0 -118.01 79.49 1.38 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.097 -0.956 . . . . 0.81 108.641 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -106.39 159.39 16.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.136 -0.483 . . . . 1.29 111.054 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.66 124.52 52.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.231 -0.44 . . . . 0.78 110.325 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -101.97 136.81 41.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.121 -0.491 . . . . 0.94 110.347 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.06 128.53 55.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.88 0.371 . . . . 0.56 111.234 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -144.51 137.59 26.98 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.387 -0.598 . . . . 1.46 109.387 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -116.26 119.34 35.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.704 0.288 . . . . 1.89 110.343 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.9 t -138.58 153.02 25.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.446 . . . . 1.09 109.877 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 13.2 t -76.73 103.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.64 -0.504 . . . . 0.65 109.64 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.3 mt -105.37 111.94 36.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.343 -0.389 . . . . 1.06 111.008 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.458 ' HB2' HH12 ' A' ' 164' ' ' ARG . 31.3 m-20 65.4 27.09 11.92 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.757 -0.656 . . . . 0.97 111.518 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.49 5.29 65.25 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.873 -0.679 . . . . 0.6 112.469 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -126.54 119.75 27.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.791 0.329 . . . . 1.41 111.172 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 23.6 m -77.11 106.75 9.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.641 -0.503 . . . . 0.63 109.641 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.1 m -117.71 147.48 42.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.224 0.535 . . . . 0.71 111.212 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.0 tp -90.74 122.22 33.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.547 -0.751 . . . . 0.48 109.113 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 53' ' ' LEU . 14.3 mt -93.61 113.44 25.54 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.955 0.407 . . . . 0.87 111.591 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -100.43 87.71 3.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.256 -1.387 . . . . 1.03 107.256 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 6.6 mt -99.54 127.64 52.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.724 -0.671 . . . . 0.68 111.881 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.9 tp -107.88 121.24 44.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.557 -0.747 . . . . 0.46 111.112 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 1.7 t70 -87.47 94.97 9.86 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.44 -0.948 . . . . 0.44 108.44 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.492 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 81.2 p -65.98 146.42 54.72 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.466 0.651 . . . . 0.73 111.838 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.01 -58.17 2.56 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.155 -0.929 . . . . 0.56 109.287 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.16 -96.96 0.15 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.799 -0.715 . . . . 0.72 111.999 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -83.77 158.44 21.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.679 0.276 . . . . 1.26 110.533 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -130.32 165.86 21.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.238 -0.437 . . . . 1.57 110.32 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -78.89 -35.36 43.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.331 -0.618 . . . . 1.38 109.331 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -119.86 124.03 45.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.592 -0.731 . . . . 0.81 109.517 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -58.46 -34.9 71.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.419 -0.355 . . . . 0.63 111.382 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.26 -27.48 69.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.32 111.4 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 78.0 mtp -72.64 -32.65 66.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.69 110.467 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -71.17 -46.07 62.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.896 -0.593 . . . . 0.9 110.071 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -73.63 -9.06 58.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.654 -0.703 . . . . 1.41 111.449 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -67.19 -60.28 2.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.817 -0.174 . . . . 1.51 111.046 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -72.51 -15.88 61.79 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.695 -0.402 . . . . 1.17 111.091 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 35.7 mtt -70.35 -25.74 63.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.24 0.543 . . . . 0.7 109.937 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 73' ' ' ARG . 48.5 mtm180 -84.17 -48.54 9.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.83 -0.623 . . . . 1.29 110.673 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -22.67 63.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.938 -0.574 . . . . 0.72 111.953 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.01 123.45 26.3 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.018 -0.61 . . . . 0.19 112.087 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -88.9 -40.85 12.8 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.943 -0.391 . . . . 0.54 109.943 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -128.88 130.12 6.37 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.414 -0.674 . . . . 0.26 111.414 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -113.98 133.83 55.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.015 0.436 . . . . 0.48 111.128 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.8 tp -100.1 106.23 17.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.864 -0.607 . . . . 0.37 110.221 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.5 m -92.36 97.44 10.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.004 0.43 . . . . 0.61 110.343 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 4.9 t -110.31 134.1 53.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.002 -0.545 . . . . 0.59 111.37 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -129.6 172.66 11.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.729 -0.668 . . . . 0.34 109.441 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.78 133.3 52.37 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.727 -0.471 . . . . 0.32 109.727 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.432 HD11 ' HA ' ' A' ' 118' ' ' CYS . 29.0 pt -76.92 -4.17 6.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 112.782 0.66 . . . . 0.78 112.782 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -85.6 -12.18 52.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.738 -0.21 . . . . 0.82 111.105 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.469 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 30.8 t-20 -139.79 123.94 17.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.367 . . . . 1.07 110.725 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.8 m -69.83 -28.2 65.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.057 -0.52 . . . . 0.65 111.652 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -60.97 -39.29 89.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.618 0.247 . . . . 0.89 110.721 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -64.75 -32.43 74.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.137 0.494 . . . . 0.64 110.313 179.147 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -76.95 -35.66 57.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.76 -0.655 . . . . 0.42 110.115 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -72.01 -29.8 64.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.707 -0.678 . . . . 1.44 110.582 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.38 -24.02 67.14 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.042 -0.527 . . . . 1.02 110.592 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.9 mm -61.45 -30.63 48.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.518 -0.764 . . . . 0.42 110.684 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -60.76 -41.38 95.34 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.205 0.526 . . . . 0.83 109.695 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -71.86 -38.43 70.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.562 -0.744 . . . . 0.79 110.639 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -63.75 -47.42 81.1 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.252 0.464 . . . . 1.17 112.252 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 25.7 tpt180 -63.73 -33.37 75.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.671 0.272 . . . . 0.6 110.856 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -79.19 -43.86 23.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.283 -0.417 . . . . 1.35 111.541 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -58.6 -56.99 14.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.086 0.402 . . . . 1.15 112.086 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.5 mt -63.38 -31.07 51.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.359 -0.382 . . . . 0.51 110.772 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 39.0 ttpt -62.97 -35.38 79.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.343 0.592 . . . . 1.05 110.198 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -78.02 -40.61 38.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.713 -0.676 . . . . 0.91 110.592 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 87.3 t -58.78 -50.75 78.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.907 -0.588 . . . . 0.35 110.863 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -82.08 -11.61 58.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.084 -0.507 . . . . 0.63 111.036 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.8 t70 54.81 48.82 19.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.583 0.706 . . . . 0.47 110.753 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.5 t -158.45 144.42 16.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.51 -0.768 . . . . 1.14 110.317 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -90.97 -17.72 25.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.079 0.466 . . . . 1.74 110.76 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -91.08 68.99 6.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.595 0.712 . . . . 0.78 110.604 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 85.2 t -108.57 112.34 60.78 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.289 -0.869 . . . . 0.47 109.659 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.82 113.42 1.31 Allowed 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.915 2.41 . . . . 0.25 111.656 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 28.6 mtt -141.99 153.35 44.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.09 -0.505 . . . . 0.79 111.223 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.3 t -131.91 123.9 52.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.482 -0.781 . . . . 0.22 109.035 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 41.0 tp -85.37 121.85 28.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.042 -0.725 . . . . 0.29 109.042 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 11.2 t -127.19 138.05 55.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.004 0.431 . . . . 0.82 111.532 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.87 106.85 2.12 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 110.164 -1.174 . . . . 0.27 110.164 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -89.2 165.5 14.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.735 0.267 . . . . 0.21 111.024 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 67.52 34.85 4.43 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 115.466 -0.788 . . . . 0.54 111.008 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.432 ' HA ' HD11 ' A' ' 84' ' ' ILE . 27.5 p -68.75 -13.0 62.11 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.869 0.366 . . . . 0.46 111.344 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.67 -13.72 47.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.7 110.612 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 44.1 mt -82.51 142.06 45.96 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.399 -0.364 . . . . 0.67 110.175 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.3 -177.52 3.9 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.603 2.202 . . . . 0.54 111.925 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.5 m 62.83 48.75 3.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.295 0.569 . . . . 0.84 111.181 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.3 ttm-85 -72.38 110.99 7.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.749 -0.66 . . . . 0.58 109.95 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 p -95.14 -21.01 18.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.07 0.462 . . . . 0.81 110.728 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -98.69 110.33 25.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.115 -0.493 . . . . 0.37 110.051 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.99 143.12 56.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.985 -0.552 . . . . 1.69 111.176 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 m -59.54 -39.92 85.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.006 -0.543 . . . . 0.82 110.787 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -61.53 -38.52 87.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.62 110.954 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -58.4 -51.94 67.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.139 0.495 . . . . 0.93 110.744 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.43 -40.52 85.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.714 -0.675 . . . . 0.3 110.875 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -61.38 -40.49 94.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.811 -0.631 . . . . 0.47 110.356 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 -46.46 79.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.384 -0.371 . . . . 1.18 110.15 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.85 -44.91 93.87 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.804 -0.634 . . . . 0.44 111.0 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.73 -43.55 98.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.965 -0.561 . . . . 0.25 110.865 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -63.66 -36.16 82.91 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.837 -0.62 . . . . 1.54 111.95 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.4 p -74.77 -23.28 58.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.428 . . . . 0.68 111.133 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -89.45 -16.92 29.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.77 111.011 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.83 30.1 33.09 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.97 -0.559 . . . . 0.25 111.806 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 40.0 pt -127.08 152.97 76.55 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.7 -0.25 . . . . 0.51 110.543 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.7 148.51 22.82 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.669 2.246 . . . . 0.36 112.189 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 17.6 t80 -125.35 124.32 41.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.381 -0.372 . . . . 0.38 110.61 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.7 mt -132.61 133.73 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.34 -0.391 . . . . 0.54 110.343 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -88.52 135.01 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.812 -0.811 . . . . 0.88 108.812 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 70.6 p -138.96 175.53 9.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.52 0.676 . . . . 0.43 112.447 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.1 t -152.06 109.44 3.58 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.008 -0.996 . . . . 0.33 108.749 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.544 ' HB2' HD23 ' A' ' 19' ' ' LEU . . . -68.42 -24.48 64.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.273 0.558 . . . . 0.45 110.286 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -67.57 -47.83 68.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.004 -0.998 . . . . 1.32 111.296 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.9 p -97.04 3.91 51.66 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.711 -0.395 . . . . 0.52 110.925 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 55.83 45.73 23.63 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.55 -0.75 . . . . 1.53 110.414 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -107.72 120.74 43.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.447 -0.797 . . . . 0.87 111.056 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.31 -1.24 57.31 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.807 -0.633 . . . . 0.51 113.747 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 32.6 t -60.1 -42.29 89.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.981 0.391 . . . . 0.74 110.744 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.28 -50.77 62.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.795 -0.639 . . . . 1.62 110.203 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.12 -45.84 72.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.575 -0.739 . . . . 1.0 111.857 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.94 81.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.664 0.268 . . . . 0.37 111.247 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -66.64 -44.1 82.87 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.385 -0.371 . . . . 1.46 111.231 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -63.73 -42.35 97.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.446 -0.343 . . . . 0.99 111.564 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.445 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 36.6 m -61.82 -38.02 86.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.693 -0.23 . . . . 0.34 110.576 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 163' ' ' ILE . 48.3 tp -62.77 -40.6 97.79 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.901 -0.407 . . . . 0.42 109.901 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.83 -41.51 85.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.494 . . . . 0.55 110.078 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -67.77 -38.26 83.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.9 110.411 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 158' ' ' THR . 63.5 mm-40 -60.11 -43.51 95.56 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.93 -0.577 . . . . 0.73 110.814 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 159' ' ' LEU . 27.1 mt -67.53 -46.07 83.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.94 -0.573 . . . . 0.42 110.758 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 85.9 mtt180 -57.2 -42.22 80.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.152 -0.477 . . . . 0.87 111.447 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -59.56 -34.99 73.37 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.812 0.339 . . . . 0.97 110.951 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -79.67 -30.91 41.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.879 0.371 . . . . 0.71 110.209 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -67.93 -33.64 75.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.106 -0.497 . . . . 1.11 111.799 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 11.9 pt-20 -102.9 17.58 23.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.198 0.523 . . . . 1.12 110.602 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 17.8 tttp . . . . . 0 C--O 1.25 1.13 0 CA-C-N 115.518 -0.764 . . . . 1.47 110.195 -179.739 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.585 ' HA ' ' O ' ' A' ' 50' ' ' THR . 24.8 ttt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.982 -0.377 . . . . 1.48 109.982 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.1 m -106.09 144.15 33.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.116 -0.493 . . . . 1.04 110.752 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -93.26 135.41 34.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.224 -0.444 . . . . 1.27 110.795 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 51' ' ' CYS . 35.0 m-85 -121.84 117.99 27.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.325 -0.62 . . . . 1.11 109.325 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -95.17 107.77 19.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.959 0.409 . . . . 0.81 110.516 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 1.2 mp -119.46 141.74 48.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.853 -0.612 . . . . 1.39 110.965 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.04 135.67 62.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.227 -0.442 . . . . 0.81 110.552 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.44 115.82 47.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.614 -0.513 . . . . 0.44 109.614 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.6 m -114.06 169.32 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.123 -0.489 . . . . 0.7 110.251 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.27 170.22 17.9 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.792 -0.718 . . . . 0.53 112.033 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.528 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -67.81 159.14 30.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.075 0.464 . . . . 0.58 111.714 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.12 99.63 0.72 Allowed Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.827 -0.624 . . . . 0.8 112.872 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.26 7.69 5.77 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.673 -0.775 . . . . 0.42 113.142 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 11' ' ' ALA . 12.4 m -79.59 -39.06 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.558 -0.457 . . . . 0.57 110.625 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.515 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 126.58 24.97 1.32 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.557 -0.83 . . . . 0.49 113.573 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -50.98 -52.38 43.25 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.907 0.354 . . . . 0.81 111.76 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.64 -40.2 92.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.419 -0.355 . . . . 0.58 111.679 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.76 -42.55 97.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 0.43 111.548 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 72.0 mt -59.59 -44.88 93.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.368 . . . . 0.92 111.341 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.461 ' O ' HG12 ' A' ' 24' ' ' ILE . 7.7 m -67.16 -51.42 53.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.214 -0.448 . . . . 0.89 111.788 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.96 -31.45 47.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.67 0.272 . . . . 0.79 111.697 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 4.8 mm-40 -61.12 -30.0 70.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.913 0.387 . . . . 0.46 111.046 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tp -95.34 -35.76 11.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.302 -0.408 . . . . 1.37 111.318 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 20' ' ' THR . 40.3 mm -74.14 -55.79 11.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.409 0.522 . . . . 0.58 112.409 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -99.82 1.48 43.08 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.045 0.387 . . . . 1.68 112.045 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 73.0 m-20 57.81 32.61 22.15 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.63 0.974 . . . . 1.6 113.63 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -153.92 146.73 24.33 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.686 -0.405 . . . . 0.74 110.805 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -82.02 129.53 34.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.952 -0.567 . . . . 0.6 110.693 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.0 t -98.86 121.41 49.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.05 -0.523 . . . . 0.64 109.891 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.51 -55.95 8.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.615 -0.72 . . . . 1.12 111.445 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -113.77 115.12 27.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.324 0.583 . . . . 1.18 111.665 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -141.77 136.04 30.3 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.906 -0.776 . . . . 0.6 108.906 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -62.71 117.47 32.14 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 120.854 0.359 . . . . 0.8 110.561 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.92 -25.87 38.33 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.69 2.26 . . . . 0.52 112.898 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -8.47 57.05 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.382 0.512 . . . . 0.89 112.382 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.3 mt -79.24 119.51 28.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.068 0.461 . . . . 0.73 111.105 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 8.6 tt0 -111.13 97.9 7.13 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.411 -0.959 . . . . 0.81 108.411 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -126.43 163.1 24.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.764 0.316 . . . . 1.29 110.706 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.13 145.39 44.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.036 -0.529 . . . . 0.78 109.841 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -131.64 138.35 48.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.748 0.309 . . . . 0.94 110.286 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.427 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 0.7 OUTLIER -112.68 127.79 56.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.194 -0.457 . . . . 0.56 110.358 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -141.6 120.88 13.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.19 -0.459 . . . . 1.46 110.144 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 10.4 pt20 -93.15 122.0 35.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.947 0.403 . . . . 1.89 110.524 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.3 t -125.83 143.75 38.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.076 -0.511 . . . . 1.09 110.169 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 t -86.24 102.22 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.299 -0.63 . . . . 0.65 109.299 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.41 HG22 ' OD2' ' A' ' 47' ' ' ASP . 9.9 mt -114.17 123.36 69.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.849 -0.614 . . . . 1.06 110.743 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.41 ' OD2' HG22 ' A' ' 46' ' ' ILE . 21.7 m-20 64.77 22.59 12.58 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.605 0.566 . . . . 0.97 111.495 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.32 0.95 72.66 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.767 -0.73 . . . . 0.6 112.679 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -116.68 132.61 56.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.657 0.265 . . . . 1.41 110.83 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 1' ' ' MET . 1.3 m -82.9 111.67 19.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.87 -0.418 . . . . 0.63 109.87 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.431 ' HB3' ' CD2' ' A' ' 4' ' ' TYR . 2.5 m -112.45 134.73 53.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.391 -0.368 . . . . 0.71 111.233 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.9 tp -92.49 107.5 19.26 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.853 -0.795 . . . . 0.48 108.853 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 35.7 mt -82.66 115.64 21.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.22 -0.445 . . . . 0.87 111.547 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.427 ' OD1' ' HD2' ' A' ' 41' ' ' ARG . 12.5 t70 -103.4 95.65 6.22 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.941 -1.133 . . . . 1.03 107.941 178.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 31.1 mt -109.47 135.01 49.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.236 0.541 . . . . 0.68 111.646 -177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.7 tp -112.13 119.48 38.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.353 -0.84 . . . . 0.46 110.631 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 2.5 t70 -87.36 99.81 12.26 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.695 -0.854 . . . . 0.44 108.695 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.7 p -72.15 153.1 41.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.806 -0.634 . . . . 0.73 111.41 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.54 -63.92 1.08 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.176 -0.675 . . . . 0.56 109.176 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.75 -91.49 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.683 -0.689 . . . . 0.72 111.549 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -121.98 130.66 53.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.071 -0.344 . . . . 1.26 110.071 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.81 179.22 6.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.44 . . . . 1.57 110.764 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.18 -43.65 94.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.728 -0.669 . . . . 1.38 110.017 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -120.59 145.04 47.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.602 -0.726 . . . . 0.81 109.577 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -63.09 -34.6 77.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.318 -0.401 . . . . 0.63 111.26 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.91 -30.94 71.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.325 -0.398 . . . . 0.32 111.861 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 95.0 mtp -66.56 -33.46 75.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.094 0.474 . . . . 0.69 109.983 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -76.96 -39.93 48.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.729 -0.669 . . . . 0.9 109.856 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.32 -11.02 60.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.686 -0.688 . . . . 1.41 110.875 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -66.03 -69.28 0.31 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.017 -0.538 . . . . 1.51 110.347 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.444 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 8.3 p90 -70.41 -11.92 61.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.439 -0.346 . . . . 1.17 111.688 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.9 mtt -73.16 -13.98 61.27 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.903 -0.406 . . . . 0.7 109.903 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.489 ' CG ' HG12 ' A' ' 103' ' ' VAL . 64.4 mtm180 -109.22 -33.61 6.81 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.062 -0.517 . . . . 1.29 110.808 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -79.9 -15.55 57.1 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.482 -0.326 . . . . 0.72 111.661 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.8 134.12 34.94 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.705 -0.759 . . . . 0.19 112.439 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.8 -36.64 11.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.836 0.351 . . . . 0.54 110.359 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.83 128.2 6.8 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.99 -0.624 . . . . 0.26 111.676 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.513 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 94.1 m-85 -112.09 121.36 44.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.121 0.486 . . . . 0.48 110.682 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.6 tp -100.18 109.27 21.52 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.86 -0.609 . . . . 0.37 110.765 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 2.7 m -94.18 102.19 14.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.137 -0.483 . . . . 0.61 110.012 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.441 HG22 ' HB ' ' A' ' 114' ' ' VAL . 15.1 t -109.3 140.61 27.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.104 0.478 . . . . 0.59 111.374 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.39 170.53 15.92 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.746 -0.835 . . . . 0.34 108.746 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . . . -105.32 133.27 50.37 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.977 -0.379 . . . . 0.32 109.977 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 pt -66.49 -16.93 21.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.891 0.376 . . . . 0.78 111.496 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -107.78 10.12 28.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.005 0.431 . . . . 0.82 110.935 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 13.0 t-20 -132.7 92.69 3.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.087 0.47 . . . . 1.07 110.539 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -33.62 71.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.657 -0.701 . . . . 0.65 111.811 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -58.24 -45.46 87.72 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.945 0.402 . . . . 0.89 110.999 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.8 p -68.0 -28.13 67.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.64 110.974 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -76.06 -43.57 43.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.005 0.431 . . . . 0.42 110.686 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -67.28 -33.37 75.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 1.44 110.98 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -66.98 -19.76 65.77 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.42 -0.355 . . . . 1.02 111.1 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.48 -29.7 42.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 121.16 0.505 . . . . 0.42 109.994 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -62.25 -36.1 80.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.752 -0.658 . . . . 0.83 110.339 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -80.73 -24.75 38.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.194 -0.912 . . . . 0.79 110.762 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -62.45 -59.37 5.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.51 . . . . 1.17 110.183 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -55.41 -46.43 76.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.928 -0.578 . . . . 0.6 109.91 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -56.15 -48.83 75.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.298 -0.865 . . . . 1.35 111.903 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.623 ' O ' HG23 ' A' ' 103' ' ' VAL . 22.7 tt0 -61.79 -57.31 12.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.264 -0.426 . . . . 1.15 111.266 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.6 mt -60.07 -35.31 60.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 111.911 0.338 . . . . 0.51 111.911 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -59.53 -39.32 83.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.863 0.363 . . . . 1.05 110.569 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -75.05 -45.98 37.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.81 -0.632 . . . . 0.91 110.954 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 99' ' ' GLN . 21.8 t -59.9 -49.42 83.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.35 112.118 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.401 ' CG ' ' HA ' ' A' ' 73' ' ' ARG . 15.0 mtpp -81.7 -13.32 58.0 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.218 -0.193 . . . . 0.63 111.416 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.5 t70 54.61 50.64 15.52 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.882 -0.599 . . . . 0.47 111.224 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.9 m -141.54 144.51 34.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.333 -0.394 . . . . 1.14 110.176 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -44.12 28.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.364 . . . . 1.74 111.372 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -99.88 119.28 37.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.846 0.355 . . . . 0.78 110.46 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.82 123.8 21.27 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 115.977 -0.556 . . . . 0.47 110.142 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.84 108.09 0.45 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.435 2.09 . . . . 0.25 111.811 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.513 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 46.5 mtt -139.27 155.19 47.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.078 0.466 . . . . 0.79 111.174 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.3 t -135.06 124.71 43.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.524 -0.762 . . . . 0.22 108.953 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 19.0 tp -84.42 120.54 26.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.567 -0.531 . . . . 0.29 109.567 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.441 ' HB ' HG22 ' A' ' 81' ' ' VAL . 21.7 t -122.96 131.21 73.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.147 -0.479 . . . . 0.82 112.132 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -108.35 95.7 0.96 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.348 -1.101 . . . . 0.27 110.348 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -78.54 161.44 27.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.925 0.393 . . . . 0.21 111.879 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 81.2 mttt 63.7 35.98 11.03 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 115.31 -0.859 . . . . 0.54 110.895 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 28.2 p -69.74 -13.16 62.15 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.978 -0.556 . . . . 0.46 111.475 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -82.36 -10.11 59.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.029 -0.532 . . . . 0.7 110.951 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 58.6 mt -83.24 141.41 42.88 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.962 0.411 . . . . 0.67 110.671 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.28 -178.69 4.61 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.186 1.924 . . . . 0.54 111.588 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.8 m 63.5 45.71 4.63 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.183 -0.462 . . . . 0.84 111.059 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 123' ' ' ARG . 29.1 ttm-85 -59.27 123.03 15.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.965 -0.562 . . . . 0.58 110.401 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.81 -24.77 14.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.913 0.387 . . . . 0.81 111.1 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.3 t -104.82 111.68 35.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.166 -0.47 . . . . 0.37 110.758 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.1 141.58 58.67 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.756 -0.461 . . . . 1.69 109.756 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.83 -30.16 56.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.189 0.518 . . . . 0.82 112.131 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -68.05 -34.32 76.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.887 -0.597 . . . . 0.62 111.723 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -59.53 -57.12 14.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.952 0.353 . . . . 0.93 111.952 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.94 89.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.509 -0.314 . . . . 0.3 111.432 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -63.01 -44.13 96.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.016 0.436 . . . . 0.47 110.069 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.48 -38.72 90.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.656 -0.702 . . . . 1.18 110.304 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 65.5 tp -68.51 -41.05 80.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.717 -0.674 . . . . 0.44 110.898 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.7 91.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.25 110.408 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 135' ' ' ARG . 37.8 ttm105 -62.89 -36.81 84.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.91 -0.586 . . . . 1.54 110.774 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.0 m -69.19 -26.28 64.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.045 0.45 . . . . 0.68 111.138 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -91.09 -19.61 22.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.491 . . . . 0.77 111.187 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.43 27.53 47.6 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.629 -0.796 . . . . 0.25 111.564 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 26.6 pt -125.54 159.11 62.14 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.887 -0.412 . . . . 0.51 109.887 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.45 160.62 17.15 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.678 2.252 . . . . 0.36 112.901 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 13.4 t80 -135.74 131.53 35.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.541 -0.754 . . . . 0.38 110.316 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 37.3 mt -142.74 134.97 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.364 -0.38 . . . . 0.54 110.386 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -84.21 137.85 33.28 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.067 -0.716 . . . . 0.88 109.067 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.9 p -138.31 173.17 11.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.633 0.73 . . . . 0.43 111.716 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.4 t -149.01 123.08 9.45 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.066 -1.087 . . . . 0.33 108.066 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.44 -11.74 61.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.746 0.308 . . . . 0.45 111.291 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -85.13 -57.77 2.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.065 -0.516 . . . . 1.32 111.498 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.9 p -86.74 -10.33 53.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.333 . . . . 0.52 111.463 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 59.69 40.27 20.08 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.683 -0.69 . . . . 1.53 110.744 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -85.29 114.99 22.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.132 -0.486 . . . . 0.87 110.78 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.1 8.4 61.58 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.941 -0.572 . . . . 0.51 112.985 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 22.2 t -65.5 -50.88 69.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.766 0.317 . . . . 0.74 110.814 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.93 -37.63 84.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.103 0.477 . . . . 1.62 109.815 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.7 -42.72 93.62 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.134 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.68 79.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.915 -0.584 . . . . 0.37 111.733 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.402 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.5 OUTLIER -70.94 -39.72 72.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.29 -0.414 . . . . 1.46 111.494 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -61.48 -35.74 78.5 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.952 -0.388 . . . . 0.99 109.952 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 22.3 m -70.59 -35.22 72.9 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.541 -0.54 . . . . 0.34 109.541 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.27 -40.53 97.65 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.494 -0.558 . . . . 0.42 109.494 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 156' ' ' PHE . 94.0 t -61.78 -42.15 93.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.344 0.592 . . . . 0.55 109.712 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -65.3 -36.03 82.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.463 -0.79 . . . . 0.9 110.146 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -66.78 -38.84 87.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.967 -0.383 . . . . 0.73 109.967 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.522 ' O ' ' HG3' ' A' ' 167' ' ' LYS . 88.4 mt -61.81 -52.21 63.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.307 -0.627 . . . . 0.42 109.307 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.607 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 99.1 mtt180 -55.91 -44.81 78.6 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 115.529 -0.759 . . . . 0.87 110.077 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -56.49 -42.81 78.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.42 -0.809 . . . . 0.97 111.842 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -71.24 -36.03 71.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.245 -0.434 . . . . 0.71 111.519 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 163' ' ' ILE . 30.7 mtpt -74.67 -29.7 61.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.407 0.521 . . . . 1.11 112.407 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 6.6 pt-20 -86.77 -12.36 48.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.717 0.294 . . . . 1.12 111.14 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 31.7 tttp . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.431 -0.795 . . . . 1.47 110.395 -179.6 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.409 ' HA ' ' O ' ' A' ' 50' ' ' THR . 13.0 tmm? . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.196 -0.298 . . . . 1.48 110.196 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.448 ' HB ' ' CE2' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -113.87 138.7 49.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.372 -0.376 . . . . 1.04 110.893 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -96.32 131.37 42.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.529 -0.545 . . . . 1.27 109.529 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.448 ' CE2' ' HB ' ' A' ' 2' ' ' THR . 85.5 m-85 -120.91 124.55 45.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.567 -0.288 . . . . 1.11 110.251 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -95.63 107.49 19.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.144 0.497 . . . . 0.81 110.545 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.744 HD23 HD23 ' A' ' 159' ' ' LEU . 8.5 mp -111.84 133.26 54.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.649 -0.705 . . . . 1.39 111.187 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 78' ' ' PHE . 16.5 t -118.47 122.1 68.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.165 -0.47 . . . . 0.81 110.491 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.2 t -94.49 119.42 42.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.281 -0.637 . . . . 0.44 109.281 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 m -116.42 157.22 17.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.05 0.453 . . . . 0.7 110.987 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.31 170.92 29.9 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.62 -0.8 . . . . 0.53 111.772 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.34 173.21 7.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.971 0.415 . . . . 0.58 111.597 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.04 112.91 3.54 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.472 -0.87 . . . . 0.8 112.49 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.26 4.1 27.35 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.523 -0.846 . . . . 0.42 113.562 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 m -76.02 -17.61 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 117.391 0.595 . . . . 0.57 111.481 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.62 25.34 8.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.522 -0.847 . . . . 0.49 113.597 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -53.55 -55.98 20.97 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.785 0.326 . . . . 0.81 111.736 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -52.86 63.75 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.591 0.589 . . . . 0.58 112.591 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.82 -38.86 67.9 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.369 0.507 . . . . 0.43 112.369 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.0 mt -62.0 -44.47 96.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.543 -0.299 . . . . 0.92 111.354 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.419 ' O ' HG12 ' A' ' 24' ' ' ILE . 1.4 m -73.97 -39.71 63.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.631 0.253 . . . . 0.89 111.026 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.79 -32.61 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.985 0.422 . . . . 0.79 110.473 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.722 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 3.6 mm-40 -67.6 -21.96 65.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.883 -0.599 . . . . 0.46 111.222 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.14 -30.58 12.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.885 0.374 . . . . 1.37 110.625 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 20' ' ' THR . 51.5 mm -81.08 -61.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.927 0.394 . . . . 0.58 110.789 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -85.77 -6.69 59.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.293 0.568 . . . . 1.68 110.383 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.722 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 1.3 m-80 55.39 40.44 31.38 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 114.944 -1.025 . . . . 1.6 112.966 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -160.7 156.02 24.79 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.873 -0.418 . . . . 0.74 109.873 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -80.82 142.29 33.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.141 -0.481 . . . . 0.6 111.963 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.59 121.44 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.958 -1.127 . . . . 0.64 107.958 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.23 -41.53 40.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.799 0.666 . . . . 1.12 112.799 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -123.17 122.47 38.51 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.073 0.463 . . . . 1.18 111.305 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -149.31 139.15 21.91 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.578 -0.897 . . . . 0.6 108.578 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.467 ' HB3' HG13 ' A' ' 36' ' ' ILE . 5.8 t70 -62.78 123.74 80.71 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 123.516 0.51 . . . . 0.8 110.95 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.2 -13.25 23.38 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.775 2.316 . . . . 0.52 113.099 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.2 3.11 56.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.839 0.352 . . . . 0.89 111.352 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.467 HG13 ' HB3' ' A' ' 33' ' ' ASP . 58.3 mt -83.01 130.84 35.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 110.038 -0.356 . . . . 0.73 110.038 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 16.9 tt0 -128.57 82.88 2.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.748 -0.66 . . . . 0.81 109.435 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -111.47 171.7 7.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.095 -0.502 . . . . 1.29 111.272 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.0 141.66 48.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.989 -0.55 . . . . 0.78 109.871 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -126.34 133.43 51.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.106 -0.331 . . . . 0.94 110.106 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -107.62 119.7 40.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.951 0.405 . . . . 0.56 110.741 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -130.31 132.19 45.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.976 -0.556 . . . . 1.46 109.988 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -101.93 123.75 46.37 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.195 0.521 . . . . 1.89 110.443 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.3 t -130.31 143.37 41.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.013 -0.54 . . . . 1.09 109.622 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.51 66.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.178 0.513 . . . . 0.65 110.448 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.8 mt -74.2 124.64 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.55 -0.75 . . . . 1.06 110.774 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.96 17.67 9.58 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.697 -0.683 . . . . 0.97 110.975 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.02 7.18 81.04 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.472 -0.871 . . . . 0.6 112.394 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -116.6 131.45 56.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.764 0.316 . . . . 1.41 110.42 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 1' ' ' MET . 1.3 m -68.15 109.84 3.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.961 0.41 . . . . 0.63 110.934 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.2 m -112.65 130.02 56.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.27 -0.423 . . . . 0.71 111.004 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.0 tp -97.84 107.3 19.76 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.497 -0.927 . . . . 0.48 108.497 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -91.13 120.48 32.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.453 0.538 . . . . 0.87 112.453 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -105.85 98.24 7.95 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.873 -1.158 . . . . 1.03 107.873 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 49.8 mt -106.02 134.33 47.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.932 0.396 . . . . 0.68 111.932 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.5 tp -109.0 123.9 49.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.671 -0.695 . . . . 0.46 110.431 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 4.0 t70 -88.27 93.04 9.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.948 -0.76 . . . . 0.44 108.948 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.428 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 40.1 p -61.05 146.48 47.06 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.265 0.555 . . . . 0.73 111.78 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.76 -73.2 0.47 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.771 -0.65 . . . . 0.56 109.953 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.29 -42.67 0.11 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.255 -0.738 . . . . 0.72 111.255 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.422 ' HA ' ' OE1' ' A' ' 61' ' ' GLN . 12.7 mm-40 -133.95 155.03 50.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.711 0.291 . . . . 1.26 110.311 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -119.99 154.05 35.09 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.019 -0.537 . . . . 1.57 109.783 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.22 -34.27 75.93 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.152 -0.684 . . . . 1.38 109.152 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -130.38 127.19 38.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.545 -0.752 . . . . 0.81 110.554 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 m -57.57 -29.03 64.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.172 -0.467 . . . . 0.63 111.09 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.66 -37.53 76.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.976 0.417 . . . . 0.32 110.812 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 6.9 mtp -71.07 -30.91 67.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.936 -0.574 . . . . 0.69 110.143 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -69.77 -51.18 36.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.312 0.577 . . . . 0.9 109.671 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -65.87 -20.77 66.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.546 -0.752 . . . . 1.41 110.779 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -57.76 -57.77 11.28 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.077 -0.51 . . . . 1.51 111.144 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.42 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 10.9 p90 -70.77 -20.28 62.63 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.552 -0.459 . . . . 1.17 110.77 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 90.9 mtp -75.24 -27.17 59.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.058 0.456 . . . . 0.7 110.071 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.5 mtm105 -82.25 -41.09 20.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.014 0.435 . . . . 1.29 109.928 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 9.7 p -75.78 -12.65 60.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.956 -0.565 . . . . 0.72 111.384 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.34 129.0 11.0 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.926 -0.654 . . . . 0.19 112.312 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -87.46 -46.45 9.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.021 0.438 . . . . 0.54 110.094 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.69 143.9 14.73 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.135 -0.786 . . . . 0.26 111.135 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.522 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 75.3 m-85 -121.56 135.74 54.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.085 0.469 . . . . 0.48 111.557 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.3 tp -97.25 106.78 19.16 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.101 -0.703 . . . . 0.37 109.101 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' ' 111' ' ' MET . 0.1 OUTLIER -78.71 85.68 4.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.065 0.459 . . . . 0.61 110.312 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.63 132.88 34.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.135 0.493 . . . . 0.59 111.824 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.475 ' HB3' HD11 ' A' ' 93' ' ' ILE . 29.2 p90 -144.63 169.15 18.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.459 -0.792 . . . . 0.34 108.908 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.74 124.05 49.96 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.897 -0.321 . . . . 0.32 110.628 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.913 HD11 ' HA ' ' A' ' 118' ' ' CYS . 3.4 pt -71.9 -4.9 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.197 0.522 . . . . 0.78 111.054 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.537 ' OD1' ' HD2' ' A' ' 117' ' ' LYS . 8.7 p-10 -106.4 14.63 27.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.071 -0.513 . . . . 0.82 109.847 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -152.54 100.47 2.57 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.815 -0.63 . . . . 1.07 110.479 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.48 -29.2 68.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.636 . . . . 0.65 112.558 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -58.23 -35.97 72.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.757 0.313 . . . . 0.89 111.385 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.3 p -80.19 -33.78 37.95 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.762 0.315 . . . . 0.64 110.778 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -68.96 -41.73 77.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.42 110.844 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.63 -18.58 62.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.186 -0.461 . . . . 1.44 111.167 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -81.78 -18.66 43.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.904 0.383 . . . . 1.02 110.402 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.475 HD11 ' HB3' ' A' ' 82' ' ' PHE . 27.8 mm -57.79 -30.69 38.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.563 -0.744 . . . . 0.42 110.834 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -63.05 -47.38 83.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.978 -0.556 . . . . 0.83 110.465 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -66.51 -39.37 88.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.89 -0.595 . . . . 0.79 111.547 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -59.99 -45.71 91.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.642 0.258 . . . . 1.17 110.681 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.437 ' HG2' ' CE1' ' A' ' 137' ' ' TYR . 18.8 tpt180 -58.63 -49.62 76.82 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.084 -0.507 . . . . 0.6 110.282 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -60.73 -39.33 88.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.842 -0.617 . . . . 1.35 110.903 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -62.24 -53.13 59.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.56 -0.291 . . . . 1.15 110.896 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.7 mt -59.22 -42.07 85.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.465 -0.334 . . . . 0.51 111.015 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -66.08 -26.03 67.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.471 -0.331 . . . . 1.05 111.621 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -87.01 -35.84 18.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.004 0.431 . . . . 0.91 110.554 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.2 t -70.35 -46.92 69.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.817 -0.629 . . . . 0.35 111.328 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -87.09 -18.52 30.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.329 . . . . 0.63 110.733 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t70 54.6 54.53 9.13 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.306 -0.861 . . . . 0.47 111.055 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.3 m -137.31 146.63 44.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.961 -0.563 . . . . 1.14 109.877 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.24 -42.9 20.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.001 0.429 . . . . 1.74 110.039 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -93.68 106.74 18.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.857 -0.61 . . . . 0.78 110.349 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . 21.3 t -121.48 119.24 29.43 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.938 -0.393 . . . . 0.47 109.938 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 109' ' ' VAL . 16.9 Cg_exo -65.92 103.7 0.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.329 2.019 . . . . 0.25 111.275 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.535 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 85.9 mtp -138.07 151.34 47.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.204 -0.453 . . . . 0.79 110.399 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.7 t -129.55 121.76 53.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.503 -0.554 . . . . 0.22 109.503 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.6 tp -76.82 117.65 18.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.346 -0.613 . . . . 0.29 109.346 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.2 t -117.82 114.99 47.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.0 -0.546 . . . . 0.82 112.069 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.55 96.43 1.89 Allowed Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.049 -1.221 . . . . 0.27 110.049 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -80.67 162.77 24.02 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.775 0.287 . . . . 0.21 111.775 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.537 ' HD2' ' OD1' ' A' ' 85' ' ' ASN . 41.7 mttt 71.39 41.27 0.76 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.382 -0.826 . . . . 0.54 111.516 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.913 ' HA ' HD11 ' A' ' 84' ' ' ILE . 29.6 p -75.17 -19.36 59.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.944 0.402 . . . . 0.46 111.449 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -89.24 -7.55 55.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.966 0.412 . . . . 0.7 111.045 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 51.4 mt -91.56 145.68 31.74 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.256 -0.429 . . . . 0.67 110.859 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.63 -170.65 0.86 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.567 2.178 . . . . 0.54 112.047 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.2 m 58.78 44.85 16.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.134 -0.485 . . . . 0.84 111.544 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -72.24 118.22 14.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.58 110.197 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.49 -17.64 15.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.964 0.411 . . . . 0.81 111.603 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.72 115.52 49.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.07 -0.514 . . . . 0.37 110.779 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.74 148.23 42.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 1.69 110.59 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.6 m -59.55 -33.71 71.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.823 -0.626 . . . . 0.82 111.281 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -64.72 -44.33 90.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.695 -0.23 . . . . 0.62 110.673 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -60.4 -41.44 93.88 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.074 0.464 . . . . 0.93 110.655 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.41 -48.33 67.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.594 -0.73 . . . . 0.3 110.561 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -62.03 -35.39 78.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.173 0.511 . . . . 0.47 110.382 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -48.92 79.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.812 -0.631 . . . . 1.18 110.578 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.32 -41.24 85.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.101 -0.499 . . . . 0.44 111.041 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.09 -44.91 83.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.951 0.405 . . . . 0.25 111.204 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -69.03 -25.17 64.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 1.54 110.899 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.0 m -71.5 -26.74 62.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.151 0.5 . . . . 0.68 110.241 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.437 ' CE1' ' HG2' ' A' ' 97' ' ' ARG . 19.1 m-85 -93.11 -33.3 14.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.245 0.545 . . . . 0.77 110.41 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.4 30.11 7.11 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.752 -0.939 . . . . 0.25 110.752 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.1 pt -123.55 156.89 63.72 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.283 -0.459 . . . . 0.51 110.486 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.4 157.37 29.19 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.192 1.928 . . . . 0.36 112.578 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -132.05 132.11 43.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.928 -0.578 . . . . 0.38 110.334 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 63.5 mt -137.81 130.76 41.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.54 111.174 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -81.8 128.15 33.71 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.389 -0.967 . . . . 0.88 108.389 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 64.2 p -131.86 174.73 9.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.272 0.558 . . . . 0.43 112.236 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.7 t -150.6 134.09 16.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.275 -0.875 . . . . 0.33 109.109 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.7 -6.88 59.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.127 0.489 . . . . 0.45 110.407 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -91.39 -48.24 7.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.008 -0.542 . . . . 1.32 110.912 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.0 p -94.22 -17.62 22.51 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.591 -0.277 . . . . 0.52 111.122 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 67.04 23.12 9.8 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.773 0.671 . . . . 1.53 110.86 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 144' ' ' THR . 35.2 tt0 -71.42 119.75 16.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.9 -0.591 . . . . 0.87 111.113 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.05 -8.87 42.17 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.923 -0.58 . . . . 0.51 114.028 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.38 -49.02 85.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 117.143 0.471 . . . . 0.74 111.14 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.37 -48.35 79.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.098 0.475 . . . . 1.62 110.148 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.0 -47.47 84.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.431 -0.804 . . . . 1.0 111.583 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -54.73 -50.41 68.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.679 0.276 . . . . 0.37 111.7 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.488 ' O ' HG23 ' A' ' 160' ' ' VAL . 26.6 m-85 -62.71 -42.68 99.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.346 -0.388 . . . . 1.46 111.578 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -70.22 -35.54 73.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.702 -0.226 . . . . 0.99 111.202 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 39.2 m -64.1 -39.45 94.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.803 0.335 . . . . 0.34 110.304 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.744 HD23 HD23 ' A' ' 6' ' ' LEU . 25.2 tp -61.64 -37.18 83.06 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.163 -0.471 . . . . 0.42 110.394 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 156' ' ' PHE . 21.2 t -64.08 -38.37 82.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.278 0.561 . . . . 0.55 109.778 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.6 mtt85 -70.49 -34.3 72.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.8 -0.636 . . . . 0.9 110.134 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -59.95 -40.43 88.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.802 -0.636 . . . . 0.73 109.96 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 65.4 mt -68.11 -45.2 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.501 -0.772 . . . . 0.42 110.268 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 93.4 mtt180 -54.23 -42.18 69.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.678 -0.692 . . . . 0.87 111.043 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -63.26 -36.95 85.36 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 115.796 -0.638 . . . . 0.97 111.135 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -69.69 -26.35 64.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.181 0.515 . . . . 0.71 110.411 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -82.82 -34.98 26.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.944 -0.571 . . . . 1.11 110.893 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 8.7 pt-20 -95.96 16.62 17.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.376 -0.375 . . . . 1.12 110.566 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.3 tttp . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.22 -0.895 . . . . 1.47 110.32 -179.855 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 50' ' ' THR . 31.8 ttm . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.967 0.413 . . . . 1.48 110.254 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.2 m -92.73 137.62 32.21 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.431 -0.349 . . . . 1.04 110.965 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -91.13 132.16 36.24 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.619 -0.511 . . . . 1.27 109.619 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -115.26 121.51 43.12 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.138 -0.319 . . . . 1.11 110.138 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -96.53 108.22 20.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.241 0.543 . . . . 0.81 110.988 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.8 mp -112.29 142.35 44.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.71 -0.677 . . . . 1.39 111.2 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.2 t -128.74 130.01 68.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.866 -0.607 . . . . 0.81 110.677 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.6 t -95.89 114.04 31.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.92 -0.582 . . . . 0.44 109.519 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -115.82 136.62 52.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.428 0.633 . . . . 0.7 111.425 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.2 176.08 45.0 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.43 -0.805 . . . . 0.53 111.589 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.431 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -71.83 167.73 19.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.864 0.364 . . . . 0.58 110.114 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.3 128.31 11.48 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.496 -0.859 . . . . 0.8 112.765 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.99 10.95 59.34 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.71 -0.757 . . . . 0.42 113.744 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 11' ' ' ALA . 27.2 m -85.94 -1.86 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 117.696 0.748 . . . . 0.57 111.357 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.511 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 92.46 29.59 10.89 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.954 -0.641 . . . . 0.49 113.371 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -60.59 -45.61 93.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.802 0.301 . . . . 0.81 111.518 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -75.63 -20.3 58.6 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.874 0.324 . . . . 0.58 111.874 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.15 -40.6 64.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.868 0.366 . . . . 0.43 110.733 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 37.8 mt -64.57 -27.58 69.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.864 -0.607 . . . . 0.92 110.616 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.468 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -74.24 -54.06 8.49 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.033 -0.53 . . . . 0.89 111.351 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.407 HG21 HG23 ' A' ' 29' ' ' VAL . 10.6 mt -61.13 -38.67 80.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.778 0.323 . . . . 0.79 111.433 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.641 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 2.5 mm-40 -66.85 -23.82 66.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.009 0.433 . . . . 0.46 111.194 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.2 tp -95.08 -40.73 9.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.74 0.305 . . . . 1.37 111.54 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 20' ' ' THR . 46.9 mm -74.61 -55.35 12.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.164 -0.471 . . . . 0.58 112.232 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 49.1 mt-30 -100.86 -11.64 19.65 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.945 0.35 . . . . 1.68 111.945 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 70.2 m-20 71.23 17.64 5.92 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.362 0.875 . . . . 1.6 113.362 178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -128.73 128.65 44.45 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.474 -0.49 . . . . 0.74 110.548 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -75.48 127.28 32.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.064 -0.971 . . . . 0.6 110.959 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.407 HG23 HG21 ' A' ' 21' ' ' ILE . 48.6 t -99.04 136.58 29.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.918 -0.583 . . . . 0.64 109.482 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -83.47 -30.5 27.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.502 -0.317 . . . . 1.12 111.778 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -134.84 116.3 14.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.902 0.382 . . . . 1.18 111.248 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -141.76 146.31 35.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.848 -0.614 . . . . 0.6 109.516 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.33 121.3 73.96 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.052 0.453 . . . . 0.8 111.357 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.43 -18.35 15.83 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.55 2.167 . . . . 0.52 112.865 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.07 3.32 52.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.261 -0.427 . . . . 0.89 111.208 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 mt -83.92 125.35 40.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.234 0.54 . . . . 0.73 111.321 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 18.4 tt0 -125.3 83.41 2.16 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.905 -1.146 . . . . 0.81 107.905 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -113.62 162.17 16.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.789 -0.641 . . . . 1.29 111.956 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.74 142.94 26.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.289 -0.869 . . . . 0.78 111.652 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -134.97 135.75 41.68 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.053 -0.351 . . . . 0.94 110.053 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.579 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 1.1 mpp_? -119.2 139.57 51.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.912 0.387 . . . . 0.56 110.565 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -143.04 131.33 22.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.1 -0.5 . . . . 1.46 110.302 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -101.7 112.27 24.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.985 0.421 . . . . 1.89 110.313 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.95 149.87 30.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.136 -0.484 . . . . 1.09 110.968 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.3 t -92.49 93.17 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.947 -0.761 . . . . 0.65 108.947 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.3 mt -91.51 114.05 28.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.049 -0.523 . . . . 1.06 111.805 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.493 ' HB2' HH12 ' A' ' 164' ' ' ARG . 56.5 m-20 58.26 37.78 26.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.662 -0.699 . . . . 0.97 111.099 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.5 -5.01 84.83 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.086 -0.578 . . . . 0.6 113.347 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -108.93 115.61 30.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.878 0.37 . . . . 1.41 111.759 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -70.22 116.92 11.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 0.63 109.768 178.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.3 m -129.89 151.64 50.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.084 0.469 . . . . 0.71 111.72 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.9 tp -104.25 113.45 27.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.001 -0.74 . . . . 0.48 109.001 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 53.7 mt -82.39 125.62 31.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.896 -0.593 . . . . 0.87 112.027 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -110.41 88.73 2.84 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.106 -1.072 . . . . 1.03 108.106 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.0 mt -99.81 130.58 48.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.96 -0.564 . . . . 0.68 111.871 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.7 tp -116.36 107.02 14.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.996 -0.547 . . . . 0.46 109.782 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -75.32 116.16 15.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.876 -0.602 . . . . 0.44 110.267 -179.633 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.7 p -73.45 156.32 38.38 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.515 0.674 . . . . 0.73 112.168 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.4 -55.78 2.38 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.79 -1.095 . . . . 0.56 109.949 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.28 -87.46 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.843 -0.617 . . . . 0.72 111.957 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -122.91 127.88 49.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.974 -0.38 . . . . 1.26 109.974 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -87.72 -173.73 4.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.271 -0.422 . . . . 1.57 111.094 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.13 -47.7 81.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 1.38 111.07 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -123.2 148.67 45.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.72 0.295 . . . . 0.81 110.521 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -60.91 -34.35 74.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.088 -0.506 . . . . 0.63 110.652 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.76 -28.87 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.891 -0.595 . . . . 0.32 111.362 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 86.0 mtp -70.05 -44.61 68.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.228 0.537 . . . . 0.69 109.847 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 71' ' ' TYR . 17.0 ttp180 -65.92 -39.0 90.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.538 -0.755 . . . . 0.9 109.91 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -77.79 -5.22 50.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.584 -0.735 . . . . 1.41 110.842 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -73.7 -62.86 1.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.661 -0.245 . . . . 1.51 111.642 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 68' ' ' ARG . 1.3 p90 -67.22 -17.83 64.98 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 120.606 0.241 . . . . 1.17 111.047 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.3 mtt -73.51 -17.43 61.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.225 0.536 . . . . 0.7 109.665 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -90.48 -49.77 6.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.557 -0.747 . . . . 1.29 110.187 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.15 -12.0 60.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.72 112.145 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.47 132.49 38.4 Favored Glycine 0 C--O 1.237 0.344 0 C-N-CA 121.123 -0.56 . . . . 0.19 113.18 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -97.96 -36.32 10.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 0.54 110.81 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.416 ' HA3' HD11 ' A' ' 163' ' ' ILE . . . -133.17 128.89 5.23 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.022 -0.831 . . . . 0.26 111.022 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.477 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 91.6 m-85 -114.99 116.85 29.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.244 0.545 . . . . 0.48 110.88 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.8 tp -88.8 109.19 19.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.54 -0.755 . . . . 0.37 109.908 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.5 m -82.53 103.54 12.14 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.356 0.41 . . . . 0.61 109.959 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.07 129.61 60.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.981 0.419 . . . . 0.59 112.084 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -136.6 162.3 33.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.652 -0.704 . . . . 0.34 109.674 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.442 ' HB1' ' OD1' ' A' ' 85' ' ' ASN . . . -100.95 126.76 47.62 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.365 -0.235 . . . . 0.32 110.365 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.1 pt -71.13 -12.16 15.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.948 0.404 . . . . 0.78 111.375 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.442 ' OD1' ' HB1' ' A' ' 83' ' ' ALA . 10.1 p-10 -95.23 5.79 50.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.826 -0.625 . . . . 0.82 110.75 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -148.43 111.73 4.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.072 0.463 . . . . 1.07 110.542 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.27 -26.96 66.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.1 -0.5 . . . . 0.65 111.938 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -58.35 -37.85 76.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.89 110.646 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -67.55 -38.15 83.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.378 -0.373 . . . . 0.64 110.796 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -66.67 -39.86 88.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.176 0.512 . . . . 0.42 110.068 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.53 -35.08 79.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.87 -0.604 . . . . 1.44 110.635 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -63.45 -32.8 74.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.901 -0.591 . . . . 1.02 110.932 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 89' ' ' SER . 45.7 mm -57.87 -31.55 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.586 . . . . 0.42 111.031 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -62.71 -35.92 81.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.126 0.489 . . . . 0.83 110.348 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -82.19 -38.5 24.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.79 110.104 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -58.69 -48.68 80.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.283 -0.417 . . . . 1.17 111.204 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -56.37 -51.78 67.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.958 -0.565 . . . . 0.6 110.919 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -39.89 95.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.032 -0.531 . . . . 1.35 111.061 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.449 ' O ' HG23 ' A' ' 103' ' ' VAL . 51.7 tt0 -59.36 -55.24 37.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.947 -0.57 . . . . 1.15 111.117 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.97 -37.76 79.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.435 -0.348 . . . . 0.51 110.755 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -61.09 -32.6 72.26 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.974 0.416 . . . . 1.05 110.026 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -77.46 -45.32 26.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.893 -0.594 . . . . 0.91 110.643 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 99' ' ' GLN . 66.4 t -59.93 -47.64 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.191 -0.459 . . . . 0.35 111.71 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -83.68 -13.32 54.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.451 -0.34 . . . . 0.63 110.541 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 t70 54.91 48.56 19.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.622 -0.717 . . . . 0.47 109.854 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.8 m -132.61 143.65 49.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.363 -0.835 . . . . 1.14 110.314 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.18 -31.06 30.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.1 0.476 . . . . 1.74 110.368 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -119.41 112.35 19.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.96 -0.564 . . . . 0.78 110.135 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.21 122.54 24.13 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.695 -0.483 . . . . 0.47 109.695 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -49.69 107.52 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.171 2.581 . . . . 0.25 111.982 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.477 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 56.5 mtt -140.04 150.2 44.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.952 -0.567 . . . . 0.79 110.719 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.4 t -132.46 121.81 46.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.665 -0.865 . . . . 0.22 108.665 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.637 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 56.3 tp -89.31 125.13 34.98 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.641 -0.503 . . . . 0.29 109.641 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.7 129.13 54.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.354 0.597 . . . . 0.82 111.861 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -94.5 103.86 3.07 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.224 -1.15 . . . . 0.27 110.224 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -81.51 164.52 21.92 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.576 -0.157 . . . . 0.21 110.576 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 69.7 mttt 66.97 36.93 4.06 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.733 0.646 . . . . 0.54 110.459 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 31.9 p -67.68 -13.63 62.26 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.24 -0.436 . . . . 0.46 111.957 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -89.53 -8.77 52.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.428 -0.351 . . . . 0.7 110.936 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 120' ' ' LEU . 16.3 mt -77.63 130.25 74.35 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.561 0.22 . . . . 0.67 110.976 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 11.2 Cg_exo -69.5 171.88 13.39 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.885 2.39 . . . . 0.54 112.081 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.8 m 61.57 54.55 3.01 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.393 0.616 . . . . 0.84 110.573 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -64.64 127.41 31.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.381 -0.827 . . . . 0.58 111.206 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.14 -41.22 7.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.074 -0.512 . . . . 0.81 110.512 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.3 t -88.96 113.32 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.222 -0.445 . . . . 0.37 110.295 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.06 147.61 49.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 1.69 110.878 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -46.85 87.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.82 111.848 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.6 tttm -65.22 -35.69 81.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.61 -0.268 . . . . 0.62 110.621 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -59.27 -44.34 92.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.93 110.881 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.56 -40.04 66.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 0.3 110.929 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.8 -34.42 78.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.761 -0.654 . . . . 0.47 110.953 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -40.82 98.46 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.789 -0.641 . . . . 1.18 110.226 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 27.8 tp -69.84 -42.07 74.07 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.872 -0.604 . . . . 0.44 109.547 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 139' ' ' ILE . . . -58.69 -45.47 89.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.302 -0.863 . . . . 0.25 110.423 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -59.07 -45.69 90.17 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.858 -0.61 . . . . 1.54 110.683 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.2 m -65.42 -35.08 79.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.945 -0.571 . . . . 0.68 111.301 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -79.02 -22.42 45.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.235 -0.439 . . . . 0.77 110.944 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.62 26.61 38.1 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.911 -0.661 . . . . 0.25 111.45 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.434 ' O ' ' HB1' ' A' ' 134' ' ' ALA . 34.7 pt -124.16 156.17 66.84 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 110.094 -0.335 . . . . 0.51 110.094 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -84.59 155.12 12.04 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.153 1.902 . . . . 0.36 112.859 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.637 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 19.0 t80 -130.93 127.03 37.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.918 -0.583 . . . . 0.38 110.549 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.9 mt -130.53 139.36 51.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.132 -0.485 . . . . 0.54 110.034 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -78.32 137.96 38.32 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.288 -1.005 . . . . 0.88 108.288 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.7 p -139.03 162.02 35.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.519 0.933 . . . . 0.43 113.519 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.6 t -155.09 117.25 4.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.687 -1.142 . . . . 0.33 108.559 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.87 -11.3 60.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.45 111.478 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -84.5 -42.84 15.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.278 -0.419 . . . . 1.32 111.439 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.5 p -96.55 -5.56 39.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.696 -0.229 . . . . 0.52 111.525 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 38.4 ttt85 59.75 47.66 10.1 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.611 0.719 . . . . 1.53 109.829 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -113.31 125.57 54.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.544 -0.753 . . . . 0.87 111.158 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.78 -21.83 3.7 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.802 -0.636 . . . . 0.51 113.303 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.17 -46.49 88.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.802 0.334 . . . . 0.74 111.654 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.452 ' O ' ' HD2' ' A' ' 157' ' ' TYR . 21.4 t70 -62.0 -49.24 76.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.495 . . . . 1.62 110.096 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -39.02 86.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.223 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -58.97 -52.05 67.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.222 -0.445 . . . . 0.37 111.94 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -62.58 -41.58 99.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.633 -0.258 . . . . 1.46 111.562 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.452 ' HD2' ' O ' ' A' ' 153' ' ' ASP . 29.0 m-85 -66.96 -34.63 78.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.99 110.807 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 99.5 m -68.42 -45.61 72.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.319 -0.4 . . . . 0.34 110.92 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 163' ' ' ILE . 31.0 tp -55.96 -41.79 75.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.361 -0.381 . . . . 0.42 111.052 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.88 -43.47 98.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.322 -0.399 . . . . 0.55 110.901 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -65.22 -34.22 77.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.444 -0.344 . . . . 0.9 111.011 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -64.05 -44.82 91.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.73 110.232 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 159' ' ' LEU . 17.2 mt -62.54 -43.9 98.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.086 0.469 . . . . 0.42 110.072 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.493 HH12 ' HB2' ' A' ' 47' ' ' ASP . 93.9 mtt180 -59.15 -42.78 91.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.42 -0.809 . . . . 0.87 111.371 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -66.08 -30.57 71.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.218 -0.446 . . . . 0.97 111.191 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -79.73 -26.06 40.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.256 -0.429 . . . . 0.71 110.213 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -77.08 -33.66 57.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.594 -0.275 . . . . 1.11 110.408 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -87.04 4.0 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 1.12 110.871 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.2 tptt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.367 -0.825 . . . . 1.47 110.848 -179.616 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttm . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 121.17 0.51 . . . . 1.48 110.371 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.0 m -76.38 126.84 31.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.133 -0.485 . . . . 1.04 110.712 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -94.14 134.67 36.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.133 -0.485 . . . . 1.27 110.253 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -122.49 128.08 50.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.375 -0.375 . . . . 1.11 110.279 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -99.58 108.82 21.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.269 -0.423 . . . . 0.81 109.921 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.467 HD11 HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -124.59 148.94 47.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.394 0.616 . . . . 1.39 110.981 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.13 132.03 70.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.924 -0.58 . . . . 0.81 110.862 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.4 t -91.24 119.19 38.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.035 -0.728 . . . . 0.44 109.035 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.7 m -116.65 157.83 17.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.829 0.347 . . . . 0.7 111.297 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.83 176.27 32.76 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.714 -0.954 . . . . 0.53 110.714 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -73.68 172.63 11.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.974 0.416 . . . . 0.58 111.415 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.91 121.19 5.67 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.697 -0.763 . . . . 0.8 112.189 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.71 3.03 55.26 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.821 -0.704 . . . . 0.42 113.245 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 11' ' ' ALA . 31.1 m -72.81 -29.09 28.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 117.391 0.596 . . . . 0.57 111.098 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.652 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 115.85 19.97 5.47 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.144 -1.027 . . . . 0.49 114.406 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -53.05 -53.58 48.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.468 0.634 . . . . 0.81 111.86 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -34.99 75.64 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.322 -0.399 . . . . 0.58 111.959 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.63 -40.62 88.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.5 -0.318 . . . . 0.43 111.278 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 23.5 mt -63.31 -39.05 93.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.375 -0.375 . . . . 0.92 110.88 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 m -66.14 -47.4 74.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.256 -0.429 . . . . 0.89 111.005 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.5 mt -65.59 -34.8 72.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 0.79 111.26 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 2.3 mm-40 -69.97 -12.67 61.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.991 0.424 . . . . 0.46 111.323 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.7 tp -102.29 -37.46 8.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.211 0.529 . . . . 1.37 110.861 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.9 mm -80.53 -59.08 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.908 -0.587 . . . . 0.58 111.425 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -89.92 -17.06 28.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.451 -0.34 . . . . 1.68 110.96 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 45.4 m-80 63.38 46.83 4.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.794 -0.639 . . . . 1.6 112.282 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -153.71 143.79 22.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.576 -0.528 . . . . 0.74 109.576 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -82.71 129.99 35.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.242 -0.435 . . . . 0.6 111.972 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.33 120.02 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.657 -0.701 . . . . 0.64 109.512 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.6 -41.17 32.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.236 -0.438 . . . . 1.12 111.888 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -115.6 108.97 17.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.181 0.515 . . . . 1.18 111.698 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -142.3 144.07 33.09 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.93 -0.767 . . . . 0.6 108.93 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -64.63 123.73 84.06 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.917 0.389 . . . . 0.8 110.9 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.18 -15.29 14.54 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.549 2.166 . . . . 0.52 113.386 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.44 3.16 56.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.674 0.273 . . . . 0.89 111.733 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.8 mt -86.0 127.46 40.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 120.849 0.357 . . . . 0.73 110.462 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 11.3 tt0 -114.86 94.94 4.98 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.215 -1.032 . . . . 0.81 108.215 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -115.47 164.18 14.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.01 -0.541 . . . . 1.29 110.918 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 1.2 p -130.06 129.84 44.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.776 -0.647 . . . . 0.78 109.961 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -125.35 143.81 50.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.642 -0.254 . . . . 0.94 110.947 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.694 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -113.2 143.06 45.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.56 110.575 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -147.02 134.85 21.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.703 -0.681 . . . . 1.46 109.459 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -103.18 114.49 28.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.943 0.401 . . . . 1.89 110.976 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 31.5 t -127.01 147.81 31.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.767 -0.652 . . . . 1.09 110.432 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.61 101.24 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.728 -0.471 . . . . 0.65 109.728 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 76.9 mt -105.96 118.1 52.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.963 0.411 . . . . 1.06 111.249 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.505 ' HB2' HH12 ' A' ' 164' ' ' ARG . 86.6 m-20 61.77 30.85 18.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.007 -0.997 . . . . 0.97 111.744 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.61 -0.21 73.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.855 -0.688 . . . . 0.6 114.163 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -121.68 126.67 49.53 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.46 0.63 . . . . 1.41 111.175 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.95 115.36 11.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.976 0.417 . . . . 0.63 110.111 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.1 m -116.89 147.72 41.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.108 -0.496 . . . . 0.71 111.576 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.9 tp -100.46 120.25 39.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.881 -0.599 . . . . 0.48 109.394 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.694 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 16.7 mt -89.73 115.99 27.5 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.047 -0.524 . . . . 0.87 112.128 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.424 ' OD1' ' HD2' ' A' ' 41' ' ' ARG . 19.0 t70 -104.31 95.18 5.77 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.53 -1.285 . . . . 1.03 107.53 176.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 39' ' ' SER . 6.1 mt -101.85 127.88 54.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.075 -0.511 . . . . 0.68 112.367 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.0 tp -114.23 119.45 37.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.057 -0.52 . . . . 0.46 109.859 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 4.5 t70 -89.84 100.88 13.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.115 -0.493 . . . . 0.44 110.074 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.4 p -62.51 138.54 58.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.779 -0.646 . . . . 0.73 112.597 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.54 -36.24 24.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.56 110.066 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.33 -74.9 0.42 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.964 -0.636 . . . . 0.72 111.83 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -108.93 117.89 35.36 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.818 -0.438 . . . . 1.26 109.818 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.94 162.7 15.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.172 -0.467 . . . . 1.57 110.432 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -55.56 -51.92 65.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.857 -0.61 . . . . 1.38 111.188 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -127.07 148.27 50.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.635 -0.506 . . . . 0.81 109.635 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -35.04 76.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.693 0.282 . . . . 0.63 111.361 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.94 -31.91 73.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 0.32 111.222 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 85.0 mtp -74.17 -31.67 62.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.268 0.556 . . . . 0.69 109.823 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.515 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 34.9 ttp180 -74.33 -46.45 40.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.453 -0.794 . . . . 0.9 109.906 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.488 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 39.2 m-20 -65.68 -24.45 67.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.409 -0.814 . . . . 1.41 110.228 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -57.9 -56.7 18.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.349 -0.841 . . . . 1.51 111.559 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 31.1 p90 -72.4 -14.26 61.66 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.861 -0.336 . . . . 1.17 111.407 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.4 mtt -76.16 -28.78 57.5 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.451 -0.574 . . . . 0.7 109.451 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 30.2 mtm180 -83.64 -34.18 25.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.831 -0.622 . . . . 1.29 111.163 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.425 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -78.91 -26.77 43.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.27 -0.423 . . . . 0.72 111.603 -179.399 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.82 125.76 28.47 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.038 -0.601 . . . . 0.19 112.712 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -92.0 -26.05 18.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.681 -0.488 . . . . 0.54 109.681 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -141.78 143.82 13.5 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 110.886 -0.886 . . . . 0.26 110.886 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.454 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 89.8 m-85 -126.8 132.43 51.03 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.229 0.538 . . . . 0.48 111.255 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 tp -100.87 112.28 24.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.724 -0.671 . . . . 0.37 109.368 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.7 m -90.01 104.72 17.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.102 0.477 . . . . 0.61 110.454 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.1 t -102.73 126.5 56.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.069 -0.514 . . . . 0.59 111.571 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -133.02 160.19 37.87 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.065 -0.717 . . . . 0.34 109.065 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.85 128.2 48.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.811 0.338 . . . . 0.32 110.492 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 pt -67.29 -14.2 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.367 . . . . 0.78 111.828 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -100.85 6.48 43.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.926 0.393 . . . . 0.82 110.397 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -135.67 103.32 5.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 1.07 110.246 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -27.22 66.97 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.447 0.536 . . . . 0.65 112.447 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -66.88 -37.74 84.98 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.161 -0.216 . . . . 0.89 111.123 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.429 ' O ' HG12 ' A' ' 93' ' ' ILE . 91.4 p -64.89 -36.87 85.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.425 . . . . 0.64 110.024 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -69.67 -35.71 75.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.924 -0.58 . . . . 0.42 109.955 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -65.62 -40.88 93.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.801 -0.636 . . . . 1.44 110.471 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.53 -26.35 68.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.737 -0.665 . . . . 1.02 111.769 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 89' ' ' SER . 48.3 mm -57.93 -28.64 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.099 0.476 . . . . 0.42 110.73 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -66.66 -41.12 88.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.973 -0.558 . . . . 0.83 110.68 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -77.71 -34.54 52.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.79 110.832 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -59.13 -48.02 83.16 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.524 -0.307 . . . . 1.17 110.741 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -60.57 -46.41 90.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.96 -0.564 . . . . 0.6 110.016 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -47.92 79.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.742 -0.663 . . . . 1.35 111.528 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.544 ' O ' HG23 ' A' ' 103' ' ' VAL . 26.0 tt0 -59.3 -58.19 9.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 1.15 112.111 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.33 -39.0 79.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 120.591 0.234 . . . . 0.51 111.026 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -61.38 -35.86 78.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.951 0.405 . . . . 1.05 110.457 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -73.64 -37.87 65.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.044 -0.525 . . . . 0.91 110.972 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 99' ' ' GLN . 47.8 t -68.96 -40.83 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.35 110.982 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -82.75 -20.15 36.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.485 -0.325 . . . . 0.63 111.222 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 54.92 57.31 5.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.507 0.67 . . . . 0.47 110.333 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -141.6 142.01 33.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.656 -0.702 . . . . 1.14 109.761 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -75.54 -31.82 60.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.906 0.384 . . . . 1.74 110.004 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.4 123.96 49.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.968 -0.56 . . . . 0.78 110.816 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.2 t -135.28 113.38 11.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.187 -0.671 . . . . 0.47 109.187 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.98 109.18 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.854 2.369 . . . . 0.25 112.783 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.454 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 30.9 mtt -139.33 152.98 47.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.964 -0.562 . . . . 0.79 110.722 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 73.3 t -131.45 127.25 59.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.171 -0.677 . . . . 0.22 109.171 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.4 tp -84.84 118.87 24.75 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.606 -0.516 . . . . 0.29 109.606 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 65.0 t -114.68 117.9 57.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.037 -0.529 . . . . 0.82 112.008 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.29 93.25 1.49 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.549 -1.02 . . . . 0.27 110.549 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -80.73 163.2 23.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.648 0.261 . . . . 0.21 111.623 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.6 mttt 68.39 33.84 3.98 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.42 -0.809 . . . . 0.54 111.233 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 20.9 p -68.05 -20.35 64.97 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 111.991 0.367 . . . . 0.46 111.991 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -86.54 -12.0 50.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.765 0.317 . . . . 0.7 111.383 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.21 142.17 54.71 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.358 -0.383 . . . . 0.67 110.737 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.05 174.14 12.48 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.382 2.055 . . . . 0.54 111.431 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.6 m 66.15 60.28 0.65 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.352 0.596 . . . . 0.84 111.054 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.5 ttm-85 -75.54 104.89 6.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.736 -0.666 . . . . 0.58 110.388 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 m -82.53 -36.84 25.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.093 -0.503 . . . . 0.81 111.045 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.0 t -97.39 111.0 26.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.22 -0.445 . . . . 0.37 110.628 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -68.6 148.21 50.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.802 -0.636 . . . . 1.69 110.135 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.2 m -57.62 -37.19 72.87 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.339 -0.391 . . . . 0.82 111.607 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -63.95 -37.57 87.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.665 0.269 . . . . 0.62 111.081 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -58.69 -45.89 88.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.93 111.236 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.76 -41.33 62.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.85 -0.614 . . . . 0.3 111.225 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -61.86 -39.48 92.04 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.031 0.443 . . . . 0.47 109.994 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.86 -46.66 89.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.776 -0.647 . . . . 1.18 110.56 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.89 -39.54 90.74 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.785 -0.643 . . . . 0.44 110.418 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.81 88.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.574 . . . . 0.25 110.945 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -64.4 -38.89 92.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.573 -0.285 . . . . 1.54 111.104 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.75 -23.71 62.48 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.094 0.473 . . . . 0.68 111.766 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -91.11 -19.12 23.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.145 -0.479 . . . . 0.77 110.283 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.8 32.85 48.5 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.407 -0.677 . . . . 0.25 111.407 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.448 ' HB ' ' O ' ' A' ' 111' ' ' MET . 36.6 pt -127.44 158.16 70.56 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.94 -0.393 . . . . 0.51 109.94 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.19 151.12 17.92 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.448 2.098 . . . . 0.36 112.718 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -124.53 129.05 49.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.76 -0.655 . . . . 0.38 109.757 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 67.0 mt -137.1 129.41 43.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.394 -0.366 . . . . 0.54 111.316 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -85.26 133.74 34.15 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.973 -0.751 . . . . 0.88 108.973 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 150' ' ' GLN . 41.4 p -138.84 179.94 6.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.541 0.686 . . . . 0.43 111.953 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.5 t -155.46 135.92 13.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.017 -0.992 . . . . 0.33 108.843 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.16 -7.4 58.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.064 0.459 . . . . 0.45 111.291 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -94.78 -48.75 5.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.068 -0.514 . . . . 1.32 111.117 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.9 p -92.71 -12.85 30.38 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 111.928 0.344 . . . . 0.52 111.928 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 57.81 38.41 27.26 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.333 0.587 . . . . 1.53 110.653 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.421 ' O ' HG22 ' A' ' 144' ' ' THR . 45.5 tt0 -69.83 94.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.146 -0.934 . . . . 0.87 112.251 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 68.72 22.25 75.28 Favored Glycine 0 CA--C 1.516 0.153 0 CA-C-N 115.788 -0.642 . . . . 0.51 114.561 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.43 -52.1 50.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 117.69 0.745 . . . . 0.74 110.618 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.8 -40.59 80.28 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.027 -0.533 . . . . 1.62 110.364 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -59.63 -49.57 77.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.251 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.28 84.96 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.099 0.476 . . . . 0.37 110.998 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -63.5 -48.87 75.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.681 -0.69 . . . . 1.46 111.058 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -67.57 -30.82 70.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.446 -0.343 . . . . 0.99 110.518 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 90.2 m -62.2 -40.84 97.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.34 110.257 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.44 ' O ' HG13 ' A' ' 163' ' ' ILE . 51.2 tp -59.14 -42.01 89.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.397 -0.365 . . . . 0.42 110.47 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 79.8 t -61.67 -39.74 84.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.55 110.365 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -68.4 -33.85 74.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.9 110.576 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 158' ' ' THR . 48.8 mm-40 -64.53 -40.89 96.44 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.299 -0.63 . . . . 0.73 109.299 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 159' ' ' LEU . 70.2 mt -62.52 -43.9 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.62 -0.718 . . . . 0.42 109.947 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.505 HH12 ' HB2' ' A' ' 47' ' ' ASP . 84.8 mtt180 -59.39 -43.94 92.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.905 -0.589 . . . . 0.87 111.021 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 168' ' ' GLU . 52.3 mtmt -62.04 -27.93 69.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.319 -0.4 . . . . 0.97 111.304 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -79.96 -35.36 37.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.013 0.435 . . . . 0.71 110.616 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 163' ' ' ILE . 29.5 mtpt -77.6 -30.99 52.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.191 -0.459 . . . . 1.11 111.483 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 6.0 pt-20 -86.09 1.17 51.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.709 0.29 . . . . 1.12 111.215 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 8.9 tttp . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.614 -0.708 . . . . 1.47 110.576 -179.57 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttt . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.95 -0.389 . . . . 1.48 109.95 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.7 127.07 32.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.908 -0.587 . . . . 1.04 111.796 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.82 122.43 46.75 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.853 -0.425 . . . . 1.27 109.853 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -122.65 130.79 53.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.479 -0.328 . . . . 1.11 111.023 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -92.19 123.0 35.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.006 -0.543 . . . . 0.81 110.915 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 2.8 mp -119.48 133.57 55.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.451 -0.795 . . . . 1.39 110.293 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.04 109.49 22.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.021 0.438 . . . . 0.81 110.301 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -76.42 125.68 36.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.287 -0.635 . . . . 0.44 109.287 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.1 m -116.84 148.04 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.145 0.498 . . . . 0.7 110.837 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.51 176.82 39.11 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.022 -0.831 . . . . 0.53 111.022 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.418 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -81.08 156.85 25.61 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.017 0.437 . . . . 0.58 111.392 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.31 102.7 0.76 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.796 -0.716 . . . . 0.8 112.032 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.15 0.73 6.9 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.822 -0.704 . . . . 0.42 112.792 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 11' ' ' ALA . 23.4 m -76.1 -19.4 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.828 0.347 . . . . 0.57 110.781 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.593 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 104.76 25.47 6.85 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.483 -0.865 . . . . 0.49 112.142 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -52.97 -50.96 63.07 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.255 0.465 . . . . 0.81 112.255 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.4 m -64.36 -34.06 77.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.922 0.342 . . . . 0.58 111.922 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.37 -34.31 75.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.712 -0.222 . . . . 0.43 111.472 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 30.4 mt -59.42 -53.98 51.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.355 -0.384 . . . . 0.92 110.756 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.409 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -67.34 -39.61 85.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.779 -0.646 . . . . 0.89 110.991 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.2 mt -58.37 -38.47 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.953 -0.567 . . . . 0.79 111.73 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -66.1 -37.56 86.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.928 0.394 . . . . 0.46 111.501 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.0 tp -78.78 -32.31 46.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.208 -0.451 . . . . 1.37 111.316 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 20' ' ' THR . 48.9 mm -89.32 -52.96 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 113.068 0.766 . . . . 0.58 113.068 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -87.1 -9.48 55.28 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.175 0.435 . . . . 1.68 112.175 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 65.25 21.41 12.05 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.202 0.445 . . . . 1.6 112.202 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -159.98 146.97 16.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.804 0.335 . . . . 0.74 110.302 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -77.18 145.62 37.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.706 -0.679 . . . . 0.6 111.499 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.7 t -119.86 122.31 68.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.183 -0.673 . . . . 0.64 109.183 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -73.71 -50.65 19.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.036 -0.529 . . . . 1.12 112.076 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -107.93 109.88 21.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.146 0.498 . . . . 1.18 111.951 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -145.46 134.32 22.44 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.875 -0.787 . . . . 0.6 108.875 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.01 126.62 90.49 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.009 -0.542 . . . . 0.8 111.707 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.27 -19.74 19.45 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.545 2.164 . . . . 0.52 112.111 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -16.02 56.25 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.008 -0.542 . . . . 0.89 111.739 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.43 116.96 24.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.382 0.611 . . . . 0.73 111.12 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -112.02 117.52 32.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.076 -0.965 . . . . 0.81 109.309 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -138.07 158.63 43.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.812 0.339 . . . . 1.29 111.326 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -106.6 127.14 53.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.855 -0.611 . . . . 0.78 109.644 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -111.02 139.36 46.44 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.55 -0.295 . . . . 0.94 110.791 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.61 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 0.2 OUTLIER -122.28 123.53 41.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.133 0.492 . . . . 0.56 110.921 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -134.69 140.44 45.99 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.6 -0.518 . . . . 1.46 109.6 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -110.01 123.18 49.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.883 0.373 . . . . 1.89 110.45 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.24 132.18 55.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.751 -0.463 . . . . 1.09 109.751 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.474 HG22 HG23 ' A' ' 50' ' ' THR . 22.1 t -84.04 91.97 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.875 -0.417 . . . . 0.65 109.875 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.4 mt -103.23 133.09 48.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.8 -0.636 . . . . 1.06 110.263 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 60.32 27.35 16.9 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.925 -0.58 . . . . 0.97 111.368 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.43 -0.15 88.26 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.184 -0.531 . . . . 0.6 113.165 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -109.85 130.99 55.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.865 0.364 . . . . 1.41 111.36 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.474 HG23 HG22 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -73.89 95.17 2.41 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.333 -0.617 . . . . 0.63 109.333 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 59.7 m -101.19 133.76 45.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.48 0.657 . . . . 0.71 111.467 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.6 tp -100.86 124.63 46.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.253 -0.885 . . . . 0.48 109.325 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 1.3 mp -93.04 113.13 25.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.116 -0.493 . . . . 0.87 111.706 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.61 ' OD1' ' HD2' ' A' ' 41' ' ' ARG . 14.8 t70 -105.3 93.41 4.67 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.154 -1.054 . . . . 1.03 108.154 177.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 13.6 mt -110.88 142.47 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.169 0.433 . . . . 0.68 112.169 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.3 tp -119.93 122.14 40.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.541 . . . . 0.46 110.999 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -88.64 89.83 8.15 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.231 -0.655 . . . . 0.44 109.231 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.1 p -65.87 134.95 54.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.004 -0.544 . . . . 0.73 111.725 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.93 -55.06 6.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.79 -0.641 . . . . 0.56 110.588 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.33 -76.52 0.17 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.442 -0.663 . . . . 0.72 111.442 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -99.95 125.57 45.99 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.955 -0.387 . . . . 1.26 109.955 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -94.46 166.62 11.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.067 -0.515 . . . . 1.57 110.659 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -58.28 -56.71 18.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.98 -0.554 . . . . 1.38 110.012 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -116.02 144.79 43.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.909 -0.587 . . . . 0.81 109.609 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -31.44 72.64 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.534 -0.303 . . . . 0.63 111.13 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.79 -27.89 69.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.32 111.458 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 81.7 mtp -68.89 -30.68 69.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.19 -0.459 . . . . 0.69 109.937 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.643 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 24.6 ttp180 -65.6 -45.09 84.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.025 -0.534 . . . . 0.9 109.672 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 67.3 m-20 -65.53 -30.55 71.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.469 -0.787 . . . . 1.41 110.255 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -58.24 -58.94 6.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.732 -0.667 . . . . 1.51 111.636 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.643 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 10.4 p90 -67.47 -21.42 65.53 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.373 -0.531 . . . . 1.17 112.104 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.5 mtt -77.19 -31.14 55.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.116 0.484 . . . . 0.7 110.637 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 39.8 mtm180 -77.62 -48.08 17.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.958 0.409 . . . . 1.29 110.532 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 m -73.69 -14.13 61.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.703 -0.681 . . . . 0.72 111.614 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.75 120.39 9.84 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.7 -0.762 . . . . 0.19 111.633 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -89.71 -32.68 16.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.964 0.411 . . . . 0.54 110.161 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -137.37 130.29 5.06 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.421 -0.672 . . . . 0.26 111.421 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.488 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 88.3 m-85 -116.34 126.11 53.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.085 0.443 . . . . 0.48 110.999 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.448 HD12 ' HB ' ' A' ' 112' ' ' VAL . 12.3 tp -96.51 106.5 18.76 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.066 -0.716 . . . . 0.37 109.066 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 56.9 m -83.79 107.46 16.21 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.737 -0.468 . . . . 0.61 109.737 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 19' ' ' LEU . 17.2 t -112.36 142.05 25.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.073 0.463 . . . . 0.59 111.952 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -142.79 167.08 22.92 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.499 -0.926 . . . . 0.34 108.499 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.86 132.48 50.08 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.056 -0.35 . . . . 0.32 110.056 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 118' ' ' CYS . 3.3 pt -67.6 -13.23 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.514 -0.312 . . . . 0.78 111.362 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -107.93 23.1 14.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.286 0.565 . . . . 0.82 110.554 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -150.31 98.08 2.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 1.07 110.477 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -31.28 71.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.083 -0.508 . . . . 0.65 111.94 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -62.84 -38.89 92.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.525 -0.307 . . . . 0.89 110.554 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 82.8 p -69.83 -23.79 63.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.993 0.425 . . . . 0.64 110.567 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -77.61 -39.38 45.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.83 -0.623 . . . . 0.42 109.652 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -74.0 -30.5 62.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 1.44 110.201 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -29.86 68.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.095 -0.502 . . . . 1.02 110.558 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.6 mm -57.58 -34.37 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.549 -0.75 . . . . 0.42 111.779 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -60.54 -45.44 93.88 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.579 -0.526 . . . . 0.83 109.579 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -69.29 -34.71 75.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.536 -0.756 . . . . 0.79 110.965 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -65.59 -51.26 61.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.728 -0.214 . . . . 1.17 110.92 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -59.37 -36.97 76.73 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.235 0.54 . . . . 0.6 110.275 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -70.58 -50.74 34.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.528 -0.76 . . . . 1.35 111.701 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -59.49 -49.46 77.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.967 0.358 . . . . 1.15 111.967 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 81.2 mt -61.67 -39.6 83.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.294 . . . . 0.51 111.243 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -66.85 -30.06 70.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.923 0.392 . . . . 1.05 110.744 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -76.66 -43.24 38.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.821 -0.627 . . . . 0.91 110.757 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.0 t -65.38 -45.48 93.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.035 -0.53 . . . . 0.35 110.801 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -79.32 -15.89 57.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.872 0.368 . . . . 0.63 110.528 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.4 t70 55.73 70.81 0.6 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.191 -0.913 . . . . 0.47 110.811 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.7 t -164.12 -172.01 2.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.657 -0.701 . . . . 1.14 109.818 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -125.41 -55.21 1.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.085 0.469 . . . . 1.74 109.865 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -77.51 91.79 3.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.801 -0.636 . . . . 0.78 110.239 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.4 t -118.45 113.13 36.92 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.828 -0.623 . . . . 0.47 109.939 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.74 111.13 0.48 Allowed 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 123.232 2.621 . . . . 0.25 113.131 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.488 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 46.3 mtt -144.25 157.44 44.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.89 -0.595 . . . . 0.79 110.491 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.448 ' HB ' HD12 ' A' ' 79' ' ' LEU . 86.1 t -135.38 124.45 40.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.053 -0.721 . . . . 0.22 109.053 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 20.5 tp -80.24 116.52 20.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.443 -0.577 . . . . 0.29 109.443 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 47.4 t -119.03 123.06 70.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.105 0.479 . . . . 0.82 111.608 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -99.11 114.76 5.12 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.192 -1.163 . . . . 0.27 110.192 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -97.32 166.06 11.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.83 0.348 . . . . 0.21 110.962 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.6 mttt 68.45 26.06 6.69 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.512 -0.767 . . . . 0.54 111.632 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 84' ' ' ILE . 24.8 p -67.32 -19.35 65.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.935 0.398 . . . . 0.46 110.802 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -79.74 -14.25 58.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.872 -0.603 . . . . 0.7 110.398 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 54.8 mt -85.72 151.58 55.61 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.128 -0.487 . . . . 0.67 109.715 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 1.4 Cg_endo -81.46 -176.63 3.18 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.968 2.445 . . . . 0.54 112.366 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 m 61.2 54.09 3.37 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.987 -0.551 . . . . 0.84 110.939 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 14.1 ttm-85 -63.79 112.03 2.7 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.673 -0.694 . . . . 0.58 110.3 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.03 -40.19 13.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.835 -0.621 . . . . 0.81 110.55 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.9 t -95.28 119.3 43.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.417 -0.356 . . . . 0.37 110.219 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -74.96 155.64 37.18 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.146 0.498 . . . . 1.69 111.482 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -38.45 83.76 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.48 -0.782 . . . . 0.82 110.958 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -69.4 -36.6 76.9 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.039 -0.528 . . . . 0.62 111.011 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -59.04 -43.02 91.6 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.087 0.47 . . . . 0.93 110.554 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.1 -40.37 60.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.887 -0.597 . . . . 0.3 110.461 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -61.95 -39.29 91.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.013 -0.54 . . . . 0.47 109.938 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.42 ' HA ' ' HD2' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -63.7 -40.56 97.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.559 -0.746 . . . . 1.18 110.578 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.8 tp -68.57 -41.39 79.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.755 -0.657 . . . . 0.44 110.937 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.54 -33.44 75.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.25 110.512 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 135' ' ' ARG . 63.8 mtt-85 -58.69 -55.52 34.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.709 -0.678 . . . . 1.54 111.623 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -42.79 96.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.081 0.467 . . . . 0.68 111.899 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -68.63 -22.34 64.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 0.77 111.051 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.36 43.2 46.89 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.968 -0.56 . . . . 0.25 112.409 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 31.3 pt -136.95 161.71 59.97 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.996 -0.372 . . . . 0.51 109.996 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.01 156.13 42.92 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.707 2.271 . . . . 0.36 112.505 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 5.7 t80 -135.37 125.15 25.45 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.572 -0.529 . . . . 0.38 109.572 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.7 mt -135.71 130.46 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.921 -0.312 . . . . 0.54 111.217 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -84.18 123.77 30.45 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.063 -1.088 . . . . 0.88 108.063 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.503 HG22 ' HA3' ' A' ' 151' ' ' GLY . 43.0 p -133.79 177.23 7.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.151 0.501 . . . . 0.43 111.252 -177.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.1 t -156.58 124.39 5.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.821 -0.627 . . . . 0.33 110.094 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.36 -12.95 60.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.29 0.566 . . . . 0.45 110.088 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.9 tttm -79.76 -53.16 7.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.574 -0.739 . . . . 1.32 110.743 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.8 p -83.27 -17.34 42.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.295 -0.411 . . . . 0.52 110.844 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.1 ttt180 70.3 21.27 5.86 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.932 0.77 . . . . 1.53 109.951 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -91.34 122.63 34.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.011 -0.54 . . . . 0.87 110.584 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.503 ' HA3' HG22 ' A' ' 144' ' ' THR . . . 91.7 -4.34 79.05 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.51 112.796 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 71.8 t -58.37 -59.99 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.666 0.247 . . . . 0.74 111.666 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.68 -47.61 84.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 1.62 110.834 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -56.16 -46.32 79.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.59 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -58.96 -53.66 55.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.869 0.322 . . . . 0.37 111.869 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.545 ' O ' HG23 ' A' ' 160' ' ' VAL . 50.4 m-85 -61.07 -49.57 76.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.421 -0.354 . . . . 1.46 111.458 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -59.42 -39.51 83.72 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.338 -0.392 . . . . 0.99 111.748 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.546 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 95.9 m -61.06 -44.45 97.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.527 -0.306 . . . . 0.34 110.86 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 35.2 tp -65.14 -36.44 84.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.713 -0.221 . . . . 0.42 111.174 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 156' ' ' PHE . 49.0 t -59.69 -41.02 83.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.194 0.521 . . . . 0.55 110.235 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -77.15 -23.62 51.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.812 -0.631 . . . . 0.9 110.916 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 158' ' ' THR . 52.6 mm-40 -64.76 -43.77 92.22 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.792 0.33 . . . . 0.73 110.379 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.427 ' H ' HG13 ' A' ' 163' ' ' ILE . 12.1 mt -65.15 -38.95 83.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.047 -0.524 . . . . 0.42 111.015 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 75.8 mtt180 -59.27 -38.8 81.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.769 -0.65 . . . . 0.87 110.991 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 162' ' ' GLU . 49.0 mtmt -62.62 -39.12 92.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.063 -0.517 . . . . 0.97 111.061 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -75.28 -34.6 61.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.299 -0.41 . . . . 0.71 110.562 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -73.06 -30.79 63.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.586 -0.279 . . . . 1.11 111.408 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -101.86 11.58 38.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.853 0.359 . . . . 1.12 110.736 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.7 tttp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.626 -0.702 . . . . 1.47 110.951 -179.204 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.5 ttm . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 110.36 -0.237 . . . . 1.48 110.36 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.2 m -92.91 134.89 34.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.496 -0.32 . . . . 1.04 110.674 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -87.71 127.14 35.3 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.808 -0.441 . . . . 1.27 109.808 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -112.46 128.02 56.21 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.849 -0.426 . . . . 1.11 109.849 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -97.04 122.83 40.47 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.129 -0.487 . . . . 0.81 111.332 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mp -129.75 137.79 50.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.923 -0.581 . . . . 1.39 110.7 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.6 t -124.15 128.1 73.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.261 -0.427 . . . . 0.81 110.276 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.2 t -89.18 124.12 41.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.194 -0.669 . . . . 0.44 109.194 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 9.8 m -115.77 148.95 18.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.606 -0.27 . . . . 0.7 110.587 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.38 178.24 38.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.985 -0.626 . . . . 0.53 112.101 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -78.24 168.68 19.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.996 0.427 . . . . 0.58 111.306 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.7 104.67 1.91 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.943 -0.646 . . . . 0.8 112.448 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.49 4.0 10.05 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.494 -0.86 . . . . 0.42 112.77 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 11' ' ' ALA . 15.9 m -74.3 -29.32 24.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.913 0.387 . . . . 0.57 111.25 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.85 22.06 5.14 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.678 -0.772 . . . . 0.49 113.788 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -52.78 -50.19 64.07 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.983 0.392 . . . . 0.81 110.933 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.4 ' O ' HG13 ' A' ' 21' ' ' ILE . 3.2 m -63.85 -43.42 96.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.722 0.296 . . . . 0.58 111.507 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.71 -48.41 79.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.857 0.317 . . . . 0.43 111.857 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.637 ' HG ' ' HB2' ' A' ' 146' ' ' ALA . 2.6 mt -65.29 -36.25 83.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.731 0.3 . . . . 0.92 111.237 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.4 m -70.16 -42.04 73.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.662 0.267 . . . . 0.89 111.024 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.46 HG21 HG21 ' A' ' 29' ' ' VAL . 82.4 mt -68.87 -31.86 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.407 . . . . 0.79 109.946 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.568 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 4.4 mm-40 -63.67 -21.43 66.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.98 -0.555 . . . . 0.46 111.599 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.7 tp -92.2 -14.98 28.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.139 0.495 . . . . 1.37 110.864 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.6 mm -104.3 -64.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.075 -0.511 . . . . 0.58 111.119 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -84.62 -7.61 59.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 1.68 110.823 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.6 OUTLIER 56.38 30.03 16.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.577 0.955 . . . . 1.6 113.577 177.654 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -142.2 146.4 35.19 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.932 -0.307 . . . . 0.74 110.36 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -68.01 143.07 55.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.12 -0.491 . . . . 0.6 111.427 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 21' ' ' ILE . 35.1 t -130.88 99.2 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.153 -0.684 . . . . 0.64 109.153 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.58 -41.46 54.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.15 -0.477 . . . . 1.12 111.122 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -94.31 97.46 10.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.216 0.531 . . . . 1.18 111.412 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -151.51 136.53 17.38 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.877 -0.786 . . . . 0.6 108.877 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -72.1 126.48 91.19 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.963 0.411 . . . . 0.8 111.494 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -65.82 -28.0 51.38 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.914 2.409 . . . . 0.52 112.83 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.24 -12.57 60.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.876 -0.602 . . . . 0.89 111.645 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -77.29 121.87 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.279 0.562 . . . . 0.73 110.34 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 15.3 tt0 -114.26 127.03 55.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.824 -1.08 . . . . 0.81 108.777 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -146.33 154.15 41.34 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.302 0.572 . . . . 1.29 111.403 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.4 129.17 53.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.483 -0.78 . . . . 0.78 109.953 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -117.83 147.49 43.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.747 0.308 . . . . 0.94 110.885 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.537 ' HD2' ' OD2' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -119.83 138.52 53.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.56 110.415 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -146.42 122.09 10.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.271 -0.422 . . . . 1.46 110.775 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.69 116.65 29.17 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.52 -0.548 . . . . 1.89 109.52 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.52 136.87 59.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.09 -0.504 . . . . 1.09 111.204 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 t -91.58 74.53 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.847 -0.797 . . . . 0.65 108.847 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.1 mt -82.9 113.54 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.604 -0.725 . . . . 1.06 111.332 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 65.95 28.84 10.48 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.319 -0.855 . . . . 0.97 111.012 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.59 -12.4 67.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.131 -0.556 . . . . 0.6 112.515 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -93.97 111.03 22.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.746 0.308 . . . . 1.41 111.053 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -73.32 104.59 4.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.137 0.494 . . . . 0.63 109.853 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.8 m -114.74 143.85 44.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.094 0.473 . . . . 0.71 111.081 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 tp -102.47 109.65 21.36 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.653 -0.869 . . . . 0.48 108.653 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 48.7 mt -82.63 117.77 22.83 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.289 -0.414 . . . . 0.87 111.654 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.537 ' OD2' ' HD2' ' A' ' 41' ' ' ARG . 15.1 t70 -101.03 86.07 2.97 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.529 -1.285 . . . . 1.03 107.529 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.1 mt -97.94 150.4 4.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.651 -0.704 . . . . 0.68 112.238 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 tp -137.84 130.4 29.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 0.46 111.02 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 3.9 t70 -91.91 107.48 19.24 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.574 -0.528 . . . . 0.44 109.574 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.8 p -72.53 137.36 46.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.146 0.498 . . . . 0.73 111.981 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.33 -37.8 66.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.542 -0.754 . . . . 0.56 110.209 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.88 -58.9 0.7 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.981 -0.628 . . . . 0.72 111.896 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -108.98 140.67 42.16 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.358 -0.608 . . . . 1.26 109.358 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -106.14 165.86 10.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 1.57 111.256 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -79.13 -42.06 27.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.113 -1.069 . . . . 1.38 108.113 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -126.42 129.67 49.19 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.854 -1.066 . . . . 0.81 109.155 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.41 -33.34 65.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.211 -0.449 . . . . 0.63 111.461 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.12 -35.15 77.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.196 -0.456 . . . . 0.32 111.205 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 87.9 mtp -69.66 -35.89 75.57 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.887 0.375 . . . . 0.69 110.849 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -66.37 -44.56 82.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.829 -0.623 . . . . 0.9 110.24 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 81.0 m-20 -80.69 -10.13 59.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.896 -0.593 . . . . 1.41 110.677 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -66.8 -58.45 5.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 1.51 110.639 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -67.16 -17.75 64.98 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.01 0.434 . . . . 1.17 111.336 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 46.0 mtt -69.07 -26.97 65.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.062 -0.517 . . . . 0.7 110.187 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 72.4 mtm180 -84.86 -42.94 14.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.055 -0.52 . . . . 1.29 110.345 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -27.39 61.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.771 -0.649 . . . . 0.72 111.812 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.91 139.79 43.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.962 -0.637 . . . . 0.19 112.692 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -93.57 -53.6 3.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.787 0.327 . . . . 0.54 110.945 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -122.76 138.43 11.8 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.716 -0.754 . . . . 0.26 111.763 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' A' ' 111' ' ' MET . 79.6 m-85 -117.96 135.27 54.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.172 0.51 . . . . 0.48 111.059 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.3 tp -101.86 113.86 27.43 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.717 -0.674 . . . . 0.37 109.866 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 3.6 m -89.44 89.45 7.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.039 -0.528 . . . . 0.61 110.579 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 11.8 t -96.86 129.63 46.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.017 -0.538 . . . . 0.59 111.189 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -129.78 179.21 5.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.175 -0.676 . . . . 0.34 109.175 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . . . -112.58 130.67 55.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.782 0.325 . . . . 0.32 110.457 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.427 ' HB ' ' HG3' ' A' ' 123' ' ' ARG . 3.1 pt -66.83 -19.3 25.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.099 -0.5 . . . . 0.78 111.505 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -104.99 15.64 27.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.145 0.498 . . . . 0.82 110.818 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.476 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 43.1 t-20 -140.44 92.75 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 1.07 110.218 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -25.46 68.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.33 -0.395 . . . . 0.65 111.349 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -67.81 -32.43 72.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.586 -0.279 . . . . 0.89 110.473 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.5 p -72.19 -30.44 64.95 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.979 -0.748 . . . . 0.64 108.979 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -69.62 -29.91 67.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.433 -0.803 . . . . 0.42 109.619 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.79 -38.52 73.37 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.728 -0.669 . . . . 1.44 110.101 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.19 -29.04 70.17 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.551 -0.749 . . . . 1.02 110.278 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.5 mm -56.21 -36.2 45.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.636 -0.711 . . . . 0.42 110.38 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -64.91 -36.32 84.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.639 . . . . 0.83 111.357 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -80.96 -32.2 34.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.347 -0.388 . . . . 0.79 111.032 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.496 ' CE1' ' HB ' ' A' ' 9' ' ' VAL . 3.6 m-85 -61.21 -51.04 70.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.496 0.188 . . . . 1.17 111.228 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.592 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 22.6 tpt180 -62.04 -30.03 70.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.313 0.577 . . . . 0.6 110.42 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -76.36 -53.06 8.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.247 -0.888 . . . . 1.35 111.98 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 103' ' ' VAL . 8.2 tt0 -62.37 -58.08 8.98 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.114 0.412 . . . . 1.15 112.114 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.5 mt -54.07 -39.74 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.914 0.338 . . . . 0.51 111.914 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 6.1 ttpt -66.36 -35.95 81.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.789 0.328 . . . . 1.05 110.802 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -76.8 -26.47 54.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.066 0.46 . . . . 0.91 110.534 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 99' ' ' GLN . 67.5 t -77.16 -40.63 30.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.35 110.02 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -80.24 -26.46 39.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.382 -0.372 . . . . 0.63 110.757 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 t70 66.73 51.01 1.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.641 -0.709 . . . . 0.47 110.34 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.94 163.14 31.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.552 -0.749 . . . . 1.14 109.893 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -96.72 -42.21 8.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.839 0.352 . . . . 1.74 110.152 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -102.1 116.35 32.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.013 -0.54 . . . . 0.78 110.039 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.4 t -127.96 122.08 22.14 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.097 -0.501 . . . . 0.47 109.794 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.57 104.23 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.787 2.325 . . . . 0.25 111.667 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.455 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 31.7 mtt -139.18 151.8 46.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.7 -0.682 . . . . 0.79 110.159 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.8 t -136.96 126.3 37.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.451 -0.574 . . . . 0.22 109.451 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 41.0 tp -81.81 122.33 27.56 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.641 -0.503 . . . . 0.29 109.641 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 142' ' ' ILE . 95.3 t -124.07 127.95 73.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.091 -0.504 . . . . 0.82 111.673 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.41 102.17 2.25 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.659 -0.976 . . . . 0.27 110.659 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 144' ' ' THR . 65.6 t30 -86.41 165.82 16.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.703 0.251 . . . . 0.21 110.356 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 69.76 29.8 4.01 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.861 0.726 . . . . 0.54 110.552 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 30.8 p -67.72 -11.91 59.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.879 -0.6 . . . . 0.46 111.38 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -87.17 -8.36 57.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.692 0.282 . . . . 0.7 110.731 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 43.0 mt -85.36 148.64 50.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.67 110.936 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.31 -177.77 3.66 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.611 2.207 . . . . 0.54 111.619 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.2 m 58.09 55.19 5.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.118 0.485 . . . . 0.84 111.055 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.427 ' HG3' ' HB ' ' A' ' 84' ' ' ILE . 16.5 ttm180 -66.97 109.71 3.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.878 -0.601 . . . . 0.58 109.9 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.01 -42.45 16.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.002 0.429 . . . . 0.81 110.619 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.31 112.53 22.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.262 -0.426 . . . . 0.37 109.875 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.89 148.13 52.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.893 0.378 . . . . 1.69 110.679 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.22 -39.51 79.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.896 -0.593 . . . . 0.82 112.34 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -68.81 -37.58 79.33 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 120.88 -0.328 . . . . 0.62 110.902 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -56.13 -43.91 78.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.763 0.316 . . . . 0.93 111.43 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.32 -46.47 55.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.911 -0.586 . . . . 0.3 110.894 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -59.96 -44.83 94.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.47 110.418 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -61.81 -42.9 99.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.462 -0.79 . . . . 1.18 110.498 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.22 -41.2 90.43 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.992 -0.549 . . . . 0.44 110.722 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.89 -35.26 80.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.365 -0.38 . . . . 0.25 110.346 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -63.87 -43.58 95.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 1.54 111.519 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.19 -17.96 65.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.637 0.256 . . . . 0.68 111.566 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -100.59 -8.12 23.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.236 -0.438 . . . . 0.77 110.214 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.8 31.25 70.16 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.762 -0.654 . . . . 0.25 112.583 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 44.1 pt -121.58 153.37 59.42 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 122.798 -0.236 . . . . 0.51 110.454 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.01 156.13 56.44 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.883 2.388 . . . . 0.36 112.856 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -128.6 120.85 27.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 0.38 109.56 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 73.8 mt -132.88 138.25 52.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.757 0.313 . . . . 0.54 111.038 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -93.57 126.72 38.88 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.288 -0.634 . . . . 0.88 109.288 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 116' ' ' ASN . 32.1 p -131.67 166.07 22.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.255 0.55 . . . . 0.43 111.257 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.2 t -146.33 122.38 10.75 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.496 -0.928 . . . . 0.33 108.496 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.637 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . . . -70.0 -10.79 59.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.103 0.478 . . . . 0.45 110.863 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -89.0 -48.02 7.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.758 -0.656 . . . . 1.32 111.476 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.0 p -93.56 -17.27 23.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.582 0.586 . . . . 0.52 112.582 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.448 ' HA ' HG21 ' A' ' 152' ' ' VAL . 0.5 OUTLIER 69.77 21.75 6.33 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.946 -0.57 . . . . 1.53 110.765 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 144' ' ' THR . 11.2 tt0 -73.9 120.27 19.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.639 -0.709 . . . . 0.87 110.809 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 66.44 6.66 35.64 Favored Glycine 0 CA--C 1.516 0.111 0 CA-C-N 116.072 -0.513 . . . . 0.51 113.633 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 149' ' ' ARG . 18.3 t -61.01 -61.04 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.521 0.2 . . . . 0.74 111.455 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.93 -37.9 83.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 1.62 110.51 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -56.93 -45.22 82.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.769 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -58.33 -47.79 82.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.37 111.266 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.434 ' O ' HG23 ' A' ' 160' ' ' VAL . 72.6 m-85 -64.55 -44.35 91.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.185 -0.461 . . . . 1.46 110.944 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -60.0 -37.02 78.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.99 111.296 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 19.3 m -65.42 -53.69 39.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.138 -0.483 . . . . 0.34 111.355 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.544 ' O ' HG13 ' A' ' 163' ' ' ILE . 14.0 tp -57.59 -35.8 70.89 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.702 0.287 . . . . 0.42 111.111 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 156' ' ' PHE . 38.3 t -58.36 -40.75 79.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.029 0.443 . . . . 0.55 110.733 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -78.96 -30.2 44.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.962 -0.563 . . . . 0.9 111.327 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 158' ' ' THR . 7.6 mm-40 -62.16 -40.89 97.5 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.854 -0.424 . . . . 0.73 109.854 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 159' ' ' LEU . 52.8 mt -63.36 -43.99 98.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.717 -0.674 . . . . 0.42 110.13 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 96.4 mtt180 -56.85 -49.43 75.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.785 -0.643 . . . . 0.87 111.068 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 169' ' ' LYS . 41.3 mtmt -57.36 -34.33 68.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.317 -0.401 . . . . 0.97 111.606 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -74.58 -37.26 62.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.486 -0.325 . . . . 0.71 110.692 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.449 ' HD2' HG22 ' A' ' 163' ' ' ILE . 47.2 mtpt -75.82 -33.0 60.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.4 -0.364 . . . . 1.11 111.903 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 10.3 pt-20 -92.49 7.4 43.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.952 0.406 . . . . 1.12 110.745 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 165' ' ' LYS . 30.7 tttp . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.245 -0.883 . . . . 1.47 110.128 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.6 ttm . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 109.926 -0.398 . . . . 1.48 109.926 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.7 m -94.48 134.7 36.73 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.048 -0.352 . . . . 1.04 110.048 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -85.71 129.98 34.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.914 -0.585 . . . . 1.27 110.496 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 51' ' ' CYS . 61.5 m-85 -125.57 115.65 20.51 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.816 -0.438 . . . . 1.11 109.816 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -100.48 113.85 26.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.158 0.504 . . . . 0.81 110.272 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.14 138.46 52.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.717 -0.674 . . . . 1.39 110.895 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.41 ' HB ' ' CD2' ' A' ' 78' ' ' PHE . 39.2 t -118.01 132.41 67.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.327 -0.397 . . . . 0.81 110.637 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 t -94.86 113.56 29.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.871 -0.789 . . . . 0.44 108.871 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 m -114.8 166.56 8.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.921 0.391 . . . . 0.7 111.291 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.19 -170.31 30.86 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.013 -0.835 . . . . 0.53 111.013 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.53 172.16 14.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.241 0.543 . . . . 0.58 110.85 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.74 128.09 8.96 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.701 -0.761 . . . . 0.8 112.595 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.99 13.32 72.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.899 -0.667 . . . . 0.42 114.02 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.4 m -73.41 -29.71 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 117.644 0.722 . . . . 0.57 111.031 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.48 20.41 2.65 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.351 -0.928 . . . . 0.49 113.84 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -54.68 -58.85 5.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.956 0.408 . . . . 0.81 110.97 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -54.28 -47.76 71.99 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.603 -0.726 . . . . 0.58 111.829 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.17 84.31 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.677 0.251 . . . . 0.43 111.677 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.3 mt -63.83 -40.63 97.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 0.92 110.524 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.9 m -72.04 -43.78 64.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.158 -0.474 . . . . 0.89 110.66 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.74 -42.11 87.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.046 -0.525 . . . . 0.79 110.915 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.555 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 4.3 mm-40 -64.02 -20.79 66.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.46 111.338 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.2 tp -91.44 -39.78 11.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.918 0.389 . . . . 1.37 111.147 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.7 mm -81.51 -50.66 16.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.263 -0.426 . . . . 0.58 112.104 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -92.29 -16.49 26.03 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.931 0.345 . . . . 1.68 111.931 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 3.7 m-80 66.42 27.51 9.87 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.735 0.643 . . . . 1.6 112.735 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 -153.04 144.1 23.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.135 -0.32 . . . . 0.74 110.135 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -68.83 142.67 54.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.182 -0.463 . . . . 0.6 111.945 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 70.5 t -130.6 114.84 29.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 109.168 -0.679 . . . . 0.64 109.168 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -78.56 -42.72 28.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.926 -0.579 . . . . 1.12 111.26 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -100.49 102.16 13.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.297 -0.41 . . . . 1.18 111.948 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -155.19 117.59 4.23 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.65 -0.87 . . . . 0.6 108.65 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -52.32 122.43 24.77 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.52 0.676 . . . . 0.8 111.618 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.61 -18.14 15.62 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.685 2.257 . . . . 0.52 113.37 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.575 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -87.09 12.5 11.33 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.282 0.475 . . . . 0.89 112.282 -178.687 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.5 mt -99.71 105.64 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.244 0.545 . . . . 0.73 110.204 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 3.7 tt0 -86.48 87.0 7.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.878 -0.601 . . . . 0.81 109.535 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.81 161.69 14.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.626 -0.716 . . . . 1.29 110.583 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 10.4 p -131.18 144.71 51.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.194 -0.457 . . . . 0.78 110.351 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -126.39 149.17 49.4 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.218 -0.446 . . . . 0.94 111.083 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 1.7 mpp_? -123.75 123.8 41.3 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.35 -0.386 . . . . 0.56 110.458 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -144.62 124.97 13.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.846 0.355 . . . . 1.46 110.281 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -86.53 119.93 27.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.002 0.429 . . . . 1.89 110.548 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.3 t -129.53 141.08 47.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.925 -0.58 . . . . 1.09 110.166 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.7 t -87.64 106.35 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.78 -0.452 . . . . 0.65 109.78 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 32.6 mt -110.6 115.24 49.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.198 -0.455 . . . . 1.06 110.403 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 61.32 43.95 10.17 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.632 0.582 . . . . 0.97 111.334 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.1 27.77 71.43 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.6 113.317 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -137.74 120.94 16.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.93 0.365 . . . . 1.41 111.254 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -75.25 103.32 5.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.862 0.363 . . . . 0.63 110.238 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 4' ' ' TYR . 11.5 m -110.44 137.33 48.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.471 -0.331 . . . . 0.71 111.751 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.2 tp -92.03 111.55 23.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.149 -1.056 . . . . 0.48 108.149 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 60.2 mt -89.97 114.02 25.78 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.052 0.76 . . . . 0.87 113.052 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -106.0 101.5 10.99 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.765 -1.198 . . . . 1.03 107.765 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.5 mt -107.0 141.66 21.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.255 -0.429 . . . . 0.68 111.727 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.7 tp -122.37 125.91 46.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.792 -0.64 . . . . 0.46 111.108 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 7.0 t70 -92.48 101.89 14.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.25 -0.648 . . . . 0.44 109.25 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.4 p -67.35 134.76 52.12 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.482 0.658 . . . . 0.73 112.184 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' A' ' 35' ' ' THR . . . -89.45 -37.94 14.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.218 -0.901 . . . . 0.56 110.067 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 142.84 -94.9 0.18 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.84 -0.695 . . . . 0.72 112.531 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -101.78 118.23 36.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.159 0.504 . . . . 1.26 111.212 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.2 167.37 14.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.508 -0.769 . . . . 1.57 109.275 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -54.19 -52.84 59.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 1.38 110.913 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -117.41 141.0 48.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.122 -0.49 . . . . 0.81 110.239 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -63.19 -29.04 70.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.879 0.371 . . . . 0.63 111.03 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.84 -26.34 68.29 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.011 -0.54 . . . . 0.32 110.347 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 71.8 mtp -72.8 -37.7 67.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.675 -0.693 . . . . 0.69 109.595 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.602 ' HA ' ' CZ ' ' A' ' 71' ' ' TYR . 30.7 ttp180 -70.49 -43.92 68.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.866 -0.606 . . . . 0.9 109.967 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -28.3 67.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.427 -0.806 . . . . 1.41 110.636 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -56.22 -65.08 0.67 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.424 -0.807 . . . . 1.51 112.088 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.602 ' CZ ' ' HA ' ' A' ' 68' ' ' ARG . 3.5 p90 -69.1 -18.71 64.01 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.337 0.495 . . . . 1.17 112.337 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 32.8 mtt -71.45 -26.76 62.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.304 0.573 . . . . 0.7 109.927 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -90.03 -28.7 18.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.205 -0.452 . . . . 1.29 110.925 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -86.53 -26.24 24.65 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.084 0.402 . . . . 0.72 112.084 -179.169 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.26 125.82 24.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.798 -0.715 . . . . 0.19 111.96 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -83.34 -41.49 18.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.78 0.324 . . . . 0.54 110.234 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -129.65 133.26 7.4 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.535 -0.626 . . . . 0.26 111.535 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.41 ' CD2' ' HB ' ' A' ' 7' ' ' VAL . 94.1 m-85 -114.5 122.39 46.43 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.053 0.454 . . . . 0.48 110.934 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.503 HD12 ' HB ' ' A' ' 112' ' ' VAL . 11.7 tp -88.05 112.0 22.15 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.102 -0.703 . . . . 0.37 109.102 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.2 m -90.54 101.16 13.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.858 0.361 . . . . 0.61 110.428 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.3 t -103.01 131.92 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.259 -0.428 . . . . 0.59 111.54 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -134.19 171.06 14.76 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.978 -0.749 . . . . 0.34 108.978 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.54 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . . . -103.77 126.64 51.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.856 0.36 . . . . 0.32 110.824 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.6 pt -68.64 -16.61 21.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.78 111.074 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -106.97 24.1 13.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.274 -0.421 . . . . 0.82 110.932 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.54 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 28.5 t-20 -156.46 102.17 2.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.07 -0.514 . . . . 1.07 110.116 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.18 -23.34 66.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.978 -0.555 . . . . 0.65 111.833 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.452 ' HB3' ' OD1' ' A' ' 86' ' ' ASN . 51.2 tptt -56.01 -50.87 69.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.313 -0.403 . . . . 0.89 110.862 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.3 p -63.43 -41.4 98.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.64 111.156 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -61.52 -40.89 96.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.265 -0.425 . . . . 0.42 111.142 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -74.85 -11.7 60.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.237 -0.438 . . . . 1.44 111.587 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.52 -20.05 23.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.094 0.473 . . . . 1.02 110.271 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.8 mm -58.91 -29.88 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.526 -0.761 . . . . 0.42 110.794 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -59.19 -52.0 67.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.83 109.821 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -65.16 -32.4 74.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.474 -0.784 . . . . 0.79 111.101 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -65.95 -50.23 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.458 0.17 . . . . 1.17 110.856 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -60.05 -46.2 90.32 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.523 -0.547 . . . . 0.6 109.523 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.42 -47.92 84.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.767 -0.651 . . . . 1.35 111.075 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.518 ' O ' HG23 ' A' ' 103' ' ' VAL . 16.5 tt0 -58.88 -58.84 6.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.834 -0.621 . . . . 1.15 111.76 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.3 mt -55.83 -37.61 48.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.522 -0.308 . . . . 0.51 111.659 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -65.75 -37.51 86.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.532 0.206 . . . . 1.05 110.921 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.0 -33.38 51.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.91 111.07 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 99' ' ' GLN . 93.5 t -66.82 -45.13 88.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.064 0.459 . . . . 0.35 110.285 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -81.46 -26.29 35.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.14 -0.482 . . . . 0.63 110.354 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.6 t0 64.66 60.25 0.89 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.336 -0.847 . . . . 0.47 110.142 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.7 t -153.69 151.55 29.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.328 -0.851 . . . . 1.14 110.016 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -81.37 -42.99 19.65 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.061 -0.518 . . . . 1.74 111.081 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -97.24 117.7 32.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.055 0.455 . . . . 0.78 111.838 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 46.9 t -135.66 113.39 10.94 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.046 -0.724 . . . . 0.47 109.046 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.59 112.13 0.96 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.02 2.48 . . . . 0.25 112.369 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 50.5 mtt -141.58 156.93 45.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.949 -0.569 . . . . 0.79 110.3 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 79' ' ' LEU . 94.6 t -135.32 129.21 49.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 109.166 -0.679 . . . . 0.22 109.166 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.8 tp -85.0 115.37 22.79 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.549 -0.537 . . . . 0.29 109.549 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.1 t -114.99 117.45 55.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.815 -0.63 . . . . 0.82 111.756 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -95.92 94.6 1.7 Allowed Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.232 -1.147 . . . . 0.27 110.232 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -80.3 166.91 20.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.652 0.263 . . . . 0.21 111.415 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 69.69 33.12 3.07 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.465 -0.788 . . . . 0.54 111.064 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 18.7 p -69.61 -4.76 20.64 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.417 -0.356 . . . . 0.46 111.853 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -93.36 -11.22 32.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.463 -0.335 . . . . 0.7 110.831 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.5 mt -91.43 142.48 27.02 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.396 -0.365 . . . . 0.67 111.182 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -79.75 -169.81 0.87 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.828 2.352 . . . . 0.54 111.572 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.4 m 57.87 43.89 20.87 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.301 0.572 . . . . 0.84 110.387 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -63.33 119.03 8.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.184 -0.916 . . . . 0.58 110.126 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.86 -32.37 12.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.179 -0.464 . . . . 0.81 111.333 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 t -97.23 110.79 25.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.95 0.405 . . . . 0.37 110.396 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.16 148.46 48.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.976 -0.556 . . . . 1.69 111.044 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.04 -39.93 69.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.581 -0.736 . . . . 0.82 112.349 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -65.79 -38.83 90.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.574 0.226 . . . . 0.62 111.445 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -61.11 -42.45 98.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.906 0.384 . . . . 0.93 110.971 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.27 63.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.269 -0.423 . . . . 0.3 110.61 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 135' ' ' ARG . 6.6 tp-100 -62.38 -42.53 99.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.47 110.006 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.76 -35.46 78.18 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.077 0.465 . . . . 1.18 110.403 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.9 tp -68.83 -46.83 67.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.727 -0.669 . . . . 0.44 109.973 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.56 95.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.716 -0.674 . . . . 0.25 110.966 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 131' ' ' GLN . 24.9 mtm180 -65.31 -32.45 74.11 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.321 -0.4 . . . . 1.54 111.093 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.6 m -73.44 -29.98 62.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.91 0.385 . . . . 0.68 110.461 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -82.67 -40.08 21.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.183 0.516 . . . . 0.77 110.46 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.36 32.1 5.32 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 109.97 -1.252 . . . . 0.25 109.97 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 4.6 pt -128.34 168.35 15.91 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.338 -0.431 . . . . 0.51 110.592 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -86.55 160.12 9.4 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.532 2.155 . . . . 0.36 112.586 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -134.26 130.36 37.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.38 110.151 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.7 mt -139.28 132.41 37.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.139 -0.482 . . . . 0.54 110.985 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -82.92 129.71 35.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.728 -1.212 . . . . 0.88 107.728 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 30.9 p -137.71 173.87 11.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.512 0.672 . . . . 0.43 111.756 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.7 t -156.24 130.53 8.74 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.82 -1.082 . . . . 0.33 108.784 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.62 -8.71 57.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.224 0.535 . . . . 0.45 110.317 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -85.48 -51.9 6.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.707 -0.679 . . . . 1.32 110.914 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.7 p -91.12 -13.64 32.67 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.173 0.434 . . . . 0.52 112.173 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 149' ' ' ARG . 14.1 mtp-105 66.56 20.47 10.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.129 0.571 . . . . 1.53 110.706 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -74.24 121.16 20.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.922 -0.581 . . . . 0.87 111.814 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.26 -4.24 12.71 Favored Glycine 0 C--N 1.33 0.219 0 N-CA-C 114.99 0.756 . . . . 0.51 114.99 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.72 -51.26 74.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 117.403 0.601 . . . . 0.74 110.645 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.34 -39.06 89.19 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.283 0.563 . . . . 1.62 110.565 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.66 -42.04 98.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.557 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.45 81.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.37 110.741 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -60.08 -43.03 95.78 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.059 -0.519 . . . . 1.46 110.654 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -63.22 -45.58 90.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.849 -0.614 . . . . 0.99 111.04 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 26.5 m -62.65 -40.26 96.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.892 -0.595 . . . . 0.34 111.514 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.449 ' O ' HG13 ' A' ' 163' ' ' ILE . 37.3 tp -59.03 -40.79 86.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.932 0.396 . . . . 0.42 110.593 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.11 -38.62 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.55 110.3 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -68.86 -30.39 68.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.9 110.667 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -67.26 -44.06 80.3 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.736 -0.839 . . . . 0.73 108.736 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 159' ' ' LEU . 74.2 mt -60.74 -44.03 96.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 115.378 -0.828 . . . . 0.42 109.837 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 91.3 mtt180 -55.9 -48.66 75.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.738 -0.665 . . . . 0.87 110.805 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -61.6 -34.44 75.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.97 111.308 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -71.97 -35.99 69.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.71 110.282 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -69.62 -36.95 76.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.078 -0.51 . . . . 1.11 111.099 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 9.2 pt-20 -100.38 20.16 15.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.154 -0.476 . . . . 1.12 111.065 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.1 mttp . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.598 -0.715 . . . . 1.47 109.622 179.403 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.773 0.321 . . . . 1.48 110.462 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.03 145.17 27.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.259 -0.428 . . . . 1.04 110.73 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -105.58 131.69 52.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.177 -0.465 . . . . 1.27 110.584 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.607 ' HE2' ' HG ' ' A' ' 51' ' ' CYS . 52.1 m-85 -116.12 116.54 28.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.16 -0.473 . . . . 1.11 110.045 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -97.11 110.68 23.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.137 -0.483 . . . . 0.81 110.411 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -127.11 142.79 51.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.872 -0.603 . . . . 1.39 111.003 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.8 t -121.91 134.52 64.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.972 0.415 . . . . 0.81 111.027 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.7 t -93.74 103.97 15.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.235 -1.024 . . . . 0.44 108.235 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.73 146.49 15.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.278 -0.419 . . . . 0.7 111.351 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.94 -175.09 42.87 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.771 -0.728 . . . . 0.53 111.299 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.78 158.17 36.08 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.01 0.433 . . . . 0.58 111.321 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.29 134.41 15.62 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.55 -0.833 . . . . 0.8 111.884 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.69 2.06 60.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.794 -0.717 . . . . 0.42 113.568 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -79.25 -24.11 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 117.285 0.542 . . . . 0.57 110.91 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.99 25.77 4.35 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.688 -0.768 . . . . 0.49 113.467 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -53.44 -55.53 24.42 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 111.891 0.33 . . . . 0.81 111.891 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.485 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 1.0 OUTLIER -59.59 -53.47 57.65 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.888 -0.596 . . . . 0.58 112.048 -178.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.83 -43.55 77.09 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.778 0.659 . . . . 0.43 112.778 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.499 ' CD1' HG11 ' A' ' 81' ' ' VAL . 39.1 mt -59.81 -41.27 90.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.823 0.344 . . . . 0.92 111.632 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 m -76.83 -46.2 25.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.411 -0.359 . . . . 0.89 111.657 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 17' ' ' SER . 79.4 mt -60.14 -27.61 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.937 0.399 . . . . 0.79 111.631 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.2 -35.07 79.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.915 0.388 . . . . 0.46 111.143 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -91.56 -6.39 52.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.992 0.425 . . . . 1.37 111.347 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.1 mm -102.81 -43.41 9.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.329 -0.396 . . . . 0.58 111.129 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -105.31 -4.78 21.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.513 -0.312 . . . . 1.68 111.676 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.3 t30 64.15 35.27 10.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.024 0.75 . . . . 1.6 113.024 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -162.81 154.58 18.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.034 0.445 . . . . 0.74 110.817 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -87.81 128.96 35.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.659 -0.701 . . . . 0.6 111.205 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.8 120.82 47.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.252 -0.886 . . . . 0.64 109.032 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -77.01 -40.73 45.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 1.12 111.176 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -127.5 117.94 23.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.276 -0.42 . . . . 1.18 110.537 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -143.29 143.96 31.92 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.297 -0.631 . . . . 0.6 109.297 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.76 124.04 66.48 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.847 0.356 . . . . 0.8 111.158 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.26 -13.69 9.87 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.883 2.389 . . . . 0.52 113.79 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.7 p -98.19 1.15 47.08 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.805 -0.358 . . . . 0.89 111.777 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 mt -83.56 132.13 32.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.073 0.463 . . . . 0.73 110.353 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 10.0 tt0 -121.87 82.24 1.93 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.37 -0.832 . . . . 0.81 109.069 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -103.45 155.67 18.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.535 -0.757 . . . . 1.29 111.422 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.34 121.45 45.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.173 -0.467 . . . . 0.78 110.397 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -108.14 144.84 34.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.744 0.306 . . . . 0.94 110.349 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -119.51 141.18 49.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.838 0.351 . . . . 0.56 110.531 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -143.48 134.63 25.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.11 -0.495 . . . . 1.46 110.072 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -106.49 122.63 46.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.865 0.364 . . . . 1.89 110.409 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -137.39 133.01 46.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 1.09 111.232 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 t -85.48 71.58 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.477 0.656 . . . . 0.65 109.5 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 pt -88.26 130.88 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.781 -0.645 . . . . 1.06 111.529 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 63.48 31.59 14.81 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.55 -0.75 . . . . 0.97 111.077 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.7 11.12 83.3 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.852 -0.613 . . . . 0.6 113.097 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -117.28 119.73 36.04 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 122.586 -0.361 . . . . 1.41 110.783 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.8 m -79.83 96.73 6.4 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.6 -0.518 . . . . 0.63 109.6 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.607 ' HG ' ' HE2' ' A' ' 4' ' ' TYR . 58.6 m -114.05 158.49 21.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.225 -0.443 . . . . 0.71 112.056 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.0 tp -112.64 119.88 39.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.27 -0.877 . . . . 0.48 108.885 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 12.3 mt -90.65 131.32 36.42 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.056 0.455 . . . . 0.87 111.919 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -114.39 103.29 10.91 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.088 -1.079 . . . . 1.03 108.088 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 3.4 mt -110.9 151.33 13.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.305 -0.407 . . . . 0.68 111.706 -177.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.424 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 37.1 tp -131.22 119.37 21.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.332 -0.394 . . . . 0.46 110.327 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.562 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 4.6 t0 -84.68 98.3 10.14 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.57 -0.53 . . . . 0.44 109.57 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 36.0 p -64.85 141.18 58.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.778 -0.646 . . . . 0.73 112.347 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.88 -58.39 2.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.364 -0.835 . . . . 0.56 109.537 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.23 -47.11 0.53 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.752 -0.658 . . . . 0.72 112.262 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -135.93 129.09 31.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.741 0.305 . . . . 1.26 110.59 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -102.44 175.7 5.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.394 -0.595 . . . . 1.57 109.394 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -65.57 -43.45 89.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.927 0.394 . . . . 1.38 110.2 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -128.72 145.35 51.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.081 -0.509 . . . . 0.81 110.038 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -38.33 89.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.309 -0.405 . . . . 0.63 110.893 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.57 -28.28 68.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.186 -0.461 . . . . 0.32 111.402 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 82.9 mtp -73.79 -38.32 64.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.93 0.395 . . . . 0.69 110.264 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.402 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 35.7 ttp180 -71.09 -43.77 67.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.893 -0.594 . . . . 0.9 109.821 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.83 -19.5 65.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.362 -0.835 . . . . 1.41 111.39 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -59.95 -57.36 13.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.466 -0.334 . . . . 1.51 111.373 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.402 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 14.7 p90 -75.05 -5.02 41.83 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.779 -0.368 . . . . 1.17 111.425 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.5 mtt -76.37 -25.24 54.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.361 -0.607 . . . . 0.7 109.361 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -87.7 -42.32 12.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.605 -0.725 . . . . 1.29 110.451 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.17 -20.71 63.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.863 -0.608 . . . . 0.72 112.24 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.78 124.57 18.04 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.491 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -88.91 -39.83 13.51 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.794 -0.447 . . . . 0.54 109.794 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -128.78 137.58 9.73 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.815 -0.914 . . . . 0.26 110.815 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.461 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 93.9 m-85 -120.75 129.67 53.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.139 0.495 . . . . 0.48 111.38 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.6 tp -97.02 110.74 23.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.473 -0.785 . . . . 0.37 108.982 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 3.8 m -96.91 92.36 6.07 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.102 -0.499 . . . . 0.61 110.981 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.499 HG11 ' CD1' ' A' ' 19' ' ' LEU . 4.1 t -98.92 136.26 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.909 -0.587 . . . . 0.59 111.369 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -130.71 172.17 12.28 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.898 -0.779 . . . . 0.34 108.898 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.528 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . . . -105.17 122.86 46.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.596 0.236 . . . . 0.32 110.514 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.43 ' HB ' ' HG3' ' A' ' 123' ' ' ARG . 31.2 pt -66.54 -17.73 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.069 0.462 . . . . 0.78 111.562 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -98.14 4.12 49.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.957 0.408 . . . . 0.82 110.236 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 14.6 t-20 -135.34 90.38 2.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.737 -0.665 . . . . 1.07 110.073 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.43 HG23 HG22 ' A' ' 125' ' ' VAL . 0.4 OUTLIER -59.61 -28.29 67.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.024 -0.535 . . . . 0.65 112.071 -178.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -59.08 -38.72 80.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 0.89 110.559 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.5 p -75.27 -25.87 58.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.64 111.326 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -74.99 -34.67 62.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.056 0.455 . . . . 0.42 110.721 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.406 ' HA ' ' OE2' ' A' ' 91' ' ' GLU . 10.7 mm-40 -74.6 -24.43 58.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.007 0.432 . . . . 1.44 110.438 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -71.5 -14.48 62.13 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.868 -0.606 . . . . 1.02 111.257 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 30.3 mm -58.14 -35.72 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.021 -0.536 . . . . 0.42 110.406 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -61.34 -45.02 96.14 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.073 -0.512 . . . . 0.83 110.565 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -63.77 -48.26 77.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.907 -0.588 . . . . 0.79 111.75 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -60.53 -52.06 66.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.162 0.43 . . . . 1.17 112.162 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -55.43 -47.55 75.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.208 0.318 . . . . 0.6 110.754 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.05 -43.9 86.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.047 -0.524 . . . . 1.35 111.763 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 103' ' ' VAL . 56.1 tt0 -63.44 -54.51 35.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 1.15 112.165 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.31 -34.41 60.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.642 0.258 . . . . 0.51 110.955 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' A' ' 107' ' ' GLU . 30.0 mtpt -62.14 -35.35 78.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.066 0.46 . . . . 1.05 110.217 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -73.88 -41.15 62.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.617 -0.719 . . . . 0.91 110.905 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 99' ' ' GLN . 46.8 t -60.72 -41.92 90.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.35 111.382 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -89.21 -14.86 35.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.504 -0.316 . . . . 0.63 111.352 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.4 t70 58.82 54.84 4.94 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.748 0.785 . . . . 0.47 109.836 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.7 m -154.83 140.26 17.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.6 -0.727 . . . . 1.14 110.895 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.416 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 21.9 mt-10 -88.22 -23.31 23.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.25 0.548 . . . . 1.74 110.003 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -101.06 85.3 2.81 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.487 -0.779 . . . . 0.78 109.939 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.5 t -117.71 119.24 34.25 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.625 -0.716 . . . . 0.47 110.098 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.403 ' HG3' ' CB ' ' A' ' 166' ' ' HIS . 35.1 Cg_exo -58.06 115.96 2.89 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.115 2.543 . . . . 0.25 112.286 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.461 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 36.5 mtt -146.11 153.05 40.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.777 -0.647 . . . . 0.79 110.457 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.9 t -132.88 125.79 52.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.895 -0.78 . . . . 0.22 108.895 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.8 tp -82.72 125.82 31.68 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.545 -0.539 . . . . 0.29 109.545 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 81' ' ' VAL . 3.2 t -122.83 127.03 74.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.173 -0.467 . . . . 0.82 112.223 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.88 96.69 1.26 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.671 -0.971 . . . . 0.27 110.671 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -81.71 166.47 20.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.067 0.433 . . . . 0.21 111.671 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.6 mttt 72.58 31.79 1.65 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.042 -0.981 . . . . 0.54 111.645 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 15.8 p -70.91 -10.13 59.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.887 0.375 . . . . 0.46 111.008 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -94.71 -2.05 51.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.7 110.621 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.41 HD11 ' N2 ' ' A' ' 201' ' ' GDP . 33.1 mt -104.82 155.34 37.67 Favored Pre-proline 0 C--O 1.236 0.372 0 CA-C-N 116.085 -0.507 . . . . 0.67 111.07 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -87.31 -169.83 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.598 2.199 . . . . 0.54 112.03 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 m 60.09 45.6 11.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.79 -0.641 . . . . 0.84 111.167 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.43 ' HG3' ' HB ' ' A' ' 84' ' ' ILE . 12.5 ttm-85 -76.75 111.81 12.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.587 -0.733 . . . . 0.58 110.73 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.6 p -92.77 -31.04 15.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.094 0.473 . . . . 0.81 110.406 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.43 HG22 HG23 ' A' ' 87' ' ' THR . 58.3 t -91.22 108.19 19.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.988 -0.551 . . . . 0.37 109.958 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -71.87 150.11 44.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.86 0.362 . . . . 1.69 110.511 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.1 m -57.3 -39.43 75.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.724 -0.671 . . . . 0.82 111.631 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -59.46 -41.62 90.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.263 -0.426 . . . . 0.62 111.642 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -60.57 -47.02 88.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.93 110.762 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.07 82.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.962 -0.563 . . . . 0.3 111.296 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.04 -40.79 98.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.919 -0.582 . . . . 0.47 109.976 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.38 -42.52 96.01 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.737 -0.665 . . . . 1.18 110.95 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 29.1 tp -66.96 -46.09 75.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.882 -0.599 . . . . 0.44 110.605 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.21 94.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.882 -0.599 . . . . 0.25 111.43 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.1 mtm105 -64.11 -30.33 71.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 1.54 110.934 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.5 m -75.15 -34.23 61.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.25 -0.432 . . . . 0.68 110.91 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -78.16 -24.64 47.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.231 -0.44 . . . . 0.77 110.715 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.33 37.1 8.38 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.828 -0.909 . . . . 0.25 110.828 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.6 pp -135.73 162.62 55.94 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.419 -0.39 . . . . 0.51 110.377 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.61 152.93 11.78 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.09 2.526 . . . . 0.36 112.73 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -134.49 130.59 36.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.513 -0.767 . . . . 0.38 110.4 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.62 137.2 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.47 -0.332 . . . . 0.54 110.169 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -77.31 141.89 39.69 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.843 -0.799 . . . . 0.88 108.843 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 64.8 p -138.47 171.69 13.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.792 0.806 . . . . 0.43 112.768 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.1 t -153.58 118.31 5.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.702 -1.136 . . . . 0.33 108.827 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.62 -23.54 62.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.042 0.448 . . . . 0.45 110.85 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -75.51 -39.93 57.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.177 -0.465 . . . . 1.32 111.621 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 61.9 p -102.32 -8.0 21.59 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.94 0.348 . . . . 0.52 111.94 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 65.1 23.13 12.38 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.419 0.628 . . . . 1.53 110.517 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 144' ' ' THR . 44.3 tt0 -81.45 127.46 32.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.11 -0.496 . . . . 0.87 111.237 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.408 ' C ' HG22 ' A' ' 144' ' ' THR . . . 78.14 -25.73 2.24 Favored Glycine 0 CA--C 1.518 0.268 0 CA-C-N 116.014 -0.539 . . . . 0.51 113.899 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.412 ' H ' HG23 ' A' ' 152' ' ' VAL . 6.6 t -57.09 -41.97 78.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 0.74 111.426 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -61.9 -46.49 89.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.364 0.602 . . . . 1.62 110.12 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.39 -45.87 82.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.291 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -54.72 -50.99 67.0 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.233 -0.439 . . . . 0.37 111.71 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -62.43 -39.34 92.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 1.46 111.292 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -68.11 -40.95 82.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.977 0.418 . . . . 0.99 110.498 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 46.5 m -62.16 -40.15 95.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.903 -0.589 . . . . 0.34 110.443 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 163' ' ' ILE . 43.5 tp -59.12 -43.35 91.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.763 0.316 . . . . 0.42 110.793 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.2 t -62.12 -43.25 97.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.031 0.443 . . . . 0.55 110.468 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -67.24 -34.53 77.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.9 110.668 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -65.73 -36.41 83.52 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.242 -0.651 . . . . 0.73 109.242 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 159' ' ' LEU . 96.2 mt -64.12 -48.63 84.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 109.112 -0.699 . . . . 0.42 109.112 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -60.77 -43.52 97.93 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.566 -0.743 . . . . 0.87 109.929 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.589 ' O ' ' HG3' ' A' ' 169' ' ' LYS . 33.8 ttmt -55.66 -42.51 75.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.778 -0.646 . . . . 0.97 110.466 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 169' ' ' LYS . 42.4 t60 -70.9 -31.26 67.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.71 111.435 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -87.39 -4.7 59.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.479 -0.328 . . . . 1.11 111.543 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -117.47 14.1 14.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.051 0.453 . . . . 1.12 111.142 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 165' ' ' LYS . 7.8 mtpp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.414 -0.803 . . . . 1.47 109.781 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.485 ' O2A' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 203' ' ' QPD . . . . . 0.424 ' N1 ' ' HB2' ' A' ' 56' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.563 ' HA ' ' O ' ' A' ' 50' ' ' THR . 42.9 ttm . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.886 -0.413 . . . . 1.48 109.886 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.6 145.52 34.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.513 -0.312 . . . . 1.04 111.466 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -100.16 138.89 36.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.213 -0.662 . . . . 1.27 109.213 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -123.1 125.36 45.03 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.886 0.374 . . . . 1.11 110.356 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -88.44 102.73 15.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.296 0.57 . . . . 0.81 110.533 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 8.0 mp -107.89 131.87 54.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.585 -0.734 . . . . 1.39 110.382 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.45 124.62 64.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.277 -0.419 . . . . 0.81 110.913 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.6 t -95.17 119.75 43.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.22 -0.445 . . . . 0.44 109.958 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.412 ' HB ' ' CD1' ' A' ' 96' ' ' TYR . 12.0 m -112.54 155.04 13.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.953 0.406 . . . . 0.7 110.779 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.79 -176.12 37.43 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.281 -0.962 . . . . 0.53 112.537 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.56 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -80.24 161.54 25.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.127 0.489 . . . . 0.58 111.132 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.74 109.13 2.75 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.748 -0.739 . . . . 0.8 112.055 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.62 -2.7 17.87 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.582 -0.818 . . . . 0.42 113.391 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 11' ' ' ALA . 12.8 m -72.44 -28.19 27.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 117.32 0.56 . . . . 0.57 110.554 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.79 25.38 4.26 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.124 -1.036 . . . . 0.49 114.135 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -55.22 -55.6 29.47 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.066 0.46 . . . . 0.81 110.912 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.518 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 1.1 m -59.84 -36.42 76.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.245 -0.888 . . . . 0.58 111.719 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.66 -42.97 95.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.43 110.96 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.6 mt -66.66 -41.24 88.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.23 -0.441 . . . . 0.92 110.825 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.4 m -68.68 -46.04 70.1 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.886 -0.597 . . . . 0.89 111.767 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 82.1 mt -66.2 -24.83 34.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.712 0.291 . . . . 0.79 110.997 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 3.9 mm-40 -61.31 -35.42 77.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.797 0.332 . . . . 0.46 111.039 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 mp -84.86 -15.44 44.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.921 0.391 . . . . 1.37 111.17 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.4 mm -95.42 -56.45 5.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 112.207 0.447 . . . . 0.58 112.207 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -96.09 -10.28 28.74 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.815 0.302 . . . . 1.68 111.815 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 32.7 m-20 59.95 36.51 21.67 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.736 0.643 . . . . 1.6 112.736 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.88 136.35 15.05 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.655 -0.498 . . . . 0.74 109.655 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -70.54 125.3 26.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.077 -0.511 . . . . 0.6 111.033 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.3 t -90.43 113.03 25.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.068 -0.715 . . . . 0.64 109.068 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -75.27 -36.91 61.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.421 -0.354 . . . . 1.12 111.503 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -124.54 114.44 19.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.768 0.318 . . . . 1.18 110.432 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -143.83 130.17 19.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.328 -0.396 . . . . 0.6 110.371 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.5 ' HB3' HG13 ' A' ' 36' ' ' ILE . 39.2 t0 -65.05 125.75 89.84 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-N 115.523 -0.762 . . . . 0.8 110.62 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.39 -18.46 26.26 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.923 2.415 . . . . 0.52 113.507 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.1 p -84.36 0.12 50.51 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.77 0.319 . . . . 0.89 111.595 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.5 HG13 ' HB3' ' A' ' 33' ' ' ASP . 83.5 mt -83.07 122.88 38.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 110.084 -0.339 . . . . 0.73 110.084 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -122.76 112.72 18.25 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.469 -0.787 . . . . 0.81 109.61 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -144.4 167.21 23.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.836 0.351 . . . . 1.29 110.993 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 1.4 m -117.89 122.62 43.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.3 -0.63 . . . . 0.78 109.3 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -103.22 132.74 49.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.325 -0.398 . . . . 0.94 110.314 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.28 134.48 51.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.024 -0.535 . . . . 0.56 110.662 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -148.47 129.63 14.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.935 -0.575 . . . . 1.46 110.002 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.44 134.53 34.86 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.725 -0.472 . . . . 1.89 109.725 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.59 151.8 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.799 0.333 . . . . 1.09 110.864 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.5 t -111.41 91.7 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.928 -0.578 . . . . 0.65 109.874 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.24 121.77 54.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.102 -0.499 . . . . 1.06 109.946 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 64.75 23.51 12.74 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.723 -0.671 . . . . 0.97 111.316 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.93 -17.18 59.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.844 -0.693 . . . . 0.6 112.491 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -82.58 126.19 32.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.942 0.401 . . . . 1.41 110.862 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 1' ' ' MET . 5.0 m -93.59 103.34 15.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.115 -0.493 . . . . 0.63 109.891 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.0 m -121.71 156.65 32.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.194 0.521 . . . . 0.71 112.188 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.1 tp -108.43 118.66 37.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.181 -0.918 . . . . 0.48 108.712 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.23 121.66 33.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.001 0.429 . . . . 0.87 111.418 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -106.88 105.4 15.42 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.125 -1.065 . . . . 1.03 108.125 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 55.4 mt -112.81 130.46 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.978 0.418 . . . . 0.68 111.819 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.402 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 23.7 tp -106.24 118.14 35.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.925 -0.579 . . . . 0.46 110.505 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.31 93.33 9.36 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.918 -0.771 . . . . 0.44 108.918 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.29 146.31 52.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.896 -0.593 . . . . 0.73 111.674 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.21 -46.8 9.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.819 -0.628 . . . . 0.56 110.624 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.79 -70.1 0.34 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.696 -0.764 . . . . 0.72 112.161 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -97.99 111.04 23.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.908 0.385 . . . . 1.26 110.849 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.67 166.07 19.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.042 -0.526 . . . . 1.57 110.56 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.413 ' HB3' ' SD ' ' A' ' 67' ' ' MET . 25.0 tt0 -62.8 -45.89 90.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.641 -0.503 . . . . 1.38 109.641 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -127.85 142.8 51.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.063 -0.718 . . . . 0.81 109.063 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 m -61.56 -26.31 67.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.065 0.459 . . . . 0.63 111.102 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.79 -29.89 69.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.914 -0.584 . . . . 0.32 110.965 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.413 ' SD ' ' HB3' ' A' ' 63' ' ' GLU . 74.3 mtp -69.96 -41.38 74.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.895 -0.593 . . . . 0.69 110.006 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.648 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 36.3 ttp180 -64.43 -39.42 93.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.538 0.685 . . . . 0.9 109.571 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.22 -19.01 64.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.775 -1.102 . . . . 1.41 111.235 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -77.02 -55.8 5.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.329 -0.396 . . . . 1.51 111.752 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.648 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 7.0 p90 -68.51 -16.97 64.06 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.479 -0.488 . . . . 1.17 111.449 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.7 mtt -81.86 -12.95 58.23 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.868 -0.419 . . . . 0.7 109.868 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -95.01 -52.18 4.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.017 -0.538 . . . . 1.29 110.997 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -20.27 63.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.72 112.083 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.09 129.2 43.28 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.592 -0.813 . . . . 0.19 112.555 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -90.78 -48.5 7.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.998 0.427 . . . . 0.54 109.999 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.07 128.94 7.73 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.868 -0.682 . . . . 0.26 111.796 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.451 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 59.1 m-85 -111.05 127.84 55.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.115 0.483 . . . . 0.48 110.611 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.3 tp -94.44 108.78 20.7 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.453 -0.573 . . . . 0.37 109.453 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -89.01 93.89 9.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.886 -0.597 . . . . 0.61 109.822 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 2.3 t -109.59 139.48 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.388 0.613 . . . . 0.59 112.349 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -134.87 179.11 6.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.236 -0.893 . . . . 0.34 108.798 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.493 ' HB1' ' OD1' ' A' ' 85' ' ' ASN . . . -111.91 129.52 56.14 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.756 -0.461 . . . . 0.32 109.756 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 pt -67.06 -14.55 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.915 0.388 . . . . 0.78 111.419 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.493 ' OD1' ' HB1' ' A' ' 83' ' ' ALA . 22.5 p-10 -99.99 -4.52 29.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.01 0.433 . . . . 0.82 110.743 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -122.72 101.58 7.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.193 0.521 . . . . 1.07 110.229 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -26.82 67.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.926 -0.579 . . . . 0.65 111.98 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -65.25 -42.62 93.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.225 -0.443 . . . . 0.89 110.782 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 99.0 p -66.16 -28.64 68.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.679 0.276 . . . . 0.64 111.078 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -72.59 -39.44 67.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.243 0.544 . . . . 0.42 110.504 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -74.67 -29.86 61.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.196 -0.456 . . . . 1.44 110.54 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.63 -16.81 64.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.942 -0.572 . . . . 1.02 110.793 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 32.9 mm -57.55 -34.83 48.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.886 -0.597 . . . . 0.42 110.354 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -62.41 -46.49 88.34 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.075 -0.511 . . . . 0.83 110.646 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -57.51 -50.18 73.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.524 -0.762 . . . . 0.79 111.389 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.412 ' CD1' ' HB ' ' A' ' 9' ' ' VAL . 17.8 m-85 -63.69 -38.8 92.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.45 -0.341 . . . . 1.17 111.437 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -58.64 -50.72 72.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.6 110.187 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -67.08 -42.55 84.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.782 -0.644 . . . . 1.35 111.138 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -58.82 -57.56 12.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.002 -0.544 . . . . 1.15 112.078 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.8 mt -61.39 -39.2 81.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.671 -0.24 . . . . 0.51 111.304 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -60.96 -38.9 87.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 1.05 110.803 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -72.62 -40.07 66.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.91 110.921 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 75.4 t -64.61 -48.01 86.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.42 -0.354 . . . . 0.35 111.414 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -81.3 -10.08 59.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 0.63 111.177 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.9 t70 51.43 58.56 5.37 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.59 0.709 . . . . 0.47 110.812 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.2 m -150.03 138.78 20.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.725 -0.67 . . . . 1.14 110.569 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -74.02 -30.26 62.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 1.74 110.631 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -116.93 124.36 49.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.234 -0.439 . . . . 0.78 110.705 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.9 t -137.43 129.46 16.62 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.543 -0.539 . . . . 0.47 109.543 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.75 106.39 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.746 2.297 . . . . 0.25 111.935 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.451 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 63.7 mtt -138.03 157.49 46.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.886 -0.597 . . . . 0.79 110.596 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -140.07 124.52 19.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.159 -0.682 . . . . 0.22 109.159 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 21.7 tp -83.18 119.33 24.4 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.438 -0.579 . . . . 0.29 109.438 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 47.7 t -124.23 133.33 69.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.045 -0.525 . . . . 0.82 111.328 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -108.58 112.51 3.55 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.258 -1.137 . . . . 0.27 110.258 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -92.74 163.91 13.57 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.107 0.453 . . . . 0.21 111.399 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.526 ' HE3' ' O ' ' A' ' 14' ' ' VAL . 89.7 mttt 68.21 34.0 4.11 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.346 -0.843 . . . . 0.54 111.781 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 24.2 p -69.43 -11.51 60.89 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.032 0.444 . . . . 0.46 110.975 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.05 -13.29 41.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.032 -0.531 . . . . 0.7 110.457 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 22.1 mt -88.1 143.48 33.03 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.942 0.401 . . . . 0.67 111.029 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.32 -178.45 4.63 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.763 2.308 . . . . 0.54 112.096 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.1 m 66.45 42.33 2.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.807 -0.633 . . . . 0.84 110.32 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.5 ttm-85 -68.16 119.94 13.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.658 -0.701 . . . . 0.58 110.48 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.4 p -99.68 -27.71 13.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.424 -0.353 . . . . 0.81 110.902 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.7 t -97.96 114.22 34.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.441 -0.345 . . . . 0.37 110.421 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -77.02 150.29 35.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.427 -0.351 . . . . 1.69 110.674 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.43 -40.47 68.34 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.399 0.518 . . . . 0.82 112.399 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -62.2 -37.63 86.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.558 -0.292 . . . . 0.62 111.362 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -59.1 -46.63 87.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.119 0.485 . . . . 0.93 110.988 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.61 -39.15 58.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.961 -0.563 . . . . 0.3 111.339 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -61.4 -42.36 98.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.47 110.739 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.78 -38.82 80.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.276 -0.42 . . . . 1.18 110.558 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 43.5 tp -63.29 -46.42 86.87 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.956 -0.565 . . . . 0.44 111.146 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.5 -37.26 77.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.943 -0.572 . . . . 0.25 110.867 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 135' ' ' ARG . 31.9 ttm180 -66.13 -29.29 69.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.45 -0.795 . . . . 1.54 110.928 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.7 m -74.17 -29.98 62.03 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.303 0.573 . . . . 0.68 110.28 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -85.47 -30.14 23.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.97 -0.559 . . . . 0.77 110.423 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.31 26.65 10.83 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.957 -0.857 . . . . 0.25 110.957 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 23.7 pt -124.56 166.25 20.81 Favored Pre-proline 0 N--CA 1.452 -0.345 0 N-CA-C 110.007 -0.368 . . . . 0.51 110.007 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -90.79 160.29 4.13 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.521 2.148 . . . . 0.36 112.736 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 16.9 t80 -127.16 131.09 50.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.376 -0.375 . . . . 0.38 110.309 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 53.4 mt -133.14 131.54 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.603 -0.272 . . . . 0.54 111.112 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -83.85 130.39 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.836 -0.801 . . . . 0.88 108.836 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 71.3 p -137.6 176.38 8.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.625 0.726 . . . . 0.43 112.162 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.8 t -161.41 114.69 1.91 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.747 -1.115 . . . . 0.33 108.71 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.45 -15.93 63.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.203 0.525 . . . . 0.45 110.605 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -80.58 -29.69 36.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.573 -0.739 . . . . 1.32 111.504 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 149' ' ' ARG . 21.1 p -116.18 -8.55 11.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.462 0.541 . . . . 0.52 112.462 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 148' ' ' THR . 21.4 mtp85 70.69 13.69 7.21 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.065 -0.516 . . . . 1.53 111.099 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 144' ' ' THR . 53.1 tt0 -66.94 112.37 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.453 -0.34 . . . . 0.87 111.78 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 67.18 3.51 24.45 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 114.602 0.601 . . . . 0.51 114.602 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 82.3 t -59.53 -49.25 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 117.83 0.815 . . . . 0.74 110.743 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.38 -46.61 87.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.25 0.547 . . . . 1.62 109.939 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -54.07 -46.85 72.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.056 -0.975 . . . . 1.0 111.851 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.61 -47.61 81.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.127 -0.488 . . . . 0.37 111.755 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.463 ' O ' HG23 ' A' ' 160' ' ' VAL . 41.6 m-85 -64.97 -43.66 91.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.307 -0.406 . . . . 1.46 111.427 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -63.89 -37.46 87.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.859 0.361 . . . . 0.99 110.739 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 93.0 m -62.37 -43.96 97.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.918 -0.583 . . . . 0.34 110.808 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.592 ' O ' HG13 ' A' ' 163' ' ' ILE . 30.7 tp -58.22 -45.53 87.51 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.642 -0.254 . . . . 0.42 110.911 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 156' ' ' PHE . 6.1 t -60.9 -39.92 83.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.941 0.4 . . . . 0.55 110.512 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -68.76 -33.76 74.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 0.9 110.985 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -65.91 -40.58 91.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.321 -0.622 . . . . 0.73 109.321 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 159' ' ' LEU . 31.3 mt -62.42 -41.9 93.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.955 -0.757 . . . . 0.42 108.955 178.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.559 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 4.4 mtt180 -53.36 -58.34 7.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.013 -0.994 . . . . 0.87 110.921 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.407 ' HA ' ' HG2' ' A' ' 168' ' ' GLU . 51.3 mtmt -62.13 -20.12 63.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.432 -0.803 . . . . 0.97 111.955 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -83.38 -33.99 25.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.767 0.318 . . . . 0.71 110.603 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 163' ' ' ILE . 46.8 mtpt -87.06 -8.33 57.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.094 0.405 . . . . 1.11 112.094 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 8.8 pt-20 -108.92 25.11 12.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.961 0.41 . . . . 1.12 110.771 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 36.4 mttm . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.447 -0.787 . . . . 1.47 109.851 179.291 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.518 ' O2A' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 203' ' ' QPD . . . . . 0.402 ' N1 ' ' HB2' ' A' ' 56' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 ttm . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 120.64 0.257 . . . . 1.48 110.574 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.0 m -111.53 149.06 31.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.523 -0.308 . . . . 1.04 110.356 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -98.41 131.75 44.43 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.046 -0.353 . . . . 1.27 110.046 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -109.91 133.35 53.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.855 -0.424 . . . . 1.11 109.855 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -94.98 104.61 16.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.267 -0.424 . . . . 0.81 110.72 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 10.2 mp -112.82 119.63 38.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.872 -0.604 . . . . 1.39 111.031 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.73 120.23 61.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.181 0.515 . . . . 0.81 110.153 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.7 t -92.25 112.9 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.827 -0.624 . . . . 0.44 109.796 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 m -114.96 -175.45 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.187 -0.46 . . . . 0.7 110.638 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.79 -176.08 22.66 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.716 -0.754 . . . . 0.53 111.789 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.91 -175.34 2.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.783 0.325 . . . . 0.58 111.188 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.23 131.41 10.39 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.586 -0.816 . . . . 0.8 113.188 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.47 17.37 79.82 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.287 -0.482 . . . . 0.42 113.835 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -77.09 -34.52 21.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 117.492 0.646 . . . . 0.57 111.004 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.47 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 132.89 24.49 0.72 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.616 -0.802 . . . . 0.49 113.137 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HB2' ' O3B' ' A' ' 201' ' ' GDP . 6.4 mtpt -56.69 -41.27 77.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.061 0.458 . . . . 0.81 111.046 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.81 2.01 50.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.58 112.093 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.47 -44.76 5.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.712 0.291 . . . . 0.43 110.801 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.544 HD23 ' HB2' ' A' ' 146' ' ' ALA . 44.7 mt -58.71 -42.78 89.47 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.558 0.694 . . . . 0.92 110.483 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.493 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -60.89 -52.44 65.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.948 -1.023 . . . . 0.89 111.701 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 29' ' ' VAL . 39.8 mt -65.37 -31.09 52.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.388 -0.369 . . . . 0.79 111.379 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.612 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 2.8 mm-40 -69.27 -22.38 63.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.999 0.428 . . . . 0.46 110.335 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.8 tp -94.16 -26.83 16.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.118 -0.492 . . . . 1.37 110.649 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 20' ' ' THR . 35.3 mm -89.73 -60.25 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.58 111.558 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -92.51 -13.95 29.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.499 -0.319 . . . . 1.68 111.437 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 7.9 m-20 66.57 24.71 10.16 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 123.513 0.508 . . . . 1.6 111.758 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -129.92 146.51 51.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.711 -0.477 . . . . 0.74 109.711 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -85.12 129.97 34.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.377 -0.374 . . . . 0.6 111.135 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.406 HG21 HD12 ' A' ' 21' ' ' ILE . 60.8 t -96.95 125.05 50.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.64 109.955 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -75.7 -46.38 31.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.763 -0.653 . . . . 1.12 111.815 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -130.07 123.73 31.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.969 0.414 . . . . 1.18 111.118 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -145.42 146.92 31.72 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.156 -0.683 . . . . 0.6 109.156 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -71.66 119.42 74.0 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 0.8 110.367 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.94 -17.33 32.31 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.49 2.127 . . . . 0.52 113.615 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.24 -7.49 59.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.096 0.474 . . . . 0.89 111.434 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.2 mt -80.77 119.69 30.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.197 0.522 . . . . 0.73 110.771 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 22.3 tt0 -118.01 79.49 1.38 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.097 -0.956 . . . . 0.81 108.641 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -106.39 159.39 16.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.136 -0.483 . . . . 1.29 111.054 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.66 124.52 52.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.231 -0.44 . . . . 0.78 110.325 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -101.97 136.81 41.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.121 -0.491 . . . . 0.94 110.347 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.06 128.53 55.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.88 0.371 . . . . 0.56 111.234 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -144.51 137.59 26.98 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.387 -0.598 . . . . 1.46 109.387 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -116.26 119.34 35.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.704 0.288 . . . . 1.89 110.343 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.9 t -138.58 153.02 25.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.446 . . . . 1.09 109.877 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 13.2 t -76.73 103.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.64 -0.504 . . . . 0.65 109.64 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.3 mt -105.37 111.94 36.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.343 -0.389 . . . . 1.06 111.008 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.458 ' HB2' HH12 ' A' ' 164' ' ' ARG . 31.3 m-20 65.4 27.09 11.92 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.757 -0.656 . . . . 0.97 111.518 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.49 5.29 65.25 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.873 -0.679 . . . . 0.6 112.469 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -126.54 119.75 27.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.791 0.329 . . . . 1.41 111.172 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 23.6 m -77.11 106.75 9.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.641 -0.503 . . . . 0.63 109.641 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.1 m -117.71 147.48 42.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.224 0.535 . . . . 0.71 111.212 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.0 tp -90.74 122.22 33.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.547 -0.751 . . . . 0.48 109.113 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 53' ' ' LEU . 14.3 mt -93.61 113.44 25.54 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.955 0.407 . . . . 0.87 111.591 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -100.43 87.71 3.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.256 -1.387 . . . . 1.03 107.256 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 6.6 mt -99.54 127.64 52.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.724 -0.671 . . . . 0.68 111.881 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.9 tp -107.88 121.24 44.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.557 -0.747 . . . . 0.46 111.112 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 1.7 t70 -87.47 94.97 9.86 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.44 -0.948 . . . . 0.44 108.44 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.492 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 81.2 p -65.98 146.42 54.72 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.466 0.651 . . . . 0.73 111.838 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.01 -58.17 2.56 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.155 -0.929 . . . . 0.56 109.287 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.16 -96.96 0.15 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.799 -0.715 . . . . 0.72 111.999 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -83.77 158.44 21.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.679 0.276 . . . . 1.26 110.533 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -130.32 165.86 21.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.238 -0.437 . . . . 1.57 110.32 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -78.89 -35.36 43.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.331 -0.618 . . . . 1.38 109.331 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -119.86 124.03 45.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.592 -0.731 . . . . 0.81 109.517 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -58.46 -34.9 71.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.419 -0.355 . . . . 0.63 111.382 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.26 -27.48 69.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.32 111.4 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 78.0 mtp -72.64 -32.65 66.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.69 110.467 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -71.17 -46.07 62.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.896 -0.593 . . . . 0.9 110.071 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -73.63 -9.06 58.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.654 -0.703 . . . . 1.41 111.449 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -67.19 -60.28 2.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.817 -0.174 . . . . 1.51 111.046 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -72.51 -15.88 61.79 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.695 -0.402 . . . . 1.17 111.091 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 35.7 mtt -70.35 -25.74 63.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.24 0.543 . . . . 0.7 109.937 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 73' ' ' ARG . 48.5 mtm180 -84.17 -48.54 9.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.83 -0.623 . . . . 1.29 110.673 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -22.67 63.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.938 -0.574 . . . . 0.72 111.953 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.01 123.45 26.3 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.018 -0.61 . . . . 0.19 112.087 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -88.9 -40.85 12.8 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.943 -0.391 . . . . 0.54 109.943 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -128.88 130.12 6.37 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.414 -0.674 . . . . 0.26 111.414 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -113.98 133.83 55.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.015 0.436 . . . . 0.48 111.128 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.8 tp -100.1 106.23 17.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.864 -0.607 . . . . 0.37 110.221 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.5 m -92.36 97.44 10.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.004 0.43 . . . . 0.61 110.343 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 4.9 t -110.31 134.1 53.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.002 -0.545 . . . . 0.59 111.37 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -129.6 172.66 11.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.729 -0.668 . . . . 0.34 109.441 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.78 133.3 52.37 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.727 -0.471 . . . . 0.32 109.727 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.432 HD11 ' HA ' ' A' ' 118' ' ' CYS . 29.0 pt -76.92 -4.17 6.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 112.782 0.66 . . . . 0.78 112.782 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -85.6 -12.18 52.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.738 -0.21 . . . . 0.82 111.105 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.469 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 30.8 t-20 -139.79 123.94 17.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.367 . . . . 1.07 110.725 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.8 m -69.83 -28.2 65.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.057 -0.52 . . . . 0.65 111.652 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -60.97 -39.29 89.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.618 0.247 . . . . 0.89 110.721 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -64.75 -32.43 74.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.137 0.494 . . . . 0.64 110.313 179.147 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -76.95 -35.66 57.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.76 -0.655 . . . . 0.42 110.115 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -72.01 -29.8 64.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.707 -0.678 . . . . 1.44 110.582 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.38 -24.02 67.14 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.042 -0.527 . . . . 1.02 110.592 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.9 mm -61.45 -30.63 48.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.518 -0.764 . . . . 0.42 110.684 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -60.76 -41.38 95.34 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.205 0.526 . . . . 0.83 109.695 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -71.86 -38.43 70.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.562 -0.744 . . . . 0.79 110.639 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -63.75 -47.42 81.1 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.252 0.464 . . . . 1.17 112.252 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 25.7 tpt180 -63.73 -33.37 75.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.671 0.272 . . . . 0.6 110.856 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -79.19 -43.86 23.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.283 -0.417 . . . . 1.35 111.541 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -58.6 -56.99 14.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.086 0.402 . . . . 1.15 112.086 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.5 mt -63.38 -31.07 51.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.359 -0.382 . . . . 0.51 110.772 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 39.0 ttpt -62.97 -35.38 79.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.343 0.592 . . . . 1.05 110.198 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -78.02 -40.61 38.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.713 -0.676 . . . . 0.91 110.592 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 87.3 t -58.78 -50.75 78.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.907 -0.588 . . . . 0.35 110.863 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -82.08 -11.61 58.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.084 -0.507 . . . . 0.63 111.036 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.8 t70 54.81 48.82 19.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.583 0.706 . . . . 0.47 110.753 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.5 t -158.45 144.42 16.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.51 -0.768 . . . . 1.14 110.317 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -90.97 -17.72 25.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.079 0.466 . . . . 1.74 110.76 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -91.08 68.99 6.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.595 0.712 . . . . 0.78 110.604 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 85.2 t -108.57 112.34 60.78 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.289 -0.869 . . . . 0.47 109.659 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.82 113.42 1.31 Allowed 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.915 2.41 . . . . 0.25 111.656 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 28.6 mtt -141.99 153.35 44.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.09 -0.505 . . . . 0.79 111.223 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.3 t -131.91 123.9 52.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.482 -0.781 . . . . 0.22 109.035 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 41.0 tp -85.37 121.85 28.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.042 -0.725 . . . . 0.29 109.042 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 11.2 t -127.19 138.05 55.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.004 0.431 . . . . 0.82 111.532 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.87 106.85 2.12 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 110.164 -1.174 . . . . 0.27 110.164 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -89.2 165.5 14.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.735 0.267 . . . . 0.21 111.024 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 67.52 34.85 4.43 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 115.466 -0.788 . . . . 0.54 111.008 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.432 ' HA ' HD11 ' A' ' 84' ' ' ILE . 27.5 p -68.75 -13.0 62.11 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.869 0.366 . . . . 0.46 111.344 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.67 -13.72 47.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.7 110.612 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 44.1 mt -82.51 142.06 45.96 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.399 -0.364 . . . . 0.67 110.175 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.3 -177.52 3.9 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.603 2.202 . . . . 0.54 111.925 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.5 m 62.83 48.75 3.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.295 0.569 . . . . 0.84 111.181 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.3 ttm-85 -72.38 110.99 7.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.749 -0.66 . . . . 0.58 109.95 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 p -95.14 -21.01 18.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.07 0.462 . . . . 0.81 110.728 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -98.69 110.33 25.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.115 -0.493 . . . . 0.37 110.051 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.99 143.12 56.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.985 -0.552 . . . . 1.69 111.176 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 m -59.54 -39.92 85.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.006 -0.543 . . . . 0.82 110.787 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -61.53 -38.52 87.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.62 110.954 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -58.4 -51.94 67.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.139 0.495 . . . . 0.93 110.744 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.43 -40.52 85.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.714 -0.675 . . . . 0.3 110.875 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -61.38 -40.49 94.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.811 -0.631 . . . . 0.47 110.356 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 -46.46 79.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.384 -0.371 . . . . 1.18 110.15 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.85 -44.91 93.87 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.804 -0.634 . . . . 0.44 111.0 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.73 -43.55 98.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.965 -0.561 . . . . 0.25 110.865 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -63.66 -36.16 82.91 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.837 -0.62 . . . . 1.54 111.95 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.4 p -74.77 -23.28 58.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.428 . . . . 0.68 111.133 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -89.45 -16.92 29.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.77 111.011 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.83 30.1 33.09 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.97 -0.559 . . . . 0.25 111.806 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 40.0 pt -127.08 152.97 76.55 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.7 -0.25 . . . . 0.51 110.543 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.7 148.51 22.82 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.669 2.246 . . . . 0.36 112.189 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 17.6 t80 -125.35 124.32 41.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.381 -0.372 . . . . 0.38 110.61 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.7 mt -132.61 133.73 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.34 -0.391 . . . . 0.54 110.343 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -88.52 135.01 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.812 -0.811 . . . . 0.88 108.812 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 70.6 p -138.96 175.53 9.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.52 0.676 . . . . 0.43 112.447 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.1 t -152.06 109.44 3.58 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.008 -0.996 . . . . 0.33 108.749 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.544 ' HB2' HD23 ' A' ' 19' ' ' LEU . . . -68.42 -24.48 64.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.273 0.558 . . . . 0.45 110.286 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -67.57 -47.83 68.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.004 -0.998 . . . . 1.32 111.296 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.9 p -97.04 3.91 51.66 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.711 -0.395 . . . . 0.52 110.925 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 55.83 45.73 23.63 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.55 -0.75 . . . . 1.53 110.414 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -107.72 120.74 43.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.447 -0.797 . . . . 0.87 111.056 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.31 -1.24 57.31 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.807 -0.633 . . . . 0.51 113.747 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 32.6 t -60.1 -42.29 89.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.981 0.391 . . . . 0.74 110.744 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.28 -50.77 62.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.795 -0.639 . . . . 1.62 110.203 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.12 -45.84 72.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.575 -0.739 . . . . 1.0 111.857 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.94 81.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.664 0.268 . . . . 0.37 111.247 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -66.64 -44.1 82.87 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.385 -0.371 . . . . 1.46 111.231 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -63.73 -42.35 97.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.446 -0.343 . . . . 0.99 111.564 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.445 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 36.6 m -61.82 -38.02 86.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.693 -0.23 . . . . 0.34 110.576 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 163' ' ' ILE . 48.3 tp -62.77 -40.6 97.79 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.901 -0.407 . . . . 0.42 109.901 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.83 -41.51 85.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.494 . . . . 0.55 110.078 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -67.77 -38.26 83.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.9 110.411 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 158' ' ' THR . 63.5 mm-40 -60.11 -43.51 95.56 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.93 -0.577 . . . . 0.73 110.814 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 159' ' ' LEU . 27.1 mt -67.53 -46.07 83.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.94 -0.573 . . . . 0.42 110.758 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 85.9 mtt180 -57.2 -42.22 80.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.152 -0.477 . . . . 0.87 111.447 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -59.56 -34.99 73.37 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.812 0.339 . . . . 0.97 110.951 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -79.67 -30.91 41.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.879 0.371 . . . . 0.71 110.209 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -67.93 -33.64 75.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.106 -0.497 . . . . 1.11 111.799 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 11.9 pt-20 -102.9 17.58 23.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.198 0.523 . . . . 1.12 110.602 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 17.8 tttp . . . . . 0 C--O 1.25 1.13 0 CA-C-N 115.518 -0.764 . . . . 1.47 110.195 -179.739 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.436 ' O3B' ' HB2' ' A' ' 16' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 203' ' ' QPD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.585 ' HA ' ' O ' ' A' ' 50' ' ' THR . 24.8 ttt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.982 -0.377 . . . . 1.48 109.982 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.1 m -106.09 144.15 33.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.116 -0.493 . . . . 1.04 110.752 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -93.26 135.41 34.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.224 -0.444 . . . . 1.27 110.795 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 51' ' ' CYS . 35.0 m-85 -121.84 117.99 27.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.325 -0.62 . . . . 1.11 109.325 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -95.17 107.77 19.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.959 0.409 . . . . 0.81 110.516 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 1.2 mp -119.46 141.74 48.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.853 -0.612 . . . . 1.39 110.965 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.04 135.67 62.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.227 -0.442 . . . . 0.81 110.552 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.44 115.82 47.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.614 -0.513 . . . . 0.44 109.614 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.6 m -114.06 169.32 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.123 -0.489 . . . . 0.7 110.251 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.27 170.22 17.9 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.792 -0.718 . . . . 0.53 112.033 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.528 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -67.81 159.14 30.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.075 0.464 . . . . 0.58 111.714 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.12 99.63 0.72 Allowed Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.827 -0.624 . . . . 0.8 112.872 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.26 7.69 5.77 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.673 -0.775 . . . . 0.42 113.142 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 11' ' ' ALA . 12.4 m -79.59 -39.06 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.558 -0.457 . . . . 0.57 110.625 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.515 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 126.58 24.97 1.32 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.557 -0.83 . . . . 0.49 113.573 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -50.98 -52.38 43.25 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.907 0.354 . . . . 0.81 111.76 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.48 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 1.0 OUTLIER -65.64 -40.2 92.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.419 -0.355 . . . . 0.58 111.679 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.76 -42.55 97.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 0.43 111.548 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 72.0 mt -59.59 -44.88 93.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.368 . . . . 0.92 111.341 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.461 ' O ' HG12 ' A' ' 24' ' ' ILE . 7.7 m -67.16 -51.42 53.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.214 -0.448 . . . . 0.89 111.788 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.96 -31.45 47.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.67 0.272 . . . . 0.79 111.697 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 4.8 mm-40 -61.12 -30.0 70.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.913 0.387 . . . . 0.46 111.046 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tp -95.34 -35.76 11.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.302 -0.408 . . . . 1.37 111.318 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 20' ' ' THR . 40.3 mm -74.14 -55.79 11.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.409 0.522 . . . . 0.58 112.409 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -99.82 1.48 43.08 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.045 0.387 . . . . 1.68 112.045 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 73.0 m-20 57.81 32.61 22.15 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.63 0.974 . . . . 1.6 113.63 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -153.92 146.73 24.33 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.686 -0.405 . . . . 0.74 110.805 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -82.02 129.53 34.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.952 -0.567 . . . . 0.6 110.693 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.0 t -98.86 121.41 49.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.05 -0.523 . . . . 0.64 109.891 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.51 -55.95 8.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.615 -0.72 . . . . 1.12 111.445 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -113.77 115.12 27.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.324 0.583 . . . . 1.18 111.665 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -141.77 136.04 30.3 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.906 -0.776 . . . . 0.6 108.906 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -62.71 117.47 32.14 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 120.854 0.359 . . . . 0.8 110.561 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.92 -25.87 38.33 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.69 2.26 . . . . 0.52 112.898 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -8.47 57.05 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.382 0.512 . . . . 0.89 112.382 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.3 mt -79.24 119.51 28.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.068 0.461 . . . . 0.73 111.105 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 8.6 tt0 -111.13 97.9 7.13 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.411 -0.959 . . . . 0.81 108.411 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -126.43 163.1 24.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.764 0.316 . . . . 1.29 110.706 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.13 145.39 44.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.036 -0.529 . . . . 0.78 109.841 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -131.64 138.35 48.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.748 0.309 . . . . 0.94 110.286 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.427 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 0.7 OUTLIER -112.68 127.79 56.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.194 -0.457 . . . . 0.56 110.358 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -141.6 120.88 13.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.19 -0.459 . . . . 1.46 110.144 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 10.4 pt20 -93.15 122.0 35.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.947 0.403 . . . . 1.89 110.524 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.3 t -125.83 143.75 38.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.076 -0.511 . . . . 1.09 110.169 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 t -86.24 102.22 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.299 -0.63 . . . . 0.65 109.299 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.41 HG22 ' OD2' ' A' ' 47' ' ' ASP . 9.9 mt -114.17 123.36 69.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.849 -0.614 . . . . 1.06 110.743 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.41 ' OD2' HG22 ' A' ' 46' ' ' ILE . 21.7 m-20 64.77 22.59 12.58 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.605 0.566 . . . . 0.97 111.495 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.32 0.95 72.66 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.767 -0.73 . . . . 0.6 112.679 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -116.68 132.61 56.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.657 0.265 . . . . 1.41 110.83 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 1' ' ' MET . 1.3 m -82.9 111.67 19.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.87 -0.418 . . . . 0.63 109.87 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.431 ' HB3' ' CD2' ' A' ' 4' ' ' TYR . 2.5 m -112.45 134.73 53.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.391 -0.368 . . . . 0.71 111.233 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.9 tp -92.49 107.5 19.26 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.853 -0.795 . . . . 0.48 108.853 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 35.7 mt -82.66 115.64 21.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.22 -0.445 . . . . 0.87 111.547 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.427 ' OD1' ' HD2' ' A' ' 41' ' ' ARG . 12.5 t70 -103.4 95.65 6.22 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.941 -1.133 . . . . 1.03 107.941 178.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 31.1 mt -109.47 135.01 49.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.236 0.541 . . . . 0.68 111.646 -177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.458 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 26.7 tp -112.13 119.48 38.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.353 -0.84 . . . . 0.46 110.631 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 2.5 t70 -87.36 99.81 12.26 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.695 -0.854 . . . . 0.44 108.695 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.7 p -72.15 153.1 41.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.806 -0.634 . . . . 0.73 111.41 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.54 -63.92 1.08 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.176 -0.675 . . . . 0.56 109.176 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.75 -91.49 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.683 -0.689 . . . . 0.72 111.549 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -121.98 130.66 53.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.071 -0.344 . . . . 1.26 110.071 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.81 179.22 6.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.44 . . . . 1.57 110.764 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.18 -43.65 94.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.728 -0.669 . . . . 1.38 110.017 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -120.59 145.04 47.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.602 -0.726 . . . . 0.81 109.577 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -63.09 -34.6 77.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.318 -0.401 . . . . 0.63 111.26 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.91 -30.94 71.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.325 -0.398 . . . . 0.32 111.861 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 95.0 mtp -66.56 -33.46 75.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.094 0.474 . . . . 0.69 109.983 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -76.96 -39.93 48.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.729 -0.669 . . . . 0.9 109.856 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.32 -11.02 60.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.686 -0.688 . . . . 1.41 110.875 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -66.03 -69.28 0.31 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.017 -0.538 . . . . 1.51 110.347 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.444 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 8.3 p90 -70.41 -11.92 61.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.439 -0.346 . . . . 1.17 111.688 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.9 mtt -73.16 -13.98 61.27 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.903 -0.406 . . . . 0.7 109.903 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.489 ' CG ' HG12 ' A' ' 103' ' ' VAL . 64.4 mtm180 -109.22 -33.61 6.81 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.062 -0.517 . . . . 1.29 110.808 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -79.9 -15.55 57.1 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.482 -0.326 . . . . 0.72 111.661 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.8 134.12 34.94 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.705 -0.759 . . . . 0.19 112.439 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.8 -36.64 11.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.836 0.351 . . . . 0.54 110.359 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.83 128.2 6.8 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.99 -0.624 . . . . 0.26 111.676 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.513 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 94.1 m-85 -112.09 121.36 44.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.121 0.486 . . . . 0.48 110.682 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.6 tp -100.18 109.27 21.52 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.86 -0.609 . . . . 0.37 110.765 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 2.7 m -94.18 102.19 14.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.137 -0.483 . . . . 0.61 110.012 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.441 HG22 ' HB ' ' A' ' 114' ' ' VAL . 15.1 t -109.3 140.61 27.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.104 0.478 . . . . 0.59 111.374 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.39 170.53 15.92 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.746 -0.835 . . . . 0.34 108.746 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . . . -105.32 133.27 50.37 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.977 -0.379 . . . . 0.32 109.977 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 pt -66.49 -16.93 21.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.891 0.376 . . . . 0.78 111.496 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -107.78 10.12 28.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.005 0.431 . . . . 0.82 110.935 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 13.0 t-20 -132.7 92.69 3.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.087 0.47 . . . . 1.07 110.539 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -33.62 71.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.657 -0.701 . . . . 0.65 111.811 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -58.24 -45.46 87.72 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.945 0.402 . . . . 0.89 110.999 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.8 p -68.0 -28.13 67.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.64 110.974 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -76.06 -43.57 43.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.005 0.431 . . . . 0.42 110.686 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -67.28 -33.37 75.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 1.44 110.98 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -66.98 -19.76 65.77 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.42 -0.355 . . . . 1.02 111.1 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.48 -29.7 42.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 121.16 0.505 . . . . 0.42 109.994 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -62.25 -36.1 80.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.752 -0.658 . . . . 0.83 110.339 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -80.73 -24.75 38.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.194 -0.912 . . . . 0.79 110.762 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -62.45 -59.37 5.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.51 . . . . 1.17 110.183 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -55.41 -46.43 76.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.928 -0.578 . . . . 0.6 109.91 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -56.15 -48.83 75.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.298 -0.865 . . . . 1.35 111.903 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.623 ' O ' HG23 ' A' ' 103' ' ' VAL . 22.7 tt0 -61.79 -57.31 12.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.264 -0.426 . . . . 1.15 111.266 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.6 mt -60.07 -35.31 60.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 111.911 0.338 . . . . 0.51 111.911 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -59.53 -39.32 83.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.863 0.363 . . . . 1.05 110.569 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -75.05 -45.98 37.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.81 -0.632 . . . . 0.91 110.954 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 99' ' ' GLN . 21.8 t -59.9 -49.42 83.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.35 112.118 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.401 ' CG ' ' HA ' ' A' ' 73' ' ' ARG . 15.0 mtpp -81.7 -13.32 58.0 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.218 -0.193 . . . . 0.63 111.416 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.5 t70 54.61 50.64 15.52 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.882 -0.599 . . . . 0.47 111.224 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.9 m -141.54 144.51 34.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.333 -0.394 . . . . 1.14 110.176 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -44.12 28.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.364 . . . . 1.74 111.372 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -99.88 119.28 37.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.846 0.355 . . . . 0.78 110.46 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.82 123.8 21.27 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 115.977 -0.556 . . . . 0.47 110.142 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.84 108.09 0.45 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.435 2.09 . . . . 0.25 111.811 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.513 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 46.5 mtt -139.27 155.19 47.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.078 0.466 . . . . 0.79 111.174 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.3 t -135.06 124.71 43.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.524 -0.762 . . . . 0.22 108.953 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 19.0 tp -84.42 120.54 26.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.567 -0.531 . . . . 0.29 109.567 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.441 ' HB ' HG22 ' A' ' 81' ' ' VAL . 21.7 t -122.96 131.21 73.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.147 -0.479 . . . . 0.82 112.132 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -108.35 95.7 0.96 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.348 -1.101 . . . . 0.27 110.348 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -78.54 161.44 27.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.925 0.393 . . . . 0.21 111.879 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 81.2 mttt 63.7 35.98 11.03 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 115.31 -0.859 . . . . 0.54 110.895 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 28.2 p -69.74 -13.16 62.15 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.978 -0.556 . . . . 0.46 111.475 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -82.36 -10.11 59.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.029 -0.532 . . . . 0.7 110.951 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 58.6 mt -83.24 141.41 42.88 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.962 0.411 . . . . 0.67 110.671 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.28 -178.69 4.61 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.186 1.924 . . . . 0.54 111.588 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.8 m 63.5 45.71 4.63 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.183 -0.462 . . . . 0.84 111.059 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 123' ' ' ARG . 29.1 ttm-85 -59.27 123.03 15.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.965 -0.562 . . . . 0.58 110.401 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.81 -24.77 14.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.913 0.387 . . . . 0.81 111.1 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.3 t -104.82 111.68 35.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.166 -0.47 . . . . 0.37 110.758 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.1 141.58 58.67 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.756 -0.461 . . . . 1.69 109.756 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.83 -30.16 56.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.189 0.518 . . . . 0.82 112.131 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -68.05 -34.32 76.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.887 -0.597 . . . . 0.62 111.723 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -59.53 -57.12 14.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.952 0.353 . . . . 0.93 111.952 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.94 89.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.509 -0.314 . . . . 0.3 111.432 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -63.01 -44.13 96.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.016 0.436 . . . . 0.47 110.069 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.48 -38.72 90.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.656 -0.702 . . . . 1.18 110.304 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 65.5 tp -68.51 -41.05 80.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.717 -0.674 . . . . 0.44 110.898 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.7 91.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.25 110.408 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 135' ' ' ARG . 37.8 ttm105 -62.89 -36.81 84.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.91 -0.586 . . . . 1.54 110.774 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.0 m -69.19 -26.28 64.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.045 0.45 . . . . 0.68 111.138 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -91.09 -19.61 22.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.491 . . . . 0.77 111.187 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.43 27.53 47.6 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.629 -0.796 . . . . 0.25 111.564 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 26.6 pt -125.54 159.11 62.14 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.887 -0.412 . . . . 0.51 109.887 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.45 160.62 17.15 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.678 2.252 . . . . 0.36 112.901 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 13.4 t80 -135.74 131.53 35.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.541 -0.754 . . . . 0.38 110.316 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 37.3 mt -142.74 134.97 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.364 -0.38 . . . . 0.54 110.386 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -84.21 137.85 33.28 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.067 -0.716 . . . . 0.88 109.067 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.9 p -138.31 173.17 11.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.633 0.73 . . . . 0.43 111.716 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.4 t -149.01 123.08 9.45 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.066 -1.087 . . . . 0.33 108.066 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.44 -11.74 61.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.746 0.308 . . . . 0.45 111.291 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -85.13 -57.77 2.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.065 -0.516 . . . . 1.32 111.498 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.9 p -86.74 -10.33 53.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.333 . . . . 0.52 111.463 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 59.69 40.27 20.08 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.683 -0.69 . . . . 1.53 110.744 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -85.29 114.99 22.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.132 -0.486 . . . . 0.87 110.78 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.1 8.4 61.58 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.941 -0.572 . . . . 0.51 112.985 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 22.2 t -65.5 -50.88 69.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.766 0.317 . . . . 0.74 110.814 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.93 -37.63 84.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.103 0.477 . . . . 1.62 109.815 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.7 -42.72 93.62 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.134 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.68 79.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.915 -0.584 . . . . 0.37 111.733 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.402 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.5 OUTLIER -70.94 -39.72 72.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.29 -0.414 . . . . 1.46 111.494 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -61.48 -35.74 78.5 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.952 -0.388 . . . . 0.99 109.952 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 22.3 m -70.59 -35.22 72.9 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.541 -0.54 . . . . 0.34 109.541 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.27 -40.53 97.65 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.494 -0.558 . . . . 0.42 109.494 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 156' ' ' PHE . 94.0 t -61.78 -42.15 93.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.344 0.592 . . . . 0.55 109.712 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -65.3 -36.03 82.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.463 -0.79 . . . . 0.9 110.146 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -66.78 -38.84 87.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.967 -0.383 . . . . 0.73 109.967 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.522 ' O ' ' HG3' ' A' ' 167' ' ' LYS . 88.4 mt -61.81 -52.21 63.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.307 -0.627 . . . . 0.42 109.307 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.607 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 99.1 mtt180 -55.91 -44.81 78.6 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 115.529 -0.759 . . . . 0.87 110.077 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -56.49 -42.81 78.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.42 -0.809 . . . . 0.97 111.842 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -71.24 -36.03 71.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.245 -0.434 . . . . 0.71 111.519 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 163' ' ' ILE . 30.7 mtpt -74.67 -29.7 61.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.407 0.521 . . . . 1.11 112.407 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 6.6 pt-20 -86.77 -12.36 48.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.717 0.294 . . . . 1.12 111.14 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 31.7 tttp . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.431 -0.795 . . . . 1.47 110.395 -179.6 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.48 ' O2A' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 203' ' ' QPD . . . . . 0.458 ' N1 ' ' HB2' ' A' ' 56' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.409 ' HA ' ' O ' ' A' ' 50' ' ' THR . 13.0 tmm? . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.196 -0.298 . . . . 1.48 110.196 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.448 ' HB ' ' CE2' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -113.87 138.7 49.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.372 -0.376 . . . . 1.04 110.893 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -96.32 131.37 42.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.529 -0.545 . . . . 1.27 109.529 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.448 ' CE2' ' HB ' ' A' ' 2' ' ' THR . 85.5 m-85 -120.91 124.55 45.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.567 -0.288 . . . . 1.11 110.251 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -95.63 107.49 19.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.144 0.497 . . . . 0.81 110.545 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.744 HD23 HD23 ' A' ' 159' ' ' LEU . 8.5 mp -111.84 133.26 54.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.649 -0.705 . . . . 1.39 111.187 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 78' ' ' PHE . 16.5 t -118.47 122.1 68.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.165 -0.47 . . . . 0.81 110.491 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.2 t -94.49 119.42 42.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.281 -0.637 . . . . 0.44 109.281 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 m -116.42 157.22 17.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.05 0.453 . . . . 0.7 110.987 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.31 170.92 29.9 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.62 -0.8 . . . . 0.53 111.772 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.34 173.21 7.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.971 0.415 . . . . 0.58 111.597 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.04 112.91 3.54 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.472 -0.87 . . . . 0.8 112.49 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.26 4.1 27.35 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.523 -0.846 . . . . 0.42 113.562 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 m -76.02 -17.61 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 117.391 0.595 . . . . 0.57 111.481 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.62 25.34 8.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.522 -0.847 . . . . 0.49 113.597 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -53.55 -55.98 20.97 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.785 0.326 . . . . 0.81 111.736 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.498 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 1.0 OUTLIER -57.85 -52.86 63.75 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.591 0.589 . . . . 0.58 112.591 -178.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.82 -38.86 67.9 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.369 0.507 . . . . 0.43 112.369 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.0 mt -62.0 -44.47 96.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.543 -0.299 . . . . 0.92 111.354 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.419 ' O ' HG12 ' A' ' 24' ' ' ILE . 1.4 m -73.97 -39.71 63.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.631 0.253 . . . . 0.89 111.026 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.79 -32.61 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.985 0.422 . . . . 0.79 110.473 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.722 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 3.6 mm-40 -67.6 -21.96 65.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.883 -0.599 . . . . 0.46 111.222 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.14 -30.58 12.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.885 0.374 . . . . 1.37 110.625 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 20' ' ' THR . 51.5 mm -81.08 -61.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.927 0.394 . . . . 0.58 110.789 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -85.77 -6.69 59.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.293 0.568 . . . . 1.68 110.383 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.722 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 1.3 m-80 55.39 40.44 31.38 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 114.944 -1.025 . . . . 1.6 112.966 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -160.7 156.02 24.79 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.873 -0.418 . . . . 0.74 109.873 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -80.82 142.29 33.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.141 -0.481 . . . . 0.6 111.963 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.59 121.44 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.958 -1.127 . . . . 0.64 107.958 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.23 -41.53 40.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.799 0.666 . . . . 1.12 112.799 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -123.17 122.47 38.51 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.073 0.463 . . . . 1.18 111.305 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -149.31 139.15 21.91 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.578 -0.897 . . . . 0.6 108.578 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.467 ' HB3' HG13 ' A' ' 36' ' ' ILE . 5.8 t70 -62.78 123.74 80.71 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 123.516 0.51 . . . . 0.8 110.95 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.2 -13.25 23.38 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.775 2.316 . . . . 0.52 113.099 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.2 3.11 56.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.839 0.352 . . . . 0.89 111.352 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.467 HG13 ' HB3' ' A' ' 33' ' ' ASP . 58.3 mt -83.01 130.84 35.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 110.038 -0.356 . . . . 0.73 110.038 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 16.9 tt0 -128.57 82.88 2.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.748 -0.66 . . . . 0.81 109.435 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -111.47 171.7 7.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.095 -0.502 . . . . 1.29 111.272 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.0 141.66 48.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.989 -0.55 . . . . 0.78 109.871 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -126.34 133.43 51.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.106 -0.331 . . . . 0.94 110.106 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -107.62 119.7 40.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.951 0.405 . . . . 0.56 110.741 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -130.31 132.19 45.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.976 -0.556 . . . . 1.46 109.988 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -101.93 123.75 46.37 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.195 0.521 . . . . 1.89 110.443 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.3 t -130.31 143.37 41.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.013 -0.54 . . . . 1.09 109.622 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.51 66.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.178 0.513 . . . . 0.65 110.448 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.8 mt -74.2 124.64 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.55 -0.75 . . . . 1.06 110.774 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.96 17.67 9.58 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.697 -0.683 . . . . 0.97 110.975 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.02 7.18 81.04 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.472 -0.871 . . . . 0.6 112.394 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -116.6 131.45 56.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.764 0.316 . . . . 1.41 110.42 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 1' ' ' MET . 1.3 m -68.15 109.84 3.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.961 0.41 . . . . 0.63 110.934 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.2 m -112.65 130.02 56.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.27 -0.423 . . . . 0.71 111.004 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.0 tp -97.84 107.3 19.76 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.497 -0.927 . . . . 0.48 108.497 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -91.13 120.48 32.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.453 0.538 . . . . 0.87 112.453 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -105.85 98.24 7.95 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.873 -1.158 . . . . 1.03 107.873 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 49.8 mt -106.02 134.33 47.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.932 0.396 . . . . 0.68 111.932 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.516 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 37.5 tp -109.0 123.9 49.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.671 -0.695 . . . . 0.46 110.431 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 4.0 t70 -88.27 93.04 9.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.948 -0.76 . . . . 0.44 108.948 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.428 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 40.1 p -61.05 146.48 47.06 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.265 0.555 . . . . 0.73 111.78 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.76 -73.2 0.47 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.771 -0.65 . . . . 0.56 109.953 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.29 -42.67 0.11 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.255 -0.738 . . . . 0.72 111.255 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.422 ' HA ' ' OE1' ' A' ' 61' ' ' GLN . 12.7 mm-40 -133.95 155.03 50.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.711 0.291 . . . . 1.26 110.311 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -119.99 154.05 35.09 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.019 -0.537 . . . . 1.57 109.783 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.22 -34.27 75.93 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.152 -0.684 . . . . 1.38 109.152 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -130.38 127.19 38.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.545 -0.752 . . . . 0.81 110.554 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 m -57.57 -29.03 64.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.172 -0.467 . . . . 0.63 111.09 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.66 -37.53 76.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.976 0.417 . . . . 0.32 110.812 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 6.9 mtp -71.07 -30.91 67.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.936 -0.574 . . . . 0.69 110.143 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -69.77 -51.18 36.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.312 0.577 . . . . 0.9 109.671 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -65.87 -20.77 66.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.546 -0.752 . . . . 1.41 110.779 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -57.76 -57.77 11.28 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.077 -0.51 . . . . 1.51 111.144 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.42 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 10.9 p90 -70.77 -20.28 62.63 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.552 -0.459 . . . . 1.17 110.77 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 90.9 mtp -75.24 -27.17 59.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.058 0.456 . . . . 0.7 110.071 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.5 mtm105 -82.25 -41.09 20.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.014 0.435 . . . . 1.29 109.928 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 9.7 p -75.78 -12.65 60.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.956 -0.565 . . . . 0.72 111.384 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.34 129.0 11.0 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.926 -0.654 . . . . 0.19 112.312 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -87.46 -46.45 9.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.021 0.438 . . . . 0.54 110.094 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.69 143.9 14.73 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.135 -0.786 . . . . 0.26 111.135 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.522 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 75.3 m-85 -121.56 135.74 54.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.085 0.469 . . . . 0.48 111.557 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.3 tp -97.25 106.78 19.16 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.101 -0.703 . . . . 0.37 109.101 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' ' 111' ' ' MET . 0.1 OUTLIER -78.71 85.68 4.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.065 0.459 . . . . 0.61 110.312 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.63 132.88 34.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.135 0.493 . . . . 0.59 111.824 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.475 ' HB3' HD11 ' A' ' 93' ' ' ILE . 29.2 p90 -144.63 169.15 18.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.459 -0.792 . . . . 0.34 108.908 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.74 124.05 49.96 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.897 -0.321 . . . . 0.32 110.628 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.913 HD11 ' HA ' ' A' ' 118' ' ' CYS . 3.4 pt -71.9 -4.9 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.197 0.522 . . . . 0.78 111.054 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.537 ' OD1' ' HD2' ' A' ' 117' ' ' LYS . 8.7 p-10 -106.4 14.63 27.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.071 -0.513 . . . . 0.82 109.847 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -152.54 100.47 2.57 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.815 -0.63 . . . . 1.07 110.479 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.48 -29.2 68.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.636 . . . . 0.65 112.558 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -58.23 -35.97 72.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.757 0.313 . . . . 0.89 111.385 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.3 p -80.19 -33.78 37.95 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.762 0.315 . . . . 0.64 110.778 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -68.96 -41.73 77.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.42 110.844 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.63 -18.58 62.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.186 -0.461 . . . . 1.44 111.167 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -81.78 -18.66 43.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.904 0.383 . . . . 1.02 110.402 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.475 HD11 ' HB3' ' A' ' 82' ' ' PHE . 27.8 mm -57.79 -30.69 38.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.563 -0.744 . . . . 0.42 110.834 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -63.05 -47.38 83.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.978 -0.556 . . . . 0.83 110.465 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -66.51 -39.37 88.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.89 -0.595 . . . . 0.79 111.547 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -59.99 -45.71 91.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.642 0.258 . . . . 1.17 110.681 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.437 ' HG2' ' CE1' ' A' ' 137' ' ' TYR . 18.8 tpt180 -58.63 -49.62 76.82 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.084 -0.507 . . . . 0.6 110.282 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -60.73 -39.33 88.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.842 -0.617 . . . . 1.35 110.903 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -62.24 -53.13 59.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.56 -0.291 . . . . 1.15 110.896 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.7 mt -59.22 -42.07 85.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.465 -0.334 . . . . 0.51 111.015 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -66.08 -26.03 67.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.471 -0.331 . . . . 1.05 111.621 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -87.01 -35.84 18.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.004 0.431 . . . . 0.91 110.554 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.2 t -70.35 -46.92 69.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.817 -0.629 . . . . 0.35 111.328 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -87.09 -18.52 30.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.329 . . . . 0.63 110.733 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t70 54.6 54.53 9.13 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.306 -0.861 . . . . 0.47 111.055 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.3 m -137.31 146.63 44.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.961 -0.563 . . . . 1.14 109.877 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.24 -42.9 20.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.001 0.429 . . . . 1.74 110.039 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -93.68 106.74 18.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.857 -0.61 . . . . 0.78 110.349 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . 21.3 t -121.48 119.24 29.43 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.938 -0.393 . . . . 0.47 109.938 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 109' ' ' VAL . 16.9 Cg_exo -65.92 103.7 0.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.329 2.019 . . . . 0.25 111.275 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.535 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 85.9 mtp -138.07 151.34 47.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.204 -0.453 . . . . 0.79 110.399 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.7 t -129.55 121.76 53.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.503 -0.554 . . . . 0.22 109.503 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.6 tp -76.82 117.65 18.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.346 -0.613 . . . . 0.29 109.346 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.2 t -117.82 114.99 47.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.0 -0.546 . . . . 0.82 112.069 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.55 96.43 1.89 Allowed Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.049 -1.221 . . . . 0.27 110.049 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -80.67 162.77 24.02 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.775 0.287 . . . . 0.21 111.775 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.537 ' HD2' ' OD1' ' A' ' 85' ' ' ASN . 41.7 mttt 71.39 41.27 0.76 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.382 -0.826 . . . . 0.54 111.516 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.913 ' HA ' HD11 ' A' ' 84' ' ' ILE . 29.6 p -75.17 -19.36 59.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.944 0.402 . . . . 0.46 111.449 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -89.24 -7.55 55.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.966 0.412 . . . . 0.7 111.045 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 51.4 mt -91.56 145.68 31.74 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.256 -0.429 . . . . 0.67 110.859 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.63 -170.65 0.86 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.567 2.178 . . . . 0.54 112.047 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.2 m 58.78 44.85 16.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.134 -0.485 . . . . 0.84 111.544 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -72.24 118.22 14.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.58 110.197 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.49 -17.64 15.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.964 0.411 . . . . 0.81 111.603 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.72 115.52 49.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.07 -0.514 . . . . 0.37 110.779 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.74 148.23 42.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 1.69 110.59 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.6 m -59.55 -33.71 71.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.823 -0.626 . . . . 0.82 111.281 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -64.72 -44.33 90.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.695 -0.23 . . . . 0.62 110.673 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -60.4 -41.44 93.88 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.074 0.464 . . . . 0.93 110.655 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.41 -48.33 67.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.594 -0.73 . . . . 0.3 110.561 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -62.03 -35.39 78.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.173 0.511 . . . . 0.47 110.382 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -48.92 79.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.812 -0.631 . . . . 1.18 110.578 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.32 -41.24 85.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.101 -0.499 . . . . 0.44 111.041 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.09 -44.91 83.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.951 0.405 . . . . 0.25 111.204 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -69.03 -25.17 64.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 1.54 110.899 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.0 m -71.5 -26.74 62.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.151 0.5 . . . . 0.68 110.241 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.437 ' CE1' ' HG2' ' A' ' 97' ' ' ARG . 19.1 m-85 -93.11 -33.3 14.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.245 0.545 . . . . 0.77 110.41 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.4 30.11 7.11 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.752 -0.939 . . . . 0.25 110.752 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.1 pt -123.55 156.89 63.72 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.283 -0.459 . . . . 0.51 110.486 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.4 157.37 29.19 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.192 1.928 . . . . 0.36 112.578 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -132.05 132.11 43.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.928 -0.578 . . . . 0.38 110.334 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 63.5 mt -137.81 130.76 41.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.54 111.174 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -81.8 128.15 33.71 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.389 -0.967 . . . . 0.88 108.389 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 64.2 p -131.86 174.73 9.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.272 0.558 . . . . 0.43 112.236 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.7 t -150.6 134.09 16.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.275 -0.875 . . . . 0.33 109.109 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.7 -6.88 59.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.127 0.489 . . . . 0.45 110.407 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -91.39 -48.24 7.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.008 -0.542 . . . . 1.32 110.912 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.0 p -94.22 -17.62 22.51 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.591 -0.277 . . . . 0.52 111.122 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 67.04 23.12 9.8 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.773 0.671 . . . . 1.53 110.86 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 144' ' ' THR . 35.2 tt0 -71.42 119.75 16.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.9 -0.591 . . . . 0.87 111.113 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.05 -8.87 42.17 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.923 -0.58 . . . . 0.51 114.028 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.38 -49.02 85.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 117.143 0.471 . . . . 0.74 111.14 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.37 -48.35 79.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.098 0.475 . . . . 1.62 110.148 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.0 -47.47 84.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.431 -0.804 . . . . 1.0 111.583 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -54.73 -50.41 68.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.679 0.276 . . . . 0.37 111.7 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.488 ' O ' HG23 ' A' ' 160' ' ' VAL . 26.6 m-85 -62.71 -42.68 99.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.346 -0.388 . . . . 1.46 111.578 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -70.22 -35.54 73.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.702 -0.226 . . . . 0.99 111.202 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 39.2 m -64.1 -39.45 94.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.803 0.335 . . . . 0.34 110.304 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.744 HD23 HD23 ' A' ' 6' ' ' LEU . 25.2 tp -61.64 -37.18 83.06 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.163 -0.471 . . . . 0.42 110.394 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 156' ' ' PHE . 21.2 t -64.08 -38.37 82.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.278 0.561 . . . . 0.55 109.778 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.6 mtt85 -70.49 -34.3 72.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.8 -0.636 . . . . 0.9 110.134 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -59.95 -40.43 88.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.802 -0.636 . . . . 0.73 109.96 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 65.4 mt -68.11 -45.2 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.501 -0.772 . . . . 0.42 110.268 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 93.4 mtt180 -54.23 -42.18 69.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.678 -0.692 . . . . 0.87 111.043 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -63.26 -36.95 85.36 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 115.796 -0.638 . . . . 0.97 111.135 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -69.69 -26.35 64.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.181 0.515 . . . . 0.71 110.411 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -82.82 -34.98 26.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.944 -0.571 . . . . 1.11 110.893 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 8.7 pt-20 -95.96 16.62 17.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.376 -0.375 . . . . 1.12 110.566 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.3 tttp . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.22 -0.895 . . . . 1.47 110.32 -179.855 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.498 ' O2A' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 203' ' ' QPD . . . . . 0.516 ' N1 ' ' HB2' ' A' ' 56' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 50' ' ' THR . 31.8 ttm . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.967 0.413 . . . . 1.48 110.254 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.2 m -92.73 137.62 32.21 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.431 -0.349 . . . . 1.04 110.965 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -91.13 132.16 36.24 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.619 -0.511 . . . . 1.27 109.619 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -115.26 121.51 43.12 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.138 -0.319 . . . . 1.11 110.138 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.4 ' HB3' ' C6 ' ' A' ' 203' ' ' QPD . 18.5 mtpp -96.53 108.22 20.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.241 0.543 . . . . 0.81 110.988 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.8 mp -112.29 142.35 44.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.71 -0.677 . . . . 1.39 111.2 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.2 t -128.74 130.01 68.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.866 -0.607 . . . . 0.81 110.677 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.6 t -95.89 114.04 31.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.92 -0.582 . . . . 0.44 109.519 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -115.82 136.62 52.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.428 0.633 . . . . 0.7 111.425 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.2 176.08 45.0 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.43 -0.805 . . . . 0.53 111.589 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.431 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -71.83 167.73 19.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.864 0.364 . . . . 0.58 110.114 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.3 128.31 11.48 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.496 -0.859 . . . . 0.8 112.765 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.99 10.95 59.34 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.71 -0.757 . . . . 0.42 113.744 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 11' ' ' ALA . 27.2 m -85.94 -1.86 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 117.696 0.748 . . . . 0.57 111.357 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.511 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 92.46 29.59 10.89 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.954 -0.641 . . . . 0.49 113.371 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -60.59 -45.61 93.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.802 0.301 . . . . 0.81 111.518 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.606 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 1.3 m -75.63 -20.3 58.6 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.874 0.324 . . . . 0.58 111.874 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.15 -40.6 64.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.868 0.366 . . . . 0.43 110.733 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 37.8 mt -64.57 -27.58 69.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.864 -0.607 . . . . 0.92 110.616 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.468 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -74.24 -54.06 8.49 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.033 -0.53 . . . . 0.89 111.351 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.407 HG21 HG23 ' A' ' 29' ' ' VAL . 10.6 mt -61.13 -38.67 80.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.778 0.323 . . . . 0.79 111.433 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.641 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 2.5 mm-40 -66.85 -23.82 66.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.009 0.433 . . . . 0.46 111.194 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.2 tp -95.08 -40.73 9.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.74 0.305 . . . . 1.37 111.54 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 20' ' ' THR . 46.9 mm -74.61 -55.35 12.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.164 -0.471 . . . . 0.58 112.232 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 49.1 mt-30 -100.86 -11.64 19.65 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.945 0.35 . . . . 1.68 111.945 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 70.2 m-20 71.23 17.64 5.92 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.362 0.875 . . . . 1.6 113.362 178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -128.73 128.65 44.45 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.474 -0.49 . . . . 0.74 110.548 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -75.48 127.28 32.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.064 -0.971 . . . . 0.6 110.959 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.407 HG23 HG21 ' A' ' 21' ' ' ILE . 48.6 t -99.04 136.58 29.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.918 -0.583 . . . . 0.64 109.482 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -83.47 -30.5 27.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.502 -0.317 . . . . 1.12 111.778 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -134.84 116.3 14.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.902 0.382 . . . . 1.18 111.248 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -141.76 146.31 35.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.848 -0.614 . . . . 0.6 109.516 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.33 121.3 73.96 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.052 0.453 . . . . 0.8 111.357 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.43 -18.35 15.83 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.55 2.167 . . . . 0.52 112.865 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.07 3.32 52.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.261 -0.427 . . . . 0.89 111.208 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 mt -83.92 125.35 40.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.234 0.54 . . . . 0.73 111.321 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 18.4 tt0 -125.3 83.41 2.16 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.905 -1.146 . . . . 0.81 107.905 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -113.62 162.17 16.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.789 -0.641 . . . . 1.29 111.956 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.74 142.94 26.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.289 -0.869 . . . . 0.78 111.652 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -134.97 135.75 41.68 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.053 -0.351 . . . . 0.94 110.053 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.579 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 1.1 mpp_? -119.2 139.57 51.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.912 0.387 . . . . 0.56 110.565 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -143.04 131.33 22.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.1 -0.5 . . . . 1.46 110.302 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -101.7 112.27 24.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.985 0.421 . . . . 1.89 110.313 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.95 149.87 30.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.136 -0.484 . . . . 1.09 110.968 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.3 t -92.49 93.17 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.947 -0.761 . . . . 0.65 108.947 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.3 mt -91.51 114.05 28.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.049 -0.523 . . . . 1.06 111.805 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.493 ' HB2' HH12 ' A' ' 164' ' ' ARG . 56.5 m-20 58.26 37.78 26.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.662 -0.699 . . . . 0.97 111.099 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.5 -5.01 84.83 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.086 -0.578 . . . . 0.6 113.347 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -108.93 115.61 30.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.878 0.37 . . . . 1.41 111.759 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -70.22 116.92 11.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 0.63 109.768 178.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.3 m -129.89 151.64 50.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.084 0.469 . . . . 0.71 111.72 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.9 tp -104.25 113.45 27.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.001 -0.74 . . . . 0.48 109.001 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 53.7 mt -82.39 125.62 31.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.896 -0.593 . . . . 0.87 112.027 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -110.41 88.73 2.84 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.106 -1.072 . . . . 1.03 108.106 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.0 mt -99.81 130.58 48.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.96 -0.564 . . . . 0.68 111.871 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.468 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 22.7 tp -116.36 107.02 14.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.996 -0.547 . . . . 0.46 109.782 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -75.32 116.16 15.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.876 -0.602 . . . . 0.44 110.267 -179.633 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.7 p -73.45 156.32 38.38 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.515 0.674 . . . . 0.73 112.168 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.4 -55.78 2.38 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.79 -1.095 . . . . 0.56 109.949 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.28 -87.46 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.843 -0.617 . . . . 0.72 111.957 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -122.91 127.88 49.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.974 -0.38 . . . . 1.26 109.974 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -87.72 -173.73 4.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.271 -0.422 . . . . 1.57 111.094 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.13 -47.7 81.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 1.38 111.07 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -123.2 148.67 45.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.72 0.295 . . . . 0.81 110.521 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -60.91 -34.35 74.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.088 -0.506 . . . . 0.63 110.652 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.76 -28.87 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.891 -0.595 . . . . 0.32 111.362 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 86.0 mtp -70.05 -44.61 68.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.228 0.537 . . . . 0.69 109.847 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 71' ' ' TYR . 17.0 ttp180 -65.92 -39.0 90.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.538 -0.755 . . . . 0.9 109.91 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -77.79 -5.22 50.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.584 -0.735 . . . . 1.41 110.842 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -73.7 -62.86 1.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.661 -0.245 . . . . 1.51 111.642 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 68' ' ' ARG . 1.3 p90 -67.22 -17.83 64.98 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 120.606 0.241 . . . . 1.17 111.047 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.3 mtt -73.51 -17.43 61.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.225 0.536 . . . . 0.7 109.665 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -90.48 -49.77 6.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.557 -0.747 . . . . 1.29 110.187 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.15 -12.0 60.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.72 112.145 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.47 132.49 38.4 Favored Glycine 0 C--O 1.237 0.344 0 C-N-CA 121.123 -0.56 . . . . 0.19 113.18 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -97.96 -36.32 10.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 0.54 110.81 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.416 ' HA3' HD11 ' A' ' 163' ' ' ILE . . . -133.17 128.89 5.23 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.022 -0.831 . . . . 0.26 111.022 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.477 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 91.6 m-85 -114.99 116.85 29.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.244 0.545 . . . . 0.48 110.88 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.8 tp -88.8 109.19 19.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.54 -0.755 . . . . 0.37 109.908 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.5 m -82.53 103.54 12.14 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.356 0.41 . . . . 0.61 109.959 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.07 129.61 60.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.981 0.419 . . . . 0.59 112.084 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -136.6 162.3 33.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.652 -0.704 . . . . 0.34 109.674 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.442 ' HB1' ' OD1' ' A' ' 85' ' ' ASN . . . -100.95 126.76 47.62 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.365 -0.235 . . . . 0.32 110.365 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.1 pt -71.13 -12.16 15.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.948 0.404 . . . . 0.78 111.375 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.442 ' OD1' ' HB1' ' A' ' 83' ' ' ALA . 10.1 p-10 -95.23 5.79 50.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.826 -0.625 . . . . 0.82 110.75 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -148.43 111.73 4.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.072 0.463 . . . . 1.07 110.542 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.27 -26.96 66.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.1 -0.5 . . . . 0.65 111.938 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -58.35 -37.85 76.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.89 110.646 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -67.55 -38.15 83.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.378 -0.373 . . . . 0.64 110.796 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -66.67 -39.86 88.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.176 0.512 . . . . 0.42 110.068 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.53 -35.08 79.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.87 -0.604 . . . . 1.44 110.635 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -63.45 -32.8 74.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.901 -0.591 . . . . 1.02 110.932 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 89' ' ' SER . 45.7 mm -57.87 -31.55 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.586 . . . . 0.42 111.031 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -62.71 -35.92 81.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.126 0.489 . . . . 0.83 110.348 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -82.19 -38.5 24.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.79 110.104 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -58.69 -48.68 80.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.283 -0.417 . . . . 1.17 111.204 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -56.37 -51.78 67.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.958 -0.565 . . . . 0.6 110.919 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -39.89 95.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.032 -0.531 . . . . 1.35 111.061 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.449 ' O ' HG23 ' A' ' 103' ' ' VAL . 51.7 tt0 -59.36 -55.24 37.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.947 -0.57 . . . . 1.15 111.117 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.97 -37.76 79.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.435 -0.348 . . . . 0.51 110.755 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -61.09 -32.6 72.26 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.974 0.416 . . . . 1.05 110.026 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -77.46 -45.32 26.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.893 -0.594 . . . . 0.91 110.643 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 99' ' ' GLN . 66.4 t -59.93 -47.64 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.191 -0.459 . . . . 0.35 111.71 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -83.68 -13.32 54.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.451 -0.34 . . . . 0.63 110.541 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 t70 54.91 48.56 19.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.622 -0.717 . . . . 0.47 109.854 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.8 m -132.61 143.65 49.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.363 -0.835 . . . . 1.14 110.314 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.18 -31.06 30.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.1 0.476 . . . . 1.74 110.368 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -119.41 112.35 19.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.96 -0.564 . . . . 0.78 110.135 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.21 122.54 24.13 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.695 -0.483 . . . . 0.47 109.695 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -49.69 107.52 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.171 2.581 . . . . 0.25 111.982 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.477 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 56.5 mtt -140.04 150.2 44.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.952 -0.567 . . . . 0.79 110.719 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.4 t -132.46 121.81 46.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.665 -0.865 . . . . 0.22 108.665 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.637 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 56.3 tp -89.31 125.13 34.98 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.641 -0.503 . . . . 0.29 109.641 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.7 129.13 54.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.354 0.597 . . . . 0.82 111.861 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -94.5 103.86 3.07 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.224 -1.15 . . . . 0.27 110.224 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -81.51 164.52 21.92 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.576 -0.157 . . . . 0.21 110.576 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 69.7 mttt 66.97 36.93 4.06 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.733 0.646 . . . . 0.54 110.459 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 31.9 p -67.68 -13.63 62.26 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.24 -0.436 . . . . 0.46 111.957 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -89.53 -8.77 52.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.428 -0.351 . . . . 0.7 110.936 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 120' ' ' LEU . 16.3 mt -77.63 130.25 74.35 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.561 0.22 . . . . 0.67 110.976 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 11.2 Cg_exo -69.5 171.88 13.39 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.885 2.39 . . . . 0.54 112.081 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.8 m 61.57 54.55 3.01 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.393 0.616 . . . . 0.84 110.573 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -64.64 127.41 31.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.381 -0.827 . . . . 0.58 111.206 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.14 -41.22 7.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.074 -0.512 . . . . 0.81 110.512 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.3 t -88.96 113.32 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.222 -0.445 . . . . 0.37 110.295 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.06 147.61 49.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 1.69 110.878 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -46.85 87.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.82 111.848 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.6 tttm -65.22 -35.69 81.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.61 -0.268 . . . . 0.62 110.621 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -59.27 -44.34 92.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.93 110.881 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.56 -40.04 66.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 0.3 110.929 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.8 -34.42 78.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.761 -0.654 . . . . 0.47 110.953 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -40.82 98.46 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.789 -0.641 . . . . 1.18 110.226 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 27.8 tp -69.84 -42.07 74.07 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.872 -0.604 . . . . 0.44 109.547 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 139' ' ' ILE . . . -58.69 -45.47 89.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.302 -0.863 . . . . 0.25 110.423 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -59.07 -45.69 90.17 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.858 -0.61 . . . . 1.54 110.683 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.2 m -65.42 -35.08 79.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.945 -0.571 . . . . 0.68 111.301 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -79.02 -22.42 45.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.235 -0.439 . . . . 0.77 110.944 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.62 26.61 38.1 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.911 -0.661 . . . . 0.25 111.45 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.434 ' O ' ' HB1' ' A' ' 134' ' ' ALA . 34.7 pt -124.16 156.17 66.84 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 110.094 -0.335 . . . . 0.51 110.094 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -84.59 155.12 12.04 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.153 1.902 . . . . 0.36 112.859 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.637 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 19.0 t80 -130.93 127.03 37.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.918 -0.583 . . . . 0.38 110.549 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.9 mt -130.53 139.36 51.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.132 -0.485 . . . . 0.54 110.034 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -78.32 137.96 38.32 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.288 -1.005 . . . . 0.88 108.288 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.7 p -139.03 162.02 35.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.519 0.933 . . . . 0.43 113.519 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.6 t -155.09 117.25 4.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.687 -1.142 . . . . 0.33 108.559 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.87 -11.3 60.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.45 111.478 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -84.5 -42.84 15.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.278 -0.419 . . . . 1.32 111.439 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.5 p -96.55 -5.56 39.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.696 -0.229 . . . . 0.52 111.525 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 38.4 ttt85 59.75 47.66 10.1 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.611 0.719 . . . . 1.53 109.829 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -113.31 125.57 54.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.544 -0.753 . . . . 0.87 111.158 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.78 -21.83 3.7 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.802 -0.636 . . . . 0.51 113.303 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.17 -46.49 88.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.802 0.334 . . . . 0.74 111.654 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.452 ' O ' ' HD2' ' A' ' 157' ' ' TYR . 21.4 t70 -62.0 -49.24 76.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.495 . . . . 1.62 110.096 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -39.02 86.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.223 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -58.97 -52.05 67.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.222 -0.445 . . . . 0.37 111.94 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -62.58 -41.58 99.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.633 -0.258 . . . . 1.46 111.562 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.452 ' HD2' ' O ' ' A' ' 153' ' ' ASP . 29.0 m-85 -66.96 -34.63 78.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.99 110.807 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 99.5 m -68.42 -45.61 72.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.319 -0.4 . . . . 0.34 110.92 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 163' ' ' ILE . 31.0 tp -55.96 -41.79 75.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.361 -0.381 . . . . 0.42 111.052 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.88 -43.47 98.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.322 -0.399 . . . . 0.55 110.901 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -65.22 -34.22 77.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.444 -0.344 . . . . 0.9 111.011 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -64.05 -44.82 91.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.73 110.232 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 159' ' ' LEU . 17.2 mt -62.54 -43.9 98.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.086 0.469 . . . . 0.42 110.072 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.493 HH12 ' HB2' ' A' ' 47' ' ' ASP . 93.9 mtt180 -59.15 -42.78 91.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.42 -0.809 . . . . 0.87 111.371 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -66.08 -30.57 71.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.218 -0.446 . . . . 0.97 111.191 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -79.73 -26.06 40.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.256 -0.429 . . . . 0.71 110.213 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -77.08 -33.66 57.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.594 -0.275 . . . . 1.11 110.408 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -87.04 4.0 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 1.12 110.871 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.2 tptt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.367 -0.825 . . . . 1.47 110.848 -179.616 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.606 ' O2A' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 203' ' ' QPD . . . . . 0.468 ' N1 ' ' HB2' ' A' ' 56' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttm . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 121.17 0.51 . . . . 1.48 110.371 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.0 m -76.38 126.84 31.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.133 -0.485 . . . . 1.04 110.712 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -94.14 134.67 36.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.133 -0.485 . . . . 1.27 110.253 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -122.49 128.08 50.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.375 -0.375 . . . . 1.11 110.279 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -99.58 108.82 21.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.269 -0.423 . . . . 0.81 109.921 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.467 HD11 HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -124.59 148.94 47.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.394 0.616 . . . . 1.39 110.981 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.13 132.03 70.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.924 -0.58 . . . . 0.81 110.862 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.4 t -91.24 119.19 38.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.035 -0.728 . . . . 0.44 109.035 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.7 m -116.65 157.83 17.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.829 0.347 . . . . 0.7 111.297 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.83 176.27 32.76 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.714 -0.954 . . . . 0.53 110.714 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -73.68 172.63 11.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.974 0.416 . . . . 0.58 111.415 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.91 121.19 5.67 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.697 -0.763 . . . . 0.8 112.189 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.71 3.03 55.26 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.821 -0.704 . . . . 0.42 113.245 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 11' ' ' ALA . 31.1 m -72.81 -29.09 28.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 117.391 0.596 . . . . 0.57 111.098 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.652 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 115.85 19.97 5.47 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.144 -1.027 . . . . 0.49 114.406 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -53.05 -53.58 48.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.468 0.634 . . . . 0.81 111.86 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -34.99 75.64 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.322 -0.399 . . . . 0.58 111.959 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.63 -40.62 88.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.5 -0.318 . . . . 0.43 111.278 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 23.5 mt -63.31 -39.05 93.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.375 -0.375 . . . . 0.92 110.88 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 m -66.14 -47.4 74.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.256 -0.429 . . . . 0.89 111.005 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.5 mt -65.59 -34.8 72.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 0.79 111.26 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 2.3 mm-40 -69.97 -12.67 61.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.991 0.424 . . . . 0.46 111.323 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.7 tp -102.29 -37.46 8.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.211 0.529 . . . . 1.37 110.861 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.9 mm -80.53 -59.08 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.908 -0.587 . . . . 0.58 111.425 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -89.92 -17.06 28.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.451 -0.34 . . . . 1.68 110.96 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 45.4 m-80 63.38 46.83 4.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.794 -0.639 . . . . 1.6 112.282 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -153.71 143.79 22.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.576 -0.528 . . . . 0.74 109.576 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -82.71 129.99 35.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.242 -0.435 . . . . 0.6 111.972 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.33 120.02 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.657 -0.701 . . . . 0.64 109.512 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.6 -41.17 32.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.236 -0.438 . . . . 1.12 111.888 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -115.6 108.97 17.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.181 0.515 . . . . 1.18 111.698 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -142.3 144.07 33.09 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.93 -0.767 . . . . 0.6 108.93 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -64.63 123.73 84.06 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.917 0.389 . . . . 0.8 110.9 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.18 -15.29 14.54 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.549 2.166 . . . . 0.52 113.386 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.44 3.16 56.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.674 0.273 . . . . 0.89 111.733 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.8 mt -86.0 127.46 40.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 120.849 0.357 . . . . 0.73 110.462 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 11.3 tt0 -114.86 94.94 4.98 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.215 -1.032 . . . . 0.81 108.215 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -115.47 164.18 14.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.01 -0.541 . . . . 1.29 110.918 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 1.2 p -130.06 129.84 44.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.776 -0.647 . . . . 0.78 109.961 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -125.35 143.81 50.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.642 -0.254 . . . . 0.94 110.947 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.694 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -113.2 143.06 45.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.56 110.575 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -147.02 134.85 21.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.703 -0.681 . . . . 1.46 109.459 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -103.18 114.49 28.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.943 0.401 . . . . 1.89 110.976 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 31.5 t -127.01 147.81 31.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.767 -0.652 . . . . 1.09 110.432 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.61 101.24 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.728 -0.471 . . . . 0.65 109.728 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 76.9 mt -105.96 118.1 52.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.963 0.411 . . . . 1.06 111.249 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.505 ' HB2' HH12 ' A' ' 164' ' ' ARG . 86.6 m-20 61.77 30.85 18.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.007 -0.997 . . . . 0.97 111.744 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.61 -0.21 73.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.855 -0.688 . . . . 0.6 114.163 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -121.68 126.67 49.53 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.46 0.63 . . . . 1.41 111.175 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.95 115.36 11.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.976 0.417 . . . . 0.63 110.111 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.1 m -116.89 147.72 41.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.108 -0.496 . . . . 0.71 111.576 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.9 tp -100.46 120.25 39.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.881 -0.599 . . . . 0.48 109.394 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.694 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 16.7 mt -89.73 115.99 27.5 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.047 -0.524 . . . . 0.87 112.128 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.424 ' OD1' ' HD2' ' A' ' 41' ' ' ARG . 19.0 t70 -104.31 95.18 5.77 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.53 -1.285 . . . . 1.03 107.53 176.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 39' ' ' SER . 6.1 mt -101.85 127.88 54.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.075 -0.511 . . . . 0.68 112.367 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.418 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 42.0 tp -114.23 119.45 37.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.057 -0.52 . . . . 0.46 109.859 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 4.5 t70 -89.84 100.88 13.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.115 -0.493 . . . . 0.44 110.074 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.4 p -62.51 138.54 58.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.779 -0.646 . . . . 0.73 112.597 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.54 -36.24 24.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.56 110.066 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.33 -74.9 0.42 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.964 -0.636 . . . . 0.72 111.83 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -108.93 117.89 35.36 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.818 -0.438 . . . . 1.26 109.818 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.94 162.7 15.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.172 -0.467 . . . . 1.57 110.432 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -55.56 -51.92 65.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.857 -0.61 . . . . 1.38 111.188 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -127.07 148.27 50.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.635 -0.506 . . . . 0.81 109.635 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -35.04 76.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.693 0.282 . . . . 0.63 111.361 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.94 -31.91 73.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 0.32 111.222 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 85.0 mtp -74.17 -31.67 62.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.268 0.556 . . . . 0.69 109.823 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.515 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 34.9 ttp180 -74.33 -46.45 40.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.453 -0.794 . . . . 0.9 109.906 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.488 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 39.2 m-20 -65.68 -24.45 67.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.409 -0.814 . . . . 1.41 110.228 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -57.9 -56.7 18.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.349 -0.841 . . . . 1.51 111.559 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 31.1 p90 -72.4 -14.26 61.66 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.861 -0.336 . . . . 1.17 111.407 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.4 mtt -76.16 -28.78 57.5 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.451 -0.574 . . . . 0.7 109.451 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 30.2 mtm180 -83.64 -34.18 25.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.831 -0.622 . . . . 1.29 111.163 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.425 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -78.91 -26.77 43.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.27 -0.423 . . . . 0.72 111.603 -179.399 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.82 125.76 28.47 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.038 -0.601 . . . . 0.19 112.712 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -92.0 -26.05 18.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.681 -0.488 . . . . 0.54 109.681 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -141.78 143.82 13.5 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 110.886 -0.886 . . . . 0.26 110.886 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.454 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 89.8 m-85 -126.8 132.43 51.03 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.229 0.538 . . . . 0.48 111.255 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 tp -100.87 112.28 24.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.724 -0.671 . . . . 0.37 109.368 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.7 m -90.01 104.72 17.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.102 0.477 . . . . 0.61 110.454 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.1 t -102.73 126.5 56.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.069 -0.514 . . . . 0.59 111.571 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -133.02 160.19 37.87 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.065 -0.717 . . . . 0.34 109.065 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.85 128.2 48.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.811 0.338 . . . . 0.32 110.492 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 pt -67.29 -14.2 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.367 . . . . 0.78 111.828 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -100.85 6.48 43.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.926 0.393 . . . . 0.82 110.397 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -135.67 103.32 5.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 1.07 110.246 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -27.22 66.97 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.447 0.536 . . . . 0.65 112.447 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -66.88 -37.74 84.98 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.161 -0.216 . . . . 0.89 111.123 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.429 ' O ' HG12 ' A' ' 93' ' ' ILE . 91.4 p -64.89 -36.87 85.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.425 . . . . 0.64 110.024 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -69.67 -35.71 75.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.924 -0.58 . . . . 0.42 109.955 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -65.62 -40.88 93.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.801 -0.636 . . . . 1.44 110.471 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.53 -26.35 68.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.737 -0.665 . . . . 1.02 111.769 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 89' ' ' SER . 48.3 mm -57.93 -28.64 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.099 0.476 . . . . 0.42 110.73 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -66.66 -41.12 88.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.973 -0.558 . . . . 0.83 110.68 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -77.71 -34.54 52.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.79 110.832 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -59.13 -48.02 83.16 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.524 -0.307 . . . . 1.17 110.741 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -60.57 -46.41 90.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.96 -0.564 . . . . 0.6 110.016 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -47.92 79.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.742 -0.663 . . . . 1.35 111.528 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.544 ' O ' HG23 ' A' ' 103' ' ' VAL . 26.0 tt0 -59.3 -58.19 9.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 1.15 112.111 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.33 -39.0 79.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 120.591 0.234 . . . . 0.51 111.026 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -61.38 -35.86 78.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.951 0.405 . . . . 1.05 110.457 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -73.64 -37.87 65.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.044 -0.525 . . . . 0.91 110.972 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 99' ' ' GLN . 47.8 t -68.96 -40.83 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.35 110.982 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -82.75 -20.15 36.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.485 -0.325 . . . . 0.63 111.222 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 54.92 57.31 5.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.507 0.67 . . . . 0.47 110.333 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -141.6 142.01 33.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.656 -0.702 . . . . 1.14 109.761 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -75.54 -31.82 60.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.906 0.384 . . . . 1.74 110.004 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.4 123.96 49.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.968 -0.56 . . . . 0.78 110.816 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.2 t -135.28 113.38 11.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.187 -0.671 . . . . 0.47 109.187 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.98 109.18 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.854 2.369 . . . . 0.25 112.783 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.454 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 30.9 mtt -139.33 152.98 47.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.964 -0.562 . . . . 0.79 110.722 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 73.3 t -131.45 127.25 59.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.171 -0.677 . . . . 0.22 109.171 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.4 tp -84.84 118.87 24.75 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.606 -0.516 . . . . 0.29 109.606 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 65.0 t -114.68 117.9 57.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.037 -0.529 . . . . 0.82 112.008 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.29 93.25 1.49 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.549 -1.02 . . . . 0.27 110.549 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -80.73 163.2 23.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.648 0.261 . . . . 0.21 111.623 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.6 mttt 68.39 33.84 3.98 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.42 -0.809 . . . . 0.54 111.233 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 20.9 p -68.05 -20.35 64.97 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 111.991 0.367 . . . . 0.46 111.991 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -86.54 -12.0 50.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.765 0.317 . . . . 0.7 111.383 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.429 HD11 ' N2 ' ' A' ' 201' ' ' GDP . 17.5 mt -80.21 142.17 54.71 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.358 -0.383 . . . . 0.67 110.737 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.05 174.14 12.48 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.382 2.055 . . . . 0.54 111.431 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.6 m 66.15 60.28 0.65 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.352 0.596 . . . . 0.84 111.054 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.5 ttm-85 -75.54 104.89 6.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.736 -0.666 . . . . 0.58 110.388 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 m -82.53 -36.84 25.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.093 -0.503 . . . . 0.81 111.045 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.0 t -97.39 111.0 26.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.22 -0.445 . . . . 0.37 110.628 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -68.6 148.21 50.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.802 -0.636 . . . . 1.69 110.135 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.2 m -57.62 -37.19 72.87 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.339 -0.391 . . . . 0.82 111.607 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -63.95 -37.57 87.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.665 0.269 . . . . 0.62 111.081 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -58.69 -45.89 88.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.93 111.236 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.76 -41.33 62.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.85 -0.614 . . . . 0.3 111.225 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -61.86 -39.48 92.04 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.031 0.443 . . . . 0.47 109.994 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.86 -46.66 89.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.776 -0.647 . . . . 1.18 110.56 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.89 -39.54 90.74 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.785 -0.643 . . . . 0.44 110.418 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.81 88.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.574 . . . . 0.25 110.945 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -64.4 -38.89 92.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.573 -0.285 . . . . 1.54 111.104 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.75 -23.71 62.48 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.094 0.473 . . . . 0.68 111.766 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -91.11 -19.12 23.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.145 -0.479 . . . . 0.77 110.283 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.8 32.85 48.5 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.407 -0.677 . . . . 0.25 111.407 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.448 ' HB ' ' O ' ' A' ' 111' ' ' MET . 36.6 pt -127.44 158.16 70.56 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.94 -0.393 . . . . 0.51 109.94 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.19 151.12 17.92 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.448 2.098 . . . . 0.36 112.718 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -124.53 129.05 49.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.76 -0.655 . . . . 0.38 109.757 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 67.0 mt -137.1 129.41 43.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.394 -0.366 . . . . 0.54 111.316 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -85.26 133.74 34.15 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.973 -0.751 . . . . 0.88 108.973 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 150' ' ' GLN . 41.4 p -138.84 179.94 6.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.541 0.686 . . . . 0.43 111.953 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.5 t -155.46 135.92 13.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.017 -0.992 . . . . 0.33 108.843 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.16 -7.4 58.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.064 0.459 . . . . 0.45 111.291 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -94.78 -48.75 5.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.068 -0.514 . . . . 1.32 111.117 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.9 p -92.71 -12.85 30.38 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 111.928 0.344 . . . . 0.52 111.928 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 57.81 38.41 27.26 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.333 0.587 . . . . 1.53 110.653 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.421 ' O ' HG22 ' A' ' 144' ' ' THR . 45.5 tt0 -69.83 94.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.146 -0.934 . . . . 0.87 112.251 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 68.72 22.25 75.28 Favored Glycine 0 CA--C 1.516 0.153 0 CA-C-N 115.788 -0.642 . . . . 0.51 114.561 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.43 -52.1 50.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 117.69 0.745 . . . . 0.74 110.618 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.8 -40.59 80.28 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.027 -0.533 . . . . 1.62 110.364 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -59.63 -49.57 77.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.251 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.28 84.96 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.099 0.476 . . . . 0.37 110.998 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -63.5 -48.87 75.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.681 -0.69 . . . . 1.46 111.058 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -67.57 -30.82 70.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.446 -0.343 . . . . 0.99 110.518 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 90.2 m -62.2 -40.84 97.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.34 110.257 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.44 ' O ' HG13 ' A' ' 163' ' ' ILE . 51.2 tp -59.14 -42.01 89.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.397 -0.365 . . . . 0.42 110.47 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 79.8 t -61.67 -39.74 84.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.55 110.365 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -68.4 -33.85 74.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.9 110.576 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 158' ' ' THR . 48.8 mm-40 -64.53 -40.89 96.44 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.299 -0.63 . . . . 0.73 109.299 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 159' ' ' LEU . 70.2 mt -62.52 -43.9 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.62 -0.718 . . . . 0.42 109.947 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.505 HH12 ' HB2' ' A' ' 47' ' ' ASP . 84.8 mtt180 -59.39 -43.94 92.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.905 -0.589 . . . . 0.87 111.021 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 168' ' ' GLU . 52.3 mtmt -62.04 -27.93 69.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.319 -0.4 . . . . 0.97 111.304 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -79.96 -35.36 37.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.013 0.435 . . . . 0.71 110.616 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 163' ' ' ILE . 29.5 mtpt -77.6 -30.99 52.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.191 -0.459 . . . . 1.11 111.483 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 6.0 pt-20 -86.09 1.17 51.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.709 0.29 . . . . 1.12 111.215 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 8.9 tttp . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.614 -0.708 . . . . 1.47 110.576 -179.57 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.45 ' O1B' ' O1A' ' A' ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 203' ' ' QPD . . . . . 0.418 ' N1 ' ' HB2' ' A' ' 56' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttt . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.95 -0.389 . . . . 1.48 109.95 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.7 127.07 32.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.908 -0.587 . . . . 1.04 111.796 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.82 122.43 46.75 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.853 -0.425 . . . . 1.27 109.853 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -122.65 130.79 53.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.479 -0.328 . . . . 1.11 111.023 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -92.19 123.0 35.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.006 -0.543 . . . . 0.81 110.915 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 2.8 mp -119.48 133.57 55.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.451 -0.795 . . . . 1.39 110.293 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.466 HG22 ' C6 ' ' A' ' 203' ' ' QPD . 0.1 OUTLIER -125.04 109.49 22.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.021 0.438 . . . . 0.81 110.301 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -76.42 125.68 36.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.287 -0.635 . . . . 0.44 109.287 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.1 m -116.84 148.04 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.145 0.498 . . . . 0.7 110.837 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.51 176.82 39.11 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.022 -0.831 . . . . 0.53 111.022 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -81.08 156.85 25.61 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.017 0.437 . . . . 0.58 111.392 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.31 102.7 0.76 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.796 -0.716 . . . . 0.8 112.032 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.15 0.73 6.9 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.822 -0.704 . . . . 0.42 112.792 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 11' ' ' ALA . 23.4 m -76.1 -19.4 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.828 0.347 . . . . 0.57 110.781 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.593 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 104.76 25.47 6.85 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.483 -0.865 . . . . 0.49 112.142 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -52.97 -50.96 63.07 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.255 0.465 . . . . 0.81 112.255 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.534 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 2.4 m -64.36 -34.06 77.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.922 0.342 . . . . 0.58 111.922 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.37 -34.31 75.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.712 -0.222 . . . . 0.43 111.472 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 30.4 mt -59.42 -53.98 51.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.355 -0.384 . . . . 0.92 110.756 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.409 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -67.34 -39.61 85.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.779 -0.646 . . . . 0.89 110.991 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.2 mt -58.37 -38.47 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.953 -0.567 . . . . 0.79 111.73 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -66.1 -37.56 86.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.928 0.394 . . . . 0.46 111.501 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.0 tp -78.78 -32.31 46.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.208 -0.451 . . . . 1.37 111.316 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 20' ' ' THR . 48.9 mm -89.32 -52.96 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 113.068 0.766 . . . . 0.58 113.068 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -87.1 -9.48 55.28 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.175 0.435 . . . . 1.68 112.175 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 65.25 21.41 12.05 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.202 0.445 . . . . 1.6 112.202 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -159.98 146.97 16.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.804 0.335 . . . . 0.74 110.302 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.581 ' HZ ' HO2' ' A' ' 201' ' ' GDP . 68.6 t80 -77.18 145.62 37.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.706 -0.679 . . . . 0.6 111.499 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.7 t -119.86 122.31 68.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.183 -0.673 . . . . 0.64 109.183 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -73.71 -50.65 19.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.036 -0.529 . . . . 1.12 112.076 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -107.93 109.88 21.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.146 0.498 . . . . 1.18 111.951 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -145.46 134.32 22.44 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.875 -0.787 . . . . 0.6 108.875 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.01 126.62 90.49 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.009 -0.542 . . . . 0.8 111.707 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.27 -19.74 19.45 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.545 2.164 . . . . 0.52 112.111 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -16.02 56.25 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.008 -0.542 . . . . 0.89 111.739 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.43 116.96 24.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.382 0.611 . . . . 0.73 111.12 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -112.02 117.52 32.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.076 -0.965 . . . . 0.81 109.309 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -138.07 158.63 43.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.812 0.339 . . . . 1.29 111.326 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -106.6 127.14 53.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.855 -0.611 . . . . 0.78 109.644 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -111.02 139.36 46.44 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.55 -0.295 . . . . 0.94 110.791 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.61 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 0.2 OUTLIER -122.28 123.53 41.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.133 0.492 . . . . 0.56 110.921 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -134.69 140.44 45.99 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.6 -0.518 . . . . 1.46 109.6 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -110.01 123.18 49.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.883 0.373 . . . . 1.89 110.45 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.24 132.18 55.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.751 -0.463 . . . . 1.09 109.751 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.474 HG22 HG23 ' A' ' 50' ' ' THR . 22.1 t -84.04 91.97 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.875 -0.417 . . . . 0.65 109.875 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.4 mt -103.23 133.09 48.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.8 -0.636 . . . . 1.06 110.263 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 60.32 27.35 16.9 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.925 -0.58 . . . . 0.97 111.368 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.43 -0.15 88.26 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.184 -0.531 . . . . 0.6 113.165 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -109.85 130.99 55.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.865 0.364 . . . . 1.41 111.36 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.474 HG23 HG22 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -73.89 95.17 2.41 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.333 -0.617 . . . . 0.63 109.333 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 59.7 m -101.19 133.76 45.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.48 0.657 . . . . 0.71 111.467 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.6 tp -100.86 124.63 46.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.253 -0.885 . . . . 0.48 109.325 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 1.3 mp -93.04 113.13 25.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.116 -0.493 . . . . 0.87 111.706 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.61 ' OD1' ' HD2' ' A' ' 41' ' ' ARG . 14.8 t70 -105.3 93.41 4.67 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.154 -1.054 . . . . 1.03 108.154 177.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 13.6 mt -110.88 142.47 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.169 0.433 . . . . 0.68 112.169 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.3 tp -119.93 122.14 40.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.541 . . . . 0.46 110.999 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -88.64 89.83 8.15 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.231 -0.655 . . . . 0.44 109.231 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.1 p -65.87 134.95 54.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.004 -0.544 . . . . 0.73 111.725 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.93 -55.06 6.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.79 -0.641 . . . . 0.56 110.588 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.33 -76.52 0.17 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.442 -0.663 . . . . 0.72 111.442 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -99.95 125.57 45.99 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.955 -0.387 . . . . 1.26 109.955 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -94.46 166.62 11.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.067 -0.515 . . . . 1.57 110.659 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -58.28 -56.71 18.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.98 -0.554 . . . . 1.38 110.012 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -116.02 144.79 43.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.909 -0.587 . . . . 0.81 109.609 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -31.44 72.64 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.534 -0.303 . . . . 0.63 111.13 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.79 -27.89 69.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.32 111.458 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 81.7 mtp -68.89 -30.68 69.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.19 -0.459 . . . . 0.69 109.937 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.643 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 24.6 ttp180 -65.6 -45.09 84.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.025 -0.534 . . . . 0.9 109.672 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 67.3 m-20 -65.53 -30.55 71.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.469 -0.787 . . . . 1.41 110.255 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -58.24 -58.94 6.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.732 -0.667 . . . . 1.51 111.636 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.643 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 10.4 p90 -67.47 -21.42 65.53 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.373 -0.531 . . . . 1.17 112.104 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.5 mtt -77.19 -31.14 55.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.116 0.484 . . . . 0.7 110.637 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 39.8 mtm180 -77.62 -48.08 17.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.958 0.409 . . . . 1.29 110.532 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 m -73.69 -14.13 61.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.703 -0.681 . . . . 0.72 111.614 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.75 120.39 9.84 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.7 -0.762 . . . . 0.19 111.633 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -89.71 -32.68 16.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.964 0.411 . . . . 0.54 110.161 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -137.37 130.29 5.06 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.421 -0.672 . . . . 0.26 111.421 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.488 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 88.3 m-85 -116.34 126.11 53.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.085 0.443 . . . . 0.48 110.999 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.448 HD12 ' HB ' ' A' ' 112' ' ' VAL . 12.3 tp -96.51 106.5 18.76 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.066 -0.716 . . . . 0.37 109.066 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 56.9 m -83.79 107.46 16.21 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.737 -0.468 . . . . 0.61 109.737 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 19' ' ' LEU . 17.2 t -112.36 142.05 25.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.073 0.463 . . . . 0.59 111.952 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -142.79 167.08 22.92 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.499 -0.926 . . . . 0.34 108.499 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.86 132.48 50.08 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.056 -0.35 . . . . 0.32 110.056 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 118' ' ' CYS . 3.3 pt -67.6 -13.23 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.514 -0.312 . . . . 0.78 111.362 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -107.93 23.1 14.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.286 0.565 . . . . 0.82 110.554 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -150.31 98.08 2.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 1.07 110.477 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -31.28 71.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.083 -0.508 . . . . 0.65 111.94 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -62.84 -38.89 92.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.525 -0.307 . . . . 0.89 110.554 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 82.8 p -69.83 -23.79 63.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.993 0.425 . . . . 0.64 110.567 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -77.61 -39.38 45.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.83 -0.623 . . . . 0.42 109.652 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -74.0 -30.5 62.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 1.44 110.201 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -29.86 68.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.095 -0.502 . . . . 1.02 110.558 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.6 mm -57.58 -34.37 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.549 -0.75 . . . . 0.42 111.779 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -60.54 -45.44 93.88 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.579 -0.526 . . . . 0.83 109.579 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -69.29 -34.71 75.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.536 -0.756 . . . . 0.79 110.965 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -65.59 -51.26 61.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.728 -0.214 . . . . 1.17 110.92 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -59.37 -36.97 76.73 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.235 0.54 . . . . 0.6 110.275 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -70.58 -50.74 34.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.528 -0.76 . . . . 1.35 111.701 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -59.49 -49.46 77.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.967 0.358 . . . . 1.15 111.967 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 81.2 mt -61.67 -39.6 83.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.294 . . . . 0.51 111.243 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -66.85 -30.06 70.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.923 0.392 . . . . 1.05 110.744 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -76.66 -43.24 38.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.821 -0.627 . . . . 0.91 110.757 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.0 t -65.38 -45.48 93.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.035 -0.53 . . . . 0.35 110.801 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -79.32 -15.89 57.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.872 0.368 . . . . 0.63 110.528 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.4 t70 55.73 70.81 0.6 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.191 -0.913 . . . . 0.47 110.811 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.7 t -164.12 -172.01 2.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.657 -0.701 . . . . 1.14 109.818 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -125.41 -55.21 1.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.085 0.469 . . . . 1.74 109.865 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -77.51 91.79 3.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.801 -0.636 . . . . 0.78 110.239 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.4 t -118.45 113.13 36.92 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.828 -0.623 . . . . 0.47 109.939 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.74 111.13 0.48 Allowed 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 123.232 2.621 . . . . 0.25 113.131 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.488 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 46.3 mtt -144.25 157.44 44.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.89 -0.595 . . . . 0.79 110.491 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.448 ' HB ' HD12 ' A' ' 79' ' ' LEU . 86.1 t -135.38 124.45 40.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.053 -0.721 . . . . 0.22 109.053 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 20.5 tp -80.24 116.52 20.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.443 -0.577 . . . . 0.29 109.443 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 47.4 t -119.03 123.06 70.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.105 0.479 . . . . 0.82 111.608 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -99.11 114.76 5.12 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.192 -1.163 . . . . 0.27 110.192 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -97.32 166.06 11.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.83 0.348 . . . . 0.21 110.962 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.6 mttt 68.45 26.06 6.69 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.512 -0.767 . . . . 0.54 111.632 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 84' ' ' ILE . 24.8 p -67.32 -19.35 65.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.935 0.398 . . . . 0.46 110.802 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -79.74 -14.25 58.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.872 -0.603 . . . . 0.7 110.398 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 54.8 mt -85.72 151.58 55.61 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.128 -0.487 . . . . 0.67 109.715 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 1.4 Cg_endo -81.46 -176.63 3.18 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.968 2.445 . . . . 0.54 112.366 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 m 61.2 54.09 3.37 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.987 -0.551 . . . . 0.84 110.939 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 14.1 ttm-85 -63.79 112.03 2.7 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.673 -0.694 . . . . 0.58 110.3 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.03 -40.19 13.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.835 -0.621 . . . . 0.81 110.55 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.9 t -95.28 119.3 43.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.417 -0.356 . . . . 0.37 110.219 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -74.96 155.64 37.18 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.146 0.498 . . . . 1.69 111.482 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -38.45 83.76 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.48 -0.782 . . . . 0.82 110.958 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -69.4 -36.6 76.9 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.039 -0.528 . . . . 0.62 111.011 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -59.04 -43.02 91.6 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.087 0.47 . . . . 0.93 110.554 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.1 -40.37 60.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.887 -0.597 . . . . 0.3 110.461 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -61.95 -39.29 91.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.013 -0.54 . . . . 0.47 109.938 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.42 ' HA ' ' HD2' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -63.7 -40.56 97.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.559 -0.746 . . . . 1.18 110.578 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.8 tp -68.57 -41.39 79.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.755 -0.657 . . . . 0.44 110.937 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.54 -33.44 75.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.25 110.512 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 135' ' ' ARG . 63.8 mtt-85 -58.69 -55.52 34.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.709 -0.678 . . . . 1.54 111.623 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -42.79 96.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.081 0.467 . . . . 0.68 111.899 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -68.63 -22.34 64.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 0.77 111.051 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.36 43.2 46.89 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.968 -0.56 . . . . 0.25 112.409 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 31.3 pt -136.95 161.71 59.97 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.996 -0.372 . . . . 0.51 109.996 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.01 156.13 42.92 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.707 2.271 . . . . 0.36 112.505 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 5.7 t80 -135.37 125.15 25.45 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.572 -0.529 . . . . 0.38 109.572 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.7 mt -135.71 130.46 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.921 -0.312 . . . . 0.54 111.217 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -84.18 123.77 30.45 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.063 -1.088 . . . . 0.88 108.063 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.503 HG22 ' HA3' ' A' ' 151' ' ' GLY . 43.0 p -133.79 177.23 7.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.151 0.501 . . . . 0.43 111.252 -177.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.1 t -156.58 124.39 5.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.821 -0.627 . . . . 0.33 110.094 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.36 -12.95 60.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.29 0.566 . . . . 0.45 110.088 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.9 tttm -79.76 -53.16 7.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.574 -0.739 . . . . 1.32 110.743 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.8 p -83.27 -17.34 42.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.295 -0.411 . . . . 0.52 110.844 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.1 ttt180 70.3 21.27 5.86 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.932 0.77 . . . . 1.53 109.951 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -91.34 122.63 34.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.011 -0.54 . . . . 0.87 110.584 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.503 ' HA3' HG22 ' A' ' 144' ' ' THR . . . 91.7 -4.34 79.05 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.51 112.796 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 71.8 t -58.37 -59.99 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.666 0.247 . . . . 0.74 111.666 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.68 -47.61 84.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 1.62 110.834 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -56.16 -46.32 79.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.59 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -58.96 -53.66 55.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.869 0.322 . . . . 0.37 111.869 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.545 ' O ' HG23 ' A' ' 160' ' ' VAL . 50.4 m-85 -61.07 -49.57 76.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.421 -0.354 . . . . 1.46 111.458 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -59.42 -39.51 83.72 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.338 -0.392 . . . . 0.99 111.748 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.546 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 95.9 m -61.06 -44.45 97.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.527 -0.306 . . . . 0.34 110.86 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 35.2 tp -65.14 -36.44 84.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.713 -0.221 . . . . 0.42 111.174 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 156' ' ' PHE . 49.0 t -59.69 -41.02 83.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.194 0.521 . . . . 0.55 110.235 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -77.15 -23.62 51.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.812 -0.631 . . . . 0.9 110.916 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 158' ' ' THR . 52.6 mm-40 -64.76 -43.77 92.22 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.792 0.33 . . . . 0.73 110.379 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.427 ' H ' HG13 ' A' ' 163' ' ' ILE . 12.1 mt -65.15 -38.95 83.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.047 -0.524 . . . . 0.42 111.015 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 75.8 mtt180 -59.27 -38.8 81.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.769 -0.65 . . . . 0.87 110.991 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 162' ' ' GLU . 49.0 mtmt -62.62 -39.12 92.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.063 -0.517 . . . . 0.97 111.061 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -75.28 -34.6 61.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.299 -0.41 . . . . 0.71 110.562 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -73.06 -30.79 63.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.586 -0.279 . . . . 1.11 111.408 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -101.86 11.58 38.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.853 0.359 . . . . 1.12 110.736 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.7 tttp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.626 -0.702 . . . . 1.47 110.951 -179.204 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.581 HO2' ' HZ ' ' A' ' 28' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 203' ' ' QPD . . . . . 0.475 ' C8 ' ' C14' ' A' ' 203' ' ' QPD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.5 ttm . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 110.36 -0.237 . . . . 1.48 110.36 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.2 m -92.91 134.89 34.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.496 -0.32 . . . . 1.04 110.674 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -87.71 127.14 35.3 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.808 -0.441 . . . . 1.27 109.808 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -112.46 128.02 56.21 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.849 -0.426 . . . . 1.11 109.849 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -97.04 122.83 40.47 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.129 -0.487 . . . . 0.81 111.332 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mp -129.75 137.79 50.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.923 -0.581 . . . . 1.39 110.7 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.6 t -124.15 128.1 73.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.261 -0.427 . . . . 0.81 110.276 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.2 t -89.18 124.12 41.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.194 -0.669 . . . . 0.44 109.194 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 9.8 m -115.77 148.95 18.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.606 -0.27 . . . . 0.7 110.587 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.38 178.24 38.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.985 -0.626 . . . . 0.53 112.101 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -78.24 168.68 19.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.996 0.427 . . . . 0.58 111.306 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.7 104.67 1.91 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.943 -0.646 . . . . 0.8 112.448 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.49 4.0 10.05 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.494 -0.86 . . . . 0.42 112.77 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 11' ' ' ALA . 15.9 m -74.3 -29.32 24.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.913 0.387 . . . . 0.57 111.25 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.85 22.06 5.14 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.678 -0.772 . . . . 0.49 113.788 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HB2' ' O3B' ' A' ' 201' ' ' GDP . 54.4 mtmt -52.78 -50.19 64.07 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.983 0.392 . . . . 0.81 110.933 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.4 ' O ' HG13 ' A' ' 21' ' ' ILE . 3.2 m -63.85 -43.42 96.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.722 0.296 . . . . 0.58 111.507 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.71 -48.41 79.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.857 0.317 . . . . 0.43 111.857 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.637 ' HG ' ' HB2' ' A' ' 146' ' ' ALA . 2.6 mt -65.29 -36.25 83.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.731 0.3 . . . . 0.92 111.237 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.4 m -70.16 -42.04 73.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.662 0.267 . . . . 0.89 111.024 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.46 HG21 HG21 ' A' ' 29' ' ' VAL . 82.4 mt -68.87 -31.86 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.407 . . . . 0.79 109.946 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.568 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 4.4 mm-40 -63.67 -21.43 66.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.98 -0.555 . . . . 0.46 111.599 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.7 tp -92.2 -14.98 28.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.139 0.495 . . . . 1.37 110.864 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.6 mm -104.3 -64.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.075 -0.511 . . . . 0.58 111.119 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -84.62 -7.61 59.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 1.68 110.823 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.6 OUTLIER 56.38 30.03 16.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.577 0.955 . . . . 1.6 113.577 177.654 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -142.2 146.4 35.19 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.932 -0.307 . . . . 0.74 110.36 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -68.01 143.07 55.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.12 -0.491 . . . . 0.6 111.427 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 21' ' ' ILE . 35.1 t -130.88 99.2 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.153 -0.684 . . . . 0.64 109.153 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.473 ' HA ' " O2'" ' A' ' 201' ' ' GDP . 7.3 t70 -75.58 -41.46 54.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.15 -0.477 . . . . 1.12 111.122 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -94.31 97.46 10.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.216 0.531 . . . . 1.18 111.412 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -151.51 136.53 17.38 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.877 -0.786 . . . . 0.6 108.877 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -72.1 126.48 91.19 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.963 0.411 . . . . 0.8 111.494 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -65.82 -28.0 51.38 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.914 2.409 . . . . 0.52 112.83 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.24 -12.57 60.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.876 -0.602 . . . . 0.89 111.645 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -77.29 121.87 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.279 0.562 . . . . 0.73 110.34 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 15.3 tt0 -114.26 127.03 55.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.824 -1.08 . . . . 0.81 108.777 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -146.33 154.15 41.34 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.302 0.572 . . . . 1.29 111.403 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.4 129.17 53.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.483 -0.78 . . . . 0.78 109.953 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -117.83 147.49 43.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.747 0.308 . . . . 0.94 110.885 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.537 ' HD2' ' OD2' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -119.83 138.52 53.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.56 110.415 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -146.42 122.09 10.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.271 -0.422 . . . . 1.46 110.775 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.69 116.65 29.17 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.52 -0.548 . . . . 1.89 109.52 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.52 136.87 59.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.09 -0.504 . . . . 1.09 111.204 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 t -91.58 74.53 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.847 -0.797 . . . . 0.65 108.847 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.1 mt -82.9 113.54 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.604 -0.725 . . . . 1.06 111.332 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 65.95 28.84 10.48 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.319 -0.855 . . . . 0.97 111.012 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.59 -12.4 67.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.131 -0.556 . . . . 0.6 112.515 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -93.97 111.03 22.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.746 0.308 . . . . 1.41 111.053 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -73.32 104.59 4.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.137 0.494 . . . . 0.63 109.853 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.8 m -114.74 143.85 44.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.094 0.473 . . . . 0.71 111.081 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 tp -102.47 109.65 21.36 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.653 -0.869 . . . . 0.48 108.653 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 48.7 mt -82.63 117.77 22.83 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.289 -0.414 . . . . 0.87 111.654 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.537 ' OD2' ' HD2' ' A' ' 41' ' ' ARG . 15.1 t70 -101.03 86.07 2.97 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.529 -1.285 . . . . 1.03 107.529 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.1 mt -97.94 150.4 4.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.651 -0.704 . . . . 0.68 112.238 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 tp -137.84 130.4 29.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 0.46 111.02 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 3.9 t70 -91.91 107.48 19.24 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.574 -0.528 . . . . 0.44 109.574 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.8 p -72.53 137.36 46.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.146 0.498 . . . . 0.73 111.981 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.33 -37.8 66.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.542 -0.754 . . . . 0.56 110.209 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.88 -58.9 0.7 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.981 -0.628 . . . . 0.72 111.896 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -108.98 140.67 42.16 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.358 -0.608 . . . . 1.26 109.358 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -106.14 165.86 10.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 1.57 111.256 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -79.13 -42.06 27.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.113 -1.069 . . . . 1.38 108.113 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -126.42 129.67 49.19 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.854 -1.066 . . . . 0.81 109.155 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.41 -33.34 65.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.211 -0.449 . . . . 0.63 111.461 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.12 -35.15 77.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.196 -0.456 . . . . 0.32 111.205 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 87.9 mtp -69.66 -35.89 75.57 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.887 0.375 . . . . 0.69 110.849 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -66.37 -44.56 82.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.829 -0.623 . . . . 0.9 110.24 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 81.0 m-20 -80.69 -10.13 59.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.896 -0.593 . . . . 1.41 110.677 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -66.8 -58.45 5.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 1.51 110.639 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -67.16 -17.75 64.98 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.01 0.434 . . . . 1.17 111.336 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 46.0 mtt -69.07 -26.97 65.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.062 -0.517 . . . . 0.7 110.187 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 72.4 mtm180 -84.86 -42.94 14.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.055 -0.52 . . . . 1.29 110.345 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -27.39 61.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.771 -0.649 . . . . 0.72 111.812 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.91 139.79 43.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.962 -0.637 . . . . 0.19 112.692 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -93.57 -53.6 3.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.787 0.327 . . . . 0.54 110.945 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -122.76 138.43 11.8 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.716 -0.754 . . . . 0.26 111.763 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' A' ' 111' ' ' MET . 79.6 m-85 -117.96 135.27 54.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.172 0.51 . . . . 0.48 111.059 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.3 tp -101.86 113.86 27.43 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.717 -0.674 . . . . 0.37 109.866 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 3.6 m -89.44 89.45 7.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.039 -0.528 . . . . 0.61 110.579 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 11.8 t -96.86 129.63 46.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.017 -0.538 . . . . 0.59 111.189 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -129.78 179.21 5.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.175 -0.676 . . . . 0.34 109.175 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . . . -112.58 130.67 55.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.782 0.325 . . . . 0.32 110.457 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.427 ' HB ' ' HG3' ' A' ' 123' ' ' ARG . 3.1 pt -66.83 -19.3 25.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.099 -0.5 . . . . 0.78 111.505 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -104.99 15.64 27.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.145 0.498 . . . . 0.82 110.818 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.476 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 43.1 t-20 -140.44 92.75 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 1.07 110.218 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -25.46 68.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.33 -0.395 . . . . 0.65 111.349 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -67.81 -32.43 72.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.586 -0.279 . . . . 0.89 110.473 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.5 p -72.19 -30.44 64.95 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.979 -0.748 . . . . 0.64 108.979 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -69.62 -29.91 67.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.433 -0.803 . . . . 0.42 109.619 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.79 -38.52 73.37 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.728 -0.669 . . . . 1.44 110.101 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.19 -29.04 70.17 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.551 -0.749 . . . . 1.02 110.278 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.5 mm -56.21 -36.2 45.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.636 -0.711 . . . . 0.42 110.38 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -64.91 -36.32 84.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.639 . . . . 0.83 111.357 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -80.96 -32.2 34.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.347 -0.388 . . . . 0.79 111.032 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.496 ' CE1' ' HB ' ' A' ' 9' ' ' VAL . 3.6 m-85 -61.21 -51.04 70.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.496 0.188 . . . . 1.17 111.228 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.592 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 22.6 tpt180 -62.04 -30.03 70.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.313 0.577 . . . . 0.6 110.42 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -76.36 -53.06 8.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.247 -0.888 . . . . 1.35 111.98 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 103' ' ' VAL . 8.2 tt0 -62.37 -58.08 8.98 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.114 0.412 . . . . 1.15 112.114 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.5 mt -54.07 -39.74 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.914 0.338 . . . . 0.51 111.914 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 6.1 ttpt -66.36 -35.95 81.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.789 0.328 . . . . 1.05 110.802 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -76.8 -26.47 54.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.066 0.46 . . . . 0.91 110.534 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 99' ' ' GLN . 67.5 t -77.16 -40.63 30.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.35 110.02 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -80.24 -26.46 39.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.382 -0.372 . . . . 0.63 110.757 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 t70 66.73 51.01 1.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.641 -0.709 . . . . 0.47 110.34 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.94 163.14 31.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.552 -0.749 . . . . 1.14 109.893 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -96.72 -42.21 8.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.839 0.352 . . . . 1.74 110.152 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -102.1 116.35 32.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.013 -0.54 . . . . 0.78 110.039 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.4 t -127.96 122.08 22.14 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.097 -0.501 . . . . 0.47 109.794 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.57 104.23 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.787 2.325 . . . . 0.25 111.667 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.455 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 31.7 mtt -139.18 151.8 46.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.7 -0.682 . . . . 0.79 110.159 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.8 t -136.96 126.3 37.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.451 -0.574 . . . . 0.22 109.451 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 41.0 tp -81.81 122.33 27.56 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.641 -0.503 . . . . 0.29 109.641 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 142' ' ' ILE . 95.3 t -124.07 127.95 73.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.091 -0.504 . . . . 0.82 111.673 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.41 102.17 2.25 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.659 -0.976 . . . . 0.27 110.659 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 144' ' ' THR . 65.6 t30 -86.41 165.82 16.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.703 0.251 . . . . 0.21 110.356 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 69.76 29.8 4.01 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.861 0.726 . . . . 0.54 110.552 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 30.8 p -67.72 -11.91 59.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.879 -0.6 . . . . 0.46 111.38 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -87.17 -8.36 57.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.692 0.282 . . . . 0.7 110.731 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 43.0 mt -85.36 148.64 50.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.67 110.936 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.31 -177.77 3.66 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.611 2.207 . . . . 0.54 111.619 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.2 m 58.09 55.19 5.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.118 0.485 . . . . 0.84 111.055 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.427 ' HG3' ' HB ' ' A' ' 84' ' ' ILE . 16.5 ttm180 -66.97 109.71 3.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.878 -0.601 . . . . 0.58 109.9 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.01 -42.45 16.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.002 0.429 . . . . 0.81 110.619 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.31 112.53 22.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.262 -0.426 . . . . 0.37 109.875 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.89 148.13 52.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.893 0.378 . . . . 1.69 110.679 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.22 -39.51 79.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.896 -0.593 . . . . 0.82 112.34 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -68.81 -37.58 79.33 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 120.88 -0.328 . . . . 0.62 110.902 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -56.13 -43.91 78.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.763 0.316 . . . . 0.93 111.43 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.32 -46.47 55.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.911 -0.586 . . . . 0.3 110.894 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -59.96 -44.83 94.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.47 110.418 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -61.81 -42.9 99.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.462 -0.79 . . . . 1.18 110.498 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.22 -41.2 90.43 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.992 -0.549 . . . . 0.44 110.722 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.89 -35.26 80.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.365 -0.38 . . . . 0.25 110.346 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -63.87 -43.58 95.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 1.54 111.519 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.19 -17.96 65.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.637 0.256 . . . . 0.68 111.566 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -100.59 -8.12 23.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.236 -0.438 . . . . 0.77 110.214 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.8 31.25 70.16 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.762 -0.654 . . . . 0.25 112.583 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 44.1 pt -121.58 153.37 59.42 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 122.798 -0.236 . . . . 0.51 110.454 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.01 156.13 56.44 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.883 2.388 . . . . 0.36 112.856 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -128.6 120.85 27.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 0.38 109.56 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 73.8 mt -132.88 138.25 52.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.757 0.313 . . . . 0.54 111.038 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -93.57 126.72 38.88 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.288 -0.634 . . . . 0.88 109.288 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 116' ' ' ASN . 32.1 p -131.67 166.07 22.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.255 0.55 . . . . 0.43 111.257 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.2 t -146.33 122.38 10.75 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.496 -0.928 . . . . 0.33 108.496 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.637 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . . . -70.0 -10.79 59.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.103 0.478 . . . . 0.45 110.863 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -89.0 -48.02 7.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.758 -0.656 . . . . 1.32 111.476 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.0 p -93.56 -17.27 23.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.582 0.586 . . . . 0.52 112.582 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.448 ' HA ' HG21 ' A' ' 152' ' ' VAL . 0.5 OUTLIER 69.77 21.75 6.33 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.946 -0.57 . . . . 1.53 110.765 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 144' ' ' THR . 11.2 tt0 -73.9 120.27 19.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.639 -0.709 . . . . 0.87 110.809 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 66.44 6.66 35.64 Favored Glycine 0 CA--C 1.516 0.111 0 CA-C-N 116.072 -0.513 . . . . 0.51 113.633 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 149' ' ' ARG . 18.3 t -61.01 -61.04 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.521 0.2 . . . . 0.74 111.455 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.93 -37.9 83.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 1.62 110.51 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -56.93 -45.22 82.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.769 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -58.33 -47.79 82.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.37 111.266 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.434 ' O ' HG23 ' A' ' 160' ' ' VAL . 72.6 m-85 -64.55 -44.35 91.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.185 -0.461 . . . . 1.46 110.944 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -60.0 -37.02 78.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.99 111.296 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 19.3 m -65.42 -53.69 39.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.138 -0.483 . . . . 0.34 111.355 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.544 ' O ' HG13 ' A' ' 163' ' ' ILE . 14.0 tp -57.59 -35.8 70.89 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.702 0.287 . . . . 0.42 111.111 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 156' ' ' PHE . 38.3 t -58.36 -40.75 79.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.029 0.443 . . . . 0.55 110.733 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -78.96 -30.2 44.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.962 -0.563 . . . . 0.9 111.327 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 158' ' ' THR . 7.6 mm-40 -62.16 -40.89 97.5 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.854 -0.424 . . . . 0.73 109.854 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 159' ' ' LEU . 52.8 mt -63.36 -43.99 98.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.717 -0.674 . . . . 0.42 110.13 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 96.4 mtt180 -56.85 -49.43 75.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.785 -0.643 . . . . 0.87 111.068 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 169' ' ' LYS . 41.3 mtmt -57.36 -34.33 68.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.317 -0.401 . . . . 0.97 111.606 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -74.58 -37.26 62.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.486 -0.325 . . . . 0.71 110.692 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.449 ' HD2' HG22 ' A' ' 163' ' ' ILE . 47.2 mtpt -75.82 -33.0 60.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.4 -0.364 . . . . 1.11 111.903 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 10.3 pt-20 -92.49 7.4 43.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.952 0.406 . . . . 1.12 110.745 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 165' ' ' LYS . 30.7 tttp . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.245 -0.883 . . . . 1.47 110.128 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.473 " O2'" ' HA ' ' A' ' 30' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 203' ' ' QPD . . . . . 0.492 ' O1 ' ' C14' ' A' ' 203' ' ' QPD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.6 ttm . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 109.926 -0.398 . . . . 1.48 109.926 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.7 m -94.48 134.7 36.73 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.048 -0.352 . . . . 1.04 110.048 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -85.71 129.98 34.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.914 -0.585 . . . . 1.27 110.496 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 51' ' ' CYS . 61.5 m-85 -125.57 115.65 20.51 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.816 -0.438 . . . . 1.11 109.816 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -100.48 113.85 26.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.158 0.504 . . . . 0.81 110.272 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.14 138.46 52.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.717 -0.674 . . . . 1.39 110.895 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.41 ' HB ' ' CD2' ' A' ' 78' ' ' PHE . 39.2 t -118.01 132.41 67.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.327 -0.397 . . . . 0.81 110.637 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 t -94.86 113.56 29.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.871 -0.789 . . . . 0.44 108.871 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 m -114.8 166.56 8.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.921 0.391 . . . . 0.7 111.291 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.19 -170.31 30.86 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.013 -0.835 . . . . 0.53 111.013 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.53 172.16 14.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.241 0.543 . . . . 0.58 110.85 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.74 128.09 8.96 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.701 -0.761 . . . . 0.8 112.595 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.99 13.32 72.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.899 -0.667 . . . . 0.42 114.02 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.4 m -73.41 -29.71 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 117.644 0.722 . . . . 0.57 111.031 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.48 20.41 2.65 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.351 -0.928 . . . . 0.49 113.84 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -54.68 -58.85 5.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.956 0.408 . . . . 0.81 110.97 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.454 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 1.2 m -54.28 -47.76 71.99 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.603 -0.726 . . . . 0.58 111.829 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.17 84.31 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.677 0.251 . . . . 0.43 111.677 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.3 mt -63.83 -40.63 97.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 0.92 110.524 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.9 m -72.04 -43.78 64.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.158 -0.474 . . . . 0.89 110.66 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.74 -42.11 87.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.046 -0.525 . . . . 0.79 110.915 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.555 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 4.3 mm-40 -64.02 -20.79 66.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.46 111.338 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.2 tp -91.44 -39.78 11.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.918 0.389 . . . . 1.37 111.147 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.7 mm -81.51 -50.66 16.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.263 -0.426 . . . . 0.58 112.104 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -92.29 -16.49 26.03 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.931 0.345 . . . . 1.68 111.931 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 3.7 m-80 66.42 27.51 9.87 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.735 0.643 . . . . 1.6 112.735 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 -153.04 144.1 23.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.135 -0.32 . . . . 0.74 110.135 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -68.83 142.67 54.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.182 -0.463 . . . . 0.6 111.945 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 70.5 t -130.6 114.84 29.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 109.168 -0.679 . . . . 0.64 109.168 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -78.56 -42.72 28.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.926 -0.579 . . . . 1.12 111.26 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -100.49 102.16 13.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.297 -0.41 . . . . 1.18 111.948 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -155.19 117.59 4.23 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.65 -0.87 . . . . 0.6 108.65 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -52.32 122.43 24.77 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.52 0.676 . . . . 0.8 111.618 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.61 -18.14 15.62 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.685 2.257 . . . . 0.52 113.37 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.575 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -87.09 12.5 11.33 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.282 0.475 . . . . 0.89 112.282 -178.687 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.5 mt -99.71 105.64 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.244 0.545 . . . . 0.73 110.204 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 3.7 tt0 -86.48 87.0 7.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.878 -0.601 . . . . 0.81 109.535 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.81 161.69 14.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.626 -0.716 . . . . 1.29 110.583 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 10.4 p -131.18 144.71 51.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.194 -0.457 . . . . 0.78 110.351 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -126.39 149.17 49.4 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.218 -0.446 . . . . 0.94 111.083 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 1.7 mpp_? -123.75 123.8 41.3 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.35 -0.386 . . . . 0.56 110.458 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -144.62 124.97 13.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.846 0.355 . . . . 1.46 110.281 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -86.53 119.93 27.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.002 0.429 . . . . 1.89 110.548 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.3 t -129.53 141.08 47.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.925 -0.58 . . . . 1.09 110.166 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.7 t -87.64 106.35 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.78 -0.452 . . . . 0.65 109.78 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 32.6 mt -110.6 115.24 49.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.198 -0.455 . . . . 1.06 110.403 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 61.32 43.95 10.17 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.632 0.582 . . . . 0.97 111.334 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.1 27.77 71.43 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.6 113.317 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -137.74 120.94 16.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.93 0.365 . . . . 1.41 111.254 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -75.25 103.32 5.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.862 0.363 . . . . 0.63 110.238 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 4' ' ' TYR . 11.5 m -110.44 137.33 48.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.471 -0.331 . . . . 0.71 111.751 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.2 tp -92.03 111.55 23.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.149 -1.056 . . . . 0.48 108.149 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 60.2 mt -89.97 114.02 25.78 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.052 0.76 . . . . 0.87 113.052 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -106.0 101.5 10.99 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.765 -1.198 . . . . 1.03 107.765 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.5 mt -107.0 141.66 21.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.255 -0.429 . . . . 0.68 111.727 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.449 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 58.7 tp -122.37 125.91 46.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.792 -0.64 . . . . 0.46 111.108 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 7.0 t70 -92.48 101.89 14.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.25 -0.648 . . . . 0.44 109.25 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.4 p -67.35 134.76 52.12 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.482 0.658 . . . . 0.73 112.184 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' A' ' 35' ' ' THR . . . -89.45 -37.94 14.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.218 -0.901 . . . . 0.56 110.067 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 142.84 -94.9 0.18 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.84 -0.695 . . . . 0.72 112.531 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -101.78 118.23 36.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.159 0.504 . . . . 1.26 111.212 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.2 167.37 14.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.508 -0.769 . . . . 1.57 109.275 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -54.19 -52.84 59.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 1.38 110.913 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -117.41 141.0 48.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.122 -0.49 . . . . 0.81 110.239 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -63.19 -29.04 70.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.879 0.371 . . . . 0.63 111.03 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.84 -26.34 68.29 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.011 -0.54 . . . . 0.32 110.347 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 71.8 mtp -72.8 -37.7 67.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.675 -0.693 . . . . 0.69 109.595 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.602 ' HA ' ' CZ ' ' A' ' 71' ' ' TYR . 30.7 ttp180 -70.49 -43.92 68.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.866 -0.606 . . . . 0.9 109.967 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -28.3 67.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.427 -0.806 . . . . 1.41 110.636 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -56.22 -65.08 0.67 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.424 -0.807 . . . . 1.51 112.088 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.602 ' CZ ' ' HA ' ' A' ' 68' ' ' ARG . 3.5 p90 -69.1 -18.71 64.01 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.337 0.495 . . . . 1.17 112.337 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 32.8 mtt -71.45 -26.76 62.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.304 0.573 . . . . 0.7 109.927 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -90.03 -28.7 18.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.205 -0.452 . . . . 1.29 110.925 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -86.53 -26.24 24.65 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.084 0.402 . . . . 0.72 112.084 -179.169 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.26 125.82 24.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.798 -0.715 . . . . 0.19 111.96 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -83.34 -41.49 18.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.78 0.324 . . . . 0.54 110.234 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -129.65 133.26 7.4 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.535 -0.626 . . . . 0.26 111.535 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.41 ' CD2' ' HB ' ' A' ' 7' ' ' VAL . 94.1 m-85 -114.5 122.39 46.43 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.053 0.454 . . . . 0.48 110.934 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.503 HD12 ' HB ' ' A' ' 112' ' ' VAL . 11.7 tp -88.05 112.0 22.15 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.102 -0.703 . . . . 0.37 109.102 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.2 m -90.54 101.16 13.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.858 0.361 . . . . 0.61 110.428 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.3 t -103.01 131.92 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.259 -0.428 . . . . 0.59 111.54 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -134.19 171.06 14.76 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.978 -0.749 . . . . 0.34 108.978 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.54 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . . . -103.77 126.64 51.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.856 0.36 . . . . 0.32 110.824 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.6 pt -68.64 -16.61 21.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.78 111.074 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -106.97 24.1 13.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.274 -0.421 . . . . 0.82 110.932 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.54 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 28.5 t-20 -156.46 102.17 2.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.07 -0.514 . . . . 1.07 110.116 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.18 -23.34 66.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.978 -0.555 . . . . 0.65 111.833 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.452 ' HB3' ' OD1' ' A' ' 86' ' ' ASN . 51.2 tptt -56.01 -50.87 69.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.313 -0.403 . . . . 0.89 110.862 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.3 p -63.43 -41.4 98.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.64 111.156 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -61.52 -40.89 96.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.265 -0.425 . . . . 0.42 111.142 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -74.85 -11.7 60.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.237 -0.438 . . . . 1.44 111.587 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.52 -20.05 23.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.094 0.473 . . . . 1.02 110.271 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.8 mm -58.91 -29.88 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.526 -0.761 . . . . 0.42 110.794 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -59.19 -52.0 67.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.83 109.821 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -65.16 -32.4 74.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.474 -0.784 . . . . 0.79 111.101 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -65.95 -50.23 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.458 0.17 . . . . 1.17 110.856 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -60.05 -46.2 90.32 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.523 -0.547 . . . . 0.6 109.523 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.42 -47.92 84.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.767 -0.651 . . . . 1.35 111.075 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.518 ' O ' HG23 ' A' ' 103' ' ' VAL . 16.5 tt0 -58.88 -58.84 6.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.834 -0.621 . . . . 1.15 111.76 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.3 mt -55.83 -37.61 48.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.522 -0.308 . . . . 0.51 111.659 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -65.75 -37.51 86.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.532 0.206 . . . . 1.05 110.921 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.0 -33.38 51.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.91 111.07 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 99' ' ' GLN . 93.5 t -66.82 -45.13 88.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.064 0.459 . . . . 0.35 110.285 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -81.46 -26.29 35.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.14 -0.482 . . . . 0.63 110.354 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.6 t0 64.66 60.25 0.89 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.336 -0.847 . . . . 0.47 110.142 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.7 t -153.69 151.55 29.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.328 -0.851 . . . . 1.14 110.016 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -81.37 -42.99 19.65 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.061 -0.518 . . . . 1.74 111.081 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -97.24 117.7 32.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.055 0.455 . . . . 0.78 111.838 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 46.9 t -135.66 113.39 10.94 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.046 -0.724 . . . . 0.47 109.046 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.59 112.13 0.96 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.02 2.48 . . . . 0.25 112.369 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 50.5 mtt -141.58 156.93 45.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.949 -0.569 . . . . 0.79 110.3 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 79' ' ' LEU . 94.6 t -135.32 129.21 49.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 109.166 -0.679 . . . . 0.22 109.166 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.8 tp -85.0 115.37 22.79 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.549 -0.537 . . . . 0.29 109.549 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.1 t -114.99 117.45 55.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.815 -0.63 . . . . 0.82 111.756 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -95.92 94.6 1.7 Allowed Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.232 -1.147 . . . . 0.27 110.232 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -80.3 166.91 20.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.652 0.263 . . . . 0.21 111.415 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 69.69 33.12 3.07 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.465 -0.788 . . . . 0.54 111.064 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 18.7 p -69.61 -4.76 20.64 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.417 -0.356 . . . . 0.46 111.853 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -93.36 -11.22 32.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.463 -0.335 . . . . 0.7 110.831 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.5 mt -91.43 142.48 27.02 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.396 -0.365 . . . . 0.67 111.182 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -79.75 -169.81 0.87 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.828 2.352 . . . . 0.54 111.572 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.4 m 57.87 43.89 20.87 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.301 0.572 . . . . 0.84 110.387 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -63.33 119.03 8.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.184 -0.916 . . . . 0.58 110.126 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.86 -32.37 12.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.179 -0.464 . . . . 0.81 111.333 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 t -97.23 110.79 25.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.95 0.405 . . . . 0.37 110.396 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.16 148.46 48.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.976 -0.556 . . . . 1.69 111.044 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.04 -39.93 69.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.581 -0.736 . . . . 0.82 112.349 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -65.79 -38.83 90.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.574 0.226 . . . . 0.62 111.445 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -61.11 -42.45 98.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.906 0.384 . . . . 0.93 110.971 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.27 63.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.269 -0.423 . . . . 0.3 110.61 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 135' ' ' ARG . 6.6 tp-100 -62.38 -42.53 99.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.47 110.006 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.76 -35.46 78.18 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.077 0.465 . . . . 1.18 110.403 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.9 tp -68.83 -46.83 67.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.727 -0.669 . . . . 0.44 109.973 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.56 95.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.716 -0.674 . . . . 0.25 110.966 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 131' ' ' GLN . 24.9 mtm180 -65.31 -32.45 74.11 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.321 -0.4 . . . . 1.54 111.093 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.6 m -73.44 -29.98 62.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.91 0.385 . . . . 0.68 110.461 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -82.67 -40.08 21.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.183 0.516 . . . . 0.77 110.46 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.36 32.1 5.32 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 109.97 -1.252 . . . . 0.25 109.97 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 4.6 pt -128.34 168.35 15.91 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.338 -0.431 . . . . 0.51 110.592 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -86.55 160.12 9.4 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.532 2.155 . . . . 0.36 112.586 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -134.26 130.36 37.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.38 110.151 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.7 mt -139.28 132.41 37.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.139 -0.482 . . . . 0.54 110.985 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -82.92 129.71 35.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.728 -1.212 . . . . 0.88 107.728 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 30.9 p -137.71 173.87 11.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.512 0.672 . . . . 0.43 111.756 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.7 t -156.24 130.53 8.74 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.82 -1.082 . . . . 0.33 108.784 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.62 -8.71 57.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.224 0.535 . . . . 0.45 110.317 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -85.48 -51.9 6.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.707 -0.679 . . . . 1.32 110.914 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.7 p -91.12 -13.64 32.67 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.173 0.434 . . . . 0.52 112.173 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 149' ' ' ARG . 14.1 mtp-105 66.56 20.47 10.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.129 0.571 . . . . 1.53 110.706 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -74.24 121.16 20.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.922 -0.581 . . . . 0.87 111.814 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.26 -4.24 12.71 Favored Glycine 0 C--N 1.33 0.219 0 N-CA-C 114.99 0.756 . . . . 0.51 114.99 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.72 -51.26 74.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 117.403 0.601 . . . . 0.74 110.645 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.34 -39.06 89.19 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.283 0.563 . . . . 1.62 110.565 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.66 -42.04 98.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.557 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.45 81.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.37 110.741 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -60.08 -43.03 95.78 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.059 -0.519 . . . . 1.46 110.654 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -63.22 -45.58 90.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.849 -0.614 . . . . 0.99 111.04 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 26.5 m -62.65 -40.26 96.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.892 -0.595 . . . . 0.34 111.514 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.449 ' O ' HG13 ' A' ' 163' ' ' ILE . 37.3 tp -59.03 -40.79 86.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.932 0.396 . . . . 0.42 110.593 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.11 -38.62 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.55 110.3 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -68.86 -30.39 68.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.9 110.667 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -67.26 -44.06 80.3 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.736 -0.839 . . . . 0.73 108.736 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 159' ' ' LEU . 74.2 mt -60.74 -44.03 96.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 115.378 -0.828 . . . . 0.42 109.837 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 91.3 mtt180 -55.9 -48.66 75.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.738 -0.665 . . . . 0.87 110.805 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -61.6 -34.44 75.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.97 111.308 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -71.97 -35.99 69.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.71 110.282 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -69.62 -36.95 76.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.078 -0.51 . . . . 1.11 111.099 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 9.2 pt-20 -100.38 20.16 15.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.154 -0.476 . . . . 1.12 111.065 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.1 mttp . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.598 -0.715 . . . . 1.47 109.622 179.403 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.454 ' O2A' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 203' ' ' QPD . . . . . 0.449 ' N1 ' ' HB2' ' A' ' 56' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.773 0.321 . . . . 1.48 110.462 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.03 145.17 27.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.259 -0.428 . . . . 1.04 110.73 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -105.58 131.69 52.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.177 -0.465 . . . . 1.27 110.584 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.607 ' HE2' ' HG ' ' A' ' 51' ' ' CYS . 52.1 m-85 -116.12 116.54 28.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.16 -0.473 . . . . 1.11 110.045 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -97.11 110.68 23.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.137 -0.483 . . . . 0.81 110.411 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -127.11 142.79 51.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.872 -0.603 . . . . 1.39 111.003 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.8 t -121.91 134.52 64.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.972 0.415 . . . . 0.81 111.027 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.7 t -93.74 103.97 15.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.235 -1.024 . . . . 0.44 108.235 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.73 146.49 15.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.278 -0.419 . . . . 0.7 111.351 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.94 -175.09 42.87 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.771 -0.728 . . . . 0.53 111.299 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.78 158.17 36.08 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.01 0.433 . . . . 0.58 111.321 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.29 134.41 15.62 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.55 -0.833 . . . . 0.8 111.884 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.69 2.06 60.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.794 -0.717 . . . . 0.42 113.568 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -79.25 -24.11 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 117.285 0.542 . . . . 0.57 110.91 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.99 25.77 4.35 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.688 -0.768 . . . . 0.49 113.467 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -53.44 -55.53 24.42 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 111.891 0.33 . . . . 0.81 111.891 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.409 ' O ' HG13 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -59.59 -53.47 57.65 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.888 -0.596 . . . . 0.58 112.048 -178.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.83 -43.55 77.09 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.778 0.659 . . . . 0.43 112.778 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.499 ' CD1' HG11 ' A' ' 81' ' ' VAL . 39.1 mt -59.81 -41.27 90.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.823 0.344 . . . . 0.92 111.632 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 m -76.83 -46.2 25.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.411 -0.359 . . . . 0.89 111.657 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 17' ' ' SER . 79.4 mt -60.14 -27.61 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.937 0.399 . . . . 0.79 111.631 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.2 -35.07 79.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.915 0.388 . . . . 0.46 111.143 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -91.56 -6.39 52.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.992 0.425 . . . . 1.37 111.347 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.1 mm -102.81 -43.41 9.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.329 -0.396 . . . . 0.58 111.129 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -105.31 -4.78 21.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.513 -0.312 . . . . 1.68 111.676 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.3 t30 64.15 35.27 10.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.024 0.75 . . . . 1.6 113.024 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -162.81 154.58 18.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.034 0.445 . . . . 0.74 110.817 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -87.81 128.96 35.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.659 -0.701 . . . . 0.6 111.205 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.8 120.82 47.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.252 -0.886 . . . . 0.64 109.032 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -77.01 -40.73 45.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 1.12 111.176 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -127.5 117.94 23.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.276 -0.42 . . . . 1.18 110.537 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -143.29 143.96 31.92 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.297 -0.631 . . . . 0.6 109.297 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.76 124.04 66.48 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.847 0.356 . . . . 0.8 111.158 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.26 -13.69 9.87 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.883 2.389 . . . . 0.52 113.79 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.7 p -98.19 1.15 47.08 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.805 -0.358 . . . . 0.89 111.777 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 mt -83.56 132.13 32.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.073 0.463 . . . . 0.73 110.353 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 10.0 tt0 -121.87 82.24 1.93 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.37 -0.832 . . . . 0.81 109.069 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -103.45 155.67 18.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.535 -0.757 . . . . 1.29 111.422 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.34 121.45 45.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.173 -0.467 . . . . 0.78 110.397 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -108.14 144.84 34.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.744 0.306 . . . . 0.94 110.349 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -119.51 141.18 49.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.838 0.351 . . . . 0.56 110.531 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -143.48 134.63 25.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.11 -0.495 . . . . 1.46 110.072 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -106.49 122.63 46.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.865 0.364 . . . . 1.89 110.409 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -137.39 133.01 46.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 1.09 111.232 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 t -85.48 71.58 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.477 0.656 . . . . 0.65 109.5 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 pt -88.26 130.88 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.781 -0.645 . . . . 1.06 111.529 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 63.48 31.59 14.81 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.55 -0.75 . . . . 0.97 111.077 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.7 11.12 83.3 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.852 -0.613 . . . . 0.6 113.097 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -117.28 119.73 36.04 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 122.586 -0.361 . . . . 1.41 110.783 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.8 m -79.83 96.73 6.4 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.6 -0.518 . . . . 0.63 109.6 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.607 ' HG ' ' HE2' ' A' ' 4' ' ' TYR . 58.6 m -114.05 158.49 21.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.225 -0.443 . . . . 0.71 112.056 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.0 tp -112.64 119.88 39.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.27 -0.877 . . . . 0.48 108.885 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 12.3 mt -90.65 131.32 36.42 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.056 0.455 . . . . 0.87 111.919 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -114.39 103.29 10.91 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.088 -1.079 . . . . 1.03 108.088 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 3.4 mt -110.9 151.33 13.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.305 -0.407 . . . . 0.68 111.706 -177.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.1 tp -131.22 119.37 21.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.332 -0.394 . . . . 0.46 110.327 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.562 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 4.6 t0 -84.68 98.3 10.14 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.57 -0.53 . . . . 0.44 109.57 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 36.0 p -64.85 141.18 58.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.778 -0.646 . . . . 0.73 112.347 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.88 -58.39 2.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.364 -0.835 . . . . 0.56 109.537 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.23 -47.11 0.53 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.752 -0.658 . . . . 0.72 112.262 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -135.93 129.09 31.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.741 0.305 . . . . 1.26 110.59 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -102.44 175.7 5.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.394 -0.595 . . . . 1.57 109.394 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -65.57 -43.45 89.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.927 0.394 . . . . 1.38 110.2 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -128.72 145.35 51.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.081 -0.509 . . . . 0.81 110.038 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -38.33 89.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.309 -0.405 . . . . 0.63 110.893 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.57 -28.28 68.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.186 -0.461 . . . . 0.32 111.402 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 82.9 mtp -73.79 -38.32 64.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.93 0.395 . . . . 0.69 110.264 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.402 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 35.7 ttp180 -71.09 -43.77 67.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.893 -0.594 . . . . 0.9 109.821 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.83 -19.5 65.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.362 -0.835 . . . . 1.41 111.39 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -59.95 -57.36 13.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.466 -0.334 . . . . 1.51 111.373 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.402 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 14.7 p90 -75.05 -5.02 41.83 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.779 -0.368 . . . . 1.17 111.425 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.5 mtt -76.37 -25.24 54.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.361 -0.607 . . . . 0.7 109.361 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -87.7 -42.32 12.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.605 -0.725 . . . . 1.29 110.451 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.17 -20.71 63.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.863 -0.608 . . . . 0.72 112.24 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.78 124.57 18.04 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.491 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -88.91 -39.83 13.51 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.794 -0.447 . . . . 0.54 109.794 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -128.78 137.58 9.73 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.815 -0.914 . . . . 0.26 110.815 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.461 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 93.9 m-85 -120.75 129.67 53.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.139 0.495 . . . . 0.48 111.38 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.6 tp -97.02 110.74 23.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.473 -0.785 . . . . 0.37 108.982 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 3.8 m -96.91 92.36 6.07 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.102 -0.499 . . . . 0.61 110.981 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.499 HG11 ' CD1' ' A' ' 19' ' ' LEU . 4.1 t -98.92 136.26 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.909 -0.587 . . . . 0.59 111.369 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -130.71 172.17 12.28 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.898 -0.779 . . . . 0.34 108.898 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.528 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . . . -105.17 122.86 46.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.596 0.236 . . . . 0.32 110.514 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.43 ' HB ' ' HG3' ' A' ' 123' ' ' ARG . 31.2 pt -66.54 -17.73 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.069 0.462 . . . . 0.78 111.562 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -98.14 4.12 49.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.957 0.408 . . . . 0.82 110.236 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 14.6 t-20 -135.34 90.38 2.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.737 -0.665 . . . . 1.07 110.073 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.43 HG23 HG22 ' A' ' 125' ' ' VAL . 0.4 OUTLIER -59.61 -28.29 67.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.024 -0.535 . . . . 0.65 112.071 -178.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -59.08 -38.72 80.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 0.89 110.559 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.5 p -75.27 -25.87 58.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.64 111.326 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -74.99 -34.67 62.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.056 0.455 . . . . 0.42 110.721 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.406 ' HA ' ' OE2' ' A' ' 91' ' ' GLU . 10.7 mm-40 -74.6 -24.43 58.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.007 0.432 . . . . 1.44 110.438 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -71.5 -14.48 62.13 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.868 -0.606 . . . . 1.02 111.257 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 30.3 mm -58.14 -35.72 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.021 -0.536 . . . . 0.42 110.406 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -61.34 -45.02 96.14 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.073 -0.512 . . . . 0.83 110.565 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -63.77 -48.26 77.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.907 -0.588 . . . . 0.79 111.75 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -60.53 -52.06 66.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.162 0.43 . . . . 1.17 112.162 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -55.43 -47.55 75.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.208 0.318 . . . . 0.6 110.754 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.05 -43.9 86.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.047 -0.524 . . . . 1.35 111.763 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 103' ' ' VAL . 56.1 tt0 -63.44 -54.51 35.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 1.15 112.165 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.31 -34.41 60.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.642 0.258 . . . . 0.51 110.955 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' A' ' 107' ' ' GLU . 30.0 mtpt -62.14 -35.35 78.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.066 0.46 . . . . 1.05 110.217 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -73.88 -41.15 62.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.617 -0.719 . . . . 0.91 110.905 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 99' ' ' GLN . 46.8 t -60.72 -41.92 90.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.35 111.382 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -89.21 -14.86 35.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.504 -0.316 . . . . 0.63 111.352 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.4 t70 58.82 54.84 4.94 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.748 0.785 . . . . 0.47 109.836 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.7 m -154.83 140.26 17.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.6 -0.727 . . . . 1.14 110.895 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.416 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 21.9 mt-10 -88.22 -23.31 23.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.25 0.548 . . . . 1.74 110.003 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -101.06 85.3 2.81 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.487 -0.779 . . . . 0.78 109.939 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.5 t -117.71 119.24 34.25 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.625 -0.716 . . . . 0.47 110.098 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.403 ' HG3' ' CB ' ' A' ' 166' ' ' HIS . 35.1 Cg_exo -58.06 115.96 2.89 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.115 2.543 . . . . 0.25 112.286 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.461 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 36.5 mtt -146.11 153.05 40.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.777 -0.647 . . . . 0.79 110.457 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.9 t -132.88 125.79 52.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.895 -0.78 . . . . 0.22 108.895 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.8 tp -82.72 125.82 31.68 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.545 -0.539 . . . . 0.29 109.545 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 81' ' ' VAL . 3.2 t -122.83 127.03 74.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.173 -0.467 . . . . 0.82 112.223 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.88 96.69 1.26 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.671 -0.971 . . . . 0.27 110.671 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -81.71 166.47 20.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.067 0.433 . . . . 0.21 111.671 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.6 mttt 72.58 31.79 1.65 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.042 -0.981 . . . . 0.54 111.645 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 15.8 p -70.91 -10.13 59.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.887 0.375 . . . . 0.46 111.008 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -94.71 -2.05 51.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.7 110.621 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 33.1 mt -104.82 155.34 37.67 Favored Pre-proline 0 C--O 1.236 0.372 0 CA-C-N 116.085 -0.507 . . . . 0.67 111.07 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -87.31 -169.83 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.598 2.199 . . . . 0.54 112.03 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 m 60.09 45.6 11.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.79 -0.641 . . . . 0.84 111.167 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.43 ' HG3' ' HB ' ' A' ' 84' ' ' ILE . 12.5 ttm-85 -76.75 111.81 12.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.587 -0.733 . . . . 0.58 110.73 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.6 p -92.77 -31.04 15.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.094 0.473 . . . . 0.81 110.406 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.43 HG22 HG23 ' A' ' 87' ' ' THR . 58.3 t -91.22 108.19 19.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.988 -0.551 . . . . 0.37 109.958 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -71.87 150.11 44.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.86 0.362 . . . . 1.69 110.511 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.1 m -57.3 -39.43 75.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.724 -0.671 . . . . 0.82 111.631 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -59.46 -41.62 90.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.263 -0.426 . . . . 0.62 111.642 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -60.57 -47.02 88.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.93 110.762 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.07 82.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.962 -0.563 . . . . 0.3 111.296 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.04 -40.79 98.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.919 -0.582 . . . . 0.47 109.976 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.38 -42.52 96.01 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.737 -0.665 . . . . 1.18 110.95 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 29.1 tp -66.96 -46.09 75.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.882 -0.599 . . . . 0.44 110.605 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.21 94.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.882 -0.599 . . . . 0.25 111.43 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.1 mtm105 -64.11 -30.33 71.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 1.54 110.934 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.5 m -75.15 -34.23 61.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.25 -0.432 . . . . 0.68 110.91 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -78.16 -24.64 47.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.231 -0.44 . . . . 0.77 110.715 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.33 37.1 8.38 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.828 -0.909 . . . . 0.25 110.828 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.6 pp -135.73 162.62 55.94 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.419 -0.39 . . . . 0.51 110.377 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.61 152.93 11.78 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.09 2.526 . . . . 0.36 112.73 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -134.49 130.59 36.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.513 -0.767 . . . . 0.38 110.4 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.62 137.2 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.47 -0.332 . . . . 0.54 110.169 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -77.31 141.89 39.69 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.843 -0.799 . . . . 0.88 108.843 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 64.8 p -138.47 171.69 13.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.792 0.806 . . . . 0.43 112.768 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.1 t -153.58 118.31 5.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.702 -1.136 . . . . 0.33 108.827 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.62 -23.54 62.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.042 0.448 . . . . 0.45 110.85 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -75.51 -39.93 57.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.177 -0.465 . . . . 1.32 111.621 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 61.9 p -102.32 -8.0 21.59 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.94 0.348 . . . . 0.52 111.94 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 65.1 23.13 12.38 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.419 0.628 . . . . 1.53 110.517 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 144' ' ' THR . 44.3 tt0 -81.45 127.46 32.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.11 -0.496 . . . . 0.87 111.237 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.408 ' C ' HG22 ' A' ' 144' ' ' THR . . . 78.14 -25.73 2.24 Favored Glycine 0 CA--C 1.518 0.268 0 CA-C-N 116.014 -0.539 . . . . 0.51 113.899 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.412 ' H ' HG23 ' A' ' 152' ' ' VAL . 6.6 t -57.09 -41.97 78.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 0.74 111.426 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -61.9 -46.49 89.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.364 0.602 . . . . 1.62 110.12 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.39 -45.87 82.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.291 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -54.72 -50.99 67.0 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.233 -0.439 . . . . 0.37 111.71 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -62.43 -39.34 92.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 1.46 111.292 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -68.11 -40.95 82.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.977 0.418 . . . . 0.99 110.498 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 46.5 m -62.16 -40.15 95.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.903 -0.589 . . . . 0.34 110.443 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 163' ' ' ILE . 43.5 tp -59.12 -43.35 91.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.763 0.316 . . . . 0.42 110.793 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.2 t -62.12 -43.25 97.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.031 0.443 . . . . 0.55 110.468 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -67.24 -34.53 77.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.9 110.668 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -65.73 -36.41 83.52 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.242 -0.651 . . . . 0.73 109.242 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 159' ' ' LEU . 96.2 mt -64.12 -48.63 84.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 109.112 -0.699 . . . . 0.42 109.112 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -60.77 -43.52 97.93 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.566 -0.743 . . . . 0.87 109.929 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.589 ' O ' ' HG3' ' A' ' 169' ' ' LYS . 33.8 ttmt -55.66 -42.51 75.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.778 -0.646 . . . . 0.97 110.466 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 169' ' ' LYS . 42.4 t60 -70.9 -31.26 67.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.71 111.435 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -87.39 -4.7 59.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.479 -0.328 . . . . 1.11 111.543 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -117.47 14.1 14.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.051 0.453 . . . . 1.12 111.142 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 165' ' ' LYS . 7.8 mtpp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.414 -0.803 . . . . 1.47 109.781 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.563 ' HA ' ' O ' ' A' ' 50' ' ' THR . 42.9 ttm . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.886 -0.413 . . . . 1.48 109.886 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.6 145.52 34.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.513 -0.312 . . . . 1.04 111.466 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -100.16 138.89 36.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.213 -0.662 . . . . 1.27 109.213 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -123.1 125.36 45.03 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.886 0.374 . . . . 1.11 110.356 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -88.44 102.73 15.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.296 0.57 . . . . 0.81 110.533 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 8.0 mp -107.89 131.87 54.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.585 -0.734 . . . . 1.39 110.382 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.45 124.62 64.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.277 -0.419 . . . . 0.81 110.913 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.6 t -95.17 119.75 43.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.22 -0.445 . . . . 0.44 109.958 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.412 ' HB ' ' CD1' ' A' ' 96' ' ' TYR . 12.0 m -112.54 155.04 13.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.953 0.406 . . . . 0.7 110.779 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.79 -176.12 37.43 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.281 -0.962 . . . . 0.53 112.537 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.56 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -80.24 161.54 25.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.127 0.489 . . . . 0.58 111.132 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.74 109.13 2.75 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.748 -0.739 . . . . 0.8 112.055 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.62 -2.7 17.87 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.582 -0.818 . . . . 0.42 113.391 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 11' ' ' ALA . 12.8 m -72.44 -28.19 27.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 117.32 0.56 . . . . 0.57 110.554 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.79 25.38 4.26 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.124 -1.036 . . . . 0.49 114.135 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -55.22 -55.6 29.47 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.066 0.46 . . . . 0.81 110.912 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -59.84 -36.42 76.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.245 -0.888 . . . . 0.58 111.719 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.66 -42.97 95.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.43 110.96 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.6 mt -66.66 -41.24 88.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.23 -0.441 . . . . 0.92 110.825 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.4 m -68.68 -46.04 70.1 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.886 -0.597 . . . . 0.89 111.767 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 82.1 mt -66.2 -24.83 34.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.712 0.291 . . . . 0.79 110.997 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 3.9 mm-40 -61.31 -35.42 77.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.797 0.332 . . . . 0.46 111.039 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 mp -84.86 -15.44 44.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.921 0.391 . . . . 1.37 111.17 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.4 mm -95.42 -56.45 5.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 112.207 0.447 . . . . 0.58 112.207 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -96.09 -10.28 28.74 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.815 0.302 . . . . 1.68 111.815 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 32.7 m-20 59.95 36.51 21.67 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.736 0.643 . . . . 1.6 112.736 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.88 136.35 15.05 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.655 -0.498 . . . . 0.74 109.655 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -70.54 125.3 26.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.077 -0.511 . . . . 0.6 111.033 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.3 t -90.43 113.03 25.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.068 -0.715 . . . . 0.64 109.068 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -75.27 -36.91 61.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.421 -0.354 . . . . 1.12 111.503 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -124.54 114.44 19.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.768 0.318 . . . . 1.18 110.432 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -143.83 130.17 19.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.328 -0.396 . . . . 0.6 110.371 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.5 ' HB3' HG13 ' A' ' 36' ' ' ILE . 39.2 t0 -65.05 125.75 89.84 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-N 115.523 -0.762 . . . . 0.8 110.62 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.39 -18.46 26.26 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.923 2.415 . . . . 0.52 113.507 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.1 p -84.36 0.12 50.51 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.77 0.319 . . . . 0.89 111.595 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.5 HG13 ' HB3' ' A' ' 33' ' ' ASP . 83.5 mt -83.07 122.88 38.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 110.084 -0.339 . . . . 0.73 110.084 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -122.76 112.72 18.25 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.469 -0.787 . . . . 0.81 109.61 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -144.4 167.21 23.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.836 0.351 . . . . 1.29 110.993 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 1.4 m -117.89 122.62 43.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.3 -0.63 . . . . 0.78 109.3 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -103.22 132.74 49.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.325 -0.398 . . . . 0.94 110.314 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.28 134.48 51.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.024 -0.535 . . . . 0.56 110.662 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -148.47 129.63 14.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.935 -0.575 . . . . 1.46 110.002 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.468 ' NE2' ' H ' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -92.44 134.53 34.86 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.725 -0.472 . . . . 1.89 109.725 179.052 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.59 151.8 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.799 0.333 . . . . 1.09 110.864 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.5 t -111.41 91.7 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.928 -0.578 . . . . 0.65 109.874 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.24 121.77 54.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.102 -0.499 . . . . 1.06 109.946 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 64.75 23.51 12.74 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.723 -0.671 . . . . 0.97 111.316 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.93 -17.18 59.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.844 -0.693 . . . . 0.6 112.491 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -82.58 126.19 32.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.942 0.401 . . . . 1.41 110.862 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 1' ' ' MET . 5.0 m -93.59 103.34 15.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.115 -0.493 . . . . 0.63 109.891 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.0 m -121.71 156.65 32.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.194 0.521 . . . . 0.71 112.188 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.1 tp -108.43 118.66 37.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.181 -0.918 . . . . 0.48 108.712 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.23 121.66 33.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.001 0.429 . . . . 0.87 111.418 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -106.88 105.4 15.42 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.125 -1.065 . . . . 1.03 108.125 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 55.4 mt -112.81 130.46 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.978 0.418 . . . . 0.68 111.819 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 23.7 tp -106.24 118.14 35.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.925 -0.579 . . . . 0.46 110.505 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.31 93.33 9.36 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.918 -0.771 . . . . 0.44 108.918 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.29 146.31 52.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.896 -0.593 . . . . 0.73 111.674 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.21 -46.8 9.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.819 -0.628 . . . . 0.56 110.624 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.79 -70.1 0.34 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.696 -0.764 . . . . 0.72 112.161 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -97.99 111.04 23.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.908 0.385 . . . . 1.26 110.849 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.67 166.07 19.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.042 -0.526 . . . . 1.57 110.56 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.413 ' HB3' ' SD ' ' A' ' 67' ' ' MET . 25.0 tt0 -62.8 -45.89 90.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.641 -0.503 . . . . 1.38 109.641 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -127.85 142.8 51.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.063 -0.718 . . . . 0.81 109.063 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 m -61.56 -26.31 67.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.065 0.459 . . . . 0.63 111.102 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.79 -29.89 69.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.914 -0.584 . . . . 0.32 110.965 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.413 ' SD ' ' HB3' ' A' ' 63' ' ' GLU . 74.3 mtp -69.96 -41.38 74.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.895 -0.593 . . . . 0.69 110.006 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.648 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 36.3 ttp180 -64.43 -39.42 93.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.538 0.685 . . . . 0.9 109.571 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.22 -19.01 64.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.775 -1.102 . . . . 1.41 111.235 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -77.02 -55.8 5.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.329 -0.396 . . . . 1.51 111.752 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.648 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 7.0 p90 -68.51 -16.97 64.06 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.479 -0.488 . . . . 1.17 111.449 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.7 mtt -81.86 -12.95 58.23 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.868 -0.419 . . . . 0.7 109.868 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -95.01 -52.18 4.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.017 -0.538 . . . . 1.29 110.997 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -20.27 63.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.72 112.083 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.09 129.2 43.28 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.592 -0.813 . . . . 0.19 112.555 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -90.78 -48.5 7.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.998 0.427 . . . . 0.54 109.999 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.07 128.94 7.73 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.868 -0.682 . . . . 0.26 111.796 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.451 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 59.1 m-85 -111.05 127.84 55.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.115 0.483 . . . . 0.48 110.611 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.3 tp -94.44 108.78 20.7 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.453 -0.573 . . . . 0.37 109.453 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -89.01 93.89 9.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.886 -0.597 . . . . 0.61 109.822 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 2.3 t -109.59 139.48 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.388 0.613 . . . . 0.59 112.349 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -134.87 179.11 6.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.236 -0.893 . . . . 0.34 108.798 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.493 ' HB1' ' OD1' ' A' ' 85' ' ' ASN . . . -111.91 129.52 56.14 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.756 -0.461 . . . . 0.32 109.756 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 pt -67.06 -14.55 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.915 0.388 . . . . 0.78 111.419 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.493 ' OD1' ' HB1' ' A' ' 83' ' ' ALA . 22.5 p-10 -99.99 -4.52 29.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.01 0.433 . . . . 0.82 110.743 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -122.72 101.58 7.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.193 0.521 . . . . 1.07 110.229 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -26.82 67.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.926 -0.579 . . . . 0.65 111.98 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -65.25 -42.62 93.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.225 -0.443 . . . . 0.89 110.782 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 99.0 p -66.16 -28.64 68.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.679 0.276 . . . . 0.64 111.078 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -72.59 -39.44 67.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.243 0.544 . . . . 0.42 110.504 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -74.67 -29.86 61.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.196 -0.456 . . . . 1.44 110.54 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.63 -16.81 64.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.942 -0.572 . . . . 1.02 110.793 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 32.9 mm -57.55 -34.83 48.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.886 -0.597 . . . . 0.42 110.354 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -62.41 -46.49 88.34 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.075 -0.511 . . . . 0.83 110.646 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -57.51 -50.18 73.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.524 -0.762 . . . . 0.79 111.389 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.412 ' CD1' ' HB ' ' A' ' 9' ' ' VAL . 17.8 m-85 -63.69 -38.8 92.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.45 -0.341 . . . . 1.17 111.437 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -58.64 -50.72 72.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.6 110.187 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -67.08 -42.55 84.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.782 -0.644 . . . . 1.35 111.138 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -58.82 -57.56 12.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.002 -0.544 . . . . 1.15 112.078 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.8 mt -61.39 -39.2 81.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.671 -0.24 . . . . 0.51 111.304 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -60.96 -38.9 87.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 1.05 110.803 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -72.62 -40.07 66.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.91 110.921 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 75.4 t -64.61 -48.01 86.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.42 -0.354 . . . . 0.35 111.414 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -81.3 -10.08 59.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 0.63 111.177 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.9 t70 51.43 58.56 5.37 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.59 0.709 . . . . 0.47 110.812 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.2 m -150.03 138.78 20.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.725 -0.67 . . . . 1.14 110.569 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -74.02 -30.26 62.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 1.74 110.631 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -116.93 124.36 49.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.234 -0.439 . . . . 0.78 110.705 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.9 t -137.43 129.46 16.62 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.543 -0.539 . . . . 0.47 109.543 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.75 106.39 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.746 2.297 . . . . 0.25 111.935 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.451 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 63.7 mtt -138.03 157.49 46.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.886 -0.597 . . . . 0.79 110.596 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -140.07 124.52 19.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.159 -0.682 . . . . 0.22 109.159 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 21.7 tp -83.18 119.33 24.4 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.438 -0.579 . . . . 0.29 109.438 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 47.7 t -124.23 133.33 69.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.045 -0.525 . . . . 0.82 111.328 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -108.58 112.51 3.55 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.258 -1.137 . . . . 0.27 110.258 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -92.74 163.91 13.57 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.107 0.453 . . . . 0.21 111.399 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.526 ' HE3' ' O ' ' A' ' 14' ' ' VAL . 89.7 mttt 68.21 34.0 4.11 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.346 -0.843 . . . . 0.54 111.781 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 24.2 p -69.43 -11.51 60.89 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.032 0.444 . . . . 0.46 110.975 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.05 -13.29 41.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.032 -0.531 . . . . 0.7 110.457 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 22.1 mt -88.1 143.48 33.03 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.942 0.401 . . . . 0.67 111.029 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.32 -178.45 4.63 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.763 2.308 . . . . 0.54 112.096 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.1 m 66.45 42.33 2.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.807 -0.633 . . . . 0.84 110.32 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.5 ttm-85 -68.16 119.94 13.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.658 -0.701 . . . . 0.58 110.48 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.4 p -99.68 -27.71 13.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.424 -0.353 . . . . 0.81 110.902 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.7 t -97.96 114.22 34.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.441 -0.345 . . . . 0.37 110.421 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -77.02 150.29 35.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.427 -0.351 . . . . 1.69 110.674 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.43 -40.47 68.34 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.399 0.518 . . . . 0.82 112.399 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -62.2 -37.63 86.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.558 -0.292 . . . . 0.62 111.362 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -59.1 -46.63 87.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.119 0.485 . . . . 0.93 110.988 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.61 -39.15 58.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.961 -0.563 . . . . 0.3 111.339 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -61.4 -42.36 98.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.47 110.739 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.78 -38.82 80.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.276 -0.42 . . . . 1.18 110.558 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 43.5 tp -63.29 -46.42 86.87 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.956 -0.565 . . . . 0.44 111.146 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.5 -37.26 77.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.943 -0.572 . . . . 0.25 110.867 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 135' ' ' ARG . 31.9 ttm180 -66.13 -29.29 69.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.45 -0.795 . . . . 1.54 110.928 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.7 m -74.17 -29.98 62.03 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.303 0.573 . . . . 0.68 110.28 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -85.47 -30.14 23.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.97 -0.559 . . . . 0.77 110.423 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.31 26.65 10.83 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.957 -0.857 . . . . 0.25 110.957 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 23.7 pt -124.56 166.25 20.81 Favored Pre-proline 0 N--CA 1.452 -0.345 0 N-CA-C 110.007 -0.368 . . . . 0.51 110.007 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -90.79 160.29 4.13 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.521 2.148 . . . . 0.36 112.736 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 16.9 t80 -127.16 131.09 50.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.376 -0.375 . . . . 0.38 110.309 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 53.4 mt -133.14 131.54 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.603 -0.272 . . . . 0.54 111.112 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -83.85 130.39 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.836 -0.801 . . . . 0.88 108.836 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 71.3 p -137.6 176.38 8.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.625 0.726 . . . . 0.43 112.162 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.8 t -161.41 114.69 1.91 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.747 -1.115 . . . . 0.33 108.71 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.45 -15.93 63.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.203 0.525 . . . . 0.45 110.605 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -80.58 -29.69 36.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.573 -0.739 . . . . 1.32 111.504 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 149' ' ' ARG . 21.1 p -116.18 -8.55 11.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.462 0.541 . . . . 0.52 112.462 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 148' ' ' THR . 21.4 mtp85 70.69 13.69 7.21 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.065 -0.516 . . . . 1.53 111.099 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 144' ' ' THR . 53.1 tt0 -66.94 112.37 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.453 -0.34 . . . . 0.87 111.78 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 67.18 3.51 24.45 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 114.602 0.601 . . . . 0.51 114.602 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 82.3 t -59.53 -49.25 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 117.83 0.815 . . . . 0.74 110.743 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.38 -46.61 87.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.25 0.547 . . . . 1.62 109.939 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -54.07 -46.85 72.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.056 -0.975 . . . . 1.0 111.851 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.61 -47.61 81.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.127 -0.488 . . . . 0.37 111.755 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.463 ' O ' HG23 ' A' ' 160' ' ' VAL . 41.6 m-85 -64.97 -43.66 91.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.307 -0.406 . . . . 1.46 111.427 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -63.89 -37.46 87.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.859 0.361 . . . . 0.99 110.739 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 93.0 m -62.37 -43.96 97.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.918 -0.583 . . . . 0.34 110.808 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.592 ' O ' HG13 ' A' ' 163' ' ' ILE . 30.7 tp -58.22 -45.53 87.51 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.642 -0.254 . . . . 0.42 110.911 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 156' ' ' PHE . 6.1 t -60.9 -39.92 83.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.941 0.4 . . . . 0.55 110.512 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -68.76 -33.76 74.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 0.9 110.985 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -65.91 -40.58 91.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.321 -0.622 . . . . 0.73 109.321 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 159' ' ' LEU . 31.3 mt -62.42 -41.9 93.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.955 -0.757 . . . . 0.42 108.955 178.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.559 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 4.4 mtt180 -53.36 -58.34 7.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.013 -0.994 . . . . 0.87 110.921 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.407 ' HA ' ' HG2' ' A' ' 168' ' ' GLU . 51.3 mtmt -62.13 -20.12 63.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.432 -0.803 . . . . 0.97 111.955 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -83.38 -33.99 25.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.767 0.318 . . . . 0.71 110.603 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 163' ' ' ILE . 46.8 mtpt -87.06 -8.33 57.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.094 0.405 . . . . 1.11 112.094 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 8.8 pt-20 -108.92 25.11 12.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.961 0.41 . . . . 1.12 110.771 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 36.4 mttm . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.447 -0.787 . . . . 1.47 109.851 179.291 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 ttm . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 120.64 0.257 . . . . 1.48 110.574 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.0 m -111.53 149.06 31.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.523 -0.308 . . . . 1.04 110.356 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -98.41 131.75 44.43 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.046 -0.353 . . . . 1.27 110.046 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -109.91 133.35 53.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.855 -0.424 . . . . 1.11 109.855 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -94.98 104.61 16.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.267 -0.424 . . . . 0.81 110.72 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 10.2 mp -112.82 119.63 38.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.872 -0.604 . . . . 1.39 111.031 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.73 120.23 61.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.181 0.515 . . . . 0.81 110.153 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.7 t -92.25 112.9 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.827 -0.624 . . . . 0.44 109.796 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 m -114.96 -175.45 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.187 -0.46 . . . . 0.7 110.638 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.79 -176.08 22.66 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.716 -0.754 . . . . 0.53 111.789 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.91 -175.34 2.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.783 0.325 . . . . 0.58 111.188 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.23 131.41 10.39 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.586 -0.816 . . . . 0.8 113.188 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.47 17.37 79.82 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.287 -0.482 . . . . 0.42 113.835 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -77.09 -34.52 21.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 117.492 0.646 . . . . 0.57 111.004 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.47 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 132.89 24.49 0.72 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.616 -0.802 . . . . 0.49 113.137 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -56.69 -41.27 77.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.061 0.458 . . . . 0.81 111.046 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.81 2.01 50.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.58 112.093 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.47 -44.76 5.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.712 0.291 . . . . 0.43 110.801 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.544 HD23 ' HB2' ' A' ' 146' ' ' ALA . 44.7 mt -58.71 -42.78 89.47 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.558 0.694 . . . . 0.92 110.483 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.493 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -60.89 -52.44 65.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.948 -1.023 . . . . 0.89 111.701 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 29' ' ' VAL . 39.8 mt -65.37 -31.09 52.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.388 -0.369 . . . . 0.79 111.379 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.612 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 2.8 mm-40 -69.27 -22.38 63.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.999 0.428 . . . . 0.46 110.335 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.8 tp -94.16 -26.83 16.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.118 -0.492 . . . . 1.37 110.649 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 20' ' ' THR . 35.3 mm -89.73 -60.25 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.58 111.558 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -92.51 -13.95 29.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.499 -0.319 . . . . 1.68 111.437 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 7.9 m-20 66.57 24.71 10.16 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 123.513 0.508 . . . . 1.6 111.758 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -129.92 146.51 51.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.711 -0.477 . . . . 0.74 109.711 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -85.12 129.97 34.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.377 -0.374 . . . . 0.6 111.135 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.406 HG21 HD12 ' A' ' 21' ' ' ILE . 60.8 t -96.95 125.05 50.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.64 109.955 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -75.7 -46.38 31.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.763 -0.653 . . . . 1.12 111.815 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -130.07 123.73 31.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.969 0.414 . . . . 1.18 111.118 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -145.42 146.92 31.72 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.156 -0.683 . . . . 0.6 109.156 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -71.66 119.42 74.0 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 0.8 110.367 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.94 -17.33 32.31 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.49 2.127 . . . . 0.52 113.615 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.24 -7.49 59.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.096 0.474 . . . . 0.89 111.434 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.2 mt -80.77 119.69 30.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.197 0.522 . . . . 0.73 110.771 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 22.3 tt0 -118.01 79.49 1.38 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.097 -0.956 . . . . 0.81 108.641 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -106.39 159.39 16.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.136 -0.483 . . . . 1.29 111.054 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.66 124.52 52.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.231 -0.44 . . . . 0.78 110.325 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -101.97 136.81 41.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.121 -0.491 . . . . 0.94 110.347 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.06 128.53 55.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.88 0.371 . . . . 0.56 111.234 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -144.51 137.59 26.98 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.387 -0.598 . . . . 1.46 109.387 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -116.26 119.34 35.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.704 0.288 . . . . 1.89 110.343 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.9 t -138.58 153.02 25.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.446 . . . . 1.09 109.877 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 13.2 t -76.73 103.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.64 -0.504 . . . . 0.65 109.64 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.3 mt -105.37 111.94 36.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.343 -0.389 . . . . 1.06 111.008 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.458 ' HB2' HH12 ' A' ' 164' ' ' ARG . 31.3 m-20 65.4 27.09 11.92 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.757 -0.656 . . . . 0.97 111.518 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.49 5.29 65.25 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.873 -0.679 . . . . 0.6 112.469 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -126.54 119.75 27.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.791 0.329 . . . . 1.41 111.172 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 23.6 m -77.11 106.75 9.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.641 -0.503 . . . . 0.63 109.641 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.1 m -117.71 147.48 42.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.224 0.535 . . . . 0.71 111.212 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.0 tp -90.74 122.22 33.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.547 -0.751 . . . . 0.48 109.113 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 53' ' ' LEU . 14.3 mt -93.61 113.44 25.54 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.955 0.407 . . . . 0.87 111.591 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -100.43 87.71 3.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.256 -1.387 . . . . 1.03 107.256 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 6.6 mt -99.54 127.64 52.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.724 -0.671 . . . . 0.68 111.881 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.9 tp -107.88 121.24 44.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.557 -0.747 . . . . 0.46 111.112 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 1.7 t70 -87.47 94.97 9.86 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.44 -0.948 . . . . 0.44 108.44 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.492 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 81.2 p -65.98 146.42 54.72 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.466 0.651 . . . . 0.73 111.838 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.01 -58.17 2.56 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.155 -0.929 . . . . 0.56 109.287 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.16 -96.96 0.15 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.799 -0.715 . . . . 0.72 111.999 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -83.77 158.44 21.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.679 0.276 . . . . 1.26 110.533 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -130.32 165.86 21.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.238 -0.437 . . . . 1.57 110.32 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -78.89 -35.36 43.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.331 -0.618 . . . . 1.38 109.331 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -119.86 124.03 45.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.592 -0.731 . . . . 0.81 109.517 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -58.46 -34.9 71.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.419 -0.355 . . . . 0.63 111.382 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.26 -27.48 69.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.32 111.4 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 78.0 mtp -72.64 -32.65 66.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.69 110.467 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -71.17 -46.07 62.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.896 -0.593 . . . . 0.9 110.071 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -73.63 -9.06 58.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.654 -0.703 . . . . 1.41 111.449 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -67.19 -60.28 2.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.817 -0.174 . . . . 1.51 111.046 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -72.51 -15.88 61.79 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.695 -0.402 . . . . 1.17 111.091 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 35.7 mtt -70.35 -25.74 63.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.24 0.543 . . . . 0.7 109.937 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 73' ' ' ARG . 48.5 mtm180 -84.17 -48.54 9.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.83 -0.623 . . . . 1.29 110.673 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -22.67 63.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.938 -0.574 . . . . 0.72 111.953 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.01 123.45 26.3 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.018 -0.61 . . . . 0.19 112.087 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -88.9 -40.85 12.8 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.943 -0.391 . . . . 0.54 109.943 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -128.88 130.12 6.37 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.414 -0.674 . . . . 0.26 111.414 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -113.98 133.83 55.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.015 0.436 . . . . 0.48 111.128 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.8 tp -100.1 106.23 17.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.864 -0.607 . . . . 0.37 110.221 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.5 m -92.36 97.44 10.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.004 0.43 . . . . 0.61 110.343 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 4.9 t -110.31 134.1 53.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.002 -0.545 . . . . 0.59 111.37 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -129.6 172.66 11.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.729 -0.668 . . . . 0.34 109.441 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.78 133.3 52.37 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.727 -0.471 . . . . 0.32 109.727 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.432 HD11 ' HA ' ' A' ' 118' ' ' CYS . 29.0 pt -76.92 -4.17 6.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 112.782 0.66 . . . . 0.78 112.782 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -85.6 -12.18 52.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.738 -0.21 . . . . 0.82 111.105 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.469 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 30.8 t-20 -139.79 123.94 17.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.367 . . . . 1.07 110.725 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.8 m -69.83 -28.2 65.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.057 -0.52 . . . . 0.65 111.652 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -60.97 -39.29 89.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.618 0.247 . . . . 0.89 110.721 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -64.75 -32.43 74.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.137 0.494 . . . . 0.64 110.313 179.147 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -76.95 -35.66 57.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.76 -0.655 . . . . 0.42 110.115 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -72.01 -29.8 64.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.707 -0.678 . . . . 1.44 110.582 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.38 -24.02 67.14 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.042 -0.527 . . . . 1.02 110.592 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.9 mm -61.45 -30.63 48.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.518 -0.764 . . . . 0.42 110.684 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -60.76 -41.38 95.34 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.205 0.526 . . . . 0.83 109.695 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -71.86 -38.43 70.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.562 -0.744 . . . . 0.79 110.639 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -63.75 -47.42 81.1 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.252 0.464 . . . . 1.17 112.252 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 25.7 tpt180 -63.73 -33.37 75.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.671 0.272 . . . . 0.6 110.856 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -79.19 -43.86 23.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.283 -0.417 . . . . 1.35 111.541 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -58.6 -56.99 14.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.086 0.402 . . . . 1.15 112.086 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.5 mt -63.38 -31.07 51.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.359 -0.382 . . . . 0.51 110.772 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 39.0 ttpt -62.97 -35.38 79.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.343 0.592 . . . . 1.05 110.198 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -78.02 -40.61 38.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.713 -0.676 . . . . 0.91 110.592 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 87.3 t -58.78 -50.75 78.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.907 -0.588 . . . . 0.35 110.863 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -82.08 -11.61 58.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.084 -0.507 . . . . 0.63 111.036 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.8 t70 54.81 48.82 19.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.583 0.706 . . . . 0.47 110.753 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.5 t -158.45 144.42 16.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.51 -0.768 . . . . 1.14 110.317 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -90.97 -17.72 25.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.079 0.466 . . . . 1.74 110.76 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -91.08 68.99 6.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.595 0.712 . . . . 0.78 110.604 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 85.2 t -108.57 112.34 60.78 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.289 -0.869 . . . . 0.47 109.659 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.82 113.42 1.31 Allowed 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.915 2.41 . . . . 0.25 111.656 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 28.6 mtt -141.99 153.35 44.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.09 -0.505 . . . . 0.79 111.223 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.3 t -131.91 123.9 52.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.482 -0.781 . . . . 0.22 109.035 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 41.0 tp -85.37 121.85 28.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.042 -0.725 . . . . 0.29 109.042 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 11.2 t -127.19 138.05 55.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.004 0.431 . . . . 0.82 111.532 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.87 106.85 2.12 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 110.164 -1.174 . . . . 0.27 110.164 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -89.2 165.5 14.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.735 0.267 . . . . 0.21 111.024 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 67.52 34.85 4.43 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 115.466 -0.788 . . . . 0.54 111.008 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.432 ' HA ' HD11 ' A' ' 84' ' ' ILE . 27.5 p -68.75 -13.0 62.11 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.869 0.366 . . . . 0.46 111.344 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.67 -13.72 47.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.7 110.612 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 44.1 mt -82.51 142.06 45.96 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.399 -0.364 . . . . 0.67 110.175 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.3 -177.52 3.9 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.603 2.202 . . . . 0.54 111.925 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.5 m 62.83 48.75 3.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.295 0.569 . . . . 0.84 111.181 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.3 ttm-85 -72.38 110.99 7.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.749 -0.66 . . . . 0.58 109.95 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 p -95.14 -21.01 18.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.07 0.462 . . . . 0.81 110.728 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -98.69 110.33 25.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.115 -0.493 . . . . 0.37 110.051 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.99 143.12 56.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.985 -0.552 . . . . 1.69 111.176 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 m -59.54 -39.92 85.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.006 -0.543 . . . . 0.82 110.787 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -61.53 -38.52 87.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.62 110.954 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -58.4 -51.94 67.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.139 0.495 . . . . 0.93 110.744 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.43 -40.52 85.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.714 -0.675 . . . . 0.3 110.875 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -61.38 -40.49 94.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.811 -0.631 . . . . 0.47 110.356 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 -46.46 79.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.384 -0.371 . . . . 1.18 110.15 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.85 -44.91 93.87 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.804 -0.634 . . . . 0.44 111.0 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.73 -43.55 98.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.965 -0.561 . . . . 0.25 110.865 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -63.66 -36.16 82.91 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.837 -0.62 . . . . 1.54 111.95 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.4 p -74.77 -23.28 58.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.428 . . . . 0.68 111.133 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -89.45 -16.92 29.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.77 111.011 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.83 30.1 33.09 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.97 -0.559 . . . . 0.25 111.806 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 40.0 pt -127.08 152.97 76.55 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.7 -0.25 . . . . 0.51 110.543 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.7 148.51 22.82 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.669 2.246 . . . . 0.36 112.189 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 17.6 t80 -125.35 124.32 41.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.381 -0.372 . . . . 0.38 110.61 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.7 mt -132.61 133.73 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.34 -0.391 . . . . 0.54 110.343 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -88.52 135.01 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.812 -0.811 . . . . 0.88 108.812 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 70.6 p -138.96 175.53 9.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.52 0.676 . . . . 0.43 112.447 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.1 t -152.06 109.44 3.58 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.008 -0.996 . . . . 0.33 108.749 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.544 ' HB2' HD23 ' A' ' 19' ' ' LEU . . . -68.42 -24.48 64.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.273 0.558 . . . . 0.45 110.286 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -67.57 -47.83 68.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.004 -0.998 . . . . 1.32 111.296 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.9 p -97.04 3.91 51.66 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.711 -0.395 . . . . 0.52 110.925 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 55.83 45.73 23.63 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.55 -0.75 . . . . 1.53 110.414 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -107.72 120.74 43.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.447 -0.797 . . . . 0.87 111.056 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.31 -1.24 57.31 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.807 -0.633 . . . . 0.51 113.747 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 32.6 t -60.1 -42.29 89.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.981 0.391 . . . . 0.74 110.744 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.28 -50.77 62.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.795 -0.639 . . . . 1.62 110.203 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.12 -45.84 72.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.575 -0.739 . . . . 1.0 111.857 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.94 81.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.664 0.268 . . . . 0.37 111.247 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -66.64 -44.1 82.87 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.385 -0.371 . . . . 1.46 111.231 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -63.73 -42.35 97.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.446 -0.343 . . . . 0.99 111.564 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.445 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 36.6 m -61.82 -38.02 86.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.693 -0.23 . . . . 0.34 110.576 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 163' ' ' ILE . 48.3 tp -62.77 -40.6 97.79 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.901 -0.407 . . . . 0.42 109.901 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.83 -41.51 85.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.494 . . . . 0.55 110.078 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -67.77 -38.26 83.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.9 110.411 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 158' ' ' THR . 63.5 mm-40 -60.11 -43.51 95.56 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.93 -0.577 . . . . 0.73 110.814 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 159' ' ' LEU . 27.1 mt -67.53 -46.07 83.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.94 -0.573 . . . . 0.42 110.758 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 85.9 mtt180 -57.2 -42.22 80.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.152 -0.477 . . . . 0.87 111.447 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -59.56 -34.99 73.37 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.812 0.339 . . . . 0.97 110.951 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -79.67 -30.91 41.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.879 0.371 . . . . 0.71 110.209 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -67.93 -33.64 75.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.106 -0.497 . . . . 1.11 111.799 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 11.9 pt-20 -102.9 17.58 23.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.198 0.523 . . . . 1.12 110.602 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 17.8 tttp . . . . . 0 C--O 1.25 1.13 0 CA-C-N 115.518 -0.764 . . . . 1.47 110.195 -179.739 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.585 ' HA ' ' O ' ' A' ' 50' ' ' THR . 24.8 ttt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.982 -0.377 . . . . 1.48 109.982 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.1 m -106.09 144.15 33.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.116 -0.493 . . . . 1.04 110.752 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -93.26 135.41 34.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.224 -0.444 . . . . 1.27 110.795 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 51' ' ' CYS . 35.0 m-85 -121.84 117.99 27.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.325 -0.62 . . . . 1.11 109.325 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -95.17 107.77 19.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.959 0.409 . . . . 0.81 110.516 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 1.2 mp -119.46 141.74 48.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.853 -0.612 . . . . 1.39 110.965 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.04 135.67 62.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.227 -0.442 . . . . 0.81 110.552 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.44 115.82 47.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.614 -0.513 . . . . 0.44 109.614 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.6 m -114.06 169.32 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.123 -0.489 . . . . 0.7 110.251 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.27 170.22 17.9 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.792 -0.718 . . . . 0.53 112.033 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.528 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -67.81 159.14 30.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.075 0.464 . . . . 0.58 111.714 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.12 99.63 0.72 Allowed Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.827 -0.624 . . . . 0.8 112.872 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.26 7.69 5.77 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.673 -0.775 . . . . 0.42 113.142 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 11' ' ' ALA . 12.4 m -79.59 -39.06 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.558 -0.457 . . . . 0.57 110.625 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.515 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 126.58 24.97 1.32 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.557 -0.83 . . . . 0.49 113.573 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -50.98 -52.38 43.25 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.907 0.354 . . . . 0.81 111.76 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.64 -40.2 92.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.419 -0.355 . . . . 0.58 111.679 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.76 -42.55 97.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 0.43 111.548 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 72.0 mt -59.59 -44.88 93.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.368 . . . . 0.92 111.341 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.461 ' O ' HG12 ' A' ' 24' ' ' ILE . 7.7 m -67.16 -51.42 53.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.214 -0.448 . . . . 0.89 111.788 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.96 -31.45 47.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.67 0.272 . . . . 0.79 111.697 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 4.8 mm-40 -61.12 -30.0 70.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.913 0.387 . . . . 0.46 111.046 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tp -95.34 -35.76 11.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.302 -0.408 . . . . 1.37 111.318 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 20' ' ' THR . 40.3 mm -74.14 -55.79 11.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.409 0.522 . . . . 0.58 112.409 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -99.82 1.48 43.08 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.045 0.387 . . . . 1.68 112.045 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 73.0 m-20 57.81 32.61 22.15 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.63 0.974 . . . . 1.6 113.63 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -153.92 146.73 24.33 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.686 -0.405 . . . . 0.74 110.805 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -82.02 129.53 34.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.952 -0.567 . . . . 0.6 110.693 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.0 t -98.86 121.41 49.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.05 -0.523 . . . . 0.64 109.891 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.51 -55.95 8.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.615 -0.72 . . . . 1.12 111.445 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -113.77 115.12 27.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.324 0.583 . . . . 1.18 111.665 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -141.77 136.04 30.3 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.906 -0.776 . . . . 0.6 108.906 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -62.71 117.47 32.14 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 120.854 0.359 . . . . 0.8 110.561 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.92 -25.87 38.33 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.69 2.26 . . . . 0.52 112.898 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -8.47 57.05 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.382 0.512 . . . . 0.89 112.382 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.3 mt -79.24 119.51 28.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.068 0.461 . . . . 0.73 111.105 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 8.6 tt0 -111.13 97.9 7.13 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.411 -0.959 . . . . 0.81 108.411 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -126.43 163.1 24.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.764 0.316 . . . . 1.29 110.706 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.13 145.39 44.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.036 -0.529 . . . . 0.78 109.841 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -131.64 138.35 48.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.748 0.309 . . . . 0.94 110.286 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.427 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 0.7 OUTLIER -112.68 127.79 56.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.194 -0.457 . . . . 0.56 110.358 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -141.6 120.88 13.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.19 -0.459 . . . . 1.46 110.144 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 10.4 pt20 -93.15 122.0 35.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.947 0.403 . . . . 1.89 110.524 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.3 t -125.83 143.75 38.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.076 -0.511 . . . . 1.09 110.169 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 t -86.24 102.22 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.299 -0.63 . . . . 0.65 109.299 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.41 HG22 ' OD2' ' A' ' 47' ' ' ASP . 9.9 mt -114.17 123.36 69.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.849 -0.614 . . . . 1.06 110.743 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.41 ' OD2' HG22 ' A' ' 46' ' ' ILE . 21.7 m-20 64.77 22.59 12.58 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.605 0.566 . . . . 0.97 111.495 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.32 0.95 72.66 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.767 -0.73 . . . . 0.6 112.679 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -116.68 132.61 56.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.657 0.265 . . . . 1.41 110.83 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 1' ' ' MET . 1.3 m -82.9 111.67 19.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.87 -0.418 . . . . 0.63 109.87 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.431 ' HB3' ' CD2' ' A' ' 4' ' ' TYR . 2.5 m -112.45 134.73 53.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.391 -0.368 . . . . 0.71 111.233 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.9 tp -92.49 107.5 19.26 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.853 -0.795 . . . . 0.48 108.853 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 35.7 mt -82.66 115.64 21.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.22 -0.445 . . . . 0.87 111.547 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.427 ' OD1' ' HD2' ' A' ' 41' ' ' ARG . 12.5 t70 -103.4 95.65 6.22 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.941 -1.133 . . . . 1.03 107.941 178.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 31.1 mt -109.47 135.01 49.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.236 0.541 . . . . 0.68 111.646 -177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.7 tp -112.13 119.48 38.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.353 -0.84 . . . . 0.46 110.631 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 2.5 t70 -87.36 99.81 12.26 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.695 -0.854 . . . . 0.44 108.695 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.7 p -72.15 153.1 41.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.806 -0.634 . . . . 0.73 111.41 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.54 -63.92 1.08 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.176 -0.675 . . . . 0.56 109.176 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.75 -91.49 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.683 -0.689 . . . . 0.72 111.549 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -121.98 130.66 53.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.071 -0.344 . . . . 1.26 110.071 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.81 179.22 6.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.44 . . . . 1.57 110.764 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.18 -43.65 94.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.728 -0.669 . . . . 1.38 110.017 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -120.59 145.04 47.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.602 -0.726 . . . . 0.81 109.577 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -63.09 -34.6 77.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.318 -0.401 . . . . 0.63 111.26 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.91 -30.94 71.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.325 -0.398 . . . . 0.32 111.861 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 95.0 mtp -66.56 -33.46 75.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.094 0.474 . . . . 0.69 109.983 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -76.96 -39.93 48.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.729 -0.669 . . . . 0.9 109.856 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.32 -11.02 60.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.686 -0.688 . . . . 1.41 110.875 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -66.03 -69.28 0.31 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.017 -0.538 . . . . 1.51 110.347 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.444 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 8.3 p90 -70.41 -11.92 61.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.439 -0.346 . . . . 1.17 111.688 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.9 mtt -73.16 -13.98 61.27 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.903 -0.406 . . . . 0.7 109.903 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.489 ' CG ' HG12 ' A' ' 103' ' ' VAL . 64.4 mtm180 -109.22 -33.61 6.81 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.062 -0.517 . . . . 1.29 110.808 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -79.9 -15.55 57.1 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.482 -0.326 . . . . 0.72 111.661 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.8 134.12 34.94 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.705 -0.759 . . . . 0.19 112.439 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.8 -36.64 11.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.836 0.351 . . . . 0.54 110.359 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.83 128.2 6.8 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.99 -0.624 . . . . 0.26 111.676 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.513 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 94.1 m-85 -112.09 121.36 44.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.121 0.486 . . . . 0.48 110.682 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.6 tp -100.18 109.27 21.52 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.86 -0.609 . . . . 0.37 110.765 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 2.7 m -94.18 102.19 14.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.137 -0.483 . . . . 0.61 110.012 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.441 HG22 ' HB ' ' A' ' 114' ' ' VAL . 15.1 t -109.3 140.61 27.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.104 0.478 . . . . 0.59 111.374 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.39 170.53 15.92 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.746 -0.835 . . . . 0.34 108.746 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . . . -105.32 133.27 50.37 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.977 -0.379 . . . . 0.32 109.977 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 pt -66.49 -16.93 21.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.891 0.376 . . . . 0.78 111.496 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -107.78 10.12 28.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.005 0.431 . . . . 0.82 110.935 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 13.0 t-20 -132.7 92.69 3.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.087 0.47 . . . . 1.07 110.539 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -33.62 71.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.657 -0.701 . . . . 0.65 111.811 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -58.24 -45.46 87.72 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.945 0.402 . . . . 0.89 110.999 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.8 p -68.0 -28.13 67.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.64 110.974 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -76.06 -43.57 43.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.005 0.431 . . . . 0.42 110.686 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -67.28 -33.37 75.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 1.44 110.98 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -66.98 -19.76 65.77 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.42 -0.355 . . . . 1.02 111.1 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.48 -29.7 42.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 121.16 0.505 . . . . 0.42 109.994 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -62.25 -36.1 80.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.752 -0.658 . . . . 0.83 110.339 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -80.73 -24.75 38.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.194 -0.912 . . . . 0.79 110.762 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -62.45 -59.37 5.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.51 . . . . 1.17 110.183 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -55.41 -46.43 76.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.928 -0.578 . . . . 0.6 109.91 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -56.15 -48.83 75.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.298 -0.865 . . . . 1.35 111.903 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.623 ' O ' HG23 ' A' ' 103' ' ' VAL . 22.7 tt0 -61.79 -57.31 12.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.264 -0.426 . . . . 1.15 111.266 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.6 mt -60.07 -35.31 60.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 111.911 0.338 . . . . 0.51 111.911 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -59.53 -39.32 83.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.863 0.363 . . . . 1.05 110.569 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -75.05 -45.98 37.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.81 -0.632 . . . . 0.91 110.954 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 99' ' ' GLN . 21.8 t -59.9 -49.42 83.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.35 112.118 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.401 ' CG ' ' HA ' ' A' ' 73' ' ' ARG . 15.0 mtpp -81.7 -13.32 58.0 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.218 -0.193 . . . . 0.63 111.416 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.5 t70 54.61 50.64 15.52 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.882 -0.599 . . . . 0.47 111.224 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.9 m -141.54 144.51 34.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.333 -0.394 . . . . 1.14 110.176 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -44.12 28.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.364 . . . . 1.74 111.372 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -99.88 119.28 37.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.846 0.355 . . . . 0.78 110.46 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.82 123.8 21.27 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 115.977 -0.556 . . . . 0.47 110.142 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.84 108.09 0.45 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.435 2.09 . . . . 0.25 111.811 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.513 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 46.5 mtt -139.27 155.19 47.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.078 0.466 . . . . 0.79 111.174 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.3 t -135.06 124.71 43.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.524 -0.762 . . . . 0.22 108.953 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 19.0 tp -84.42 120.54 26.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.567 -0.531 . . . . 0.29 109.567 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.441 ' HB ' HG22 ' A' ' 81' ' ' VAL . 21.7 t -122.96 131.21 73.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.147 -0.479 . . . . 0.82 112.132 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -108.35 95.7 0.96 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.348 -1.101 . . . . 0.27 110.348 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -78.54 161.44 27.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.925 0.393 . . . . 0.21 111.879 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 81.2 mttt 63.7 35.98 11.03 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 115.31 -0.859 . . . . 0.54 110.895 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 28.2 p -69.74 -13.16 62.15 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.978 -0.556 . . . . 0.46 111.475 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -82.36 -10.11 59.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.029 -0.532 . . . . 0.7 110.951 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 58.6 mt -83.24 141.41 42.88 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.962 0.411 . . . . 0.67 110.671 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.28 -178.69 4.61 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.186 1.924 . . . . 0.54 111.588 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.8 m 63.5 45.71 4.63 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.183 -0.462 . . . . 0.84 111.059 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 123' ' ' ARG . 29.1 ttm-85 -59.27 123.03 15.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.965 -0.562 . . . . 0.58 110.401 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.81 -24.77 14.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.913 0.387 . . . . 0.81 111.1 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.3 t -104.82 111.68 35.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.166 -0.47 . . . . 0.37 110.758 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.1 141.58 58.67 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.756 -0.461 . . . . 1.69 109.756 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.83 -30.16 56.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.189 0.518 . . . . 0.82 112.131 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -68.05 -34.32 76.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.887 -0.597 . . . . 0.62 111.723 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -59.53 -57.12 14.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.952 0.353 . . . . 0.93 111.952 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.94 89.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.509 -0.314 . . . . 0.3 111.432 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -63.01 -44.13 96.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.016 0.436 . . . . 0.47 110.069 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.48 -38.72 90.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.656 -0.702 . . . . 1.18 110.304 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 65.5 tp -68.51 -41.05 80.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.717 -0.674 . . . . 0.44 110.898 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.7 91.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.25 110.408 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 135' ' ' ARG . 37.8 ttm105 -62.89 -36.81 84.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.91 -0.586 . . . . 1.54 110.774 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.0 m -69.19 -26.28 64.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.045 0.45 . . . . 0.68 111.138 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -91.09 -19.61 22.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.491 . . . . 0.77 111.187 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.43 27.53 47.6 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.629 -0.796 . . . . 0.25 111.564 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 26.6 pt -125.54 159.11 62.14 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.887 -0.412 . . . . 0.51 109.887 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.45 160.62 17.15 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.678 2.252 . . . . 0.36 112.901 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 13.4 t80 -135.74 131.53 35.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.541 -0.754 . . . . 0.38 110.316 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 37.3 mt -142.74 134.97 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.364 -0.38 . . . . 0.54 110.386 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -84.21 137.85 33.28 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.067 -0.716 . . . . 0.88 109.067 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.9 p -138.31 173.17 11.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.633 0.73 . . . . 0.43 111.716 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.4 t -149.01 123.08 9.45 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.066 -1.087 . . . . 0.33 108.066 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.44 -11.74 61.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.746 0.308 . . . . 0.45 111.291 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -85.13 -57.77 2.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.065 -0.516 . . . . 1.32 111.498 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.9 p -86.74 -10.33 53.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.333 . . . . 0.52 111.463 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 59.69 40.27 20.08 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.683 -0.69 . . . . 1.53 110.744 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -85.29 114.99 22.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.132 -0.486 . . . . 0.87 110.78 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.1 8.4 61.58 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.941 -0.572 . . . . 0.51 112.985 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 22.2 t -65.5 -50.88 69.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.766 0.317 . . . . 0.74 110.814 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.93 -37.63 84.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.103 0.477 . . . . 1.62 109.815 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.7 -42.72 93.62 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.134 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.68 79.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.915 -0.584 . . . . 0.37 111.733 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.402 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.5 OUTLIER -70.94 -39.72 72.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.29 -0.414 . . . . 1.46 111.494 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -61.48 -35.74 78.5 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.952 -0.388 . . . . 0.99 109.952 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 22.3 m -70.59 -35.22 72.9 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.541 -0.54 . . . . 0.34 109.541 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.27 -40.53 97.65 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.494 -0.558 . . . . 0.42 109.494 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 156' ' ' PHE . 94.0 t -61.78 -42.15 93.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.344 0.592 . . . . 0.55 109.712 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -65.3 -36.03 82.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.463 -0.79 . . . . 0.9 110.146 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -66.78 -38.84 87.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.967 -0.383 . . . . 0.73 109.967 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.522 ' O ' ' HG3' ' A' ' 167' ' ' LYS . 88.4 mt -61.81 -52.21 63.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.307 -0.627 . . . . 0.42 109.307 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.607 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 99.1 mtt180 -55.91 -44.81 78.6 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 115.529 -0.759 . . . . 0.87 110.077 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -56.49 -42.81 78.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.42 -0.809 . . . . 0.97 111.842 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -71.24 -36.03 71.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.245 -0.434 . . . . 0.71 111.519 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 163' ' ' ILE . 30.7 mtpt -74.67 -29.7 61.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.407 0.521 . . . . 1.11 112.407 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 6.6 pt-20 -86.77 -12.36 48.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.717 0.294 . . . . 1.12 111.14 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 31.7 tttp . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.431 -0.795 . . . . 1.47 110.395 -179.6 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.409 ' HA ' ' O ' ' A' ' 50' ' ' THR . 13.0 tmm? . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.196 -0.298 . . . . 1.48 110.196 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.448 ' HB ' ' CE2' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -113.87 138.7 49.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.372 -0.376 . . . . 1.04 110.893 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -96.32 131.37 42.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.529 -0.545 . . . . 1.27 109.529 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.448 ' CE2' ' HB ' ' A' ' 2' ' ' THR . 85.5 m-85 -120.91 124.55 45.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.567 -0.288 . . . . 1.11 110.251 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -95.63 107.49 19.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.144 0.497 . . . . 0.81 110.545 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.744 HD23 HD23 ' A' ' 159' ' ' LEU . 8.5 mp -111.84 133.26 54.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.649 -0.705 . . . . 1.39 111.187 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 78' ' ' PHE . 16.5 t -118.47 122.1 68.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.165 -0.47 . . . . 0.81 110.491 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.2 t -94.49 119.42 42.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.281 -0.637 . . . . 0.44 109.281 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 m -116.42 157.22 17.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.05 0.453 . . . . 0.7 110.987 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.31 170.92 29.9 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.62 -0.8 . . . . 0.53 111.772 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.34 173.21 7.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.971 0.415 . . . . 0.58 111.597 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.04 112.91 3.54 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.472 -0.87 . . . . 0.8 112.49 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.26 4.1 27.35 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.523 -0.846 . . . . 0.42 113.562 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 m -76.02 -17.61 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 117.391 0.595 . . . . 0.57 111.481 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.62 25.34 8.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.522 -0.847 . . . . 0.49 113.597 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -53.55 -55.98 20.97 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.785 0.326 . . . . 0.81 111.736 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -52.86 63.75 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.591 0.589 . . . . 0.58 112.591 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.82 -38.86 67.9 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.369 0.507 . . . . 0.43 112.369 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.0 mt -62.0 -44.47 96.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.543 -0.299 . . . . 0.92 111.354 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.419 ' O ' HG12 ' A' ' 24' ' ' ILE . 1.4 m -73.97 -39.71 63.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.631 0.253 . . . . 0.89 111.026 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.79 -32.61 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.985 0.422 . . . . 0.79 110.473 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.722 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 3.6 mm-40 -67.6 -21.96 65.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.883 -0.599 . . . . 0.46 111.222 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.14 -30.58 12.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.885 0.374 . . . . 1.37 110.625 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 20' ' ' THR . 51.5 mm -81.08 -61.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.927 0.394 . . . . 0.58 110.789 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -85.77 -6.69 59.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.293 0.568 . . . . 1.68 110.383 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.722 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 1.3 m-80 55.39 40.44 31.38 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 114.944 -1.025 . . . . 1.6 112.966 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -160.7 156.02 24.79 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.873 -0.418 . . . . 0.74 109.873 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -80.82 142.29 33.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.141 -0.481 . . . . 0.6 111.963 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.59 121.44 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.958 -1.127 . . . . 0.64 107.958 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.23 -41.53 40.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.799 0.666 . . . . 1.12 112.799 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -123.17 122.47 38.51 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.073 0.463 . . . . 1.18 111.305 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -149.31 139.15 21.91 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.578 -0.897 . . . . 0.6 108.578 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.467 ' HB3' HG13 ' A' ' 36' ' ' ILE . 5.8 t70 -62.78 123.74 80.71 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 123.516 0.51 . . . . 0.8 110.95 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.2 -13.25 23.38 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.775 2.316 . . . . 0.52 113.099 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.2 3.11 56.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.839 0.352 . . . . 0.89 111.352 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.467 HG13 ' HB3' ' A' ' 33' ' ' ASP . 58.3 mt -83.01 130.84 35.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 110.038 -0.356 . . . . 0.73 110.038 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 16.9 tt0 -128.57 82.88 2.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.748 -0.66 . . . . 0.81 109.435 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -111.47 171.7 7.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.095 -0.502 . . . . 1.29 111.272 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.0 141.66 48.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.989 -0.55 . . . . 0.78 109.871 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -126.34 133.43 51.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.106 -0.331 . . . . 0.94 110.106 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -107.62 119.7 40.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.951 0.405 . . . . 0.56 110.741 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -130.31 132.19 45.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.976 -0.556 . . . . 1.46 109.988 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.573 ' NE2' ' H ' ' A' ' 43' ' ' GLN . 1.4 pm0 -101.93 123.75 46.37 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.195 0.521 . . . . 1.89 110.443 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.3 t -130.31 143.37 41.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.013 -0.54 . . . . 1.09 109.622 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.51 66.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.178 0.513 . . . . 0.65 110.448 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.8 mt -74.2 124.64 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.55 -0.75 . . . . 1.06 110.774 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.96 17.67 9.58 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.697 -0.683 . . . . 0.97 110.975 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.02 7.18 81.04 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.472 -0.871 . . . . 0.6 112.394 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -116.6 131.45 56.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.764 0.316 . . . . 1.41 110.42 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 1' ' ' MET . 1.3 m -68.15 109.84 3.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.961 0.41 . . . . 0.63 110.934 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.2 m -112.65 130.02 56.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.27 -0.423 . . . . 0.71 111.004 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.0 tp -97.84 107.3 19.76 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.497 -0.927 . . . . 0.48 108.497 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -91.13 120.48 32.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.453 0.538 . . . . 0.87 112.453 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -105.85 98.24 7.95 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.873 -1.158 . . . . 1.03 107.873 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 49.8 mt -106.02 134.33 47.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.932 0.396 . . . . 0.68 111.932 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.5 tp -109.0 123.9 49.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.671 -0.695 . . . . 0.46 110.431 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 4.0 t70 -88.27 93.04 9.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.948 -0.76 . . . . 0.44 108.948 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.428 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 40.1 p -61.05 146.48 47.06 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.265 0.555 . . . . 0.73 111.78 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.76 -73.2 0.47 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.771 -0.65 . . . . 0.56 109.953 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.29 -42.67 0.11 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.255 -0.738 . . . . 0.72 111.255 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.422 ' HA ' ' OE1' ' A' ' 61' ' ' GLN . 12.7 mm-40 -133.95 155.03 50.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.711 0.291 . . . . 1.26 110.311 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -119.99 154.05 35.09 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.019 -0.537 . . . . 1.57 109.783 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.22 -34.27 75.93 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.152 -0.684 . . . . 1.38 109.152 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -130.38 127.19 38.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.545 -0.752 . . . . 0.81 110.554 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 m -57.57 -29.03 64.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.172 -0.467 . . . . 0.63 111.09 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.66 -37.53 76.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.976 0.417 . . . . 0.32 110.812 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 6.9 mtp -71.07 -30.91 67.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.936 -0.574 . . . . 0.69 110.143 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -69.77 -51.18 36.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.312 0.577 . . . . 0.9 109.671 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -65.87 -20.77 66.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.546 -0.752 . . . . 1.41 110.779 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -57.76 -57.77 11.28 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.077 -0.51 . . . . 1.51 111.144 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.42 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 10.9 p90 -70.77 -20.28 62.63 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.552 -0.459 . . . . 1.17 110.77 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 90.9 mtp -75.24 -27.17 59.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.058 0.456 . . . . 0.7 110.071 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.5 mtm105 -82.25 -41.09 20.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.014 0.435 . . . . 1.29 109.928 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 9.7 p -75.78 -12.65 60.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.956 -0.565 . . . . 0.72 111.384 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.34 129.0 11.0 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.926 -0.654 . . . . 0.19 112.312 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -87.46 -46.45 9.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.021 0.438 . . . . 0.54 110.094 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.69 143.9 14.73 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.135 -0.786 . . . . 0.26 111.135 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.522 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 75.3 m-85 -121.56 135.74 54.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.085 0.469 . . . . 0.48 111.557 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.3 tp -97.25 106.78 19.16 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.101 -0.703 . . . . 0.37 109.101 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' ' 111' ' ' MET . 0.1 OUTLIER -78.71 85.68 4.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.065 0.459 . . . . 0.61 110.312 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.63 132.88 34.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.135 0.493 . . . . 0.59 111.824 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.475 ' HB3' HD11 ' A' ' 93' ' ' ILE . 29.2 p90 -144.63 169.15 18.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.459 -0.792 . . . . 0.34 108.908 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.74 124.05 49.96 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.897 -0.321 . . . . 0.32 110.628 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.913 HD11 ' HA ' ' A' ' 118' ' ' CYS . 3.4 pt -71.9 -4.9 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.197 0.522 . . . . 0.78 111.054 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.537 ' OD1' ' HD2' ' A' ' 117' ' ' LYS . 8.7 p-10 -106.4 14.63 27.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.071 -0.513 . . . . 0.82 109.847 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -152.54 100.47 2.57 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.815 -0.63 . . . . 1.07 110.479 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.48 -29.2 68.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.636 . . . . 0.65 112.558 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -58.23 -35.97 72.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.757 0.313 . . . . 0.89 111.385 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.3 p -80.19 -33.78 37.95 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.762 0.315 . . . . 0.64 110.778 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -68.96 -41.73 77.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.42 110.844 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.63 -18.58 62.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.186 -0.461 . . . . 1.44 111.167 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -81.78 -18.66 43.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.904 0.383 . . . . 1.02 110.402 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.475 HD11 ' HB3' ' A' ' 82' ' ' PHE . 27.8 mm -57.79 -30.69 38.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.563 -0.744 . . . . 0.42 110.834 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -63.05 -47.38 83.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.978 -0.556 . . . . 0.83 110.465 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -66.51 -39.37 88.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.89 -0.595 . . . . 0.79 111.547 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -59.99 -45.71 91.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.642 0.258 . . . . 1.17 110.681 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.437 ' HG2' ' CE1' ' A' ' 137' ' ' TYR . 18.8 tpt180 -58.63 -49.62 76.82 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.084 -0.507 . . . . 0.6 110.282 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -60.73 -39.33 88.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.842 -0.617 . . . . 1.35 110.903 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -62.24 -53.13 59.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.56 -0.291 . . . . 1.15 110.896 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.7 mt -59.22 -42.07 85.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.465 -0.334 . . . . 0.51 111.015 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -66.08 -26.03 67.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.471 -0.331 . . . . 1.05 111.621 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -87.01 -35.84 18.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.004 0.431 . . . . 0.91 110.554 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.2 t -70.35 -46.92 69.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.817 -0.629 . . . . 0.35 111.328 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -87.09 -18.52 30.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.329 . . . . 0.63 110.733 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t70 54.6 54.53 9.13 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.306 -0.861 . . . . 0.47 111.055 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.3 m -137.31 146.63 44.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.961 -0.563 . . . . 1.14 109.877 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.24 -42.9 20.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.001 0.429 . . . . 1.74 110.039 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -93.68 106.74 18.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.857 -0.61 . . . . 0.78 110.349 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . 21.3 t -121.48 119.24 29.43 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.938 -0.393 . . . . 0.47 109.938 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 109' ' ' VAL . 16.9 Cg_exo -65.92 103.7 0.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.329 2.019 . . . . 0.25 111.275 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.535 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 85.9 mtp -138.07 151.34 47.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.204 -0.453 . . . . 0.79 110.399 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.7 t -129.55 121.76 53.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.503 -0.554 . . . . 0.22 109.503 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.6 tp -76.82 117.65 18.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.346 -0.613 . . . . 0.29 109.346 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.2 t -117.82 114.99 47.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.0 -0.546 . . . . 0.82 112.069 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.55 96.43 1.89 Allowed Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.049 -1.221 . . . . 0.27 110.049 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -80.67 162.77 24.02 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.775 0.287 . . . . 0.21 111.775 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.537 ' HD2' ' OD1' ' A' ' 85' ' ' ASN . 41.7 mttt 71.39 41.27 0.76 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.382 -0.826 . . . . 0.54 111.516 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.913 ' HA ' HD11 ' A' ' 84' ' ' ILE . 29.6 p -75.17 -19.36 59.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.944 0.402 . . . . 0.46 111.449 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -89.24 -7.55 55.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.966 0.412 . . . . 0.7 111.045 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 51.4 mt -91.56 145.68 31.74 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.256 -0.429 . . . . 0.67 110.859 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.63 -170.65 0.86 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.567 2.178 . . . . 0.54 112.047 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.2 m 58.78 44.85 16.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.134 -0.485 . . . . 0.84 111.544 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -72.24 118.22 14.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.58 110.197 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.49 -17.64 15.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.964 0.411 . . . . 0.81 111.603 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.72 115.52 49.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.07 -0.514 . . . . 0.37 110.779 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.74 148.23 42.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 1.69 110.59 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.6 m -59.55 -33.71 71.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.823 -0.626 . . . . 0.82 111.281 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -64.72 -44.33 90.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.695 -0.23 . . . . 0.62 110.673 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.45 HE21 ' HB3' ' A' ' 129' ' ' GLN . 0.1 OUTLIER -60.4 -41.44 93.88 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.074 0.464 . . . . 0.93 110.655 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.41 -48.33 67.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.594 -0.73 . . . . 0.3 110.561 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -62.03 -35.39 78.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.173 0.511 . . . . 0.47 110.382 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -48.92 79.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.812 -0.631 . . . . 1.18 110.578 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.32 -41.24 85.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.101 -0.499 . . . . 0.44 111.041 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.09 -44.91 83.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.951 0.405 . . . . 0.25 111.204 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -69.03 -25.17 64.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 1.54 110.899 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.0 m -71.5 -26.74 62.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.151 0.5 . . . . 0.68 110.241 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.437 ' CE1' ' HG2' ' A' ' 97' ' ' ARG . 19.1 m-85 -93.11 -33.3 14.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.245 0.545 . . . . 0.77 110.41 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.4 30.11 7.11 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.752 -0.939 . . . . 0.25 110.752 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.1 pt -123.55 156.89 63.72 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.283 -0.459 . . . . 0.51 110.486 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.4 157.37 29.19 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.192 1.928 . . . . 0.36 112.578 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -132.05 132.11 43.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.928 -0.578 . . . . 0.38 110.334 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 63.5 mt -137.81 130.76 41.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.54 111.174 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -81.8 128.15 33.71 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.389 -0.967 . . . . 0.88 108.389 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 64.2 p -131.86 174.73 9.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.272 0.558 . . . . 0.43 112.236 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.7 t -150.6 134.09 16.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.275 -0.875 . . . . 0.33 109.109 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.7 -6.88 59.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.127 0.489 . . . . 0.45 110.407 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -91.39 -48.24 7.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.008 -0.542 . . . . 1.32 110.912 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.0 p -94.22 -17.62 22.51 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.591 -0.277 . . . . 0.52 111.122 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 67.04 23.12 9.8 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.773 0.671 . . . . 1.53 110.86 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 144' ' ' THR . 35.2 tt0 -71.42 119.75 16.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.9 -0.591 . . . . 0.87 111.113 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.05 -8.87 42.17 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.923 -0.58 . . . . 0.51 114.028 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.38 -49.02 85.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 117.143 0.471 . . . . 0.74 111.14 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.37 -48.35 79.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.098 0.475 . . . . 1.62 110.148 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.0 -47.47 84.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.431 -0.804 . . . . 1.0 111.583 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -54.73 -50.41 68.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.679 0.276 . . . . 0.37 111.7 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.488 ' O ' HG23 ' A' ' 160' ' ' VAL . 26.6 m-85 -62.71 -42.68 99.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.346 -0.388 . . . . 1.46 111.578 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -70.22 -35.54 73.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.702 -0.226 . . . . 0.99 111.202 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 39.2 m -64.1 -39.45 94.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.803 0.335 . . . . 0.34 110.304 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.744 HD23 HD23 ' A' ' 6' ' ' LEU . 25.2 tp -61.64 -37.18 83.06 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.163 -0.471 . . . . 0.42 110.394 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 156' ' ' PHE . 21.2 t -64.08 -38.37 82.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.278 0.561 . . . . 0.55 109.778 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.6 mtt85 -70.49 -34.3 72.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.8 -0.636 . . . . 0.9 110.134 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -59.95 -40.43 88.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.802 -0.636 . . . . 0.73 109.96 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 65.4 mt -68.11 -45.2 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.501 -0.772 . . . . 0.42 110.268 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 93.4 mtt180 -54.23 -42.18 69.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.678 -0.692 . . . . 0.87 111.043 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -63.26 -36.95 85.36 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 115.796 -0.638 . . . . 0.97 111.135 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -69.69 -26.35 64.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.181 0.515 . . . . 0.71 110.411 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -82.82 -34.98 26.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.944 -0.571 . . . . 1.11 110.893 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 8.7 pt-20 -95.96 16.62 17.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.376 -0.375 . . . . 1.12 110.566 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.3 tttp . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.22 -0.895 . . . . 1.47 110.32 -179.855 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 50' ' ' THR . 31.8 ttm . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.967 0.413 . . . . 1.48 110.254 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.2 m -92.73 137.62 32.21 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.431 -0.349 . . . . 1.04 110.965 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -91.13 132.16 36.24 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.619 -0.511 . . . . 1.27 109.619 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -115.26 121.51 43.12 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.138 -0.319 . . . . 1.11 110.138 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -96.53 108.22 20.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.241 0.543 . . . . 0.81 110.988 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.8 mp -112.29 142.35 44.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.71 -0.677 . . . . 1.39 111.2 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.2 t -128.74 130.01 68.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.866 -0.607 . . . . 0.81 110.677 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.6 t -95.89 114.04 31.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.92 -0.582 . . . . 0.44 109.519 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -115.82 136.62 52.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.428 0.633 . . . . 0.7 111.425 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.2 176.08 45.0 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.43 -0.805 . . . . 0.53 111.589 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.431 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -71.83 167.73 19.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.864 0.364 . . . . 0.58 110.114 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.3 128.31 11.48 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.496 -0.859 . . . . 0.8 112.765 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.99 10.95 59.34 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.71 -0.757 . . . . 0.42 113.744 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 11' ' ' ALA . 27.2 m -85.94 -1.86 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 117.696 0.748 . . . . 0.57 111.357 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.511 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 92.46 29.59 10.89 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.954 -0.641 . . . . 0.49 113.371 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -60.59 -45.61 93.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.802 0.301 . . . . 0.81 111.518 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -75.63 -20.3 58.6 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.874 0.324 . . . . 0.58 111.874 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.15 -40.6 64.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.868 0.366 . . . . 0.43 110.733 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 37.8 mt -64.57 -27.58 69.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.864 -0.607 . . . . 0.92 110.616 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.468 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -74.24 -54.06 8.49 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.033 -0.53 . . . . 0.89 111.351 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.407 HG21 HG23 ' A' ' 29' ' ' VAL . 10.6 mt -61.13 -38.67 80.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.778 0.323 . . . . 0.79 111.433 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.641 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 2.5 mm-40 -66.85 -23.82 66.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.009 0.433 . . . . 0.46 111.194 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.2 tp -95.08 -40.73 9.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.74 0.305 . . . . 1.37 111.54 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 20' ' ' THR . 46.9 mm -74.61 -55.35 12.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.164 -0.471 . . . . 0.58 112.232 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 50.9 mt-30 -100.86 -11.64 19.65 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.945 0.35 . . . . 1.68 111.945 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 70.2 m-20 71.23 17.64 5.92 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.362 0.875 . . . . 1.6 113.362 178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -128.73 128.65 44.45 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.474 -0.49 . . . . 0.74 110.548 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -75.48 127.28 32.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.064 -0.971 . . . . 0.6 110.959 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.407 HG23 HG21 ' A' ' 21' ' ' ILE . 48.6 t -99.04 136.58 29.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.918 -0.583 . . . . 0.64 109.482 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -83.47 -30.5 27.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.502 -0.317 . . . . 1.12 111.778 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -134.84 116.3 14.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.902 0.382 . . . . 1.18 111.248 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -141.76 146.31 35.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.848 -0.614 . . . . 0.6 109.516 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.33 121.3 73.96 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.052 0.453 . . . . 0.8 111.357 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.43 -18.35 15.83 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.55 2.167 . . . . 0.52 112.865 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.07 3.32 52.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.261 -0.427 . . . . 0.89 111.208 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 mt -83.92 125.35 40.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.234 0.54 . . . . 0.73 111.321 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 18.4 tt0 -125.3 83.41 2.16 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.905 -1.146 . . . . 0.81 107.905 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -113.62 162.17 16.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.789 -0.641 . . . . 1.29 111.956 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.74 142.94 26.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.289 -0.869 . . . . 0.78 111.652 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -134.97 135.75 41.68 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.053 -0.351 . . . . 0.94 110.053 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.579 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 1.1 mpp_? -119.2 139.57 51.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.912 0.387 . . . . 0.56 110.565 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -143.04 131.33 22.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.1 -0.5 . . . . 1.46 110.302 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -101.7 112.27 24.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.985 0.421 . . . . 1.89 110.313 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.95 149.87 30.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.136 -0.484 . . . . 1.09 110.968 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.3 t -92.49 93.17 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.947 -0.761 . . . . 0.65 108.947 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.3 mt -91.51 114.05 28.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.049 -0.523 . . . . 1.06 111.805 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.493 ' HB2' HH12 ' A' ' 164' ' ' ARG . 56.5 m-20 58.26 37.78 26.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.662 -0.699 . . . . 0.97 111.099 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.5 -5.01 84.83 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.086 -0.578 . . . . 0.6 113.347 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -108.93 115.61 30.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.878 0.37 . . . . 1.41 111.759 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -70.22 116.92 11.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 0.63 109.768 178.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.3 m -129.89 151.64 50.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.084 0.469 . . . . 0.71 111.72 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.9 tp -104.25 113.45 27.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.001 -0.74 . . . . 0.48 109.001 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 53.7 mt -82.39 125.62 31.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.896 -0.593 . . . . 0.87 112.027 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -110.41 88.73 2.84 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.106 -1.072 . . . . 1.03 108.106 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.0 mt -99.81 130.58 48.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.96 -0.564 . . . . 0.68 111.871 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.7 tp -116.36 107.02 14.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.996 -0.547 . . . . 0.46 109.782 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -75.32 116.16 15.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.876 -0.602 . . . . 0.44 110.267 -179.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.7 p -73.45 156.32 38.38 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.515 0.674 . . . . 0.73 112.168 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.4 -55.78 2.38 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.79 -1.095 . . . . 0.56 109.949 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.28 -87.46 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.843 -0.617 . . . . 0.72 111.957 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -122.91 127.88 49.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.974 -0.38 . . . . 1.26 109.974 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -87.72 -173.73 4.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.271 -0.422 . . . . 1.57 111.094 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.13 -47.7 81.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 1.38 111.07 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -123.2 148.67 45.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.72 0.295 . . . . 0.81 110.521 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -60.91 -34.35 74.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.088 -0.506 . . . . 0.63 110.652 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.76 -28.87 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.891 -0.595 . . . . 0.32 111.362 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 86.0 mtp -70.05 -44.61 68.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.228 0.537 . . . . 0.69 109.847 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 71' ' ' TYR . 17.0 ttp180 -65.92 -39.0 90.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.538 -0.755 . . . . 0.9 109.91 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -77.79 -5.22 50.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.584 -0.735 . . . . 1.41 110.842 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -73.7 -62.86 1.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.661 -0.245 . . . . 1.51 111.642 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 68' ' ' ARG . 1.3 p90 -67.22 -17.83 64.98 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 120.606 0.241 . . . . 1.17 111.047 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.3 mtt -73.51 -17.43 61.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.225 0.536 . . . . 0.7 109.665 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -90.48 -49.77 6.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.557 -0.747 . . . . 1.29 110.187 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.15 -12.0 60.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.72 112.145 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.47 132.49 38.4 Favored Glycine 0 C--O 1.237 0.344 0 C-N-CA 121.123 -0.56 . . . . 0.19 113.18 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -97.96 -36.32 10.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 0.54 110.81 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.416 ' HA3' HD11 ' A' ' 163' ' ' ILE . . . -133.17 128.89 5.23 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.022 -0.831 . . . . 0.26 111.022 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.477 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 91.6 m-85 -114.99 116.85 29.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.244 0.545 . . . . 0.48 110.88 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.8 tp -88.8 109.19 19.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.54 -0.755 . . . . 0.37 109.908 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.5 m -82.53 103.54 12.14 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.356 0.41 . . . . 0.61 109.959 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.07 129.61 60.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.981 0.419 . . . . 0.59 112.084 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -136.6 162.3 33.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.652 -0.704 . . . . 0.34 109.674 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.442 ' HB1' ' OD1' ' A' ' 85' ' ' ASN . . . -100.95 126.76 47.62 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.365 -0.235 . . . . 0.32 110.365 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.1 pt -71.13 -12.16 15.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.948 0.404 . . . . 0.78 111.375 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.442 ' OD1' ' HB1' ' A' ' 83' ' ' ALA . 10.1 p-10 -95.23 5.79 50.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.826 -0.625 . . . . 0.82 110.75 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -148.43 111.73 4.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.072 0.463 . . . . 1.07 110.542 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.27 -26.96 66.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.1 -0.5 . . . . 0.65 111.938 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -58.35 -37.85 76.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.89 110.646 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -67.55 -38.15 83.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.378 -0.373 . . . . 0.64 110.796 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -66.67 -39.86 88.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.176 0.512 . . . . 0.42 110.068 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.53 -35.08 79.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.87 -0.604 . . . . 1.44 110.635 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -63.45 -32.8 74.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.901 -0.591 . . . . 1.02 110.932 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 89' ' ' SER . 45.7 mm -57.87 -31.55 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.586 . . . . 0.42 111.031 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -62.71 -35.92 81.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.126 0.489 . . . . 0.83 110.348 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -82.19 -38.5 24.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.79 110.104 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -58.69 -48.68 80.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.283 -0.417 . . . . 1.17 111.204 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -56.37 -51.78 67.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.958 -0.565 . . . . 0.6 110.919 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -39.89 95.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.032 -0.531 . . . . 1.35 111.061 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.449 ' O ' HG23 ' A' ' 103' ' ' VAL . 51.7 tt0 -59.36 -55.24 37.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.947 -0.57 . . . . 1.15 111.117 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.97 -37.76 79.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.435 -0.348 . . . . 0.51 110.755 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -61.09 -32.6 72.26 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.974 0.416 . . . . 1.05 110.026 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -77.46 -45.32 26.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.893 -0.594 . . . . 0.91 110.643 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 99' ' ' GLN . 66.4 t -59.93 -47.64 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.191 -0.459 . . . . 0.35 111.71 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -83.68 -13.32 54.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.451 -0.34 . . . . 0.63 110.541 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 t70 54.91 48.56 19.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.622 -0.717 . . . . 0.47 109.854 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.8 m -132.61 143.65 49.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.363 -0.835 . . . . 1.14 110.314 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.18 -31.06 30.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.1 0.476 . . . . 1.74 110.368 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -119.41 112.35 19.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.96 -0.564 . . . . 0.78 110.135 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.21 122.54 24.13 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.695 -0.483 . . . . 0.47 109.695 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -49.69 107.52 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.171 2.581 . . . . 0.25 111.982 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.477 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 56.5 mtt -140.04 150.2 44.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.952 -0.567 . . . . 0.79 110.719 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.4 t -132.46 121.81 46.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.665 -0.865 . . . . 0.22 108.665 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.637 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 56.3 tp -89.31 125.13 34.98 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.641 -0.503 . . . . 0.29 109.641 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.7 129.13 54.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.354 0.597 . . . . 0.82 111.861 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -94.5 103.86 3.07 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.224 -1.15 . . . . 0.27 110.224 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -81.51 164.52 21.92 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.576 -0.157 . . . . 0.21 110.576 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 69.7 mttt 66.97 36.93 4.06 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.733 0.646 . . . . 0.54 110.459 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 31.9 p -67.68 -13.63 62.26 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.24 -0.436 . . . . 0.46 111.957 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -89.53 -8.77 52.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.428 -0.351 . . . . 0.7 110.936 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 120' ' ' LEU . 16.3 mt -77.63 130.25 74.35 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.561 0.22 . . . . 0.67 110.976 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 11.2 Cg_exo -69.5 171.88 13.39 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.885 2.39 . . . . 0.54 112.081 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.8 m 61.57 54.55 3.01 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.393 0.616 . . . . 0.84 110.573 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -64.64 127.41 31.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.381 -0.827 . . . . 0.58 111.206 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.14 -41.22 7.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.074 -0.512 . . . . 0.81 110.512 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.3 t -88.96 113.32 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.222 -0.445 . . . . 0.37 110.295 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.06 147.61 49.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 1.69 110.878 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -46.85 87.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.82 111.848 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.6 tttm -65.22 -35.69 81.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.61 -0.268 . . . . 0.62 110.621 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -59.27 -44.34 92.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.93 110.881 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.56 -40.04 66.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 0.3 110.929 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.8 -34.42 78.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.761 -0.654 . . . . 0.47 110.953 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -40.82 98.46 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.789 -0.641 . . . . 1.18 110.226 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 27.8 tp -69.84 -42.07 74.07 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.872 -0.604 . . . . 0.44 109.547 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 139' ' ' ILE . . . -58.69 -45.47 89.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.302 -0.863 . . . . 0.25 110.423 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -59.07 -45.69 90.17 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.858 -0.61 . . . . 1.54 110.683 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.2 m -65.42 -35.08 79.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.945 -0.571 . . . . 0.68 111.301 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -79.02 -22.42 45.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.235 -0.439 . . . . 0.77 110.944 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.62 26.61 38.1 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.911 -0.661 . . . . 0.25 111.45 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.434 ' O ' ' HB1' ' A' ' 134' ' ' ALA . 34.7 pt -124.16 156.17 66.84 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 110.094 -0.335 . . . . 0.51 110.094 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -84.59 155.12 12.04 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.153 1.902 . . . . 0.36 112.859 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.637 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 19.0 t80 -130.93 127.03 37.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.918 -0.583 . . . . 0.38 110.549 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.9 mt -130.53 139.36 51.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.132 -0.485 . . . . 0.54 110.034 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -78.32 137.96 38.32 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.288 -1.005 . . . . 0.88 108.288 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.7 p -139.03 162.02 35.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.519 0.933 . . . . 0.43 113.519 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.6 t -155.09 117.25 4.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.687 -1.142 . . . . 0.33 108.559 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.87 -11.3 60.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.45 111.478 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -84.5 -42.84 15.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.278 -0.419 . . . . 1.32 111.439 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.5 p -96.55 -5.56 39.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.696 -0.229 . . . . 0.52 111.525 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 38.4 ttt85 59.75 47.66 10.1 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.611 0.719 . . . . 1.53 109.829 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -113.31 125.57 54.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.544 -0.753 . . . . 0.87 111.158 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.78 -21.83 3.7 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.802 -0.636 . . . . 0.51 113.303 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.17 -46.49 88.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.802 0.334 . . . . 0.74 111.654 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.452 ' O ' ' HD2' ' A' ' 157' ' ' TYR . 21.4 t70 -62.0 -49.24 76.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.495 . . . . 1.62 110.096 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -39.02 86.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.223 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -58.97 -52.05 67.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.222 -0.445 . . . . 0.37 111.94 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -62.58 -41.58 99.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.633 -0.258 . . . . 1.46 111.562 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.452 ' HD2' ' O ' ' A' ' 153' ' ' ASP . 29.0 m-85 -66.96 -34.63 78.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.99 110.807 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 99.5 m -68.42 -45.61 72.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.319 -0.4 . . . . 0.34 110.92 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 163' ' ' ILE . 31.0 tp -55.96 -41.79 75.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.361 -0.381 . . . . 0.42 111.052 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.88 -43.47 98.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.322 -0.399 . . . . 0.55 110.901 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -65.22 -34.22 77.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.444 -0.344 . . . . 0.9 111.011 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -64.05 -44.82 91.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.73 110.232 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 159' ' ' LEU . 17.2 mt -62.54 -43.9 98.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.086 0.469 . . . . 0.42 110.072 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.493 HH12 ' HB2' ' A' ' 47' ' ' ASP . 93.9 mtt180 -59.15 -42.78 91.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.42 -0.809 . . . . 0.87 111.371 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -66.08 -30.57 71.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.218 -0.446 . . . . 0.97 111.191 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -79.73 -26.06 40.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.256 -0.429 . . . . 0.71 110.213 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -77.08 -33.66 57.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.594 -0.275 . . . . 1.11 110.408 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -87.04 4.0 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 1.12 110.871 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.2 tptt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.367 -0.825 . . . . 1.47 110.848 -179.616 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttm . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 121.17 0.51 . . . . 1.48 110.371 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.0 m -76.38 126.84 31.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.133 -0.485 . . . . 1.04 110.712 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -94.14 134.67 36.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.133 -0.485 . . . . 1.27 110.253 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -122.49 128.08 50.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.375 -0.375 . . . . 1.11 110.279 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -99.58 108.82 21.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.269 -0.423 . . . . 0.81 109.921 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.467 HD11 HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -124.59 148.94 47.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.394 0.616 . . . . 1.39 110.981 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.13 132.03 70.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.924 -0.58 . . . . 0.81 110.862 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.4 t -91.24 119.19 38.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.035 -0.728 . . . . 0.44 109.035 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.7 m -116.65 157.83 17.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.829 0.347 . . . . 0.7 111.297 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.83 176.27 32.76 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.714 -0.954 . . . . 0.53 110.714 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -73.68 172.63 11.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.974 0.416 . . . . 0.58 111.415 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.91 121.19 5.67 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.697 -0.763 . . . . 0.8 112.189 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.71 3.03 55.26 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.821 -0.704 . . . . 0.42 113.245 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 11' ' ' ALA . 31.1 m -72.81 -29.09 28.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 117.391 0.596 . . . . 0.57 111.098 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.652 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 115.85 19.97 5.47 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.144 -1.027 . . . . 0.49 114.406 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -53.05 -53.58 48.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.468 0.634 . . . . 0.81 111.86 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -34.99 75.64 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.322 -0.399 . . . . 0.58 111.959 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.63 -40.62 88.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.5 -0.318 . . . . 0.43 111.278 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 23.5 mt -63.31 -39.05 93.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.375 -0.375 . . . . 0.92 110.88 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 m -66.14 -47.4 74.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.256 -0.429 . . . . 0.89 111.005 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.5 mt -65.59 -34.8 72.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 0.79 111.26 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 2.3 mm-40 -69.97 -12.67 61.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.991 0.424 . . . . 0.46 111.323 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.7 tp -102.29 -37.46 8.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.211 0.529 . . . . 1.37 110.861 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.9 mm -80.53 -59.08 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.908 -0.587 . . . . 0.58 111.425 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -89.92 -17.06 28.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.451 -0.34 . . . . 1.68 110.96 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 45.4 m-80 63.38 46.83 4.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.794 -0.639 . . . . 1.6 112.282 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -153.71 143.79 22.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.576 -0.528 . . . . 0.74 109.576 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -82.71 129.99 35.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.242 -0.435 . . . . 0.6 111.972 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.33 120.02 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.657 -0.701 . . . . 0.64 109.512 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.6 -41.17 32.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.236 -0.438 . . . . 1.12 111.888 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -115.6 108.97 17.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.181 0.515 . . . . 1.18 111.698 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -142.3 144.07 33.09 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.93 -0.767 . . . . 0.6 108.93 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -64.63 123.73 84.06 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.917 0.389 . . . . 0.8 110.9 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.18 -15.29 14.54 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.549 2.166 . . . . 0.52 113.386 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.44 3.16 56.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.674 0.273 . . . . 0.89 111.733 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.8 mt -86.0 127.46 40.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 120.849 0.357 . . . . 0.73 110.462 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 11.3 tt0 -114.86 94.94 4.98 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.215 -1.032 . . . . 0.81 108.215 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -115.47 164.18 14.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.01 -0.541 . . . . 1.29 110.918 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 1.2 p -130.06 129.84 44.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.776 -0.647 . . . . 0.78 109.961 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -125.35 143.81 50.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.642 -0.254 . . . . 0.94 110.947 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.694 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -113.2 143.06 45.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.56 110.575 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -147.02 134.85 21.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.703 -0.681 . . . . 1.46 109.459 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -103.18 114.49 28.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.943 0.401 . . . . 1.89 110.976 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 31.5 t -127.01 147.81 31.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.767 -0.652 . . . . 1.09 110.432 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.61 101.24 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.728 -0.471 . . . . 0.65 109.728 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 76.9 mt -105.96 118.1 52.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.963 0.411 . . . . 1.06 111.249 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.505 ' HB2' HH12 ' A' ' 164' ' ' ARG . 86.6 m-20 61.77 30.85 18.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.007 -0.997 . . . . 0.97 111.744 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.61 -0.21 73.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.855 -0.688 . . . . 0.6 114.163 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -121.68 126.67 49.53 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.46 0.63 . . . . 1.41 111.175 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.95 115.36 11.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.976 0.417 . . . . 0.63 110.111 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.1 m -116.89 147.72 41.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.108 -0.496 . . . . 0.71 111.576 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.9 tp -100.46 120.25 39.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.881 -0.599 . . . . 0.48 109.394 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.694 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 16.7 mt -89.73 115.99 27.5 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.047 -0.524 . . . . 0.87 112.128 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.424 ' OD1' ' HD2' ' A' ' 41' ' ' ARG . 19.0 t70 -104.31 95.18 5.77 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.53 -1.285 . . . . 1.03 107.53 176.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 39' ' ' SER . 6.1 mt -101.85 127.88 54.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.075 -0.511 . . . . 0.68 112.367 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.0 tp -114.23 119.45 37.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.057 -0.52 . . . . 0.46 109.859 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 4.5 t70 -89.84 100.88 13.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.115 -0.493 . . . . 0.44 110.074 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.4 p -62.51 138.54 58.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.779 -0.646 . . . . 0.73 112.597 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.54 -36.24 24.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.56 110.066 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.33 -74.9 0.42 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.964 -0.636 . . . . 0.72 111.83 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -108.93 117.89 35.36 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.818 -0.438 . . . . 1.26 109.818 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.94 162.7 15.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.172 -0.467 . . . . 1.57 110.432 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -55.56 -51.92 65.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.857 -0.61 . . . . 1.38 111.188 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -127.07 148.27 50.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.635 -0.506 . . . . 0.81 109.635 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -35.04 76.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.693 0.282 . . . . 0.63 111.361 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.94 -31.91 73.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 0.32 111.222 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 85.0 mtp -74.17 -31.67 62.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.268 0.556 . . . . 0.69 109.823 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.515 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 34.9 ttp180 -74.33 -46.45 40.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.453 -0.794 . . . . 0.9 109.906 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.488 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 39.2 m-20 -65.68 -24.45 67.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.409 -0.814 . . . . 1.41 110.228 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -57.9 -56.7 18.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.349 -0.841 . . . . 1.51 111.559 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 31.1 p90 -72.4 -14.26 61.66 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.861 -0.336 . . . . 1.17 111.407 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.4 mtt -76.16 -28.78 57.5 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.451 -0.574 . . . . 0.7 109.451 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 30.2 mtm180 -83.64 -34.18 25.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.831 -0.622 . . . . 1.29 111.163 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.425 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -78.91 -26.77 43.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.27 -0.423 . . . . 0.72 111.603 -179.399 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.82 125.76 28.47 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.038 -0.601 . . . . 0.19 112.712 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -92.0 -26.05 18.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.681 -0.488 . . . . 0.54 109.681 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -141.78 143.82 13.5 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 110.886 -0.886 . . . . 0.26 110.886 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.454 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 89.8 m-85 -126.8 132.43 51.03 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.229 0.538 . . . . 0.48 111.255 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 tp -100.87 112.28 24.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.724 -0.671 . . . . 0.37 109.368 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.7 m -90.01 104.72 17.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.102 0.477 . . . . 0.61 110.454 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.1 t -102.73 126.5 56.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.069 -0.514 . . . . 0.59 111.571 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -133.02 160.19 37.87 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.065 -0.717 . . . . 0.34 109.065 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.85 128.2 48.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.811 0.338 . . . . 0.32 110.492 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 pt -67.29 -14.2 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.367 . . . . 0.78 111.828 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -100.85 6.48 43.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.926 0.393 . . . . 0.82 110.397 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -135.67 103.32 5.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 1.07 110.246 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -27.22 66.97 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.447 0.536 . . . . 0.65 112.447 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -66.88 -37.74 84.98 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.161 -0.216 . . . . 0.89 111.123 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.429 ' O ' HG12 ' A' ' 93' ' ' ILE . 91.4 p -64.89 -36.87 85.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.425 . . . . 0.64 110.024 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -69.67 -35.71 75.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.924 -0.58 . . . . 0.42 109.955 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -65.62 -40.88 93.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.801 -0.636 . . . . 1.44 110.471 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.53 -26.35 68.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.737 -0.665 . . . . 1.02 111.769 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 89' ' ' SER . 48.3 mm -57.93 -28.64 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.099 0.476 . . . . 0.42 110.73 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -66.66 -41.12 88.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.973 -0.558 . . . . 0.83 110.68 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -77.71 -34.54 52.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.79 110.832 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -59.13 -48.02 83.16 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.524 -0.307 . . . . 1.17 110.741 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -60.57 -46.41 90.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.96 -0.564 . . . . 0.6 110.016 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -47.92 79.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.742 -0.663 . . . . 1.35 111.528 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.544 ' O ' HG23 ' A' ' 103' ' ' VAL . 26.0 tt0 -59.3 -58.19 9.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 1.15 112.111 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.33 -39.0 79.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 120.591 0.234 . . . . 0.51 111.026 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -61.38 -35.86 78.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.951 0.405 . . . . 1.05 110.457 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -73.64 -37.87 65.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.044 -0.525 . . . . 0.91 110.972 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 99' ' ' GLN . 47.8 t -68.96 -40.83 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.35 110.982 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -82.75 -20.15 36.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.485 -0.325 . . . . 0.63 111.222 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 54.92 57.31 5.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.507 0.67 . . . . 0.47 110.333 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -141.6 142.01 33.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.656 -0.702 . . . . 1.14 109.761 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -75.54 -31.82 60.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.906 0.384 . . . . 1.74 110.004 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.4 123.96 49.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.968 -0.56 . . . . 0.78 110.816 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.2 t -135.28 113.38 11.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.187 -0.671 . . . . 0.47 109.187 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.98 109.18 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.854 2.369 . . . . 0.25 112.783 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.454 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 30.9 mtt -139.33 152.98 47.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.964 -0.562 . . . . 0.79 110.722 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 73.3 t -131.45 127.25 59.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.171 -0.677 . . . . 0.22 109.171 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.4 tp -84.84 118.87 24.75 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.606 -0.516 . . . . 0.29 109.606 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 65.0 t -114.68 117.9 57.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.037 -0.529 . . . . 0.82 112.008 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.29 93.25 1.49 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.549 -1.02 . . . . 0.27 110.549 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -80.73 163.2 23.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.648 0.261 . . . . 0.21 111.623 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.6 mttt 68.39 33.84 3.98 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.42 -0.809 . . . . 0.54 111.233 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 20.9 p -68.05 -20.35 64.97 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 111.991 0.367 . . . . 0.46 111.991 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -86.54 -12.0 50.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.765 0.317 . . . . 0.7 111.383 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.21 142.17 54.71 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.358 -0.383 . . . . 0.67 110.737 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.05 174.14 12.48 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.382 2.055 . . . . 0.54 111.431 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.6 m 66.15 60.28 0.65 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.352 0.596 . . . . 0.84 111.054 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.5 ttm-85 -75.54 104.89 6.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.736 -0.666 . . . . 0.58 110.388 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 m -82.53 -36.84 25.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.093 -0.503 . . . . 0.81 111.045 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.0 t -97.39 111.0 26.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.22 -0.445 . . . . 0.37 110.628 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -68.6 148.21 50.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.802 -0.636 . . . . 1.69 110.135 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.2 m -57.62 -37.19 72.87 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.339 -0.391 . . . . 0.82 111.607 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -63.95 -37.57 87.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.665 0.269 . . . . 0.62 111.081 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -58.69 -45.89 88.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.93 111.236 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.76 -41.33 62.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.85 -0.614 . . . . 0.3 111.225 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -61.86 -39.48 92.04 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.031 0.443 . . . . 0.47 109.994 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.86 -46.66 89.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.776 -0.647 . . . . 1.18 110.56 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.89 -39.54 90.74 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.785 -0.643 . . . . 0.44 110.418 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.81 88.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.574 . . . . 0.25 110.945 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -64.4 -38.89 92.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.573 -0.285 . . . . 1.54 111.104 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.75 -23.71 62.48 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.094 0.473 . . . . 0.68 111.766 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -91.11 -19.12 23.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.145 -0.479 . . . . 0.77 110.283 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.8 32.85 48.5 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.407 -0.677 . . . . 0.25 111.407 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.448 ' HB ' ' O ' ' A' ' 111' ' ' MET . 36.6 pt -127.44 158.16 70.56 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.94 -0.393 . . . . 0.51 109.94 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.19 151.12 17.92 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.448 2.098 . . . . 0.36 112.718 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -124.53 129.05 49.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.76 -0.655 . . . . 0.38 109.757 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 67.0 mt -137.1 129.41 43.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.394 -0.366 . . . . 0.54 111.316 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -85.26 133.74 34.15 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.973 -0.751 . . . . 0.88 108.973 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 150' ' ' GLN . 41.4 p -138.84 179.94 6.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.541 0.686 . . . . 0.43 111.953 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.5 t -155.46 135.92 13.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.017 -0.992 . . . . 0.33 108.843 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.16 -7.4 58.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.064 0.459 . . . . 0.45 111.291 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -94.78 -48.75 5.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.068 -0.514 . . . . 1.32 111.117 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.9 p -92.71 -12.85 30.38 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 111.928 0.344 . . . . 0.52 111.928 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 57.81 38.41 27.26 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.333 0.587 . . . . 1.53 110.653 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.421 ' O ' HG22 ' A' ' 144' ' ' THR . 45.5 tt0 -69.83 94.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.146 -0.934 . . . . 0.87 112.251 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 68.72 22.25 75.28 Favored Glycine 0 CA--C 1.516 0.153 0 CA-C-N 115.788 -0.642 . . . . 0.51 114.561 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.43 -52.1 50.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 117.69 0.745 . . . . 0.74 110.618 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.8 -40.59 80.28 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.027 -0.533 . . . . 1.62 110.364 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -59.63 -49.57 77.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.251 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.28 84.96 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.099 0.476 . . . . 0.37 110.998 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -63.5 -48.87 75.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.681 -0.69 . . . . 1.46 111.058 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -67.57 -30.82 70.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.446 -0.343 . . . . 0.99 110.518 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 90.2 m -62.2 -40.84 97.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.34 110.257 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.44 ' O ' HG13 ' A' ' 163' ' ' ILE . 51.2 tp -59.14 -42.01 89.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.397 -0.365 . . . . 0.42 110.47 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 79.8 t -61.67 -39.74 84.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.55 110.365 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -68.4 -33.85 74.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.9 110.576 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 158' ' ' THR . 48.8 mm-40 -64.53 -40.89 96.44 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.299 -0.63 . . . . 0.73 109.299 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 159' ' ' LEU . 70.2 mt -62.52 -43.9 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.62 -0.718 . . . . 0.42 109.947 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.505 HH12 ' HB2' ' A' ' 47' ' ' ASP . 84.8 mtt180 -59.39 -43.94 92.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.905 -0.589 . . . . 0.87 111.021 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 168' ' ' GLU . 52.3 mtmt -62.04 -27.93 69.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.319 -0.4 . . . . 0.97 111.304 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -79.96 -35.36 37.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.013 0.435 . . . . 0.71 110.616 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 163' ' ' ILE . 29.5 mtpt -77.6 -30.99 52.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.191 -0.459 . . . . 1.11 111.483 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 6.0 pt-20 -86.09 1.17 51.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.709 0.29 . . . . 1.12 111.215 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 8.9 tttp . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.614 -0.708 . . . . 1.47 110.576 -179.57 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttt . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.95 -0.389 . . . . 1.48 109.95 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.7 127.07 32.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.908 -0.587 . . . . 1.04 111.796 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.82 122.43 46.75 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.853 -0.425 . . . . 1.27 109.853 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -122.65 130.79 53.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.479 -0.328 . . . . 1.11 111.023 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -92.19 123.0 35.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.006 -0.543 . . . . 0.81 110.915 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 2.8 mp -119.48 133.57 55.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.451 -0.795 . . . . 1.39 110.293 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.04 109.49 22.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.021 0.438 . . . . 0.81 110.301 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -76.42 125.68 36.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.287 -0.635 . . . . 0.44 109.287 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.1 m -116.84 148.04 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.145 0.498 . . . . 0.7 110.837 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.51 176.82 39.11 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.022 -0.831 . . . . 0.53 111.022 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.418 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -81.08 156.85 25.61 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.017 0.437 . . . . 0.58 111.392 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.31 102.7 0.76 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.796 -0.716 . . . . 0.8 112.032 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.15 0.73 6.9 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.822 -0.704 . . . . 0.42 112.792 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 11' ' ' ALA . 23.4 m -76.1 -19.4 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.828 0.347 . . . . 0.57 110.781 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.593 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 104.76 25.47 6.85 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.483 -0.865 . . . . 0.49 112.142 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -52.97 -50.96 63.07 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.255 0.465 . . . . 0.81 112.255 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.4 m -64.36 -34.06 77.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.922 0.342 . . . . 0.58 111.922 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.37 -34.31 75.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.712 -0.222 . . . . 0.43 111.472 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 30.4 mt -59.42 -53.98 51.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.355 -0.384 . . . . 0.92 110.756 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.409 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -67.34 -39.61 85.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.779 -0.646 . . . . 0.89 110.991 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.2 mt -58.37 -38.47 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.953 -0.567 . . . . 0.79 111.73 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -66.1 -37.56 86.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.928 0.394 . . . . 0.46 111.501 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.0 tp -78.78 -32.31 46.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.208 -0.451 . . . . 1.37 111.316 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 20' ' ' THR . 48.9 mm -89.32 -52.96 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 113.068 0.766 . . . . 0.58 113.068 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -87.1 -9.48 55.28 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.175 0.435 . . . . 1.68 112.175 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 65.25 21.41 12.05 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.202 0.445 . . . . 1.6 112.202 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -159.98 146.97 16.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.804 0.335 . . . . 0.74 110.302 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -77.18 145.62 37.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.706 -0.679 . . . . 0.6 111.499 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.7 t -119.86 122.31 68.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.183 -0.673 . . . . 0.64 109.183 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -73.71 -50.65 19.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.036 -0.529 . . . . 1.12 112.076 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -107.93 109.88 21.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.146 0.498 . . . . 1.18 111.951 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -145.46 134.32 22.44 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.875 -0.787 . . . . 0.6 108.875 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.01 126.62 90.49 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.009 -0.542 . . . . 0.8 111.707 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.27 -19.74 19.45 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.545 2.164 . . . . 0.52 112.111 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -16.02 56.25 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.008 -0.542 . . . . 0.89 111.739 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.43 116.96 24.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.382 0.611 . . . . 0.73 111.12 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -112.02 117.52 32.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.076 -0.965 . . . . 0.81 109.309 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -138.07 158.63 43.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.812 0.339 . . . . 1.29 111.326 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -106.6 127.14 53.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.855 -0.611 . . . . 0.78 109.644 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -111.02 139.36 46.44 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.55 -0.295 . . . . 0.94 110.791 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.61 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 0.2 OUTLIER -122.28 123.53 41.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.133 0.492 . . . . 0.56 110.921 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -134.69 140.44 45.99 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.6 -0.518 . . . . 1.46 109.6 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -110.01 123.18 49.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.883 0.373 . . . . 1.89 110.45 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.24 132.18 55.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.751 -0.463 . . . . 1.09 109.751 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.474 HG22 HG23 ' A' ' 50' ' ' THR . 22.1 t -84.04 91.97 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.875 -0.417 . . . . 0.65 109.875 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.4 mt -103.23 133.09 48.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.8 -0.636 . . . . 1.06 110.263 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 60.32 27.35 16.9 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.925 -0.58 . . . . 0.97 111.368 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.43 -0.15 88.26 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.184 -0.531 . . . . 0.6 113.165 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -109.85 130.99 55.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.865 0.364 . . . . 1.41 111.36 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.474 HG23 HG22 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -73.89 95.17 2.41 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.333 -0.617 . . . . 0.63 109.333 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 59.7 m -101.19 133.76 45.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.48 0.657 . . . . 0.71 111.467 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.6 tp -100.86 124.63 46.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.253 -0.885 . . . . 0.48 109.325 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 1.3 mp -93.04 113.13 25.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.116 -0.493 . . . . 0.87 111.706 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.61 ' OD1' ' HD2' ' A' ' 41' ' ' ARG . 14.8 t70 -105.3 93.41 4.67 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.154 -1.054 . . . . 1.03 108.154 177.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 13.6 mt -110.88 142.47 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.169 0.433 . . . . 0.68 112.169 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.3 tp -119.93 122.14 40.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.541 . . . . 0.46 110.999 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -88.64 89.83 8.15 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.231 -0.655 . . . . 0.44 109.231 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.1 p -65.87 134.95 54.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.004 -0.544 . . . . 0.73 111.725 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.93 -55.06 6.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.79 -0.641 . . . . 0.56 110.588 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.33 -76.52 0.17 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.442 -0.663 . . . . 0.72 111.442 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -99.95 125.57 45.99 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.955 -0.387 . . . . 1.26 109.955 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -94.46 166.62 11.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.067 -0.515 . . . . 1.57 110.659 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -58.28 -56.71 18.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.98 -0.554 . . . . 1.38 110.012 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -116.02 144.79 43.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.909 -0.587 . . . . 0.81 109.609 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -31.44 72.64 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.534 -0.303 . . . . 0.63 111.13 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.79 -27.89 69.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.32 111.458 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 81.7 mtp -68.89 -30.68 69.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.19 -0.459 . . . . 0.69 109.937 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.643 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 24.6 ttp180 -65.6 -45.09 84.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.025 -0.534 . . . . 0.9 109.672 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 67.3 m-20 -65.53 -30.55 71.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.469 -0.787 . . . . 1.41 110.255 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -58.24 -58.94 6.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.732 -0.667 . . . . 1.51 111.636 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.643 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 10.4 p90 -67.47 -21.42 65.53 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.373 -0.531 . . . . 1.17 112.104 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.5 mtt -77.19 -31.14 55.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.116 0.484 . . . . 0.7 110.637 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 39.8 mtm180 -77.62 -48.08 17.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.958 0.409 . . . . 1.29 110.532 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 m -73.69 -14.13 61.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.703 -0.681 . . . . 0.72 111.614 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.75 120.39 9.84 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.7 -0.762 . . . . 0.19 111.633 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -89.71 -32.68 16.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.964 0.411 . . . . 0.54 110.161 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -137.37 130.29 5.06 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.421 -0.672 . . . . 0.26 111.421 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.488 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 88.3 m-85 -116.34 126.11 53.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.085 0.443 . . . . 0.48 110.999 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.448 HD12 ' HB ' ' A' ' 112' ' ' VAL . 12.3 tp -96.51 106.5 18.76 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.066 -0.716 . . . . 0.37 109.066 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 56.9 m -83.79 107.46 16.21 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.737 -0.468 . . . . 0.61 109.737 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 19' ' ' LEU . 17.2 t -112.36 142.05 25.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.073 0.463 . . . . 0.59 111.952 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -142.79 167.08 22.92 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.499 -0.926 . . . . 0.34 108.499 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.86 132.48 50.08 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.056 -0.35 . . . . 0.32 110.056 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 118' ' ' CYS . 3.3 pt -67.6 -13.23 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.514 -0.312 . . . . 0.78 111.362 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -107.93 23.1 14.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.286 0.565 . . . . 0.82 110.554 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -150.31 98.08 2.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 1.07 110.477 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -31.28 71.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.083 -0.508 . . . . 0.65 111.94 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -62.84 -38.89 92.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.525 -0.307 . . . . 0.89 110.554 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 82.8 p -69.83 -23.79 63.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.993 0.425 . . . . 0.64 110.567 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -77.61 -39.38 45.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.83 -0.623 . . . . 0.42 109.652 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -74.0 -30.5 62.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 1.44 110.201 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -29.86 68.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.095 -0.502 . . . . 1.02 110.558 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.6 mm -57.58 -34.37 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.549 -0.75 . . . . 0.42 111.779 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -60.54 -45.44 93.88 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.579 -0.526 . . . . 0.83 109.579 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -69.29 -34.71 75.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.536 -0.756 . . . . 0.79 110.965 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -65.59 -51.26 61.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.728 -0.214 . . . . 1.17 110.92 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -59.37 -36.97 76.73 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.235 0.54 . . . . 0.6 110.275 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -70.58 -50.74 34.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.528 -0.76 . . . . 1.35 111.701 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -59.49 -49.46 77.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.967 0.358 . . . . 1.15 111.967 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 81.2 mt -61.67 -39.6 83.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.294 . . . . 0.51 111.243 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -66.85 -30.06 70.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.923 0.392 . . . . 1.05 110.744 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -76.66 -43.24 38.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.821 -0.627 . . . . 0.91 110.757 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.0 t -65.38 -45.48 93.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.035 -0.53 . . . . 0.35 110.801 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -79.32 -15.89 57.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.872 0.368 . . . . 0.63 110.528 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.4 t70 55.73 70.81 0.6 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.191 -0.913 . . . . 0.47 110.811 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.7 t -164.12 -172.01 2.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.657 -0.701 . . . . 1.14 109.818 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -125.41 -55.21 1.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.085 0.469 . . . . 1.74 109.865 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -77.51 91.79 3.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.801 -0.636 . . . . 0.78 110.239 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.4 t -118.45 113.13 36.92 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.828 -0.623 . . . . 0.47 109.939 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.74 111.13 0.48 Allowed 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 123.232 2.621 . . . . 0.25 113.131 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.488 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 46.3 mtt -144.25 157.44 44.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.89 -0.595 . . . . 0.79 110.491 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.448 ' HB ' HD12 ' A' ' 79' ' ' LEU . 86.1 t -135.38 124.45 40.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.053 -0.721 . . . . 0.22 109.053 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 20.5 tp -80.24 116.52 20.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.443 -0.577 . . . . 0.29 109.443 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 47.4 t -119.03 123.06 70.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.105 0.479 . . . . 0.82 111.608 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -99.11 114.76 5.12 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.192 -1.163 . . . . 0.27 110.192 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -97.32 166.06 11.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.83 0.348 . . . . 0.21 110.962 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.6 mttt 68.45 26.06 6.69 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.512 -0.767 . . . . 0.54 111.632 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 84' ' ' ILE . 24.8 p -67.32 -19.35 65.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.935 0.398 . . . . 0.46 110.802 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -79.74 -14.25 58.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.872 -0.603 . . . . 0.7 110.398 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 54.8 mt -85.72 151.58 55.61 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.128 -0.487 . . . . 0.67 109.715 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 1.4 Cg_endo -81.46 -176.63 3.18 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.968 2.445 . . . . 0.54 112.366 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 m 61.2 54.09 3.37 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.987 -0.551 . . . . 0.84 110.939 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 14.1 ttm-85 -63.79 112.03 2.7 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.673 -0.694 . . . . 0.58 110.3 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.03 -40.19 13.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.835 -0.621 . . . . 0.81 110.55 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.9 t -95.28 119.3 43.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.417 -0.356 . . . . 0.37 110.219 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -74.96 155.64 37.18 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.146 0.498 . . . . 1.69 111.482 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -38.45 83.76 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.48 -0.782 . . . . 0.82 110.958 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -69.4 -36.6 76.9 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.039 -0.528 . . . . 0.62 111.011 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -59.04 -43.02 91.6 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.087 0.47 . . . . 0.93 110.554 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.1 -40.37 60.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.887 -0.597 . . . . 0.3 110.461 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -61.95 -39.29 91.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.013 -0.54 . . . . 0.47 109.938 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.42 ' HA ' ' HD2' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -63.7 -40.56 97.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.559 -0.746 . . . . 1.18 110.578 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.8 tp -68.57 -41.39 79.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.755 -0.657 . . . . 0.44 110.937 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.54 -33.44 75.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.25 110.512 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 135' ' ' ARG . 63.8 mtt-85 -58.69 -55.52 34.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.709 -0.678 . . . . 1.54 111.623 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -42.79 96.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.081 0.467 . . . . 0.68 111.899 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -68.63 -22.34 64.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 0.77 111.051 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.36 43.2 46.89 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.968 -0.56 . . . . 0.25 112.409 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 31.3 pt -136.95 161.71 59.97 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.996 -0.372 . . . . 0.51 109.996 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.01 156.13 42.92 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.707 2.271 . . . . 0.36 112.505 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 5.7 t80 -135.37 125.15 25.45 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.572 -0.529 . . . . 0.38 109.572 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.7 mt -135.71 130.46 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.921 -0.312 . . . . 0.54 111.217 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -84.18 123.77 30.45 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.063 -1.088 . . . . 0.88 108.063 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.503 HG22 ' HA3' ' A' ' 151' ' ' GLY . 43.0 p -133.79 177.23 7.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.151 0.501 . . . . 0.43 111.252 -177.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.1 t -156.58 124.39 5.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.821 -0.627 . . . . 0.33 110.094 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.36 -12.95 60.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.29 0.566 . . . . 0.45 110.088 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.9 tttm -79.76 -53.16 7.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.574 -0.739 . . . . 1.32 110.743 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.8 p -83.27 -17.34 42.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.295 -0.411 . . . . 0.52 110.844 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.1 ttt180 70.3 21.27 5.86 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.932 0.77 . . . . 1.53 109.951 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -91.34 122.63 34.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.011 -0.54 . . . . 0.87 110.584 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.503 ' HA3' HG22 ' A' ' 144' ' ' THR . . . 91.7 -4.34 79.05 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.51 112.796 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 71.8 t -58.37 -59.99 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.666 0.247 . . . . 0.74 111.666 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.68 -47.61 84.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 1.62 110.834 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -56.16 -46.32 79.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.59 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -58.96 -53.66 55.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.869 0.322 . . . . 0.37 111.869 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.545 ' O ' HG23 ' A' ' 160' ' ' VAL . 50.4 m-85 -61.07 -49.57 76.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.421 -0.354 . . . . 1.46 111.458 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -59.42 -39.51 83.72 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.338 -0.392 . . . . 0.99 111.748 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.546 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 95.9 m -61.06 -44.45 97.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.527 -0.306 . . . . 0.34 110.86 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 35.2 tp -65.14 -36.44 84.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.713 -0.221 . . . . 0.42 111.174 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 156' ' ' PHE . 49.0 t -59.69 -41.02 83.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.194 0.521 . . . . 0.55 110.235 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -77.15 -23.62 51.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.812 -0.631 . . . . 0.9 110.916 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 158' ' ' THR . 52.6 mm-40 -64.76 -43.77 92.22 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.792 0.33 . . . . 0.73 110.379 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.427 ' H ' HG13 ' A' ' 163' ' ' ILE . 12.1 mt -65.15 -38.95 83.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.047 -0.524 . . . . 0.42 111.015 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 75.8 mtt180 -59.27 -38.8 81.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.769 -0.65 . . . . 0.87 110.991 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 162' ' ' GLU . 49.0 mtmt -62.62 -39.12 92.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.063 -0.517 . . . . 0.97 111.061 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -75.28 -34.6 61.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.299 -0.41 . . . . 0.71 110.562 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -73.06 -30.79 63.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.586 -0.279 . . . . 1.11 111.408 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -101.86 11.58 38.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.853 0.359 . . . . 1.12 110.736 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.7 tttp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.626 -0.702 . . . . 1.47 110.951 -179.204 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.5 ttm . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 110.36 -0.237 . . . . 1.48 110.36 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.2 m -92.91 134.89 34.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.496 -0.32 . . . . 1.04 110.674 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -87.71 127.14 35.3 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.808 -0.441 . . . . 1.27 109.808 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -112.46 128.02 56.21 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.849 -0.426 . . . . 1.11 109.849 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -97.04 122.83 40.47 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.129 -0.487 . . . . 0.81 111.332 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mp -129.75 137.79 50.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.923 -0.581 . . . . 1.39 110.7 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.6 t -124.15 128.1 73.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.261 -0.427 . . . . 0.81 110.276 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.2 t -89.18 124.12 41.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.194 -0.669 . . . . 0.44 109.194 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 9.8 m -115.77 148.95 18.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.606 -0.27 . . . . 0.7 110.587 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.38 178.24 38.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.985 -0.626 . . . . 0.53 112.101 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -78.24 168.68 19.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.996 0.427 . . . . 0.58 111.306 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.7 104.67 1.91 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.943 -0.646 . . . . 0.8 112.448 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.49 4.0 10.05 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.494 -0.86 . . . . 0.42 112.77 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 11' ' ' ALA . 15.9 m -74.3 -29.32 24.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.913 0.387 . . . . 0.57 111.25 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.85 22.06 5.14 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.678 -0.772 . . . . 0.49 113.788 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -52.78 -50.19 64.07 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.983 0.392 . . . . 0.81 110.933 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.4 ' O ' HG13 ' A' ' 21' ' ' ILE . 3.2 m -63.85 -43.42 96.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.722 0.296 . . . . 0.58 111.507 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.71 -48.41 79.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.857 0.317 . . . . 0.43 111.857 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.637 ' HG ' ' HB2' ' A' ' 146' ' ' ALA . 2.6 mt -65.29 -36.25 83.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.731 0.3 . . . . 0.92 111.237 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.4 m -70.16 -42.04 73.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.662 0.267 . . . . 0.89 111.024 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.46 HG21 HG21 ' A' ' 29' ' ' VAL . 82.4 mt -68.87 -31.86 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.407 . . . . 0.79 109.946 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.568 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 4.4 mm-40 -63.67 -21.43 66.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.98 -0.555 . . . . 0.46 111.599 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.7 tp -92.2 -14.98 28.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.139 0.495 . . . . 1.37 110.864 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.6 mm -104.3 -64.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.075 -0.511 . . . . 0.58 111.119 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -84.62 -7.61 59.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 1.68 110.823 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.6 OUTLIER 56.38 30.03 16.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.577 0.955 . . . . 1.6 113.577 177.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -142.2 146.4 35.19 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.932 -0.307 . . . . 0.74 110.36 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -68.01 143.07 55.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.12 -0.491 . . . . 0.6 111.427 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 21' ' ' ILE . 35.1 t -130.88 99.2 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.153 -0.684 . . . . 0.64 109.153 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.58 -41.46 54.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.15 -0.477 . . . . 1.12 111.122 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -94.31 97.46 10.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.216 0.531 . . . . 1.18 111.412 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -151.51 136.53 17.38 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.877 -0.786 . . . . 0.6 108.877 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -72.1 126.48 91.19 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.963 0.411 . . . . 0.8 111.494 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -65.82 -28.0 51.38 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.914 2.409 . . . . 0.52 112.83 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.24 -12.57 60.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.876 -0.602 . . . . 0.89 111.645 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -77.29 121.87 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.279 0.562 . . . . 0.73 110.34 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 15.3 tt0 -114.26 127.03 55.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.824 -1.08 . . . . 0.81 108.777 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -146.33 154.15 41.34 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.302 0.572 . . . . 1.29 111.403 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.4 129.17 53.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.483 -0.78 . . . . 0.78 109.953 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -117.83 147.49 43.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.747 0.308 . . . . 0.94 110.885 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.537 ' HD2' ' OD2' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -119.83 138.52 53.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.56 110.415 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -146.42 122.09 10.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.271 -0.422 . . . . 1.46 110.775 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.69 116.65 29.17 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.52 -0.548 . . . . 1.89 109.52 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.52 136.87 59.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.09 -0.504 . . . . 1.09 111.204 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 t -91.58 74.53 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.847 -0.797 . . . . 0.65 108.847 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.1 mt -82.9 113.54 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.604 -0.725 . . . . 1.06 111.332 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 65.95 28.84 10.48 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.319 -0.855 . . . . 0.97 111.012 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.59 -12.4 67.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.131 -0.556 . . . . 0.6 112.515 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -93.97 111.03 22.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.746 0.308 . . . . 1.41 111.053 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -73.32 104.59 4.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.137 0.494 . . . . 0.63 109.853 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.8 m -114.74 143.85 44.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.094 0.473 . . . . 0.71 111.081 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 tp -102.47 109.65 21.36 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.653 -0.869 . . . . 0.48 108.653 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 48.7 mt -82.63 117.77 22.83 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.289 -0.414 . . . . 0.87 111.654 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.537 ' OD2' ' HD2' ' A' ' 41' ' ' ARG . 15.1 t70 -101.03 86.07 2.97 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.529 -1.285 . . . . 1.03 107.529 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.1 mt -97.94 150.4 4.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.651 -0.704 . . . . 0.68 112.238 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 tp -137.84 130.4 29.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 0.46 111.02 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 3.9 t70 -91.91 107.48 19.24 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.574 -0.528 . . . . 0.44 109.574 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.8 p -72.53 137.36 46.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.146 0.498 . . . . 0.73 111.981 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.33 -37.8 66.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.542 -0.754 . . . . 0.56 110.209 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.88 -58.9 0.7 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.981 -0.628 . . . . 0.72 111.896 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -108.98 140.67 42.16 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.358 -0.608 . . . . 1.26 109.358 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -106.14 165.86 10.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 1.57 111.256 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -79.13 -42.06 27.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.113 -1.069 . . . . 1.38 108.113 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -126.42 129.67 49.19 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.854 -1.066 . . . . 0.81 109.155 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.41 -33.34 65.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.211 -0.449 . . . . 0.63 111.461 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.12 -35.15 77.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.196 -0.456 . . . . 0.32 111.205 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 87.9 mtp -69.66 -35.89 75.57 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.887 0.375 . . . . 0.69 110.849 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -66.37 -44.56 82.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.829 -0.623 . . . . 0.9 110.24 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 81.0 m-20 -80.69 -10.13 59.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.896 -0.593 . . . . 1.41 110.677 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -66.8 -58.45 5.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 1.51 110.639 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -67.16 -17.75 64.98 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.01 0.434 . . . . 1.17 111.336 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 46.0 mtt -69.07 -26.97 65.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.062 -0.517 . . . . 0.7 110.187 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 72.4 mtm180 -84.86 -42.94 14.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.055 -0.52 . . . . 1.29 110.345 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -27.39 61.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.771 -0.649 . . . . 0.72 111.812 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.91 139.79 43.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.962 -0.637 . . . . 0.19 112.692 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -93.57 -53.6 3.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.787 0.327 . . . . 0.54 110.945 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -122.76 138.43 11.8 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.716 -0.754 . . . . 0.26 111.763 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' A' ' 111' ' ' MET . 79.6 m-85 -117.96 135.27 54.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.172 0.51 . . . . 0.48 111.059 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.3 tp -101.86 113.86 27.43 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.717 -0.674 . . . . 0.37 109.866 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 3.6 m -89.44 89.45 7.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.039 -0.528 . . . . 0.61 110.579 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 11.8 t -96.86 129.63 46.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.017 -0.538 . . . . 0.59 111.189 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -129.78 179.21 5.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.175 -0.676 . . . . 0.34 109.175 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . . . -112.58 130.67 55.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.782 0.325 . . . . 0.32 110.457 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.427 ' HB ' ' HG3' ' A' ' 123' ' ' ARG . 3.1 pt -66.83 -19.3 25.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.099 -0.5 . . . . 0.78 111.505 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -104.99 15.64 27.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.145 0.498 . . . . 0.82 110.818 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.476 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 43.1 t-20 -140.44 92.75 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 1.07 110.218 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -25.46 68.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.33 -0.395 . . . . 0.65 111.349 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -67.81 -32.43 72.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.586 -0.279 . . . . 0.89 110.473 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.5 p -72.19 -30.44 64.95 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.979 -0.748 . . . . 0.64 108.979 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -69.62 -29.91 67.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.433 -0.803 . . . . 0.42 109.619 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.79 -38.52 73.37 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.728 -0.669 . . . . 1.44 110.101 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.19 -29.04 70.17 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.551 -0.749 . . . . 1.02 110.278 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.5 mm -56.21 -36.2 45.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.636 -0.711 . . . . 0.42 110.38 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -64.91 -36.32 84.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.639 . . . . 0.83 111.357 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -80.96 -32.2 34.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.347 -0.388 . . . . 0.79 111.032 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.496 ' CE1' ' HB ' ' A' ' 9' ' ' VAL . 3.6 m-85 -61.21 -51.04 70.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.496 0.188 . . . . 1.17 111.228 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.592 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 22.6 tpt180 -62.04 -30.03 70.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.313 0.577 . . . . 0.6 110.42 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -76.36 -53.06 8.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.247 -0.888 . . . . 1.35 111.98 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 103' ' ' VAL . 51.3 tt0 -62.37 -58.08 8.98 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.114 0.412 . . . . 1.15 112.114 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.5 mt -54.07 -39.74 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.914 0.338 . . . . 0.51 111.914 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 6.1 ttpt -66.36 -35.95 81.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.789 0.328 . . . . 1.05 110.802 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -76.8 -26.47 54.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.066 0.46 . . . . 0.91 110.534 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 99' ' ' GLN . 67.5 t -77.16 -40.63 30.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.35 110.02 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -80.24 -26.46 39.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.382 -0.372 . . . . 0.63 110.757 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 t70 66.73 51.01 1.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.641 -0.709 . . . . 0.47 110.34 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.94 163.14 31.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.552 -0.749 . . . . 1.14 109.893 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -96.72 -42.21 8.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.839 0.352 . . . . 1.74 110.152 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -102.1 116.35 32.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.013 -0.54 . . . . 0.78 110.039 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.4 t -127.96 122.08 22.14 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.097 -0.501 . . . . 0.47 109.794 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.57 104.23 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.787 2.325 . . . . 0.25 111.667 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.455 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 31.7 mtt -139.18 151.8 46.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.7 -0.682 . . . . 0.79 110.159 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.8 t -136.96 126.3 37.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.451 -0.574 . . . . 0.22 109.451 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 41.0 tp -81.81 122.33 27.56 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.641 -0.503 . . . . 0.29 109.641 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 142' ' ' ILE . 95.3 t -124.07 127.95 73.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.091 -0.504 . . . . 0.82 111.673 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.41 102.17 2.25 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.659 -0.976 . . . . 0.27 110.659 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 144' ' ' THR . 65.6 t30 -86.41 165.82 16.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.703 0.251 . . . . 0.21 110.356 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 69.76 29.8 4.01 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.861 0.726 . . . . 0.54 110.552 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 30.8 p -67.72 -11.91 59.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.879 -0.6 . . . . 0.46 111.38 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -87.17 -8.36 57.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.692 0.282 . . . . 0.7 110.731 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 43.0 mt -85.36 148.64 50.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.67 110.936 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.31 -177.77 3.66 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.611 2.207 . . . . 0.54 111.619 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.2 m 58.09 55.19 5.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.118 0.485 . . . . 0.84 111.055 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.427 ' HG3' ' HB ' ' A' ' 84' ' ' ILE . 16.5 ttm180 -66.97 109.71 3.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.878 -0.601 . . . . 0.58 109.9 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.01 -42.45 16.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.002 0.429 . . . . 0.81 110.619 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.31 112.53 22.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.262 -0.426 . . . . 0.37 109.875 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.89 148.13 52.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.893 0.378 . . . . 1.69 110.679 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.22 -39.51 79.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.896 -0.593 . . . . 0.82 112.34 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -68.81 -37.58 79.33 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 120.88 -0.328 . . . . 0.62 110.902 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -56.13 -43.91 78.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.763 0.316 . . . . 0.93 111.43 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.32 -46.47 55.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.911 -0.586 . . . . 0.3 110.894 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -59.96 -44.83 94.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.47 110.418 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -61.81 -42.9 99.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.462 -0.79 . . . . 1.18 110.498 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.22 -41.2 90.43 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.992 -0.549 . . . . 0.44 110.722 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.89 -35.26 80.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.365 -0.38 . . . . 0.25 110.346 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -63.87 -43.58 95.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 1.54 111.519 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.19 -17.96 65.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.637 0.256 . . . . 0.68 111.566 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -100.59 -8.12 23.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.236 -0.438 . . . . 0.77 110.214 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.8 31.25 70.16 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.762 -0.654 . . . . 0.25 112.583 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 44.1 pt -121.58 153.37 59.42 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 122.798 -0.236 . . . . 0.51 110.454 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.01 156.13 56.44 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.883 2.388 . . . . 0.36 112.856 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -128.6 120.85 27.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 0.38 109.56 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 73.8 mt -132.88 138.25 52.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.757 0.313 . . . . 0.54 111.038 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -93.57 126.72 38.88 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.288 -0.634 . . . . 0.88 109.288 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 116' ' ' ASN . 32.1 p -131.67 166.07 22.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.255 0.55 . . . . 0.43 111.257 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.2 t -146.33 122.38 10.75 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.496 -0.928 . . . . 0.33 108.496 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.637 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . . . -70.0 -10.79 59.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.103 0.478 . . . . 0.45 110.863 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -89.0 -48.02 7.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.758 -0.656 . . . . 1.32 111.476 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.0 p -93.56 -17.27 23.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.582 0.586 . . . . 0.52 112.582 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.448 ' HA ' HG21 ' A' ' 152' ' ' VAL . 0.5 OUTLIER 69.77 21.75 6.33 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.946 -0.57 . . . . 1.53 110.765 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 144' ' ' THR . 6.5 tt0 -73.9 120.27 19.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.639 -0.709 . . . . 0.87 110.809 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 66.44 6.66 35.64 Favored Glycine 0 CA--C 1.516 0.111 0 CA-C-N 116.072 -0.513 . . . . 0.51 113.633 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 149' ' ' ARG . 18.3 t -61.01 -61.04 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.521 0.2 . . . . 0.74 111.455 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.93 -37.9 83.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 1.62 110.51 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -56.93 -45.22 82.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.769 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -58.33 -47.79 82.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.37 111.266 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.434 ' O ' HG23 ' A' ' 160' ' ' VAL . 72.6 m-85 -64.55 -44.35 91.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.185 -0.461 . . . . 1.46 110.944 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -60.0 -37.02 78.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.99 111.296 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 19.3 m -65.42 -53.69 39.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.138 -0.483 . . . . 0.34 111.355 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.544 ' O ' HG13 ' A' ' 163' ' ' ILE . 14.0 tp -57.59 -35.8 70.89 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.702 0.287 . . . . 0.42 111.111 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 156' ' ' PHE . 38.3 t -58.36 -40.75 79.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.029 0.443 . . . . 0.55 110.733 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -78.96 -30.2 44.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.962 -0.563 . . . . 0.9 111.327 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 158' ' ' THR . 7.6 mm-40 -62.16 -40.89 97.5 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.854 -0.424 . . . . 0.73 109.854 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 159' ' ' LEU . 52.8 mt -63.36 -43.99 98.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.717 -0.674 . . . . 0.42 110.13 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 96.4 mtt180 -56.85 -49.43 75.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.785 -0.643 . . . . 0.87 111.068 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 169' ' ' LYS . 41.3 mtmt -57.36 -34.33 68.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.317 -0.401 . . . . 0.97 111.606 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -74.58 -37.26 62.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.486 -0.325 . . . . 0.71 110.692 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.449 ' HD2' HG22 ' A' ' 163' ' ' ILE . 47.2 mtpt -75.82 -33.0 60.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.4 -0.364 . . . . 1.11 111.903 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 10.3 pt-20 -92.49 7.4 43.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.952 0.406 . . . . 1.12 110.745 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 165' ' ' LYS . 30.7 tttp . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.245 -0.883 . . . . 1.47 110.128 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.6 ttm . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 109.926 -0.398 . . . . 1.48 109.926 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.7 m -94.48 134.7 36.73 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.048 -0.352 . . . . 1.04 110.048 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -85.71 129.98 34.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.914 -0.585 . . . . 1.27 110.496 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 51' ' ' CYS . 61.5 m-85 -125.57 115.65 20.51 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.816 -0.438 . . . . 1.11 109.816 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -100.48 113.85 26.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.158 0.504 . . . . 0.81 110.272 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.14 138.46 52.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.717 -0.674 . . . . 1.39 110.895 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.41 ' HB ' ' CD2' ' A' ' 78' ' ' PHE . 39.2 t -118.01 132.41 67.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.327 -0.397 . . . . 0.81 110.637 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 t -94.86 113.56 29.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.871 -0.789 . . . . 0.44 108.871 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 m -114.8 166.56 8.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.921 0.391 . . . . 0.7 111.291 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.19 -170.31 30.86 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.013 -0.835 . . . . 0.53 111.013 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.53 172.16 14.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.241 0.543 . . . . 0.58 110.85 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.74 128.09 8.96 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.701 -0.761 . . . . 0.8 112.595 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.99 13.32 72.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.899 -0.667 . . . . 0.42 114.02 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.4 m -73.41 -29.71 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 117.644 0.722 . . . . 0.57 111.031 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.48 20.41 2.65 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.351 -0.928 . . . . 0.49 113.84 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -54.68 -58.85 5.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.956 0.408 . . . . 0.81 110.97 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -54.28 -47.76 71.99 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.603 -0.726 . . . . 0.58 111.829 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.17 84.31 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.677 0.251 . . . . 0.43 111.677 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.3 mt -63.83 -40.63 97.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 0.92 110.524 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.9 m -72.04 -43.78 64.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.158 -0.474 . . . . 0.89 110.66 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.74 -42.11 87.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.046 -0.525 . . . . 0.79 110.915 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.555 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 4.3 mm-40 -64.02 -20.79 66.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.46 111.338 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.2 tp -91.44 -39.78 11.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.918 0.389 . . . . 1.37 111.147 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.7 mm -81.51 -50.66 16.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.263 -0.426 . . . . 0.58 112.104 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . 52.1 mt-30 -92.29 -16.49 26.03 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.931 0.345 . . . . 1.68 111.931 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 3.7 m-80 66.42 27.51 9.87 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.735 0.643 . . . . 1.6 112.735 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 25' ' ' GLN . 15.0 p80 -153.04 144.1 23.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.135 -0.32 . . . . 0.74 110.135 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -68.83 142.67 54.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.182 -0.463 . . . . 0.6 111.945 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 70.5 t -130.6 114.84 29.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 109.168 -0.679 . . . . 0.64 109.168 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -78.56 -42.72 28.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.926 -0.579 . . . . 1.12 111.26 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -100.49 102.16 13.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.297 -0.41 . . . . 1.18 111.948 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -155.19 117.59 4.23 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.65 -0.87 . . . . 0.6 108.65 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -52.32 122.43 24.77 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.52 0.676 . . . . 0.8 111.618 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.61 -18.14 15.62 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.685 2.257 . . . . 0.52 113.37 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.575 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -87.09 12.5 11.33 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.282 0.475 . . . . 0.89 112.282 -178.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.5 mt -99.71 105.64 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.244 0.545 . . . . 0.73 110.204 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 3.7 tt0 -86.48 87.0 7.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.878 -0.601 . . . . 0.81 109.535 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.81 161.69 14.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.626 -0.716 . . . . 1.29 110.583 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 10.4 p -131.18 144.71 51.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.194 -0.457 . . . . 0.78 110.351 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -126.39 149.17 49.4 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.218 -0.446 . . . . 0.94 111.083 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 1.7 mpp_? -123.75 123.8 41.3 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.35 -0.386 . . . . 0.56 110.458 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -144.62 124.97 13.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.846 0.355 . . . . 1.46 110.281 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -86.53 119.93 27.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.002 0.429 . . . . 1.89 110.548 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.3 t -129.53 141.08 47.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.925 -0.58 . . . . 1.09 110.166 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.7 t -87.64 106.35 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.78 -0.452 . . . . 0.65 109.78 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 32.6 mt -110.6 115.24 49.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.198 -0.455 . . . . 1.06 110.403 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 61.32 43.95 10.17 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.632 0.582 . . . . 0.97 111.334 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.1 27.77 71.43 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.6 113.317 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -137.74 120.94 16.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.93 0.365 . . . . 1.41 111.254 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -75.25 103.32 5.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.862 0.363 . . . . 0.63 110.238 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 4' ' ' TYR . 11.5 m -110.44 137.33 48.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.471 -0.331 . . . . 0.71 111.751 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.2 tp -92.03 111.55 23.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.149 -1.056 . . . . 0.48 108.149 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 60.2 mt -89.97 114.02 25.78 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.052 0.76 . . . . 0.87 113.052 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -106.0 101.5 10.99 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.765 -1.198 . . . . 1.03 107.765 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.5 mt -107.0 141.66 21.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.255 -0.429 . . . . 0.68 111.727 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.7 tp -122.37 125.91 46.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.792 -0.64 . . . . 0.46 111.108 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 7.0 t70 -92.48 101.89 14.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.25 -0.648 . . . . 0.44 109.25 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.4 p -67.35 134.76 52.12 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.482 0.658 . . . . 0.73 112.184 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' A' ' 35' ' ' THR . . . -89.45 -37.94 14.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.218 -0.901 . . . . 0.56 110.067 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 142.84 -94.9 0.18 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.84 -0.695 . . . . 0.72 112.531 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -101.78 118.23 36.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.159 0.504 . . . . 1.26 111.212 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.2 167.37 14.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.508 -0.769 . . . . 1.57 109.275 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -54.19 -52.84 59.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 1.38 110.913 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -117.41 141.0 48.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.122 -0.49 . . . . 0.81 110.239 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -63.19 -29.04 70.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.879 0.371 . . . . 0.63 111.03 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.84 -26.34 68.29 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.011 -0.54 . . . . 0.32 110.347 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 71.8 mtp -72.8 -37.7 67.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.675 -0.693 . . . . 0.69 109.595 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.602 ' HA ' ' CZ ' ' A' ' 71' ' ' TYR . 30.7 ttp180 -70.49 -43.92 68.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.866 -0.606 . . . . 0.9 109.967 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -28.3 67.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.427 -0.806 . . . . 1.41 110.636 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -56.22 -65.08 0.67 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.424 -0.807 . . . . 1.51 112.088 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.602 ' CZ ' ' HA ' ' A' ' 68' ' ' ARG . 3.5 p90 -69.1 -18.71 64.01 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.337 0.495 . . . . 1.17 112.337 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 32.8 mtt -71.45 -26.76 62.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.304 0.573 . . . . 0.7 109.927 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -90.03 -28.7 18.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.205 -0.452 . . . . 1.29 110.925 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -86.53 -26.24 24.65 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.084 0.402 . . . . 0.72 112.084 -179.169 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.26 125.82 24.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.798 -0.715 . . . . 0.19 111.96 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -83.34 -41.49 18.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.78 0.324 . . . . 0.54 110.234 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -129.65 133.26 7.4 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.535 -0.626 . . . . 0.26 111.535 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.41 ' CD2' ' HB ' ' A' ' 7' ' ' VAL . 94.1 m-85 -114.5 122.39 46.43 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.053 0.454 . . . . 0.48 110.934 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.503 HD12 ' HB ' ' A' ' 112' ' ' VAL . 11.7 tp -88.05 112.0 22.15 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.102 -0.703 . . . . 0.37 109.102 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.2 m -90.54 101.16 13.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.858 0.361 . . . . 0.61 110.428 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.3 t -103.01 131.92 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.259 -0.428 . . . . 0.59 111.54 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -134.19 171.06 14.76 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.978 -0.749 . . . . 0.34 108.978 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.54 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . . . -103.77 126.64 51.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.856 0.36 . . . . 0.32 110.824 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.6 pt -68.64 -16.61 21.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.78 111.074 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -106.97 24.1 13.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.274 -0.421 . . . . 0.82 110.932 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.54 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 28.5 t-20 -156.46 102.17 2.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.07 -0.514 . . . . 1.07 110.116 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.18 -23.34 66.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.978 -0.555 . . . . 0.65 111.833 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.452 ' HB3' ' OD1' ' A' ' 86' ' ' ASN . 51.2 tptt -56.01 -50.87 69.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.313 -0.403 . . . . 0.89 110.862 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.3 p -63.43 -41.4 98.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.64 111.156 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -61.52 -40.89 96.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.265 -0.425 . . . . 0.42 111.142 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -74.85 -11.7 60.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.237 -0.438 . . . . 1.44 111.587 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.52 -20.05 23.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.094 0.473 . . . . 1.02 110.271 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.8 mm -58.91 -29.88 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.526 -0.761 . . . . 0.42 110.794 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -59.19 -52.0 67.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.83 109.821 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -65.16 -32.4 74.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.474 -0.784 . . . . 0.79 111.101 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -65.95 -50.23 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.458 0.17 . . . . 1.17 110.856 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -60.05 -46.2 90.32 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.523 -0.547 . . . . 0.6 109.523 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.42 -47.92 84.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.767 -0.651 . . . . 1.35 111.075 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.518 ' O ' HG23 ' A' ' 103' ' ' VAL . 16.5 tt0 -58.88 -58.84 6.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.834 -0.621 . . . . 1.15 111.76 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.3 mt -55.83 -37.61 48.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.522 -0.308 . . . . 0.51 111.659 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -65.75 -37.51 86.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.532 0.206 . . . . 1.05 110.921 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.0 -33.38 51.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.91 111.07 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 99' ' ' GLN . 93.5 t -66.82 -45.13 88.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.064 0.459 . . . . 0.35 110.285 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -81.46 -26.29 35.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.14 -0.482 . . . . 0.63 110.354 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.6 t0 64.66 60.25 0.89 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.336 -0.847 . . . . 0.47 110.142 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.7 t -153.69 151.55 29.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.328 -0.851 . . . . 1.14 110.016 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -81.37 -42.99 19.65 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.061 -0.518 . . . . 1.74 111.081 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -97.24 117.7 32.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.055 0.455 . . . . 0.78 111.838 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 46.9 t -135.66 113.39 10.94 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.046 -0.724 . . . . 0.47 109.046 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.59 112.13 0.96 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.02 2.48 . . . . 0.25 112.369 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 50.5 mtt -141.58 156.93 45.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.949 -0.569 . . . . 0.79 110.3 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 79' ' ' LEU . 94.6 t -135.32 129.21 49.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 109.166 -0.679 . . . . 0.22 109.166 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.8 tp -85.0 115.37 22.79 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.549 -0.537 . . . . 0.29 109.549 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.1 t -114.99 117.45 55.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.815 -0.63 . . . . 0.82 111.756 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -95.92 94.6 1.7 Allowed Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.232 -1.147 . . . . 0.27 110.232 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -80.3 166.91 20.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.652 0.263 . . . . 0.21 111.415 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 69.69 33.12 3.07 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.465 -0.788 . . . . 0.54 111.064 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 18.7 p -69.61 -4.76 20.64 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.417 -0.356 . . . . 0.46 111.853 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -93.36 -11.22 32.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.463 -0.335 . . . . 0.7 110.831 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.5 mt -91.43 142.48 27.02 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.396 -0.365 . . . . 0.67 111.182 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -79.75 -169.81 0.87 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.828 2.352 . . . . 0.54 111.572 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.4 m 57.87 43.89 20.87 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.301 0.572 . . . . 0.84 110.387 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -63.33 119.03 8.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.184 -0.916 . . . . 0.58 110.126 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.86 -32.37 12.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.179 -0.464 . . . . 0.81 111.333 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 t -97.23 110.79 25.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.95 0.405 . . . . 0.37 110.396 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.16 148.46 48.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.976 -0.556 . . . . 1.69 111.044 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.04 -39.93 69.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.581 -0.736 . . . . 0.82 112.349 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -65.79 -38.83 90.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.574 0.226 . . . . 0.62 111.445 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -61.11 -42.45 98.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.906 0.384 . . . . 0.93 110.971 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.27 63.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.269 -0.423 . . . . 0.3 110.61 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 135' ' ' ARG . 6.6 tp-100 -62.38 -42.53 99.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.47 110.006 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.76 -35.46 78.18 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.077 0.465 . . . . 1.18 110.403 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.9 tp -68.83 -46.83 67.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.727 -0.669 . . . . 0.44 109.973 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.56 95.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.716 -0.674 . . . . 0.25 110.966 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 131' ' ' GLN . 24.9 mtm180 -65.31 -32.45 74.11 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.321 -0.4 . . . . 1.54 111.093 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.6 m -73.44 -29.98 62.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.91 0.385 . . . . 0.68 110.461 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -82.67 -40.08 21.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.183 0.516 . . . . 0.77 110.46 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.36 32.1 5.32 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 109.97 -1.252 . . . . 0.25 109.97 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 4.6 pt -128.34 168.35 15.91 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.338 -0.431 . . . . 0.51 110.592 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -86.55 160.12 9.4 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.532 2.155 . . . . 0.36 112.586 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -134.26 130.36 37.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.38 110.151 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.7 mt -139.28 132.41 37.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.139 -0.482 . . . . 0.54 110.985 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -82.92 129.71 35.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.728 -1.212 . . . . 0.88 107.728 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 30.9 p -137.71 173.87 11.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.512 0.672 . . . . 0.43 111.756 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.7 t -156.24 130.53 8.74 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.82 -1.082 . . . . 0.33 108.784 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.62 -8.71 57.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.224 0.535 . . . . 0.45 110.317 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -85.48 -51.9 6.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.707 -0.679 . . . . 1.32 110.914 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.7 p -91.12 -13.64 32.67 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.173 0.434 . . . . 0.52 112.173 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 149' ' ' ARG . 14.1 mtp-105 66.56 20.47 10.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.129 0.571 . . . . 1.53 110.706 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -74.24 121.16 20.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.922 -0.581 . . . . 0.87 111.814 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.26 -4.24 12.71 Favored Glycine 0 C--N 1.33 0.219 0 N-CA-C 114.99 0.756 . . . . 0.51 114.99 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.72 -51.26 74.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 117.403 0.601 . . . . 0.74 110.645 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.34 -39.06 89.19 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.283 0.563 . . . . 1.62 110.565 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.66 -42.04 98.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.557 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.45 81.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.37 110.741 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -60.08 -43.03 95.78 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.059 -0.519 . . . . 1.46 110.654 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -63.22 -45.58 90.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.849 -0.614 . . . . 0.99 111.04 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 26.5 m -62.65 -40.26 96.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.892 -0.595 . . . . 0.34 111.514 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.449 ' O ' HG13 ' A' ' 163' ' ' ILE . 37.3 tp -59.03 -40.79 86.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.932 0.396 . . . . 0.42 110.593 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.11 -38.62 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.55 110.3 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -68.86 -30.39 68.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.9 110.667 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -67.26 -44.06 80.3 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.736 -0.839 . . . . 0.73 108.736 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 159' ' ' LEU . 74.2 mt -60.74 -44.03 96.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 115.378 -0.828 . . . . 0.42 109.837 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 91.3 mtt180 -55.9 -48.66 75.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.738 -0.665 . . . . 0.87 110.805 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -61.6 -34.44 75.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.97 111.308 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -71.97 -35.99 69.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.71 110.282 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -69.62 -36.95 76.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.078 -0.51 . . . . 1.11 111.099 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 9.2 pt-20 -100.38 20.16 15.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.154 -0.476 . . . . 1.12 111.065 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.1 mttp . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.598 -0.715 . . . . 1.47 109.622 179.403 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.773 0.321 . . . . 1.48 110.462 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.03 145.17 27.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.259 -0.428 . . . . 1.04 110.73 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -105.58 131.69 52.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.177 -0.465 . . . . 1.27 110.584 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.607 ' HE2' ' HG ' ' A' ' 51' ' ' CYS . 52.1 m-85 -116.12 116.54 28.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.16 -0.473 . . . . 1.11 110.045 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -97.11 110.68 23.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.137 -0.483 . . . . 0.81 110.411 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -127.11 142.79 51.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.872 -0.603 . . . . 1.39 111.003 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.8 t -121.91 134.52 64.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.972 0.415 . . . . 0.81 111.027 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.7 t -93.74 103.97 15.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.235 -1.024 . . . . 0.44 108.235 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.73 146.49 15.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.278 -0.419 . . . . 0.7 111.351 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.94 -175.09 42.87 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.771 -0.728 . . . . 0.53 111.299 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.78 158.17 36.08 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.01 0.433 . . . . 0.58 111.321 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.29 134.41 15.62 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.55 -0.833 . . . . 0.8 111.884 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.69 2.06 60.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.794 -0.717 . . . . 0.42 113.568 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -79.25 -24.11 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 117.285 0.542 . . . . 0.57 110.91 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.99 25.77 4.35 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.688 -0.768 . . . . 0.49 113.467 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -53.44 -55.53 24.42 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 111.891 0.33 . . . . 0.81 111.891 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.485 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 1.0 OUTLIER -59.59 -53.47 57.65 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.888 -0.596 . . . . 0.58 112.048 -178.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.83 -43.55 77.09 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.778 0.659 . . . . 0.43 112.778 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.499 ' CD1' HG11 ' A' ' 81' ' ' VAL . 39.1 mt -59.81 -41.27 90.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.823 0.344 . . . . 0.92 111.632 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 m -76.83 -46.2 25.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.411 -0.359 . . . . 0.89 111.657 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 17' ' ' SER . 79.4 mt -60.14 -27.61 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.937 0.399 . . . . 0.79 111.631 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.2 -35.07 79.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.915 0.388 . . . . 0.46 111.143 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -91.56 -6.39 52.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.992 0.425 . . . . 1.37 111.347 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.1 mm -102.81 -43.41 9.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.329 -0.396 . . . . 0.58 111.129 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -105.31 -4.78 21.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.513 -0.312 . . . . 1.68 111.676 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.3 t30 64.15 35.27 10.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.024 0.75 . . . . 1.6 113.024 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -162.81 154.58 18.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.034 0.445 . . . . 0.74 110.817 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -87.81 128.96 35.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.659 -0.701 . . . . 0.6 111.205 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.8 120.82 47.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.252 -0.886 . . . . 0.64 109.032 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -77.01 -40.73 45.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 1.12 111.176 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -127.5 117.94 23.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.276 -0.42 . . . . 1.18 110.537 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -143.29 143.96 31.92 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.297 -0.631 . . . . 0.6 109.297 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.76 124.04 66.48 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.847 0.356 . . . . 0.8 111.158 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.26 -13.69 9.87 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.883 2.389 . . . . 0.52 113.79 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.7 p -98.19 1.15 47.08 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.805 -0.358 . . . . 0.89 111.777 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 mt -83.56 132.13 32.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.073 0.463 . . . . 0.73 110.353 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 10.0 tt0 -121.87 82.24 1.93 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.37 -0.832 . . . . 0.81 109.069 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -103.45 155.67 18.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.535 -0.757 . . . . 1.29 111.422 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.34 121.45 45.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.173 -0.467 . . . . 0.78 110.397 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -108.14 144.84 34.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.744 0.306 . . . . 0.94 110.349 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -119.51 141.18 49.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.838 0.351 . . . . 0.56 110.531 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -143.48 134.63 25.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.11 -0.495 . . . . 1.46 110.072 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -106.49 122.63 46.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.865 0.364 . . . . 1.89 110.409 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -137.39 133.01 46.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 1.09 111.232 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 t -85.48 71.58 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.477 0.656 . . . . 0.65 109.5 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 pt -88.26 130.88 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.781 -0.645 . . . . 1.06 111.529 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 63.48 31.59 14.81 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.55 -0.75 . . . . 0.97 111.077 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.7 11.12 83.3 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.852 -0.613 . . . . 0.6 113.097 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -117.28 119.73 36.04 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 122.586 -0.361 . . . . 1.41 110.783 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.8 m -79.83 96.73 6.4 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.6 -0.518 . . . . 0.63 109.6 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.607 ' HG ' ' HE2' ' A' ' 4' ' ' TYR . 58.6 m -114.05 158.49 21.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.225 -0.443 . . . . 0.71 112.056 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.0 tp -112.64 119.88 39.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.27 -0.877 . . . . 0.48 108.885 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 12.3 mt -90.65 131.32 36.42 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.056 0.455 . . . . 0.87 111.919 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -114.39 103.29 10.91 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.088 -1.079 . . . . 1.03 108.088 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 3.4 mt -110.9 151.33 13.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.305 -0.407 . . . . 0.68 111.706 -177.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.424 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 37.1 tp -131.22 119.37 21.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.332 -0.394 . . . . 0.46 110.327 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.562 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 4.6 t0 -84.68 98.3 10.14 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.57 -0.53 . . . . 0.44 109.57 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 36.0 p -64.85 141.18 58.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.778 -0.646 . . . . 0.73 112.347 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.88 -58.39 2.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.364 -0.835 . . . . 0.56 109.537 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.23 -47.11 0.53 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.752 -0.658 . . . . 0.72 112.262 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -135.93 129.09 31.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.741 0.305 . . . . 1.26 110.59 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -102.44 175.7 5.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.394 -0.595 . . . . 1.57 109.394 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -65.57 -43.45 89.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.927 0.394 . . . . 1.38 110.2 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -128.72 145.35 51.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.081 -0.509 . . . . 0.81 110.038 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -38.33 89.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.309 -0.405 . . . . 0.63 110.893 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.57 -28.28 68.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.186 -0.461 . . . . 0.32 111.402 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 82.9 mtp -73.79 -38.32 64.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.93 0.395 . . . . 0.69 110.264 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.402 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 35.7 ttp180 -71.09 -43.77 67.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.893 -0.594 . . . . 0.9 109.821 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.83 -19.5 65.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.362 -0.835 . . . . 1.41 111.39 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.444 HE22 ' C19' ' A' ' 203' ' ' QPD . 8.0 tt0 -59.95 -57.36 13.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.466 -0.334 . . . . 1.51 111.373 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.402 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 14.7 p90 -75.05 -5.02 41.83 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.779 -0.368 . . . . 1.17 111.425 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.5 mtt -76.37 -25.24 54.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.361 -0.607 . . . . 0.7 109.361 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -87.7 -42.32 12.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.605 -0.725 . . . . 1.29 110.451 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.17 -20.71 63.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.863 -0.608 . . . . 0.72 112.24 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.78 124.57 18.04 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.491 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -88.91 -39.83 13.51 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.794 -0.447 . . . . 0.54 109.794 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -128.78 137.58 9.73 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.815 -0.914 . . . . 0.26 110.815 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.461 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 93.9 m-85 -120.75 129.67 53.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.139 0.495 . . . . 0.48 111.38 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.6 tp -97.02 110.74 23.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.473 -0.785 . . . . 0.37 108.982 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 3.8 m -96.91 92.36 6.07 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.102 -0.499 . . . . 0.61 110.981 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.499 HG11 ' CD1' ' A' ' 19' ' ' LEU . 4.1 t -98.92 136.26 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.909 -0.587 . . . . 0.59 111.369 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -130.71 172.17 12.28 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.898 -0.779 . . . . 0.34 108.898 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.528 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . . . -105.17 122.86 46.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.596 0.236 . . . . 0.32 110.514 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.43 ' HB ' ' HG3' ' A' ' 123' ' ' ARG . 31.2 pt -66.54 -17.73 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.069 0.462 . . . . 0.78 111.562 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -98.14 4.12 49.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.957 0.408 . . . . 0.82 110.236 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 14.6 t-20 -135.34 90.38 2.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.737 -0.665 . . . . 1.07 110.073 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.43 HG23 HG22 ' A' ' 125' ' ' VAL . 0.4 OUTLIER -59.61 -28.29 67.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.024 -0.535 . . . . 0.65 112.071 -178.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -59.08 -38.72 80.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 0.89 110.559 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.5 p -75.27 -25.87 58.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.64 111.326 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -74.99 -34.67 62.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.056 0.455 . . . . 0.42 110.721 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.406 ' HA ' ' OE2' ' A' ' 91' ' ' GLU . 10.7 mm-40 -74.6 -24.43 58.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.007 0.432 . . . . 1.44 110.438 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -71.5 -14.48 62.13 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.868 -0.606 . . . . 1.02 111.257 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 30.3 mm -58.14 -35.72 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.021 -0.536 . . . . 0.42 110.406 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -61.34 -45.02 96.14 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.073 -0.512 . . . . 0.83 110.565 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -63.77 -48.26 77.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.907 -0.588 . . . . 0.79 111.75 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -60.53 -52.06 66.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.162 0.43 . . . . 1.17 112.162 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -55.43 -47.55 75.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.208 0.318 . . . . 0.6 110.754 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.05 -43.9 86.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.047 -0.524 . . . . 1.35 111.763 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 103' ' ' VAL . 56.1 tt0 -63.44 -54.51 35.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 1.15 112.165 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.31 -34.41 60.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.642 0.258 . . . . 0.51 110.955 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' A' ' 107' ' ' GLU . 30.0 mtpt -62.14 -35.35 78.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.066 0.46 . . . . 1.05 110.217 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -73.88 -41.15 62.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.617 -0.719 . . . . 0.91 110.905 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 99' ' ' GLN . 46.8 t -60.72 -41.92 90.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.35 111.382 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -89.21 -14.86 35.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.504 -0.316 . . . . 0.63 111.352 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.4 t70 58.82 54.84 4.94 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.748 0.785 . . . . 0.47 109.836 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.7 m -154.83 140.26 17.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.6 -0.727 . . . . 1.14 110.895 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.416 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 21.9 mt-10 -88.22 -23.31 23.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.25 0.548 . . . . 1.74 110.003 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -101.06 85.3 2.81 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.487 -0.779 . . . . 0.78 109.939 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.5 t -117.71 119.24 34.25 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.625 -0.716 . . . . 0.47 110.098 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.403 ' HG3' ' CB ' ' A' ' 166' ' ' HIS . 35.1 Cg_exo -58.06 115.96 2.89 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.115 2.543 . . . . 0.25 112.286 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.461 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 36.5 mtt -146.11 153.05 40.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.777 -0.647 . . . . 0.79 110.457 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.9 t -132.88 125.79 52.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.895 -0.78 . . . . 0.22 108.895 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.8 tp -82.72 125.82 31.68 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.545 -0.539 . . . . 0.29 109.545 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 81' ' ' VAL . 3.2 t -122.83 127.03 74.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.173 -0.467 . . . . 0.82 112.223 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.88 96.69 1.26 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.671 -0.971 . . . . 0.27 110.671 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -81.71 166.47 20.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.067 0.433 . . . . 0.21 111.671 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.6 mttt 72.58 31.79 1.65 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.042 -0.981 . . . . 0.54 111.645 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 15.8 p -70.91 -10.13 59.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.887 0.375 . . . . 0.46 111.008 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -94.71 -2.05 51.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.7 110.621 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.41 HD11 ' N2 ' ' A' ' 201' ' ' GDP . 33.1 mt -104.82 155.34 37.67 Favored Pre-proline 0 C--O 1.236 0.372 0 CA-C-N 116.085 -0.507 . . . . 0.67 111.07 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -87.31 -169.83 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.598 2.199 . . . . 0.54 112.03 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 m 60.09 45.6 11.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.79 -0.641 . . . . 0.84 111.167 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.43 ' HG3' ' HB ' ' A' ' 84' ' ' ILE . 12.5 ttm-85 -76.75 111.81 12.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.587 -0.733 . . . . 0.58 110.73 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.6 p -92.77 -31.04 15.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.094 0.473 . . . . 0.81 110.406 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.43 HG22 HG23 ' A' ' 87' ' ' THR . 58.3 t -91.22 108.19 19.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.988 -0.551 . . . . 0.37 109.958 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -71.87 150.11 44.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.86 0.362 . . . . 1.69 110.511 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.1 m -57.3 -39.43 75.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.724 -0.671 . . . . 0.82 111.631 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -59.46 -41.62 90.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.263 -0.426 . . . . 0.62 111.642 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -60.57 -47.02 88.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.93 110.762 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.07 82.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.962 -0.563 . . . . 0.3 111.296 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.04 -40.79 98.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.919 -0.582 . . . . 0.47 109.976 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.38 -42.52 96.01 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.737 -0.665 . . . . 1.18 110.95 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 29.1 tp -66.96 -46.09 75.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.882 -0.599 . . . . 0.44 110.605 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.21 94.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.882 -0.599 . . . . 0.25 111.43 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.1 mtm105 -64.11 -30.33 71.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 1.54 110.934 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.5 m -75.15 -34.23 61.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.25 -0.432 . . . . 0.68 110.91 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -78.16 -24.64 47.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.231 -0.44 . . . . 0.77 110.715 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.33 37.1 8.38 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.828 -0.909 . . . . 0.25 110.828 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.6 pp -135.73 162.62 55.94 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.419 -0.39 . . . . 0.51 110.377 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.61 152.93 11.78 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.09 2.526 . . . . 0.36 112.73 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -134.49 130.59 36.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.513 -0.767 . . . . 0.38 110.4 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.62 137.2 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.47 -0.332 . . . . 0.54 110.169 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -77.31 141.89 39.69 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.843 -0.799 . . . . 0.88 108.843 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 64.8 p -138.47 171.69 13.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.792 0.806 . . . . 0.43 112.768 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.1 t -153.58 118.31 5.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.702 -1.136 . . . . 0.33 108.827 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.62 -23.54 62.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.042 0.448 . . . . 0.45 110.85 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -75.51 -39.93 57.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.177 -0.465 . . . . 1.32 111.621 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 61.9 p -102.32 -8.0 21.59 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.94 0.348 . . . . 0.52 111.94 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 65.1 23.13 12.38 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.419 0.628 . . . . 1.53 110.517 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 144' ' ' THR . 44.3 tt0 -81.45 127.46 32.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.11 -0.496 . . . . 0.87 111.237 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.408 ' C ' HG22 ' A' ' 144' ' ' THR . . . 78.14 -25.73 2.24 Favored Glycine 0 CA--C 1.518 0.268 0 CA-C-N 116.014 -0.539 . . . . 0.51 113.899 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.412 ' H ' HG23 ' A' ' 152' ' ' VAL . 6.6 t -57.09 -41.97 78.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 0.74 111.426 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -61.9 -46.49 89.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.364 0.602 . . . . 1.62 110.12 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.39 -45.87 82.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.291 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -54.72 -50.99 67.0 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.233 -0.439 . . . . 0.37 111.71 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -62.43 -39.34 92.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 1.46 111.292 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -68.11 -40.95 82.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.977 0.418 . . . . 0.99 110.498 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 46.5 m -62.16 -40.15 95.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.903 -0.589 . . . . 0.34 110.443 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 163' ' ' ILE . 43.5 tp -59.12 -43.35 91.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.763 0.316 . . . . 0.42 110.793 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.2 t -62.12 -43.25 97.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.031 0.443 . . . . 0.55 110.468 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -67.24 -34.53 77.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.9 110.668 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -65.73 -36.41 83.52 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.242 -0.651 . . . . 0.73 109.242 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 159' ' ' LEU . 96.2 mt -64.12 -48.63 84.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 109.112 -0.699 . . . . 0.42 109.112 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -60.77 -43.52 97.93 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.566 -0.743 . . . . 0.87 109.929 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.589 ' O ' ' HG3' ' A' ' 169' ' ' LYS . 33.8 ttmt -55.66 -42.51 75.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.778 -0.646 . . . . 0.97 110.466 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 169' ' ' LYS . 42.4 t60 -70.9 -31.26 67.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.71 111.435 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -87.39 -4.7 59.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.479 -0.328 . . . . 1.11 111.543 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -117.47 14.1 14.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.051 0.453 . . . . 1.12 111.142 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 165' ' ' LYS . 7.8 mtpp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.414 -0.803 . . . . 1.47 109.781 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.485 ' O2A' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' QPD . . . . . 0.444 ' C19' HE22 ' A' ' 70' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.563 ' HA ' ' O ' ' A' ' 50' ' ' THR . 42.9 ttm . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.886 -0.413 . . . . 1.48 109.886 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.6 145.52 34.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.513 -0.312 . . . . 1.04 111.466 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -100.16 138.89 36.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.213 -0.662 . . . . 1.27 109.213 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -123.1 125.36 45.03 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.886 0.374 . . . . 1.11 110.356 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -88.44 102.73 15.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.296 0.57 . . . . 0.81 110.533 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 8.0 mp -107.89 131.87 54.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.585 -0.734 . . . . 1.39 110.382 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.45 124.62 64.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.277 -0.419 . . . . 0.81 110.913 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.6 t -95.17 119.75 43.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.22 -0.445 . . . . 0.44 109.958 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.412 ' HB ' ' CD1' ' A' ' 96' ' ' TYR . 12.0 m -112.54 155.04 13.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.953 0.406 . . . . 0.7 110.779 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.79 -176.12 37.43 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.281 -0.962 . . . . 0.53 112.537 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.56 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -80.24 161.54 25.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.127 0.489 . . . . 0.58 111.132 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.74 109.13 2.75 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.748 -0.739 . . . . 0.8 112.055 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.62 -2.7 17.87 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.582 -0.818 . . . . 0.42 113.391 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 11' ' ' ALA . 12.8 m -72.44 -28.19 27.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 117.32 0.56 . . . . 0.57 110.554 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.79 25.38 4.26 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.124 -1.036 . . . . 0.49 114.135 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -55.22 -55.6 29.47 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.066 0.46 . . . . 0.81 110.912 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.518 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 1.1 m -59.84 -36.42 76.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.245 -0.888 . . . . 0.58 111.719 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.66 -42.97 95.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.43 110.96 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.6 mt -66.66 -41.24 88.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.23 -0.441 . . . . 0.92 110.825 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.4 m -68.68 -46.04 70.1 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.886 -0.597 . . . . 0.89 111.767 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 82.1 mt -66.2 -24.83 34.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.712 0.291 . . . . 0.79 110.997 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 3.9 mm-40 -61.31 -35.42 77.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.797 0.332 . . . . 0.46 111.039 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 mp -84.86 -15.44 44.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.921 0.391 . . . . 1.37 111.17 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.4 mm -95.42 -56.45 5.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 112.207 0.447 . . . . 0.58 112.207 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -96.09 -10.28 28.74 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.815 0.302 . . . . 1.68 111.815 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 32.7 m-20 59.95 36.51 21.67 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.736 0.643 . . . . 1.6 112.736 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.88 136.35 15.05 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.655 -0.498 . . . . 0.74 109.655 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -70.54 125.3 26.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.077 -0.511 . . . . 0.6 111.033 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.3 t -90.43 113.03 25.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.068 -0.715 . . . . 0.64 109.068 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -75.27 -36.91 61.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.421 -0.354 . . . . 1.12 111.503 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -124.54 114.44 19.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.768 0.318 . . . . 1.18 110.432 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -143.83 130.17 19.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.328 -0.396 . . . . 0.6 110.371 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.5 ' HB3' HG13 ' A' ' 36' ' ' ILE . 39.2 t0 -65.05 125.75 89.84 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-N 115.523 -0.762 . . . . 0.8 110.62 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.39 -18.46 26.26 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.923 2.415 . . . . 0.52 113.507 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.1 p -84.36 0.12 50.51 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.77 0.319 . . . . 0.89 111.595 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.5 HG13 ' HB3' ' A' ' 33' ' ' ASP . 83.5 mt -83.07 122.88 38.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 110.084 -0.339 . . . . 0.73 110.084 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -122.76 112.72 18.25 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.469 -0.787 . . . . 0.81 109.61 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -144.4 167.21 23.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.836 0.351 . . . . 1.29 110.993 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 1.4 m -117.89 122.62 43.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.3 -0.63 . . . . 0.78 109.3 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -103.22 132.74 49.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.325 -0.398 . . . . 0.94 110.314 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.28 134.48 51.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.024 -0.535 . . . . 0.56 110.662 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -148.47 129.63 14.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.935 -0.575 . . . . 1.46 110.002 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.468 ' NE2' ' H ' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -92.44 134.53 34.86 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.725 -0.472 . . . . 1.89 109.725 179.052 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.59 151.8 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.799 0.333 . . . . 1.09 110.864 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.5 t -111.41 91.7 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.928 -0.578 . . . . 0.65 109.874 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.24 121.77 54.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.102 -0.499 . . . . 1.06 109.946 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 64.75 23.51 12.74 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.723 -0.671 . . . . 0.97 111.316 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.93 -17.18 59.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.844 -0.693 . . . . 0.6 112.491 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -82.58 126.19 32.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.942 0.401 . . . . 1.41 110.862 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 1' ' ' MET . 5.0 m -93.59 103.34 15.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.115 -0.493 . . . . 0.63 109.891 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.0 m -121.71 156.65 32.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.194 0.521 . . . . 0.71 112.188 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.1 tp -108.43 118.66 37.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.181 -0.918 . . . . 0.48 108.712 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.23 121.66 33.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.001 0.429 . . . . 0.87 111.418 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -106.88 105.4 15.42 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.125 -1.065 . . . . 1.03 108.125 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 55.4 mt -112.81 130.46 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.978 0.418 . . . . 0.68 111.819 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.402 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 23.7 tp -106.24 118.14 35.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.925 -0.579 . . . . 0.46 110.505 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.31 93.33 9.36 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.918 -0.771 . . . . 0.44 108.918 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.29 146.31 52.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.896 -0.593 . . . . 0.73 111.674 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.21 -46.8 9.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.819 -0.628 . . . . 0.56 110.624 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.79 -70.1 0.34 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.696 -0.764 . . . . 0.72 112.161 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -97.99 111.04 23.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.908 0.385 . . . . 1.26 110.849 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.67 166.07 19.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.042 -0.526 . . . . 1.57 110.56 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.413 ' HB3' ' SD ' ' A' ' 67' ' ' MET . 25.0 tt0 -62.8 -45.89 90.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.641 -0.503 . . . . 1.38 109.641 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -127.85 142.8 51.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.063 -0.718 . . . . 0.81 109.063 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 m -61.56 -26.31 67.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.065 0.459 . . . . 0.63 111.102 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.79 -29.89 69.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.914 -0.584 . . . . 0.32 110.965 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.413 ' SD ' ' HB3' ' A' ' 63' ' ' GLU . 74.3 mtp -69.96 -41.38 74.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.895 -0.593 . . . . 0.69 110.006 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.648 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 36.3 ttp180 -64.43 -39.42 93.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.538 0.685 . . . . 0.9 109.571 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.22 -19.01 64.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.775 -1.102 . . . . 1.41 111.235 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -77.02 -55.8 5.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.329 -0.396 . . . . 1.51 111.752 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.648 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 7.0 p90 -68.51 -16.97 64.06 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.479 -0.488 . . . . 1.17 111.449 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.7 mtt -81.86 -12.95 58.23 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.868 -0.419 . . . . 0.7 109.868 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -95.01 -52.18 4.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.017 -0.538 . . . . 1.29 110.997 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -20.27 63.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.72 112.083 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.09 129.2 43.28 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.592 -0.813 . . . . 0.19 112.555 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -90.78 -48.5 7.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.998 0.427 . . . . 0.54 109.999 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.07 128.94 7.73 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.868 -0.682 . . . . 0.26 111.796 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.451 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 59.1 m-85 -111.05 127.84 55.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.115 0.483 . . . . 0.48 110.611 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.3 tp -94.44 108.78 20.7 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.453 -0.573 . . . . 0.37 109.453 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -89.01 93.89 9.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.886 -0.597 . . . . 0.61 109.822 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 2.3 t -109.59 139.48 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.388 0.613 . . . . 0.59 112.349 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -134.87 179.11 6.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.236 -0.893 . . . . 0.34 108.798 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.493 ' HB1' ' OD1' ' A' ' 85' ' ' ASN . . . -111.91 129.52 56.14 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.756 -0.461 . . . . 0.32 109.756 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 pt -67.06 -14.55 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.915 0.388 . . . . 0.78 111.419 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.493 ' OD1' ' HB1' ' A' ' 83' ' ' ALA . 22.5 p-10 -99.99 -4.52 29.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.01 0.433 . . . . 0.82 110.743 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -122.72 101.58 7.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.193 0.521 . . . . 1.07 110.229 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -26.82 67.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.926 -0.579 . . . . 0.65 111.98 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -65.25 -42.62 93.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.225 -0.443 . . . . 0.89 110.782 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 99.0 p -66.16 -28.64 68.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.679 0.276 . . . . 0.64 111.078 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -72.59 -39.44 67.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.243 0.544 . . . . 0.42 110.504 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -74.67 -29.86 61.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.196 -0.456 . . . . 1.44 110.54 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.63 -16.81 64.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.942 -0.572 . . . . 1.02 110.793 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 32.9 mm -57.55 -34.83 48.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.886 -0.597 . . . . 0.42 110.354 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -62.41 -46.49 88.34 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.075 -0.511 . . . . 0.83 110.646 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -57.51 -50.18 73.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.524 -0.762 . . . . 0.79 111.389 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.412 ' CD1' ' HB ' ' A' ' 9' ' ' VAL . 17.8 m-85 -63.69 -38.8 92.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.45 -0.341 . . . . 1.17 111.437 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -58.64 -50.72 72.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.6 110.187 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -67.08 -42.55 84.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.782 -0.644 . . . . 1.35 111.138 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -58.82 -57.56 12.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.002 -0.544 . . . . 1.15 112.078 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.8 mt -61.39 -39.2 81.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.671 -0.24 . . . . 0.51 111.304 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -60.96 -38.9 87.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 1.05 110.803 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -72.62 -40.07 66.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.91 110.921 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 75.4 t -64.61 -48.01 86.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.42 -0.354 . . . . 0.35 111.414 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -81.3 -10.08 59.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 0.63 111.177 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.9 t70 51.43 58.56 5.37 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.59 0.709 . . . . 0.47 110.812 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.2 m -150.03 138.78 20.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.725 -0.67 . . . . 1.14 110.569 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -74.02 -30.26 62.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 1.74 110.631 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -116.93 124.36 49.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.234 -0.439 . . . . 0.78 110.705 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.9 t -137.43 129.46 16.62 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.543 -0.539 . . . . 0.47 109.543 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.75 106.39 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.746 2.297 . . . . 0.25 111.935 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.451 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 63.7 mtt -138.03 157.49 46.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.886 -0.597 . . . . 0.79 110.596 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -140.07 124.52 19.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.159 -0.682 . . . . 0.22 109.159 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 21.7 tp -83.18 119.33 24.4 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.438 -0.579 . . . . 0.29 109.438 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 47.7 t -124.23 133.33 69.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.045 -0.525 . . . . 0.82 111.328 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -108.58 112.51 3.55 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.258 -1.137 . . . . 0.27 110.258 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -92.74 163.91 13.57 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.107 0.453 . . . . 0.21 111.399 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.526 ' HE3' ' O ' ' A' ' 14' ' ' VAL . 89.7 mttt 68.21 34.0 4.11 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.346 -0.843 . . . . 0.54 111.781 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 24.2 p -69.43 -11.51 60.89 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.032 0.444 . . . . 0.46 110.975 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.05 -13.29 41.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.032 -0.531 . . . . 0.7 110.457 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 22.1 mt -88.1 143.48 33.03 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.942 0.401 . . . . 0.67 111.029 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.32 -178.45 4.63 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.763 2.308 . . . . 0.54 112.096 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.1 m 66.45 42.33 2.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.807 -0.633 . . . . 0.84 110.32 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.5 ttm-85 -68.16 119.94 13.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.658 -0.701 . . . . 0.58 110.48 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.4 p -99.68 -27.71 13.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.424 -0.353 . . . . 0.81 110.902 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.7 t -97.96 114.22 34.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.441 -0.345 . . . . 0.37 110.421 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -77.02 150.29 35.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.427 -0.351 . . . . 1.69 110.674 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.43 -40.47 68.34 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.399 0.518 . . . . 0.82 112.399 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -62.2 -37.63 86.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.558 -0.292 . . . . 0.62 111.362 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -59.1 -46.63 87.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.119 0.485 . . . . 0.93 110.988 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.61 -39.15 58.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.961 -0.563 . . . . 0.3 111.339 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -61.4 -42.36 98.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.47 110.739 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.78 -38.82 80.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.276 -0.42 . . . . 1.18 110.558 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 43.5 tp -63.29 -46.42 86.87 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.956 -0.565 . . . . 0.44 111.146 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.5 -37.26 77.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.943 -0.572 . . . . 0.25 110.867 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 135' ' ' ARG . 31.9 ttm180 -66.13 -29.29 69.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.45 -0.795 . . . . 1.54 110.928 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.7 m -74.17 -29.98 62.03 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.303 0.573 . . . . 0.68 110.28 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -85.47 -30.14 23.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.97 -0.559 . . . . 0.77 110.423 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.31 26.65 10.83 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.957 -0.857 . . . . 0.25 110.957 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 23.7 pt -124.56 166.25 20.81 Favored Pre-proline 0 N--CA 1.452 -0.345 0 N-CA-C 110.007 -0.368 . . . . 0.51 110.007 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -90.79 160.29 4.13 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.521 2.148 . . . . 0.36 112.736 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 16.9 t80 -127.16 131.09 50.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.376 -0.375 . . . . 0.38 110.309 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 53.4 mt -133.14 131.54 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.603 -0.272 . . . . 0.54 111.112 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -83.85 130.39 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.836 -0.801 . . . . 0.88 108.836 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 71.3 p -137.6 176.38 8.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.625 0.726 . . . . 0.43 112.162 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.8 t -161.41 114.69 1.91 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.747 -1.115 . . . . 0.33 108.71 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.45 -15.93 63.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.203 0.525 . . . . 0.45 110.605 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -80.58 -29.69 36.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.573 -0.739 . . . . 1.32 111.504 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 149' ' ' ARG . 21.1 p -116.18 -8.55 11.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.462 0.541 . . . . 0.52 112.462 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 148' ' ' THR . 21.4 mtp85 70.69 13.69 7.21 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.065 -0.516 . . . . 1.53 111.099 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 144' ' ' THR . 53.1 tt0 -66.94 112.37 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.453 -0.34 . . . . 0.87 111.78 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 67.18 3.51 24.45 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 114.602 0.601 . . . . 0.51 114.602 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 82.3 t -59.53 -49.25 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 117.83 0.815 . . . . 0.74 110.743 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.38 -46.61 87.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.25 0.547 . . . . 1.62 109.939 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -54.07 -46.85 72.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.056 -0.975 . . . . 1.0 111.851 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.61 -47.61 81.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.127 -0.488 . . . . 0.37 111.755 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.463 ' O ' HG23 ' A' ' 160' ' ' VAL . 41.6 m-85 -64.97 -43.66 91.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.307 -0.406 . . . . 1.46 111.427 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -63.89 -37.46 87.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.859 0.361 . . . . 0.99 110.739 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 93.0 m -62.37 -43.96 97.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.918 -0.583 . . . . 0.34 110.808 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.592 ' O ' HG13 ' A' ' 163' ' ' ILE . 30.7 tp -58.22 -45.53 87.51 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.642 -0.254 . . . . 0.42 110.911 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 156' ' ' PHE . 6.1 t -60.9 -39.92 83.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.941 0.4 . . . . 0.55 110.512 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -68.76 -33.76 74.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 0.9 110.985 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -65.91 -40.58 91.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.321 -0.622 . . . . 0.73 109.321 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 159' ' ' LEU . 31.3 mt -62.42 -41.9 93.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.955 -0.757 . . . . 0.42 108.955 178.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.559 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 4.4 mtt180 -53.36 -58.34 7.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.013 -0.994 . . . . 0.87 110.921 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.407 ' HA ' ' HG2' ' A' ' 168' ' ' GLU . 51.3 mtmt -62.13 -20.12 63.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.432 -0.803 . . . . 0.97 111.955 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -83.38 -33.99 25.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.767 0.318 . . . . 0.71 110.603 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 163' ' ' ILE . 46.8 mtpt -87.06 -8.33 57.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.094 0.405 . . . . 1.11 112.094 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 8.8 pt-20 -108.92 25.11 12.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.961 0.41 . . . . 1.12 110.771 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 36.4 mttm . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.447 -0.787 . . . . 1.47 109.851 179.291 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.518 ' O2A' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' QPD . . . . . 0.402 ' N1 ' ' HB2' ' A' ' 56' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 ttm . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 120.64 0.257 . . . . 1.48 110.574 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.0 m -111.53 149.06 31.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.523 -0.308 . . . . 1.04 110.356 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -98.41 131.75 44.43 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.046 -0.353 . . . . 1.27 110.046 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -109.91 133.35 53.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.855 -0.424 . . . . 1.11 109.855 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -94.98 104.61 16.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.267 -0.424 . . . . 0.81 110.72 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 10.2 mp -112.82 119.63 38.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.872 -0.604 . . . . 1.39 111.031 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.73 120.23 61.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.181 0.515 . . . . 0.81 110.153 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.7 t -92.25 112.9 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.827 -0.624 . . . . 0.44 109.796 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 m -114.96 -175.45 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.187 -0.46 . . . . 0.7 110.638 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.79 -176.08 22.66 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.716 -0.754 . . . . 0.53 111.789 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.91 -175.34 2.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.783 0.325 . . . . 0.58 111.188 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.23 131.41 10.39 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.586 -0.816 . . . . 0.8 113.188 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.47 17.37 79.82 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.287 -0.482 . . . . 0.42 113.835 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -77.09 -34.52 21.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 117.492 0.646 . . . . 0.57 111.004 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.47 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 132.89 24.49 0.72 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.616 -0.802 . . . . 0.49 113.137 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HB2' ' O3B' ' A' ' 201' ' ' GDP . 6.4 mtpt -56.69 -41.27 77.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.061 0.458 . . . . 0.81 111.046 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.81 2.01 50.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.58 112.093 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.47 -44.76 5.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.712 0.291 . . . . 0.43 110.801 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.544 HD23 ' HB2' ' A' ' 146' ' ' ALA . 44.7 mt -58.71 -42.78 89.47 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.558 0.694 . . . . 0.92 110.483 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.493 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -60.89 -52.44 65.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.948 -1.023 . . . . 0.89 111.701 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 29' ' ' VAL . 39.8 mt -65.37 -31.09 52.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.388 -0.369 . . . . 0.79 111.379 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.612 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 2.8 mm-40 -69.27 -22.38 63.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.999 0.428 . . . . 0.46 110.335 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.8 tp -94.16 -26.83 16.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.118 -0.492 . . . . 1.37 110.649 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 20' ' ' THR . 35.3 mm -89.73 -60.25 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.58 111.558 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -92.51 -13.95 29.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.499 -0.319 . . . . 1.68 111.437 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 7.9 m-20 66.57 24.71 10.16 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 123.513 0.508 . . . . 1.6 111.758 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -129.92 146.51 51.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.711 -0.477 . . . . 0.74 109.711 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -85.12 129.97 34.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.377 -0.374 . . . . 0.6 111.135 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.406 HG21 HD12 ' A' ' 21' ' ' ILE . 60.8 t -96.95 125.05 50.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.64 109.955 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -75.7 -46.38 31.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.763 -0.653 . . . . 1.12 111.815 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -130.07 123.73 31.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.969 0.414 . . . . 1.18 111.118 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -145.42 146.92 31.72 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.156 -0.683 . . . . 0.6 109.156 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -71.66 119.42 74.0 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 0.8 110.367 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.94 -17.33 32.31 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.49 2.127 . . . . 0.52 113.615 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.24 -7.49 59.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.096 0.474 . . . . 0.89 111.434 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.2 mt -80.77 119.69 30.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.197 0.522 . . . . 0.73 110.771 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 22.3 tt0 -118.01 79.49 1.38 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.097 -0.956 . . . . 0.81 108.641 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -106.39 159.39 16.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.136 -0.483 . . . . 1.29 111.054 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.66 124.52 52.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.231 -0.44 . . . . 0.78 110.325 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -101.97 136.81 41.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.121 -0.491 . . . . 0.94 110.347 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.06 128.53 55.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.88 0.371 . . . . 0.56 111.234 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -144.51 137.59 26.98 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.387 -0.598 . . . . 1.46 109.387 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -116.26 119.34 35.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.704 0.288 . . . . 1.89 110.343 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.9 t -138.58 153.02 25.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.446 . . . . 1.09 109.877 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 13.2 t -76.73 103.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.64 -0.504 . . . . 0.65 109.64 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.3 mt -105.37 111.94 36.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.343 -0.389 . . . . 1.06 111.008 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.458 ' HB2' HH12 ' A' ' 164' ' ' ARG . 31.3 m-20 65.4 27.09 11.92 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.757 -0.656 . . . . 0.97 111.518 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.49 5.29 65.25 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.873 -0.679 . . . . 0.6 112.469 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -126.54 119.75 27.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.791 0.329 . . . . 1.41 111.172 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 23.6 m -77.11 106.75 9.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.641 -0.503 . . . . 0.63 109.641 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.1 m -117.71 147.48 42.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.224 0.535 . . . . 0.71 111.212 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.0 tp -90.74 122.22 33.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.547 -0.751 . . . . 0.48 109.113 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 53' ' ' LEU . 14.3 mt -93.61 113.44 25.54 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.955 0.407 . . . . 0.87 111.591 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -100.43 87.71 3.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.256 -1.387 . . . . 1.03 107.256 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 6.6 mt -99.54 127.64 52.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.724 -0.671 . . . . 0.68 111.881 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.9 tp -107.88 121.24 44.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.557 -0.747 . . . . 0.46 111.112 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 1.7 t70 -87.47 94.97 9.86 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.44 -0.948 . . . . 0.44 108.44 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.492 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 81.2 p -65.98 146.42 54.72 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.466 0.651 . . . . 0.73 111.838 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.01 -58.17 2.56 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.155 -0.929 . . . . 0.56 109.287 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.16 -96.96 0.15 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.799 -0.715 . . . . 0.72 111.999 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -83.77 158.44 21.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.679 0.276 . . . . 1.26 110.533 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -130.32 165.86 21.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.238 -0.437 . . . . 1.57 110.32 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -78.89 -35.36 43.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.331 -0.618 . . . . 1.38 109.331 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -119.86 124.03 45.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.592 -0.731 . . . . 0.81 109.517 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -58.46 -34.9 71.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.419 -0.355 . . . . 0.63 111.382 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.26 -27.48 69.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.32 111.4 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 78.0 mtp -72.64 -32.65 66.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.69 110.467 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -71.17 -46.07 62.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.896 -0.593 . . . . 0.9 110.071 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -73.63 -9.06 58.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.654 -0.703 . . . . 1.41 111.449 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -67.19 -60.28 2.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.817 -0.174 . . . . 1.51 111.046 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -72.51 -15.88 61.79 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.695 -0.402 . . . . 1.17 111.091 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 35.7 mtt -70.35 -25.74 63.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.24 0.543 . . . . 0.7 109.937 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 73' ' ' ARG . 48.5 mtm180 -84.17 -48.54 9.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.83 -0.623 . . . . 1.29 110.673 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -22.67 63.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.938 -0.574 . . . . 0.72 111.953 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.01 123.45 26.3 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.018 -0.61 . . . . 0.19 112.087 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -88.9 -40.85 12.8 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.943 -0.391 . . . . 0.54 109.943 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -128.88 130.12 6.37 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.414 -0.674 . . . . 0.26 111.414 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -113.98 133.83 55.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.015 0.436 . . . . 0.48 111.128 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.8 tp -100.1 106.23 17.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.864 -0.607 . . . . 0.37 110.221 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.5 m -92.36 97.44 10.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.004 0.43 . . . . 0.61 110.343 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 4.9 t -110.31 134.1 53.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.002 -0.545 . . . . 0.59 111.37 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -129.6 172.66 11.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.729 -0.668 . . . . 0.34 109.441 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.78 133.3 52.37 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.727 -0.471 . . . . 0.32 109.727 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.432 HD11 ' HA ' ' A' ' 118' ' ' CYS . 29.0 pt -76.92 -4.17 6.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 112.782 0.66 . . . . 0.78 112.782 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -85.6 -12.18 52.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.738 -0.21 . . . . 0.82 111.105 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.469 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 30.8 t-20 -139.79 123.94 17.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.367 . . . . 1.07 110.725 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.8 m -69.83 -28.2 65.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.057 -0.52 . . . . 0.65 111.652 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -60.97 -39.29 89.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.618 0.247 . . . . 0.89 110.721 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -64.75 -32.43 74.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.137 0.494 . . . . 0.64 110.313 179.147 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -76.95 -35.66 57.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.76 -0.655 . . . . 0.42 110.115 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -72.01 -29.8 64.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.707 -0.678 . . . . 1.44 110.582 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.38 -24.02 67.14 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.042 -0.527 . . . . 1.02 110.592 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.9 mm -61.45 -30.63 48.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.518 -0.764 . . . . 0.42 110.684 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -60.76 -41.38 95.34 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.205 0.526 . . . . 0.83 109.695 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -71.86 -38.43 70.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.562 -0.744 . . . . 0.79 110.639 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -63.75 -47.42 81.1 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.252 0.464 . . . . 1.17 112.252 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 25.7 tpt180 -63.73 -33.37 75.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.671 0.272 . . . . 0.6 110.856 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -79.19 -43.86 23.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.283 -0.417 . . . . 1.35 111.541 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -58.6 -56.99 14.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.086 0.402 . . . . 1.15 112.086 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.5 mt -63.38 -31.07 51.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.359 -0.382 . . . . 0.51 110.772 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 39.0 ttpt -62.97 -35.38 79.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.343 0.592 . . . . 1.05 110.198 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -78.02 -40.61 38.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.713 -0.676 . . . . 0.91 110.592 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 87.3 t -58.78 -50.75 78.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.907 -0.588 . . . . 0.35 110.863 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -82.08 -11.61 58.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.084 -0.507 . . . . 0.63 111.036 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.8 t70 54.81 48.82 19.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.583 0.706 . . . . 0.47 110.753 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.5 t -158.45 144.42 16.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.51 -0.768 . . . . 1.14 110.317 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -90.97 -17.72 25.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.079 0.466 . . . . 1.74 110.76 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -91.08 68.99 6.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.595 0.712 . . . . 0.78 110.604 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 85.2 t -108.57 112.34 60.78 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.289 -0.869 . . . . 0.47 109.659 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.82 113.42 1.31 Allowed 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.915 2.41 . . . . 0.25 111.656 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 28.6 mtt -141.99 153.35 44.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.09 -0.505 . . . . 0.79 111.223 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.3 t -131.91 123.9 52.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.482 -0.781 . . . . 0.22 109.035 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 41.0 tp -85.37 121.85 28.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.042 -0.725 . . . . 0.29 109.042 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 11.2 t -127.19 138.05 55.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.004 0.431 . . . . 0.82 111.532 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.87 106.85 2.12 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 110.164 -1.174 . . . . 0.27 110.164 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -89.2 165.5 14.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.735 0.267 . . . . 0.21 111.024 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 67.52 34.85 4.43 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 115.466 -0.788 . . . . 0.54 111.008 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.432 ' HA ' HD11 ' A' ' 84' ' ' ILE . 27.5 p -68.75 -13.0 62.11 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.869 0.366 . . . . 0.46 111.344 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.67 -13.72 47.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.7 110.612 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 44.1 mt -82.51 142.06 45.96 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.399 -0.364 . . . . 0.67 110.175 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.3 -177.52 3.9 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.603 2.202 . . . . 0.54 111.925 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.5 m 62.83 48.75 3.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.295 0.569 . . . . 0.84 111.181 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.3 ttm-85 -72.38 110.99 7.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.749 -0.66 . . . . 0.58 109.95 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 p -95.14 -21.01 18.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.07 0.462 . . . . 0.81 110.728 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -98.69 110.33 25.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.115 -0.493 . . . . 0.37 110.051 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.99 143.12 56.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.985 -0.552 . . . . 1.69 111.176 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 m -59.54 -39.92 85.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.006 -0.543 . . . . 0.82 110.787 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -61.53 -38.52 87.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.62 110.954 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -58.4 -51.94 67.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.139 0.495 . . . . 0.93 110.744 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.43 -40.52 85.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.714 -0.675 . . . . 0.3 110.875 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -61.38 -40.49 94.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.811 -0.631 . . . . 0.47 110.356 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 -46.46 79.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.384 -0.371 . . . . 1.18 110.15 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.85 -44.91 93.87 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.804 -0.634 . . . . 0.44 111.0 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.73 -43.55 98.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.965 -0.561 . . . . 0.25 110.865 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -63.66 -36.16 82.91 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.837 -0.62 . . . . 1.54 111.95 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.4 p -74.77 -23.28 58.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.428 . . . . 0.68 111.133 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -89.45 -16.92 29.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.77 111.011 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.83 30.1 33.09 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.97 -0.559 . . . . 0.25 111.806 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 40.0 pt -127.08 152.97 76.55 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.7 -0.25 . . . . 0.51 110.543 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.7 148.51 22.82 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.669 2.246 . . . . 0.36 112.189 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 17.6 t80 -125.35 124.32 41.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.381 -0.372 . . . . 0.38 110.61 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.7 mt -132.61 133.73 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.34 -0.391 . . . . 0.54 110.343 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -88.52 135.01 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.812 -0.811 . . . . 0.88 108.812 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 70.6 p -138.96 175.53 9.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.52 0.676 . . . . 0.43 112.447 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.1 t -152.06 109.44 3.58 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.008 -0.996 . . . . 0.33 108.749 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.544 ' HB2' HD23 ' A' ' 19' ' ' LEU . . . -68.42 -24.48 64.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.273 0.558 . . . . 0.45 110.286 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -67.57 -47.83 68.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.004 -0.998 . . . . 1.32 111.296 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.9 p -97.04 3.91 51.66 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.711 -0.395 . . . . 0.52 110.925 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 55.83 45.73 23.63 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.55 -0.75 . . . . 1.53 110.414 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -107.72 120.74 43.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.447 -0.797 . . . . 0.87 111.056 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.31 -1.24 57.31 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.807 -0.633 . . . . 0.51 113.747 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 32.6 t -60.1 -42.29 89.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.981 0.391 . . . . 0.74 110.744 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.28 -50.77 62.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.795 -0.639 . . . . 1.62 110.203 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.12 -45.84 72.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.575 -0.739 . . . . 1.0 111.857 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.94 81.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.664 0.268 . . . . 0.37 111.247 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -66.64 -44.1 82.87 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.385 -0.371 . . . . 1.46 111.231 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -63.73 -42.35 97.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.446 -0.343 . . . . 0.99 111.564 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.445 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 36.6 m -61.82 -38.02 86.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.693 -0.23 . . . . 0.34 110.576 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 163' ' ' ILE . 48.3 tp -62.77 -40.6 97.79 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.901 -0.407 . . . . 0.42 109.901 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.83 -41.51 85.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.494 . . . . 0.55 110.078 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -67.77 -38.26 83.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.9 110.411 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 158' ' ' THR . 63.5 mm-40 -60.11 -43.51 95.56 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.93 -0.577 . . . . 0.73 110.814 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 159' ' ' LEU . 27.1 mt -67.53 -46.07 83.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.94 -0.573 . . . . 0.42 110.758 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 85.9 mtt180 -57.2 -42.22 80.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.152 -0.477 . . . . 0.87 111.447 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -59.56 -34.99 73.37 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.812 0.339 . . . . 0.97 110.951 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -79.67 -30.91 41.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.879 0.371 . . . . 0.71 110.209 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -67.93 -33.64 75.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.106 -0.497 . . . . 1.11 111.799 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 11.9 pt-20 -102.9 17.58 23.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.198 0.523 . . . . 1.12 110.602 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 17.8 tttp . . . . . 0 C--O 1.25 1.13 0 CA-C-N 115.518 -0.764 . . . . 1.47 110.195 -179.739 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.436 ' O3B' ' HB2' ' A' ' 16' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' QPD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.585 ' HA ' ' O ' ' A' ' 50' ' ' THR . 24.8 ttt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.982 -0.377 . . . . 1.48 109.982 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.1 m -106.09 144.15 33.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.116 -0.493 . . . . 1.04 110.752 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -93.26 135.41 34.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.224 -0.444 . . . . 1.27 110.795 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 51' ' ' CYS . 35.0 m-85 -121.84 117.99 27.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.325 -0.62 . . . . 1.11 109.325 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -95.17 107.77 19.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.959 0.409 . . . . 0.81 110.516 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 1.2 mp -119.46 141.74 48.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.853 -0.612 . . . . 1.39 110.965 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.04 135.67 62.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.227 -0.442 . . . . 0.81 110.552 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.44 115.82 47.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.614 -0.513 . . . . 0.44 109.614 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.6 m -114.06 169.32 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.123 -0.489 . . . . 0.7 110.251 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.27 170.22 17.9 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.792 -0.718 . . . . 0.53 112.033 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.528 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -67.81 159.14 30.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.075 0.464 . . . . 0.58 111.714 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.12 99.63 0.72 Allowed Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.827 -0.624 . . . . 0.8 112.872 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.26 7.69 5.77 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.673 -0.775 . . . . 0.42 113.142 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 11' ' ' ALA . 12.4 m -79.59 -39.06 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.558 -0.457 . . . . 0.57 110.625 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.515 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 126.58 24.97 1.32 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.557 -0.83 . . . . 0.49 113.573 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -50.98 -52.38 43.25 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.907 0.354 . . . . 0.81 111.76 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.48 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 1.0 OUTLIER -65.64 -40.2 92.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.419 -0.355 . . . . 0.58 111.679 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.76 -42.55 97.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 0.43 111.548 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 72.0 mt -59.59 -44.88 93.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.368 . . . . 0.92 111.341 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.461 ' O ' HG12 ' A' ' 24' ' ' ILE . 7.7 m -67.16 -51.42 53.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.214 -0.448 . . . . 0.89 111.788 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.96 -31.45 47.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.67 0.272 . . . . 0.79 111.697 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 4.8 mm-40 -61.12 -30.0 70.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.913 0.387 . . . . 0.46 111.046 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tp -95.34 -35.76 11.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.302 -0.408 . . . . 1.37 111.318 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 20' ' ' THR . 40.3 mm -74.14 -55.79 11.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.409 0.522 . . . . 0.58 112.409 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -99.82 1.48 43.08 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.045 0.387 . . . . 1.68 112.045 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 73.0 m-20 57.81 32.61 22.15 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.63 0.974 . . . . 1.6 113.63 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -153.92 146.73 24.33 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.686 -0.405 . . . . 0.74 110.805 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -82.02 129.53 34.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.952 -0.567 . . . . 0.6 110.693 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.0 t -98.86 121.41 49.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.05 -0.523 . . . . 0.64 109.891 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.51 -55.95 8.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.615 -0.72 . . . . 1.12 111.445 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -113.77 115.12 27.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.324 0.583 . . . . 1.18 111.665 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -141.77 136.04 30.3 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.906 -0.776 . . . . 0.6 108.906 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -62.71 117.47 32.14 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 120.854 0.359 . . . . 0.8 110.561 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.92 -25.87 38.33 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.69 2.26 . . . . 0.52 112.898 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -8.47 57.05 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.382 0.512 . . . . 0.89 112.382 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.3 mt -79.24 119.51 28.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.068 0.461 . . . . 0.73 111.105 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 8.6 tt0 -111.13 97.9 7.13 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.411 -0.959 . . . . 0.81 108.411 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -126.43 163.1 24.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.764 0.316 . . . . 1.29 110.706 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.13 145.39 44.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.036 -0.529 . . . . 0.78 109.841 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -131.64 138.35 48.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.748 0.309 . . . . 0.94 110.286 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.427 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 0.7 OUTLIER -112.68 127.79 56.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.194 -0.457 . . . . 0.56 110.358 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -141.6 120.88 13.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.19 -0.459 . . . . 1.46 110.144 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 10.4 pt20 -93.15 122.0 35.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.947 0.403 . . . . 1.89 110.524 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.3 t -125.83 143.75 38.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.076 -0.511 . . . . 1.09 110.169 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 t -86.24 102.22 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.299 -0.63 . . . . 0.65 109.299 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.41 HG22 ' OD2' ' A' ' 47' ' ' ASP . 9.9 mt -114.17 123.36 69.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.849 -0.614 . . . . 1.06 110.743 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.41 ' OD2' HG22 ' A' ' 46' ' ' ILE . 21.7 m-20 64.77 22.59 12.58 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.605 0.566 . . . . 0.97 111.495 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.32 0.95 72.66 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.767 -0.73 . . . . 0.6 112.679 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -116.68 132.61 56.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.657 0.265 . . . . 1.41 110.83 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 1' ' ' MET . 1.3 m -82.9 111.67 19.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.87 -0.418 . . . . 0.63 109.87 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.431 ' HB3' ' CD2' ' A' ' 4' ' ' TYR . 2.5 m -112.45 134.73 53.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.391 -0.368 . . . . 0.71 111.233 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.9 tp -92.49 107.5 19.26 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.853 -0.795 . . . . 0.48 108.853 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 35.7 mt -82.66 115.64 21.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.22 -0.445 . . . . 0.87 111.547 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.427 ' OD1' ' HD2' ' A' ' 41' ' ' ARG . 12.5 t70 -103.4 95.65 6.22 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.941 -1.133 . . . . 1.03 107.941 178.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 31.1 mt -109.47 135.01 49.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.236 0.541 . . . . 0.68 111.646 -177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.458 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 26.7 tp -112.13 119.48 38.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.353 -0.84 . . . . 0.46 110.631 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 2.5 t70 -87.36 99.81 12.26 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.695 -0.854 . . . . 0.44 108.695 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.7 p -72.15 153.1 41.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.806 -0.634 . . . . 0.73 111.41 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.54 -63.92 1.08 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.176 -0.675 . . . . 0.56 109.176 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.75 -91.49 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.683 -0.689 . . . . 0.72 111.549 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -121.98 130.66 53.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.071 -0.344 . . . . 1.26 110.071 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.81 179.22 6.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.44 . . . . 1.57 110.764 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.18 -43.65 94.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.728 -0.669 . . . . 1.38 110.017 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -120.59 145.04 47.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.602 -0.726 . . . . 0.81 109.577 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -63.09 -34.6 77.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.318 -0.401 . . . . 0.63 111.26 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.91 -30.94 71.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.325 -0.398 . . . . 0.32 111.861 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 95.0 mtp -66.56 -33.46 75.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.094 0.474 . . . . 0.69 109.983 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -76.96 -39.93 48.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.729 -0.669 . . . . 0.9 109.856 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.32 -11.02 60.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.686 -0.688 . . . . 1.41 110.875 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -66.03 -69.28 0.31 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.017 -0.538 . . . . 1.51 110.347 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.444 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 8.3 p90 -70.41 -11.92 61.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.439 -0.346 . . . . 1.17 111.688 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.9 mtt -73.16 -13.98 61.27 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.903 -0.406 . . . . 0.7 109.903 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.489 ' CG ' HG12 ' A' ' 103' ' ' VAL . 64.4 mtm180 -109.22 -33.61 6.81 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.062 -0.517 . . . . 1.29 110.808 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -79.9 -15.55 57.1 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.482 -0.326 . . . . 0.72 111.661 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.8 134.12 34.94 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.705 -0.759 . . . . 0.19 112.439 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.8 -36.64 11.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.836 0.351 . . . . 0.54 110.359 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.83 128.2 6.8 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.99 -0.624 . . . . 0.26 111.676 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.513 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 94.1 m-85 -112.09 121.36 44.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.121 0.486 . . . . 0.48 110.682 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.6 tp -100.18 109.27 21.52 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.86 -0.609 . . . . 0.37 110.765 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 2.7 m -94.18 102.19 14.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.137 -0.483 . . . . 0.61 110.012 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.441 HG22 ' HB ' ' A' ' 114' ' ' VAL . 15.1 t -109.3 140.61 27.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.104 0.478 . . . . 0.59 111.374 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.39 170.53 15.92 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.746 -0.835 . . . . 0.34 108.746 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . . . -105.32 133.27 50.37 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.977 -0.379 . . . . 0.32 109.977 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 pt -66.49 -16.93 21.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.891 0.376 . . . . 0.78 111.496 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -107.78 10.12 28.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.005 0.431 . . . . 0.82 110.935 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 13.0 t-20 -132.7 92.69 3.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.087 0.47 . . . . 1.07 110.539 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -33.62 71.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.657 -0.701 . . . . 0.65 111.811 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -58.24 -45.46 87.72 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.945 0.402 . . . . 0.89 110.999 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.8 p -68.0 -28.13 67.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.64 110.974 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -76.06 -43.57 43.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.005 0.431 . . . . 0.42 110.686 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -67.28 -33.37 75.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 1.44 110.98 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -66.98 -19.76 65.77 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.42 -0.355 . . . . 1.02 111.1 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.48 -29.7 42.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 121.16 0.505 . . . . 0.42 109.994 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -62.25 -36.1 80.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.752 -0.658 . . . . 0.83 110.339 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -80.73 -24.75 38.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.194 -0.912 . . . . 0.79 110.762 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -62.45 -59.37 5.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.51 . . . . 1.17 110.183 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -55.41 -46.43 76.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.928 -0.578 . . . . 0.6 109.91 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -56.15 -48.83 75.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.298 -0.865 . . . . 1.35 111.903 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.623 ' O ' HG23 ' A' ' 103' ' ' VAL . 22.7 tt0 -61.79 -57.31 12.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.264 -0.426 . . . . 1.15 111.266 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.6 mt -60.07 -35.31 60.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 111.911 0.338 . . . . 0.51 111.911 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -59.53 -39.32 83.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.863 0.363 . . . . 1.05 110.569 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -75.05 -45.98 37.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.81 -0.632 . . . . 0.91 110.954 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 99' ' ' GLN . 21.8 t -59.9 -49.42 83.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.35 112.118 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.401 ' CG ' ' HA ' ' A' ' 73' ' ' ARG . 15.0 mtpp -81.7 -13.32 58.0 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.218 -0.193 . . . . 0.63 111.416 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.5 t70 54.61 50.64 15.52 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.882 -0.599 . . . . 0.47 111.224 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.9 m -141.54 144.51 34.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.333 -0.394 . . . . 1.14 110.176 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -44.12 28.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.364 . . . . 1.74 111.372 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -99.88 119.28 37.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.846 0.355 . . . . 0.78 110.46 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.82 123.8 21.27 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 115.977 -0.556 . . . . 0.47 110.142 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.84 108.09 0.45 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.435 2.09 . . . . 0.25 111.811 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.513 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 46.5 mtt -139.27 155.19 47.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.078 0.466 . . . . 0.79 111.174 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.3 t -135.06 124.71 43.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.524 -0.762 . . . . 0.22 108.953 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 19.0 tp -84.42 120.54 26.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.567 -0.531 . . . . 0.29 109.567 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.441 ' HB ' HG22 ' A' ' 81' ' ' VAL . 21.7 t -122.96 131.21 73.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.147 -0.479 . . . . 0.82 112.132 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -108.35 95.7 0.96 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.348 -1.101 . . . . 0.27 110.348 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -78.54 161.44 27.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.925 0.393 . . . . 0.21 111.879 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 81.2 mttt 63.7 35.98 11.03 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 115.31 -0.859 . . . . 0.54 110.895 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 28.2 p -69.74 -13.16 62.15 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.978 -0.556 . . . . 0.46 111.475 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -82.36 -10.11 59.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.029 -0.532 . . . . 0.7 110.951 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 58.6 mt -83.24 141.41 42.88 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.962 0.411 . . . . 0.67 110.671 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.28 -178.69 4.61 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.186 1.924 . . . . 0.54 111.588 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.8 m 63.5 45.71 4.63 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.183 -0.462 . . . . 0.84 111.059 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 123' ' ' ARG . 29.1 ttm-85 -59.27 123.03 15.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.965 -0.562 . . . . 0.58 110.401 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.81 -24.77 14.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.913 0.387 . . . . 0.81 111.1 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.3 t -104.82 111.68 35.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.166 -0.47 . . . . 0.37 110.758 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.1 141.58 58.67 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.756 -0.461 . . . . 1.69 109.756 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.83 -30.16 56.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.189 0.518 . . . . 0.82 112.131 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -68.05 -34.32 76.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.887 -0.597 . . . . 0.62 111.723 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -59.53 -57.12 14.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.952 0.353 . . . . 0.93 111.952 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.94 89.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.509 -0.314 . . . . 0.3 111.432 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -63.01 -44.13 96.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.016 0.436 . . . . 0.47 110.069 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.48 -38.72 90.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.656 -0.702 . . . . 1.18 110.304 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 65.5 tp -68.51 -41.05 80.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.717 -0.674 . . . . 0.44 110.898 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.7 91.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.25 110.408 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 135' ' ' ARG . 37.8 ttm105 -62.89 -36.81 84.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.91 -0.586 . . . . 1.54 110.774 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.0 m -69.19 -26.28 64.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.045 0.45 . . . . 0.68 111.138 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -91.09 -19.61 22.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.491 . . . . 0.77 111.187 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.43 27.53 47.6 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.629 -0.796 . . . . 0.25 111.564 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 26.6 pt -125.54 159.11 62.14 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.887 -0.412 . . . . 0.51 109.887 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.45 160.62 17.15 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.678 2.252 . . . . 0.36 112.901 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 13.4 t80 -135.74 131.53 35.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.541 -0.754 . . . . 0.38 110.316 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 37.3 mt -142.74 134.97 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.364 -0.38 . . . . 0.54 110.386 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -84.21 137.85 33.28 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.067 -0.716 . . . . 0.88 109.067 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.9 p -138.31 173.17 11.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.633 0.73 . . . . 0.43 111.716 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.4 t -149.01 123.08 9.45 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.066 -1.087 . . . . 0.33 108.066 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.44 -11.74 61.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.746 0.308 . . . . 0.45 111.291 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -85.13 -57.77 2.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.065 -0.516 . . . . 1.32 111.498 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.9 p -86.74 -10.33 53.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.333 . . . . 0.52 111.463 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 59.69 40.27 20.08 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.683 -0.69 . . . . 1.53 110.744 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -85.29 114.99 22.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.132 -0.486 . . . . 0.87 110.78 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.1 8.4 61.58 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.941 -0.572 . . . . 0.51 112.985 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 22.2 t -65.5 -50.88 69.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.766 0.317 . . . . 0.74 110.814 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.93 -37.63 84.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.103 0.477 . . . . 1.62 109.815 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.7 -42.72 93.62 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.134 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.68 79.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.915 -0.584 . . . . 0.37 111.733 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.402 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.5 OUTLIER -70.94 -39.72 72.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.29 -0.414 . . . . 1.46 111.494 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -61.48 -35.74 78.5 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.952 -0.388 . . . . 0.99 109.952 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 22.3 m -70.59 -35.22 72.9 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.541 -0.54 . . . . 0.34 109.541 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.27 -40.53 97.65 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.494 -0.558 . . . . 0.42 109.494 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 156' ' ' PHE . 94.0 t -61.78 -42.15 93.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.344 0.592 . . . . 0.55 109.712 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -65.3 -36.03 82.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.463 -0.79 . . . . 0.9 110.146 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -66.78 -38.84 87.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.967 -0.383 . . . . 0.73 109.967 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.522 ' O ' ' HG3' ' A' ' 167' ' ' LYS . 88.4 mt -61.81 -52.21 63.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.307 -0.627 . . . . 0.42 109.307 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.607 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 99.1 mtt180 -55.91 -44.81 78.6 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 115.529 -0.759 . . . . 0.87 110.077 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -56.49 -42.81 78.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.42 -0.809 . . . . 0.97 111.842 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -71.24 -36.03 71.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.245 -0.434 . . . . 0.71 111.519 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 163' ' ' ILE . 30.7 mtpt -74.67 -29.7 61.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.407 0.521 . . . . 1.11 112.407 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 6.6 pt-20 -86.77 -12.36 48.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.717 0.294 . . . . 1.12 111.14 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 31.7 tttp . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.431 -0.795 . . . . 1.47 110.395 -179.6 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.48 ' O2A' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' QPD . . . . . 0.458 ' N1 ' ' HB2' ' A' ' 56' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.409 ' HA ' ' O ' ' A' ' 50' ' ' THR . 13.0 tmm? . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.196 -0.298 . . . . 1.48 110.196 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.448 ' HB ' ' CE2' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -113.87 138.7 49.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.372 -0.376 . . . . 1.04 110.893 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -96.32 131.37 42.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.529 -0.545 . . . . 1.27 109.529 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.448 ' CE2' ' HB ' ' A' ' 2' ' ' THR . 85.5 m-85 -120.91 124.55 45.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.567 -0.288 . . . . 1.11 110.251 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -95.63 107.49 19.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.144 0.497 . . . . 0.81 110.545 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.744 HD23 HD23 ' A' ' 159' ' ' LEU . 8.5 mp -111.84 133.26 54.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.649 -0.705 . . . . 1.39 111.187 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 78' ' ' PHE . 16.5 t -118.47 122.1 68.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.165 -0.47 . . . . 0.81 110.491 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.2 t -94.49 119.42 42.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.281 -0.637 . . . . 0.44 109.281 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 m -116.42 157.22 17.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.05 0.453 . . . . 0.7 110.987 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.31 170.92 29.9 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.62 -0.8 . . . . 0.53 111.772 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.34 173.21 7.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.971 0.415 . . . . 0.58 111.597 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.04 112.91 3.54 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.472 -0.87 . . . . 0.8 112.49 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.26 4.1 27.35 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.523 -0.846 . . . . 0.42 113.562 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 m -76.02 -17.61 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 117.391 0.595 . . . . 0.57 111.481 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.62 25.34 8.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.522 -0.847 . . . . 0.49 113.597 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -53.55 -55.98 20.97 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.785 0.326 . . . . 0.81 111.736 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.498 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 1.0 OUTLIER -57.85 -52.86 63.75 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.591 0.589 . . . . 0.58 112.591 -178.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.82 -38.86 67.9 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.369 0.507 . . . . 0.43 112.369 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.0 mt -62.0 -44.47 96.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.543 -0.299 . . . . 0.92 111.354 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.419 ' O ' HG12 ' A' ' 24' ' ' ILE . 1.4 m -73.97 -39.71 63.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.631 0.253 . . . . 0.89 111.026 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.79 -32.61 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.985 0.422 . . . . 0.79 110.473 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.722 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 3.6 mm-40 -67.6 -21.96 65.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.883 -0.599 . . . . 0.46 111.222 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.14 -30.58 12.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.885 0.374 . . . . 1.37 110.625 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 20' ' ' THR . 51.5 mm -81.08 -61.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.927 0.394 . . . . 0.58 110.789 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -85.77 -6.69 59.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.293 0.568 . . . . 1.68 110.383 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.722 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 1.3 m-80 55.39 40.44 31.38 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 114.944 -1.025 . . . . 1.6 112.966 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -160.7 156.02 24.79 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.873 -0.418 . . . . 0.74 109.873 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -80.82 142.29 33.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.141 -0.481 . . . . 0.6 111.963 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.59 121.44 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.958 -1.127 . . . . 0.64 107.958 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.23 -41.53 40.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.799 0.666 . . . . 1.12 112.799 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -123.17 122.47 38.51 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.073 0.463 . . . . 1.18 111.305 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -149.31 139.15 21.91 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.578 -0.897 . . . . 0.6 108.578 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.467 ' HB3' HG13 ' A' ' 36' ' ' ILE . 5.8 t70 -62.78 123.74 80.71 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 123.516 0.51 . . . . 0.8 110.95 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.2 -13.25 23.38 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.775 2.316 . . . . 0.52 113.099 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.2 3.11 56.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.839 0.352 . . . . 0.89 111.352 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.467 HG13 ' HB3' ' A' ' 33' ' ' ASP . 58.3 mt -83.01 130.84 35.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 110.038 -0.356 . . . . 0.73 110.038 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 16.9 tt0 -128.57 82.88 2.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.748 -0.66 . . . . 0.81 109.435 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -111.47 171.7 7.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.095 -0.502 . . . . 1.29 111.272 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.0 141.66 48.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.989 -0.55 . . . . 0.78 109.871 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -126.34 133.43 51.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.106 -0.331 . . . . 0.94 110.106 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -107.62 119.7 40.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.951 0.405 . . . . 0.56 110.741 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -130.31 132.19 45.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.976 -0.556 . . . . 1.46 109.988 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.573 ' NE2' ' H ' ' A' ' 43' ' ' GLN . 1.4 pm0 -101.93 123.75 46.37 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.195 0.521 . . . . 1.89 110.443 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.3 t -130.31 143.37 41.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.013 -0.54 . . . . 1.09 109.622 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.51 66.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.178 0.513 . . . . 0.65 110.448 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.8 mt -74.2 124.64 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.55 -0.75 . . . . 1.06 110.774 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.96 17.67 9.58 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.697 -0.683 . . . . 0.97 110.975 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.02 7.18 81.04 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.472 -0.871 . . . . 0.6 112.394 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -116.6 131.45 56.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.764 0.316 . . . . 1.41 110.42 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 1' ' ' MET . 1.3 m -68.15 109.84 3.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.961 0.41 . . . . 0.63 110.934 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.2 m -112.65 130.02 56.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.27 -0.423 . . . . 0.71 111.004 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.0 tp -97.84 107.3 19.76 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.497 -0.927 . . . . 0.48 108.497 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -91.13 120.48 32.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.453 0.538 . . . . 0.87 112.453 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -105.85 98.24 7.95 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.873 -1.158 . . . . 1.03 107.873 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 49.8 mt -106.02 134.33 47.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.932 0.396 . . . . 0.68 111.932 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.516 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 37.5 tp -109.0 123.9 49.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.671 -0.695 . . . . 0.46 110.431 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 4.0 t70 -88.27 93.04 9.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.948 -0.76 . . . . 0.44 108.948 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.428 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 40.1 p -61.05 146.48 47.06 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.265 0.555 . . . . 0.73 111.78 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.76 -73.2 0.47 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.771 -0.65 . . . . 0.56 109.953 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.29 -42.67 0.11 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.255 -0.738 . . . . 0.72 111.255 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.422 ' HA ' ' OE1' ' A' ' 61' ' ' GLN . 12.7 mm-40 -133.95 155.03 50.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.711 0.291 . . . . 1.26 110.311 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -119.99 154.05 35.09 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.019 -0.537 . . . . 1.57 109.783 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.22 -34.27 75.93 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.152 -0.684 . . . . 1.38 109.152 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -130.38 127.19 38.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.545 -0.752 . . . . 0.81 110.554 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 m -57.57 -29.03 64.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.172 -0.467 . . . . 0.63 111.09 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.66 -37.53 76.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.976 0.417 . . . . 0.32 110.812 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 6.9 mtp -71.07 -30.91 67.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.936 -0.574 . . . . 0.69 110.143 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -69.77 -51.18 36.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.312 0.577 . . . . 0.9 109.671 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -65.87 -20.77 66.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.546 -0.752 . . . . 1.41 110.779 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -57.76 -57.77 11.28 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.077 -0.51 . . . . 1.51 111.144 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.42 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 10.9 p90 -70.77 -20.28 62.63 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.552 -0.459 . . . . 1.17 110.77 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 90.9 mtp -75.24 -27.17 59.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.058 0.456 . . . . 0.7 110.071 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.5 mtm105 -82.25 -41.09 20.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.014 0.435 . . . . 1.29 109.928 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 9.7 p -75.78 -12.65 60.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.956 -0.565 . . . . 0.72 111.384 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.34 129.0 11.0 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.926 -0.654 . . . . 0.19 112.312 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -87.46 -46.45 9.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.021 0.438 . . . . 0.54 110.094 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.69 143.9 14.73 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.135 -0.786 . . . . 0.26 111.135 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.522 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 75.3 m-85 -121.56 135.74 54.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.085 0.469 . . . . 0.48 111.557 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.3 tp -97.25 106.78 19.16 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.101 -0.703 . . . . 0.37 109.101 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' ' 111' ' ' MET . 0.1 OUTLIER -78.71 85.68 4.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.065 0.459 . . . . 0.61 110.312 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.63 132.88 34.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.135 0.493 . . . . 0.59 111.824 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.475 ' HB3' HD11 ' A' ' 93' ' ' ILE . 29.2 p90 -144.63 169.15 18.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.459 -0.792 . . . . 0.34 108.908 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.74 124.05 49.96 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.897 -0.321 . . . . 0.32 110.628 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.913 HD11 ' HA ' ' A' ' 118' ' ' CYS . 3.4 pt -71.9 -4.9 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.197 0.522 . . . . 0.78 111.054 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.537 ' OD1' ' HD2' ' A' ' 117' ' ' LYS . 8.7 p-10 -106.4 14.63 27.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.071 -0.513 . . . . 0.82 109.847 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -152.54 100.47 2.57 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.815 -0.63 . . . . 1.07 110.479 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.48 -29.2 68.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.636 . . . . 0.65 112.558 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -58.23 -35.97 72.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.757 0.313 . . . . 0.89 111.385 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.3 p -80.19 -33.78 37.95 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.762 0.315 . . . . 0.64 110.778 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -68.96 -41.73 77.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.42 110.844 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.63 -18.58 62.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.186 -0.461 . . . . 1.44 111.167 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -81.78 -18.66 43.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.904 0.383 . . . . 1.02 110.402 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.475 HD11 ' HB3' ' A' ' 82' ' ' PHE . 27.8 mm -57.79 -30.69 38.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.563 -0.744 . . . . 0.42 110.834 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -63.05 -47.38 83.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.978 -0.556 . . . . 0.83 110.465 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -66.51 -39.37 88.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.89 -0.595 . . . . 0.79 111.547 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -59.99 -45.71 91.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.642 0.258 . . . . 1.17 110.681 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.437 ' HG2' ' CE1' ' A' ' 137' ' ' TYR . 18.8 tpt180 -58.63 -49.62 76.82 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.084 -0.507 . . . . 0.6 110.282 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -60.73 -39.33 88.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.842 -0.617 . . . . 1.35 110.903 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -62.24 -53.13 59.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.56 -0.291 . . . . 1.15 110.896 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.7 mt -59.22 -42.07 85.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.465 -0.334 . . . . 0.51 111.015 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -66.08 -26.03 67.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.471 -0.331 . . . . 1.05 111.621 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -87.01 -35.84 18.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.004 0.431 . . . . 0.91 110.554 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.2 t -70.35 -46.92 69.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.817 -0.629 . . . . 0.35 111.328 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -87.09 -18.52 30.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.329 . . . . 0.63 110.733 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t70 54.6 54.53 9.13 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.306 -0.861 . . . . 0.47 111.055 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.3 m -137.31 146.63 44.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.961 -0.563 . . . . 1.14 109.877 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.24 -42.9 20.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.001 0.429 . . . . 1.74 110.039 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -93.68 106.74 18.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.857 -0.61 . . . . 0.78 110.349 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . 21.3 t -121.48 119.24 29.43 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.938 -0.393 . . . . 0.47 109.938 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 109' ' ' VAL . 16.9 Cg_exo -65.92 103.7 0.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.329 2.019 . . . . 0.25 111.275 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.535 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 85.9 mtp -138.07 151.34 47.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.204 -0.453 . . . . 0.79 110.399 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.7 t -129.55 121.76 53.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.503 -0.554 . . . . 0.22 109.503 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.6 tp -76.82 117.65 18.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.346 -0.613 . . . . 0.29 109.346 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.2 t -117.82 114.99 47.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.0 -0.546 . . . . 0.82 112.069 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.55 96.43 1.89 Allowed Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.049 -1.221 . . . . 0.27 110.049 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -80.67 162.77 24.02 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.775 0.287 . . . . 0.21 111.775 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.537 ' HD2' ' OD1' ' A' ' 85' ' ' ASN . 41.7 mttt 71.39 41.27 0.76 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.382 -0.826 . . . . 0.54 111.516 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.913 ' HA ' HD11 ' A' ' 84' ' ' ILE . 29.6 p -75.17 -19.36 59.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.944 0.402 . . . . 0.46 111.449 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -89.24 -7.55 55.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.966 0.412 . . . . 0.7 111.045 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 51.4 mt -91.56 145.68 31.74 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.256 -0.429 . . . . 0.67 110.859 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.63 -170.65 0.86 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.567 2.178 . . . . 0.54 112.047 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.2 m 58.78 44.85 16.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.134 -0.485 . . . . 0.84 111.544 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -72.24 118.22 14.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.58 110.197 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.49 -17.64 15.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.964 0.411 . . . . 0.81 111.603 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.72 115.52 49.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.07 -0.514 . . . . 0.37 110.779 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.74 148.23 42.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 1.69 110.59 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.6 m -59.55 -33.71 71.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.823 -0.626 . . . . 0.82 111.281 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -64.72 -44.33 90.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.695 -0.23 . . . . 0.62 110.673 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.45 HE21 ' HB3' ' A' ' 129' ' ' GLN . 0.1 OUTLIER -60.4 -41.44 93.88 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.074 0.464 . . . . 0.93 110.655 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.41 -48.33 67.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.594 -0.73 . . . . 0.3 110.561 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -62.03 -35.39 78.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.173 0.511 . . . . 0.47 110.382 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -48.92 79.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.812 -0.631 . . . . 1.18 110.578 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.32 -41.24 85.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.101 -0.499 . . . . 0.44 111.041 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.09 -44.91 83.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.951 0.405 . . . . 0.25 111.204 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -69.03 -25.17 64.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 1.54 110.899 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.0 m -71.5 -26.74 62.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.151 0.5 . . . . 0.68 110.241 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.437 ' CE1' ' HG2' ' A' ' 97' ' ' ARG . 19.1 m-85 -93.11 -33.3 14.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.245 0.545 . . . . 0.77 110.41 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.4 30.11 7.11 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.752 -0.939 . . . . 0.25 110.752 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.1 pt -123.55 156.89 63.72 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.283 -0.459 . . . . 0.51 110.486 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.4 157.37 29.19 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.192 1.928 . . . . 0.36 112.578 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -132.05 132.11 43.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.928 -0.578 . . . . 0.38 110.334 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 63.5 mt -137.81 130.76 41.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.54 111.174 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -81.8 128.15 33.71 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.389 -0.967 . . . . 0.88 108.389 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 64.2 p -131.86 174.73 9.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.272 0.558 . . . . 0.43 112.236 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.7 t -150.6 134.09 16.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.275 -0.875 . . . . 0.33 109.109 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.7 -6.88 59.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.127 0.489 . . . . 0.45 110.407 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -91.39 -48.24 7.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.008 -0.542 . . . . 1.32 110.912 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.0 p -94.22 -17.62 22.51 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.591 -0.277 . . . . 0.52 111.122 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 67.04 23.12 9.8 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.773 0.671 . . . . 1.53 110.86 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 144' ' ' THR . 35.2 tt0 -71.42 119.75 16.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.9 -0.591 . . . . 0.87 111.113 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.05 -8.87 42.17 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.923 -0.58 . . . . 0.51 114.028 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.38 -49.02 85.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 117.143 0.471 . . . . 0.74 111.14 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.37 -48.35 79.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.098 0.475 . . . . 1.62 110.148 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.0 -47.47 84.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.431 -0.804 . . . . 1.0 111.583 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -54.73 -50.41 68.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.679 0.276 . . . . 0.37 111.7 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.488 ' O ' HG23 ' A' ' 160' ' ' VAL . 26.6 m-85 -62.71 -42.68 99.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.346 -0.388 . . . . 1.46 111.578 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -70.22 -35.54 73.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.702 -0.226 . . . . 0.99 111.202 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 39.2 m -64.1 -39.45 94.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.803 0.335 . . . . 0.34 110.304 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.744 HD23 HD23 ' A' ' 6' ' ' LEU . 25.2 tp -61.64 -37.18 83.06 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.163 -0.471 . . . . 0.42 110.394 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 156' ' ' PHE . 21.2 t -64.08 -38.37 82.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.278 0.561 . . . . 0.55 109.778 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.6 mtt85 -70.49 -34.3 72.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.8 -0.636 . . . . 0.9 110.134 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -59.95 -40.43 88.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.802 -0.636 . . . . 0.73 109.96 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 65.4 mt -68.11 -45.2 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.501 -0.772 . . . . 0.42 110.268 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 93.4 mtt180 -54.23 -42.18 69.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.678 -0.692 . . . . 0.87 111.043 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -63.26 -36.95 85.36 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 115.796 -0.638 . . . . 0.97 111.135 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -69.69 -26.35 64.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.181 0.515 . . . . 0.71 110.411 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -82.82 -34.98 26.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.944 -0.571 . . . . 1.11 110.893 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 8.7 pt-20 -95.96 16.62 17.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.376 -0.375 . . . . 1.12 110.566 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.3 tttp . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.22 -0.895 . . . . 1.47 110.32 -179.855 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.498 ' O2A' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' QPD . . . . . 0.516 ' N1 ' ' HB2' ' A' ' 56' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 50' ' ' THR . 31.8 ttm . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.967 0.413 . . . . 1.48 110.254 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.2 m -92.73 137.62 32.21 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.431 -0.349 . . . . 1.04 110.965 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -91.13 132.16 36.24 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.619 -0.511 . . . . 1.27 109.619 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -115.26 121.51 43.12 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.138 -0.319 . . . . 1.11 110.138 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.4 ' HB3' ' C6 ' ' A' ' 203' ' ' QPD . 18.5 mtpp -96.53 108.22 20.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.241 0.543 . . . . 0.81 110.988 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.8 mp -112.29 142.35 44.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.71 -0.677 . . . . 1.39 111.2 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.2 t -128.74 130.01 68.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.866 -0.607 . . . . 0.81 110.677 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.6 t -95.89 114.04 31.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.92 -0.582 . . . . 0.44 109.519 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -115.82 136.62 52.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.428 0.633 . . . . 0.7 111.425 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.2 176.08 45.0 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.43 -0.805 . . . . 0.53 111.589 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.431 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -71.83 167.73 19.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.864 0.364 . . . . 0.58 110.114 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.3 128.31 11.48 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.496 -0.859 . . . . 0.8 112.765 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.99 10.95 59.34 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.71 -0.757 . . . . 0.42 113.744 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 11' ' ' ALA . 27.2 m -85.94 -1.86 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 117.696 0.748 . . . . 0.57 111.357 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.511 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 92.46 29.59 10.89 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.954 -0.641 . . . . 0.49 113.371 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -60.59 -45.61 93.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.802 0.301 . . . . 0.81 111.518 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.606 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 1.3 m -75.63 -20.3 58.6 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.874 0.324 . . . . 0.58 111.874 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.15 -40.6 64.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.868 0.366 . . . . 0.43 110.733 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 37.8 mt -64.57 -27.58 69.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.864 -0.607 . . . . 0.92 110.616 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.468 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -74.24 -54.06 8.49 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.033 -0.53 . . . . 0.89 111.351 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.407 HG21 HG23 ' A' ' 29' ' ' VAL . 10.6 mt -61.13 -38.67 80.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.778 0.323 . . . . 0.79 111.433 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.641 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 2.5 mm-40 -66.85 -23.82 66.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.009 0.433 . . . . 0.46 111.194 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.2 tp -95.08 -40.73 9.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.74 0.305 . . . . 1.37 111.54 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 20' ' ' THR . 46.9 mm -74.61 -55.35 12.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.164 -0.471 . . . . 0.58 112.232 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 50.9 mt-30 -100.86 -11.64 19.65 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.945 0.35 . . . . 1.68 111.945 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 70.2 m-20 71.23 17.64 5.92 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.362 0.875 . . . . 1.6 113.362 178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -128.73 128.65 44.45 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.474 -0.49 . . . . 0.74 110.548 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -75.48 127.28 32.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.064 -0.971 . . . . 0.6 110.959 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.407 HG23 HG21 ' A' ' 21' ' ' ILE . 48.6 t -99.04 136.58 29.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.918 -0.583 . . . . 0.64 109.482 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -83.47 -30.5 27.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.502 -0.317 . . . . 1.12 111.778 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -134.84 116.3 14.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.902 0.382 . . . . 1.18 111.248 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -141.76 146.31 35.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.848 -0.614 . . . . 0.6 109.516 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.33 121.3 73.96 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.052 0.453 . . . . 0.8 111.357 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.43 -18.35 15.83 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.55 2.167 . . . . 0.52 112.865 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.07 3.32 52.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.261 -0.427 . . . . 0.89 111.208 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 mt -83.92 125.35 40.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.234 0.54 . . . . 0.73 111.321 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 18.4 tt0 -125.3 83.41 2.16 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.905 -1.146 . . . . 0.81 107.905 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -113.62 162.17 16.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.789 -0.641 . . . . 1.29 111.956 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.74 142.94 26.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.289 -0.869 . . . . 0.78 111.652 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -134.97 135.75 41.68 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.053 -0.351 . . . . 0.94 110.053 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.579 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 1.1 mpp_? -119.2 139.57 51.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.912 0.387 . . . . 0.56 110.565 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -143.04 131.33 22.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.1 -0.5 . . . . 1.46 110.302 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -101.7 112.27 24.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.985 0.421 . . . . 1.89 110.313 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.95 149.87 30.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.136 -0.484 . . . . 1.09 110.968 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.3 t -92.49 93.17 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.947 -0.761 . . . . 0.65 108.947 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.3 mt -91.51 114.05 28.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.049 -0.523 . . . . 1.06 111.805 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.493 ' HB2' HH12 ' A' ' 164' ' ' ARG . 56.5 m-20 58.26 37.78 26.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.662 -0.699 . . . . 0.97 111.099 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.5 -5.01 84.83 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.086 -0.578 . . . . 0.6 113.347 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -108.93 115.61 30.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.878 0.37 . . . . 1.41 111.759 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -70.22 116.92 11.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 0.63 109.768 178.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.3 m -129.89 151.64 50.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.084 0.469 . . . . 0.71 111.72 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.9 tp -104.25 113.45 27.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.001 -0.74 . . . . 0.48 109.001 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 53.7 mt -82.39 125.62 31.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.896 -0.593 . . . . 0.87 112.027 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -110.41 88.73 2.84 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.106 -1.072 . . . . 1.03 108.106 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.0 mt -99.81 130.58 48.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.96 -0.564 . . . . 0.68 111.871 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.468 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 22.7 tp -116.36 107.02 14.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.996 -0.547 . . . . 0.46 109.782 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -75.32 116.16 15.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.876 -0.602 . . . . 0.44 110.267 -179.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.7 p -73.45 156.32 38.38 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.515 0.674 . . . . 0.73 112.168 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.4 -55.78 2.38 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.79 -1.095 . . . . 0.56 109.949 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.28 -87.46 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.843 -0.617 . . . . 0.72 111.957 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -122.91 127.88 49.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.974 -0.38 . . . . 1.26 109.974 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -87.72 -173.73 4.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.271 -0.422 . . . . 1.57 111.094 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.13 -47.7 81.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 1.38 111.07 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -123.2 148.67 45.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.72 0.295 . . . . 0.81 110.521 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -60.91 -34.35 74.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.088 -0.506 . . . . 0.63 110.652 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.76 -28.87 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.891 -0.595 . . . . 0.32 111.362 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 86.0 mtp -70.05 -44.61 68.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.228 0.537 . . . . 0.69 109.847 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 71' ' ' TYR . 17.0 ttp180 -65.92 -39.0 90.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.538 -0.755 . . . . 0.9 109.91 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -77.79 -5.22 50.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.584 -0.735 . . . . 1.41 110.842 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -73.7 -62.86 1.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.661 -0.245 . . . . 1.51 111.642 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 68' ' ' ARG . 1.3 p90 -67.22 -17.83 64.98 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 120.606 0.241 . . . . 1.17 111.047 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.3 mtt -73.51 -17.43 61.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.225 0.536 . . . . 0.7 109.665 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -90.48 -49.77 6.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.557 -0.747 . . . . 1.29 110.187 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.15 -12.0 60.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.72 112.145 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.47 132.49 38.4 Favored Glycine 0 C--O 1.237 0.344 0 C-N-CA 121.123 -0.56 . . . . 0.19 113.18 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -97.96 -36.32 10.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 0.54 110.81 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.416 ' HA3' HD11 ' A' ' 163' ' ' ILE . . . -133.17 128.89 5.23 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.022 -0.831 . . . . 0.26 111.022 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.477 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 91.6 m-85 -114.99 116.85 29.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.244 0.545 . . . . 0.48 110.88 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.8 tp -88.8 109.19 19.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.54 -0.755 . . . . 0.37 109.908 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.5 m -82.53 103.54 12.14 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.356 0.41 . . . . 0.61 109.959 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.07 129.61 60.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.981 0.419 . . . . 0.59 112.084 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -136.6 162.3 33.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.652 -0.704 . . . . 0.34 109.674 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.442 ' HB1' ' OD1' ' A' ' 85' ' ' ASN . . . -100.95 126.76 47.62 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.365 -0.235 . . . . 0.32 110.365 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.1 pt -71.13 -12.16 15.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.948 0.404 . . . . 0.78 111.375 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.442 ' OD1' ' HB1' ' A' ' 83' ' ' ALA . 10.1 p-10 -95.23 5.79 50.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.826 -0.625 . . . . 0.82 110.75 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -148.43 111.73 4.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.072 0.463 . . . . 1.07 110.542 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.27 -26.96 66.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.1 -0.5 . . . . 0.65 111.938 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -58.35 -37.85 76.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.89 110.646 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -67.55 -38.15 83.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.378 -0.373 . . . . 0.64 110.796 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -66.67 -39.86 88.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.176 0.512 . . . . 0.42 110.068 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.53 -35.08 79.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.87 -0.604 . . . . 1.44 110.635 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -63.45 -32.8 74.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.901 -0.591 . . . . 1.02 110.932 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 89' ' ' SER . 45.7 mm -57.87 -31.55 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.586 . . . . 0.42 111.031 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -62.71 -35.92 81.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.126 0.489 . . . . 0.83 110.348 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -82.19 -38.5 24.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.79 110.104 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -58.69 -48.68 80.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.283 -0.417 . . . . 1.17 111.204 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -56.37 -51.78 67.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.958 -0.565 . . . . 0.6 110.919 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -39.89 95.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.032 -0.531 . . . . 1.35 111.061 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.449 ' O ' HG23 ' A' ' 103' ' ' VAL . 51.7 tt0 -59.36 -55.24 37.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.947 -0.57 . . . . 1.15 111.117 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.97 -37.76 79.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.435 -0.348 . . . . 0.51 110.755 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -61.09 -32.6 72.26 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.974 0.416 . . . . 1.05 110.026 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -77.46 -45.32 26.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.893 -0.594 . . . . 0.91 110.643 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 99' ' ' GLN . 66.4 t -59.93 -47.64 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.191 -0.459 . . . . 0.35 111.71 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -83.68 -13.32 54.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.451 -0.34 . . . . 0.63 110.541 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 t70 54.91 48.56 19.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.622 -0.717 . . . . 0.47 109.854 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.8 m -132.61 143.65 49.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.363 -0.835 . . . . 1.14 110.314 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.18 -31.06 30.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.1 0.476 . . . . 1.74 110.368 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -119.41 112.35 19.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.96 -0.564 . . . . 0.78 110.135 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.21 122.54 24.13 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.695 -0.483 . . . . 0.47 109.695 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -49.69 107.52 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.171 2.581 . . . . 0.25 111.982 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.477 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 56.5 mtt -140.04 150.2 44.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.952 -0.567 . . . . 0.79 110.719 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.4 t -132.46 121.81 46.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.665 -0.865 . . . . 0.22 108.665 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.637 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 56.3 tp -89.31 125.13 34.98 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.641 -0.503 . . . . 0.29 109.641 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.7 129.13 54.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.354 0.597 . . . . 0.82 111.861 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -94.5 103.86 3.07 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.224 -1.15 . . . . 0.27 110.224 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -81.51 164.52 21.92 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.576 -0.157 . . . . 0.21 110.576 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 69.7 mttt 66.97 36.93 4.06 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.733 0.646 . . . . 0.54 110.459 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 31.9 p -67.68 -13.63 62.26 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.24 -0.436 . . . . 0.46 111.957 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -89.53 -8.77 52.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.428 -0.351 . . . . 0.7 110.936 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 120' ' ' LEU . 16.3 mt -77.63 130.25 74.35 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.561 0.22 . . . . 0.67 110.976 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 11.2 Cg_exo -69.5 171.88 13.39 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.885 2.39 . . . . 0.54 112.081 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.8 m 61.57 54.55 3.01 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.393 0.616 . . . . 0.84 110.573 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -64.64 127.41 31.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.381 -0.827 . . . . 0.58 111.206 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.14 -41.22 7.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.074 -0.512 . . . . 0.81 110.512 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.3 t -88.96 113.32 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.222 -0.445 . . . . 0.37 110.295 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.06 147.61 49.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 1.69 110.878 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -46.85 87.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.82 111.848 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.6 tttm -65.22 -35.69 81.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.61 -0.268 . . . . 0.62 110.621 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -59.27 -44.34 92.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.93 110.881 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.56 -40.04 66.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 0.3 110.929 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.8 -34.42 78.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.761 -0.654 . . . . 0.47 110.953 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -40.82 98.46 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.789 -0.641 . . . . 1.18 110.226 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 27.8 tp -69.84 -42.07 74.07 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.872 -0.604 . . . . 0.44 109.547 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 139' ' ' ILE . . . -58.69 -45.47 89.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.302 -0.863 . . . . 0.25 110.423 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -59.07 -45.69 90.17 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.858 -0.61 . . . . 1.54 110.683 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.2 m -65.42 -35.08 79.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.945 -0.571 . . . . 0.68 111.301 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -79.02 -22.42 45.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.235 -0.439 . . . . 0.77 110.944 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.62 26.61 38.1 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.911 -0.661 . . . . 0.25 111.45 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.434 ' O ' ' HB1' ' A' ' 134' ' ' ALA . 34.7 pt -124.16 156.17 66.84 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 110.094 -0.335 . . . . 0.51 110.094 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -84.59 155.12 12.04 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.153 1.902 . . . . 0.36 112.859 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.637 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 19.0 t80 -130.93 127.03 37.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.918 -0.583 . . . . 0.38 110.549 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.9 mt -130.53 139.36 51.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.132 -0.485 . . . . 0.54 110.034 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -78.32 137.96 38.32 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.288 -1.005 . . . . 0.88 108.288 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.7 p -139.03 162.02 35.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.519 0.933 . . . . 0.43 113.519 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.6 t -155.09 117.25 4.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.687 -1.142 . . . . 0.33 108.559 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.87 -11.3 60.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.45 111.478 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -84.5 -42.84 15.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.278 -0.419 . . . . 1.32 111.439 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.5 p -96.55 -5.56 39.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.696 -0.229 . . . . 0.52 111.525 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 38.4 ttt85 59.75 47.66 10.1 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.611 0.719 . . . . 1.53 109.829 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -113.31 125.57 54.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.544 -0.753 . . . . 0.87 111.158 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.78 -21.83 3.7 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.802 -0.636 . . . . 0.51 113.303 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.17 -46.49 88.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.802 0.334 . . . . 0.74 111.654 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.452 ' O ' ' HD2' ' A' ' 157' ' ' TYR . 21.4 t70 -62.0 -49.24 76.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.495 . . . . 1.62 110.096 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -39.02 86.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.223 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -58.97 -52.05 67.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.222 -0.445 . . . . 0.37 111.94 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -62.58 -41.58 99.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.633 -0.258 . . . . 1.46 111.562 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.452 ' HD2' ' O ' ' A' ' 153' ' ' ASP . 29.0 m-85 -66.96 -34.63 78.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.99 110.807 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 99.5 m -68.42 -45.61 72.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.319 -0.4 . . . . 0.34 110.92 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 163' ' ' ILE . 31.0 tp -55.96 -41.79 75.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.361 -0.381 . . . . 0.42 111.052 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.88 -43.47 98.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.322 -0.399 . . . . 0.55 110.901 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -65.22 -34.22 77.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.444 -0.344 . . . . 0.9 111.011 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -64.05 -44.82 91.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.73 110.232 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 159' ' ' LEU . 17.2 mt -62.54 -43.9 98.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.086 0.469 . . . . 0.42 110.072 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.493 HH12 ' HB2' ' A' ' 47' ' ' ASP . 93.9 mtt180 -59.15 -42.78 91.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.42 -0.809 . . . . 0.87 111.371 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -66.08 -30.57 71.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.218 -0.446 . . . . 0.97 111.191 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -79.73 -26.06 40.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.256 -0.429 . . . . 0.71 110.213 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -77.08 -33.66 57.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.594 -0.275 . . . . 1.11 110.408 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -87.04 4.0 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 1.12 110.871 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.2 tptt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.367 -0.825 . . . . 1.47 110.848 -179.616 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.606 ' O2A' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' QPD . . . . . 0.468 ' N1 ' ' HB2' ' A' ' 56' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttm . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 121.17 0.51 . . . . 1.48 110.371 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.0 m -76.38 126.84 31.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.133 -0.485 . . . . 1.04 110.712 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -94.14 134.67 36.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.133 -0.485 . . . . 1.27 110.253 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -122.49 128.08 50.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.375 -0.375 . . . . 1.11 110.279 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -99.58 108.82 21.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.269 -0.423 . . . . 0.81 109.921 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.467 HD11 HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -124.59 148.94 47.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.394 0.616 . . . . 1.39 110.981 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.13 132.03 70.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.924 -0.58 . . . . 0.81 110.862 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.4 t -91.24 119.19 38.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.035 -0.728 . . . . 0.44 109.035 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.7 m -116.65 157.83 17.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.829 0.347 . . . . 0.7 111.297 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.83 176.27 32.76 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.714 -0.954 . . . . 0.53 110.714 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -73.68 172.63 11.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.974 0.416 . . . . 0.58 111.415 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.91 121.19 5.67 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.697 -0.763 . . . . 0.8 112.189 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.71 3.03 55.26 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.821 -0.704 . . . . 0.42 113.245 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 11' ' ' ALA . 31.1 m -72.81 -29.09 28.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 117.391 0.596 . . . . 0.57 111.098 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.652 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 115.85 19.97 5.47 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.144 -1.027 . . . . 0.49 114.406 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -53.05 -53.58 48.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.468 0.634 . . . . 0.81 111.86 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -34.99 75.64 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.322 -0.399 . . . . 0.58 111.959 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.63 -40.62 88.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.5 -0.318 . . . . 0.43 111.278 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 23.5 mt -63.31 -39.05 93.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.375 -0.375 . . . . 0.92 110.88 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 m -66.14 -47.4 74.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.256 -0.429 . . . . 0.89 111.005 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.5 mt -65.59 -34.8 72.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 0.79 111.26 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 2.3 mm-40 -69.97 -12.67 61.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.991 0.424 . . . . 0.46 111.323 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.7 tp -102.29 -37.46 8.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.211 0.529 . . . . 1.37 110.861 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.9 mm -80.53 -59.08 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.908 -0.587 . . . . 0.58 111.425 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -89.92 -17.06 28.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.451 -0.34 . . . . 1.68 110.96 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 45.4 m-80 63.38 46.83 4.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.794 -0.639 . . . . 1.6 112.282 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -153.71 143.79 22.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.576 -0.528 . . . . 0.74 109.576 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -82.71 129.99 35.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.242 -0.435 . . . . 0.6 111.972 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.33 120.02 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.657 -0.701 . . . . 0.64 109.512 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.6 -41.17 32.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.236 -0.438 . . . . 1.12 111.888 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -115.6 108.97 17.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.181 0.515 . . . . 1.18 111.698 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -142.3 144.07 33.09 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.93 -0.767 . . . . 0.6 108.93 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -64.63 123.73 84.06 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.917 0.389 . . . . 0.8 110.9 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.18 -15.29 14.54 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.549 2.166 . . . . 0.52 113.386 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.44 3.16 56.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.674 0.273 . . . . 0.89 111.733 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.8 mt -86.0 127.46 40.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 120.849 0.357 . . . . 0.73 110.462 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 11.3 tt0 -114.86 94.94 4.98 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.215 -1.032 . . . . 0.81 108.215 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -115.47 164.18 14.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.01 -0.541 . . . . 1.29 110.918 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 1.2 p -130.06 129.84 44.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.776 -0.647 . . . . 0.78 109.961 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -125.35 143.81 50.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.642 -0.254 . . . . 0.94 110.947 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.694 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -113.2 143.06 45.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.56 110.575 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -147.02 134.85 21.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.703 -0.681 . . . . 1.46 109.459 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -103.18 114.49 28.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.943 0.401 . . . . 1.89 110.976 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 31.5 t -127.01 147.81 31.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.767 -0.652 . . . . 1.09 110.432 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.61 101.24 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.728 -0.471 . . . . 0.65 109.728 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 76.9 mt -105.96 118.1 52.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.963 0.411 . . . . 1.06 111.249 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.505 ' HB2' HH12 ' A' ' 164' ' ' ARG . 86.6 m-20 61.77 30.85 18.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.007 -0.997 . . . . 0.97 111.744 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.61 -0.21 73.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.855 -0.688 . . . . 0.6 114.163 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -121.68 126.67 49.53 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.46 0.63 . . . . 1.41 111.175 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.95 115.36 11.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.976 0.417 . . . . 0.63 110.111 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.1 m -116.89 147.72 41.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.108 -0.496 . . . . 0.71 111.576 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.9 tp -100.46 120.25 39.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.881 -0.599 . . . . 0.48 109.394 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.694 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 16.7 mt -89.73 115.99 27.5 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.047 -0.524 . . . . 0.87 112.128 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.424 ' OD1' ' HD2' ' A' ' 41' ' ' ARG . 19.0 t70 -104.31 95.18 5.77 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.53 -1.285 . . . . 1.03 107.53 176.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 39' ' ' SER . 6.1 mt -101.85 127.88 54.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.075 -0.511 . . . . 0.68 112.367 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.418 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 42.0 tp -114.23 119.45 37.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.057 -0.52 . . . . 0.46 109.859 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 4.5 t70 -89.84 100.88 13.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.115 -0.493 . . . . 0.44 110.074 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.4 p -62.51 138.54 58.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.779 -0.646 . . . . 0.73 112.597 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.54 -36.24 24.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.56 110.066 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.33 -74.9 0.42 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.964 -0.636 . . . . 0.72 111.83 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -108.93 117.89 35.36 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.818 -0.438 . . . . 1.26 109.818 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.94 162.7 15.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.172 -0.467 . . . . 1.57 110.432 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -55.56 -51.92 65.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.857 -0.61 . . . . 1.38 111.188 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -127.07 148.27 50.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.635 -0.506 . . . . 0.81 109.635 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -35.04 76.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.693 0.282 . . . . 0.63 111.361 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.94 -31.91 73.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 0.32 111.222 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 85.0 mtp -74.17 -31.67 62.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.268 0.556 . . . . 0.69 109.823 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.515 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 34.9 ttp180 -74.33 -46.45 40.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.453 -0.794 . . . . 0.9 109.906 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.488 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 39.2 m-20 -65.68 -24.45 67.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.409 -0.814 . . . . 1.41 110.228 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -57.9 -56.7 18.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.349 -0.841 . . . . 1.51 111.559 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 31.1 p90 -72.4 -14.26 61.66 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.861 -0.336 . . . . 1.17 111.407 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.4 mtt -76.16 -28.78 57.5 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.451 -0.574 . . . . 0.7 109.451 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 30.2 mtm180 -83.64 -34.18 25.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.831 -0.622 . . . . 1.29 111.163 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.425 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -78.91 -26.77 43.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.27 -0.423 . . . . 0.72 111.603 -179.399 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.82 125.76 28.47 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.038 -0.601 . . . . 0.19 112.712 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -92.0 -26.05 18.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.681 -0.488 . . . . 0.54 109.681 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -141.78 143.82 13.5 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 110.886 -0.886 . . . . 0.26 110.886 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.454 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 89.8 m-85 -126.8 132.43 51.03 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.229 0.538 . . . . 0.48 111.255 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 tp -100.87 112.28 24.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.724 -0.671 . . . . 0.37 109.368 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.7 m -90.01 104.72 17.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.102 0.477 . . . . 0.61 110.454 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.1 t -102.73 126.5 56.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.069 -0.514 . . . . 0.59 111.571 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -133.02 160.19 37.87 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.065 -0.717 . . . . 0.34 109.065 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.85 128.2 48.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.811 0.338 . . . . 0.32 110.492 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 pt -67.29 -14.2 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.367 . . . . 0.78 111.828 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -100.85 6.48 43.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.926 0.393 . . . . 0.82 110.397 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -135.67 103.32 5.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 1.07 110.246 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -27.22 66.97 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.447 0.536 . . . . 0.65 112.447 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -66.88 -37.74 84.98 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.161 -0.216 . . . . 0.89 111.123 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.429 ' O ' HG12 ' A' ' 93' ' ' ILE . 91.4 p -64.89 -36.87 85.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.425 . . . . 0.64 110.024 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -69.67 -35.71 75.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.924 -0.58 . . . . 0.42 109.955 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -65.62 -40.88 93.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.801 -0.636 . . . . 1.44 110.471 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.53 -26.35 68.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.737 -0.665 . . . . 1.02 111.769 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 89' ' ' SER . 48.3 mm -57.93 -28.64 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.099 0.476 . . . . 0.42 110.73 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -66.66 -41.12 88.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.973 -0.558 . . . . 0.83 110.68 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -77.71 -34.54 52.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.79 110.832 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -59.13 -48.02 83.16 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.524 -0.307 . . . . 1.17 110.741 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -60.57 -46.41 90.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.96 -0.564 . . . . 0.6 110.016 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -47.92 79.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.742 -0.663 . . . . 1.35 111.528 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.544 ' O ' HG23 ' A' ' 103' ' ' VAL . 26.0 tt0 -59.3 -58.19 9.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 1.15 112.111 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.33 -39.0 79.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 120.591 0.234 . . . . 0.51 111.026 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -61.38 -35.86 78.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.951 0.405 . . . . 1.05 110.457 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -73.64 -37.87 65.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.044 -0.525 . . . . 0.91 110.972 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 99' ' ' GLN . 47.8 t -68.96 -40.83 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.35 110.982 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -82.75 -20.15 36.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.485 -0.325 . . . . 0.63 111.222 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 54.92 57.31 5.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.507 0.67 . . . . 0.47 110.333 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -141.6 142.01 33.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.656 -0.702 . . . . 1.14 109.761 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -75.54 -31.82 60.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.906 0.384 . . . . 1.74 110.004 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.4 123.96 49.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.968 -0.56 . . . . 0.78 110.816 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.2 t -135.28 113.38 11.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.187 -0.671 . . . . 0.47 109.187 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.98 109.18 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.854 2.369 . . . . 0.25 112.783 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.454 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 30.9 mtt -139.33 152.98 47.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.964 -0.562 . . . . 0.79 110.722 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 73.3 t -131.45 127.25 59.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.171 -0.677 . . . . 0.22 109.171 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.4 tp -84.84 118.87 24.75 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.606 -0.516 . . . . 0.29 109.606 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 65.0 t -114.68 117.9 57.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.037 -0.529 . . . . 0.82 112.008 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.29 93.25 1.49 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.549 -1.02 . . . . 0.27 110.549 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -80.73 163.2 23.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.648 0.261 . . . . 0.21 111.623 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.6 mttt 68.39 33.84 3.98 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.42 -0.809 . . . . 0.54 111.233 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 20.9 p -68.05 -20.35 64.97 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 111.991 0.367 . . . . 0.46 111.991 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -86.54 -12.0 50.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.765 0.317 . . . . 0.7 111.383 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.429 HD11 ' N2 ' ' A' ' 201' ' ' GDP . 17.5 mt -80.21 142.17 54.71 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.358 -0.383 . . . . 0.67 110.737 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.05 174.14 12.48 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.382 2.055 . . . . 0.54 111.431 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.6 m 66.15 60.28 0.65 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.352 0.596 . . . . 0.84 111.054 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.5 ttm-85 -75.54 104.89 6.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.736 -0.666 . . . . 0.58 110.388 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 m -82.53 -36.84 25.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.093 -0.503 . . . . 0.81 111.045 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.0 t -97.39 111.0 26.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.22 -0.445 . . . . 0.37 110.628 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -68.6 148.21 50.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.802 -0.636 . . . . 1.69 110.135 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.2 m -57.62 -37.19 72.87 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.339 -0.391 . . . . 0.82 111.607 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -63.95 -37.57 87.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.665 0.269 . . . . 0.62 111.081 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -58.69 -45.89 88.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 0.93 111.236 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.76 -41.33 62.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.85 -0.614 . . . . 0.3 111.225 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -61.86 -39.48 92.04 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.031 0.443 . . . . 0.47 109.994 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.86 -46.66 89.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.776 -0.647 . . . . 1.18 110.56 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.89 -39.54 90.74 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.785 -0.643 . . . . 0.44 110.418 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.81 88.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.574 . . . . 0.25 110.945 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -64.4 -38.89 92.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.573 -0.285 . . . . 1.54 111.104 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.75 -23.71 62.48 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.094 0.473 . . . . 0.68 111.766 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -91.11 -19.12 23.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.145 -0.479 . . . . 0.77 110.283 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.8 32.85 48.5 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.407 -0.677 . . . . 0.25 111.407 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.448 ' HB ' ' O ' ' A' ' 111' ' ' MET . 36.6 pt -127.44 158.16 70.56 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.94 -0.393 . . . . 0.51 109.94 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.19 151.12 17.92 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.448 2.098 . . . . 0.36 112.718 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -124.53 129.05 49.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.76 -0.655 . . . . 0.38 109.757 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 67.0 mt -137.1 129.41 43.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.394 -0.366 . . . . 0.54 111.316 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -85.26 133.74 34.15 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.973 -0.751 . . . . 0.88 108.973 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 150' ' ' GLN . 41.4 p -138.84 179.94 6.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.541 0.686 . . . . 0.43 111.953 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.5 t -155.46 135.92 13.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.017 -0.992 . . . . 0.33 108.843 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.16 -7.4 58.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.064 0.459 . . . . 0.45 111.291 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -94.78 -48.75 5.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.068 -0.514 . . . . 1.32 111.117 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.9 p -92.71 -12.85 30.38 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 111.928 0.344 . . . . 0.52 111.928 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 57.81 38.41 27.26 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.333 0.587 . . . . 1.53 110.653 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.421 ' O ' HG22 ' A' ' 144' ' ' THR . 45.5 tt0 -69.83 94.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.146 -0.934 . . . . 0.87 112.251 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 68.72 22.25 75.28 Favored Glycine 0 CA--C 1.516 0.153 0 CA-C-N 115.788 -0.642 . . . . 0.51 114.561 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.43 -52.1 50.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 117.69 0.745 . . . . 0.74 110.618 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.8 -40.59 80.28 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.027 -0.533 . . . . 1.62 110.364 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -59.63 -49.57 77.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.251 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.28 84.96 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.099 0.476 . . . . 0.37 110.998 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -63.5 -48.87 75.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.681 -0.69 . . . . 1.46 111.058 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -67.57 -30.82 70.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.446 -0.343 . . . . 0.99 110.518 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 90.2 m -62.2 -40.84 97.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.34 110.257 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.44 ' O ' HG13 ' A' ' 163' ' ' ILE . 51.2 tp -59.14 -42.01 89.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.397 -0.365 . . . . 0.42 110.47 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 79.8 t -61.67 -39.74 84.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.55 110.365 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -68.4 -33.85 74.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.9 110.576 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 158' ' ' THR . 48.8 mm-40 -64.53 -40.89 96.44 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.299 -0.63 . . . . 0.73 109.299 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 159' ' ' LEU . 70.2 mt -62.52 -43.9 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.62 -0.718 . . . . 0.42 109.947 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.505 HH12 ' HB2' ' A' ' 47' ' ' ASP . 84.8 mtt180 -59.39 -43.94 92.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.905 -0.589 . . . . 0.87 111.021 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 168' ' ' GLU . 52.3 mtmt -62.04 -27.93 69.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.319 -0.4 . . . . 0.97 111.304 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -79.96 -35.36 37.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.013 0.435 . . . . 0.71 110.616 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 163' ' ' ILE . 29.5 mtpt -77.6 -30.99 52.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.191 -0.459 . . . . 1.11 111.483 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 6.0 pt-20 -86.09 1.17 51.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.709 0.29 . . . . 1.12 111.215 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 8.9 tttp . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.614 -0.708 . . . . 1.47 110.576 -179.57 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.45 ' O1B' ' O1A' ' A' ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' QPD . . . . . 0.418 ' N1 ' ' HB2' ' A' ' 56' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttt . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.95 -0.389 . . . . 1.48 109.95 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.7 127.07 32.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.908 -0.587 . . . . 1.04 111.796 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.82 122.43 46.75 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.853 -0.425 . . . . 1.27 109.853 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -122.65 130.79 53.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.479 -0.328 . . . . 1.11 111.023 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -92.19 123.0 35.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.006 -0.543 . . . . 0.81 110.915 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 2.8 mp -119.48 133.57 55.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.451 -0.795 . . . . 1.39 110.293 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.466 HG22 ' C6 ' ' A' ' 203' ' ' QPD . 0.1 OUTLIER -125.04 109.49 22.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.021 0.438 . . . . 0.81 110.301 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -76.42 125.68 36.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.287 -0.635 . . . . 0.44 109.287 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.1 m -116.84 148.04 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.145 0.498 . . . . 0.7 110.837 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.51 176.82 39.11 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.022 -0.831 . . . . 0.53 111.022 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -81.08 156.85 25.61 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.017 0.437 . . . . 0.58 111.392 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.31 102.7 0.76 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.796 -0.716 . . . . 0.8 112.032 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.15 0.73 6.9 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.822 -0.704 . . . . 0.42 112.792 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 11' ' ' ALA . 23.4 m -76.1 -19.4 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.828 0.347 . . . . 0.57 110.781 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.593 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 104.76 25.47 6.85 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.483 -0.865 . . . . 0.49 112.142 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -52.97 -50.96 63.07 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.255 0.465 . . . . 0.81 112.255 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.534 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 2.4 m -64.36 -34.06 77.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.922 0.342 . . . . 0.58 111.922 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.37 -34.31 75.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.712 -0.222 . . . . 0.43 111.472 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 15' ' ' GLY . 30.4 mt -59.42 -53.98 51.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.355 -0.384 . . . . 0.92 110.756 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.409 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -67.34 -39.61 85.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.779 -0.646 . . . . 0.89 110.991 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.2 mt -58.37 -38.47 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.953 -0.567 . . . . 0.79 111.73 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -66.1 -37.56 86.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.928 0.394 . . . . 0.46 111.501 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.0 tp -78.78 -32.31 46.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.208 -0.451 . . . . 1.37 111.316 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 20' ' ' THR . 48.9 mm -89.32 -52.96 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 113.068 0.766 . . . . 0.58 113.068 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -87.1 -9.48 55.28 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.175 0.435 . . . . 1.68 112.175 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 65.25 21.41 12.05 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.202 0.445 . . . . 1.6 112.202 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -159.98 146.97 16.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.804 0.335 . . . . 0.74 110.302 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.581 ' HZ ' HO2' ' A' ' 201' ' ' GDP . 68.6 t80 -77.18 145.62 37.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.706 -0.679 . . . . 0.6 111.499 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.7 t -119.86 122.31 68.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.183 -0.673 . . . . 0.64 109.183 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -73.71 -50.65 19.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.036 -0.529 . . . . 1.12 112.076 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -107.93 109.88 21.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.146 0.498 . . . . 1.18 111.951 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -145.46 134.32 22.44 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.875 -0.787 . . . . 0.6 108.875 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.01 126.62 90.49 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.009 -0.542 . . . . 0.8 111.707 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.27 -19.74 19.45 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.545 2.164 . . . . 0.52 112.111 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -16.02 56.25 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.008 -0.542 . . . . 0.89 111.739 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.43 116.96 24.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.382 0.611 . . . . 0.73 111.12 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -112.02 117.52 32.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.076 -0.965 . . . . 0.81 109.309 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -138.07 158.63 43.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.812 0.339 . . . . 1.29 111.326 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -106.6 127.14 53.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.855 -0.611 . . . . 0.78 109.644 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -111.02 139.36 46.44 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.55 -0.295 . . . . 0.94 110.791 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.61 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 0.2 OUTLIER -122.28 123.53 41.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.133 0.492 . . . . 0.56 110.921 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -134.69 140.44 45.99 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.6 -0.518 . . . . 1.46 109.6 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -110.01 123.18 49.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.883 0.373 . . . . 1.89 110.45 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.24 132.18 55.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.751 -0.463 . . . . 1.09 109.751 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.474 HG22 HG23 ' A' ' 50' ' ' THR . 22.1 t -84.04 91.97 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.875 -0.417 . . . . 0.65 109.875 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.4 mt -103.23 133.09 48.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.8 -0.636 . . . . 1.06 110.263 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 60.32 27.35 16.9 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.925 -0.58 . . . . 0.97 111.368 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.43 -0.15 88.26 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.184 -0.531 . . . . 0.6 113.165 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -109.85 130.99 55.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.865 0.364 . . . . 1.41 111.36 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.474 HG23 HG22 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -73.89 95.17 2.41 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.333 -0.617 . . . . 0.63 109.333 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 59.7 m -101.19 133.76 45.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.48 0.657 . . . . 0.71 111.467 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.6 tp -100.86 124.63 46.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.253 -0.885 . . . . 0.48 109.325 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 1.3 mp -93.04 113.13 25.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.116 -0.493 . . . . 0.87 111.706 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.61 ' OD1' ' HD2' ' A' ' 41' ' ' ARG . 14.8 t70 -105.3 93.41 4.67 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.154 -1.054 . . . . 1.03 108.154 177.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 13.6 mt -110.88 142.47 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.169 0.433 . . . . 0.68 112.169 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.3 tp -119.93 122.14 40.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.541 . . . . 0.46 110.999 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -88.64 89.83 8.15 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.231 -0.655 . . . . 0.44 109.231 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.1 p -65.87 134.95 54.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.004 -0.544 . . . . 0.73 111.725 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.93 -55.06 6.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.79 -0.641 . . . . 0.56 110.588 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.33 -76.52 0.17 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.442 -0.663 . . . . 0.72 111.442 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -99.95 125.57 45.99 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.955 -0.387 . . . . 1.26 109.955 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -94.46 166.62 11.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.067 -0.515 . . . . 1.57 110.659 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -58.28 -56.71 18.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.98 -0.554 . . . . 1.38 110.012 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -116.02 144.79 43.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.909 -0.587 . . . . 0.81 109.609 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -31.44 72.64 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.534 -0.303 . . . . 0.63 111.13 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.79 -27.89 69.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.32 111.458 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 81.7 mtp -68.89 -30.68 69.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.19 -0.459 . . . . 0.69 109.937 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.643 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . 24.6 ttp180 -65.6 -45.09 84.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.025 -0.534 . . . . 0.9 109.672 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 67.3 m-20 -65.53 -30.55 71.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.469 -0.787 . . . . 1.41 110.255 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -58.24 -58.94 6.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.732 -0.667 . . . . 1.51 111.636 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.643 ' CE2' ' HA ' ' A' ' 68' ' ' ARG . 10.4 p90 -67.47 -21.42 65.53 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.373 -0.531 . . . . 1.17 112.104 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.5 mtt -77.19 -31.14 55.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.116 0.484 . . . . 0.7 110.637 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 39.8 mtm180 -77.62 -48.08 17.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.958 0.409 . . . . 1.29 110.532 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 m -73.69 -14.13 61.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.703 -0.681 . . . . 0.72 111.614 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.75 120.39 9.84 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.7 -0.762 . . . . 0.19 111.633 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -89.71 -32.68 16.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.964 0.411 . . . . 0.54 110.161 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -137.37 130.29 5.06 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.421 -0.672 . . . . 0.26 111.421 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.488 ' HB2' ' HG2' ' A' ' 111' ' ' MET . 88.3 m-85 -116.34 126.11 53.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.085 0.443 . . . . 0.48 110.999 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.448 HD12 ' HB ' ' A' ' 112' ' ' VAL . 12.3 tp -96.51 106.5 18.76 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.066 -0.716 . . . . 0.37 109.066 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 56.9 m -83.79 107.46 16.21 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.737 -0.468 . . . . 0.61 109.737 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 19' ' ' LEU . 17.2 t -112.36 142.05 25.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.073 0.463 . . . . 0.59 111.952 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -142.79 167.08 22.92 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.499 -0.926 . . . . 0.34 108.499 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.86 132.48 50.08 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.056 -0.35 . . . . 0.32 110.056 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 118' ' ' CYS . 3.3 pt -67.6 -13.23 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.514 -0.312 . . . . 0.78 111.362 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -107.93 23.1 14.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.286 0.565 . . . . 0.82 110.554 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -150.31 98.08 2.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 1.07 110.477 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -31.28 71.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.083 -0.508 . . . . 0.65 111.94 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -62.84 -38.89 92.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.525 -0.307 . . . . 0.89 110.554 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 82.8 p -69.83 -23.79 63.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.993 0.425 . . . . 0.64 110.567 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -77.61 -39.38 45.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.83 -0.623 . . . . 0.42 109.652 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -74.0 -30.5 62.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 1.44 110.201 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -29.86 68.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.095 -0.502 . . . . 1.02 110.558 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.6 mm -57.58 -34.37 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.549 -0.75 . . . . 0.42 111.779 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -60.54 -45.44 93.88 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.579 -0.526 . . . . 0.83 109.579 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -69.29 -34.71 75.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.536 -0.756 . . . . 0.79 110.965 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -65.59 -51.26 61.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.728 -0.214 . . . . 1.17 110.92 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -59.37 -36.97 76.73 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.235 0.54 . . . . 0.6 110.275 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -70.58 -50.74 34.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.528 -0.76 . . . . 1.35 111.701 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -59.49 -49.46 77.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.967 0.358 . . . . 1.15 111.967 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 81.2 mt -61.67 -39.6 83.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.294 . . . . 0.51 111.243 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -66.85 -30.06 70.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.923 0.392 . . . . 1.05 110.744 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -76.66 -43.24 38.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.821 -0.627 . . . . 0.91 110.757 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.0 t -65.38 -45.48 93.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.035 -0.53 . . . . 0.35 110.801 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -79.32 -15.89 57.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.872 0.368 . . . . 0.63 110.528 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.4 t70 55.73 70.81 0.6 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.191 -0.913 . . . . 0.47 110.811 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.7 t -164.12 -172.01 2.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.657 -0.701 . . . . 1.14 109.818 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -125.41 -55.21 1.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.085 0.469 . . . . 1.74 109.865 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -77.51 91.79 3.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.801 -0.636 . . . . 0.78 110.239 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.4 t -118.45 113.13 36.92 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.828 -0.623 . . . . 0.47 109.939 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.74 111.13 0.48 Allowed 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 123.232 2.621 . . . . 0.25 113.131 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.488 ' HG2' ' HB2' ' A' ' 78' ' ' PHE . 46.3 mtt -144.25 157.44 44.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.89 -0.595 . . . . 0.79 110.491 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.448 ' HB ' HD12 ' A' ' 79' ' ' LEU . 86.1 t -135.38 124.45 40.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.053 -0.721 . . . . 0.22 109.053 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 141' ' ' PHE . 20.5 tp -80.24 116.52 20.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.443 -0.577 . . . . 0.29 109.443 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 47.4 t -119.03 123.06 70.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.105 0.479 . . . . 0.82 111.608 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -99.11 114.76 5.12 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.192 -1.163 . . . . 0.27 110.192 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -97.32 166.06 11.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.83 0.348 . . . . 0.21 110.962 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.6 mttt 68.45 26.06 6.69 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.512 -0.767 . . . . 0.54 111.632 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 84' ' ' ILE . 24.8 p -67.32 -19.35 65.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.935 0.398 . . . . 0.46 110.802 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -79.74 -14.25 58.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.872 -0.603 . . . . 0.7 110.398 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 54.8 mt -85.72 151.58 55.61 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.128 -0.487 . . . . 0.67 109.715 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 1.4 Cg_endo -81.46 -176.63 3.18 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.968 2.445 . . . . 0.54 112.366 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 m 61.2 54.09 3.37 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.987 -0.551 . . . . 0.84 110.939 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 14.1 ttm-85 -63.79 112.03 2.7 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.673 -0.694 . . . . 0.58 110.3 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.03 -40.19 13.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.835 -0.621 . . . . 0.81 110.55 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.9 t -95.28 119.3 43.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.417 -0.356 . . . . 0.37 110.219 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -74.96 155.64 37.18 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.146 0.498 . . . . 1.69 111.482 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -38.45 83.76 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.48 -0.782 . . . . 0.82 110.958 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -69.4 -36.6 76.9 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.039 -0.528 . . . . 0.62 111.011 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -59.04 -43.02 91.6 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.087 0.47 . . . . 0.93 110.554 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.1 -40.37 60.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.887 -0.597 . . . . 0.3 110.461 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -61.95 -39.29 91.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.013 -0.54 . . . . 0.47 109.938 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.42 ' HA ' ' HD2' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -63.7 -40.56 97.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.559 -0.746 . . . . 1.18 110.578 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.8 tp -68.57 -41.39 79.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.755 -0.657 . . . . 0.44 110.937 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.54 -33.44 75.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.25 110.512 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 135' ' ' ARG . 63.8 mtt-85 -58.69 -55.52 34.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.709 -0.678 . . . . 1.54 111.623 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -42.79 96.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.081 0.467 . . . . 0.68 111.899 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -68.63 -22.34 64.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 0.77 111.051 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.36 43.2 46.89 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.968 -0.56 . . . . 0.25 112.409 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 31.3 pt -136.95 161.71 59.97 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.996 -0.372 . . . . 0.51 109.996 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.01 156.13 42.92 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.707 2.271 . . . . 0.36 112.505 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 5.7 t80 -135.37 125.15 25.45 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.572 -0.529 . . . . 0.38 109.572 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.7 mt -135.71 130.46 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.921 -0.312 . . . . 0.54 111.217 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -84.18 123.77 30.45 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.063 -1.088 . . . . 0.88 108.063 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.503 HG22 ' HA3' ' A' ' 151' ' ' GLY . 43.0 p -133.79 177.23 7.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.151 0.501 . . . . 0.43 111.252 -177.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.1 t -156.58 124.39 5.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.821 -0.627 . . . . 0.33 110.094 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.36 -12.95 60.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.29 0.566 . . . . 0.45 110.088 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.9 tttm -79.76 -53.16 7.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.574 -0.739 . . . . 1.32 110.743 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.8 p -83.27 -17.34 42.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.295 -0.411 . . . . 0.52 110.844 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.1 ttt180 70.3 21.27 5.86 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.932 0.77 . . . . 1.53 109.951 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -91.34 122.63 34.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.011 -0.54 . . . . 0.87 110.584 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.503 ' HA3' HG22 ' A' ' 144' ' ' THR . . . 91.7 -4.34 79.05 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.51 112.796 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 71.8 t -58.37 -59.99 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.666 0.247 . . . . 0.74 111.666 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.68 -47.61 84.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 1.62 110.834 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -56.16 -46.32 79.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.59 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -58.96 -53.66 55.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.869 0.322 . . . . 0.37 111.869 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.545 ' O ' HG23 ' A' ' 160' ' ' VAL . 50.4 m-85 -61.07 -49.57 76.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.421 -0.354 . . . . 1.46 111.458 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -59.42 -39.51 83.72 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.338 -0.392 . . . . 0.99 111.748 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.546 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 95.9 m -61.06 -44.45 97.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.527 -0.306 . . . . 0.34 110.86 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 35.2 tp -65.14 -36.44 84.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.713 -0.221 . . . . 0.42 111.174 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 156' ' ' PHE . 49.0 t -59.69 -41.02 83.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.194 0.521 . . . . 0.55 110.235 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -77.15 -23.62 51.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.812 -0.631 . . . . 0.9 110.916 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 158' ' ' THR . 52.6 mm-40 -64.76 -43.77 92.22 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.792 0.33 . . . . 0.73 110.379 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.427 ' H ' HG13 ' A' ' 163' ' ' ILE . 12.1 mt -65.15 -38.95 83.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.047 -0.524 . . . . 0.42 111.015 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 75.8 mtt180 -59.27 -38.8 81.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.769 -0.65 . . . . 0.87 110.991 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 162' ' ' GLU . 49.0 mtmt -62.62 -39.12 92.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.063 -0.517 . . . . 0.97 111.061 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -75.28 -34.6 61.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.299 -0.41 . . . . 0.71 110.562 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -73.06 -30.79 63.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.586 -0.279 . . . . 1.11 111.408 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -101.86 11.58 38.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.853 0.359 . . . . 1.12 110.736 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.7 tttp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.626 -0.702 . . . . 1.47 110.951 -179.204 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.581 HO2' ' HZ ' ' A' ' 28' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' QPD . . . . . 0.475 ' C8 ' ' C14' ' A' ' 203' ' ' QPD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.5 ttm . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 110.36 -0.237 . . . . 1.48 110.36 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.2 m -92.91 134.89 34.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.496 -0.32 . . . . 1.04 110.674 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -87.71 127.14 35.3 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.808 -0.441 . . . . 1.27 109.808 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -112.46 128.02 56.21 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.849 -0.426 . . . . 1.11 109.849 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -97.04 122.83 40.47 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.129 -0.487 . . . . 0.81 111.332 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mp -129.75 137.79 50.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.923 -0.581 . . . . 1.39 110.7 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.6 t -124.15 128.1 73.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.261 -0.427 . . . . 0.81 110.276 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.2 t -89.18 124.12 41.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.194 -0.669 . . . . 0.44 109.194 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 96' ' ' TYR . 9.8 m -115.77 148.95 18.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.606 -0.27 . . . . 0.7 110.587 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.38 178.24 38.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.985 -0.626 . . . . 0.53 112.101 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -78.24 168.68 19.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.996 0.427 . . . . 0.58 111.306 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.7 104.67 1.91 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.943 -0.646 . . . . 0.8 112.448 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.49 4.0 10.05 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.494 -0.86 . . . . 0.42 112.77 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 11' ' ' ALA . 15.9 m -74.3 -29.32 24.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.913 0.387 . . . . 0.57 111.25 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.85 22.06 5.14 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.678 -0.772 . . . . 0.49 113.788 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HB2' ' O3B' ' A' ' 201' ' ' GDP . 54.4 mtmt -52.78 -50.19 64.07 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.983 0.392 . . . . 0.81 110.933 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.4 ' O ' HG13 ' A' ' 21' ' ' ILE . 3.2 m -63.85 -43.42 96.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.722 0.296 . . . . 0.58 111.507 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.71 -48.41 79.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.857 0.317 . . . . 0.43 111.857 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.637 ' HG ' ' HB2' ' A' ' 146' ' ' ALA . 2.6 mt -65.29 -36.25 83.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.731 0.3 . . . . 0.92 111.237 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.4 m -70.16 -42.04 73.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.662 0.267 . . . . 0.89 111.024 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.46 HG21 HG21 ' A' ' 29' ' ' VAL . 82.4 mt -68.87 -31.86 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.407 . . . . 0.79 109.946 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.568 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 4.4 mm-40 -63.67 -21.43 66.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.98 -0.555 . . . . 0.46 111.599 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.7 tp -92.2 -14.98 28.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.139 0.495 . . . . 1.37 110.864 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.6 mm -104.3 -64.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.075 -0.511 . . . . 0.58 111.119 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -84.62 -7.61 59.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 1.68 110.823 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.6 OUTLIER 56.38 30.03 16.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.577 0.955 . . . . 1.6 113.577 177.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -142.2 146.4 35.19 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.932 -0.307 . . . . 0.74 110.36 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -68.01 143.07 55.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.12 -0.491 . . . . 0.6 111.427 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 21' ' ' ILE . 35.1 t -130.88 99.2 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.153 -0.684 . . . . 0.64 109.153 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.473 ' HA ' " O2'" ' A' ' 201' ' ' GDP . 7.3 t70 -75.58 -41.46 54.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.15 -0.477 . . . . 1.12 111.122 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -94.31 97.46 10.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.216 0.531 . . . . 1.18 111.412 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -151.51 136.53 17.38 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.877 -0.786 . . . . 0.6 108.877 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -72.1 126.48 91.19 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.963 0.411 . . . . 0.8 111.494 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -65.82 -28.0 51.38 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.914 2.409 . . . . 0.52 112.83 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.24 -12.57 60.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.876 -0.602 . . . . 0.89 111.645 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -77.29 121.87 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.279 0.562 . . . . 0.73 110.34 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 15.3 tt0 -114.26 127.03 55.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.824 -1.08 . . . . 0.81 108.777 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -146.33 154.15 41.34 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.302 0.572 . . . . 1.29 111.403 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.4 129.17 53.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.483 -0.78 . . . . 0.78 109.953 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -117.83 147.49 43.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.747 0.308 . . . . 0.94 110.885 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.537 ' HD2' ' OD2' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -119.83 138.52 53.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.56 110.415 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -146.42 122.09 10.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.271 -0.422 . . . . 1.46 110.775 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.69 116.65 29.17 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.52 -0.548 . . . . 1.89 109.52 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.52 136.87 59.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.09 -0.504 . . . . 1.09 111.204 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 t -91.58 74.53 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.847 -0.797 . . . . 0.65 108.847 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.1 mt -82.9 113.54 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.604 -0.725 . . . . 1.06 111.332 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 65.95 28.84 10.48 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.319 -0.855 . . . . 0.97 111.012 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.59 -12.4 67.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.131 -0.556 . . . . 0.6 112.515 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -93.97 111.03 22.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.746 0.308 . . . . 1.41 111.053 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -73.32 104.59 4.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.137 0.494 . . . . 0.63 109.853 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.8 m -114.74 143.85 44.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.094 0.473 . . . . 0.71 111.081 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 tp -102.47 109.65 21.36 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.653 -0.869 . . . . 0.48 108.653 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 48.7 mt -82.63 117.77 22.83 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.289 -0.414 . . . . 0.87 111.654 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.537 ' OD2' ' HD2' ' A' ' 41' ' ' ARG . 15.1 t70 -101.03 86.07 2.97 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.529 -1.285 . . . . 1.03 107.529 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.1 mt -97.94 150.4 4.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.651 -0.704 . . . . 0.68 112.238 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 tp -137.84 130.4 29.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 0.46 111.02 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 3.9 t70 -91.91 107.48 19.24 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.574 -0.528 . . . . 0.44 109.574 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.8 p -72.53 137.36 46.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.146 0.498 . . . . 0.73 111.981 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.33 -37.8 66.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.542 -0.754 . . . . 0.56 110.209 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.88 -58.9 0.7 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.981 -0.628 . . . . 0.72 111.896 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -108.98 140.67 42.16 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.358 -0.608 . . . . 1.26 109.358 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -106.14 165.86 10.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 1.57 111.256 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -79.13 -42.06 27.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.113 -1.069 . . . . 1.38 108.113 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -126.42 129.67 49.19 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.854 -1.066 . . . . 0.81 109.155 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.41 -33.34 65.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.211 -0.449 . . . . 0.63 111.461 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.12 -35.15 77.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.196 -0.456 . . . . 0.32 111.205 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 87.9 mtp -69.66 -35.89 75.57 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.887 0.375 . . . . 0.69 110.849 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -66.37 -44.56 82.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.829 -0.623 . . . . 0.9 110.24 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 81.0 m-20 -80.69 -10.13 59.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.896 -0.593 . . . . 1.41 110.677 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -66.8 -58.45 5.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 1.51 110.639 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -67.16 -17.75 64.98 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.01 0.434 . . . . 1.17 111.336 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 46.0 mtt -69.07 -26.97 65.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.062 -0.517 . . . . 0.7 110.187 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 72.4 mtm180 -84.86 -42.94 14.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.055 -0.52 . . . . 1.29 110.345 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -27.39 61.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.771 -0.649 . . . . 0.72 111.812 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.91 139.79 43.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.962 -0.637 . . . . 0.19 112.692 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -93.57 -53.6 3.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.787 0.327 . . . . 0.54 110.945 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -122.76 138.43 11.8 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.716 -0.754 . . . . 0.26 111.763 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' A' ' 111' ' ' MET . 79.6 m-85 -117.96 135.27 54.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.172 0.51 . . . . 0.48 111.059 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.3 tp -101.86 113.86 27.43 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.717 -0.674 . . . . 0.37 109.866 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 3.6 m -89.44 89.45 7.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.039 -0.528 . . . . 0.61 110.579 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 11.8 t -96.86 129.63 46.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.017 -0.538 . . . . 0.59 111.189 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -129.78 179.21 5.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.175 -0.676 . . . . 0.34 109.175 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . . . -112.58 130.67 55.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.782 0.325 . . . . 0.32 110.457 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.427 ' HB ' ' HG3' ' A' ' 123' ' ' ARG . 3.1 pt -66.83 -19.3 25.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.099 -0.5 . . . . 0.78 111.505 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -104.99 15.64 27.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.145 0.498 . . . . 0.82 110.818 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.476 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 43.1 t-20 -140.44 92.75 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 1.07 110.218 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -25.46 68.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.33 -0.395 . . . . 0.65 111.349 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -67.81 -32.43 72.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.586 -0.279 . . . . 0.89 110.473 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.5 p -72.19 -30.44 64.95 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.979 -0.748 . . . . 0.64 108.979 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -69.62 -29.91 67.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.433 -0.803 . . . . 0.42 109.619 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.79 -38.52 73.37 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.728 -0.669 . . . . 1.44 110.101 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.19 -29.04 70.17 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.551 -0.749 . . . . 1.02 110.278 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.5 mm -56.21 -36.2 45.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.636 -0.711 . . . . 0.42 110.38 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -64.91 -36.32 84.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.639 . . . . 0.83 111.357 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -80.96 -32.2 34.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.347 -0.388 . . . . 0.79 111.032 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.496 ' CE1' ' HB ' ' A' ' 9' ' ' VAL . 3.6 m-85 -61.21 -51.04 70.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.496 0.188 . . . . 1.17 111.228 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.592 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 22.6 tpt180 -62.04 -30.03 70.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.313 0.577 . . . . 0.6 110.42 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -76.36 -53.06 8.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.247 -0.888 . . . . 1.35 111.98 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 103' ' ' VAL . 51.3 tt0 -62.37 -58.08 8.98 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.114 0.412 . . . . 1.15 112.114 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.5 mt -54.07 -39.74 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.914 0.338 . . . . 0.51 111.914 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 6.1 ttpt -66.36 -35.95 81.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.789 0.328 . . . . 1.05 110.802 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -76.8 -26.47 54.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.066 0.46 . . . . 0.91 110.534 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 99' ' ' GLN . 67.5 t -77.16 -40.63 30.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.35 110.02 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -80.24 -26.46 39.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.382 -0.372 . . . . 0.63 110.757 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 t70 66.73 51.01 1.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.641 -0.709 . . . . 0.47 110.34 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.94 163.14 31.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.552 -0.749 . . . . 1.14 109.893 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -96.72 -42.21 8.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.839 0.352 . . . . 1.74 110.152 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -102.1 116.35 32.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.013 -0.54 . . . . 0.78 110.039 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.4 t -127.96 122.08 22.14 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.097 -0.501 . . . . 0.47 109.794 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.57 104.23 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.787 2.325 . . . . 0.25 111.667 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.455 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 31.7 mtt -139.18 151.8 46.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.7 -0.682 . . . . 0.79 110.159 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.8 t -136.96 126.3 37.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.451 -0.574 . . . . 0.22 109.451 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 41.0 tp -81.81 122.33 27.56 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.641 -0.503 . . . . 0.29 109.641 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 142' ' ' ILE . 95.3 t -124.07 127.95 73.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.091 -0.504 . . . . 0.82 111.673 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.41 102.17 2.25 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.659 -0.976 . . . . 0.27 110.659 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 144' ' ' THR . 65.6 t30 -86.41 165.82 16.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.703 0.251 . . . . 0.21 110.356 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 69.76 29.8 4.01 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.861 0.726 . . . . 0.54 110.552 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 30.8 p -67.72 -11.91 59.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.879 -0.6 . . . . 0.46 111.38 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -87.17 -8.36 57.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.692 0.282 . . . . 0.7 110.731 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 43.0 mt -85.36 148.64 50.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.67 110.936 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.31 -177.77 3.66 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.611 2.207 . . . . 0.54 111.619 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.2 m 58.09 55.19 5.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.118 0.485 . . . . 0.84 111.055 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.427 ' HG3' ' HB ' ' A' ' 84' ' ' ILE . 16.5 ttm180 -66.97 109.71 3.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.878 -0.601 . . . . 0.58 109.9 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.01 -42.45 16.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.002 0.429 . . . . 0.81 110.619 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.31 112.53 22.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.262 -0.426 . . . . 0.37 109.875 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.89 148.13 52.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.893 0.378 . . . . 1.69 110.679 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.22 -39.51 79.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.896 -0.593 . . . . 0.82 112.34 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -68.81 -37.58 79.33 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 120.88 -0.328 . . . . 0.62 110.902 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -56.13 -43.91 78.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.763 0.316 . . . . 0.93 111.43 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.32 -46.47 55.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.911 -0.586 . . . . 0.3 110.894 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -59.96 -44.83 94.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.47 110.418 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -61.81 -42.9 99.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.462 -0.79 . . . . 1.18 110.498 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.22 -41.2 90.43 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.992 -0.549 . . . . 0.44 110.722 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.89 -35.26 80.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.365 -0.38 . . . . 0.25 110.346 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -63.87 -43.58 95.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 1.54 111.519 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.19 -17.96 65.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.637 0.256 . . . . 0.68 111.566 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -100.59 -8.12 23.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.236 -0.438 . . . . 0.77 110.214 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.8 31.25 70.16 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.762 -0.654 . . . . 0.25 112.583 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 44.1 pt -121.58 153.37 59.42 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 122.798 -0.236 . . . . 0.51 110.454 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.01 156.13 56.44 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.883 2.388 . . . . 0.36 112.856 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -128.6 120.85 27.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 0.38 109.56 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 73.8 mt -132.88 138.25 52.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.757 0.313 . . . . 0.54 111.038 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -93.57 126.72 38.88 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.288 -0.634 . . . . 0.88 109.288 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 116' ' ' ASN . 32.1 p -131.67 166.07 22.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.255 0.55 . . . . 0.43 111.257 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.2 t -146.33 122.38 10.75 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.496 -0.928 . . . . 0.33 108.496 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.637 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . . . -70.0 -10.79 59.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.103 0.478 . . . . 0.45 110.863 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -89.0 -48.02 7.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.758 -0.656 . . . . 1.32 111.476 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.0 p -93.56 -17.27 23.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.582 0.586 . . . . 0.52 112.582 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.448 ' HA ' HG21 ' A' ' 152' ' ' VAL . 0.5 OUTLIER 69.77 21.75 6.33 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.946 -0.57 . . . . 1.53 110.765 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 144' ' ' THR . 6.5 tt0 -73.9 120.27 19.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.639 -0.709 . . . . 0.87 110.809 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 66.44 6.66 35.64 Favored Glycine 0 CA--C 1.516 0.111 0 CA-C-N 116.072 -0.513 . . . . 0.51 113.633 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 149' ' ' ARG . 18.3 t -61.01 -61.04 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.521 0.2 . . . . 0.74 111.455 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.93 -37.9 83.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 1.62 110.51 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -56.93 -45.22 82.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.769 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -58.33 -47.79 82.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.37 111.266 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.434 ' O ' HG23 ' A' ' 160' ' ' VAL . 72.6 m-85 -64.55 -44.35 91.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.185 -0.461 . . . . 1.46 110.944 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -60.0 -37.02 78.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.99 111.296 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 162' ' ' GLU . 19.3 m -65.42 -53.69 39.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.138 -0.483 . . . . 0.34 111.355 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.544 ' O ' HG13 ' A' ' 163' ' ' ILE . 14.0 tp -57.59 -35.8 70.89 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.702 0.287 . . . . 0.42 111.111 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 156' ' ' PHE . 38.3 t -58.36 -40.75 79.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.029 0.443 . . . . 0.55 110.733 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -78.96 -30.2 44.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.962 -0.563 . . . . 0.9 111.327 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 158' ' ' THR . 7.6 mm-40 -62.16 -40.89 97.5 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.854 -0.424 . . . . 0.73 109.854 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 159' ' ' LEU . 52.8 mt -63.36 -43.99 98.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.717 -0.674 . . . . 0.42 110.13 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 96.4 mtt180 -56.85 -49.43 75.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.785 -0.643 . . . . 0.87 111.068 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 169' ' ' LYS . 41.3 mtmt -57.36 -34.33 68.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.317 -0.401 . . . . 0.97 111.606 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -74.58 -37.26 62.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.486 -0.325 . . . . 0.71 110.692 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.449 ' HD2' HG22 ' A' ' 163' ' ' ILE . 47.2 mtpt -75.82 -33.0 60.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.4 -0.364 . . . . 1.11 111.903 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 10.3 pt-20 -92.49 7.4 43.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.952 0.406 . . . . 1.12 110.745 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 165' ' ' LYS . 30.7 tttp . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.245 -0.883 . . . . 1.47 110.128 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.473 " O2'" ' HA ' ' A' ' 30' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' QPD . . . . . 0.492 ' O1 ' ' C14' ' A' ' 203' ' ' QPD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.6 ttm . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 109.926 -0.398 . . . . 1.48 109.926 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.7 m -94.48 134.7 36.73 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.048 -0.352 . . . . 1.04 110.048 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -85.71 129.98 34.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.914 -0.585 . . . . 1.27 110.496 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 51' ' ' CYS . 61.5 m-85 -125.57 115.65 20.51 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.816 -0.438 . . . . 1.11 109.816 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -100.48 113.85 26.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.158 0.504 . . . . 0.81 110.272 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.14 138.46 52.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.717 -0.674 . . . . 1.39 110.895 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.41 ' HB ' ' CD2' ' A' ' 78' ' ' PHE . 39.2 t -118.01 132.41 67.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.327 -0.397 . . . . 0.81 110.637 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 t -94.86 113.56 29.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.871 -0.789 . . . . 0.44 108.871 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 m -114.8 166.56 8.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.921 0.391 . . . . 0.7 111.291 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.19 -170.31 30.86 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.013 -0.835 . . . . 0.53 111.013 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.53 172.16 14.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.241 0.543 . . . . 0.58 110.85 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.74 128.09 8.96 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.701 -0.761 . . . . 0.8 112.595 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.99 13.32 72.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.899 -0.667 . . . . 0.42 114.02 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.4 m -73.41 -29.71 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 117.644 0.722 . . . . 0.57 111.031 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.48 20.41 2.65 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.351 -0.928 . . . . 0.49 113.84 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -54.68 -58.85 5.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.956 0.408 . . . . 0.81 110.97 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.454 ' HB2' ' O2A' ' A' ' 201' ' ' GDP . 1.2 m -54.28 -47.76 71.99 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.603 -0.726 . . . . 0.58 111.829 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.17 84.31 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.677 0.251 . . . . 0.43 111.677 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.3 mt -63.83 -40.63 97.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 0.92 110.524 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.9 m -72.04 -43.78 64.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.158 -0.474 . . . . 0.89 110.66 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.74 -42.11 87.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.046 -0.525 . . . . 0.79 110.915 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.555 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 4.3 mm-40 -64.02 -20.79 66.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.46 111.338 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.2 tp -91.44 -39.78 11.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.918 0.389 . . . . 1.37 111.147 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.7 mm -81.51 -50.66 16.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.263 -0.426 . . . . 0.58 112.104 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . 52.1 mt-30 -92.29 -16.49 26.03 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.931 0.345 . . . . 1.68 111.931 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 3.7 m-80 66.42 27.51 9.87 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.735 0.643 . . . . 1.6 112.735 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 25' ' ' GLN . 15.0 p80 -153.04 144.1 23.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.135 -0.32 . . . . 0.74 110.135 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -68.83 142.67 54.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.182 -0.463 . . . . 0.6 111.945 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 70.5 t -130.6 114.84 29.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 109.168 -0.679 . . . . 0.64 109.168 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -78.56 -42.72 28.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.926 -0.579 . . . . 1.12 111.26 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -100.49 102.16 13.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.297 -0.41 . . . . 1.18 111.948 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -155.19 117.59 4.23 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.65 -0.87 . . . . 0.6 108.65 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -52.32 122.43 24.77 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.52 0.676 . . . . 0.8 111.618 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.61 -18.14 15.62 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.685 2.257 . . . . 0.52 113.37 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.575 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -87.09 12.5 11.33 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.282 0.475 . . . . 0.89 112.282 -178.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.5 mt -99.71 105.64 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.244 0.545 . . . . 0.73 110.204 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 3.7 tt0 -86.48 87.0 7.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.878 -0.601 . . . . 0.81 109.535 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.81 161.69 14.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.626 -0.716 . . . . 1.29 110.583 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 10.4 p -131.18 144.71 51.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.194 -0.457 . . . . 0.78 110.351 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -126.39 149.17 49.4 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.218 -0.446 . . . . 0.94 111.083 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 1.7 mpp_? -123.75 123.8 41.3 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.35 -0.386 . . . . 0.56 110.458 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -144.62 124.97 13.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.846 0.355 . . . . 1.46 110.281 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -86.53 119.93 27.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.002 0.429 . . . . 1.89 110.548 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.3 t -129.53 141.08 47.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.925 -0.58 . . . . 1.09 110.166 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.7 t -87.64 106.35 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.78 -0.452 . . . . 0.65 109.78 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 32.6 mt -110.6 115.24 49.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.198 -0.455 . . . . 1.06 110.403 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 61.32 43.95 10.17 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.632 0.582 . . . . 0.97 111.334 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.1 27.77 71.43 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.88 -0.6 . . . . 0.6 113.317 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -137.74 120.94 16.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.93 0.365 . . . . 1.41 111.254 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -75.25 103.32 5.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.862 0.363 . . . . 0.63 110.238 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 4' ' ' TYR . 11.5 m -110.44 137.33 48.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.471 -0.331 . . . . 0.71 111.751 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.2 tp -92.03 111.55 23.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.149 -1.056 . . . . 0.48 108.149 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 60.2 mt -89.97 114.02 25.78 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.052 0.76 . . . . 0.87 113.052 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -106.0 101.5 10.99 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.765 -1.198 . . . . 1.03 107.765 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.5 mt -107.0 141.66 21.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.255 -0.429 . . . . 0.68 111.727 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.449 ' HB2' ' N1 ' ' A' ' 203' ' ' QPD . 58.7 tp -122.37 125.91 46.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.792 -0.64 . . . . 0.46 111.108 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 7.0 t70 -92.48 101.89 14.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.25 -0.648 . . . . 0.44 109.25 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.4 p -67.35 134.76 52.12 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.482 0.658 . . . . 0.73 112.184 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' A' ' 35' ' ' THR . . . -89.45 -37.94 14.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.218 -0.901 . . . . 0.56 110.067 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 142.84 -94.9 0.18 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.84 -0.695 . . . . 0.72 112.531 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -101.78 118.23 36.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.159 0.504 . . . . 1.26 111.212 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.2 167.37 14.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.508 -0.769 . . . . 1.57 109.275 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -54.19 -52.84 59.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 1.38 110.913 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -117.41 141.0 48.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.122 -0.49 . . . . 0.81 110.239 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -63.19 -29.04 70.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.879 0.371 . . . . 0.63 111.03 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.84 -26.34 68.29 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.011 -0.54 . . . . 0.32 110.347 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 71.8 mtp -72.8 -37.7 67.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.675 -0.693 . . . . 0.69 109.595 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.602 ' HA ' ' CZ ' ' A' ' 71' ' ' TYR . 30.7 ttp180 -70.49 -43.92 68.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.866 -0.606 . . . . 0.9 109.967 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -28.3 67.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.427 -0.806 . . . . 1.41 110.636 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -56.22 -65.08 0.67 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.424 -0.807 . . . . 1.51 112.088 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.602 ' CZ ' ' HA ' ' A' ' 68' ' ' ARG . 3.5 p90 -69.1 -18.71 64.01 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.337 0.495 . . . . 1.17 112.337 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 32.8 mtt -71.45 -26.76 62.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.304 0.573 . . . . 0.7 109.927 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -90.03 -28.7 18.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.205 -0.452 . . . . 1.29 110.925 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -86.53 -26.24 24.65 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.084 0.402 . . . . 0.72 112.084 -179.169 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.26 125.82 24.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.798 -0.715 . . . . 0.19 111.96 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -83.34 -41.49 18.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.78 0.324 . . . . 0.54 110.234 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -129.65 133.26 7.4 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.535 -0.626 . . . . 0.26 111.535 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.41 ' CD2' ' HB ' ' A' ' 7' ' ' VAL . 94.1 m-85 -114.5 122.39 46.43 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.053 0.454 . . . . 0.48 110.934 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.503 HD12 ' HB ' ' A' ' 112' ' ' VAL . 11.7 tp -88.05 112.0 22.15 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.102 -0.703 . . . . 0.37 109.102 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.2 m -90.54 101.16 13.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.858 0.361 . . . . 0.61 110.428 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.3 t -103.01 131.92 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.259 -0.428 . . . . 0.59 111.54 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -134.19 171.06 14.76 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.978 -0.749 . . . . 0.34 108.978 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.54 ' HB3' ' HB3' ' A' ' 86' ' ' ASN . . . -103.77 126.64 51.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.856 0.36 . . . . 0.32 110.824 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.6 pt -68.64 -16.61 21.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.78 111.074 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -106.97 24.1 13.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.274 -0.421 . . . . 0.82 110.932 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.54 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 28.5 t-20 -156.46 102.17 2.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.07 -0.514 . . . . 1.07 110.116 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.18 -23.34 66.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.978 -0.555 . . . . 0.65 111.833 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.452 ' HB3' ' OD1' ' A' ' 86' ' ' ASN . 51.2 tptt -56.01 -50.87 69.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.313 -0.403 . . . . 0.89 110.862 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.3 p -63.43 -41.4 98.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.64 111.156 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -61.52 -40.89 96.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.265 -0.425 . . . . 0.42 111.142 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -74.85 -11.7 60.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.237 -0.438 . . . . 1.44 111.587 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.52 -20.05 23.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.094 0.473 . . . . 1.02 110.271 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.8 mm -58.91 -29.88 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.526 -0.761 . . . . 0.42 110.794 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -59.19 -52.0 67.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.83 109.821 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -65.16 -32.4 74.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.474 -0.784 . . . . 0.79 111.101 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -65.95 -50.23 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.458 0.17 . . . . 1.17 110.856 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -60.05 -46.2 90.32 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.523 -0.547 . . . . 0.6 109.523 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.42 -47.92 84.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.767 -0.651 . . . . 1.35 111.075 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.518 ' O ' HG23 ' A' ' 103' ' ' VAL . 16.5 tt0 -58.88 -58.84 6.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.834 -0.621 . . . . 1.15 111.76 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.3 mt -55.83 -37.61 48.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.522 -0.308 . . . . 0.51 111.659 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -65.75 -37.51 86.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.532 0.206 . . . . 1.05 110.921 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.0 -33.38 51.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.91 111.07 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 99' ' ' GLN . 93.5 t -66.82 -45.13 88.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.064 0.459 . . . . 0.35 110.285 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -81.46 -26.29 35.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.14 -0.482 . . . . 0.63 110.354 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.6 t0 64.66 60.25 0.89 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.336 -0.847 . . . . 0.47 110.142 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.7 t -153.69 151.55 29.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.328 -0.851 . . . . 1.14 110.016 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -81.37 -42.99 19.65 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.061 -0.518 . . . . 1.74 111.081 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -97.24 117.7 32.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.055 0.455 . . . . 0.78 111.838 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 46.9 t -135.66 113.39 10.94 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.046 -0.724 . . . . 0.47 109.046 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.59 112.13 0.96 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.02 2.48 . . . . 0.25 112.369 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 50.5 mtt -141.58 156.93 45.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.949 -0.569 . . . . 0.79 110.3 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 79' ' ' LEU . 94.6 t -135.32 129.21 49.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 109.166 -0.679 . . . . 0.22 109.166 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.8 tp -85.0 115.37 22.79 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.549 -0.537 . . . . 0.29 109.549 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.1 t -114.99 117.45 55.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.815 -0.63 . . . . 0.82 111.756 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -95.92 94.6 1.7 Allowed Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.232 -1.147 . . . . 0.27 110.232 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -80.3 166.91 20.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.652 0.263 . . . . 0.21 111.415 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 69.69 33.12 3.07 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.465 -0.788 . . . . 0.54 111.064 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 18.7 p -69.61 -4.76 20.64 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.417 -0.356 . . . . 0.46 111.853 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -93.36 -11.22 32.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.463 -0.335 . . . . 0.7 110.831 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.5 mt -91.43 142.48 27.02 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.396 -0.365 . . . . 0.67 111.182 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -79.75 -169.81 0.87 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.828 2.352 . . . . 0.54 111.572 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.4 m 57.87 43.89 20.87 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.301 0.572 . . . . 0.84 110.387 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -63.33 119.03 8.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.184 -0.916 . . . . 0.58 110.126 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.86 -32.37 12.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.179 -0.464 . . . . 0.81 111.333 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 t -97.23 110.79 25.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.95 0.405 . . . . 0.37 110.396 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.16 148.46 48.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.976 -0.556 . . . . 1.69 111.044 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.04 -39.93 69.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.581 -0.736 . . . . 0.82 112.349 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -65.79 -38.83 90.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.574 0.226 . . . . 0.62 111.445 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -61.11 -42.45 98.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.906 0.384 . . . . 0.93 110.971 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.27 63.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.269 -0.423 . . . . 0.3 110.61 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 135' ' ' ARG . 6.6 tp-100 -62.38 -42.53 99.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.47 110.006 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.76 -35.46 78.18 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.077 0.465 . . . . 1.18 110.403 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.9 tp -68.83 -46.83 67.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.727 -0.669 . . . . 0.44 109.973 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.56 95.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.716 -0.674 . . . . 0.25 110.966 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 131' ' ' GLN . 24.9 mtm180 -65.31 -32.45 74.11 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.321 -0.4 . . . . 1.54 111.093 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.6 m -73.44 -29.98 62.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.91 0.385 . . . . 0.68 110.461 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -82.67 -40.08 21.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.183 0.516 . . . . 0.77 110.46 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.36 32.1 5.32 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 109.97 -1.252 . . . . 0.25 109.97 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 4.6 pt -128.34 168.35 15.91 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.338 -0.431 . . . . 0.51 110.592 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -86.55 160.12 9.4 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.532 2.155 . . . . 0.36 112.586 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -134.26 130.36 37.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.38 110.151 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.7 mt -139.28 132.41 37.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.139 -0.482 . . . . 0.54 110.985 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -82.92 129.71 35.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.728 -1.212 . . . . 0.88 107.728 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 30.9 p -137.71 173.87 11.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.512 0.672 . . . . 0.43 111.756 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.7 t -156.24 130.53 8.74 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.82 -1.082 . . . . 0.33 108.784 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.62 -8.71 57.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.224 0.535 . . . . 0.45 110.317 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -85.48 -51.9 6.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.707 -0.679 . . . . 1.32 110.914 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.7 p -91.12 -13.64 32.67 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.173 0.434 . . . . 0.52 112.173 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 149' ' ' ARG . 14.1 mtp-105 66.56 20.47 10.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.129 0.571 . . . . 1.53 110.706 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -74.24 121.16 20.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.922 -0.581 . . . . 0.87 111.814 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.26 -4.24 12.71 Favored Glycine 0 C--N 1.33 0.219 0 N-CA-C 114.99 0.756 . . . . 0.51 114.99 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.72 -51.26 74.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 117.403 0.601 . . . . 0.74 110.645 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.34 -39.06 89.19 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.283 0.563 . . . . 1.62 110.565 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.66 -42.04 98.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.557 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.45 81.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.37 110.741 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -60.08 -43.03 95.78 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.059 -0.519 . . . . 1.46 110.654 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -63.22 -45.58 90.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.849 -0.614 . . . . 0.99 111.04 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 26.5 m -62.65 -40.26 96.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.892 -0.595 . . . . 0.34 111.514 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.449 ' O ' HG13 ' A' ' 163' ' ' ILE . 37.3 tp -59.03 -40.79 86.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.932 0.396 . . . . 0.42 110.593 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.11 -38.62 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.55 110.3 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -68.86 -30.39 68.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.9 110.667 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -67.26 -44.06 80.3 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.736 -0.839 . . . . 0.73 108.736 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 159' ' ' LEU . 74.2 mt -60.74 -44.03 96.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 115.378 -0.828 . . . . 0.42 109.837 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 91.3 mtt180 -55.9 -48.66 75.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.738 -0.665 . . . . 0.87 110.805 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -61.6 -34.44 75.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.97 111.308 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -71.97 -35.99 69.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.71 110.282 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -69.62 -36.95 76.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.078 -0.51 . . . . 1.11 111.099 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 164' ' ' ARG . 9.2 pt-20 -100.38 20.16 15.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.154 -0.476 . . . . 1.12 111.065 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.1 mttp . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.598 -0.715 . . . . 1.47 109.622 179.403 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.454 ' O2A' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' QPD . . . . . 0.449 ' N1 ' ' HB2' ' A' ' 56' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_